data_2m3m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m3m _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 CA--C 1.492 -1.275 0 N-CA-C 105.766 -1.938 . . . . 73.25 105.766 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -127.12 140.39 52.3 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 113.878 1.066 . . . . 70.519999999999996 113.878 -174.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 363' ' ' GLY . 84.0 mt -129.0 116.83 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 CA-C-N 113.504 -1.68 . . . . 72.450000000000003 109.19 -174.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.5 127.33 34.86 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.836 -0.801 . . . . 74.120000000000005 108.836 175.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 80.9 mt -122.8 152.5 40.62 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.062 -0.718 . . . . 74.219999999999999 109.062 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 32.4 mm -105.76 111.51 35.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.653 -1.24 . . . . 73.129999999999995 107.653 173.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.429 ' HE3' ' HA2' ' A' ' 328' ' ' GLY . 1.4 tmtp? -75.92 141.05 42.4 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.8 -0.444 . . . . 75.310000000000002 109.8 -176.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -149.14 -154.55 6.39 Favored Glycine 0 C--N 1.301 -1.413 0 C-N-CA 120.41 -0.9 . . . . 74.25 112.646 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.66 -12.85 35.76 Favored 'Trans proline' 0 N--CA 1.484 0.926 0 C-N-CA 123.594 2.863 . . . . 62.140000000000001 113.99 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -107.39 10.66 29.51 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.427 -0.953 . . . . 62.210000000000001 108.427 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . 0.429 ' HA2' ' HE3' ' A' ' 324' ' ' LYS . . . 83.72 -133.87 12.26 Favored Glycine 0 CA--C 1.484 -1.881 0 CA-C-N 114.389 -1.278 . . . . 71.340000000000003 109.91 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.1 mp -93.38 -19.68 21.08 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.073 -1.454 . . . . 73.209999999999994 107.073 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.51 40.05 7.99 Favored Glycine 0 N--CA 1.426 -1.996 0 CA-C-N 113.869 -1.514 . . . . 75.230000000000004 115.064 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -154.92 167.8 29.1 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 117.409 0.604 . . . . 73.219999999999999 110.324 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 2.8 m -121.76 132.75 54.78 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.492 -0.559 . . . . 75.450000000000003 109.492 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 18.2 pt -113.68 154.98 14.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 116.234 -0.439 . . . . 75.140000000000001 110.978 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.45 115.38 5.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 124.68 1.238 . . . . 61.43 107.937 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 168.77 161.29 18.66 Favored Glycine 0 C--N 1.275 -2.823 0 N-CA-C 108.928 -1.669 . . . . 70.430000000000007 108.928 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.67 178.2 15.43 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 108.601 -1.8 . . . . 75.150000000000006 108.601 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.8 t -53.05 104.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.65 0.738 . . . . 72.420000000000002 110.933 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.65 -19.88 52.3 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.001 -0.999 . . . . 72.430000000000007 113.269 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.541 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 60.2 t30 -107.65 22.39 16.03 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 117.288 0.544 . . . . 75.129999999999995 110.246 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.34 119.64 4.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.263 0.554 . . . . 73.329999999999998 110.801 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -73.25 -44.82 58.77 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.149 -0.932 . . . . 74.420000000000002 109.979 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 42.7 mm -104.66 125.34 34.22 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 108.766 -0.827 . . . . 74.010000000000005 108.766 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.62 107.73 0.21 Allowed 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 123.21 2.607 . . . . 74.340000000000003 112.898 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 107.14 -7.63 37.83 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-N 115.281 -0.872 . . . . 53.229999999999997 112.362 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.419 ' CG ' ' HH ' ' A' ' 349' ' ' TYR . 8.6 t0 -125.03 98.74 5.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.941 -0.763 . . . . 74.150000000000006 108.941 -176.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -83.05 33.67 0.45 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.878 0.871 . . . . 74.5 111.511 -171.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 16.4 m -95.06 171.44 8.75 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.157 -0.474 . . . . 72.510000000000005 111.006 -177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.6 mm -83.91 127.5 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 107.678 -1.23 . . . . 72.109999999999999 107.678 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.459 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 47.6 m-85 -123.88 136.68 54.51 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.328 0.585 . . . . 60.200000000000003 112.465 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.18 113.81 5.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.796 -1.187 . . . . 71.230000000000004 107.796 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 53.2 m -102.14 -23.9 14.0 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.236 0.541 . . . . 74.319999999999993 111.276 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 94.7 mttt -151.32 156.28 40.45 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.964 -1.124 . . . . 74.129999999999995 107.964 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 78.0 mt -130.47 128.95 64.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.309 -1.367 . . . . 75.299999999999997 107.309 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 49.4 mm -85.35 141.78 14.1 Favored 'Isoleucine or valine' 0 C--O 1.256 1.419 0 C-N-CA 123.315 0.646 . . . . 74.129999999999995 111.22 -171.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.19 127.83 34.13 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.201 1.0 . . . . 74.120000000000005 111.555 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 71.71 8.9 68.86 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.534 -0.757 . . . . 72.200000000000003 112.584 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -70.46 159.75 53.63 Favored Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.831 -0.699 . . . . 71.340000000000003 111.498 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -59.15 -40.86 86.86 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.592 -0.522 . . . . 72.430000000000007 109.592 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . 0.479 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -73.01 -13.13 61.16 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.262 0.553 . . . . 63.119999999999997 112.298 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -92.53 -25.74 18.24 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.899 0.857 . . . . 72.150000000000006 109.434 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.46 ' NZ ' ' HA ' ' A' ' 361' ' ' LYS . 0.2 OUTLIER -96.57 -59.21 1.87 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 113.332 0.864 . . . . 74.430000000000007 113.332 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -86.14 -36.53 19.51 Favored 'General case' 0 CA--C 1.475 -1.913 0 N-CA-C 107.844 -1.169 . . . . 64.409999999999997 107.844 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.519 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -44.75 -35.15 4.16 Favored Glycine 0 C--O 1.201 -1.923 0 N-CA-C 118.677 2.231 . . . . 74.340000000000003 118.677 -166.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.519 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.58 29.86 0.19 Allowed 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 118.29 1.045 . . . . 72.420000000000002 111.198 -173.038 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 47.2 tp -97.64 151.8 19.73 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 125.009 1.324 . . . . 74.540000000000006 109.807 -169.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -121.1 149.19 43.13 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-O 121.409 0.623 . . . . 74.349999999999994 111.409 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 77.8 mt -65.89 121.7 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 107.622 -1.251 . . . . 73.140000000000001 107.622 172.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.4 -1.76 22.13 Favored Glycine 0 C--N 1.313 -0.734 0 C-N-CA 121.0 -0.619 . . . . 62.020000000000003 112.133 -175.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -75.16 137.11 41.1 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 113.087 0.773 . . . . 74.450000000000003 113.087 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 37.9 tttp -92.83 119.43 32.15 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 124.327 1.051 . . . . 73.010000000000005 110.453 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 78.6 mt -87.63 121.03 29.54 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 120.393 -0.523 . . . . 73.239999999999995 110.002 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.455 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 92.6 mt -82.19 -40.16 22.14 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.088 -1.415 . . . . 74.239999999999995 108.439 177.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -165.17 165.65 19.6 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.281 -0.872 . . . . 75.150000000000006 111.944 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.2 p -133.79 119.58 33.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.863 -1.162 . . . . 74.439999999999998 107.863 171.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 63.14 28.65 16.05 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 123.95 1.833 . . . . 71.329999999999998 108.406 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 66.18 17.92 10.84 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 109.726 -3.397 . . . . 75.329999999999998 112.52 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.5 t -84.14 123.63 39.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.567 -1.642 . . . . 71.230000000000004 106.567 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 10.4 p -59.49 124.04 18.77 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.163 1.172 . . . . 73.329999999999998 114.163 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . 0.414 HD23 HD11 ' A' ' 391' ' ' LEU . 5.8 mp -106.49 6.7 30.43 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.64 1.176 . . . . 73.310000000000002 110.119 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.455 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 20.1 mm-40 -71.26 110.67 6.05 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.073 -0.967 . . . . 73.230000000000004 110.902 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 54.1 66.86 1.12 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.65 1.18 . . . . 71.319999999999993 112.715 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.36 171.72 16.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.629 -1.249 . . . . 74.530000000000001 107.629 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 2.3 m -75.79 144.78 41.17 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.661 -0.866 . . . . 64.530000000000001 108.661 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . 0.587 ' O ' HG21 ' A' ' 388' ' ' VAL . 10.0 t-160 -51.88 -49.78 62.3 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 111.601 0.223 . . . . 75.140000000000001 111.601 -176.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.22 -29.52 70.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.966 0.412 . . . . 74.129999999999995 111.848 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.447 ' HB3' ' O ' ' A' ' 383' ' ' THR . 60.7 tt0 -71.52 -40.27 70.22 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.688 -1.227 . . . . 71.329999999999998 107.688 -176.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -69.59 -50.55 43.5 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.864 -1.062 . . . . 74.219999999999999 110.178 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.587 HG21 ' O ' ' A' ' 384' ' ' HIS . 40.6 t -57.38 -37.16 55.74 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 O-C-N 123.032 0.208 . . . . 74.310000000000002 111.38 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 91.5 m -62.55 -34.34 76.73 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 116.653 -0.248 . . . . 74.340000000000003 111.108 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -70.06 -35.95 74.63 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.644 0.259 . . . . 71.540000000000006 110.363 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.414 HD11 HD23 ' A' ' 379' ' ' LEU . 5.6 mp -78.51 -27.93 46.17 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 120.164 -0.614 . . . . 71.420000000000002 110.599 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 53.5 mttm -71.42 -37.24 71.49 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.85 0.685 . . . . 72.239999999999995 112.85 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -82.45 65.83 7.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.282 1.039 . . . . 74.310000000000002 110.79 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 31.0 p -137.18 146.93 45.51 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.034 -1.439 . . . . 74.319999999999993 107.506 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 42.1 m -142.78 120.39 11.79 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.71 -0.478 . . . . 73.510000000000005 109.71 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 324' ' ' LYS . 3.9 m-20 58.46 0.95 0.15 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.691 1.996 . . . . 74.400000000000006 115.694 172.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -161.61 135.57 6.74 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.416 -0.957 . . . . 74.030000000000001 108.416 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 61.4 t -142.02 133.45 26.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.682 -0.859 . . . . 74.530000000000001 108.682 177.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -107.73 96.29 6.28 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.192 -1.781 . . . . 74.310000000000002 106.192 173.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.4 tt -86.36 129.67 34.77 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 120.949 0.404 . . . . 63.439999999999998 110.292 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -108.96 108.54 19.33 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.817 -1.179 . . . . 74.409999999999997 107.817 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 3.4 p -118.93 150.55 21.22 Favored 'Isoleucine or valine' 0 C--O 1.274 2.353 0 CA-C-O 121.784 0.802 . . . . 74.209999999999994 111.265 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.63 158.15 45.11 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 105.721 -1.955 . . . . 71.120000000000005 105.721 171.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.284 -2.248 0 N-CA-C 105.463 -2.051 . . . . 73.209999999999994 105.463 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.507 -0.707 0 N-CA-C 109.708 -0.479 . . . . 74.409999999999997 109.708 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -91.36 161.3 15.07 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.657 -0.868 . . . . 75.239999999999995 108.657 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 51.6 m -147.27 140.43 25.23 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.927 -0.483 . . . . 74.430000000000007 110.414 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -71.13 139.24 50.2 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.865 -0.607 . . . . 73.510000000000005 109.916 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 12.4 m . . . . . 0 C--O 1.265 1.878 0 CA-C-N 115.79 -0.641 . . . . 74.510000000000005 112.065 -179.828 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 C--O 1.203 -1.394 0 N-CA-C 106.373 -1.714 . . . . 73.430000000000007 106.373 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.472 1.9 pm0 -115.58 128.98 56.35 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 117.05 2.241 . . . . 72.340000000000003 117.05 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.485 HG21 ' CD ' ' A' ' 364' ' ' LYS . 66.9 mt -107.38 107.0 21.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 CA-C-N 111.425 -2.625 . . . . 75.329999999999998 108.552 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.498 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 29.4 ttpt -80.44 118.92 22.49 Favored 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 119.865 -0.734 . . . . 74.219999999999999 109.073 174.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.561 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 27.5 mt -113.05 148.07 35.93 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 113.904 -1.498 . . . . 72.439999999999998 110.316 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.0 mp -106.55 117.2 51.89 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.017 0 N-CA-C 107.119 -1.437 . . . . 73.439999999999998 107.119 169.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.608 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 10.2 tmtt? -63.03 151.57 39.45 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 108.639 -0.875 . . . . 75.209999999999994 108.639 171.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . 0.436 ' O ' ' HE2' ' A' ' 324' ' ' LYS . . . -141.98 -160.58 8.39 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 119.832 -1.175 . . . . 64.040000000000006 113.365 -171.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.22 -30.62 45.82 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.155 2.57 . . . . 74.409999999999997 113.651 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -101.58 18.85 19.21 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 122.279 1.037 . . . . 75.310000000000002 108.791 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.34 -129.0 8.92 Favored Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 109.799 -1.32 . . . . 72.329999999999998 109.799 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.401 ' HB2' HG21 ' B' ' 151' ' ' VAL . 5.3 mp -96.98 -42.58 7.84 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.161 -1.792 . . . . 75.239999999999995 106.161 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . 0.431 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 84.41 50.19 4.36 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 114.754 -1.112 . . . . 52.329999999999998 114.806 171.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -151.25 150.71 30.9 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.413 -0.588 . . . . 72.340000000000003 109.413 173.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.439 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 6.4 m -104.15 129.15 51.87 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.601 -0.518 . . . . 72.109999999999999 109.601 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.3 pt -113.36 151.69 15.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-N 115.824 -0.625 . . . . 72.230000000000004 109.943 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.66 121.75 10.1 Favored 'General case' 0 N--CA 1.425 -1.713 0 O-C-N 124.226 0.954 . . . . 74.230000000000004 108.685 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 167.7 179.07 40.18 Favored Glycine 0 C--N 1.281 -2.498 0 N-CA-C 107.452 -2.259 . . . . 61.409999999999997 107.452 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 132.54 175.98 14.21 Favored Glycine 0 CA--C 1.474 -2.526 0 N-CA-C 108.712 -1.755 . . . . 52.439999999999998 108.712 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . 0.447 HG21 ' OE2' ' A' ' 381' ' ' GLU . 93.4 t -51.0 100.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 O-C-N 124.432 0.725 . . . . 73.200000000000003 111.437 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 88.13 -7.47 81.35 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.593 -0.731 . . . . 73.519999999999996 112.312 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.477 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 65.6 t30 -106.3 16.56 24.66 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.066 -0.716 . . . . 63.140000000000001 109.066 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.429 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -49.57 125.88 12.33 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.52 1.128 . . . . 74.400000000000006 111.835 -177.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -80.3 -44.11 20.12 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.18 -0.918 . . . . 65.109999999999999 109.429 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.5 mm -103.62 125.28 35.24 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 115.846 -0.615 . . . . 65.409999999999997 109.357 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.33 108.8 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.553 2.836 . . . . 75.409999999999997 113.416 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 101.87 -4.92 53.26 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.512 -0.767 . . . . 74.439999999999998 111.936 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -124.99 96.7 4.96 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.322 -0.992 . . . . 73.319999999999993 108.322 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 51.7 t30 -81.01 29.04 0.34 Allowed 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 124.343 1.057 . . . . 74.230000000000004 111.781 -170.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 73.0 m -93.34 177.97 5.87 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.726 0.774 . . . . 75.450000000000003 112.755 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.5 mm -91.21 129.33 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 114.609 -1.178 . . . . 72.209999999999994 108.32 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 28.9 m-85 -123.54 132.47 53.91 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.193 0.52 . . . . 75.329999999999998 112.197 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 52.9 t -67.1 109.84 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.581 -1.266 . . . . 75.510000000000005 107.581 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.4 m -99.83 -22.07 15.48 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.207 0.527 . . . . 72.109999999999999 110.711 -175.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 31.8 mmtp -148.25 154.27 39.83 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.375 -1.343 . . . . 74.25 107.375 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . 0.415 HG22 ' HB2' ' A' ' 360' ' ' HIS . 65.5 mt -131.72 107.59 13.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 106.815 -1.55 . . . . 72.129999999999995 106.815 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 38.7 mm -78.73 129.6 37.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 123.731 0.813 . . . . 74.340000000000003 109.788 -171.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.513 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 0.6 OUTLIER -63.83 146.25 54.29 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.429 -1.323 . . . . 63.109999999999999 107.429 -178.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.471 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.05 -19.53 53.66 Favored Glycine 0 C--N 1.28 -2.529 0 N-CA-C 109.299 -1.521 . . . . 64.420000000000002 109.299 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . 0.431 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -69.29 142.37 37.28 Favored Glycine 1 N--CA 1.384 -4.811 0 N-CA-C 107.968 -2.053 . . . . 74.319999999999993 107.968 172.034 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 362' ' ' ASP . . . -62.97 -32.65 74.04 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.826 -0.805 . . . . 74.420000000000002 108.826 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . 0.565 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.72 -6.28 49.75 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.981 -0.554 . . . . 74.040000000000006 112.132 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . 0.513 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 19.5 t60 -94.19 -39.4 10.57 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.432 -0.951 . . . . 75.239999999999995 108.432 175.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.471 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 73.7 mmtt -82.7 -57.65 3.23 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.599 0.714 . . . . 73.25 110.79 -178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 358' ' ' ALA . 10.9 t70 -85.86 -34.85 20.9 Favored 'General case' 0 CA--C 1.468 -2.187 0 C-N-CA 125.182 1.393 . . . . 71.150000000000006 111.112 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -42.71 -23.97 0.22 Allowed Glycine 0 C--N 1.287 -2.186 0 N-CA-C 120.862 3.105 . . . . 64.25 120.862 -162.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.493 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 41.47 36.99 0.6 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.802 1.301 . . . . 74.510000000000005 111.54 -178.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 50.3 tp -114.21 156.06 24.97 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.536 1.134 . . . . 64.25 109.891 -170.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -122.19 142.66 50.19 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.434 0.635 . . . . 75.209999999999994 111.678 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.39 121.53 15.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.507 -1.294 . . . . 74.430000000000007 107.507 169.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 114.55 -0.61 23.43 Favored Glycine 0 C--N 1.314 -0.687 0 N-CA-C 111.656 -0.578 . . . . 50.240000000000002 111.656 -176.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 83.2 m-20 -76.27 136.77 39.64 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.196 0.813 . . . . 73.120000000000005 113.196 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.657 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 37.7 tttp -94.86 116.61 28.93 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.99 1.316 . . . . 72.120000000000005 108.948 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 83.6 mt -83.25 113.45 20.69 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 109.779 -0.452 . . . . 72.430000000000007 109.779 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' ' 403' ' ' ALA . 3.9 tt -81.49 -39.67 24.4 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.08 -1.452 . . . . 74.530000000000001 107.08 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.41 159.18 21.99 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.493 -0.776 . . . . 72.030000000000001 110.644 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.5 p -133.75 121.09 39.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.07 -1.085 . . . . 73.549999999999997 108.07 172.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 62.83 29.85 16.63 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 123.987 1.851 . . . . 74.030000000000001 108.652 -174.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 67.42 10.39 7.71 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 109.652 -3.431 . . . . 71.340000000000003 113.355 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 50.3 t -78.74 124.56 37.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.585 -1.635 . . . . 64.439999999999998 106.585 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.5 p -61.51 124.62 21.17 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.677 0.992 . . . . 74.430000000000007 113.677 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 8.5 mp -109.18 3.48 21.88 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.027 0.931 . . . . 75.510000000000005 110.836 176.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -78.15 115.97 18.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.34 -0.985 . . . . 72.319999999999993 108.34 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . 0.447 ' OE2' HG21 ' A' ' 337' ' ' VAL . 17.1 tp10 62.83 83.34 0.16 Allowed 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 124.607 1.192 . . . . 75.319999999999993 111.625 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 18.4 m -153.81 160.36 2.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 113.966 -1.47 . . . . 74.530000000000001 109.171 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.474 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.5 m -81.65 145.14 30.73 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.443 -1.317 . . . . 75.209999999999994 107.443 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . 0.608 ' O ' HG21 ' A' ' 388' ' ' VAL . 7.3 t-160 -52.1 -48.27 64.85 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 112.533 0.568 . . . . 74.219999999999999 112.533 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -57.86 -37.34 73.72 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.653 0.74 . . . . 74.319999999999993 110.896 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 383' ' ' THR . 55.5 tt0 -70.54 -35.8 73.34 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.942 -1.026 . . . . 75.040000000000006 108.484 -174.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -75.47 -50.94 14.21 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.662 -1.154 . . . . 61.350000000000001 111.052 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.608 HG21 ' O ' ' A' ' 384' ' ' HIS . 20.7 t -57.64 -40.75 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 110.022 -0.362 . . . . 74.109999999999999 110.022 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 94.8 m -58.55 -40.01 81.83 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.101 -0.499 . . . . 71.109999999999999 110.749 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -63.65 -33.22 75.15 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.477 0.18 . . . . 61.149999999999999 110.972 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 5.8 mp -81.44 -28.92 34.0 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 120.388 -0.525 . . . . 65.409999999999997 110.943 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -74.74 -24.18 58.67 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.213 0.449 . . . . 73.329999999999998 112.213 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -78.62 46.39 0.65 Allowed 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 123.428 0.691 . . . . 73.530000000000001 110.692 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' THR . . . . . 0.406 ' HB ' HG21 ' A' ' 398' ' ' VAL . 34.0 p -124.57 143.49 50.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.056 0.455 . . . . 65.010000000000005 110.061 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 324' ' ' LYS . 49.3 m -142.49 100.98 3.8 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 122.32 1.057 . . . . 75.420000000000002 112.171 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . 0.608 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 5.3 m-20 60.47 15.85 5.9 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 128.232 2.613 . . . . 74.219999999999999 113.897 169.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -165.91 126.53 1.79 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.035 -1.098 . . . . 74.150000000000006 108.035 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 25.1 t -145.61 146.6 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 123.296 0.638 . . . . 72.239999999999995 110.642 -175.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . 0.498 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 20.4 m-85 -118.56 96.68 5.39 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.465 0.706 . . . . 74.0 109.191 169.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.8 tt -88.34 121.5 30.8 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.34 -0.615 . . . . 62.340000000000003 109.34 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -104.64 108.42 19.86 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.256 -1.016 . . . . 75.219999999999999 108.256 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 5.6 p -106.41 150.48 8.98 Favored 'Isoleucine or valine' 0 C--O 1.276 2.5 0 CA-C-O 121.651 0.739 . . . . 74.040000000000006 110.247 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.657 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.7 159.58 41.39 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 125.966 1.706 . . . . 72.120000000000005 107.149 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 404' ' ' LYS . 7.1 mmpt? . . . . . 0 C--N 1.287 -2.126 0 N-CA-C 108.803 -0.814 . . . . 73.549999999999997 108.803 174.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 N--CA 1.425 -1.712 0 N-CA-C 108.052 -1.092 . . . . 75.109999999999999 108.052 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -90.47 158.03 17.26 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 124.159 0.912 . . . . 74.420000000000002 108.54 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 55.2 m -145.85 138.16 25.47 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.796 -0.446 . . . . 73.230000000000004 109.796 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -81.52 132.35 35.31 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 109.525 -0.546 . . . . 74.040000000000006 109.525 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 329' ' ' LEU . 7.9 m . . . . . 0 C--N 1.291 -1.957 0 CA-C-N 116.026 -0.534 . . . . 74.030000000000001 111.291 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 CA--C 1.493 -1.247 0 N-CA-C 107.427 -1.323 . . . . 75.329999999999998 107.427 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.298 1.6 pm0 -115.34 133.85 55.65 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-O 122.847 1.308 . . . . 73.230000000000004 114.087 -175.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.437 HG21 ' HE2' ' A' ' 364' ' ' LYS . 86.6 mt -123.62 106.59 17.41 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.732 0 CA-C-N 112.662 -2.063 . . . . 72.329999999999998 110.025 -173.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.512 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 30.2 ttpt -81.07 130.5 35.05 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.931 -1.137 . . . . 73.340000000000003 107.931 170.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 10.3 mt -129.97 156.76 43.91 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 124.805 1.316 . . . . 74.430000000000007 110.396 -177.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 39.0 mm -106.5 117.57 52.52 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.762 0 N-CA-C 107.696 -1.224 . . . . 75.25 107.696 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.55 ' HG2' ' N ' ' A' ' 325' ' ' GLY . 17.5 tttm -71.69 160.92 31.8 Favored 'General case' 0 C--O 1.206 -1.185 0 N-CA-C 107.933 -1.136 . . . . 74.510000000000005 107.933 174.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . 0.55 ' N ' ' HG2' ' A' ' 324' ' ' LYS . . . -149.33 -164.34 11.57 Favored Glycine 0 C--N 1.29 -1.981 0 N-CA-C 110.315 -1.114 . . . . 62.420000000000002 110.315 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.31 -12.84 27.86 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.892 2.394 . . . . 74.340000000000003 111.493 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -97.61 6.72 47.64 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 122.078 0.942 . . . . 70.120000000000005 108.968 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.03 -134.79 13.05 Favored Glycine 0 CA--C 1.491 -1.412 0 N-CA-C 109.824 -1.31 . . . . 74.450000000000003 109.824 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.78 -27.11 12.88 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.157 -1.423 . . . . 75.420000000000002 107.157 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 86.02 48.12 4.75 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.366 -1.288 . . . . 61.409999999999997 115.216 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -154.46 171.34 19.52 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 110.043 -0.354 . . . . 74.409999999999997 110.043 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.7 m -127.96 128.4 44.99 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.093 -0.706 . . . . 61.149999999999999 109.093 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 21.4 pt -113.79 157.92 14.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 115.84 -0.618 . . . . 75.329999999999998 110.622 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.39 125.96 10.98 Favored 'General case' 0 N--CA 1.428 -1.559 0 O-C-N 124.36 1.037 . . . . 63.119999999999997 108.454 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 164.13 -177.0 40.03 Favored Glycine 0 C--N 1.284 -2.333 0 N-CA-C 108.581 -1.808 . . . . 72.209999999999994 108.581 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.19 177.05 14.68 Favored Glycine 0 CA--C 1.482 -1.987 0 N-CA-C 109.833 -1.307 . . . . 71.25 109.833 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . 0.454 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 92.8 t -57.76 103.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 O-C-N 124.121 0.542 . . . . 71.129999999999995 110.202 175.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 92.96 -14.08 66.11 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.375 -0.83 . . . . 72.319999999999993 112.101 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.542 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 65.0 t30 -106.02 21.56 17.11 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.553 -0.536 . . . . 73.420000000000002 109.553 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.67 123.5 7.96 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 115.104 -0.953 . . . . 72.230000000000004 111.49 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -78.72 -40.85 32.45 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.032 -0.985 . . . . 73.340000000000003 108.916 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 37.0 mm -103.62 122.36 45.07 Favored Pre-proline 0 C--N 1.302 -1.488 0 CA-C-N 115.2 -0.909 . . . . 75.239999999999995 109.334 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -52.2 108.11 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.429 2.752 . . . . 74.530000000000001 112.91 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 104.44 -2.6 42.97 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 115.178 -0.919 . . . . 64.540000000000006 112.308 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -127.14 103.66 7.55 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.747 0.784 . . . . 75.5 109.587 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . 0.454 ' OD1' ' HA ' ' A' ' 337' ' ' VAL . 65.9 t30 -83.32 38.02 0.59 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 125.038 1.335 . . . . 73.239999999999995 111.14 -171.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 21.5 m -110.9 177.86 4.53 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.723 -0.671 . . . . 75.129999999999995 112.346 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 35.0 mm -91.92 131.15 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.053 0.541 . . . . 74.430000000000007 109.702 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 36.6 m-85 -124.39 139.16 54.16 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.582 0.586 . . . . 73.120000000000005 112.582 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.24 115.05 10.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 108.256 -1.016 . . . . 74.200000000000003 108.256 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 31.6 m -101.06 -24.0 14.39 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.341 0.591 . . . . 74.519999999999996 111.308 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.63 147.93 23.7 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.792 -1.188 . . . . 73.129999999999995 107.792 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 85.1 mt -118.27 133.09 66.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 106.168 -1.79 . . . . 74.010000000000005 106.168 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 48.6 mm -75.83 130.87 35.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.315 0.579 . . . . 73.25 109.831 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.526 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.6 pm0 -60.09 122.36 14.2 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 125.006 1.322 . . . . 72.099999999999994 111.627 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 74.29 16.16 79.91 Favored Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 114.368 -1.287 . . . . 74.409999999999997 111.393 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.78 163.95 52.84 Favored Glycine 0 C--O 1.251 1.177 0 N-CA-C 110.97 -0.852 . . . . 52.25 110.97 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -64.33 -42.34 96.33 Favored 'General case' 0 C--O 1.207 -1.15 0 N-CA-C 108.816 -0.809 . . . . 74.040000000000006 108.816 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . 0.405 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -71.49 -5.74 35.3 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 121.876 -0.515 . . . . 72.409999999999997 112.135 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -93.85 -36.12 12.39 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.67 -0.863 . . . . 64.040000000000006 108.67 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -92.62 -58.59 2.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.98 1.371 . . . . 75.420000000000002 110.221 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -85.9 -26.76 25.41 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.709 -2.041 . . . . 64.319999999999993 110.283 -170.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -56.69 -39.35 86.21 Favored Glycine 0 C--N 1.278 -2.641 0 CA-C-N 112.779 -2.01 . . . . 71.329999999999998 118.109 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.437 ' HE2' HG21 ' A' ' 320' ' ' ILE 0.255 0.0 OUTLIER 45.94 32.59 1.37 Allowed 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 119.113 1.456 . . . . 73.340000000000003 111.489 -170.56 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 48.3 tp -101.31 149.62 23.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.436 -1.257 . . . . 74.439999999999998 109.036 -172.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.95 147.74 42.86 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.285 0.564 . . . . 71.230000000000004 109.686 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 76.7 mt -66.03 123.3 18.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 106.927 -1.509 . . . . 74.239999999999995 106.927 170.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.54 -9.31 19.66 Favored Glycine 0 C--N 1.308 -1.005 0 C-N-CA 120.536 -0.84 . . . . 74.040000000000006 112.29 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -68.51 137.09 54.1 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 120.882 0.373 . . . . 74.439999999999998 111.504 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 2.1 ttmm -94.55 125.14 39.01 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.81 -0.632 . . . . 73.230000000000004 109.502 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 95.9 mt -81.45 112.36 18.63 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.671 -0.863 . . . . 73.420000000000002 108.671 176.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.41 HD12 ' HB3' ' A' ' 403' ' ' ALA . 2.8 tt -80.5 -43.61 20.51 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.104 -2.184 . . . . 74.519999999999996 105.104 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -160.45 161.41 32.91 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.738 -1.119 . . . . 71.400000000000006 110.909 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.14 126.81 50.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.365 -1.346 . . . . 63.109999999999999 107.365 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.01 34.79 23.74 Favored 'General case' 0 CA--C 1.475 -1.925 0 CA-C-O 124.631 2.158 . . . . 74.439999999999998 110.339 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 60.42 17.33 7.11 Favored 'General case' 0 C--N 1.266 -3.058 1 CA-C-N 108.341 -4.027 . . . . 72.230000000000004 113.362 -177.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.4 t -89.04 125.86 42.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.64 -1.245 . . . . 70.140000000000001 107.64 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.4 p -57.58 123.42 15.53 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 123.847 0.859 . . . . 53.520000000000003 112.837 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 2.9 mp -107.32 -5.84 17.55 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.457 -0.792 . . . . 75.430000000000007 112.602 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -83.89 136.28 34.16 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.779 -0.768 . . . . 51.240000000000002 111.035 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 63.05 32.37 15.41 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.113 1.365 . . . . 74.409999999999997 114.469 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 33.2 m -112.07 169.15 4.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.257 -1.386 . . . . 74.0 107.257 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 82.6 p -79.26 150.46 31.54 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.359 -0.937 . . . . 73.540000000000006 108.937 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . 0.555 ' O ' HG21 ' A' ' 388' ' ' VAL . 6.8 t-160 -51.2 -37.25 45.63 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.212 0.449 . . . . 61.219999999999999 112.212 -175.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.33 -40.69 97.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 121.386 -0.126 . . . . 74.510000000000005 110.903 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -67.24 -37.15 83.08 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 109.188 -0.671 . . . . 75.5 109.188 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.508 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -68.66 -56.56 7.77 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 114.581 -1.19 . . . . 72.319999999999993 110.685 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.555 HG21 ' O ' ' A' ' 384' ' ' HIS . 27.4 t -58.98 -44.56 91.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 110.043 -0.354 . . . . 70.549999999999997 110.043 -177.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 87.3 m -60.29 -33.72 72.76 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.178 -0.465 . . . . 73.140000000000001 111.171 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.66 -38.03 86.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.425 -0.172 . . . . 74.329999999999998 110.757 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.4 mp -75.54 -30.12 59.63 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 119.914 -0.714 . . . . 72.510000000000005 110.219 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 55.0 mttm -72.31 -27.71 62.62 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 112.289 0.477 . . . . 75.310000000000002 112.289 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -80.07 51.36 1.35 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.047 0.927 . . . . 63.32 111.833 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 17.5 p -124.78 162.88 23.32 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 107.246 -1.39 . . . . 73.049999999999997 107.246 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' SER . . . . . 0.49 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 55.1 m -148.69 101.38 3.2 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.939 0.876 . . . . 74.349999999999994 110.669 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . 0.509 ' N ' ' HB3' ' A' ' 324' ' ' LYS . 0.8 OUTLIER 47.18 30.28 1.36 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 111.425 -2.625 . . . . 75.150000000000006 114.259 172.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -169.24 117.56 0.64 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 106.334 -1.728 . . . . 71.310000000000002 106.334 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.81 146.16 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.754 0.422 . . . . 74.329999999999998 111.036 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . 0.512 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 28.0 m-85 -121.93 96.84 5.22 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.625 0.77 . . . . 72.310000000000002 108.975 171.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.436 ' CD2' HG22 ' A' ' 402' ' ' VAL . 7.0 tt -91.61 133.89 35.16 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.799 -0.637 . . . . 73.430000000000007 109.695 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -117.55 110.9 18.52 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.242 0.617 . . . . 70.230000000000004 110.651 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.436 HG22 ' CD2' ' A' ' 400' ' ' LEU . 53.7 t -104.99 143.13 16.8 Favored 'Isoleucine or valine' 0 C--O 1.27 2.162 0 C-N-CA 124.047 0.939 . . . . 73.140000000000001 110.525 177.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -125.76 154.52 42.41 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 103.957 -2.608 . . . . 73.430000000000007 103.957 167.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt . . . . . 0 C--N 1.285 -2.198 0 C-N-CA 119.303 -0.959 . . . . 71.099999999999994 111.085 -177.435 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 C--O 1.26 1.608 0 N-CA-C 106.478 -1.675 . . . . 75.049999999999997 106.478 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' B' ' 148' ' ' GLU . 0.1 OUTLIER -95.61 159.79 14.82 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 123.797 0.686 . . . . 74.030000000000001 110.074 -178.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 45.9 m -145.12 140.08 27.76 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.729 -0.607 . . . . 73.510000000000005 110.585 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -81.9 135.88 35.37 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.673 0.789 . . . . 73.439999999999998 110.393 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.27 2.146 0 CA-C-N 116.077 -0.51 . . . . 75.430000000000007 111.641 179.476 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 C--O 1.209 -1.046 0 N-CA-C 108.233 -1.025 . . . . 70.430000000000007 108.233 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.285 2.0 pm0 -104.31 139.51 39.19 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 114.069 1.137 . . . . 74.109999999999999 114.069 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 363' ' ' GLY . 89.9 mt -128.66 122.53 57.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.168 -1.833 . . . . 73.150000000000006 107.986 -172.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.523 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 33.1 ttpt -94.79 109.67 21.62 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.38 -0.528 . . . . 75.140000000000001 110.622 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.61 151.49 24.98 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.678 -1.147 . . . . 72.340000000000003 109.769 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 24.2 mm -105.25 111.22 33.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.038 -1.467 . . . . 75.310000000000002 107.038 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -75.98 130.55 38.6 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.355 -0.384 . . . . 74.340000000000003 111.548 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -133.09 -154.97 7.65 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 119.386 -1.388 . . . . 53.210000000000001 112.696 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.51 -13.26 35.03 Favored 'Trans proline' 0 N--CA 1.481 0.77 0 C-N-CA 123.411 2.741 . . . . 73.329999999999998 114.177 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -106.27 8.57 31.94 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.176 0.988 . . . . 62.229999999999997 108.386 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.02 -136.28 14.66 Favored Glycine 0 CA--C 1.492 -1.376 0 CA-C-N 113.844 -1.525 . . . . 42.240000000000002 110.497 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.0 mp -98.55 -26.26 14.47 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.746 -1.946 . . . . 73.519999999999996 105.746 171.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . 0.489 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 80.28 54.04 3.93 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 113.689 -1.596 . . . . 54.210000000000001 115.113 172.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -155.35 158.52 38.83 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.218 -1.03 . . . . 75.319999999999993 108.218 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.9 m -113.08 133.64 54.9 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.388 -0.597 . . . . 74.420000000000002 109.388 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.3 pt -116.16 154.54 17.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 115.833 -0.622 . . . . 73.540000000000006 110.996 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -143.58 127.37 17.21 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.478 -1.675 . . . . 63.5 106.478 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 148.33 150.67 5.26 Favored Glycine 0 C--N 1.283 -2.416 0 N-CA-C 109.323 -1.511 . . . . 73.510000000000005 109.323 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.65 171.84 12.75 Favored Glycine 0 C--N 1.287 -2.189 0 N-CA-C 108.044 -2.022 . . . . 75.129999999999995 108.044 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.1 t -45.57 111.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.087 0.943 . . . . 63.299999999999997 111.58 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 94.05 -30.49 7.53 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.097 -0.956 . . . . 71.329999999999998 112.361 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.451 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 63.3 t30 -105.46 26.75 9.08 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.808 -0.442 . . . . 74.420000000000002 109.808 -177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.83 123.93 8.91 Favored 'General case' 0 C--O 1.26 1.646 0 CA-C-N 116.017 -0.538 . . . . 75.450000000000003 109.793 177.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -75.81 -52.62 9.99 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.141 -0.936 . . . . 71.340000000000003 109.497 -173.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 73.3 mt -103.26 133.18 20.46 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 107.817 -1.179 . . . . 71.140000000000001 107.817 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.61 110.84 0.47 Allowed 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 123.424 2.749 . . . . 71.140000000000001 113.755 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 97.54 -4.58 61.91 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.322 -0.854 . . . . 74.230000000000004 112.045 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -120.15 96.82 5.32 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.831 0.824 . . . . 72.310000000000002 108.841 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -85.05 28.91 0.67 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.506 0.669 . . . . 74.299999999999997 110.7 -171.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 0.443 ' HB2' ' CE2' ' A' ' 349' ' ' TYR . 15.2 m -90.45 164.71 14.17 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.105 0.479 . . . . 64.409999999999997 111.106 -175.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 24.6 mm -79.54 125.01 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 108.428 -0.953 . . . . 75.109999999999999 108.428 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 370' ' ' LYS . 47.7 m-85 -123.71 130.22 52.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.089 0.471 . . . . 73.450000000000003 111.801 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.17 117.1 6.31 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 CA-C-N 115.432 -0.804 . . . . 73.140000000000001 109.254 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.2 m -100.06 -18.16 17.13 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.484 0.659 . . . . 75.439999999999998 110.476 -175.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.502 ' NZ ' ' HB2' ' A' ' 352' ' ' LYS . 2.3 ttmp? -166.57 153.05 8.81 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.047 -1.094 . . . . 72.329999999999998 108.047 -175.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 64.8 mt -126.87 119.86 54.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 107.037 -1.468 . . . . 70.030000000000001 107.037 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 42.8 mm -86.28 125.94 40.68 Favored 'Isoleucine or valine' 0 C--O 1.259 1.568 0 C-N-CA 123.234 0.614 . . . . 75.409999999999997 109.72 -175.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.31 147.6 47.69 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 108.285 -1.005 . . . . 73.219999999999999 108.285 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.438 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.49 -19.06 56.03 Favored Glycine 0 C--N 1.281 -2.487 0 N-CA-C 109.714 -1.355 . . . . 70.430000000000007 109.714 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . 0.489 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -72.93 149.85 43.51 Favored Glycine 1 N--CA 1.395 -4.095 0 N-CA-C 109.515 -1.434 . . . . 64.129999999999995 109.515 173.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -56.95 -36.84 70.73 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.132 -0.692 . . . . 74.319999999999993 109.132 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . 0.491 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.81 -13.04 60.28 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 113.263 0.838 . . . . 51.32 113.263 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -94.14 -31.4 14.18 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.369 -0.974 . . . . 74.129999999999995 108.369 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.438 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 75.1 mmtt -84.69 -58.2 2.82 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.738 -0.785 . . . . 74.099999999999994 110.676 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.46 -42.17 13.81 Favored 'General case' 0 CA--C 1.467 -2.225 0 CA-C-O 121.887 0.851 . . . . 74.319999999999993 111.124 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.508 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -42.66 -23.1 0.17 Allowed Glycine 0 CA--C 1.482 -2.024 0 N-CA-C 120.328 2.891 . . . . 74.430000000000007 120.328 -158.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.508 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.84 32.48 0.4 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 119.037 1.418 . . . . 73.140000000000001 111.658 -178.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 48.5 tp -99.69 152.78 19.69 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.519 -1.219 . . . . 73.25 109.83 -171.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -117.14 144.65 44.47 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.478 0.656 . . . . 70.209999999999994 110.677 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.9 mt -66.12 120.81 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 106.958 -1.497 . . . . 72.219999999999999 106.958 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.56 -7.46 20.27 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 120.803 -0.713 . . . . 75.310000000000002 112.157 -176.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -70.14 137.54 51.14 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-O 121.17 0.509 . . . . 70.129999999999995 111.742 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.575 ' HB2' ' CE1' ' A' ' 349' ' ' TYR . 36.1 tttp -92.07 119.14 31.48 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.281 -0.872 . . . . 74.040000000000006 110.118 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.461 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 93.8 mt -79.08 114.71 18.24 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.293 -0.632 . . . . 75.329999999999998 109.293 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.443 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 3.3 tt -82.49 -39.84 21.92 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.205 -1.776 . . . . 74.329999999999998 106.205 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.92 166.86 21.29 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.538 -0.756 . . . . 53.439999999999998 112.331 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.0 p -132.74 116.69 27.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 107.493 -1.299 . . . . 62.030000000000001 107.493 171.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 63.22 29.58 15.94 Favored 'General case' 0 CA--C 1.469 -2.145 0 CA-C-O 123.943 1.83 . . . . 71.239999999999995 109.672 -172.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 66.39 11.8 8.23 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 109.556 -3.475 . . . . 74.420000000000002 113.182 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 49.8 t -78.57 119.31 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 106.214 -1.773 . . . . 74.109999999999999 106.214 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -59.45 124.62 20.64 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 114.328 1.233 . . . . 70.340000000000003 114.328 -173.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 6.6 mp -101.76 11.15 39.24 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 124.921 1.288 . . . . 64.030000000000001 108.973 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.443 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 24.0 mm-40 -78.43 112.23 15.25 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.258 -1.337 . . . . 75.25 108.682 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 61.06 83.55 0.14 Allowed 'General case' 0 CA--C 1.544 0.719 0 O-C-N 124.51 1.131 . . . . 71.430000000000007 111.721 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 19.3 m -153.13 162.83 2.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.061 -1.427 . . . . 74.519999999999996 107.975 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 2.0 m -78.64 143.32 36.46 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.726 -0.842 . . . . 72.409999999999997 108.726 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 388' ' ' VAL . 86.4 t60 -51.95 -49.66 62.73 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 120.872 0.367 . . . . 75.450000000000003 111.695 -175.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -61.05 -36.55 79.9 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.119 -0.946 . . . . 73.150000000000006 110.7 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 383' ' ' THR . 48.6 tt0 -73.75 -34.04 64.56 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.417 -1.265 . . . . 71.209999999999994 108.799 -174.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.522 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -71.83 -48.16 48.1 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.744 -1.117 . . . . 71.010000000000005 110.137 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 384' ' ' HIS . 19.3 t -58.52 -45.37 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.409 -0.589 . . . . 75.120000000000005 109.409 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 66.0 m -61.34 -31.72 71.59 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 116.08 -0.509 . . . . 65.099999999999994 111.348 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.65 84.16 Favored 'General case' 0 C--N 1.343 0.313 0 O-C-N 122.019 -0.426 . . . . 70.340000000000003 110.312 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.3 mp -79.08 -23.99 43.79 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 120.199 -0.6 . . . . 75.109999999999999 110.915 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 61.5 mttm -75.91 -32.19 59.51 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.528 0.566 . . . . 75.340000000000003 112.528 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -74.83 32.55 0.09 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.364 1.065 . . . . 72.25 113.761 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 1.7 p -124.77 158.45 33.28 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 109.968 -0.382 . . . . 71.200000000000003 109.968 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 62.8 m -148.53 125.84 11.55 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.535 -0.543 . . . . 73.530000000000001 109.535 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 26.6 t70 60.98 0.17 0.36 Allowed 'General case' 0 C--O 1.2 -1.513 0 C-N-CA 126.578 1.951 . . . . 72.349999999999994 114.954 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -158.38 119.12 3.36 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 120.276 -1.515 . . . . 74.319999999999993 110.333 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 93.7 t -142.21 117.93 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 122.553 0.341 . . . . 73.109999999999999 111.678 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . 0.523 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 17.8 m-85 -90.07 96.53 10.72 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.123 -1.066 . . . . 65.109999999999999 108.123 167.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 tt -83.35 130.82 35.08 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.097 -0.705 . . . . 73.219999999999999 109.097 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 38.8 tttp -121.19 112.62 18.88 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 109.954 -0.387 . . . . 74.299999999999997 109.954 -173.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 53.7 t -104.92 144.58 14.52 Favored 'Isoleucine or valine' 0 C--O 1.263 1.788 0 C-N-CA 123.753 0.821 . . . . 73.319999999999993 110.882 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -121.58 157.75 30.07 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 104.95 -2.241 . . . . 65.400000000000006 104.95 172.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.497 ' HA ' ' HE2' ' A' ' 404' ' ' LYS . 9.5 mmpt? . . . . . 0 C--N 1.285 -2.208 0 C-N-CA 119.184 -1.006 . . . . 74.120000000000005 109.051 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 N--CA 1.417 -2.098 0 N-CA-C 106.621 -1.622 . . . . 65.099999999999994 106.621 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . 0.489 ' CD ' ' HZ2' ' A' ' 352' ' ' LYS . 12.5 pt-20 -95.04 146.3 24.36 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 107.406 -1.331 . . . . 74.230000000000004 107.406 174.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 15.0 m -134.14 132.39 39.81 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 120.424 -0.51 . . . . 74.530000000000001 109.701 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -75.58 136.36 40.52 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 109.671 -0.492 . . . . 75.400000000000006 109.671 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 C--N 1.296 -1.73 0 CA-C-O 117.107 -1.425 . . . . 71.230000000000004 112.107 -179.888 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 109.331 -0.618 . . . . 72.140000000000001 109.331 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.33 119.8 11.67 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 122.247 1.022 . . . . 72.019999999999996 109.203 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 65.3 mt -98.47 106.56 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.895 0 CA-C-N 113.689 -1.596 . . . . 74.299999999999997 109.736 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -76.5 104.01 6.79 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 104.408 -2.442 . . . . 73.540000000000006 104.408 165.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 359' ' ' ALA . 0.6 OUTLIER -109.25 136.23 49.05 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 113.751 -1.568 . . . . 75.439999999999998 106.976 -173.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 21.9 mm -95.03 137.14 24.08 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 C-N-CA 119.36 -0.936 . . . . 71.319999999999993 109.292 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.533 ' HD3' ' HA ' ' A' ' 395' ' ' SER . 1.2 ttpm? -68.16 177.64 2.18 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-O 121.106 0.479 . . . . 74.209999999999994 109.835 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . 0.432 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -150.68 -173.88 21.2 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.229 -1.148 . . . . 65.150000000000006 110.229 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.47 -41.02 21.6 Favored 'Trans proline' 0 N--CA 1.482 0.831 0 C-N-CA 122.955 2.436 . . . . 74.030000000000001 112.178 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.35 -14.54 46.1 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 123.31 1.529 . . . . 70.129999999999995 107.656 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 98.74 -143.75 16.81 Favored Glycine 0 C--N 1.256 -3.885 0 CA-C-N 113.38 -1.736 . . . . 71.040000000000006 109.437 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.1 mp -74.76 -46.24 38.48 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 117.679 0.739 . . . . 73.030000000000001 111.105 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 83.41 53.15 3.51 Favored Glycine 0 C--O 1.22 -0.72 0 C-N-CA 120.173 -1.013 . . . . 73.439999999999998 115.364 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 49.0 p90 -151.82 172.98 15.33 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.185 -0.672 . . . . 71.329999999999998 109.185 173.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.463 ' OG ' ' HG2' ' B' ' 150' ' ' GLN . 3.9 m -123.38 136.1 54.47 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.951 -0.388 . . . . 62.219999999999999 109.951 -177.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 16.4 pt -120.57 156.55 23.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 116.318 -0.401 . . . . 74.299999999999997 110.146 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -148.02 133.3 18.46 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.96 -1.126 . . . . 73.040000000000006 107.96 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 157.83 -177.43 34.59 Favored Glycine 0 C--N 1.273 -2.922 0 N-CA-C 108.5 -1.84 . . . . 75.420000000000002 108.5 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.11 175.47 13.98 Favored Glycine 0 C--N 1.272 -2.986 0 N-CA-C 108.054 -2.018 . . . . 54.549999999999997 108.054 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.8 100.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.49 0.662 . . . . 75.409999999999997 110.769 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 80.71 2.45 89.96 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 115.164 -0.926 . . . . 61.229999999999997 113.445 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.426 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 62.2 t30 -107.69 11.81 28.06 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.057 -1.09 . . . . 73.430000000000007 108.057 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.88 134.27 56.48 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 115.624 1.713 . . . . 73.420000000000002 115.624 -173.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -71.62 -34.97 70.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.005 -1.452 . . . . 73.430000000000007 109.515 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 41.8 mm -104.75 118.89 55.23 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.998 -0.546 . . . . 75.510000000000005 110.299 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.94 110.17 0.59 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.745 2.297 . . . . 73.340000000000003 111.489 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.33 -28.23 9.87 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.95 -0.643 . . . . 71.010000000000005 111.832 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -106.77 102.51 11.87 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.766 -0.827 . . . . 64.239999999999995 108.766 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -82.66 38.11 0.55 Allowed 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 123.721 0.809 . . . . 73.140000000000001 112.208 -170.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 75.2 m -103.2 178.44 4.56 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 113.268 0.84 . . . . 74.329999999999998 113.268 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.415 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 25.7 mm -93.96 131.32 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 114.853 -1.067 . . . . 74.129999999999995 108.128 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 369' ' ' ASP . 28.9 m-85 -124.11 135.14 53.32 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 112.691 0.626 . . . . 74.120000000000005 112.691 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.69 116.57 5.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.072 -1.084 . . . . 74.400000000000006 108.072 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' THR . . . . . 0.401 HG21 ' HZ1' ' A' ' 352' ' ' LYS . 28.3 m -107.57 -20.41 13.25 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 120.852 0.358 . . . . 74.120000000000005 111.537 -175.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 331' ' ' PHE . 47.0 mmtm -149.34 159.06 44.61 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 107.524 -1.287 . . . . 75.510000000000005 107.524 177.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . 0.408 HG23 ' HB2' ' A' ' 360' ' ' HIS . 75.9 mt -140.54 124.97 18.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 107.049 -1.463 . . . . 73.319999999999993 107.049 172.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 39.2 mm -85.62 116.49 28.89 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 N-CA-C 108.15 -1.055 . . . . 74.049999999999997 108.15 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.506 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 1.1 pp20? -66.23 147.53 53.18 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 107.257 -1.386 . . . . 73.099999999999994 107.257 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.69 -26.66 19.11 Favored Glycine 0 C--N 1.288 -2.123 0 N-CA-C 109.691 -1.364 . . . . 63.420000000000002 109.691 -175.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -69.98 156.83 53.49 Favored Glycine 0 C--O 1.272 2.489 0 N-CA-C 110.914 -0.874 . . . . 75.209999999999994 110.914 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -57.6 -41.17 80.71 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 109.792 -0.448 . . . . 65.439999999999998 109.792 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . 0.645 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.99 -4.88 43.6 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 113.394 0.887 . . . . 73.25 113.394 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . 0.506 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 69.6 t60 -94.8 -38.18 10.88 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.641 -0.824 . . . . 71.219999999999999 109.136 172.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -83.42 -57.2 3.35 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.976 -0.689 . . . . 74.530000000000001 111.362 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -85.54 -30.81 23.09 Favored 'General case' 0 CA--C 1.463 -2.383 0 CA-C-O 121.672 0.749 . . . . 75.310000000000002 109.588 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -43.31 -32.66 1.81 Allowed Glycine 0 CA--C 1.475 -2.413 0 CA-C-N 113.239 -1.801 . . . . 71.040000000000006 117.22 -168.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? 45.09 36.85 2.21 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 124.626 0.839 . . . . 75.519999999999996 110.408 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 29.9 tp -119.78 158.56 26.29 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 113.79 -1.55 . . . . 73.540000000000006 109.339 -168.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.75 145.23 49.63 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 115.82 -0.627 . . . . 71.540000000000006 109.936 -174.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 81.1 mt -66.77 119.23 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 108.991 -0.744 . . . . 74.299999999999997 108.991 175.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.76 3.33 20.25 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.984 -0.627 . . . . 71.329999999999998 111.996 -175.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 8.0 m-20 -73.25 133.02 43.83 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.818 0.673 . . . . 74.340000000000003 112.818 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 44.5 tttp -92.9 114.83 27.5 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.444 1.098 . . . . 73.099999999999994 108.473 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 83.9 mt -83.61 112.07 19.68 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.848 -0.427 . . . . 74.310000000000002 109.848 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.4 tt -83.7 -40.71 18.55 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.531 -1.213 . . . . 74.329999999999998 107.918 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -162.6 145.82 11.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.689 -0.687 . . . . 71.200000000000003 109.72 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.56 130.19 49.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 109.377 -0.601 . . . . 74.120000000000005 109.377 175.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 44.93 67.27 0.73 Allowed 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 125.652 1.581 . . . . 71.019999999999996 110.343 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 66.43 -26.69 0.11 Allowed 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 114.771 1.397 . . . . 75.299999999999997 114.771 -176.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 42.5 t -78.84 125.7 38.41 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 O-C-N 121.651 -0.656 . . . . 73.439999999999998 110.487 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -74.92 130.04 38.71 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 122.481 0.312 . . . . 74.0 110.521 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.6 0.09 22.34 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.474 0.546 . . . . 74.530000000000001 112.474 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -68.36 106.71 2.59 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.43 -0.582 . . . . 72.420000000000002 109.43 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 62.85 73.82 0.45 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 122.678 1.228 . . . . 72.519999999999996 113.077 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.56 169.71 16.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.515 -1.221 . . . . 72.209999999999994 107.834 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.513 ' OG1' ' HG2' ' A' ' 386' ' ' GLU . 3.0 p -76.63 147.85 37.3 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.639 -0.874 . . . . 74.329999999999998 108.639 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . 0.594 ' O ' HG22 ' A' ' 388' ' ' VAL . 10.6 t-80 -57.52 -37.04 72.37 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.496 0.665 . . . . 74.540000000000006 109.446 -172.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -56.45 -44.05 80.12 Favored 'General case' 0 N--CA 1.403 -2.8 0 CA-C-N 113.88 -1.509 . . . . 72.420000000000002 112.826 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.513 ' HG2' ' OG1' ' A' ' 383' ' ' THR . 20.0 mm-40 -75.28 -29.33 60.1 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 109.189 -0.671 . . . . 74.310000000000002 109.189 -176.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.449 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -67.33 -58.12 5.38 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.489 -1.232 . . . . 64.140000000000001 109.086 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 384' ' ' HIS . 17.8 t -59.27 -41.42 83.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 N-CA-C 109.447 -0.575 . . . . 65.340000000000003 109.447 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 35.1 m -61.46 -35.63 78.16 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 115.977 -0.556 . . . . 71.129999999999995 111.477 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -69.07 -38.02 78.82 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 122.341 -0.224 . . . . 63.130000000000003 110.583 176.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 387' ' ' ALA . 6.1 mp -72.16 -28.92 63.55 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.419 -0.513 . . . . 71.230000000000004 110.596 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 61.5 mttm -73.91 -34.88 64.55 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 120.602 -0.439 . . . . 75.510000000000005 112.106 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -84.77 62.39 7.37 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.785 0.802 . . . . 71.430000000000007 110.877 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 22.5 p -125.6 152.44 45.13 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.311 -0.859 . . . . 73.430000000000007 109.282 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' SER . . . . . 0.533 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 50.4 m -146.83 90.11 1.88 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 122.218 1.009 . . . . 70.129999999999995 111.072 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . 0.265 22.1 m-20 62.2 14.35 6.6 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 111.951 -2.386 . . . . 73.310000000000002 115.208 170.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -157.77 107.6 2.15 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 108.034 -1.098 . . . . 71.430000000000007 108.034 173.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 43.7 t -114.73 123.73 70.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.787 -0.819 . . . . 63.340000000000003 108.787 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.74 95.7 6.83 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 105.108 -2.182 . . . . 73.299999999999997 105.108 174.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 8.0 tt -102.22 104.02 14.56 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-O 121.376 0.608 . . . . 72.530000000000001 109.582 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -93.61 112.03 23.83 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.138 -1.43 . . . . 70.420000000000002 107.138 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 4.7 p -119.16 146.17 24.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.209 -0.905 . . . . 75.25 110.557 -173.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -125.17 158.38 34.1 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.298 -1.001 . . . . 72.329999999999998 108.298 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? . . . . . 0 C--N 1.299 -1.611 0 N-CA-C 106.958 -1.497 . . . . 64.430000000000007 106.958 177.566 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . 0.454 ' C ' HD21 ' B' ' 147' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.489 -1.376 0 N-CA-C 107.988 -1.116 . . . . 73.540000000000006 107.988 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -85.56 156.61 20.67 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.733 -0.839 . . . . 74.150000000000006 108.733 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 49.0 m -144.17 141.0 29.68 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.9 -0.5 . . . . 75.120000000000005 110.265 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . 0.463 ' HG2' ' OG ' ' A' ' 332' ' ' SER . 77.7 mt-30 -85.35 149.22 25.6 Favored 'General case' 0 CA--C 1.454 -2.742 0 CA-C-O 121.445 0.64 . . . . 73.25 111.631 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . 0.272 22.0 m . . . . . 1 N--CA 1.374 -4.253 0 CA-C-O 117.453 -1.261 . . . . 73.439999999999998 110.443 174.59 . . . . . . . . 2 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 CA--C 1.494 -1.193 0 N-CA-C 106.559 -1.645 . . . . 75.230000000000004 106.559 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . 0.435 ' HG3' ' HH ' ' A' ' 399' ' ' TYR 0.429 1.8 pm0 -114.61 134.4 55.09 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 116.319 1.97 . . . . 74.519999999999996 116.319 -174.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 73.7 mt -124.43 112.88 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-N 112.573 -2.103 . . . . 74.430000000000007 109.186 -173.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -79.66 124.97 29.05 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.416 -1.327 . . . . 70.340000000000003 107.416 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 45.2 mt -114.48 144.33 43.51 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.072 -1.084 . . . . 75.019999999999996 108.072 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 54.3 mt -105.86 110.79 32.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 108.504 -0.925 . . . . 73.219999999999999 108.504 171.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.624 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 9.6 tmtt? -55.68 158.78 3.33 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 124.568 1.168 . . . . 74.400000000000006 111.601 177.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -144.37 -166.66 11.59 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 111.435 -0.666 . . . . 62.109999999999999 111.435 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.81 -15.08 46.22 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 123.324 2.683 . . . . 74.219999999999999 112.991 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -112.67 19.58 17.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.048 0.928 . . . . 74.329999999999998 109.248 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.92 -127.3 8.0 Favored Glycine 0 CA--C 1.497 -1.032 0 CA-C-N 114.994 -1.003 . . . . 54.420000000000002 111.31 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.425 HD12 ' OG1' ' A' ' 394' ' ' THR . 4.0 mp -104.89 -22.72 13.11 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.224 -1.028 . . . . 73.519999999999996 108.224 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 73.72 50.98 9.93 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 114.807 -1.088 . . . . 63.329999999999998 115.606 171.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' B' ' 150' ' ' GLN . 28.8 p90 -154.43 149.79 27.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.442 -0.577 . . . . 74.239999999999995 109.442 172.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 7.5 m -105.01 128.3 53.25 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.95 0.405 . . . . 74.530000000000001 109.919 -175.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 30.3 pt -122.82 151.58 27.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.596 -0.729 . . . . 73.439999999999998 111.03 -175.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -140.9 137.16 32.97 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 105.55 -2.018 . . . . 74.040000000000006 105.55 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 347' ' ' SER . . . 147.45 162.54 10.07 Favored Glycine 0 C--N 1.281 -2.49 0 N-CA-C 109.771 -1.332 . . . . 65.400000000000006 109.771 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.53 177.34 14.88 Favored Glycine 0 C--N 1.284 -2.345 0 N-CA-C 108.718 -1.753 . . . . 74.340000000000003 108.718 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 99.2 t -55.8 108.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 117.522 0.661 . . . . 73.200000000000003 109.971 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 86.45 -11.1 64.53 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.648 -0.706 . . . . 75.329999999999998 112.712 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.446 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -106.39 9.74 31.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.051 -1.463 . . . . 63.210000000000001 107.051 179.162 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.95 121.66 4.97 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.939 1.296 . . . . 72.549999999999997 111.969 -175.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -82.28 -27.03 32.61 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.942 -1.026 . . . . 71.219999999999999 109.132 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.577 HD13 ' CE1' ' A' ' 349' ' ' TYR . 2.9 mp -116.52 131.48 23.84 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 106.779 -1.563 . . . . 75.200000000000003 106.779 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.53 107.01 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.571 2.18 . . . . 71.340000000000003 112.909 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 102.22 0.91 51.02 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.621 -0.718 . . . . 75.109999999999999 112.861 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.494 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 22.0 t70 -129.67 101.38 5.88 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.398 0.618 . . . . 72.519999999999996 109.617 -177.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . 0.432 ' HB2' ' OE2' ' A' ' 381' ' ' GLU . 32.6 m-80 -87.1 38.01 0.79 Allowed 'General case' 0 CA--C 1.5 -0.96 0 O-C-N 121.556 -0.715 . . . . 74.099999999999994 110.684 -174.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 0.509 ' O ' ' HA3' ' A' ' 335' ' ' GLY . 14.3 m -86.3 157.43 19.91 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.703 0.763 . . . . 75.420000000000002 111.202 -176.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 38.4 mm -75.63 122.82 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.563 0 N-CA-C 106.606 -1.627 . . . . 74.140000000000001 106.606 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.577 ' CE1' HD13 ' A' ' 342' ' ' ILE . 3.5 t80 -124.0 133.78 53.6 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 108.319 -0.993 . . . . 74.109999999999999 108.319 -173.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 43.9 t -74.82 109.78 8.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.851 -0.613 . . . . 73.310000000000002 109.581 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' THR . . . . . 0.553 ' O ' ' HD2' ' A' ' 352' ' ' LYS . 8.6 m -90.78 -36.73 14.1 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.975 -0.557 . . . . 74.439999999999998 109.976 -178.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.558 ' HZ1' ' CD ' ' B' ' 148' ' ' GLU . 1.2 mptm? -144.6 156.46 44.14 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.099 -0.704 . . . . 74.140000000000001 109.099 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 71.6 mt -125.35 129.51 73.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 106.284 -1.747 . . . . 73.230000000000004 106.284 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 47.2 mm -85.64 141.83 13.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 123.525 0.516 . . . . 73.310000000000002 110.186 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.03 120.87 8.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.286 1.034 . . . . 72.140000000000001 112.584 -174.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 72.59 14.49 77.68 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 115.281 -0.872 . . . . 64.5 112.97 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -73.54 168.42 53.95 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.213 -1.155 . . . . 74.340000000000003 110.213 176.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -58.76 -39.11 80.03 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 117.312 0.556 . . . . 72.329999999999998 110.346 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . 0.599 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -72.58 -15.16 61.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.225 0.536 . . . . 65.530000000000001 111.94 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -95.19 -23.56 17.22 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.959 -0.756 . . . . 74.450000000000003 108.959 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 4.0 tmmt? -95.76 -60.16 1.71 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.649 0.738 . . . . 75.310000000000002 111.062 -175.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -86.94 -31.14 20.82 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.336 1.065 . . . . 74.310000000000002 109.426 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.777 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -53.61 -50.41 53.66 Favored Glycine 0 CA--C 1.481 -2.072 0 N-CA-C 119.135 2.414 . . . . 61.329999999999998 119.135 -167.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.777 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 43.8 34.17 0.83 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.253 1.025 . . . . 74.400000000000006 109.676 -167.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 21.7 tp -92.2 158.27 16.25 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 113.547 -1.66 . . . . 71.450000000000003 109.752 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -117.07 144.3 44.8 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.726 0.774 . . . . 71.099999999999994 110.845 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 71.0 mt -65.85 119.99 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 106.108 -1.812 . . . . 72.329999999999998 106.108 167.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.409 ' HA2' ' CE2' ' A' ' 349' ' ' TYR . . . 115.46 3.45 20.72 Favored Glycine 0 C--N 1.295 -1.699 0 C-N-CA 119.669 -1.253 . . . . 50.240000000000002 112.16 -173.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.8 137.19 40.36 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 113.139 0.792 . . . . 74.030000000000001 113.139 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -100.47 115.28 29.71 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.13 -1.063 . . . . 71.530000000000001 108.13 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 60.5 mt -84.67 115.51 22.7 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.236 0.541 . . . . 74.519999999999996 110.246 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.77 -37.11 27.68 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.837 -1.529 . . . . 63.539999999999999 107.695 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.34 157.25 19.85 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.79 -0.641 . . . . 71.219999999999999 111.216 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.88 122.93 43.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 107.569 -1.271 . . . . 74.219999999999999 107.569 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 62.2 29.32 17.44 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 124.036 1.874 . . . . 55.530000000000001 108.853 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 67.21 10.42 7.7 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 109.515 -3.493 . . . . 73.129999999999995 113.479 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.9 t -79.94 124.49 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 106.576 -1.639 . . . . 74.129999999999995 106.576 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -64.35 127.51 31.79 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.009 0.744 . . . . 75.5 113.009 -175.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 6.9 mp -106.31 6.71 30.83 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 123.865 0.866 . . . . 74.219999999999999 110.973 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -76.91 122.97 25.6 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.16 -1.792 . . . . 71.349999999999994 106.16 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . 0.432 ' OE2' ' HB2' ' A' ' 346' ' ' ASN 0.32 1.5 mp0 48.52 83.09 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 116.062 1.875 . . . . 74.109999999999999 116.062 -172.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 15.8 m -149.85 157.82 6.12 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-N 113.428 -1.714 . . . . 72.439999999999998 107.735 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.8 m -81.16 140.73 34.81 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.424 -0.954 . . . . 75.230000000000004 108.424 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . 0.557 ' O ' HG22 ' A' ' 388' ' ' VAL . 82.6 t60 -50.93 -46.18 60.77 Favored 'General case' 0 C--O 1.207 -1.168 0 N-CA-C 112.993 0.738 . . . . 74.430000000000007 112.993 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -59.24 -40.45 85.98 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.966 0.888 . . . . 73.109999999999999 109.677 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.0 tt0 -72.52 -39.76 67.33 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.074 -1.421 . . . . 72.200000000000003 108.856 -173.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -71.35 -46.17 61.17 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.449 -1.251 . . . . 63.350000000000001 110.997 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 384' ' ' HIS . 57.9 t -59.98 -41.64 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 109.872 -0.418 . . . . 74.049999999999997 109.872 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 62.2 m -58.9 -35.63 73.35 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 123.443 0.464 . . . . 73.510000000000005 110.478 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.31 -34.54 78.57 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 122.075 -0.391 . . . . 74.209999999999994 110.82 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 5.9 mp -80.74 -30.3 36.21 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 120.426 -0.509 . . . . 74.230000000000004 110.943 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.402 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 51.7 mttm -73.91 -23.54 59.56 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.23 0.456 . . . . 75.25 112.23 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -77.69 49.41 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.371 0.605 . . . . 71.030000000000001 110.562 175.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' THR . . . . . 0.425 ' OG1' HD12 ' A' ' 329' ' ' LEU . 21.5 p -124.77 142.35 51.48 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 109.472 -0.566 . . . . 75.319999999999993 109.472 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 62.1 m -144.48 99.09 3.31 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 122.571 1.177 . . . . 72.010000000000005 112.076 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . 0.624 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 7.7 m-20 65.58 12.36 8.16 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 111.023 -2.808 . . . . 73.030000000000001 112.819 168.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -160.76 129.37 4.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.332 -1.729 . . . . 74.450000000000003 106.332 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.7 t -139.53 141.74 34.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 107.668 -1.234 . . . . 72.219999999999999 107.668 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . 0.435 ' HH ' ' HG3' ' A' ' 319' ' ' GLU . 28.2 t80 -118.5 95.93 5.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.756 -1.572 . . . . 75.420000000000002 106.756 174.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.58 130.72 35.85 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 122.785 0.434 . . . . 73.120000000000005 110.571 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -116.21 108.97 16.8 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.178 -1.045 . . . . 72.510000000000005 108.178 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 7.9 p -113.38 155.39 14.6 Favored 'Isoleucine or valine' 0 C--O 1.269 2.113 0 CA-C-N 116.035 -0.53 . . . . 74.219999999999999 110.449 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -136.62 157.58 46.44 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.422 -1.325 . . . . 74.329999999999998 107.422 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' A' ' 404' ' ' LYS . 9.7 mmpt? . . . . . 0 C--N 1.306 -1.312 0 N-CA-C 107.302 -1.37 . . . . 73.530000000000001 107.302 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . 0.479 ' C ' HD21 ' B' ' 147' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.499 -1.0 0 N-CA-C 111.991 0.367 . . . . 71.510000000000005 111.991 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . 0.558 ' CD ' ' HZ1' ' A' ' 352' ' ' LYS . 11.9 pt-20 -96.33 145.69 25.39 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.668 -1.234 . . . . 75.439999999999998 107.668 172.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 65.7 m -147.4 144.23 28.53 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.992 -0.443 . . . . 74.340000000000003 110.011 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 331' ' ' PHE . 12.7 tt0 -76.34 136.08 39.55 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.096 0.474 . . . . 73.310000000000002 110.593 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 4.3 m . . . . . 0 C--N 1.292 -1.912 0 CA-C-N 115.59 -0.732 . . . . 72.319999999999993 110.309 173.013 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 C--O 1.202 -1.442 0 N-CA-C 106.242 -1.762 . . . . 71.439999999999998 106.242 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 401' ' ' LYS 0.343 1.8 pm0 -118.24 136.94 53.36 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 114.919 1.452 . . . . 64.420000000000002 114.919 -174.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 363' ' ' GLY . 75.3 mt -126.23 114.38 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 CA-C-N 113.214 -1.812 . . . . 73.25 110.048 -172.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.463 ' HG3' ' CZ ' ' A' ' 397' ' ' PHE . 0.9 OUTLIER -79.71 136.43 36.77 Favored 'General case' 0 C--N 1.279 -2.498 0 N-CA-C 107.718 -1.216 . . . . 71.319999999999993 107.718 172.046 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.529 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 97.0 mt -131.63 157.26 44.15 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.581 -0.525 . . . . 74.439999999999998 109.581 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 324' ' ' LYS . 2.4 mp -106.27 140.97 22.65 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 N-CA-C 106.006 -1.85 . . . . 74.200000000000003 106.006 171.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.468 ' HG2' ' H ' ' A' ' 325' ' ' GLY . 1.3 ttpm? -75.36 177.85 6.3 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.007 -1.108 . . . . 73.129999999999995 108.007 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . 0.468 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -160.91 -172.26 27.97 Favored Glycine 0 C--N 1.284 -2.325 0 N-CA-C 110.848 -0.901 . . . . 73.530000000000001 110.848 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.12 -13.95 28.74 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.879 2.386 . . . . 73.519999999999996 112.064 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.531 ' HB3' ' HZ1' ' A' ' 327' ' ' LYS . 9.0 mtpm? -115.18 20.08 15.2 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 115.973 -0.558 . . . . 74.129999999999995 110.996 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.44 -127.12 7.96 Favored Glycine 0 C--N 1.299 -1.492 0 N-CA-C 110.643 -0.983 . . . . 61.100000000000001 110.643 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.9 mp -105.83 -27.19 11.4 Favored 'General case' 0 C--O 1.268 2.054 0 N-CA-C 108.235 -1.024 . . . . 74.140000000000001 108.235 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 86.08 49.45 4.24 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 114.054 -1.43 . . . . 72.400000000000006 115.695 173.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -155.07 145.06 21.67 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 117.097 0.449 . . . . 75.230000000000004 111.144 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 14.5 m -96.34 126.38 41.5 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 124.005 0.922 . . . . 73.430000000000007 109.233 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 28.0 pt -117.11 144.37 25.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 116.28 -0.418 . . . . 73.319999999999993 111.377 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' B' ' 148' ' ' GLU . . . -130.99 136.16 48.27 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.414 -1.698 . . . . 73.329999999999998 106.414 174.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.556 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 145.12 161.45 9.06 Favored Glycine 0 C--N 1.268 -3.241 0 N-CA-C 109.685 -1.366 . . . . 72.120000000000005 109.685 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.82 173.49 13.22 Favored Glycine 0 N--CA 1.418 -2.512 0 N-CA-C 107.245 -2.342 . . . . 63.100000000000001 107.245 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 66.3 t -53.11 107.49 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 118.137 0.969 . . . . 72.239999999999995 110.554 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.45 -18.47 57.34 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.109 -0.951 . . . . 71.239999999999995 112.586 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.556 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 60.1 t30 -106.5 18.2 22.27 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.655 -0.498 . . . . 74.219999999999999 109.655 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.68 120.09 4.86 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.828 -0.624 . . . . 75.129999999999995 111.297 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -76.96 -40.24 47.63 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.431 -0.804 . . . . 74.340000000000003 109.803 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.2 mm -104.29 120.72 49.85 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 115.736 -0.665 . . . . 75.010000000000005 109.715 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.6 106.61 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 123.28 2.653 . . . . 74.010000000000005 112.349 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 107.96 -3.42 33.72 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 115.475 -0.784 . . . . 74.519999999999996 111.881 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.437 ' CG ' ' HH ' ' A' ' 349' ' ' TYR . 12.7 t70 -132.38 98.0 4.26 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.569 -0.9 . . . . 72.109999999999999 108.569 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -83.37 38.05 0.59 Allowed 'General case' 0 CA--C 1.553 1.068 0 CA-C-O 121.953 0.882 . . . . 75.439999999999998 111.89 -170.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 73.7 m -102.12 178.46 4.6 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.682 -0.69 . . . . 72.310000000000002 112.765 -178.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.413 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 31.3 mm -88.94 129.37 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 114.969 -1.014 . . . . 70.25 108.644 -178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 35.6 m-85 -124.06 140.43 52.98 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.195 0.521 . . . . 75.120000000000005 111.691 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 42.7 t -78.94 111.0 15.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.132 -0.94 . . . . 73.239999999999995 109.243 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 25.7 m -88.28 -30.46 19.62 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.198 0.523 . . . . 74.030000000000001 110.882 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.417 ' HD3' ' N ' ' A' ' 353' ' ' ILE . 9.1 tmtt? -155.36 137.83 15.0 Favored 'General case' 0 C--O 1.203 -1.385 0 N-CA-C 108.284 -1.006 . . . . 73.040000000000006 108.284 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . 0.417 ' N ' ' HD3' ' A' ' 352' ' ' LYS . 74.1 mt -109.17 129.73 63.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.632 -1.247 . . . . 73.549999999999997 107.632 174.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 49.7 mm -77.47 126.33 37.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.358 0.599 . . . . 75.209999999999994 110.037 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 355' ' ' GLU . 1.4 pm0 -62.31 127.04 29.45 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 114.39 -1.277 . . . . 75.310000000000002 110.739 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.56 -19.56 53.72 Favored Glycine 0 N--CA 1.426 -1.994 0 CA-C-N 115.021 -0.99 . . . . 62.32 112.533 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -68.19 167.03 43.82 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 114.278 0.471 . . . . 72.200000000000003 114.278 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -61.26 -41.99 97.85 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.313 0.645 . . . . 52.240000000000002 111.132 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -75.11 -7.74 54.61 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 119.692 -0.803 . . . . 72.510000000000005 111.954 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -94.09 -30.53 14.62 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.928 -0.767 . . . . 73.400000000000006 108.928 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -89.65 -59.65 2.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.028 -0.533 . . . . 73.400000000000006 111.671 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -87.14 -38.96 15.96 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 108.608 -0.886 . . . . 72.200000000000003 108.608 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.521 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -44.68 -31.25 2.51 Favored Glycine 0 C--O 1.207 -1.57 0 N-CA-C 119.195 2.438 . . . . 71.340000000000003 119.195 -167.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.521 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 41.37 32.21 0.2 Allowed 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 118.803 1.302 . . . . 75.310000000000002 111.377 -174.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 43.7 tp -98.11 155.07 17.32 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.551 -1.204 . . . . 74.310000000000002 109.474 -170.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -125.08 150.98 46.27 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.344 0.592 . . . . 75.540000000000006 111.267 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 75.9 mt -65.95 122.98 17.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.297 -1.001 . . . . 72.340000000000003 108.297 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 113.25 -2.3 25.29 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.686 -0.769 . . . . 63.420000000000002 112.126 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 3.5 m-20 -72.13 136.68 46.59 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 112.83 0.678 . . . . 73.439999999999998 112.83 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.623 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 33.9 tttp -96.2 115.28 27.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.213 1.405 . . . . 74.120000000000005 109.648 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 68.3 mt -85.21 118.92 25.05 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.156 0.503 . . . . 74.329999999999998 109.693 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.3 tt -87.61 -39.38 15.11 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.074 -1.421 . . . . 65.219999999999999 108.093 -176.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -160.77 156.09 24.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.05 -0.523 . . . . 71.430000000000007 111.095 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p -134.74 123.33 41.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 108.139 -1.06 . . . . 73.549999999999997 108.139 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 62.32 29.55 17.32 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 123.516 1.627 . . . . 74.400000000000006 108.282 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 67.0 18.87 10.61 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 110.449 -3.068 . . . . 72.519999999999996 112.331 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 50.7 t -88.91 128.22 41.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 106.505 -1.665 . . . . 75.120000000000005 106.505 172.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.9 p -64.4 124.75 22.58 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 113.126 0.788 . . . . 74.510000000000005 113.126 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.5 mp -108.27 -2.48 19.24 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.561 0.745 . . . . 71.420000000000002 111.224 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -68.2 107.6 2.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.952 -0.567 . . . . 64.0 109.605 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 60.66 74.91 0.43 Allowed 'General case' 0 CA--C 1.545 0.775 0 O-C-N 124.619 1.199 . . . . 72.519999999999996 113.296 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 24.1 m -135.05 167.09 26.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.183 -1.414 . . . . 72.329999999999998 107.183 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 51.6 p -79.73 141.22 36.56 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 118.918 0.781 . . . . 71.049999999999997 110.325 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . 0.477 ' O ' HG22 ' A' ' 388' ' ' VAL . 82.7 t60 -45.56 -49.27 14.12 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.672 0.99 . . . . 73.420000000000002 113.672 -174.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -61.33 -38.78 88.13 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.212 0.53 . . . . 73.530000000000001 111.54 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.0 tt0 -70.46 -35.05 73.1 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.511 -0.922 . . . . 75.299999999999997 108.511 -177.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.409 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -70.54 -53.91 14.24 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 114.441 -1.254 . . . . 61.219999999999999 110.582 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 384' ' ' HIS . 44.5 t -59.54 -43.36 90.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 C-N-CA 121.147 -0.221 . . . . 71.140000000000001 110.57 -177.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 53.8 m -62.04 -30.32 70.89 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 111.953 0.353 . . . . 75.109999999999999 111.953 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.13 -35.08 78.98 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 122.124 -0.36 . . . . 74.409999999999997 110.331 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.7 mp -80.57 -28.61 37.15 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 120.394 -0.523 . . . . 73.310000000000002 110.783 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 54.3 mttm -74.31 -24.23 59.19 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.576 -0.45 . . . . 74.510000000000005 111.536 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -82.16 65.2 7.18 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.347 1.07 . . . . 71.519999999999996 110.19 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 13.3 p -130.65 145.63 51.96 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 113.987 -1.46 . . . . 74.150000000000006 107.679 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 43.8 m -141.77 91.28 2.35 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 122.568 1.175 . . . . 75.329999999999998 111.25 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . 0.343 12.4 m-20 65.16 4.79 2.72 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 111.438 -2.619 . . . . 73.319999999999993 115.616 172.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . 0.463 ' CZ ' ' HG3' ' A' ' 321' ' ' LYS . 37.6 t80 -151.85 134.52 15.5 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 106.368 -1.716 . . . . 73.209999999999994 106.368 171.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.8 t -138.29 145.69 28.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.812 -1.181 . . . . 75.530000000000001 107.812 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -126.0 96.1 4.63 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.027 -1.101 . . . . 74.099999999999994 108.027 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 tt -92.63 132.84 36.54 Favored 'General case' 0 C--N 1.277 -2.546 0 C-N-CA 123.031 0.532 . . . . 75.040000000000006 110.739 -174.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 319' ' ' GLU . 65.8 mttm -114.31 118.72 34.7 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.152 -0.684 . . . . 73.230000000000004 109.152 174.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 3.6 p -118.58 149.04 21.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 CA-C-N 115.048 -0.978 . . . . 75.120000000000005 109.979 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.623 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.45 159.32 42.15 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 125.119 1.368 . . . . 72.239999999999995 107.337 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 12.6 mptt . . . . . 0 C--N 1.291 -1.947 0 N-CA-C 109.267 -0.642 . . . . 75.140000000000001 109.267 175.627 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 C--O 1.245 0.833 0 N-CA-C 107.494 -1.298 . . . . 74.140000000000001 107.494 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 334' ' ' ALA . 0.9 OUTLIER -95.96 157.18 16.01 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.232 0.539 . . . . 74.310000000000002 110.948 174.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 51.6 m -147.84 146.85 29.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.726 -0.842 . . . . 74.409999999999997 108.726 174.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 1.2 tt0 -79.79 137.84 37.09 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 120.996 0.427 . . . . 74.519999999999996 110.952 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.426 -1.633 0 CA-C-N 115.711 -0.677 . . . . 74.209999999999994 110.767 174.501 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' MET . . . . . 0.593 ' SD ' ' HE3' ' A' ' 404' ' ' LYS . 27.5 ttt . . . . . 0 CA--C 1.495 -1.168 0 N-CA-C 107.041 -1.466 . . . . 74.319999999999993 107.041 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.325 2.3 pm0 -115.87 137.56 51.99 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-O 122.202 1.001 . . . . 75.540000000000006 113.658 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 363' ' ' GLY . 70.2 mt -128.62 130.49 68.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 113.225 -1.807 . . . . 73.0 108.155 -169.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -108.07 107.66 18.42 Favored 'General case' 0 N--CA 1.411 -2.387 0 N-CA-C 108.348 -0.982 . . . . 73.540000000000006 108.348 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 93.3 mt -105.65 160.07 15.48 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.346 -0.843 . . . . 74.439999999999998 110.055 -176.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.2 113.41 42.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 N-CA-C 108.148 -1.056 . . . . 74.450000000000003 108.148 171.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.506 ' HB3' ' H ' ' A' ' 396' ' ' ASP . 0.0 OUTLIER -67.13 140.87 57.56 Favored 'General case' 0 C--O 1.207 -1.168 0 N-CA-C 106.953 -1.499 . . . . 74.430000000000007 106.953 174.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . 0.502 ' N ' ' HD2' ' A' ' 324' ' ' LYS . . . -142.31 -161.2 8.67 Favored Glycine 0 C--N 1.27 -3.099 0 CA-C-O 119.946 -0.363 . . . . 75.420000000000002 112.498 -171.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.94 -12.92 37.43 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 123.829 3.02 . . . . 51.229999999999997 113.507 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -109.43 5.96 23.83 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.175 0.988 . . . . 71.409999999999997 108.932 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.99 -121.35 5.49 Favored Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 108.965 -1.654 . . . . 63.539999999999999 108.965 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.79 -26.2 11.38 Favored 'General case' 0 C--O 1.266 1.952 0 N-CA-C 107.844 -1.169 . . . . 75.219999999999999 107.844 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.41 43.49 6.54 Favored Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 113.707 -1.588 . . . . 63.109999999999999 114.675 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -155.22 151.1 27.72 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 117.056 0.428 . . . . 72.109999999999999 110.286 174.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 29.2 m -106.28 129.58 54.28 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 124.145 0.978 . . . . 74.439999999999998 109.578 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 14.8 pt -114.32 156.63 15.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.776 -0.647 . . . . 74.25 110.666 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -143.68 130.02 19.89 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.896 -1.89 . . . . 73.319999999999993 105.896 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 149.67 153.21 5.98 Favored Glycine 0 C--N 1.27 -3.094 0 N-CA-C 109.012 -1.635 . . . . 62.229999999999997 109.012 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.82 173.1 13.09 Favored Glycine 0 C--N 1.283 -2.39 0 N-CA-C 106.558 -2.617 . . . . 62.020000000000003 106.558 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.8 t -45.75 106.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 118.597 1.198 . . . . 75.120000000000005 111.705 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 93.01 -23.92 27.05 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.541 -0.754 . . . . 64.0 112.27 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.53 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 32.7 t-20 -97.78 19.41 13.75 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.353 -0.98 . . . . 70.310000000000002 108.353 -177.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.1 118.7 3.09 Favored 'General case' 0 C--O 1.257 1.493 0 CA-C-O 121.263 0.554 . . . . 62.310000000000002 110.301 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -77.75 -43.59 30.35 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.075 -0.966 . . . . 73.439999999999998 109.052 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.439 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 39.3 mm -103.65 131.25 22.21 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 108.119 -1.067 . . . . 75.239999999999995 108.119 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.1 110.46 0.48 Allowed 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 123.173 2.582 . . . . 74.239999999999995 113.551 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.86 -3.6 65.11 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.407 -0.815 . . . . 73.310000000000002 112.189 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.439 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 29.2 t0 -119.64 99.69 6.81 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.716 -0.846 . . . . 73.329999999999998 108.716 -176.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -84.0 26.04 0.77 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.532 0.682 . . . . 73.219999999999999 110.845 -171.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 20.0 m -88.5 172.29 9.46 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.369 0.604 . . . . 72.540000000000006 111.762 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 18.3 mm -88.28 122.76 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 115.185 -0.916 . . . . 71.129999999999995 108.575 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 51.2 m-85 -123.62 131.93 53.74 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.031 0.443 . . . . 71.510000000000005 110.748 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.9 t -70.64 120.75 19.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.888 -0.597 . . . . 74.319999999999993 109.4 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 22.4 m -101.03 -23.16 14.56 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.102 0.477 . . . . 73.340000000000003 111.353 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -155.55 137.03 14.09 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 107.618 -1.253 . . . . 74.120000000000005 107.618 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 73.4 mt -108.94 126.03 65.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.099 -1.445 . . . . 74.540000000000006 107.099 172.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 49.7 mm -74.48 134.9 28.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.293 0.568 . . . . 64.420000000000002 109.853 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 355' ' ' GLU . 1.4 pm0 -62.39 120.84 11.81 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-O 122.45 1.119 . . . . 74.019999999999996 111.588 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 79.44 18.63 73.31 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-N 114.284 -1.325 . . . . 71.109999999999999 111.484 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.78 162.75 52.13 Favored Glycine 0 C--O 1.25 1.143 0 N-CA-C 111.783 -0.527 . . . . 75.409999999999997 111.783 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.61 98.97 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.892 -0.781 . . . . 75.329999999999998 108.892 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . 0.457 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.64 -9.29 58.46 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.475 -0.89 . . . . 70.510000000000005 111.917 177.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -88.85 -29.19 19.86 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.596 -0.89 . . . . 74.239999999999995 108.596 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.595 ' NZ ' ' HA ' ' A' ' 361' ' ' LYS . 1.1 mmpm? -95.04 -57.65 2.37 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 113.13 0.789 . . . . 75.299999999999997 113.13 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -85.68 -43.05 13.75 Favored 'General case' 0 CA--C 1.457 -2.628 0 O-C-N 123.771 0.669 . . . . 72.109999999999999 110.647 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.56 ' O ' HD13 ' A' ' 320' ' ' ILE . . . -42.74 -25.5 0.33 Allowed Glycine 0 C--O 1.203 -1.79 0 N-CA-C 119.379 2.512 . . . . 73.310000000000002 119.379 -163.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.465 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.59 34.45 0.56 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 119.133 1.467 . . . . 73.129999999999995 111.265 -178.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . 0.566 HD11 ' N ' ' A' ' 366' ' ' GLN . 2.6 tm? -109.36 148.6 30.81 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.163 -1.38 . . . . 65.409999999999997 107.786 -170.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . 0.566 ' N ' HD11 ' A' ' 365' ' ' LEU . 0.0 OUTLIER -117.06 142.06 47.46 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.796 -0.446 . . . . 75.439999999999998 109.796 -178.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.76 121.3 8.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.111 -1.07 . . . . 64.299999999999997 108.111 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.35 -4.45 21.76 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 111.426 -0.67 . . . . 73.120000000000005 111.426 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.409 ' HB3' HG22 ' A' ' 402' ' ' VAL . 56.3 m-20 -75.63 136.28 40.45 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 113.193 0.812 . . . . 71.519999999999996 113.193 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 36.4 tttp -88.8 119.69 29.52 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 124.658 1.183 . . . . 74.209999999999994 111.135 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.41 124.84 32.46 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.885 -0.783 . . . . 75.329999999999998 108.885 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.466 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 5.3 tt -92.08 -40.16 11.22 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.336 -1.302 . . . . 74.219999999999999 107.965 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -159.86 160.94 34.27 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 116.017 -0.538 . . . . 71.319999999999993 111.733 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.55 117.33 27.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.413 -0.958 . . . . 74.25 108.413 171.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 58.54 36.17 25.04 Favored 'General case' 0 CA--C 1.485 -1.526 0 CA-C-O 123.4 1.571 . . . . 75.530000000000001 109.347 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 66.79 9.55 6.84 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 110.831 -2.895 . . . . 61.240000000000002 113.693 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.9 121.09 31.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.263 -1.754 . . . . 62.299999999999997 106.263 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.8 p -64.35 125.82 25.81 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 113.366 0.876 . . . . 74.409999999999997 113.366 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.1 mp -101.32 7.13 42.94 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.731 -1.122 . . . . 74.409999999999997 109.445 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.466 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 18.4 mm-40 -79.9 111.24 16.03 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.59 -1.186 . . . . 75.239999999999995 108.958 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 61.14 83.57 0.14 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.718 1.207 . . . . 72.329999999999998 112.232 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 19.7 m -153.58 165.21 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 125.563 1.545 . . . . 62.310000000000002 107.139 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.707 ' HB ' ' OE1' ' A' ' 386' ' ' GLU . 2.8 m -85.08 156.85 20.9 Favored 'General case' 0 C--O 1.258 1.539 0 N-CA-C 107.221 -1.4 . . . . 73.239999999999995 107.221 176.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . 0.523 ' O ' HG21 ' A' ' 388' ' ' VAL . 85.7 t60 -57.13 -40.73 77.7 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.303 0.573 . . . . 72.340000000000003 109.988 -170.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -54.68 -46.64 74.1 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 114.187 -1.37 . . . . 71.310000000000002 113.871 177.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.707 ' OE1' ' HB ' ' A' ' 383' ' ' THR . 1.8 mp0 -71.72 -32.14 67.45 Favored 'General case' 0 CA--C 1.476 -1.872 0 CA-C-N 118.711 0.687 . . . . 74.439999999999998 109.423 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.58 ' O ' HD11 ' A' ' 391' ' ' LEU . . . -64.46 -57.72 8.44 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 114.728 -1.124 . . . . 73.209999999999994 109.218 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.523 HG21 ' O ' ' A' ' 384' ' ' HIS . 21.7 t -61.35 -41.76 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 116.446 -0.343 . . . . 74.530000000000001 110.55 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 90.4 m -62.13 -34.35 76.2 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.071 -0.513 . . . . 64.530000000000001 111.433 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.08 80.05 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.522 -0.111 . . . . 71.5 110.859 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.58 HD11 ' O ' ' A' ' 387' ' ' ALA . 5.1 mp -79.66 -32.47 41.55 Favored 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 119.217 -0.993 . . . . 70.310000000000002 110.777 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -65.21 -35.41 80.97 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 112.663 0.616 . . . . 71.420000000000002 112.663 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -83.57 62.08 6.62 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.803 0.811 . . . . 74.400000000000006 110.926 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' THR . . . . . 0.414 ' HB ' HG21 ' A' ' 398' ' ' VAL . 41.9 p -132.28 149.52 52.35 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 107.526 -1.287 . . . . 73.340000000000003 107.526 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' SER . . . . . 0.429 ' HA ' ' HE3' ' A' ' 324' ' ' LYS . 34.9 p -141.96 100.99 3.85 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 118.461 -1.296 . . . . 72.329999999999998 112.578 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . 0.506 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 3.5 m-20 63.38 7.27 2.84 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 112.504 -2.135 . . . . 71.310000000000002 113.621 170.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -152.64 115.25 4.52 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 106.033 -1.84 . . . . 64.329999999999998 106.033 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 52.4 t -128.28 113.81 31.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 108.342 -0.984 . . . . 75.519999999999996 108.342 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -95.15 95.53 8.61 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.393 -1.336 . . . . 72.010000000000005 107.393 174.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.3 tt -89.97 139.02 31.01 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 116.147 -0.479 . . . . 72.319999999999993 109.748 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 40.6 tttp -126.84 111.7 14.48 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 108.403 -0.962 . . . . 73.25 108.403 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 369' ' ' ASP . 2.1 p -115.05 145.94 20.13 Favored 'Isoleucine or valine' 0 C--O 1.266 1.96 0 C-N-CA 123.732 0.813 . . . . 74.120000000000005 110.597 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.74 147.77 46.89 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 106.266 -1.753 . . . . 75.510000000000005 106.266 174.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.593 ' HE3' ' SD ' ' A' ' 318' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.881 0 C-N-CA 119.774 -0.77 . . . . 74.310000000000002 109.102 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . 0.424 ' C ' HD21 ' B' ' 147' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.504 -0.793 0 N-CA-C 110.521 -0.177 . . . . 72.319999999999993 110.521 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.51 166.62 11.77 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.185 0.517 . . . . 74.400000000000006 111.8 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 40.7 m -146.06 123.97 12.01 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.736 -0.665 . . . . 75.049999999999997 109.608 166.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -68.25 130.14 42.02 Favored 'General case' 0 C--O 1.257 1.468 0 N-CA-C 108.563 -0.903 . . . . 72.319999999999993 108.563 172.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.296 -1.726 0 CA-C-O 117.228 -1.368 . . . . 74.510000000000005 109.09 178.168 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 CA--C 1.485 -1.521 0 N-CA-C 106.309 -1.738 . . . . 75.439999999999998 106.309 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.477 2.0 pm0 -119.09 127.09 53.06 Favored 'General case' 0 N--CA 1.406 -2.641 0 N-CA-C 116.936 2.198 . . . . 65.310000000000002 116.936 -174.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.403 HG21 ' CD ' ' A' ' 364' ' ' LYS . 64.5 mt -102.54 106.17 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.623 0 CA-C-N 111.524 -2.58 . . . . 74.400000000000006 109.715 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.484 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 28.9 ttpt -80.81 110.72 16.59 Favored 'General case' 0 N--CA 1.41 -2.427 0 N-CA-C 106.319 -1.734 . . . . 75.209999999999994 106.319 170.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.435 ' HA ' ' OD2' ' A' ' 362' ' ' ASP . 0.6 OUTLIER -110.33 145.7 37.01 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 113.944 -1.48 . . . . 73.349999999999994 109.734 -171.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 39.0 mm -105.2 116.8 49.71 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-O 121.306 0.574 . . . . 75.310000000000002 110.606 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.589 ' HD2' ' N ' ' A' ' 396' ' ' ASP . 9.7 tmtt? -65.89 156.78 32.38 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.948 -1.024 . . . . 73.400000000000006 110.783 175.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -140.44 -165.97 10.5 Favored Glycine 0 C--N 1.303 -1.284 0 N-CA-C 110.748 -0.941 . . . . 73.209999999999994 110.748 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.91 -21.51 64.0 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 122.877 2.385 . . . . 71.409999999999997 112.59 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -91.61 -9.97 42.18 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.132 0.968 . . . . 74.230000000000004 110.449 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 97.42 -112.76 4.54 Favored Glycine 0 C--N 1.272 -3.014 0 N-CA-C 108.381 -1.887 . . . . 75.010000000000005 108.381 -171.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.13 -35.64 6.26 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 117.89 0.845 . . . . 70.129999999999995 109.589 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 84.48 50.72 4.14 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.841 -1.171 . . . . 72.420000000000002 114.903 175.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 54.4 p90 -155.07 163.04 40.83 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 117.146 0.473 . . . . 73.310000000000002 110.239 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 66.2 m -108.78 132.72 53.7 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 109.757 -0.46 . . . . 73.010000000000005 109.757 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 19.3 pt -122.84 149.6 26.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 109.863 -0.421 . . . . 70.120000000000005 109.863 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.7 129.3 16.04 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.537 -0.912 . . . . 74.329999999999998 108.537 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 165.1 -178.24 40.23 Favored Glycine 0 C--N 1.283 -2.393 0 N-CA-C 108.63 -1.788 . . . . 74.430000000000007 108.63 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.03 173.22 13.22 Favored Glycine 0 C--N 1.279 -2.592 0 N-CA-C 108.466 -1.853 . . . . 54.219999999999999 108.466 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 90.6 t -56.15 100.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 117.682 0.741 . . . . 74.329999999999998 110.623 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 88.33 -2.08 84.79 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.373 -0.83 . . . . 54.520000000000003 112.616 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.438 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 63.2 t30 -109.02 3.55 22.23 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.575 0.702 . . . . 74.310000000000002 109.644 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER -61.39 127.29 30.76 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 115.042 1.497 . . . . 73.299999999999997 115.042 -174.299 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -66.67 -32.25 73.45 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.876 -1.511 . . . . 73.450000000000003 110.809 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 43.3 mm -104.64 114.61 63.83 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 116.319 -0.4 . . . . 74.340000000000003 110.033 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.23 111.19 0.78 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.888 2.392 . . . . 74.120000000000005 111.789 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.07 -22.98 20.09 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.84 -0.695 . . . . 65.239999999999995 111.607 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -112.39 106.97 15.61 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.175 -0.676 . . . . 71.109999999999999 109.175 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -85.22 63.04 7.87 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.502 0.668 . . . . 75.010000000000005 111.095 -173.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 0.461 ' HB2' ' CE1' ' A' ' 349' ' ' TYR . 7.2 m -119.06 177.68 4.78 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 119.588 -0.845 . . . . 73.140000000000001 111.861 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 26.0 mm -98.15 131.67 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 N-CA-C 106.052 -1.833 . . . . 71.310000000000002 106.052 176.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' A' ' 347' ' ' SER . 42.7 m-85 -123.72 132.55 53.85 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.574 0.583 . . . . 71.030000000000001 112.574 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.16 112.46 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.865 -1.062 . . . . 72.420000000000002 108.527 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.1 m -92.8 -28.69 16.41 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.458 0.647 . . . . 72.420000000000002 109.973 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 331' ' ' PHE . 54.3 tttm -155.89 153.57 29.87 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 108.249 -1.019 . . . . 72.319999999999993 108.249 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 86.9 mt -118.22 144.23 26.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 104.873 -2.269 . . . . 71.420000000000002 104.873 169.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 39.6 mm -79.92 129.68 37.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.69 -0.485 . . . . 74.329999999999998 109.69 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 355' ' ' GLU . 1.4 pm0 -63.78 105.02 0.75 Allowed 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.461 -1.245 . . . . 74.209999999999994 111.265 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.97 -2.35 63.9 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 114.521 -1.218 . . . . 74.299999999999997 112.387 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -69.99 172.04 41.15 Favored Glycine 0 C--O 1.244 0.76 0 O-C-N 123.697 0.293 . . . . 74.140000000000001 112.65 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -57.34 -44.12 84.02 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 122.976 0.511 . . . . 64.329999999999998 110.894 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . 0.47 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.26 -9.87 58.94 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.726 0.639 . . . . 73.329999999999998 112.726 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -94.57 -24.3 17.29 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.19 -1.041 . . . . 75.239999999999995 108.19 177.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -89.93 -60.13 2.01 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-O 121.579 0.704 . . . . 73.430000000000007 110.054 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . 0.435 ' OD2' ' HA ' ' A' ' 322' ' ' LEU . 24.1 t70 -87.5 -44.66 11.13 Favored 'General case' 0 CA--C 1.46 -2.502 0 CA-C-N 114.588 -1.187 . . . . 72.409999999999997 111.485 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -42.82 -24.97 0.28 Allowed Glycine 0 CA--C 1.491 -1.46 0 N-CA-C 119.711 2.645 . . . . 75.200000000000003 119.711 -162.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.469 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 41.68 37.12 0.68 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 118.556 1.178 . . . . 74.430000000000007 111.34 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 39.8 tp -108.22 158.16 17.69 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.33 -1.304 . . . . 75.340000000000003 110.355 -169.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -121.26 143.66 49.04 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.646 0.736 . . . . 73.430000000000007 110.756 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.48 126.35 25.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.235 -1.395 . . . . 73.340000000000003 107.235 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.91 -1.36 30.19 Favored Glycine 0 C--N 1.302 -1.307 0 C-N-CA 120.574 -0.822 . . . . 73.010000000000005 111.965 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 5.1 m-20 -66.46 132.07 47.45 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 113.239 0.829 . . . . 65.129999999999995 113.239 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 39.9 tttp -92.19 114.28 26.79 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.68 1.192 . . . . 73.310000000000002 108.752 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 91.7 mt -85.14 116.38 23.47 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.533 -0.467 . . . . 72.519999999999996 110.224 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.1 tt -88.02 -39.13 14.91 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.999 -1.482 . . . . 74.400000000000006 106.999 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -166.95 156.0 10.47 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.648 -0.705 . . . . 75.549999999999997 110.204 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.81 122.74 39.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.968 -0.753 . . . . 75.25 108.968 173.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 60.89 35.32 19.29 Favored 'General case' 0 CA--C 1.482 -1.655 0 CA-C-O 123.713 1.72 . . . . 73.099999999999994 108.895 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 67.6 7.09 5.39 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 110.174 -3.194 . . . . 73.040000000000006 113.396 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 60.7 t -79.87 123.78 37.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 107.014 -1.476 . . . . 74.209999999999994 107.014 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.7 p -63.92 124.2 20.94 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.093 0.775 . . . . 71.510000000000005 113.093 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.74 -6.09 13.88 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.637 0.775 . . . . 70.120000000000005 110.216 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -72.58 105.07 4.08 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.337 -1.356 . . . . 73.329999999999998 107.337 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . 0.269 20.1 tt0 60.3 78.88 0.26 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.371 1.468 . . . . 73.209999999999994 113.829 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 30.5 m -147.04 175.15 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 107.592 -1.262 . . . . 72.409999999999997 107.592 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 75.0 p -81.06 155.22 26.43 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.442 -0.948 . . . . 64.299999999999997 108.442 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . 0.565 ' O ' HG22 ' A' ' 388' ' ' VAL . 8.6 t-160 -58.93 -41.26 86.91 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.226 -0.657 . . . . 74.239999999999995 109.226 -172.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -51.03 -44.94 61.13 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.659 -1.155 . . . . 72.519999999999996 113.492 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.2 -33.37 74.3 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.547 0.689 . . . . 75.409999999999997 109.268 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -74.08 -58.8 3.06 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.488 -1.233 . . . . 75.430000000000007 110.417 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 384' ' ' HIS . 15.7 t -58.31 -40.18 76.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 O-C-N 123.292 0.37 . . . . 63.310000000000002 110.314 -176.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 95.6 m -63.26 -36.81 84.9 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.298 -0.41 . . . . 72.030000000000001 110.751 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.57 -34.75 77.68 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.396 -0.19 . . . . 74.230000000000004 110.739 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.49 -32.49 60.58 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 120.67 -0.412 . . . . 74.439999999999998 110.704 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 57.7 mttm -72.99 -26.44 61.34 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 120.57 -0.452 . . . . 62.240000000000002 112.145 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -80.83 48.88 1.13 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.988 -0.551 . . . . 72.400000000000006 110.619 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' THR . . . . . 0.416 ' HB ' HG22 ' A' ' 398' ' ' VAL . 41.7 p -124.43 147.93 47.96 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.438 -0.579 . . . . 73.439999999999998 109.438 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 65.9 m -147.4 99.08 3.09 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 122.512 1.149 . . . . 70.209999999999994 112.003 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . 0.589 ' N ' ' HD2' ' A' ' 324' ' ' LYS . 8.4 m-20 65.26 13.02 8.5 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 111.195 -2.73 . . . . 73.549999999999997 113.218 168.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -165.72 129.08 2.16 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 106.863 -1.532 . . . . 74.099999999999994 106.863 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.416 HG22 ' HB ' ' A' ' 394' ' ' THR . 38.9 t -142.39 142.75 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 122.735 0.414 . . . . 73.329999999999998 110.361 -177.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . 0.484 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 13.0 m-85 -118.68 95.6 4.91 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.811 -0.811 . . . . 73.150000000000006 108.811 168.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.4 tt -93.7 121.3 34.99 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 123.383 0.673 . . . . 75.109999999999999 109.744 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -103.31 107.7 18.62 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.7 -0.852 . . . . 74.129999999999995 108.7 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 10.2 p -114.63 157.35 15.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 CA-C-N 114.815 -1.084 . . . . 72.209999999999994 110.194 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -135.98 158.6 44.01 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.868 -1.53 . . . . 71.420000000000002 106.868 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.47 ' HA ' ' HE2' ' A' ' 404' ' ' LYS . 10.9 mmpt? . . . . . 0 C--N 1.303 -1.424 0 N-CA-C 108.54 -0.911 . . . . 75.019999999999996 108.54 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 N--CA 1.426 -1.638 0 N-CA-C 106.067 -1.827 . . . . 72.140000000000001 106.067 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.03 161.55 15.08 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 107.44 -1.318 . . . . 75.349999999999994 107.44 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 32.9 m -142.42 104.01 4.34 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 108.353 -0.98 . . . . 72.209999999999994 108.353 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -60.11 132.19 53.17 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.183 -1.372 . . . . 71.109999999999999 110.899 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.442 ' HA ' ' NZ ' ' A' ' 392' ' ' LYS . 17.8 m . . . . . 0 C--O 1.262 1.75 0 CA-C-N 116.082 -0.508 . . . . 71.5 111.163 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 51.8 tpp . . . . . 0 CA--C 1.512 -0.503 0 N-CA-C 108.327 -0.99 . . . . 63.420000000000002 108.327 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.474 2.0 pm0 -117.67 128.67 55.14 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 116.744 2.127 . . . . 70.340000000000003 116.744 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.51 HG23 ' HZ2' ' A' ' 364' ' ' LYS . 70.8 mt -117.33 106.75 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 CA-C-N 111.74 -2.482 . . . . 75.409999999999997 109.793 -174.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 398' ' ' VAL . 40.7 ttmt -85.74 132.6 34.1 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.458 -1.312 . . . . 64.450000000000003 107.458 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.484 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 74.1 mt -129.02 152.12 48.97 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.02 -1.104 . . . . 74.120000000000005 108.02 178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 35.7 mm -106.2 112.34 39.01 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.589 0 N-CA-C 107.781 -1.192 . . . . 73.019999999999996 107.781 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.482 ' HB3' ' H ' ' A' ' 396' ' ' ASP . 0.0 OUTLIER -59.86 135.88 57.83 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 108.608 -0.886 . . . . 75.109999999999999 108.608 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . 0.433 ' N ' ' HD2' ' A' ' 324' ' ' LYS . . . -134.4 -161.12 9.43 Favored Glycine 0 C--N 1.287 -2.158 0 CA-C-N 116.281 -0.418 . . . . 43.219999999999999 113.008 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -62.08 -22.94 75.11 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 123.894 3.062 . . . . 71.109999999999999 114.033 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -109.03 18.06 21.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.255 0.55 . . . . 73.120000000000005 109.93 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.86 -119.19 4.86 Favored Glycine 0 CA--C 1.492 -1.379 0 N-CA-C 109.967 -1.253 . . . . 74.510000000000005 109.967 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.27 -30.5 8.69 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.55 -1.278 . . . . 64.530000000000001 107.55 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.12 50.2 4.19 Favored Glycine 0 N--CA 1.432 -1.57 0 CA-C-N 114.532 -1.213 . . . . 75.329999999999998 115.403 171.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -154.88 159.87 40.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 117.061 0.43 . . . . 74.209999999999994 110.797 172.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 5.8 m -110.07 127.92 55.13 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 109.139 -0.689 . . . . 73.409999999999997 109.139 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 10.1 pt -117.72 154.15 19.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 122.495 0.318 . . . . 75.349999999999994 111.02 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.62 120.38 7.56 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.774 -1.565 . . . . 73.400000000000006 106.774 174.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 156.97 154.52 7.08 Favored Glycine 0 C--N 1.293 -1.831 0 N-CA-C 110.829 -0.908 . . . . 63.229999999999997 110.829 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.55 -177.27 19.36 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 108.484 -1.846 . . . . 60.109999999999999 108.484 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 86.1 t -53.52 108.53 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 117.972 0.886 . . . . 74.140000000000001 111.245 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 88.83 -16.99 53.26 Favored Glycine 0 C--O 1.219 -0.813 0 CA-C-N 115.271 -0.877 . . . . 74.430000000000007 112.419 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.48 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -107.27 9.61 30.01 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.913 -0.773 . . . . 74.010000000000005 108.913 -178.154 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.97 126.26 13.88 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 123.557 0.743 . . . . 70.25 112.26 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -82.34 -45.26 15.13 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.09 -0.959 . . . . 72.040000000000006 110.107 -173.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.7 122.11 45.87 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 108.246 -1.02 . . . . 75.310000000000002 108.246 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.81 105.16 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 123.156 2.571 . . . . 73.129999999999995 112.607 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.82 -6.25 29.37 Favored Glycine 0 N--CA 1.431 -1.64 0 CA-C-N 115.352 -0.84 . . . . 60.229999999999997 112.099 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -127.19 98.92 5.46 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.478 -0.934 . . . . 52.32 108.478 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -82.4 33.63 0.41 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.991 -1.004 . . . . 72.219999999999999 111.827 -170.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 66.7 m -100.35 173.25 6.68 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.807 -0.633 . . . . 74.030000000000001 112.033 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.3 mm -86.27 129.64 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 107.574 -1.269 . . . . 74.439999999999998 107.574 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 27.1 m-85 -123.78 139.48 53.94 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-N 118.384 0.538 . . . . 71.239999999999995 111.572 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 45.3 t -77.04 115.37 18.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.547 -0.751 . . . . 72.549999999999997 109.514 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 24.8 m -91.45 -28.91 17.33 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.973 -0.558 . . . . 70.420000000000002 110.263 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 85.0 mttt -152.52 160.39 43.23 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 109.268 -0.641 . . . . 72.120000000000005 109.268 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 80.0 mt -125.34 135.02 65.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 106.198 -1.779 . . . . 72.150000000000006 106.198 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 44.3 mm -85.27 137.54 20.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 C-N-CA 122.429 0.292 . . . . 71.340000000000003 111.159 -173.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.97 127.84 32.35 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.709 0.766 . . . . 72.140000000000001 112.795 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 70.18 9.86 64.57 Favored Glycine 0 C--N 1.315 -0.626 0 CA-C-N 115.558 -0.746 . . . . 74.129999999999995 112.706 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -74.74 160.63 53.02 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 110.836 -0.906 . . . . 72.140000000000001 110.836 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -59.69 -42.02 92.04 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 109.733 -0.469 . . . . 75.109999999999999 109.733 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . 0.552 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -72.3 -10.67 60.08 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.172 -0.611 . . . . 75.439999999999998 112.431 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -93.99 -29.58 15.17 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.635 -0.876 . . . . 61.43 108.635 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -94.17 -60.49 1.72 Allowed 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 122.955 1.359 . . . . 72.030000000000001 110.398 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -87.45 -25.66 23.64 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 112.47 -2.15 . . . . 74.219999999999999 110.467 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -44.11 -50.34 7.69 Favored Glycine 0 C--N 1.273 -2.967 0 N-CA-C 120.301 2.88 . . . . 65.109999999999999 120.301 -170.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 363' ' ' GLY 0.256 0.0 OUTLIER 47.99 31.29 2.34 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.383 1.592 . . . . 72.030000000000001 110.973 -164.521 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 9.8 tt -112.03 150.12 31.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.027 -0.988 . . . . 73.219999999999999 109.202 -170.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -122.21 152.43 40.0 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.294 0.569 . . . . 75.299999999999997 111.076 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 75.4 mt -65.96 129.26 30.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 107.0 -1.481 . . . . 74.329999999999998 107.0 170.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 107.72 3.34 34.63 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.471 -0.871 . . . . 62.030000000000001 112.172 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.495 ' CG ' ' HZ3' ' A' ' 404' ' ' LYS . 1.4 m-20 -72.89 128.52 35.74 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.261 0.837 . . . . 73.310000000000002 113.261 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 42.1 tttp -92.78 114.52 27.1 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.788 1.235 . . . . 75.540000000000006 109.492 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.43 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 85.8 mt -80.53 111.92 17.4 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 120.961 0.41 . . . . 75.230000000000004 110.082 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.2 tt -86.75 -39.41 15.99 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.491 -1.231 . . . . 75.030000000000001 107.694 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.55 155.69 17.6 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.772 -0.649 . . . . 74.129999999999995 110.677 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.5 p -133.4 122.36 44.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.116 -1.068 . . . . 74.530000000000001 108.116 173.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 62.26 30.52 17.57 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-O 123.873 1.797 . . . . 52.43 108.445 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.8 t30 66.32 16.89 10.58 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 109.831 -3.35 . . . . 64.319999999999993 112.556 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.95 125.28 40.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 106.557 -1.646 . . . . 74.129999999999995 106.557 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.1 p -61.62 123.3 17.53 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 113.557 0.947 . . . . 73.409999999999997 113.557 -175.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.28 -2.51 20.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.309 -0.86 . . . . 75.400000000000006 110.941 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -66.84 106.83 1.99 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.752 -0.658 . . . . 75.420000000000002 109.396 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 63.97 74.36 0.41 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 122.643 1.211 . . . . 74.519999999999996 113.591 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 21.4 m -137.29 169.5 19.37 Favored 'Isoleucine or valine' 0 C--O 1.249 1.03 0 N-CA-C 105.913 -1.884 . . . . 73.439999999999998 105.913 174.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 50.5 p -78.66 138.71 38.43 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.274 -0.97 . . . . 74.340000000000003 108.998 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . 0.584 ' O ' HG22 ' A' ' 388' ' ' VAL . 85.8 t60 -47.49 -51.06 21.69 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.31 0.855 . . . . 74.530000000000001 113.31 -173.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -65.04 -29.61 70.52 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.484 0.659 . . . . 74.25 110.663 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.513 ' HB3' ' O ' ' A' ' 383' ' ' THR . 49.8 tt0 -72.87 -39.11 66.73 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.367 -0.975 . . . . 72.510000000000005 108.367 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.462 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -67.59 -46.52 72.36 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.759 -1.109 . . . . 70.200000000000003 109.96 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 384' ' ' HIS . 24.8 t -57.87 -43.55 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 109.681 -0.489 . . . . 51.399999999999999 109.681 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 85.0 m -57.95 -38.14 75.45 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 123.49 0.494 . . . . 74.519999999999996 110.681 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.05 -33.37 75.89 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.193 -0.317 . . . . 70.140000000000001 110.959 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.7 mp -81.73 -26.58 34.44 Favored 'General case' 0 C--O 1.211 -0.949 0 C-N-CA 120.494 -0.482 . . . . 62.509999999999998 111.28 176.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.429 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 62.2 mttm -75.82 -27.33 57.86 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.698 -0.401 . . . . 75.120000000000005 111.968 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -80.27 43.67 0.64 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.844 -0.616 . . . . 74.049999999999997 110.623 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 77.4 p -124.19 144.03 50.17 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.813 -0.81 . . . . 72.099999999999994 108.813 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' SER . . . . . 0.463 ' HA ' ' HE3' ' A' ' 324' ' ' LYS . 65.4 m -146.02 116.92 7.73 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.568 0.699 . . . . 74.5 111.095 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . 0.482 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 3.3 m-20 55.77 14.52 1.33 Allowed 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 127.882 2.473 . . . . 75.340000000000003 114.903 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -163.17 126.15 2.71 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.452 -1.314 . . . . 73.340000000000003 107.452 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 321' ' ' LYS . 46.8 t -138.46 124.0 23.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.271 -1.011 . . . . 75.129999999999995 108.271 177.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -106.43 95.9 6.08 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.948 -1.871 . . . . 63.32 105.948 173.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.452 ' CD2' ' HB ' ' A' ' 402' ' ' VAL . 7.6 tt -95.14 114.58 26.39 Favored 'General case' 0 C--N 1.258 -3.374 0 N-CA-C 109.051 -0.722 . . . . 73.239999999999995 109.051 -176.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -99.58 108.66 21.11 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.795 -1.557 . . . . 72.150000000000006 106.795 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 369' ' ' ASP . 10.3 p -115.73 162.2 13.93 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.753 0 N-CA-C 108.223 -1.028 . . . . 74.019999999999996 108.223 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.9 148.83 47.26 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.58 -0.896 . . . . 73.450000000000003 108.58 173.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.495 ' HZ3' ' CG ' ' A' ' 369' ' ' ASP . 10.7 mmpt? . . . . . 0 C--N 1.303 -1.443 0 N-CA-C 108.276 -1.009 . . . . 73.420000000000002 108.276 169.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 CA--C 1.492 -1.258 0 N-CA-C 107.558 -1.275 . . . . 71.040000000000006 107.558 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . 0.48 ' CD ' ' HZ2' ' A' ' 352' ' ' LYS . 11.3 pt-20 -89.28 144.85 25.78 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.29 -1.004 . . . . 63.109999999999999 108.29 176.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 16.9 m -134.41 135.2 42.42 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 116.233 -0.44 . . . . 74.319999999999993 111.628 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -85.86 130.51 34.53 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-N 116.001 -0.545 . . . . 74.420000000000002 110.472 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.293 -1.861 0 CA-C-N 116.289 -0.414 . . . . 74.420000000000002 110.05 171.508 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 C--O 1.21 -1.016 0 N-CA-C 108.04 -1.096 . . . . 63.119999999999997 108.04 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.336 1.8 pm0 -103.45 131.86 50.2 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-O 123.012 1.387 . . . . 72.530000000000001 114.411 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 78.3 mt -113.93 106.49 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.97 0 CA-C-N 111.987 -2.37 . . . . 74.140000000000001 110.35 -172.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -85.55 105.9 16.48 Favored 'General case' 0 N--CA 1.402 -2.854 0 N-CA-C 104.324 -2.472 . . . . 75.209999999999994 104.324 170.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 359' ' ' ALA . 0.4 OUTLIER -106.5 144.59 32.96 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 113.802 -1.545 . . . . 75.120000000000005 109.299 -171.349 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.1 mp -98.34 111.24 27.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 108.75 -0.833 . . . . 75.0 108.75 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -76.32 149.91 36.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.489 -0.778 . . . . 75.530000000000001 109.979 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -141.2 -160.07 8.16 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.466 -0.874 . . . . 62.039999999999999 112.23 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.35 -12.77 34.43 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.334 2.69 . . . . 72.549999999999997 113.362 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -102.35 8.72 40.18 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.302 -0.629 . . . . 74.129999999999995 109.302 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.74 -128.2 8.45 Favored Glycine 0 CA--C 1.477 -2.338 0 N-CA-C 108.764 -1.735 . . . . 53.399999999999999 108.764 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.52 -39.16 8.87 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.582 -2.007 . . . . 72.409999999999997 105.582 172.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.36 56.03 2.48 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 114.776 -1.102 . . . . 72.109999999999999 114.154 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -154.39 158.98 40.85 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.104 -0.702 . . . . 75.0 109.104 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 10.9 m -107.32 128.82 54.79 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.165 -1.05 . . . . 74.299999999999997 108.165 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 25.2 pt -114.71 151.87 16.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 109.998 -0.371 . . . . 74.319999999999993 109.998 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -147.57 121.86 9.61 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.147 -1.427 . . . . 72.329999999999998 107.147 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 154.71 163.19 11.77 Favored Glycine 0 C--N 1.282 -2.437 0 N-CA-C 110.784 -0.926 . . . . 75.150000000000006 110.784 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.58 -174.16 21.14 Favored Glycine 0 CA--C 1.479 -2.195 0 N-CA-C 108.069 -2.012 . . . . 54.140000000000001 108.069 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . 0.43 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 68.3 t -54.08 103.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 117.545 0.672 . . . . 75.0 110.921 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 82.33 -7.79 63.27 Favored Glycine 0 C--O 1.217 -0.934 0 CA-C-N 115.419 -0.81 . . . . 73.310000000000002 112.98 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.36 0.06 26.62 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.206 -1.035 . . . . 75.430000000000007 108.206 -178.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.78 140.38 14.96 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 115.642 1.719 . . . . 74.010000000000005 115.642 -174.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -85.42 -33.64 21.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.439 -1.255 . . . . 73.430000000000007 109.078 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.406 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 46.4 mm -104.81 122.7 42.5 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.67 -0.695 . . . . 74.329999999999998 109.716 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.82 108.52 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.543 2.162 . . . . 62.219999999999999 111.412 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.29 -19.3 24.73 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.57 -0.824 . . . . 74.209999999999994 112.092 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 19.4 t70 -114.79 99.96 7.88 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.861 -1.163 . . . . 74.129999999999995 107.861 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' A' ' 337' ' ' VAL . 59.3 t30 -80.97 33.09 0.32 Allowed 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 124.018 0.927 . . . . 71.040000000000006 112.437 -169.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 68.1 m -100.01 176.97 5.24 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.772 0.656 . . . . 73.420000000000002 112.772 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.5 mm -92.2 132.66 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 107.513 -1.291 . . . . 73.209999999999994 107.513 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 32.9 m-85 -124.1 137.49 54.56 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 112.62 0.6 . . . . 74.230000000000004 112.62 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 49.9 t -70.59 117.59 13.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 115.159 -0.928 . . . . 72.310000000000002 108.606 176.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.0 m -97.26 -29.87 13.3 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.515 0.674 . . . . 72.400000000000006 110.248 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -155.39 152.36 28.98 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 107.285 -1.376 . . . . 74.409999999999997 107.285 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 80.3 mt -121.42 109.56 25.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 106.357 -1.72 . . . . 70.209999999999994 106.357 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 41.7 mm -52.21 133.73 14.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 O-C-N 124.711 1.257 . . . . 74.409999999999997 112.221 -171.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.1 pm0 -55.2 114.51 1.81 Allowed 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 125.361 1.464 . . . . 74.239999999999995 111.833 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 72.67 22.78 78.81 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 114.351 -1.295 . . . . 51.420000000000002 111.781 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.33 164.36 53.44 Favored Glycine 0 C--O 1.254 1.363 0 N-CA-C 111.466 -0.654 . . . . 74.540000000000006 111.466 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.13 96.46 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.983 -0.747 . . . . 64.219999999999999 108.983 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . 0.472 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.69 -11.03 59.92 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.986 -0.552 . . . . 73.519999999999996 112.067 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -86.52 -30.52 21.88 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.711 -1.218 . . . . 74.510000000000005 107.711 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.58 ' NZ ' ' HA ' ' A' ' 361' ' ' LYS . 1.2 mmpm? -95.52 -57.82 2.29 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.657 0.984 . . . . 75.230000000000004 113.657 176.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -85.41 -39.2 17.83 Favored 'General case' 0 CA--C 1.467 -2.25 0 C-N-CA 123.542 0.737 . . . . 64.299999999999997 111.164 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -42.68 -23.95 0.21 Allowed Glycine 0 C--N 1.3 -1.421 0 N-CA-C 119.316 2.486 . . . . 73.450000000000003 119.316 -166.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.463 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.4 38.3 1.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 118.576 1.188 . . . . 75.0 111.241 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 55.8 tp -112.86 157.59 21.23 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.25 -1.341 . . . . 74.420000000000002 110.099 -170.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -120.41 143.74 48.3 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 121.524 0.678 . . . . 73.519999999999996 111.174 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.6 125.16 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 107.116 -1.439 . . . . 75.219999999999999 107.116 169.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.75 1.19 32.31 Favored Glycine 0 C--N 1.309 -0.935 0 C-N-CA 120.567 -0.825 . . . . 71.439999999999998 112.183 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 71.6 m-20 -75.49 138.27 41.47 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 112.698 0.629 . . . . 73.109999999999999 112.698 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.559 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 45.2 tttp -94.27 115.32 27.55 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.154 1.381 . . . . 75.319999999999993 108.994 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 95.7 mt -79.86 111.24 16.0 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.951 0.405 . . . . 71.400000000000006 109.999 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 403' ' ' ALA . 4.0 tt -83.09 -40.09 20.29 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.71 -1.589 . . . . 74.450000000000003 106.71 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.25 157.38 25.51 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.163 -0.926 . . . . 62.0 109.639 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . 0.454 HG11 ' HG ' ' A' ' 391' ' ' LEU . 7.6 p -147.31 137.27 16.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.59 -0.893 . . . . 75.319999999999993 108.59 173.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 59.51 38.38 22.47 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 108.066 -1.087 . . . . 73.209999999999994 108.066 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.03 -8.06 0.45 Allowed 'General case' 0 CA--C 1.57 1.723 0 C-N-CA 125.846 1.658 . . . . 54.43 113.278 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.32 130.65 35.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.981 -0.748 . . . . 74.140000000000001 108.981 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.0 p -72.21 129.68 39.03 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 122.756 0.423 . . . . 73.230000000000004 111.35 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.38 -3.7 16.91 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.766 0.654 . . . . 73.319999999999993 112.766 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -65.23 107.19 1.51 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.588 -0.523 . . . . 73.109999999999999 109.588 174.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 63.67 72.33 0.47 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 122.742 1.258 . . . . 54.25 113.359 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.59 164.35 31.15 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 N-CA-C 105.764 -1.939 . . . . 75.349999999999994 105.764 173.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.67 ' HB ' ' OE1' ' A' ' 386' ' ' GLU . 1.4 m -82.81 146.43 28.94 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.406 -1.331 . . . . 72.409999999999997 107.406 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . 0.607 ' O ' HG22 ' A' ' 388' ' ' VAL . 67.9 t60 -51.05 -32.73 22.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.526 -0.761 . . . . 75.510000000000005 112.961 -173.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.08 -42.66 93.89 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.519 -0.549 . . . . 75.25 109.519 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.67 ' OE1' ' HB ' ' A' ' 383' ' ' THR . 1.8 mp0 -73.22 -32.46 64.77 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 108.864 -0.791 . . . . 63.100000000000001 108.864 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.507 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -62.32 -53.88 48.66 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.709 -1.132 . . . . 72.540000000000006 109.251 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 384' ' ' HIS . 33.2 t -57.34 -44.19 83.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 N-CA-C 109.746 -0.465 . . . . 72.519999999999996 109.746 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 80.6 m -57.51 -41.11 80.15 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 116.065 -0.516 . . . . 73.25 111.035 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -63.36 -38.04 89.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.729 0.3 . . . . 74.200000000000003 110.844 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.6 mp -76.47 -21.3 56.04 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 120.23 -0.588 . . . . 74.420000000000002 110.978 176.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.476 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 54.5 mttm -83.95 -27.27 28.62 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 113.474 0.916 . . . . 74.010000000000005 113.474 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -76.11 35.15 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.075 0.95 . . . . 73.219999999999999 112.681 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 8.1 p -124.76 161.05 27.25 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 122.899 0.48 . . . . 75.340000000000003 110.028 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 24.9 p -160.53 125.86 3.88 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.325 -0.62 . . . . 72.409999999999997 109.325 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 61.69 0.14 0.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 125.92 1.688 . . . . 75.450000000000003 113.757 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -168.12 137.49 2.49 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.589 -0.893 . . . . 75.310000000000002 108.589 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 62.1 t -136.66 125.71 36.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.614 -1.254 . . . . 72.329999999999998 107.614 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -101.21 95.59 6.63 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.144 -2.169 . . . . 74.140000000000001 105.144 173.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.3 tt -101.02 140.78 34.84 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 109.46 -0.57 . . . . 71.530000000000001 109.46 -176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -128.11 113.09 15.3 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.85 -0.426 . . . . 74.439999999999998 109.85 -175.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 54.1 t -105.19 145.26 13.7 Favored 'Isoleucine or valine' 0 C--O 1.269 2.12 0 C-N-CA 124.256 1.022 . . . . 73.140000000000001 111.03 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.559 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -117.17 156.39 27.75 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 104.618 -2.364 . . . . 63.520000000000003 104.618 169.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? . . . . . 0 C--N 1.285 -2.228 0 C-N-CA 118.677 -1.209 . . . . 74.140000000000001 107.991 -179.594 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . 0.465 ' C ' HD21 ' B' ' 147' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.489 -1.395 0 N-CA-C 109.62 -0.511 . . . . 71.030000000000001 109.62 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -90.4 146.27 24.29 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.996 -0.742 . . . . 71.420000000000002 108.996 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 88.9 m -134.64 138.03 44.14 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.91 -0.587 . . . . 71.129999999999995 110.16 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -83.66 132.81 34.85 Favored 'General case' 0 C--O 1.254 1.319 0 N-CA-C 109.801 -0.444 . . . . 73.340000000000003 109.801 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.296 -1.742 0 CA-C-O 116.767 -1.587 . . . . 75.239999999999995 112.63 -179.477 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' MET . . . . . 0.515 ' SD ' ' HE3' ' A' ' 404' ' ' LYS . 26.1 ttt . . . . . 0 CA--C 1.495 -1.156 0 N-CA-C 106.941 -1.503 . . . . 75.239999999999995 106.941 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.339 2.0 pm0 -115.58 132.17 56.71 Favored 'General case' 0 N--CA 1.408 -2.562 0 N-CA-C 115.013 1.486 . . . . 64.299999999999997 115.013 -175.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.599 HD13 ' O ' ' A' ' 363' ' ' GLY . 58.6 mt -116.63 111.75 36.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.351 0 CA-C-N 112.402 -2.181 . . . . 71.040000000000006 107.966 -173.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -82.71 110.5 17.81 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.207 -1.034 . . . . 64.219999999999999 108.207 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 92.6 mt -111.02 156.32 21.44 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.54 0.525 . . . . 72.340000000000003 110.327 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.6 mp -105.04 115.4 46.84 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 107.925 -1.139 . . . . 72.519999999999996 107.925 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 394' ' ' THR . 22.7 tptm -68.57 122.16 17.91 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.485 -0.78 . . . . 65.329999999999998 109.318 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -133.55 -154.42 7.39 Favored Glycine 0 C--N 1.306 -1.104 0 C-N-CA 120.61 -0.805 . . . . 74.219999999999999 113.274 -173.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.85 -40.3 39.56 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 124.79 3.66 . . . . 71.420000000000002 115.49 -175.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -109.09 16.48 22.51 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.248 0.547 . . . . 75.200000000000003 110.044 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.41 -118.22 4.6 Favored Glycine 0 N--CA 1.424 -2.124 0 CA-C-N 114.892 -1.049 . . . . 63.210000000000001 110.983 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.0 mp -96.02 -30.32 13.64 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.565 -1.272 . . . . 72.230000000000004 107.565 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.49 44.93 5.98 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 114.853 -1.067 . . . . 45.399999999999999 114.487 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . 0.4 ' HA ' ' H ' ' A' ' 354' ' ' ILE . 50.7 p90 -152.43 156.7 40.0 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.823 -0.806 . . . . 71.340000000000003 108.823 172.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 46.3 m -113.66 136.66 52.59 Favored 'General case' 0 C--N 1.282 -2.348 0 O-C-N 123.663 0.602 . . . . 75.239999999999995 110.829 -175.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 20.2 pt -120.26 149.6 23.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.409 -0.814 . . . . 72.209999999999994 112.435 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -145.15 114.59 7.15 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.285 -1.746 . . . . 61.240000000000002 106.285 174.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 164.19 164.18 18.83 Favored Glycine 0 C--N 1.285 -2.291 0 N-CA-C 109.015 -1.634 . . . . 74.340000000000003 109.015 -178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.01 178.93 15.94 Favored Glycine 0 CA--C 1.479 -2.214 0 N-CA-C 108.113 -1.995 . . . . 62.420000000000002 108.113 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 88.8 t -53.23 108.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 117.766 0.783 . . . . 73.230000000000004 110.738 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.65 -23.64 33.1 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.269 -0.878 . . . . 72.439999999999998 112.509 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.615 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 58.8 t30 -105.91 18.63 21.82 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.696 -0.483 . . . . 74.430000000000007 109.696 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.89 123.88 10.07 Favored 'General case' 0 C--O 1.257 1.476 0 C-N-CA 123.553 0.741 . . . . 73.040000000000006 110.518 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -81.4 -40.1 23.96 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.146 -0.934 . . . . 74.099999999999994 109.977 -176.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 35.9 mm -103.65 126.11 32.9 Favored Pre-proline 0 C--N 1.309 -1.176 0 N-CA-C 109.2 -0.667 . . . . 72.349999999999994 109.2 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.14 102.73 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 123.108 2.539 . . . . 73.030000000000001 112.66 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.71 -7.2 29.75 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.828 -0.624 . . . . 75.200000000000003 112.033 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.422 ' CG ' ' HH ' ' A' ' 349' ' ' TYR . 13.2 t70 -123.92 96.84 5.1 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.049 -1.093 . . . . 74.129999999999995 108.049 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -83.03 36.92 0.52 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.587 -1.188 . . . . 72.109999999999999 112.08 -169.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 74.7 m -99.47 178.11 4.97 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.675 -0.693 . . . . 71.450000000000003 112.11 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.455 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 11.0 mm -88.72 131.6 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 107.899 -1.149 . . . . 73.340000000000003 107.899 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 26.8 m-85 -124.12 138.06 54.48 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 113.507 0.929 . . . . 65.420000000000002 113.507 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.1 t -71.14 115.54 11.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 114.787 -1.097 . . . . 72.129999999999995 108.48 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 22.6 m -100.56 -25.98 13.99 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.4 0.619 . . . . 73.349999999999994 110.848 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.89 142.25 22.49 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.229 -1.397 . . . . 74.120000000000005 107.229 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 74.3 mt -109.64 107.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 106.023 -1.843 . . . . 73.420000000000002 106.023 172.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.4 ' H ' ' HA ' ' A' ' 331' ' ' PHE . 46.4 mm -57.9 127.22 16.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 O-C-N 124.478 1.111 . . . . 65.230000000000004 112.585 -170.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.538 ' CD ' ' H ' ' A' ' 355' ' ' GLU . 1.1 pm0 -57.12 117.67 4.26 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 113.314 -1.766 . . . . 72.239999999999995 111.053 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 90.01 5.31 70.85 Favored Glycine 0 C--O 1.22 -0.747 0 CA-C-N 115.02 -0.991 . . . . 73.209999999999994 111.96 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.3 158.08 48.82 Favored Glycine 0 C--O 1.255 1.443 0 C-N-CA 121.548 -0.358 . . . . 74.239999999999995 112.808 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.88 -40.1 95.75 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.972 -0.751 . . . . 74.439999999999998 108.972 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . 0.465 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.44 -9.82 58.91 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.9 -0.591 . . . . 52.420000000000002 111.504 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -87.22 -30.43 20.97 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.315 -0.995 . . . . 65.430000000000007 108.315 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.463 ' HA ' ' CE ' ' A' ' 361' ' ' LYS . 0.0 OUTLIER -95.83 -57.23 2.42 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 114.101 1.148 . . . . 74.409999999999997 114.101 176.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -85.2 -39.45 17.8 Favored 'General case' 0 CA--C 1.462 -2.414 0 O-C-N 123.58 0.55 . . . . 64.239999999999995 110.604 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.599 ' O ' HD13 ' A' ' 320' ' ' ILE . . . -42.72 -23.14 0.17 Allowed Glycine 0 C--O 1.199 -2.037 0 N-CA-C 119.199 2.44 . . . . 71.030000000000001 119.199 -164.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.463 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 43.68 32.22 0.54 Allowed 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 119.135 1.467 . . . . 75.439999999999998 111.872 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 43.9 tp -105.01 153.5 21.37 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 125.184 1.393 . . . . 75.310000000000002 109.246 -171.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -116.95 146.07 43.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.065 0.459 . . . . 74.049999999999997 111.224 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 74.9 mt -66.54 124.21 21.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.719 -1.215 . . . . 70.099999999999994 107.719 170.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.65 1.19 30.73 Favored Glycine 0 C--N 1.312 -0.774 0 N-CA-C 111.175 -0.77 . . . . 65.219999999999999 111.175 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 73.2 m-20 -75.71 138.75 41.5 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.981 1.104 . . . . 74.209999999999994 113.981 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.628 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 40.8 tttp -94.2 115.83 28.15 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.499 1.52 . . . . 73.109999999999999 110.043 -177.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 96.5 mt -80.28 112.61 17.77 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.954 -0.758 . . . . 72.030000000000001 108.954 176.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.4 tt -83.88 -37.57 22.24 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.952 -1.499 . . . . 63.119999999999997 106.952 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -162.68 158.0 22.55 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.568 -0.742 . . . . 75.340000000000003 111.186 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.8 p -133.82 125.45 49.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.629 -1.249 . . . . 75.540000000000006 107.629 171.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 59.55 36.62 22.86 Favored 'General case' 0 CA--C 1.47 -2.119 0 CA-C-O 124.287 1.994 . . . . 64.400000000000006 110.727 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.3 t30 61.99 13.2 5.44 Favored 'General case' 0 C--N 1.268 -2.935 0 CA-C-N 108.958 -3.746 . . . . 72.219999999999999 113.272 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.9 t -86.91 123.86 40.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 107.419 -1.326 . . . . 73.340000000000003 107.419 175.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.6 p -63.14 125.22 23.34 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.023 0.749 . . . . 72.329999999999998 113.023 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.57 3.68 27.26 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 123.843 0.857 . . . . 75.340000000000003 111.247 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -66.58 112.64 4.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.756 -0.656 . . . . 75.530000000000001 110.238 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 60.1 49.82 7.1 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 122.722 1.249 . . . . 72.340000000000003 112.98 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.31 169.55 4.01 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 N-CA-C 107.937 -1.135 . . . . 74.310000000000002 107.937 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.48 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 76.5 p -81.64 141.13 33.95 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.845 -0.742 . . . . 75.109999999999999 109.755 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . 0.56 ' O ' HG23 ' A' ' 388' ' ' VAL . 75.2 t60 -46.02 -45.33 15.85 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.267 0.84 . . . . 74.239999999999995 113.267 -176.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -62.33 -39.15 92.12 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 120.937 0.399 . . . . 73.420000000000002 111.122 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 383' ' ' THR . 61.4 tt0 -69.53 -34.63 74.51 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 124.321 1.048 . . . . 72.430000000000007 108.559 -176.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.506 ' O ' HD13 ' A' ' 391' ' ' LEU . . . -73.37 -53.9 9.63 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.823 -1.081 . . . . 75.109999999999999 110.633 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 384' ' ' HIS . 21.1 t -58.15 -41.38 80.61 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 109.862 -0.421 . . . . 70.209999999999994 109.862 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 31.0 m -63.24 -31.67 72.87 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 116.224 -0.444 . . . . 74.140000000000001 110.938 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -69.35 -41.09 77.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.15 -0.315 . . . . 54.329999999999998 110.15 177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 387' ' ' ALA . 5.3 mp -73.85 -23.99 59.7 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 119.937 -0.705 . . . . 75.510000000000005 110.406 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 54.9 mttm -79.12 -32.47 44.51 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 113.488 0.921 . . . . 74.219999999999999 113.488 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -84.01 64.5 8.2 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.949 0.88 . . . . 73.409999999999997 111.836 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' THR . . . . . 0.515 ' O ' ' HG2' ' A' ' 324' ' ' LYS . 12.4 p -148.62 149.46 31.56 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.422 -1.263 . . . . 74.230000000000004 108.38 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 26.8 p -148.62 128.02 13.08 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.271 -0.64 . . . . 74.409999999999997 109.271 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 31.8 t70 59.8 -1.22 0.17 Allowed 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 126.29 1.836 . . . . 71.409999999999997 114.406 177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -159.73 120.8 3.16 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 120.607 -1.308 . . . . 74.420000000000002 110.718 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 80.4 t -136.15 145.13 31.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 124.281 1.032 . . . . 74.519999999999996 108.365 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.24 96.41 4.91 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.289 -1.374 . . . . 74.030000000000001 107.289 173.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 4.8 tt -83.98 118.26 23.91 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.885 -1.154 . . . . 74.340000000000003 107.885 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -108.09 107.34 17.96 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.928 -1.138 . . . . 73.209999999999994 107.928 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 3.0 p -111.3 148.69 14.41 Favored 'Isoleucine or valine' 0 C--O 1.267 1.998 0 CA-C-N 115.408 -0.814 . . . . 63.240000000000002 109.626 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.628 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.71 157.83 45.85 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 104.325 -2.472 . . . . 74.319999999999993 104.325 172.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . 0.515 ' HE3' ' SD ' ' A' ' 318' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.599 0 C-N-CA 118.302 -1.359 . . . . 75.019999999999996 107.477 174.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . 0.476 ' C ' HD21 ' B' ' 147' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.435 -1.18 0 N-CA-C 108.759 -0.83 . . . . 71.030000000000001 108.759 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.65 151.94 19.14 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.628 -1.619 . . . . 73.219999999999999 106.628 173.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 53.8 m -147.37 129.62 15.65 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 120.534 -0.466 . . . . 73.439999999999998 110.66 174.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -67.07 129.51 40.13 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.941 -0.762 . . . . 72.230000000000004 108.941 173.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--N 1.297 -1.71 0 N-CA-C 113.404 0.89 . . . . 73.219999999999999 113.404 -179.173 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 56.8 tpp . . . . . 0 CA--C 1.487 -1.458 0 N-CA-C 106.032 -1.84 . . . . 74.340000000000003 106.032 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.426 1.8 pm0 -122.07 128.64 51.59 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 116.692 2.108 . . . . 70.239999999999995 116.692 -174.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.414 HD11 ' O ' ' A' ' 363' ' ' GLY . 89.8 mt -105.23 106.57 20.76 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.623 0 CA-C-N 111.452 -2.613 . . . . 75.109999999999999 109.305 -176.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -77.68 113.89 15.98 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 103.883 -2.636 . . . . 74.040000000000006 103.883 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.06 147.68 31.99 Favored 'General case' 0 C--N 1.266 -3.023 0 O-C-N 124.478 1.111 . . . . 61.509999999999998 109.234 -171.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 68.3 mt -106.03 134.99 46.0 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.881 0 N-CA-C 108.114 -1.069 . . . . 72.030000000000001 108.114 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 395' ' ' SER . 1.2 ttpm? -74.24 177.99 5.44 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.83 -0.804 . . . . 74.409999999999997 108.83 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . 0.406 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -155.86 -172.52 23.44 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 120.374 -0.917 . . . . 74.030000000000001 110.943 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.38 -26.16 20.82 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 122.895 2.397 . . . . 65.25 112.277 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -88.92 -8.56 53.98 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 122.469 1.128 . . . . 74.340000000000003 108.886 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 95.93 -135.55 12.38 Favored Glycine 0 CA--C 1.482 -1.985 0 CA-C-N 113.618 -1.628 . . . . 74.329999999999998 109.355 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.8 mp -83.71 -45.5 13.32 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.429 -1.693 . . . . 75.319999999999993 106.429 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 83.32 53.74 3.35 Favored Glycine 0 N--CA 1.421 -2.316 0 CA-C-N 114.645 -1.161 . . . . 74.319999999999993 114.348 170.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -154.4 164.48 38.57 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 116.736 0.268 . . . . 73.209999999999994 110.334 172.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 10.2 m -112.54 129.35 56.39 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.632 -0.507 . . . . 61.530000000000001 109.632 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.9 pt -118.75 153.33 20.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 109.927 -0.397 . . . . 75.25 109.927 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -142.22 136.57 30.01 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.288 -1.745 . . . . 73.140000000000001 106.288 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 347' ' ' SER . . . 144.81 157.44 7.22 Favored Glycine 0 C--N 1.282 -2.428 0 N-CA-C 109.288 -1.525 . . . . 43.32 109.288 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 137.74 175.5 13.91 Favored Glycine 0 C--N 1.282 -2.453 0 N-CA-C 108.386 -1.886 . . . . 73.010000000000005 108.386 -175.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . 0.501 HG23 ' OE2' ' A' ' 381' ' ' GLU . 68.7 t -50.7 110.89 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 117.719 0.76 . . . . 64.109999999999999 109.655 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 81.4 -17.04 14.95 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 121.267 -0.492 . . . . 54.420000000000002 113.298 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.28 3.65 38.37 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.592 -1.262 . . . . 62.43 107.592 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.4 HE22 ' HA ' ' A' ' 343' ' ' PRO . 0.0 OUTLIER -49.57 126.21 13.03 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.595 1.158 . . . . 75.319999999999993 111.288 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -76.83 -37.27 55.97 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.22 -0.9 . . . . 64.450000000000003 109.97 -175.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 2.8 mp -104.82 126.76 30.35 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 109.344 -0.613 . . . . 72.340000000000003 109.344 177.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.4 ' HA ' HE22 ' A' ' 340' ' ' GLN . 18.7 Cg_endo -59.38 105.99 0.28 Allowed 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.842 2.362 . . . . 75.040000000000006 112.816 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 105.83 -1.22 38.82 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 115.553 -0.749 . . . . 52.140000000000001 111.931 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.497 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 60.4 t0 -130.85 103.55 6.63 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 108.087 -1.079 . . . . 72.219999999999999 108.087 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -76.91 65.05 2.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.501 1.143 . . . . 74.450000000000003 108.924 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 0.46 ' O ' ' HA3' ' A' ' 335' ' ' GLY . 5.2 p -97.09 134.6 40.22 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 113.289 -1.778 . . . . 74.209999999999994 112.38 -176.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 44.3 mm -80.94 119.14 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 N-CA-C 104.488 -2.412 . . . . 74.329999999999998 104.488 168.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -123.89 137.92 54.56 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 120.161 -0.616 . . . . 71.420000000000002 109.724 -169.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 49.5 t -78.58 111.41 15.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.266 -0.642 . . . . 65.430000000000007 109.266 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.5 m -96.42 -28.84 14.26 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.068 -0.515 . . . . 75.540000000000006 110.928 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.554 ' HZ1' ' CD ' ' B' ' 148' ' ' GLU . 55.4 mttp -151.61 163.11 39.8 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 109.637 -0.505 . . . . 75.420000000000002 109.637 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . 0.418 HG21 ' HB2' ' A' ' 360' ' ' HIS . 73.1 mt -131.54 127.48 59.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 106.644 -1.613 . . . . 74.129999999999995 106.644 174.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 50.6 mm -85.51 141.75 14.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 123.678 0.791 . . . . 72.299999999999997 111.466 -172.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.5 133.66 50.24 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.551 0.691 . . . . 74.439999999999998 112.339 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 70.88 7.46 62.05 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 120.598 -0.81 . . . . 75.049999999999997 112.454 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -67.39 148.89 50.41 Favored Glycine 0 N--CA 1.414 -2.807 0 N-CA-C 110.289 -1.124 . . . . 74.5 110.289 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.42 -34.27 77.38 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.432 -0.581 . . . . 63.119999999999997 109.432 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . 0.484 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -76.1 -14.97 60.18 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.209 -0.597 . . . . 71.219999999999999 111.707 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . 0.536 ' CD2' ' HZ1' ' A' ' 361' ' ' LYS . 39.6 t60 -84.14 -27.79 27.88 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.695 0.759 . . . . 72.409999999999997 109.18 177.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.536 ' HZ1' ' CD2' ' A' ' 360' ' ' HIS . 19.3 mmtm -96.69 -58.28 2.08 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 114.835 1.42 . . . . 74.0 114.835 173.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -85.81 -41.57 14.93 Favored 'General case' 0 CA--C 1.465 -2.309 0 C-N-CA 122.796 0.438 . . . . 74.409999999999997 111.155 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -43.02 -25.0 0.31 Allowed Glycine 0 CA--C 1.491 -1.413 0 N-CA-C 118.79 2.276 . . . . 64.239999999999995 118.79 -165.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.467 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 43.72 36.21 1.23 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.42 1.088 . . . . 74.230000000000004 111.167 -179.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 39.5 tp -115.69 152.89 32.33 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 114.168 -1.378 . . . . 72.310000000000002 108.368 -171.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -123.84 155.56 37.8 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.751 0.786 . . . . 75.200000000000003 111.605 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 80.3 mt -66.12 125.47 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 107.204 -1.406 . . . . 73.109999999999999 107.204 173.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.34 -6.83 21.0 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.04 -1.076 . . . . 61.310000000000002 111.949 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -75.8 142.37 42.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.487 0.551 . . . . 63.299999999999997 112.487 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 76.4 tttt -101.64 131.21 47.99 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.931 -0.766 . . . . 74.209999999999994 108.931 176.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 68.8 mt -95.81 120.77 36.68 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.964 0.411 . . . . 74.129999999999995 110.812 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 40.0 mt -83.41 -39.73 20.25 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.433 -1.258 . . . . 74.200000000000003 109.736 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.23 157.93 26.47 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 120.015 -0.674 . . . . 62.229999999999997 112.088 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 14.7 p -134.28 121.69 38.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 107.984 -1.117 . . . . 71.340000000000003 107.984 172.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 399' ' ' TYR . 79.1 m-20 64.4 27.79 13.62 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 123.909 1.814 . . . . 75.420000000000002 108.641 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.2 t30 66.17 16.4 10.43 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 109.791 -3.368 . . . . 72.319999999999993 111.835 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.8 t -83.84 125.44 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.171 -1.788 . . . . 75.109999999999999 106.171 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.7 p -62.96 125.49 24.16 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 124.012 0.82 . . . . 63.439999999999998 113.008 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.21 1.1 32.59 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.229 -0.896 . . . . 73.340000000000003 110.892 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -75.3 115.05 14.54 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.644 -0.873 . . . . 72.200000000000003 108.644 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . 0.501 ' OE2' HG23 ' A' ' 337' ' ' VAL . 19.7 tp10 62.22 83.42 0.15 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.557 1.17 . . . . 62.200000000000003 112.117 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 23.9 m -153.21 165.8 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 113.24 -1.8 . . . . 75.519999999999996 107.606 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.464 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.0 OUTLIER -82.15 143.61 31.32 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.184 -1.043 . . . . 73.510000000000005 108.184 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . 0.521 ' O ' HG22 ' A' ' 388' ' ' VAL . 86.1 t60 -50.6 -53.27 31.93 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 112.394 0.516 . . . . 72.420000000000002 112.394 -174.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.69 -27.35 68.28 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.129 -0.941 . . . . 73.010000000000005 111.217 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.9 tt0 -75.0 -34.47 61.97 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.796 -1.187 . . . . 74.030000000000001 107.796 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.43 ' O ' HD13 ' A' ' 391' ' ' LEU . . . -73.08 -45.35 57.74 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.655 -1.157 . . . . 75.129999999999995 109.737 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 384' ' ' HIS . 15.4 t -56.95 -42.92 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.937 -0.764 . . . . 74.049999999999997 108.937 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 62.6 m -61.15 -36.3 79.41 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 116.016 -0.538 . . . . 71.310000000000002 110.936 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.74 80.91 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.333 -0.23 . . . . 71.349999999999994 110.512 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 387' ' ' ALA . 5.7 mp -78.03 -31.56 50.49 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 120.456 -0.498 . . . . 74.349999999999994 111.024 176.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -71.27 -25.75 62.59 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 120.569 -0.453 . . . . 73.299999999999997 112.167 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -82.68 65.39 7.78 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.227 1.013 . . . . 72.010000000000005 110.468 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 17.6 p -132.78 146.1 51.56 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.248 -1.342 . . . . 74.510000000000005 108.394 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 47.9 m -145.92 91.58 2.1 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.583 1.182 . . . . 73.400000000000006 111.426 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . 0.426 ' HA ' ' CB ' ' A' ' 324' ' ' LYS 0.346 14.4 m-20 65.08 4.44 2.55 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 111.427 -2.624 . . . . 70.349999999999994 116.075 170.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -156.39 130.32 8.48 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 106.987 -1.486 . . . . 73.439999999999998 106.987 170.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 27.6 t -138.09 149.3 24.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 124.187 0.995 . . . . 74.140000000000001 109.063 -172.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . 0.408 ' HB2' ' HA ' ' A' ' 375' ' ' ASN . 75.6 m-85 -116.34 95.9 5.28 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.248 -1.019 . . . . 74.340000000000003 108.248 170.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.5 tt -95.39 119.37 33.77 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.106 0.479 . . . . 75.530000000000001 109.999 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -102.4 110.41 22.35 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.793 -1.188 . . . . 71.209999999999994 107.793 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 3.0 p -110.87 144.51 18.69 Favored 'Isoleucine or valine' 0 C--O 1.274 2.356 0 C-N-CA 124.232 1.013 . . . . 73.439999999999998 111.526 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -137.64 159.93 40.62 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 125.907 1.683 . . . . 72.200000000000003 109.022 176.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.295 -1.788 0 N-CA-C 109.234 -0.654 . . . . 71.329999999999998 109.234 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 CA--C 1.496 -1.101 0 N-CA-C 108.913 -0.773 . . . . 71.140000000000001 108.913 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . 0.554 ' CD ' ' HZ1' ' A' ' 352' ' ' LYS . 13.2 pt-20 -91.78 144.96 24.96 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.155 -0.683 . . . . 71.310000000000002 109.155 177.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 86.6 m -134.63 142.69 46.96 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.722 -0.473 . . . . 72.030000000000001 109.722 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.87 145.4 36.27 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 122.942 0.497 . . . . 75.329999999999998 111.041 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 14.0 m . . . . . 0 C--O 1.261 1.676 0 CA-C-N 115.738 -0.665 . . . . 73.129999999999995 111.282 175.262 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 CA--C 1.495 -1.16 0 N-CA-C 107.192 -1.41 . . . . 64.200000000000003 107.192 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.323 2.0 pm0 -115.79 133.88 55.58 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-O 122.23 1.014 . . . . 74.109999999999999 113.364 -176.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.438 HD13 ' O ' ' A' ' 363' ' ' GLY . 77.3 mt -129.89 116.56 38.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 113.217 -1.81 . . . . 73.030000000000001 110.27 -168.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -75.92 134.7 40.18 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.028 -0.73 . . . . 74.239999999999995 109.028 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.502 ' HA ' ' OD2' ' A' ' 362' ' ' ASP . 95.5 mt -131.78 152.15 51.16 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 123.556 0.535 . . . . 74.310000000000002 110.217 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.44 110.64 31.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.14 -1.059 . . . . 73.510000000000005 108.14 171.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.472 ' NZ ' ' HA ' ' A' ' 392' ' ' LYS . 79.1 tttt -76.94 130.23 37.24 Favored 'General case' 0 C--O 1.201 -1.457 0 C-N-CA 119.687 -0.805 . . . . 70.140000000000001 110.112 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -133.85 -163.77 10.47 Favored Glycine 0 C--N 1.298 -1.58 0 C-N-CA 119.766 -1.207 . . . . 62.149999999999999 111.905 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.64 -12.9 33.49 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 123.775 2.983 . . . . 73.409999999999997 113.782 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.471 ' HZ2' ' HA3' ' A' ' 356' ' ' GLY . 79.1 tttt -103.53 6.99 37.75 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 122.316 1.055 . . . . 75.430000000000007 108.805 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.21 -151.02 28.01 Favored Glycine 0 CA--C 1.493 -1.331 0 CA-C-N 114.303 -1.317 . . . . 62.229999999999997 110.213 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.6 mp -88.11 -16.51 33.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.747 -1.575 . . . . 74.230000000000004 106.747 166.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 79.16 39.28 19.93 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 113.921 -1.491 . . . . 73.430000000000007 114.892 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 52.2 p90 -151.45 165.75 33.2 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 117.596 0.698 . . . . 75.319999999999993 110.487 175.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 12.2 m -121.62 136.0 54.96 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 109.706 -0.479 . . . . 70.040000000000006 109.706 -178.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' B' ' 148' ' ' GLU . 17.9 pt -119.9 152.73 22.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 122.514 0.326 . . . . 74.420000000000002 111.761 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.2 114.65 5.56 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 104.997 -2.223 . . . . 74.019999999999996 104.997 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.67 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 162.3 156.21 8.35 Favored Glycine 0 C--N 1.286 -2.222 0 N-CA-C 109.709 -1.356 . . . . 73.319999999999993 109.709 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.68 -174.81 20.88 Favored Glycine 0 CA--C 1.484 -1.873 0 N-CA-C 108.908 -1.677 . . . . 74.329999999999998 108.908 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 96.1 t -51.68 108.47 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 117.498 0.649 . . . . 72.120000000000005 111.673 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 91.37 -21.57 34.44 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.114 -0.948 . . . . 61.140000000000001 112.773 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.67 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 57.6 t30 -107.08 26.88 9.59 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.24 -0.652 . . . . 72.310000000000002 109.24 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.29 119.6 5.8 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.888 -0.596 . . . . 60.229999999999997 110.674 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -78.9 -41.5 29.52 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.304 -0.862 . . . . 72.409999999999997 109.865 -175.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 43.5 mm -103.91 123.36 41.31 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 108.918 -0.771 . . . . 74.230000000000004 108.918 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.95 105.39 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.161 2.574 . . . . 74.209999999999994 112.419 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.97 -5.14 28.93 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.477 -0.783 . . . . 64.450000000000003 111.935 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.447 ' CG ' ' HH ' ' A' ' 349' ' ' TYR . 13.7 t70 -129.29 99.46 5.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.766 0.793 . . . . 74.129999999999995 108.973 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -82.8 35.33 0.46 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.384 1.074 . . . . 72.239999999999995 111.458 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 0.445 ' CB ' ' HE3' ' A' ' 370' ' ' LYS . 68.2 m -104.79 177.89 4.72 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 113.035 0.754 . . . . 72.239999999999995 113.035 -176.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.7 129.43 39.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.337 -0.847 . . . . 73.430000000000007 109.319 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 37.3 m-85 -124.26 136.73 54.36 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 113.47 0.915 . . . . 74.319999999999993 113.47 -177.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.4 t -71.65 117.2 14.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.688 -1.142 . . . . 74.409999999999997 108.51 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.4 m -106.28 -18.16 14.08 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.799 0.333 . . . . 71.420000000000002 111.581 -175.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.593 ' HG2' ' OE1' ' B' ' 148' ' ' GLU . 44.0 mmtm -149.89 154.95 39.17 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 108.609 -0.886 . . . . 72.140000000000001 108.609 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . 0.425 ' CG2' ' HB2' ' A' ' 360' ' ' HIS . 57.0 mt -138.89 121.23 17.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 107.232 -1.395 . . . . 71.219999999999999 107.232 172.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 41.6 mm -86.0 133.15 30.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.385 -1.339 . . . . 73.5 107.385 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.43 144.83 56.64 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.627 -1.62 . . . . 73.239999999999995 106.627 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.471 ' HA3' ' HZ2' ' A' ' 327' ' ' LYS . . . 92.08 -12.79 68.65 Favored Glycine 0 CA--C 1.475 -2.415 0 C-N-CA 119.36 -1.4 . . . . 55.149999999999999 110.672 178.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -67.98 148.34 49.03 Favored Glycine 1 N--CA 1.396 -4.005 0 N-CA-C 108.716 -1.754 . . . . 73.439999999999998 108.716 172.722 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.48 77.08 Favored 'General case' 0 C--O 1.2 -1.532 0 N-CA-C 109.834 -0.432 . . . . 70.420000000000002 109.834 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . 0.492 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -73.82 -11.74 60.47 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.671 -0.812 . . . . 74.219999999999999 112.486 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . 0.425 ' HB2' ' CG2' ' A' ' 353' ' ' ILE . 70.9 t60 -88.01 -43.95 11.35 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.423 -0.584 . . . . 71.430000000000007 109.423 177.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.429 ' HE2' ' N ' ' A' ' 356' ' ' GLY . 73.4 mmtt -86.42 -57.83 2.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.143 0.973 . . . . 72.400000000000006 110.947 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' A' ' 322' ' ' LEU . 35.2 t0 -81.75 -33.83 30.77 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 125.075 1.35 . . . . 74.430000000000007 109.38 -175.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.637 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -84.6 -16.91 65.03 Favored Glycine 0 C--N 1.289 -2.074 0 N-CA-C 117.37 1.708 . . . . 55.509999999999998 117.37 -169.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.637 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.31 34.23 0.49 Allowed 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 118.054 0.927 . . . . 72.109999999999999 112.619 -177.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 33.0 tp -83.78 157.58 22.04 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.199 0.999 . . . . 72.5 111.453 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -118.1 142.24 47.62 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.279 0.561 . . . . 73.109999999999999 111.414 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 84.3 mt -66.49 121.97 16.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 107.254 -1.387 . . . . 73.129999999999995 107.254 169.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 113.76 -1.72 24.56 Favored Glycine 0 C--N 1.309 -0.917 0 N-CA-C 110.936 -0.866 . . . . 72.209999999999994 110.936 -174.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.401 ' HB3' HG23 ' A' ' 402' ' ' VAL . 2.4 m-20 -73.14 138.32 45.69 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.265 0.469 . . . . 74.329999999999998 112.265 176.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 64.1 tttt -99.95 115.99 30.95 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.164 -0.925 . . . . 63.43 110.369 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 82.1 mt -82.13 112.94 19.63 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.455 -0.572 . . . . 71.329999999999998 109.455 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.5 tt -82.31 -37.36 25.89 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.079 -1.418 . . . . 73.120000000000005 107.343 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -162.85 157.45 21.34 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.057 -0.974 . . . . 72.120000000000005 109.122 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.0 p -142.86 121.85 8.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-O 121.138 0.494 . . . . 72.129999999999995 109.704 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 66.9 t30 44.56 78.86 0.05 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 126.246 1.818 . . . . 75.530000000000001 111.745 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 65.94 -29.42 0.13 Allowed 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 114.681 1.364 . . . . 74.400000000000006 114.681 -175.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 28.2 t -83.96 124.56 39.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 O-C-N 121.471 -0.768 . . . . 74.420000000000002 110.969 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 11.6 p -75.19 132.5 41.18 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.789 -0.449 . . . . 73.329999999999998 109.789 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.8 mp -108.51 -4.67 17.05 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.067 0.766 . . . . 75.200000000000003 113.067 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -63.55 113.87 3.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.572 0.225 . . . . 62.399999999999999 111.376 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 59.57 39.91 20.93 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 122.807 1.289 . . . . 74.239999999999995 112.989 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 31.4 m -104.27 166.16 3.15 Favored 'Isoleucine or valine' 0 C--O 1.257 1.494 0 N-CA-C 106.644 -1.613 . . . . 72.409999999999997 106.644 171.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.522 ' HB ' ' OE1' ' A' ' 386' ' ' GLU . 0.4 OUTLIER -81.13 149.08 29.31 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 117.808 -1.557 . . . . 73.049999999999997 107.381 178.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . 0.594 ' O ' HG23 ' A' ' 388' ' ' VAL . 79.8 t60 -53.77 -27.92 31.64 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 114.32 1.23 . . . . 74.129999999999995 114.32 -172.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.87 -41.63 91.38 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 117.796 0.271 . . . . 74.120000000000005 110.293 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.522 ' OE1' ' HB ' ' A' ' 383' ' ' THR . 1.9 mp0 -68.38 -33.15 73.75 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 109.063 -0.718 . . . . 74.420000000000002 109.063 -177.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.566 ' O ' HD11 ' A' ' 391' ' ' LEU . . . -64.96 -58.15 6.88 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.392 -1.276 . . . . 65.019999999999996 109.058 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 384' ' ' HIS . 40.6 t -54.58 -43.35 64.53 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 0 O-C-N 123.401 0.438 . . . . 74.140000000000001 110.146 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 93.1 m -59.17 -37.5 77.5 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.355 0.662 . . . . 74.310000000000002 111.911 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -68.51 -40.64 80.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.996 0.427 . . . . 72.450000000000003 110.077 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.566 HD11 ' O ' ' A' ' 387' ' ' ALA . 5.1 mp -75.37 -19.95 59.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.201 0.524 . . . . 63.509999999999998 111.036 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.475 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 54.8 mttm -80.18 -41.53 25.1 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 113.429 0.9 . . . . 70.409999999999997 113.429 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -84.99 65.68 9.36 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.918 0.866 . . . . 73.510000000000005 111.427 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 1.3 p -145.01 148.92 34.28 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.565 -1.198 . . . . 74.519999999999996 109.296 177.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 22.0 m -145.37 120.28 9.98 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.841 -0.8 . . . . 75.140000000000001 108.841 178.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 56.1 0.98 0.06 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 127.381 2.272 . . . . 74.510000000000005 116.49 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . 0.437 ' HE2' ' CE2' ' A' ' 399' ' ' TYR . 6.0 t80 -158.73 125.12 4.62 Favored 'General case' 0 N--CA 1.437 -1.077 0 O-C-N 121.297 -0.877 . . . . 72.439999999999998 109.805 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.2 t -141.37 145.86 24.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.17 -1.048 . . . . 75.209999999999994 108.17 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . 0.437 ' CE2' ' HE2' ' A' ' 397' ' ' PHE . 21.1 m-85 -115.22 97.35 6.15 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.053 -0.721 . . . . 74.530000000000001 109.053 172.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 8.0 tt -87.01 134.42 33.49 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 110.271 -0.27 . . . . 73.019999999999996 110.271 -177.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -121.83 108.19 13.18 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.494 -0.928 . . . . 73.329999999999998 108.494 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.401 HG23 ' HB3' ' A' ' 369' ' ' ASP . 7.3 p -116.37 151.99 18.13 Favored 'Isoleucine or valine' 0 C--O 1.268 2.055 0 CA-C-O 121.561 0.696 . . . . 74.439999999999998 111.225 -175.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.86 158.66 43.95 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 125.153 1.381 . . . . 72.420000000000002 108.089 176.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.533 0 N-CA-C 108.435 -0.95 . . . . 75.200000000000003 108.435 173.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . 0.415 ' C ' HD21 ' B' ' 147' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.402 -2.857 0 N-CA-C 108.361 -0.977 . . . . 72.129999999999995 108.361 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . 0.593 ' OE1' ' HG2' ' A' ' 352' ' ' LYS . 15.6 pt-20 -96.23 140.94 30.18 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 108.515 -0.92 . . . . 71.310000000000002 108.515 174.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 149' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 332' ' ' SER . 87.7 m -134.13 135.98 43.53 Favored 'General case' 0 C--N 1.282 -2.368 0 C-N-CA 120.745 -0.382 . . . . 70.109999999999999 111.625 -176.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -80.57 124.09 28.67 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.313 -0.995 . . . . 72.120000000000005 108.313 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 C--N 1.282 -2.337 0 N-CA-C 115.435 1.643 . . . . 73.040000000000006 115.435 -174.576 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 CA--C 1.492 -1.263 0 N-CA-C 106.721 -1.585 . . . . 74.319999999999993 106.721 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.405 2.0 pm0 -115.82 130.78 56.98 Favored 'General case' 0 C--N 1.266 -3.046 0 CA-C-O 122.784 1.278 . . . . 73.099999999999994 114.408 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 69.0 mt -122.54 112.98 36.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.456 0 CA-C-N 112.482 -2.144 . . . . 73.430000000000007 110.698 -169.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.413 ' HD2' ' C ' ' A' ' 321' ' ' LYS . 0.4 OUTLIER -73.57 127.71 33.5 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 106.982 -1.488 . . . . 75.219999999999999 106.982 171.356 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.541 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 98.3 mt -120.54 154.24 35.61 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.829 -1.175 . . . . 74.010000000000005 107.829 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 324' ' ' LYS . 47.0 mt -107.43 150.58 9.89 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.028 0 N-CA-C 106.448 -1.686 . . . . 73.040000000000006 106.448 171.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.507 ' O ' HG22 ' A' ' 323' ' ' ILE . 1.0 OUTLIER -76.26 178.67 6.28 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.07 -1.455 . . . . 74.239999999999995 107.07 173.103 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -164.93 -166.98 24.79 Favored Glycine 0 C--N 1.287 -2.193 0 C-N-CA 118.373 -1.87 . . . . 72.239999999999995 113.627 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.56 -35.23 23.35 Favored 'Trans proline' 0 C--O 1.213 -0.753 0 C-N-CA 123.772 2.982 . . . . 73.409999999999997 112.41 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.407 ' NZ ' ' HA3' ' A' ' 356' ' ' GLY . 44.4 mttp -99.8 19.76 15.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.349 -0.611 . . . . 65.400000000000006 109.349 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.65 -123.97 6.5 Favored Glycine 0 CA--C 1.485 -1.84 0 N-CA-C 107.992 -2.043 . . . . 65.349999999999994 107.992 -176.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.43 HD13 ' OG1' ' A' ' 394' ' ' THR . 9.4 mp -93.13 -29.03 15.96 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.265 -1.383 . . . . 63.509999999999998 107.265 174.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . 0.446 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 77.49 39.82 24.83 Favored Glycine 0 N--CA 1.427 -1.92 0 CA-C-N 113.512 -1.676 . . . . 64.230000000000004 114.414 172.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -143.59 149.88 38.02 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 119.941 -0.703 . . . . 75.420000000000002 109.919 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 9.9 m -105.52 127.41 53.0 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 115.413 -0.812 . . . . 75.099999999999994 110.18 -176.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 22.6 pt -115.8 143.72 25.08 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-N 115.314 -0.857 . . . . 73.450000000000003 110.305 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -130.13 114.64 15.98 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.771 -1.566 . . . . 74.120000000000005 106.771 175.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 167.75 166.23 26.48 Favored Glycine 0 N--CA 1.408 -3.171 0 N-CA-C 110.609 -0.996 . . . . 63.240000000000002 110.609 177.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.12 177.12 14.72 Favored Glycine 0 N--CA 1.411 -2.995 0 N-CA-C 106.933 -2.467 . . . . 70.540000000000006 106.933 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . 0.448 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 56.7 t -56.6 99.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 117.858 0.829 . . . . 75.319999999999993 110.035 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.22 -10.92 69.55 Favored Glycine 0 N--CA 1.432 -1.594 0 CA-C-O 119.148 -0.807 . . . . 44.43 114.237 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.57 HD21 ' CD2' ' A' ' 384' ' ' HIS . 63.5 t30 -106.88 10.28 30.64 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 118.767 1.284 . . . . 52.409999999999997 109.252 175.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.95 122.48 10.18 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 114.462 1.282 . . . . 71.230000000000004 114.462 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -66.87 -35.15 79.37 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.021 -1.445 . . . . 75.129999999999995 109.412 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.5 mm -104.89 120.02 51.45 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 115.68 -0.691 . . . . 72.540000000000006 109.649 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.83 109.03 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.765 2.31 . . . . 74.230000000000004 111.574 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.12 -14.84 28.39 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.576 -0.821 . . . . 73.109999999999999 111.961 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -119.49 98.03 5.94 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 106.887 -1.523 . . . . 74.540000000000006 106.887 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 337' ' ' VAL . 62.2 t30 -80.66 34.84 0.34 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.007 0.923 . . . . 72.319999999999993 112.531 -169.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 66.7 m -97.89 178.73 5.03 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.66 0.743 . . . . 75.430000000000007 112.751 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.475 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 18.2 mm -94.17 129.84 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 CA-C-N 114.777 -1.101 . . . . 74.120000000000005 108.062 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 30.1 m-85 -124.05 134.4 53.42 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 112.632 0.605 . . . . 71.140000000000001 112.632 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.69 111.65 3.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.022 -1.473 . . . . 73.150000000000006 107.022 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 45.6 m -106.97 -24.08 12.12 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.367 0.603 . . . . 74.400000000000006 111.965 -173.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 57.7 mttp -149.34 149.74 31.37 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.818 -1.178 . . . . 74.230000000000004 107.818 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 65.7 mt -128.87 120.77 52.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.395 -0.965 . . . . 73.329999999999998 108.395 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 31.2 mm -86.65 129.28 38.63 Favored 'Isoleucine or valine' 0 C--O 1.261 1.688 0 C-N-CA 123.34 0.656 . . . . 75.109999999999999 109.693 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.91 147.13 53.93 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 107.333 -1.358 . . . . 74.409999999999997 107.333 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . 0.455 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.51 -15.25 63.57 Favored Glycine 0 C--N 1.278 -2.659 0 N-CA-C 109.657 -1.377 . . . . 71.140000000000001 109.657 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . 0.446 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -72.05 139.04 27.68 Favored Glycine 1 N--CA 1.392 -4.255 0 N-CA-C 107.922 -2.071 . . . . 72.239999999999995 107.922 170.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -65.24 -25.38 67.65 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 109.48 -0.563 . . . . 61.25 109.48 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . 0.64 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.87 -10.41 59.41 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 120.392 -0.523 . . . . 74.140000000000001 111.767 176.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -94.66 -35.24 12.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.125 -1.065 . . . . 72.400000000000006 108.125 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.455 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 75.5 mmtt -81.95 -58.56 2.92 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 120.125 -0.63 . . . . 73.420000000000002 111.173 -178.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -86.2 -35.12 20.26 Favored 'General case' 0 CA--C 1.472 -2.046 0 CA-C-O 122.028 0.918 . . . . 62.420000000000002 109.09 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.732 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -44.17 -29.22 1.54 Allowed Glycine 0 CA--C 1.487 -1.659 0 N-CA-C 119.924 2.729 . . . . 61.409999999999997 119.924 -165.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.732 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 39.98 34.75 0.2 Allowed 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 124.767 1.227 . . . . 74.519999999999996 111.92 -175.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 55.1 tp -107.03 153.55 22.43 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.597 -1.183 . . . . 74.109999999999999 109.362 -172.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -123.55 151.19 43.15 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.467 0.651 . . . . 73.230000000000004 112.18 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.14 125.76 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 108.1 -1.074 . . . . 74.209999999999994 108.1 172.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 114.99 -6.26 21.93 Favored Glycine 0 C--N 1.315 -0.623 0 C-N-CA 121.101 -0.571 . . . . 71.439999999999998 112.131 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.421 ' HB3' HG23 ' A' ' 402' ' ' VAL . 10.1 m-20 -75.02 137.09 41.27 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.208 0.818 . . . . 74.219999999999999 113.208 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.586 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 35.6 tttp -96.0 115.65 27.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.409 1.483 . . . . 75.319999999999993 109.477 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 68.1 mt -85.87 115.9 23.78 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.307 0.575 . . . . 71.120000000000005 110.224 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.1 tt -83.5 -37.77 22.66 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 113.692 -1.594 . . . . 74.209999999999994 107.273 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.81 155.86 21.94 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.157 -0.929 . . . . 75.099999999999994 109.467 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . 0.469 HG12 ' HG ' ' A' ' 391' ' ' LEU . 7.6 p -134.76 117.63 23.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 109.015 -0.735 . . . . 73.239999999999995 109.015 174.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 9.7 t30 44.91 74.79 0.12 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 125.836 1.655 . . . . 73.209999999999994 111.852 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 67.63 -23.57 0.12 Allowed 'General case' 0 CA--C 1.57 1.718 0 C-N-CA 125.386 1.474 . . . . 61.119999999999997 114.13 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 20.3 t -85.97 127.72 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 121.203 -0.936 . . . . 74.150000000000006 110.494 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -75.35 133.12 41.3 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 122.937 0.495 . . . . 75.540000000000006 110.833 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.9 mp -114.12 -4.7 13.11 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.899 1.074 . . . . 75.200000000000003 113.899 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -67.03 104.9 1.5 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.903 -0.406 . . . . 74.400000000000006 109.903 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 65.03 82.83 0.18 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.892 1.277 . . . . 73.519999999999996 113.812 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 20.6 m -143.42 163.88 15.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 106.156 -1.794 . . . . 73.219999999999999 106.156 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.9 m -79.81 149.07 31.15 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 119.17 0.895 . . . . 73.349999999999994 108.879 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . 0.57 ' CD2' HD21 ' A' ' 339' ' ' ASN . 45.2 t-80 -46.45 -48.44 18.95 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.231 0.826 . . . . 74.439999999999998 113.231 -174.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -60.84 -39.24 88.34 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.021 0.438 . . . . 73.040000000000006 110.447 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -69.29 -39.8 78.11 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.389 -0.967 . . . . 72.430000000000007 108.389 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.18 -58.3 7.68 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.354 -1.294 . . . . 71.030000000000001 110.257 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 384' ' ' HIS . 40.5 t -55.63 -40.36 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 123.464 0.477 . . . . 74.140000000000001 110.606 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 88.8 m -60.25 -38.05 82.31 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.389 -0.369 . . . . 64.239999999999995 111.813 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.28 86.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.67 0.272 . . . . 73.510000000000005 110.797 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.469 ' HG ' HG12 ' A' ' 374' ' ' VAL . 5.5 mp -77.83 -37.74 47.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.179 -0.608 . . . . 74.209999999999994 109.891 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 54.2 mttm -62.97 -31.79 72.98 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 113.642 0.978 . . . . 74.109999999999999 113.642 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -83.81 64.49 8.08 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.975 0.893 . . . . 74.140000000000001 111.67 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' THR . . . . . 0.43 ' OG1' HD13 ' A' ' 329' ' ' LEU . 13.3 p -132.36 153.91 50.29 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.77 -1.105 . . . . 72.099999999999994 109.288 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 41.8 m -143.77 96.73 2.95 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.429 1.109 . . . . 74.340000000000003 111.143 178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . 0.489 ' O ' HG21 ' A' ' 323' ' ' ILE 0.4 9.0 m-20 57.57 6.06 0.38 Allowed 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 128.303 2.641 . . . . 71.349999999999994 118.063 172.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . 0.433 ' HE2' ' CZ ' ' A' ' 399' ' ' TYR . 31.2 t80 -156.31 127.75 7.14 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.004 -1.48 . . . . 70.329999999999998 107.004 171.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 24.1 t -138.69 142.82 33.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 123.269 0.627 . . . . 75.239999999999995 109.738 -174.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . 0.433 ' CZ ' ' HE2' ' A' ' 397' ' ' PHE . 87.1 m-85 -111.6 96.41 6.07 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.837 -0.801 . . . . 73.319999999999993 108.837 172.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.6 tt -89.27 135.29 33.66 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.568 -0.707 . . . . 72.549999999999997 110.58 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -117.77 108.65 15.63 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.41 -0.959 . . . . 74.349999999999994 108.41 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 369' ' ' ASP . 3.6 p -113.77 151.86 15.54 Favored 'Isoleucine or valine' 0 C--O 1.266 1.935 0 CA-C-O 121.977 0.894 . . . . 64.439999999999998 110.842 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.586 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -135.28 157.91 45.7 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 104.362 -2.459 . . . . 71.409999999999997 104.362 174.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 62.1 mttm . . . . . 0 C--N 1.274 -2.69 0 C-N-CA 118.159 -1.417 . . . . 75.340000000000003 111.39 178.116 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 CA--C 1.486 -1.511 0 N-CA-C 107.717 -1.216 . . . . 71.319999999999993 107.717 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.58 150.3 21.28 Favored 'General case' 0 N--CA 1.408 -2.537 0 C-N-CA 118.616 -1.234 . . . . 74.450000000000003 107.804 162.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 149' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 332' ' ' SER . 97.2 m -132.23 132.04 42.7 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.38 -0.6 . . . . 73.329999999999998 109.38 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -74.16 131.59 41.42 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-N 115.608 -0.723 . . . . 72.019999999999996 110.65 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 C--N 1.286 -2.193 0 CA-C-N 115.099 -0.955 . . . . 70.299999999999997 108.686 173.307 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' MET . . . . . 0.491 ' HB3' ' O ' ' A' ' 402' ' ' VAL . 24.0 ttt . . . . . 0 C--O 1.193 -1.872 0 N-CA-C 105.814 -1.921 . . . . 75.510000000000005 105.814 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.355 2.0 pm0 -117.23 135.99 53.39 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 115.605 1.705 . . . . 75.120000000000005 115.605 -174.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.429 HD11 ' O ' ' A' ' 363' ' ' GLY . 91.4 mt -116.48 110.2 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.298 0 CA-C-N 112.637 -2.074 . . . . 74.230000000000004 108.98 -176.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -74.3 125.67 28.97 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.101 -1.444 . . . . 75.340000000000003 107.101 171.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 6.0 mt -122.91 149.39 44.3 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.107 -0.952 . . . . 63.130000000000003 110.518 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 37.8 mm -106.55 114.62 46.21 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 109.064 -0.717 . . . . 74.030000000000001 109.064 173.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.645 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 8.7 tmtt? -64.82 152.94 41.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.216 -0.661 . . . . 74.329999999999998 109.216 173.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . 0.402 ' N ' ' HD3' ' A' ' 324' ' ' LYS . . . -143.42 -159.5 8.0 Favored Glycine 0 C--N 1.296 -1.646 0 C-N-CA 120.615 -0.802 . . . . 63.350000000000001 111.678 -177.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.56 -12.71 27.15 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.947 2.431 . . . . 73.540000000000006 112.493 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -103.58 5.02 36.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.168 0.985 . . . . 75.209999999999994 108.818 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.02 -114.6 3.92 Favored Glycine 0 CA--C 1.488 -1.632 0 N-CA-C 108.283 -1.927 . . . . 74.310000000000002 108.283 -176.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.22 -35.55 5.59 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.829 -1.174 . . . . 75.310000000000002 107.829 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.43 50.59 3.98 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.194 -0.912 . . . . 74.400000000000006 115.218 172.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . 0.448 ' O ' HG22 ' B' ' 151' ' ' VAL . 25.7 p90 -154.73 144.5 21.58 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.076 0.465 . . . . 73.129999999999995 110.199 172.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 17.3 m -92.76 125.99 37.64 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.41 -0.813 . . . . 73.099999999999994 109.454 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 49.9 pt -113.09 144.18 21.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 108.502 -0.925 . . . . 73.340000000000003 108.502 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -138.83 131.66 29.29 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.753 -1.203 . . . . 74.319999999999993 107.753 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 144.77 164.12 10.41 Favored Glycine 0 C--N 1.28 -2.583 0 N-CA-C 109.606 -1.397 . . . . 61.149999999999999 109.606 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.09 177.16 14.76 Favored Glycine 0 CA--C 1.479 -2.206 0 N-CA-C 108.13 -1.988 . . . . 54.119999999999997 108.13 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 84.2 t -51.15 107.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 117.634 0.717 . . . . 62.439999999999998 110.954 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 91.34 -18.93 50.08 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.166 -0.925 . . . . 71.030000000000001 112.227 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.585 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 65.6 t30 -105.96 19.71 20.11 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.282 -0.636 . . . . 74.329999999999998 109.282 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.04 125.6 14.16 Favored 'General case' 0 C--O 1.251 1.167 0 CA-C-N 115.793 -0.64 . . . . 72.109999999999999 111.13 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -79.19 -49.11 13.07 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.127 -0.942 . . . . 75.409999999999997 109.768 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 55.7 mt -103.45 125.58 34.53 Favored Pre-proline 0 C--N 1.304 -1.407 0 CA-C-N 115.839 -0.619 . . . . 65.450000000000003 109.711 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -48.96 109.34 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 123.347 2.698 . . . . 73.129999999999995 112.638 177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 102.49 -2.24 49.81 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.387 -0.824 . . . . 73.400000000000006 112.265 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . 0.531 ' CG ' ' HH ' ' A' ' 349' ' ' TYR . 11.9 t70 -128.93 96.89 4.47 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.747 -0.834 . . . . 72.0 108.747 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -83.07 33.03 0.44 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.927 0.87 . . . . 72.099999999999994 111.624 -171.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 0.438 ' HG ' ' CD ' ' A' ' 380' ' ' GLU . 56.7 m -98.96 178.08 5.05 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.798 -0.637 . . . . 75.120000000000005 111.933 -177.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 9.1 mm -90.81 132.83 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.995 -1.113 . . . . 73.349999999999994 107.995 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.531 ' HH ' ' CG ' ' A' ' 345' ' ' ASP . 39.6 m-85 -125.17 138.69 54.14 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 112.725 0.639 . . . . 74.150000000000006 112.725 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 50.9 t -68.05 118.03 11.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.296 -1.002 . . . . 75.409999999999997 108.296 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 17.4 m -105.27 -26.15 12.14 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.065 0.46 . . . . 73.340000000000003 111.285 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -156.7 138.08 13.88 Favored 'General case' 0 C--O 1.2 -1.544 0 N-CA-C 107.198 -1.408 . . . . 74.409999999999997 107.198 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 73.6 mt -110.37 128.35 66.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.342 -1.355 . . . . 74.430000000000007 107.342 172.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 50.1 mm -73.95 134.62 29.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.143 0.497 . . . . 74.530000000000001 109.848 -175.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' A' ' 355' ' ' GLU . 1.5 pm0 -62.68 125.55 24.33 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 124.482 1.113 . . . . 73.129999999999995 110.915 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 74.37 17.96 79.81 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.581 -1.191 . . . . 53.509999999999998 110.949 -175.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.76 160.37 50.39 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 111.512 -0.635 . . . . 75.230000000000004 111.512 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.06 94.49 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.519 -0.919 . . . . 74.209999999999994 108.519 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . 0.43 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -74.64 -5.93 45.82 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.251 -0.431 . . . . 71.239999999999995 111.75 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -93.77 -33.96 13.39 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.575 -0.898 . . . . 75.140000000000001 108.575 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -91.25 -59.75 2.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 123.215 1.483 . . . . 75.400000000000006 109.838 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -87.13 -34.13 19.2 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 112.422 -2.172 . . . . 70.030000000000001 111.004 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.638 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -58.05 -33.64 70.01 Favored Glycine 0 C--O 1.199 -2.035 0 N-CA-C 117.453 1.741 . . . . 71.510000000000005 117.453 -174.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.638 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.62 33.34 0.45 Allowed 'General case' 0 N--CA 1.508 2.426 0 CA-C-N 118.457 1.129 . . . . 75.340000000000003 111.109 -173.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 58.9 tp -99.34 155.65 17.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.415 -1.266 . . . . 75.400000000000006 109.696 -171.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -117.07 146.42 43.12 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.111 0.481 . . . . 75.439999999999998 110.296 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.2 mt -66.22 120.82 14.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 107.506 -1.294 . . . . 73.219999999999999 107.506 171.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.44 -6.62 20.85 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 120.818 -0.706 . . . . 70.219999999999999 112.535 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.39 142.36 43.1 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 112.712 0.634 . . . . 74.239999999999995 112.712 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 9.2 ttmm -88.36 122.47 31.91 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 123.315 0.646 . . . . 73.219999999999999 110.02 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.471 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 3.5 mp -81.15 104.98 12.01 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.334 -1.728 . . . . 75.230000000000004 106.334 174.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.403 ' O ' HD21 ' A' ' 372' ' ' LEU . 5.7 tt -80.24 -37.74 32.38 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.053 -1.462 . . . . 74.409999999999997 107.053 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 401' ' ' LYS . . . -160.98 157.66 26.7 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.371 -0.831 . . . . 70.209999999999994 110.513 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 14.6 p -133.42 127.53 53.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.929 -1.137 . . . . 61.310000000000002 107.929 173.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 63.67 31.55 14.39 Favored 'General case' 0 C--O 1.206 -1.221 0 CA-C-O 124.011 1.862 . . . . 71.25 107.739 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 65.86 4.49 2.98 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 111.211 -2.722 . . . . 74.439999999999998 113.938 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 46.4 t -80.23 123.12 36.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.06 -1.089 . . . . 74.040000000000006 108.06 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.5 p -58.98 122.92 14.89 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.719 1.007 . . . . 75.140000000000001 113.719 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.42 -1.97 20.98 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 124.434 1.094 . . . . 65.329999999999998 111.356 177.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.438 ' CD ' ' HG ' ' A' ' 347' ' ' SER . 11.3 mm-40 -64.77 108.53 1.76 Allowed 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.554 -0.536 . . . . 73.450000000000003 109.554 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 61.78 71.07 0.56 Allowed 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 122.527 1.156 . . . . 75.430000000000007 112.909 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.0 168.77 23.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 106.989 -1.486 . . . . 74.209999999999994 106.989 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.7 m -76.52 139.33 40.71 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.559 -0.904 . . . . 72.420000000000002 108.559 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . 0.596 ' O ' HG22 ' A' ' 388' ' ' VAL . 84.8 t60 -48.42 -48.82 36.91 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.77 0.655 . . . . 75.540000000000006 112.77 -175.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -59.54 -42.58 92.65 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.936 -0.765 . . . . 75.019999999999996 108.936 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 383' ' ' THR . 49.3 tt0 -67.71 -32.44 73.08 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.213 -1.358 . . . . 71.010000000000005 109.115 -174.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.512 ' O ' HD11 ' A' ' 391' ' ' LEU . . . -73.78 -50.51 20.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.828 -1.078 . . . . 75.129999999999995 110.289 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 384' ' ' HIS . 15.8 t -59.62 -46.99 92.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 109.819 -0.437 . . . . 71.439999999999998 109.819 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 42.7 m -62.78 -29.97 71.11 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.553 -0.748 . . . . 72.540000000000006 112.164 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.94 -34.53 78.33 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.124 -0.36 . . . . 71.349999999999994 110.248 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.512 HD11 ' O ' ' A' ' 387' ' ' ALA . 5.5 mp -79.03 -33.61 44.62 Favored 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 120.253 -0.579 . . . . 73.120000000000005 110.738 176.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -67.23 -29.32 68.93 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.413 0.523 . . . . 72.540000000000006 112.413 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -80.21 48.14 0.97 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.44 0.638 . . . . 54.439999999999998 112.156 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' THR . . . . . 0.4 ' HB ' HG23 ' A' ' 398' ' ' VAL . 32.4 p -124.54 146.93 48.72 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.311 -0.996 . . . . 70.120000000000005 108.311 176.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.6 t -141.04 98.69 3.43 Favored 'General case' 0 N--CA 1.409 -2.509 0 C-N-CA 117.711 -1.596 . . . . 70.439999999999998 110.935 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . 0.645 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 6.2 m-20 65.63 16.13 10.36 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 110.89 -2.868 . . . . 64.049999999999997 112.951 166.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -161.65 115.54 1.92 Allowed 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.471 -1.307 . . . . 73.209999999999994 107.471 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.4 HG23 ' HB ' ' A' ' 394' ' ' THR . 28.8 t -133.74 151.04 32.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 123.034 0.534 . . . . 65.209999999999994 110.518 -175.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -126.24 99.79 6.03 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.723 -1.214 . . . . 70.219999999999999 107.723 171.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.2 tt -91.75 119.5 31.64 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.525 -1.287 . . . . 75.239999999999995 107.525 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 373' ' ' ALA . 24.0 ttmm -103.64 107.89 18.93 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.693 -1.225 . . . . 74.25 107.693 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 318' ' ' MET . 1.9 p -107.58 149.99 10.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 CA-C-O 121.744 0.783 . . . . 71.120000000000005 110.498 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.52 159.6 41.31 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.82 -1.082 . . . . 70.049999999999997 108.14 176.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.609 0 N-CA-C 109.079 -0.712 . . . . 71.120000000000005 109.079 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 CA--C 1.497 -1.094 0 N-CA-C 109.063 -0.717 . . . . 70.420000000000002 109.063 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.36 165.11 12.73 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.507 -0.923 . . . . 65.450000000000003 108.507 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 27.6 m -147.14 129.06 15.39 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.409 -0.589 . . . . 74.219999999999999 109.409 170.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 41.6 tt0 -71.14 131.27 43.32 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-O 121.088 0.471 . . . . 70.420000000000002 110.771 175.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 331' ' ' PHE . 17.4 m . . . . . 0 C--N 1.301 -1.527 0 CA-C-O 116.786 -1.578 . . . . 73.349999999999994 111.627 176.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 64.4 ttp . . . . . 0 CA--C 1.5 -0.951 0 N-CA-C 107.451 -1.314 . . . . 71.209999999999994 107.451 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.297 1.6 pm0 -89.88 133.22 34.87 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 114.514 1.302 . . . . 72.420000000000002 114.514 -177.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 77.9 mt -120.16 114.95 45.75 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.677 0 CA-C-N 112.135 -2.302 . . . . 74.549999999999997 108.789 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -81.43 121.29 26.06 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.235 -1.024 . . . . 73.239999999999995 108.235 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.531 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 95.5 mt -118.4 150.06 40.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 124.363 1.039 . . . . 64.239999999999995 108.807 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 42.9 mm -106.37 116.75 50.78 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 N-CA-C 109.286 -0.635 . . . . 73.340000000000003 109.286 173.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 396' ' ' ASP . 12.1 tmtt? -71.13 153.63 42.37 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 107.707 -1.22 . . . . 74.430000000000007 107.707 171.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . 0.414 ' O ' ' HE2' ' A' ' 324' ' ' LYS . . . -153.05 -154.94 6.91 Favored Glycine 0 C--N 1.302 -1.321 0 C-N-CA 119.625 -1.274 . . . . 42.399999999999999 113.291 -174.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.86 -22.59 36.2 Favored 'Trans proline' 0 C--O 1.217 -0.558 0 C-N-CA 123.165 2.577 . . . . 72.109999999999999 113.939 -175.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -106.07 20.57 18.74 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 122.224 1.011 . . . . 75.299999999999997 108.618 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.71 -133.61 11.96 Favored Glycine 0 CA--C 1.477 -2.298 0 CA-C-N 114.034 -1.439 . . . . 62.020000000000003 109.649 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 14.6 tp -109.26 -34.96 6.41 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 106.903 -1.517 . . . . 74.109999999999999 106.903 175.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . 0.467 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 86.32 47.18 5.02 Favored Glycine 0 N--CA 1.429 -1.822 0 CA-C-N 113.746 -1.57 . . . . 75.540000000000006 116.72 171.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -152.48 150.19 29.35 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 117.928 0.864 . . . . 74.549999999999997 112.23 169.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 6.5 m -104.71 129.34 52.93 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.197 -0.91 . . . . 62.32 109.263 -177.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 47.9 pt -113.75 150.96 15.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 115.544 -0.753 . . . . 73.420000000000002 108.994 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . 0.503 ' HA ' ' CE1' ' A' ' 384' ' ' HIS . . . -146.3 130.68 17.64 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.343 -1.354 . . . . 74.540000000000006 107.343 175.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.531 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 145.05 160.24 8.46 Favored Glycine 0 C--N 1.283 -2.372 0 N-CA-C 110.705 -0.958 . . . . 71.310000000000002 110.705 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.9 -175.26 20.69 Favored Glycine 0 N--CA 1.424 -2.122 0 N-CA-C 108.253 -1.939 . . . . 70.439999999999998 108.253 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 91.0 t -51.07 105.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 O-C-N 124.358 0.681 . . . . 73.049999999999997 111.392 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 87.38 -14.92 56.65 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.449 -0.796 . . . . 71.109999999999999 112.74 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.531 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -105.41 12.72 31.22 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.873 -1.158 . . . . 71.420000000000002 107.873 -177.618 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.432 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -53.31 126.65 21.89 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.614 0.766 . . . . 63.210000000000001 111.749 -176.476 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . 0.542 ' HB3' ' CD2' ' A' ' 349' ' ' TYR . 15.7 t60 -86.64 -38.0 17.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.63 -0.714 . . . . 75.319999999999993 110.003 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 37.9 mm -102.62 118.78 57.77 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 109.929 -0.397 . . . . 75.0 109.929 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.07 110.62 0.46 Allowed 'Trans proline' 0 C--O 1.252 1.183 0 C-N-CA 123.093 2.529 . . . . 74.400000000000006 111.411 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 108.29 -5.62 33.79 Favored Glycine 0 N--CA 1.429 -1.814 0 CA-C-N 115.143 -0.935 . . . . 71.030000000000001 112.159 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -131.67 104.33 6.87 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.183 -0.673 . . . . 64.430000000000007 109.183 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . 0.432 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 66.3 t30 -83.92 37.91 0.62 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.282 1.039 . . . . 65.140000000000001 110.612 -173.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 50.1 m -103.95 177.65 4.78 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.96 -1.018 . . . . 74.439999999999998 112.235 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 4.5 mm -93.16 138.6 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.428 -0.953 . . . . 75.519999999999996 108.428 -177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.542 ' CD2' ' HB3' ' A' ' 341' ' ' HIS . 95.8 m-85 -129.84 141.86 50.76 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 112.309 0.485 . . . . 63.210000000000001 112.309 -178.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 56.8 t -74.37 115.5 15.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 107.747 -1.205 . . . . 73.439999999999998 107.747 175.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.9 m -98.85 -24.2 15.08 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 121.388 0.613 . . . . 73.109999999999999 110.473 -175.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 332' ' ' SER . 33.3 ttmt -158.8 150.13 20.58 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 107.801 -1.185 . . . . 74.329999999999998 107.801 -173.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 60.1 mt -130.7 116.26 34.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 107.08 -1.452 . . . . 74.239999999999995 107.08 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 46.2 mm -84.99 124.68 40.13 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 C-N-CA 123.481 0.712 . . . . 73.129999999999995 110.491 -171.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.485 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 0.6 OUTLIER -60.53 147.26 42.05 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.873 -0.788 . . . . 72.530000000000001 108.873 -177.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 94.2 -24.63 26.12 Favored Glycine 0 CA--C 1.478 -2.265 0 N-CA-C 109.486 -1.446 . . . . 71.319999999999993 109.486 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . 0.467 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -68.53 142.86 39.52 Favored Glycine 1 N--CA 1.395 -4.053 0 N-CA-C 108.0 -2.04 . . . . 52.229999999999997 108.0 172.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 362' ' ' ASP . . . -63.87 -32.56 74.13 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.296 -0.631 . . . . 74.439999999999998 109.296 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . 0.625 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.11 -4.62 39.71 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 120.7 -0.4 . . . . 73.319999999999993 111.744 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . 0.485 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 17.1 t60 -94.68 -49.2 5.73 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.694 -0.854 . . . . 74.420000000000002 108.694 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -79.27 -50.42 10.94 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.386 -0.825 . . . . 72.519999999999996 111.928 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . 0.646 ' O ' ' HE2' ' A' ' 364' ' ' LYS . 11.4 t70 -85.76 -34.89 21.06 Favored 'General case' 0 CA--C 1.465 -2.303 0 C-N-CA 124.085 0.954 . . . . 75.430000000000007 109.888 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -42.39 -25.64 0.3 Allowed Glycine 0 CA--C 1.486 -1.763 0 N-CA-C 119.96 2.744 . . . . 74.140000000000001 119.96 -161.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.646 ' HE2' ' O ' ' A' ' 362' ' ' ASP . 0.0 OUTLIER 47.03 31.16 1.46 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.356 1.078 . . . . 70.109999999999999 111.069 178.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 48.6 tp -113.6 150.87 32.47 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 114.597 -1.183 . . . . 73.099999999999994 109.336 -170.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -122.88 148.44 45.43 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.388 0.614 . . . . 74.230000000000004 111.186 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.6 mt -65.97 126.05 24.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.272 -1.01 . . . . 65.430000000000007 108.272 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.64 -18.6 14.97 Favored Glycine 0 C--N 1.313 -0.748 0 N-CA-C 111.645 -0.582 . . . . 55.229999999999997 111.645 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -62.93 130.84 46.53 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-O 121.16 0.505 . . . . 72.010000000000005 111.827 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.535 ' HB2' ' CE1' ' A' ' 349' ' ' TYR . 50.9 tttt -88.84 127.01 35.62 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.562 -0.745 . . . . 74.150000000000006 110.581 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 3.3 mp -81.3 107.03 13.74 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.891 -1.522 . . . . 74.409999999999997 106.891 177.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.496 HD13 ' HB1' ' A' ' 403' ' ' ALA . 3.4 tt -80.31 -43.31 21.47 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 106.273 -1.751 . . . . 73.200000000000003 106.273 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -157.45 154.56 28.95 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.075 -0.966 . . . . 65.519999999999996 110.1 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.77 120.6 42.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 108.525 -0.917 . . . . 74.030000000000001 108.525 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 63.51 30.51 15.17 Favored 'General case' 0 CA--C 1.484 -1.574 0 CA-C-O 123.978 1.847 . . . . 71.109999999999999 108.321 -174.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.9 t30 66.57 16.15 10.32 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 109.793 -3.367 . . . . 75.049999999999997 112.605 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.88 124.36 39.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 106.271 -1.752 . . . . 74.099999999999994 106.271 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.9 p -65.08 125.36 24.69 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.893 0.701 . . . . 72.349999999999994 112.893 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.21 5.94 28.19 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 123.809 0.843 . . . . 74.319999999999993 111.108 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.429 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 28.4 mm-40 -68.48 111.66 4.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.227 -0.657 . . . . 73.150000000000006 109.227 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 56.09 67.9 0.94 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.572 1.177 . . . . 74.310000000000002 113.22 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.72 167.63 23.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 107.112 -1.44 . . . . 65.140000000000001 107.112 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.6 m -74.89 142.41 44.06 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.29 -1.004 . . . . 74.120000000000005 108.29 -177.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . 0.624 ' O ' HG22 ' A' ' 388' ' ' VAL . 86.3 t60 -52.93 -49.38 66.13 Favored 'General case' 0 C--O 1.213 -0.843 0 N-CA-C 112.252 0.464 . . . . 75.430000000000007 112.252 -176.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -61.64 -30.34 70.64 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.447 0.641 . . . . 73.109999999999999 111.435 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.5 tt0 -75.01 -35.74 61.96 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.044 -0.98 . . . . 75.030000000000001 108.426 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -75.09 -38.84 61.09 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.059 -0.973 . . . . 55.43 110.585 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.624 HG22 ' O ' ' A' ' 384' ' ' HIS . 11.7 t -65.08 -42.33 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 109.011 -0.737 . . . . 64.519999999999996 109.011 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 60.9 m -60.32 -40.79 91.85 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 123.417 0.448 . . . . 72.450000000000003 110.08 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -62.26 -35.43 78.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.628 -0.26 . . . . 62.409999999999997 111.479 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 57.4 tp -82.34 -22.75 35.4 Favored 'General case' 0 N--CA 1.394 -3.272 0 C-N-CA 122.823 0.449 . . . . 74.129999999999995 109.904 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 61.1 mttm -77.96 -21.63 50.7 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 120.869 0.366 . . . . 75.140000000000001 111.033 176.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -76.18 47.37 0.45 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.498 -0.774 . . . . 75.319999999999993 110.411 174.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' THR . . . . . 0.429 ' HB ' HG23 ' A' ' 398' ' ' VAL . 22.5 p -124.61 133.55 53.23 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.087 -1.079 . . . . 75.109999999999999 108.087 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' SER . . . . . 0.532 ' HA ' ' HD2' ' A' ' 324' ' ' LYS . 50.8 m -139.15 97.73 3.36 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.814 -1.154 . . . . 73.310000000000002 111.798 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . 0.593 ' HA ' ' O ' ' A' ' 324' ' ' LYS . 5.8 m-20 60.68 18.57 8.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 111.415 -2.63 . . . . 73.219999999999999 112.816 171.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -166.69 130.13 1.93 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.389 -1.278 . . . . 74.120000000000005 107.567 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 22.0 t -145.24 143.43 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 122.832 0.453 . . . . 75.140000000000001 111.086 -176.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -117.04 96.78 5.61 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.378 -0.971 . . . . 63.240000000000002 108.378 167.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.89 113.95 25.74 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.97 -0.752 . . . . 72.099999999999994 108.97 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -93.06 109.7 21.18 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.546 -1.279 . . . . 74.329999999999998 107.546 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 69.2 t -104.49 148.18 9.51 Favored 'Isoleucine or valine' 0 C--O 1.258 1.551 0 CA-C-O 121.368 0.604 . . . . 72.129999999999995 110.091 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.25 158.94 43.22 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 125.083 1.353 . . . . 75.540000000000006 107.543 176.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.293 -1.851 0 N-CA-C 107.826 -1.175 . . . . 74.329999999999998 107.826 173.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 CA--C 1.497 -1.084 0 N-CA-C 108.52 -0.919 . . . . 70.200000000000003 108.52 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -92.21 149.97 21.16 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.393 -0.966 . . . . 74.030000000000001 108.393 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 20.1 m -134.8 129.76 35.06 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.204 -0.665 . . . . 65.129999999999995 109.204 174.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 50.2 tt0 -85.29 139.98 31.18 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 112.631 0.604 . . . . 73.299999999999997 112.631 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 51.0 t . . . . . 0 C--N 1.312 -1.04 0 N-CA-C 106.641 -1.614 . . . . 74.450000000000003 106.641 172.625 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.487 -1.479 0 N-CA-C 108.93 -0.767 . . . . 75.150000000000006 108.93 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -132.84 121.19 22.56 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 108.171 -1.048 . . . . 71.239999999999995 108.171 171.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 64.5 mt -98.1 105.75 17.71 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.033 0 CA-C-N 114.275 -1.33 . . . . 74.420000000000002 108.531 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -89.24 102.43 15.09 Favored 'General case' 0 N--CA 1.38 -3.971 0 N-CA-C 105.105 -2.183 . . . . 74.219999999999999 105.105 169.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.417 ' HA ' ' OD2' ' A' ' 362' ' ' ASP . 0.5 OUTLIER -106.31 138.83 41.79 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 112.486 -2.143 . . . . 72.140000000000001 108.092 -170.15 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 25.8 mm -98.53 114.83 37.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 CA-C-O 121.344 0.593 . . . . 75.019999999999996 110.161 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -75.3 148.7 39.13 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.425 -0.807 . . . . 73.430000000000007 110.3 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -135.38 -161.09 9.2 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.857 -0.687 . . . . 75.140000000000001 111.86 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.64 -16.59 33.87 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.041 2.494 . . . . 75.409999999999997 113.333 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -101.66 10.23 40.33 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.318 1.056 . . . . 71.209999999999994 108.633 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.77 -128.67 8.7 Favored Glycine 0 CA--C 1.478 -2.234 0 CA-C-N 114.3 -1.318 . . . . 74.540000000000006 110.741 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.3 mp -101.35 -44.65 5.57 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 105.918 -1.882 . . . . 75.329999999999998 105.918 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 80.36 49.37 5.89 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 114.852 -1.067 . . . . 73.219999999999999 114.514 172.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -151.41 147.74 27.25 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.842 -0.429 . . . . 74.099999999999994 109.842 174.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 4.2 m -97.93 124.59 42.44 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 108.436 -0.95 . . . . 72.400000000000006 108.436 -176.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 46.4 pt -113.48 153.09 15.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 108.611 -0.885 . . . . 75.519999999999996 108.611 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.92 129.35 15.85 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.077 -0.712 . . . . 74.319999999999993 109.077 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 152.35 165.55 13.33 Favored Glycine 0 C--N 1.282 -2.433 0 N-CA-C 110.208 -1.157 . . . . 74.129999999999995 110.208 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 136.69 -176.83 20.14 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 107.663 -2.175 . . . . 72.540000000000006 107.663 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . 0.403 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 58.6 t -54.32 100.5 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.249 1.042 0 CA-C-O 122.096 0.951 . . . . 75.019999999999996 112.495 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 80.84 4.49 90.39 Favored Glycine 0 C--O 1.21 -1.404 0 CA-C-N 115.121 -0.945 . . . . 62.130000000000003 112.002 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.533 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -106.46 11.66 30.5 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.782 -1.562 . . . . 74.409999999999997 106.782 178.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -49.8 122.67 6.79 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.839 1.256 . . . . 72.129999999999995 112.701 -175.633 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -79.27 -38.52 35.24 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.307 -0.86 . . . . 73.129999999999995 109.572 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.6 123.97 38.54 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 108.564 -0.902 . . . . 70.430000000000007 108.564 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.36 107.51 0.21 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.971 2.447 . . . . 75.099999999999994 112.293 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.89 -8.97 29.66 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-N 115.26 -0.882 . . . . 75.409999999999997 112.591 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -125.22 106.94 10.25 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.39 -0.924 . . . . 72.540000000000006 110.288 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . 0.423 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 61.9 t30 -80.37 28.19 0.32 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.734 1.214 . . . . 73.150000000000006 111.747 -171.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 0.625 ' OG ' ' HE2' ' A' ' 370' ' ' LYS . 24.9 m -99.28 175.63 5.81 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.841 -0.618 . . . . 61.439999999999998 112.134 -175.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.487 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 6.0 mm -89.72 132.2 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 108.016 -1.105 . . . . 74.030000000000001 108.016 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.583 ' CE2' ' HB2' ' A' ' 370' ' ' LYS . 68.0 m-85 -128.01 149.57 50.3 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.948 0.404 . . . . 73.140000000000001 111.868 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.69 123.72 32.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.482 -0.933 . . . . 74.420000000000002 108.482 175.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 33.2 m -108.11 -28.47 9.5 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.932 0.396 . . . . 73.030000000000001 111.474 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 50.9 mtmt -152.27 151.96 31.58 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.862 -0.792 . . . . 74.200000000000003 108.862 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 68.4 mt -129.41 121.98 54.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.623 -1.621 . . . . 74.430000000000007 106.623 174.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 50.0 mm -78.16 142.01 14.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 123.408 0.683 . . . . 75.450000000000003 112.173 -170.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.98 122.64 12.78 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.698 1.199 . . . . 75.239999999999995 112.28 -174.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 72.31 12.25 76.39 Favored Glycine 0 C--N 1.306 -1.087 0 CA-C-N 115.605 -0.725 . . . . 61.149999999999999 112.966 177.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -74.27 164.26 54.65 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 110.735 -0.946 . . . . 62.43 110.735 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.53 98.08 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.172 -0.677 . . . . 72.319999999999993 109.172 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . 0.566 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.58 -4.6 40.91 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.134 -0.485 . . . . 74.400000000000006 112.015 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -94.11 -32.69 13.66 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.849 -0.797 . . . . 75.340000000000003 108.849 176.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -95.8 -58.17 2.17 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.997 -0.681 . . . . 74.25 112.332 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . 0.417 ' OD2' ' HA ' ' A' ' 322' ' ' LEU . 27.7 t70 -86.18 -21.97 27.22 Favored 'General case' 0 CA--C 1.473 -2.019 0 CA-C-N 115.726 -0.67 . . . . 63.009999999999998 110.366 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -43.0 -34.9 2.13 Favored Glycine 0 CA--C 1.479 -2.172 0 CA-C-O 117.751 -1.583 . . . . 33.409999999999997 116.144 -172.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? 42.8 40.37 2.07 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.937 0.875 . . . . 64.439999999999998 110.15 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 60.3 tp -133.45 154.39 50.83 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 113.588 -1.642 . . . . 75.519999999999996 108.977 -167.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -122.66 152.33 40.62 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.736 0.779 . . . . 74.420000000000002 111.141 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.7 mt -65.71 123.68 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 108.024 -1.102 . . . . 73.439999999999998 108.024 174.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.17 -6.16 21.58 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.684 -0.769 . . . . 62.130000000000003 112.342 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -74.23 141.62 45.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.026 0.75 . . . . 70.239999999999995 113.026 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.638 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 47.1 tttm -96.08 118.43 32.65 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 123.978 0.911 . . . . 64.219999999999999 110.31 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 3.0 mp -78.85 114.46 17.8 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.674 -1.232 . . . . 73.510000000000005 107.674 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.508 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 5.7 tt -86.84 -43.01 12.8 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.943 -1.132 . . . . 72.519999999999996 107.943 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -157.2 150.64 24.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.046 -0.524 . . . . 75.329999999999998 111.024 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 9.8 p -133.59 123.8 46.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 109.006 -0.739 . . . . 75.409999999999997 109.006 173.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 60.95 31.86 19.96 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-O 124.145 1.926 . . . . 75.409999999999997 109.536 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 67.23 12.36 8.9 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 109.08 -3.691 . . . . 73.25 112.903 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 54.9 t -82.29 125.3 39.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 106.697 -1.594 . . . . 74.129999999999995 106.697 173.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.8 p -66.74 126.55 29.36 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 123.61 0.569 . . . . 73.530000000000001 112.267 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.02 6.07 30.88 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.714 0.806 . . . . 72.209999999999994 110.725 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . 0.508 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 13.6 mm-40 -70.81 107.43 3.99 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.217 -0.901 . . . . 74.409999999999997 109.253 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 57.8 71.59 0.57 Allowed 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.371 1.081 . . . . 73.109999999999999 113.36 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.69 172.53 15.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.023 -1.473 . . . . 72.109999999999999 107.023 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 81.0 p -81.23 146.69 30.33 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.066 -1.054 . . . . 74.0 108.769 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -52.33 -31.45 33.32 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 112.937 0.717 . . . . 63.539999999999999 112.937 -176.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -64.5 -40.85 96.42 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-O 120.625 0.25 . . . . 74.319999999999993 110.875 177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.62 -40.22 80.44 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.637 -0.875 . . . . 74.140000000000001 108.637 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -62.42 -59.04 5.54 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.5 -1.227 . . . . 74.030000000000001 110.629 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.444 ' O ' ' HG2' ' A' ' 392' ' ' LYS . 90.4 t -57.3 -44.91 84.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 O-C-N 123.212 0.32 . . . . 73.099999999999994 111.546 -177.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 55.4 m -60.65 -34.12 73.82 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 111.927 0.343 . . . . 71.439999999999998 111.927 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.8 77.88 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 110.277 -0.268 . . . . 65.019999999999996 110.277 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.9 mp -79.28 -28.73 42.32 Favored 'General case' 0 C--O 1.218 -0.57 0 C-N-CA 120.339 -0.544 . . . . 74.439999999999998 110.792 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 388' ' ' VAL . 73.0 mmtt -61.94 -41.61 98.17 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 120.608 0.242 . . . . 73.329999999999998 111.014 176.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -77.46 70.7 3.88 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 122.561 1.172 . . . . 74.140000000000001 111.021 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 12.9 p -142.45 155.46 45.08 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 113.241 -1.8 . . . . 65.319999999999993 108.561 178.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 32.5 p -166.45 115.81 0.92 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.591 -0.522 . . . . 61.32 109.591 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.8 t70 64.39 0.07 1.0 Allowed 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 125.365 1.466 . . . . 74.439999999999998 112.043 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -163.48 137.87 6.04 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.532 -0.914 . . . . 72.530000000000001 108.532 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 48.0 t -139.51 120.62 15.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 106.437 -1.69 . . . . 75.400000000000006 106.437 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.22 95.13 5.76 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.134 -1.432 . . . . 61.329999999999998 107.134 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.4 tt -108.94 111.12 22.63 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-O 121.038 0.447 . . . . 73.319999999999993 110.439 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.24 121.25 30.43 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.013 -1.106 . . . . 73.299999999999997 108.013 176.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 2.1 p -115.9 137.33 49.92 Favored 'Isoleucine or valine' 0 C--O 1.258 1.534 0 C-N-CA 123.578 0.751 . . . . 74.019999999999996 110.045 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.638 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.48 158.72 43.77 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.364 -0.976 . . . . 61.43 108.364 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.294 -1.811 0 N-CA-C 108.723 -0.843 . . . . 63.43 108.723 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . 0.531 ' C ' HD21 ' B' ' 147' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.594 0 N-CA-C 107.991 -1.114 . . . . 62.409999999999997 107.991 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.42 152.3 19.79 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 123.427 0.454 . . . . 63.240000000000002 112.208 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 41.9 m -142.51 141.82 32.15 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.886 -0.509 . . . . 75.010000000000005 109.862 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -77.16 152.99 34.62 Favored 'General case' 0 CA--C 1.462 -2.44 0 C-N-CA 123.918 0.887 . . . . 74.129999999999995 113.193 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.392 -3.354 0 C-N-CA 118.37 -1.332 . . . . 71.349999999999994 110.847 169.433 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 53.6 ttm . . . . . 0 C--O 1.205 -1.256 0 N-CA-C 106.107 -1.812 . . . . 64.230000000000004 106.107 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.428 1.9 pm0 -114.59 130.89 56.82 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 116.787 2.143 . . . . 62.219999999999999 116.787 -173.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.428 HG21 ' CD ' ' A' ' 364' ' ' LYS . 72.5 mt -111.88 112.66 41.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-N 111.573 -2.558 . . . . 75.140000000000001 108.83 -176.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . 0.629 ' HD3' ' CE1' ' A' ' 399' ' ' TYR . 30.6 ttpt -82.97 125.08 31.01 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.42 -0.955 . . . . 72.319999999999993 108.42 173.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.546 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 96.3 mt -119.29 154.06 34.08 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 124.904 1.377 . . . . 73.230000000000004 108.762 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.402 HG23 ' O ' ' A' ' 396' ' ' ASP . 49.5 mt -106.44 145.55 14.06 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.121 0 N-CA-C 106.467 -1.679 . . . . 71.299999999999997 106.467 169.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 395' ' ' SER . 1.3 ttpm? -75.26 177.81 6.25 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.732 -1.211 . . . . 73.219999999999999 107.732 177.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . 0.423 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -160.78 -167.91 21.93 Favored Glycine 0 C--N 1.289 -2.067 0 C-N-CA 119.949 -1.119 . . . . 72.200000000000003 111.665 -177.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.27 -29.23 32.58 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 123.166 2.578 . . . . 75.310000000000002 112.405 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -106.39 25.29 11.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.241 0.543 . . . . 75.209999999999994 110.041 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.99 -125.52 7.13 Favored Glycine 0 CA--C 1.485 -1.793 0 N-CA-C 109.442 -1.463 . . . . 62.130000000000003 109.442 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.7 mp -97.49 -30.84 12.66 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.288 -1.745 . . . . 72.140000000000001 106.288 173.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.99 48.7 4.54 Favored Glycine 0 N--CA 1.429 -1.798 0 CA-C-N 114.057 -1.429 . . . . 75.549999999999997 115.041 173.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -153.23 166.43 32.58 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.504 -0.554 . . . . 72.319999999999993 109.504 172.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 9.5 m -117.9 136.78 53.24 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 120.597 -0.441 . . . . 75.140000000000001 110.18 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.0 pt -119.06 152.46 21.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 122.496 0.319 . . . . 71.340000000000003 110.948 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -141.73 135.05 29.4 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.106 -1.813 . . . . 75.25 106.106 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 144.59 156.54 6.86 Favored Glycine 0 C--N 1.277 -2.696 0 N-CA-C 109.53 -1.428 . . . . 65.209999999999994 109.53 -176.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.23 178.5 15.61 Favored Glycine 0 C--N 1.281 -2.519 0 N-CA-C 107.321 -2.311 . . . . 72.319999999999993 107.321 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 83.6 t -45.48 106.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 117.839 0.82 . . . . 72.299999999999997 111.994 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 84.91 -13.56 53.17 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.216 -0.902 . . . . 73.329999999999998 112.499 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.502 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 63.2 t30 -105.23 21.15 17.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.012 -0.736 . . . . 64.349999999999994 109.012 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.07 121.48 5.51 Favored 'General case' 0 C--O 1.256 1.436 0 CA-C-N 115.116 -0.947 . . . . 74.329999999999998 110.467 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -79.39 -43.4 23.49 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.11 -0.95 . . . . 73.129999999999995 108.734 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 37.4 mm -103.24 129.89 24.66 Favored Pre-proline 0 C--N 1.301 -1.503 0 CA-C-N 115.053 -0.976 . . . . 75.510000000000005 109.018 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.57 110.14 0.46 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 123.27 2.647 . . . . 73.530000000000001 113.292 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 97.83 -6.36 62.38 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.556 -0.747 . . . . 71.040000000000006 112.468 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -121.24 98.61 6.06 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.392 -0.966 . . . . 71.450000000000003 108.392 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -81.66 26.87 0.47 Allowed 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 124.362 1.065 . . . . 74.109999999999999 111.219 -170.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' SER . . . . . 0.516 ' CB ' ' HE3' ' A' ' 370' ' ' LYS . 55.1 m -93.94 173.57 7.6 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.16 0.8 . . . . 73.450000000000003 113.16 -174.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 34.5 mm -86.01 126.06 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.915 -1.039 . . . . 62.329999999999998 109.685 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 43.1 m-85 -124.01 132.69 53.72 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.199 0.523 . . . . 75.450000000000003 111.858 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.56 114.11 4.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 108.348 -0.982 . . . . 74.120000000000005 108.348 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 22.6 m -102.94 -20.95 14.05 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 120.865 0.364 . . . . 74.5 111.401 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 45.9 mmtm -150.71 159.46 44.51 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.342 -1.355 . . . . 75.310000000000002 107.342 177.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 61.3 mt -138.73 119.45 15.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 106.249 -1.76 . . . . 74.0 106.249 172.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 40.3 mm -86.07 118.01 31.79 Favored 'Isoleucine or valine' 0 C--O 1.255 1.387 0 N-CA-C 108.494 -0.928 . . . . 75.129999999999995 108.494 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.486 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 0.1 OUTLIER -65.62 147.42 53.43 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.181 -1.414 . . . . 74.5 107.181 -176.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.24 -16.62 60.92 Favored Glycine 0 C--N 1.289 -2.054 0 N-CA-C 109.275 -1.53 . . . . 71.310000000000002 109.275 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -75.09 150.43 40.78 Favored Glycine 0 N--CA 1.4 -3.738 0 N-CA-C 106.726 -2.55 . . . . 54.43 106.726 170.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -60.84 -35.03 75.52 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.854 -0.424 . . . . 60.030000000000001 109.854 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . 0.54 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.35 -9.08 58.24 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 112.914 0.709 . . . . 64.409999999999997 112.914 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . 0.486 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 30.2 t-80 -94.95 -39.24 10.3 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.334 -0.947 . . . . 73.319999999999993 108.575 175.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -76.84 -57.19 3.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.861 -0.608 . . . . 75.219999999999999 110.949 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -85.84 -42.15 14.39 Favored 'General case' 0 CA--C 1.476 -1.882 0 C-N-CA 124.221 1.008 . . . . 74.430000000000007 111.32 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.554 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -43.07 -20.56 0.09 OUTLIER Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 120.651 3.02 . . . . 52.439999999999998 120.651 -162.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.554 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.86 33.45 0.5 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 118.522 1.161 . . . . 74.230000000000004 111.921 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 41.6 tp -107.94 155.49 20.26 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.718 1.207 . . . . 71.439999999999998 109.706 -171.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -124.89 145.34 49.87 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.405 0.621 . . . . 73.200000000000003 111.641 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 83.9 mt -66.15 123.23 18.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 107.69 -1.226 . . . . 75.409999999999997 107.69 171.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.73 -7.92 19.69 Favored Glycine 0 C--N 1.311 -0.841 0 C-N-CA 121.173 -0.536 . . . . 71.439999999999998 111.835 -175.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -68.68 137.14 53.9 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 112.563 0.579 . . . . 70.209999999999994 112.563 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.516 ' HE3' ' CB ' ' A' ' 347' ' ' SER . 72.4 tttt -98.71 116.83 31.8 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.288 -0.869 . . . . 72.519999999999996 109.957 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 71.4 mt -83.96 114.5 21.74 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.226 0.536 . . . . 75.209999999999994 109.679 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.5 tt -81.0 -39.38 25.98 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.159 -1.382 . . . . 74.209999999999994 107.457 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -165.67 158.56 15.53 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.504 -0.771 . . . . 71.140000000000001 110.174 -177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 14.2 p -134.17 124.15 45.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.287 -1.005 . . . . 72.219999999999999 108.287 174.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 62.18 30.81 17.76 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 123.719 1.723 . . . . 64.200000000000003 109.268 -176.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 67.48 9.64 7.17 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 109.999 -3.273 . . . . 74.299999999999997 113.201 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.43 122.27 36.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 106.472 -1.677 . . . . 73.129999999999995 106.472 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.3 p -61.21 125.84 25.2 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.235 0.828 . . . . 74.109999999999999 113.235 -176.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.6 -1.36 22.98 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.662 0.785 . . . . 71.319999999999993 110.71 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -73.45 113.88 11.05 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.405 -0.961 . . . . 72.120000000000005 108.405 172.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 63.75 83.87 0.16 Allowed 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 124.587 1.179 . . . . 71.319999999999993 111.919 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 23.5 m -153.15 164.62 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.234 -1.348 . . . . 74.109999999999999 108.705 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.495 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.6 m -83.0 139.61 33.19 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.258 -1.016 . . . . 73.430000000000007 108.258 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 388' ' ' VAL . 81.5 t60 -49.53 -47.47 48.96 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.031 0.752 . . . . 72.109999999999999 113.031 -175.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -43.42 91.83 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.75 -0.833 . . . . 65.519999999999996 108.75 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' ' 383' ' ' THR . 47.8 tt0 -67.5 -31.39 71.48 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.031 -1.44 . . . . 73.319999999999993 108.974 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . 0.483 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -75.37 -49.92 17.55 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 114.7 -1.136 . . . . 74.209999999999994 110.456 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 384' ' ' HIS . 19.2 t -59.61 -46.47 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 N-CA-C 109.713 -0.477 . . . . 64.540000000000006 109.713 -178.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 52.0 m -62.12 -29.49 70.37 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.522 -0.763 . . . . 73.310000000000002 112.041 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.86 -31.92 72.85 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.689 -0.632 . . . . 70.420000000000002 110.4 175.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.6 mp -82.2 -31.6 30.26 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 120.599 -0.44 . . . . 74.340000000000003 110.875 176.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -71.12 -27.82 63.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.074 0.398 . . . . 75.439999999999998 112.074 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -78.16 55.18 1.46 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.547 0.689 . . . . 64.209999999999994 110.641 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 22.1 p -127.46 152.54 47.42 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 109.122 -0.696 . . . . 74.439999999999998 109.122 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 51.1 m -144.47 90.37 2.08 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.444 1.116 . . . . 73.049999999999997 111.628 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . 0.402 ' O ' HG23 ' A' ' 323' ' ' ILE 0.267 9.1 m-20 61.96 17.2 8.76 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 111.636 -2.529 . . . . 62.539999999999999 115.329 170.074 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -161.61 122.15 2.67 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.075 -1.454 . . . . 73.439999999999998 107.075 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.7 t -140.1 143.45 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 122.509 0.323 . . . . 70.430000000000007 110.488 -175.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . 0.629 ' CE1' ' HD3' ' A' ' 321' ' ' LYS . 4.5 m-85 -117.64 96.45 5.39 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.265 0.555 . . . . 71.530000000000001 109.696 170.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.9 tt -88.67 123.21 32.9 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.675 -0.693 . . . . 63.450000000000003 109.683 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -107.37 107.78 18.84 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.358 -0.979 . . . . 75.129999999999995 108.358 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.39 153.31 10.0 Favored 'Isoleucine or valine' 0 C--O 1.274 2.387 0 CA-C-N 115.403 -0.817 . . . . 73.319999999999993 110.231 -177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -136.41 157.61 46.39 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 105.945 -1.872 . . . . 64.230000000000004 105.945 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt . . . . . 0 C--N 1.284 -2.25 0 C-N-CA 119.792 -0.763 . . . . 73.120000000000005 109.719 178.488 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 N--CA 1.442 -0.861 0 CA-C-O 121.242 0.544 . . . . 71.099999999999994 111.67 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -95.06 158.45 15.46 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.022 -0.99 . . . . 74.400000000000006 109.466 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 23.0 m -144.93 138.58 26.98 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 116.567 -0.288 . . . . 71.549999999999997 110.329 175.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 13.9 tm0? -78.69 140.04 38.41 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.008 -0.542 . . . . 74.340000000000003 111.161 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.266 1.926 0 CA-C-N 115.476 -0.784 . . . . 64.510000000000005 112.275 178.8 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 CA--C 1.485 -1.52 0 N-CA-C 106.207 -1.775 . . . . 72.329999999999998 106.207 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.359 2.2 pm0 -121.46 131.0 53.91 Favored 'General case' 0 C--N 1.267 -2.981 0 N-CA-C 114.732 1.382 . . . . 73.219999999999999 114.732 -175.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 74.8 mt -116.96 113.7 43.66 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 CA-C-N 112.516 -2.129 . . . . 75.140000000000001 109.558 -172.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -92.81 112.4 24.34 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.323 -0.992 . . . . 64.319999999999993 108.323 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' LEU . . . . . 0.636 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 81.6 mt -107.27 152.85 23.57 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 124.363 1.039 . . . . 75.5 109.068 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 40.5 mt -106.16 126.46 61.72 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 107.917 -1.142 . . . . 74.239999999999995 107.917 169.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -75.04 156.49 36.1 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.337 -0.392 . . . . 73.540000000000006 110.473 -175.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -148.57 -154.86 6.45 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.705 -0.759 . . . . 43.229999999999997 113.151 -174.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.27 -46.85 27.62 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 124.039 3.159 . . . . 71.239999999999995 115.024 -173.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -98.47 25.82 6.03 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.265 0.555 . . . . 75.129999999999995 110.601 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.81 -124.32 6.67 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 114.987 -1.006 . . . . 72.120000000000005 111.958 177.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.417 HD13 HG12 ' B' ' 151' ' ' VAL . 8.2 mp -90.89 -39.78 12.11 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.526 -1.287 . . . . 71.400000000000006 107.526 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 87.08 47.99 4.53 Favored Glycine 0 N--CA 1.402 -3.613 0 CA-C-N 113.937 -1.483 . . . . 72.230000000000004 113.261 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 329' ' ' LEU . 48.9 p90 -155.47 147.17 23.13 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.327 0.584 . . . . 74.439999999999998 111.526 170.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 51.1 m -96.17 132.16 41.88 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.175 -0.921 . . . . 71.140000000000001 109.151 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 46.9 pt -120.45 141.91 38.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 109.941 -0.392 . . . . 71.450000000000003 109.941 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -139.58 125.59 19.81 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.768 -1.197 . . . . 64.209999999999994 107.768 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 150.22 161.65 10.03 Favored Glycine 0 C--N 1.282 -2.438 0 N-CA-C 110.469 -1.052 . . . . 63.109999999999999 110.469 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.05 -179.81 17.14 Favored Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 107.221 -2.352 . . . . 72.329999999999998 107.221 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 98.4 t -52.2 108.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 118.078 0.939 . . . . 72.439999999999998 110.778 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 94.78 -21.58 42.69 Favored Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.321 -0.854 . . . . 75.219999999999999 112.092 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' ASN . . . . . 0.622 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 32.1 t-20 -105.75 13.43 29.68 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.06 -0.719 . . . . 64.430000000000007 109.06 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.91 120.57 4.46 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 121.513 0.673 . . . . 75.319999999999993 111.098 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -77.79 -45.07 25.6 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.029 -0.987 . . . . 74.540000000000006 109.451 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 40.4 mm -103.35 124.14 39.21 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-N 115.309 -0.86 . . . . 74.349999999999994 109.16 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.66 108.01 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 123.247 2.631 . . . . 71.200000000000003 112.512 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 105.39 -4.12 40.4 Favored Glycine 0 N--CA 1.432 -1.599 0 CA-C-N 115.459 -0.791 . . . . 53.109999999999999 112.002 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -128.9 96.93 4.49 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.451 -0.944 . . . . 74.150000000000006 108.451 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -83.7 36.94 0.56 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.859 -1.064 . . . . 65.420000000000002 111.778 -170.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 72.0 m -98.66 177.34 5.34 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 115.613 -0.721 . . . . 70.5 111.249 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.509 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 4.1 mm -91.54 138.85 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 N-CA-C 106.33 -1.73 . . . . 75.310000000000002 106.33 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 369' ' ' ASP . 22.4 m-85 -127.5 139.25 52.91 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 118.34 0.518 . . . . 75.140000000000001 111.639 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.24 123.46 22.87 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 N-CA-C 108.955 -0.757 . . . . 64.319999999999993 108.955 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.1 m -102.35 -28.5 12.21 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.383 0.611 . . . . 73.409999999999997 110.529 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.458 ' HZ1' HD11 ' A' ' 354' ' ' ILE . 60.8 tttm -155.62 147.72 23.5 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.245 -1.02 . . . . 73.030000000000001 108.245 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 76.5 mt -107.74 139.7 28.78 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 N-CA-C 105.412 -2.07 . . . . 74.219999999999999 105.412 169.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.458 HD11 ' HZ1' ' A' ' 352' ' ' LYS . 44.9 mm -85.17 129.74 37.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.147 0.499 . . . . 74.209999999999994 110.799 -174.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 355' ' ' GLU . 0.5 OUTLIER -57.62 115.75 2.97 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 125.586 1.554 . . . . 71.209999999999994 111.105 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 84.24 7.98 84.27 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.725 -0.75 . . . . 43.329999999999998 111.807 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -75.9 160.2 51.36 Favored Glycine 0 C--O 1.259 1.67 0 N-CA-C 111.769 -0.532 . . . . 71.420000000000002 111.769 177.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.29 -42.21 99.06 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.184 -0.672 . . . . 64.310000000000002 109.184 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . 0.489 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -72.97 -6.74 47.4 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.852 -0.613 . . . . 74.420000000000002 111.427 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -92.66 -33.92 14.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.592 0.71 . . . . 61.310000000000002 109.473 177.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.636 ' NZ ' ' HA ' ' A' ' 361' ' ' LYS . 0.7 OUTLIER -92.9 -54.65 3.66 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.902 0.704 . . . . 64.319999999999993 112.902 177.6 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' ASP . . . . . 0.722 ' O ' ' HE2' ' A' ' 364' ' ' LYS . 23.3 t70 -85.33 -37.22 20.19 Favored 'General case' 0 CA--C 1.461 -2.458 0 O-C-N 124.16 0.912 . . . . 61.340000000000003 110.625 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' GLY . . . . . 0.636 ' HA2' ' CD2' ' A' ' 322' ' ' LEU . . . -41.2 -28.11 0.27 Allowed Glycine 0 CA--C 1.483 -1.966 0 N-CA-C 120.37 2.908 . . . . 63.130000000000003 120.37 -160.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.722 ' HE2' ' O ' ' A' ' 362' ' ' ASP . 0.0 OUTLIER 46.26 32.66 1.56 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 118.442 1.121 . . . . 72.040000000000006 110.877 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 43.0 tp -115.4 155.55 27.2 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.776 1.231 . . . . 74.120000000000005 109.103 -170.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -120.62 149.04 43.09 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.388 0.613 . . . . 75.010000000000005 111.165 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.0 mt -66.17 122.65 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 107.454 -1.313 . . . . 74.200000000000003 107.454 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.57 -9.12 19.65 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.476 -0.869 . . . . 54.039999999999999 113.013 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 4.2 m-20 -61.47 142.32 57.09 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.233 0.827 . . . . 75.400000000000006 113.233 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.5 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 43.3 tttp -93.27 115.01 27.61 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.491 1.117 . . . . 74.329999999999998 109.452 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 4.2 mp -79.9 112.81 17.55 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.873 -0.788 . . . . 75.310000000000002 108.873 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 403' ' ' ALA . 5.8 tt -87.14 -40.16 14.87 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.057 -1.09 . . . . 74.219999999999999 108.057 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.99 157.3 23.45 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.883 -0.599 . . . . 75.209999999999994 110.891 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.28 123.11 42.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 108.624 -0.88 . . . . 72.519999999999996 108.624 173.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . 0.409 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 91.8 m-20 60.49 31.59 20.33 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-O 124.089 1.899 . . . . 75.129999999999995 109.235 -174.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.7 t30 66.26 15.84 10.23 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 109.48 -3.509 . . . . 73.140000000000001 112.509 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 55.2 t -84.08 125.98 40.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 106.522 -1.658 . . . . 73.530000000000001 106.522 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.8 p -61.66 123.69 18.62 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 123.605 0.762 . . . . 74.439999999999998 113.053 -176.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.6 mp -110.81 -4.79 15.11 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.653 0.781 . . . . 72.0 111.387 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -65.65 106.29 1.44 Allowed 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.661 -0.496 . . . . 72.510000000000005 109.661 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 60.37 73.17 0.49 Allowed 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 124.616 1.198 . . . . 60.340000000000003 113.223 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.24 171.02 18.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 107.155 -1.424 . . . . 65.0 107.155 175.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.456 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.8 m -76.96 142.52 39.98 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.613 -0.884 . . . . 74.25 108.613 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' HIS . . . . . 0.526 ' O ' HG22 ' A' ' 388' ' ' VAL . 82.4 t60 -51.17 -47.75 62.07 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 111.446 0.165 . . . . 74.120000000000005 111.446 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.7 -37.39 75.98 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.835 0.826 . . . . 63.539999999999999 110.814 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 383' ' ' THR . 53.1 tt0 -73.85 -38.93 64.33 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.427 -1.26 . . . . 63.149999999999999 108.532 -174.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -70.19 -51.66 29.35 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.858 -1.065 . . . . 75.140000000000001 110.335 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 384' ' ' HIS . 40.4 t -59.28 -40.69 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.717 -0.22 . . . . 72.030000000000001 110.936 -177.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 90.5 m -60.23 -35.5 75.61 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 116.689 -0.232 . . . . 74.510000000000005 110.99 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.37 -37.98 84.05 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.587 0.232 . . . . 72.040000000000006 110.649 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.86 -32.01 59.54 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.248 -0.581 . . . . 74.340000000000003 110.841 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 57.6 mttm -67.52 -36.09 80.36 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 112.619 0.6 . . . . 75.340000000000003 112.619 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -81.1 70.62 7.97 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.38 1.086 . . . . 74.310000000000002 110.786 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 7.9 p -139.56 157.78 45.23 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 113.745 -1.571 . . . . 73.439999999999998 109.433 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 20.1 p -162.61 122.26 2.31 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.117 -0.698 . . . . 75.420000000000002 109.117 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.81 1.42 0.31 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.516 1.526 . . . . 74.450000000000003 114.446 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -162.35 128.22 3.47 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 108.835 -0.802 . . . . 73.109999999999999 108.835 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 47.6 t -140.32 111.94 4.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.766 -0.828 . . . . 75.030000000000001 108.766 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' TYR . . . . . 0.409 ' HB3' ' HA ' ' A' ' 375' ' ' ASN . 84.2 t80 -94.07 96.44 9.66 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.481 -0.933 . . . . 74.310000000000002 108.481 177.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 4.3 tt -92.25 120.61 32.97 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 108.656 -0.868 . . . . 72.329999999999998 108.656 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -106.09 110.16 22.33 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.509 -1.293 . . . . 75.010000000000005 107.509 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 370' ' ' LYS . 2.7 p -113.0 149.2 15.52 Favored 'Isoleucine or valine' 0 C--O 1.274 2.374 0 CA-C-O 121.843 0.83 . . . . 74.040000000000006 111.394 -177.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -128.12 158.37 38.19 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.595 -1.184 . . . . 71.430000000000007 108.446 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.483 0 N-CA-C 109.145 -0.687 . . . . 74.129999999999995 109.145 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 CA--C 1.5 -0.978 0 N-CA-C 109.573 -0.529 . . . . 73.209999999999994 109.573 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.83 166.73 11.66 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.041 -0.527 . . . . 72.439999999999998 109.979 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 86.5 m -144.44 126.04 15.04 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.544 -0.539 . . . . 63.340000000000003 109.544 168.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 150' ' ' GLN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 20.9 tm0? -69.59 136.35 51.15 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.107 -0.952 . . . . 72.109999999999999 110.601 175.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.417 HG12 HD13 ' A' ' 329' ' ' LEU . 21.8 t . . . . . 0 C--N 1.305 -1.363 0 N-CA-C 107.724 -1.213 . . . . 73.129999999999995 107.724 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 CA--C 1.492 -1.275 0 N-CA-C 105.766 -1.938 . . . . 73.25 105.766 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -127.12 140.39 52.3 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 113.878 1.066 . . . . 70.519999999999996 113.878 -174.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 363' ' ' GLY . 84.0 mt -129.0 116.83 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 CA-C-N 113.504 -1.68 . . . . 72.450000000000003 109.19 -174.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.5 127.33 34.86 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.836 -0.801 . . . . 74.120000000000005 108.836 175.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 80.9 mt -122.8 152.5 40.62 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.062 -0.718 . . . . 74.219999999999999 109.062 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 32.4 mm -105.76 111.51 35.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.653 -1.24 . . . . 73.129999999999995 107.653 173.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.429 ' HE3' ' HA2' ' A' ' 328' ' ' GLY . 1.4 tmtp? -75.92 141.05 42.4 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.8 -0.444 . . . . 75.310000000000002 109.8 -176.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -149.14 -154.55 6.39 Favored Glycine 0 C--N 1.301 -1.413 0 C-N-CA 120.41 -0.9 . . . . 74.25 112.646 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.66 -12.85 35.76 Favored 'Trans proline' 0 N--CA 1.484 0.926 0 C-N-CA 123.594 2.863 . . . . 62.140000000000001 113.99 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -107.39 10.66 29.51 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.427 -0.953 . . . . 62.210000000000001 108.427 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . 0.429 ' HA2' ' HE3' ' A' ' 324' ' ' LYS . . . 83.72 -133.87 12.26 Favored Glycine 0 CA--C 1.484 -1.881 0 CA-C-N 114.389 -1.278 . . . . 71.340000000000003 109.91 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.1 mp -93.38 -19.68 21.08 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.073 -1.454 . . . . 73.209999999999994 107.073 172.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.51 40.05 7.99 Favored Glycine 0 N--CA 1.426 -1.996 0 CA-C-N 113.869 -1.514 . . . . 75.230000000000004 115.064 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -154.92 167.8 29.1 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 117.409 0.604 . . . . 73.219999999999999 110.324 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 2.8 m -121.76 132.75 54.78 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.492 -0.559 . . . . 75.450000000000003 109.492 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 18.2 pt -113.68 154.98 14.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 116.234 -0.439 . . . . 75.140000000000001 110.978 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.45 115.38 5.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 124.68 1.238 . . . . 61.43 107.937 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 168.77 161.29 18.66 Favored Glycine 0 C--N 1.275 -2.823 0 N-CA-C 108.928 -1.669 . . . . 70.430000000000007 108.928 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.67 178.2 15.43 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 108.601 -1.8 . . . . 75.150000000000006 108.601 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.8 t -53.05 104.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.65 0.738 . . . . 72.420000000000002 110.933 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.65 -19.88 52.3 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.001 -0.999 . . . . 72.430000000000007 113.269 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.541 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 60.2 t30 -107.65 22.39 16.03 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 117.288 0.544 . . . . 75.129999999999995 110.246 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.34 119.64 4.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.263 0.554 . . . . 73.329999999999998 110.801 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -73.25 -44.82 58.77 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.149 -0.932 . . . . 74.420000000000002 109.979 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 42.7 mm -104.66 125.34 34.22 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 108.766 -0.827 . . . . 74.010000000000005 108.766 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.62 107.73 0.21 Allowed 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 123.21 2.607 . . . . 74.340000000000003 112.898 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 107.14 -7.63 37.83 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-N 115.281 -0.872 . . . . 53.229999999999997 112.362 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.419 ' CG ' ' HH ' ' A' ' 349' ' ' TYR . 8.6 t0 -125.03 98.74 5.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.941 -0.763 . . . . 74.150000000000006 108.941 -176.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -83.05 33.67 0.45 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.878 0.871 . . . . 74.5 111.511 -171.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 16.4 m -95.06 171.44 8.75 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.157 -0.474 . . . . 72.510000000000005 111.006 -177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.6 mm -83.91 127.5 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 107.678 -1.23 . . . . 72.109999999999999 107.678 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.459 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 47.6 m-85 -123.88 136.68 54.51 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.328 0.585 . . . . 60.200000000000003 112.465 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.18 113.81 5.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.796 -1.187 . . . . 71.230000000000004 107.796 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 53.2 m -102.14 -23.9 14.0 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.236 0.541 . . . . 74.319999999999993 111.276 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 94.7 mttt -151.32 156.28 40.45 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.964 -1.124 . . . . 74.129999999999995 107.964 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 78.0 mt -130.47 128.95 64.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.309 -1.367 . . . . 75.299999999999997 107.309 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 49.4 mm -85.35 141.78 14.1 Favored 'Isoleucine or valine' 0 C--O 1.256 1.419 0 C-N-CA 123.315 0.646 . . . . 74.129999999999995 111.22 -171.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.19 127.83 34.13 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.201 1.0 . . . . 74.120000000000005 111.555 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 71.71 8.9 68.86 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.534 -0.757 . . . . 72.200000000000003 112.584 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -70.46 159.75 53.63 Favored Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.831 -0.699 . . . . 71.340000000000003 111.498 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -59.15 -40.86 86.86 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.592 -0.522 . . . . 72.430000000000007 109.592 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.479 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -73.01 -13.13 61.16 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.262 0.553 . . . . 63.119999999999997 112.298 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -92.53 -25.74 18.24 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.899 0.857 . . . . 72.150000000000006 109.434 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.46 ' NZ ' ' HA ' ' A' ' 361' ' ' LYS . 0.2 OUTLIER -96.57 -59.21 1.87 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 113.332 0.864 . . . . 74.430000000000007 113.332 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -86.14 -36.53 19.51 Favored 'General case' 0 CA--C 1.475 -1.913 0 N-CA-C 107.844 -1.169 . . . . 64.409999999999997 107.844 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.519 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -44.75 -35.15 4.16 Favored Glycine 0 C--O 1.201 -1.923 0 N-CA-C 118.677 2.231 . . . . 74.340000000000003 118.677 -166.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.519 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.58 29.86 0.19 Allowed 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 118.29 1.045 . . . . 72.420000000000002 111.198 -173.038 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 47.2 tp -97.64 151.8 19.73 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 125.009 1.324 . . . . 74.540000000000006 109.807 -169.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -121.1 149.19 43.13 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-O 121.409 0.623 . . . . 74.349999999999994 111.409 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 77.8 mt -65.89 121.7 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 107.622 -1.251 . . . . 73.140000000000001 107.622 172.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.4 -1.76 22.13 Favored Glycine 0 C--N 1.313 -0.734 0 C-N-CA 121.0 -0.619 . . . . 62.020000000000003 112.133 -175.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -75.16 137.11 41.1 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 113.087 0.773 . . . . 74.450000000000003 113.087 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 37.9 tttp -92.83 119.43 32.15 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 124.327 1.051 . . . . 73.010000000000005 110.453 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 78.6 mt -87.63 121.03 29.54 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 120.393 -0.523 . . . . 73.239999999999995 110.002 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.455 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 92.6 mt -82.19 -40.16 22.14 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.088 -1.415 . . . . 74.239999999999995 108.439 177.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -165.17 165.65 19.6 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.281 -0.872 . . . . 75.150000000000006 111.944 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.2 p -133.79 119.58 33.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.863 -1.162 . . . . 74.439999999999998 107.863 171.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 63.14 28.65 16.05 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 123.95 1.833 . . . . 71.329999999999998 108.406 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 66.18 17.92 10.84 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 109.726 -3.397 . . . . 75.329999999999998 112.52 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.5 t -84.14 123.63 39.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.567 -1.642 . . . . 71.230000000000004 106.567 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 10.4 p -59.49 124.04 18.77 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.163 1.172 . . . . 73.329999999999998 114.163 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . 0.414 HD23 HD11 ' A' ' 391' ' ' LEU . 5.8 mp -106.49 6.7 30.43 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.64 1.176 . . . . 73.310000000000002 110.119 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.455 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 20.1 mm-40 -71.26 110.67 6.05 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.073 -0.967 . . . . 73.230000000000004 110.902 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 54.1 66.86 1.12 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.65 1.18 . . . . 71.319999999999993 112.715 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.36 171.72 16.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.629 -1.249 . . . . 74.530000000000001 107.629 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 2.3 m -75.79 144.78 41.17 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.661 -0.866 . . . . 64.530000000000001 108.661 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . 0.587 ' O ' HG21 ' A' ' 388' ' ' VAL . 10.0 t-160 -51.88 -49.78 62.3 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 111.601 0.223 . . . . 75.140000000000001 111.601 -176.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.418 ' HA ' ' HB ' ' B' ' 143' ' ' THR . 36.7 tt0 -65.22 -29.52 70.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.966 0.412 . . . . 74.129999999999995 111.848 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.447 ' HB3' ' O ' ' A' ' 383' ' ' THR . 60.7 tt0 -71.52 -40.27 70.22 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.688 -1.227 . . . . 71.329999999999998 107.688 -176.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -69.59 -50.55 43.5 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.864 -1.062 . . . . 74.219999999999999 110.178 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.587 HG21 ' O ' ' A' ' 384' ' ' HIS . 40.6 t -57.38 -37.16 55.74 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 O-C-N 123.032 0.208 . . . . 74.310000000000002 111.38 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 91.5 m -62.55 -34.34 76.73 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 116.653 -0.248 . . . . 74.340000000000003 111.108 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -70.06 -35.95 74.63 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.644 0.259 . . . . 71.540000000000006 110.363 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.414 HD11 HD23 ' A' ' 379' ' ' LEU . 5.6 mp -78.51 -27.93 46.17 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 120.164 -0.614 . . . . 71.420000000000002 110.599 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 53.5 mttm -71.42 -37.24 71.49 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.85 0.685 . . . . 72.239999999999995 112.85 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -82.45 65.83 7.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.282 1.039 . . . . 74.310000000000002 110.79 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 31.0 p -137.18 146.93 45.51 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.034 -1.439 . . . . 74.319999999999993 107.506 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 42.1 m -142.78 120.39 11.79 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.71 -0.478 . . . . 73.510000000000005 109.71 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 324' ' ' LYS . 3.9 m-20 58.46 0.95 0.15 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.691 1.996 . . . . 74.400000000000006 115.694 172.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -161.61 135.57 6.74 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.416 -0.957 . . . . 74.030000000000001 108.416 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 61.4 t -142.02 133.45 26.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.682 -0.859 . . . . 74.530000000000001 108.682 177.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -107.73 96.29 6.28 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.192 -1.781 . . . . 74.310000000000002 106.192 173.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.4 tt -86.36 129.67 34.77 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 120.949 0.404 . . . . 63.439999999999998 110.292 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -108.96 108.54 19.33 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.817 -1.179 . . . . 74.409999999999997 107.817 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 3.4 p -118.93 150.55 21.22 Favored 'Isoleucine or valine' 0 C--O 1.274 2.353 0 CA-C-O 121.784 0.802 . . . . 74.209999999999994 111.265 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.63 158.15 45.11 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 105.721 -1.955 . . . . 71.120000000000005 105.721 171.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.37 154.33 56.83 Favored Pre-proline 0 C--N 1.284 -2.248 0 N-CA-C 105.463 -2.051 . . . . 73.209999999999994 105.463 177.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . 0.452 ' HA ' ' OH ' ' A' ' 349' ' ' TYR . 3.2 Cg_exo -36.89 110.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 124.503 3.469 . . . . 73.230000000000004 113.688 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 9.9 m -95.3 -38.05 10.71 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 113.48 0.918 . . . . 72.099999999999994 113.48 -168.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -104.3 31.12 8.99 Favored Glycine 0 C--N 1.29 -2.024 0 C-N-CA 119.815 -1.183 . . . . 73.349999999999994 110.536 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 12.6 p -161.2 -164.49 1.17 Allowed 'General case' 0 N--CA 1.411 -2.387 0 CA-C-N 114.584 -0.808 . . . . 63.240000000000002 109.032 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -70.12 106.6 3.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.444 -0.576 . . . . 63.439999999999998 109.444 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -71.88 138.61 48.33 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 123.718 0.636 . . . . 73.549999999999997 112.437 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 . . . . . 0 N--CA 1.426 -1.626 0 N-CA-C 103.513 -2.773 . . . . 73.310000000000002 103.513 179.709 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 121.717 0.77 . . . . 74.239999999999995 110.013 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -95.98 -55.23 3.05 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.005 -1.85 . . . . 75.209999999999994 106.005 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.497 HG22 HG23 ' A' ' 388' ' ' VAL . 5.9 m -91.76 152.17 20.29 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 104.976 -2.231 . . . . 72.239999999999995 104.976 171.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 40.9 ttm105 -154.39 166.62 32.65 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.852 -1.139 . . . . 74.310000000000002 110.052 -163.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.1 157.66 20.63 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 123.614 0.571 . . . . 72.099999999999994 110.51 176.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.78 26.64 9.41 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.268 1.427 . . . . 73.439999999999998 112.487 -173.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.89 144.2 14.7 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.669 -0.696 . . . . 74.409999999999997 109.708 174.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -91.36 161.3 15.07 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.657 -0.868 . . . . 75.239999999999995 108.657 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 51.6 m -147.27 140.43 25.23 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.927 -0.483 . . . . 74.430000000000007 110.414 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -71.13 139.24 50.2 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.865 -0.607 . . . . 73.510000000000005 109.916 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 12.4 m . . . . . 0 C--O 1.265 1.878 0 CA-C-N 115.79 -0.641 . . . . 74.510000000000005 112.065 -179.828 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 C--O 1.203 -1.394 0 N-CA-C 106.373 -1.714 . . . . 73.430000000000007 106.373 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.472 1.9 pm0 -115.58 128.98 56.35 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 117.05 2.241 . . . . 72.340000000000003 117.05 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.485 HG21 ' CD ' ' A' ' 364' ' ' LYS . 66.9 mt -107.38 107.0 21.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 CA-C-N 111.425 -2.625 . . . . 75.329999999999998 108.552 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.498 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 29.4 ttpt -80.44 118.92 22.49 Favored 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 119.865 -0.734 . . . . 74.219999999999999 109.073 174.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.561 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 27.5 mt -113.05 148.07 35.93 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 113.904 -1.498 . . . . 72.439999999999998 110.316 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.0 mp -106.55 117.2 51.89 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.017 0 N-CA-C 107.119 -1.437 . . . . 73.439999999999998 107.119 169.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.608 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 10.2 tmtt? -63.03 151.57 39.45 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 108.639 -0.875 . . . . 75.209999999999994 108.639 171.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . 0.436 ' O ' ' HE2' ' A' ' 324' ' ' LYS . . . -141.98 -160.58 8.39 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 119.832 -1.175 . . . . 64.040000000000006 113.365 -171.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.22 -30.62 45.82 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.155 2.57 . . . . 74.409999999999997 113.651 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -101.58 18.85 19.21 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 122.279 1.037 . . . . 75.310000000000002 108.791 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.34 -129.0 8.92 Favored Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 109.799 -1.32 . . . . 72.329999999999998 109.799 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.401 ' HB2' HG21 ' B' ' 151' ' ' VAL . 5.3 mp -96.98 -42.58 7.84 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.161 -1.792 . . . . 75.239999999999995 106.161 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . 0.431 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 84.41 50.19 4.36 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 114.754 -1.112 . . . . 52.329999999999998 114.806 171.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -151.25 150.71 30.9 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.413 -0.588 . . . . 72.340000000000003 109.413 173.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.439 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 6.4 m -104.15 129.15 51.87 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.601 -0.518 . . . . 72.109999999999999 109.601 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.3 pt -113.36 151.69 15.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-N 115.824 -0.625 . . . . 72.230000000000004 109.943 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.66 121.75 10.1 Favored 'General case' 0 N--CA 1.425 -1.713 0 O-C-N 124.226 0.954 . . . . 74.230000000000004 108.685 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 167.7 179.07 40.18 Favored Glycine 0 C--N 1.281 -2.498 0 N-CA-C 107.452 -2.259 . . . . 61.409999999999997 107.452 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 132.54 175.98 14.21 Favored Glycine 0 CA--C 1.474 -2.526 0 N-CA-C 108.712 -1.755 . . . . 52.439999999999998 108.712 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.447 HG21 ' OE2' ' A' ' 381' ' ' GLU . 93.4 t -51.0 100.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 O-C-N 124.432 0.725 . . . . 73.200000000000003 111.437 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 88.13 -7.47 81.35 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.593 -0.731 . . . . 73.519999999999996 112.312 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.477 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 65.6 t30 -106.3 16.56 24.66 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.066 -0.716 . . . . 63.140000000000001 109.066 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.429 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -49.57 125.88 12.33 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.52 1.128 . . . . 74.400000000000006 111.835 -177.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -80.3 -44.11 20.12 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.18 -0.918 . . . . 65.109999999999999 109.429 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.5 mm -103.62 125.28 35.24 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 115.846 -0.615 . . . . 65.409999999999997 109.357 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.33 108.8 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.553 2.836 . . . . 75.409999999999997 113.416 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 101.87 -4.92 53.26 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.512 -0.767 . . . . 74.439999999999998 111.936 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -124.99 96.7 4.96 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.322 -0.992 . . . . 73.319999999999993 108.322 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 51.7 t30 -81.01 29.04 0.34 Allowed 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 124.343 1.057 . . . . 74.230000000000004 111.781 -170.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 73.0 m -93.34 177.97 5.87 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.726 0.774 . . . . 75.450000000000003 112.755 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.5 mm -91.21 129.33 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 114.609 -1.178 . . . . 72.209999999999994 108.32 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 28.9 m-85 -123.54 132.47 53.91 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.193 0.52 . . . . 75.329999999999998 112.197 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 52.9 t -67.1 109.84 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.581 -1.266 . . . . 75.510000000000005 107.581 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.4 m -99.83 -22.07 15.48 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.207 0.527 . . . . 72.109999999999999 110.711 -175.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 31.8 mmtp -148.25 154.27 39.83 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.375 -1.343 . . . . 74.25 107.375 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . 0.415 HG22 ' HB2' ' A' ' 360' ' ' HIS . 65.5 mt -131.72 107.59 13.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 106.815 -1.55 . . . . 72.129999999999995 106.815 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 38.7 mm -78.73 129.6 37.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 123.731 0.813 . . . . 74.340000000000003 109.788 -171.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.513 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 0.6 OUTLIER -63.83 146.25 54.29 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.429 -1.323 . . . . 63.109999999999999 107.429 -178.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.471 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.05 -19.53 53.66 Favored Glycine 0 C--N 1.28 -2.529 0 N-CA-C 109.299 -1.521 . . . . 64.420000000000002 109.299 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . 0.431 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -69.29 142.37 37.28 Favored Glycine 1 N--CA 1.384 -4.811 0 N-CA-C 107.968 -2.053 . . . . 74.319999999999993 107.968 172.034 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 362' ' ' ASP . . . -62.97 -32.65 74.04 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.826 -0.805 . . . . 74.420000000000002 108.826 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.565 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.72 -6.28 49.75 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.981 -0.554 . . . . 74.040000000000006 112.132 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . 0.513 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 19.5 t60 -94.19 -39.4 10.57 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.432 -0.951 . . . . 75.239999999999995 108.432 175.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.471 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 73.7 mmtt -82.7 -57.65 3.23 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.599 0.714 . . . . 73.25 110.79 -178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 358' ' ' ALA . 10.9 t70 -85.86 -34.85 20.9 Favored 'General case' 0 CA--C 1.468 -2.187 0 C-N-CA 125.182 1.393 . . . . 71.150000000000006 111.112 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -42.71 -23.97 0.22 Allowed Glycine 0 C--N 1.287 -2.186 0 N-CA-C 120.862 3.105 . . . . 64.25 120.862 -162.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.493 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 41.47 36.99 0.6 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.802 1.301 . . . . 74.510000000000005 111.54 -178.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 50.3 tp -114.21 156.06 24.97 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.536 1.134 . . . . 64.25 109.891 -170.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -122.19 142.66 50.19 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.434 0.635 . . . . 75.209999999999994 111.678 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.39 121.53 15.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.507 -1.294 . . . . 74.430000000000007 107.507 169.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 114.55 -0.61 23.43 Favored Glycine 0 C--N 1.314 -0.687 0 N-CA-C 111.656 -0.578 . . . . 50.240000000000002 111.656 -176.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 83.2 m-20 -76.27 136.77 39.64 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.196 0.813 . . . . 73.120000000000005 113.196 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.657 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 37.7 tttp -94.86 116.61 28.93 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.99 1.316 . . . . 72.120000000000005 108.948 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 83.6 mt -83.25 113.45 20.69 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 109.779 -0.452 . . . . 72.430000000000007 109.779 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' ' 403' ' ' ALA . 3.9 tt -81.49 -39.67 24.4 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.08 -1.452 . . . . 74.530000000000001 107.08 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.41 159.18 21.99 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.493 -0.776 . . . . 72.030000000000001 110.644 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.5 p -133.75 121.09 39.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.07 -1.085 . . . . 73.549999999999997 108.07 172.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 62.83 29.85 16.63 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 123.987 1.851 . . . . 74.030000000000001 108.652 -174.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 67.42 10.39 7.71 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 109.652 -3.431 . . . . 71.340000000000003 113.355 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 50.3 t -78.74 124.56 37.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.585 -1.635 . . . . 64.439999999999998 106.585 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.5 p -61.51 124.62 21.17 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.677 0.992 . . . . 74.430000000000007 113.677 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 8.5 mp -109.18 3.48 21.88 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.027 0.931 . . . . 75.510000000000005 110.836 176.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -78.15 115.97 18.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.34 -0.985 . . . . 72.319999999999993 108.34 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . 0.447 ' OE2' HG21 ' A' ' 337' ' ' VAL . 17.1 tp10 62.83 83.34 0.16 Allowed 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 124.607 1.192 . . . . 75.319999999999993 111.625 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 18.4 m -153.81 160.36 2.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 113.966 -1.47 . . . . 74.530000000000001 109.171 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.474 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.5 m -81.65 145.14 30.73 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.443 -1.317 . . . . 75.209999999999994 107.443 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . 0.608 ' O ' HG21 ' A' ' 388' ' ' VAL . 7.3 t-160 -52.1 -48.27 64.85 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 112.533 0.568 . . . . 74.219999999999999 112.533 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.591 ' HA ' ' OG1' ' B' ' 143' ' ' THR . 6.9 tp10 -57.86 -37.34 73.72 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.653 0.74 . . . . 74.319999999999993 110.896 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 383' ' ' THR . 55.5 tt0 -70.54 -35.8 73.34 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.942 -1.026 . . . . 75.040000000000006 108.484 -174.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -75.47 -50.94 14.21 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.662 -1.154 . . . . 61.350000000000001 111.052 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.608 HG21 ' O ' ' A' ' 384' ' ' HIS . 20.7 t -57.64 -40.75 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 110.022 -0.362 . . . . 74.109999999999999 110.022 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 94.8 m -58.55 -40.01 81.83 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.101 -0.499 . . . . 71.109999999999999 110.749 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -63.65 -33.22 75.15 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.477 0.18 . . . . 61.149999999999999 110.972 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 5.8 mp -81.44 -28.92 34.0 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 120.388 -0.525 . . . . 65.409999999999997 110.943 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -74.74 -24.18 58.67 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.213 0.449 . . . . 73.329999999999998 112.213 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -78.62 46.39 0.65 Allowed 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 123.428 0.691 . . . . 73.530000000000001 110.692 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' THR . . . . . 0.406 ' HB ' HG21 ' A' ' 398' ' ' VAL . 34.0 p -124.57 143.49 50.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.056 0.455 . . . . 65.010000000000005 110.061 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 324' ' ' LYS . 49.3 m -142.49 100.98 3.8 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 122.32 1.057 . . . . 75.420000000000002 112.171 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . 0.608 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 5.3 m-20 60.47 15.85 5.9 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 128.232 2.613 . . . . 74.219999999999999 113.897 169.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -165.91 126.53 1.79 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.035 -1.098 . . . . 74.150000000000006 108.035 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 25.1 t -145.61 146.6 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 123.296 0.638 . . . . 72.239999999999995 110.642 -175.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . 0.498 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 20.4 m-85 -118.56 96.68 5.39 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.465 0.706 . . . . 74.0 109.191 169.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.8 tt -88.34 121.5 30.8 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.34 -0.615 . . . . 62.340000000000003 109.34 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -104.64 108.42 19.86 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.256 -1.016 . . . . 75.219999999999999 108.256 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 5.6 p -106.41 150.48 8.98 Favored 'Isoleucine or valine' 0 C--O 1.276 2.5 0 CA-C-O 121.651 0.739 . . . . 74.040000000000006 110.247 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.657 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.7 159.58 41.39 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 125.966 1.706 . . . . 72.120000000000005 107.149 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 404' ' ' LYS . 7.1 mmpt? -95.99 153.91 39.07 Favored Pre-proline 0 C--N 1.287 -2.126 0 N-CA-C 108.803 -0.814 . . . . 73.549999999999997 108.803 174.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -43.33 139.28 4.39 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 123.954 3.103 . . . . 64.109999999999999 114.756 -176.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 5.9 m -75.93 78.19 2.82 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.083 -1.417 . . . . 75.319999999999993 112.147 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 87.78 -47.17 3.53 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 116.009 1.164 . . . . 73.129999999999995 116.009 169.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 17.0 m -62.18 -22.83 66.22 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.992 0.901 . . . . 72.010000000000005 110.815 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -159.61 168.47 25.98 Favored 'General case' 0 N--CA 1.405 -2.689 0 N-CA-C 103.755 -2.683 . . . . 73.310000000000002 103.755 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -159.92 49.48 0.3 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 119.433 1.015 . . . . 65.420000000000002 110.349 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 . . . . . 0 C--N 1.297 -1.681 0 N-CA-C 105.785 -1.932 . . . . 73.439999999999998 105.785 -177.841 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.869 0 N-CA-C 108.535 -0.913 . . . . 72.239999999999995 108.535 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 69.19 28.26 4.99 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.541 1.137 . . . . 75.439999999999998 110.256 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.591 ' OG1' ' HA ' ' A' ' 385' ' ' GLU . 27.3 p -112.64 174.13 6.04 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.617 -1.623 . . . . 71.409999999999997 106.617 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -153.18 154.27 34.4 Favored 'General case' 0 CA--C 1.482 -1.636 0 O-C-N 121.163 -0.961 . . . . 75.219999999999999 108.712 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . 0.438 ' HB3' ' CB ' ' A' ' 384' ' ' HIS . 12.6 pt20 -86.6 173.91 9.24 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 115.938 -0.574 . . . . 74.230000000000004 111.191 172.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . 0.56 ' HA ' ' HE ' ' B' ' 146' ' ' ARG . 2.0 mmp_? 66.63 22.02 10.55 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.527 1.131 . . . . 75.140000000000001 111.472 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -160.92 167.62 26.24 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 113.653 -1.612 . . . . 75.109999999999999 108.052 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -90.47 158.03 17.26 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 124.159 0.912 . . . . 74.420000000000002 108.54 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 55.2 m -145.85 138.16 25.47 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.796 -0.446 . . . . 73.230000000000004 109.796 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -81.52 132.35 35.31 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 109.525 -0.546 . . . . 74.040000000000006 109.525 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 329' ' ' LEU . 7.9 m . . . . . 0 C--N 1.291 -1.957 0 CA-C-N 116.026 -0.534 . . . . 74.030000000000001 111.291 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 CA--C 1.493 -1.247 0 N-CA-C 107.427 -1.323 . . . . 75.329999999999998 107.427 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.298 1.6 pm0 -115.34 133.85 55.65 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-O 122.847 1.308 . . . . 73.230000000000004 114.087 -175.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.437 HG21 ' HE2' ' A' ' 364' ' ' LYS . 86.6 mt -123.62 106.59 17.41 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.732 0 CA-C-N 112.662 -2.063 . . . . 72.329999999999998 110.025 -173.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.512 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 30.2 ttpt -81.07 130.5 35.05 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.931 -1.137 . . . . 73.340000000000003 107.931 170.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 10.3 mt -129.97 156.76 43.91 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 124.805 1.316 . . . . 74.430000000000007 110.396 -177.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 39.0 mm -106.5 117.57 52.52 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.762 0 N-CA-C 107.696 -1.224 . . . . 75.25 107.696 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.55 ' HG2' ' N ' ' A' ' 325' ' ' GLY . 17.5 tttm -71.69 160.92 31.8 Favored 'General case' 0 C--O 1.206 -1.185 0 N-CA-C 107.933 -1.136 . . . . 74.510000000000005 107.933 174.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . 0.55 ' N ' ' HG2' ' A' ' 324' ' ' LYS . . . -149.33 -164.34 11.57 Favored Glycine 0 C--N 1.29 -1.981 0 N-CA-C 110.315 -1.114 . . . . 62.420000000000002 110.315 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.31 -12.84 27.86 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.892 2.394 . . . . 74.340000000000003 111.493 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -97.61 6.72 47.64 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 122.078 0.942 . . . . 70.120000000000005 108.968 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.03 -134.79 13.05 Favored Glycine 0 CA--C 1.491 -1.412 0 N-CA-C 109.824 -1.31 . . . . 74.450000000000003 109.824 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.78 -27.11 12.88 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.157 -1.423 . . . . 75.420000000000002 107.157 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 86.02 48.12 4.75 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.366 -1.288 . . . . 61.409999999999997 115.216 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -154.46 171.34 19.52 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 110.043 -0.354 . . . . 74.409999999999997 110.043 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.7 m -127.96 128.4 44.99 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.093 -0.706 . . . . 61.149999999999999 109.093 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 21.4 pt -113.79 157.92 14.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 115.84 -0.618 . . . . 75.329999999999998 110.622 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.39 125.96 10.98 Favored 'General case' 0 N--CA 1.428 -1.559 0 O-C-N 124.36 1.037 . . . . 63.119999999999997 108.454 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 164.13 -177.0 40.03 Favored Glycine 0 C--N 1.284 -2.333 0 N-CA-C 108.581 -1.808 . . . . 72.209999999999994 108.581 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.19 177.05 14.68 Favored Glycine 0 CA--C 1.482 -1.987 0 N-CA-C 109.833 -1.307 . . . . 71.25 109.833 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.454 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 92.8 t -57.76 103.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 O-C-N 124.121 0.542 . . . . 71.129999999999995 110.202 175.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 92.96 -14.08 66.11 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.375 -0.83 . . . . 72.319999999999993 112.101 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.542 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 65.0 t30 -106.02 21.56 17.11 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.553 -0.536 . . . . 73.420000000000002 109.553 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.67 123.5 7.96 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 115.104 -0.953 . . . . 72.230000000000004 111.49 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -78.72 -40.85 32.45 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.032 -0.985 . . . . 73.340000000000003 108.916 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 37.0 mm -103.62 122.36 45.07 Favored Pre-proline 0 C--N 1.302 -1.488 0 CA-C-N 115.2 -0.909 . . . . 75.239999999999995 109.334 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -52.2 108.11 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.429 2.752 . . . . 74.530000000000001 112.91 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 104.44 -2.6 42.97 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 115.178 -0.919 . . . . 64.540000000000006 112.308 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -127.14 103.66 7.55 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.747 0.784 . . . . 75.5 109.587 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . 0.454 ' OD1' ' HA ' ' A' ' 337' ' ' VAL . 65.9 t30 -83.32 38.02 0.59 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 125.038 1.335 . . . . 73.239999999999995 111.14 -171.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 21.5 m -110.9 177.86 4.53 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.723 -0.671 . . . . 75.129999999999995 112.346 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 35.0 mm -91.92 131.15 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.053 0.541 . . . . 74.430000000000007 109.702 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 36.6 m-85 -124.39 139.16 54.16 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.582 0.586 . . . . 73.120000000000005 112.582 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.24 115.05 10.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 108.256 -1.016 . . . . 74.200000000000003 108.256 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 31.6 m -101.06 -24.0 14.39 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.341 0.591 . . . . 74.519999999999996 111.308 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.63 147.93 23.7 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.792 -1.188 . . . . 73.129999999999995 107.792 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 85.1 mt -118.27 133.09 66.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 106.168 -1.79 . . . . 74.010000000000005 106.168 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 48.6 mm -75.83 130.87 35.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.315 0.579 . . . . 73.25 109.831 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.526 ' CD ' ' H ' ' A' ' 355' ' ' GLU . 1.6 pm0 -60.09 122.36 14.2 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 125.006 1.322 . . . . 72.099999999999994 111.627 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 74.29 16.16 79.91 Favored Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 114.368 -1.287 . . . . 74.409999999999997 111.393 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.78 163.95 52.84 Favored Glycine 0 C--O 1.251 1.177 0 N-CA-C 110.97 -0.852 . . . . 52.25 110.97 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -64.33 -42.34 96.33 Favored 'General case' 0 C--O 1.207 -1.15 0 N-CA-C 108.816 -0.809 . . . . 74.040000000000006 108.816 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.405 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -71.49 -5.74 35.3 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 121.876 -0.515 . . . . 72.409999999999997 112.135 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -93.85 -36.12 12.39 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.67 -0.863 . . . . 64.040000000000006 108.67 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -92.62 -58.59 2.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.98 1.371 . . . . 75.420000000000002 110.221 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -85.9 -26.76 25.41 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.709 -2.041 . . . . 64.319999999999993 110.283 -170.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -56.69 -39.35 86.21 Favored Glycine 0 C--N 1.278 -2.641 0 CA-C-N 112.779 -2.01 . . . . 71.329999999999998 118.109 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.437 ' HE2' HG21 ' A' ' 320' ' ' ILE 0.255 0.0 OUTLIER 45.94 32.59 1.37 Allowed 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 119.113 1.456 . . . . 73.340000000000003 111.489 -170.56 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 48.3 tp -101.31 149.62 23.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.436 -1.257 . . . . 74.439999999999998 109.036 -172.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.95 147.74 42.86 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.285 0.564 . . . . 71.230000000000004 109.686 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 76.7 mt -66.03 123.3 18.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 106.927 -1.509 . . . . 74.239999999999995 106.927 170.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.54 -9.31 19.66 Favored Glycine 0 C--N 1.308 -1.005 0 C-N-CA 120.536 -0.84 . . . . 74.040000000000006 112.29 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -68.51 137.09 54.1 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 120.882 0.373 . . . . 74.439999999999998 111.504 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 2.1 ttmm -94.55 125.14 39.01 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.81 -0.632 . . . . 73.230000000000004 109.502 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 95.9 mt -81.45 112.36 18.63 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.671 -0.863 . . . . 73.420000000000002 108.671 176.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.41 HD12 ' HB3' ' A' ' 403' ' ' ALA . 2.8 tt -80.5 -43.61 20.51 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.104 -2.184 . . . . 74.519999999999996 105.104 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -160.45 161.41 32.91 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.738 -1.119 . . . . 71.400000000000006 110.909 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.14 126.81 50.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.365 -1.346 . . . . 63.109999999999999 107.365 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.01 34.79 23.74 Favored 'General case' 0 CA--C 1.475 -1.925 0 CA-C-O 124.631 2.158 . . . . 74.439999999999998 110.339 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 60.42 17.33 7.11 Favored 'General case' 0 C--N 1.266 -3.058 1 CA-C-N 108.341 -4.027 . . . . 72.230000000000004 113.362 -177.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.4 t -89.04 125.86 42.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.64 -1.245 . . . . 70.140000000000001 107.64 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.4 p -57.58 123.42 15.53 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 123.847 0.859 . . . . 53.520000000000003 112.837 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 2.9 mp -107.32 -5.84 17.55 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.457 -0.792 . . . . 75.430000000000007 112.602 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -83.89 136.28 34.16 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.779 -0.768 . . . . 51.240000000000002 111.035 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 63.05 32.37 15.41 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.113 1.365 . . . . 74.409999999999997 114.469 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 33.2 m -112.07 169.15 4.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.257 -1.386 . . . . 74.0 107.257 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 82.6 p -79.26 150.46 31.54 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.359 -0.937 . . . . 73.540000000000006 108.937 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . 0.555 ' O ' HG21 ' A' ' 388' ' ' VAL . 6.8 t-160 -51.2 -37.25 45.63 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.212 0.449 . . . . 61.219999999999999 112.212 -175.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.415 ' HA ' ' OG1' ' B' ' 143' ' ' THR . 0.5 OUTLIER -62.33 -40.69 97.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 121.386 -0.126 . . . . 74.510000000000005 110.903 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -67.24 -37.15 83.08 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 109.188 -0.671 . . . . 75.5 109.188 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.508 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -68.66 -56.56 7.77 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 114.581 -1.19 . . . . 72.319999999999993 110.685 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.555 HG21 ' O ' ' A' ' 384' ' ' HIS . 27.4 t -58.98 -44.56 91.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 110.043 -0.354 . . . . 70.549999999999997 110.043 -177.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 87.3 m -60.29 -33.72 72.76 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.178 -0.465 . . . . 73.140000000000001 111.171 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.66 -38.03 86.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.425 -0.172 . . . . 74.329999999999998 110.757 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.4 mp -75.54 -30.12 59.63 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 119.914 -0.714 . . . . 72.510000000000005 110.219 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 55.0 mttm -72.31 -27.71 62.62 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 112.289 0.477 . . . . 75.310000000000002 112.289 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -80.07 51.36 1.35 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.047 0.927 . . . . 63.32 111.833 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 17.5 p -124.78 162.88 23.32 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 107.246 -1.39 . . . . 73.049999999999997 107.246 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' SER . . . . . 0.49 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 55.1 m -148.69 101.38 3.2 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.939 0.876 . . . . 74.349999999999994 110.669 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . 0.509 ' N ' ' HB3' ' A' ' 324' ' ' LYS . 0.8 OUTLIER 47.18 30.28 1.36 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 111.425 -2.625 . . . . 75.150000000000006 114.259 172.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -169.24 117.56 0.64 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 106.334 -1.728 . . . . 71.310000000000002 106.334 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.81 146.16 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.754 0.422 . . . . 74.329999999999998 111.036 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . 0.512 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 28.0 m-85 -121.93 96.84 5.22 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.625 0.77 . . . . 72.310000000000002 108.975 171.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.436 ' CD2' HG22 ' A' ' 402' ' ' VAL . 7.0 tt -91.61 133.89 35.16 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.799 -0.637 . . . . 73.430000000000007 109.695 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -117.55 110.9 18.52 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.242 0.617 . . . . 70.230000000000004 110.651 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.436 HG22 ' CD2' ' A' ' 400' ' ' LEU . 53.7 t -104.99 143.13 16.8 Favored 'Isoleucine or valine' 0 C--O 1.27 2.162 0 C-N-CA 124.047 0.939 . . . . 73.140000000000001 110.525 177.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -125.76 154.52 42.41 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 103.957 -2.608 . . . . 73.430000000000007 103.957 167.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -89.42 153.67 48.44 Favored Pre-proline 0 C--N 1.285 -2.198 0 C-N-CA 119.303 -0.959 . . . . 71.099999999999994 111.085 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . 0.534 ' HB2' ' O ' ' A' ' 409' ' ' HIS . 2.4 Cg_endo -45.14 132.84 11.53 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 123.3 2.666 . . . . 75.439999999999998 112.394 176.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 11.4 m -70.5 75.98 0.57 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 113.912 -1.495 . . . . 64.319999999999993 114.738 -171.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 77.73 -60.62 3.72 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 117.697 1.839 . . . . 71.209999999999994 117.697 166.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 33.4 p -61.81 -33.93 75.01 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.221 1.01 . . . . 73.25 110.086 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . 0.534 ' O ' ' HB2' ' A' ' 405' ' ' PRO . 64.2 m80 -128.13 142.31 51.23 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 104.747 -2.316 . . . . 74.439999999999998 104.747 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . 0.433 ' HA ' ' HG2' ' A' ' 405' ' ' PRO . 12.4 p-80 -151.91 135.53 16.2 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 123.253 0.346 . . . . 73.409999999999997 110.735 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 . . . . . 0 C--N 1.318 -0.791 0 N-CA-C 107.263 -1.384 . . . . 73.510000000000005 107.263 -179.297 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.569 0 N-CA-C 107.296 -1.372 . . . . 72.299999999999997 107.296 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . 0.411 ' HA ' HH11 ' B' ' 142' ' ' ARG . 9.7 mmm180 -108.93 147.11 32.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.558 -1.275 . . . . 75.420000000000002 107.558 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.415 ' OG1' ' HA ' ' A' ' 385' ' ' GLU . 15.8 p -117.14 154.77 30.49 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 119.824 -0.751 . . . . 73.230000000000004 109.392 -174.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 57.1 mmt-85 -153.47 148.72 26.95 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 121.055 0.455 . . . . 74.150000000000006 111.147 -178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . 0.441 ' HB3' ' CB ' ' A' ' 384' ' ' HIS . 13.7 pt20 -86.92 170.9 11.22 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.162 -0.926 . . . . 73.120000000000005 111.399 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . 0.571 ' HA ' ' HE ' ' B' ' 146' ' ' ARG . 1.7 mmp_? 67.4 21.38 9.72 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 125.088 1.355 . . . . 75.219999999999999 110.881 -173.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -161.53 172.72 15.92 Favored 'General case' 0 C--O 1.26 1.608 0 CA-C-N 113.081 -1.872 . . . . 75.049999999999997 106.478 173.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' B' ' 148' ' ' GLU . 0.1 OUTLIER -95.61 159.79 14.82 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 123.797 0.686 . . . . 74.030000000000001 110.074 -178.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 45.9 m -145.12 140.08 27.76 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.729 -0.607 . . . . 73.510000000000005 110.585 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -81.9 135.88 35.37 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.673 0.789 . . . . 73.439999999999998 110.393 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.27 2.146 0 CA-C-N 116.077 -0.51 . . . . 75.430000000000007 111.641 179.476 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 C--O 1.209 -1.046 0 N-CA-C 108.233 -1.025 . . . . 70.430000000000007 108.233 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.285 2.0 pm0 -104.31 139.51 39.19 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 114.069 1.137 . . . . 74.109999999999999 114.069 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 363' ' ' GLY . 89.9 mt -128.66 122.53 57.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.168 -1.833 . . . . 73.150000000000006 107.986 -172.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.523 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 33.1 ttpt -94.79 109.67 21.62 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.38 -0.528 . . . . 75.140000000000001 110.622 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.61 151.49 24.98 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.678 -1.147 . . . . 72.340000000000003 109.769 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 24.2 mm -105.25 111.22 33.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.038 -1.467 . . . . 75.310000000000002 107.038 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -75.98 130.55 38.6 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.355 -0.384 . . . . 74.340000000000003 111.548 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -133.09 -154.97 7.65 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 119.386 -1.388 . . . . 53.210000000000001 112.696 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.51 -13.26 35.03 Favored 'Trans proline' 0 N--CA 1.481 0.77 0 C-N-CA 123.411 2.741 . . . . 73.329999999999998 114.177 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -106.27 8.57 31.94 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.176 0.988 . . . . 62.229999999999997 108.386 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.02 -136.28 14.66 Favored Glycine 0 CA--C 1.492 -1.376 0 CA-C-N 113.844 -1.525 . . . . 42.240000000000002 110.497 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.0 mp -98.55 -26.26 14.47 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.746 -1.946 . . . . 73.519999999999996 105.746 171.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . 0.489 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 80.28 54.04 3.93 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 113.689 -1.596 . . . . 54.210000000000001 115.113 172.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -155.35 158.52 38.83 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.218 -1.03 . . . . 75.319999999999993 108.218 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.9 m -113.08 133.64 54.9 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.388 -0.597 . . . . 74.420000000000002 109.388 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.3 pt -116.16 154.54 17.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 115.833 -0.622 . . . . 73.540000000000006 110.996 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -143.58 127.37 17.21 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.478 -1.675 . . . . 63.5 106.478 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 148.33 150.67 5.26 Favored Glycine 0 C--N 1.283 -2.416 0 N-CA-C 109.323 -1.511 . . . . 73.510000000000005 109.323 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.65 171.84 12.75 Favored Glycine 0 C--N 1.287 -2.189 0 N-CA-C 108.044 -2.022 . . . . 75.129999999999995 108.044 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.1 t -45.57 111.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.087 0.943 . . . . 63.299999999999997 111.58 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 94.05 -30.49 7.53 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.097 -0.956 . . . . 71.329999999999998 112.361 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' B' ' 146' ' ' ARG . 63.3 t30 -105.46 26.75 9.08 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.808 -0.442 . . . . 74.420000000000002 109.808 -177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.83 123.93 8.91 Favored 'General case' 0 C--O 1.26 1.646 0 CA-C-N 116.017 -0.538 . . . . 75.450000000000003 109.793 177.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -75.81 -52.62 9.99 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.141 -0.936 . . . . 71.340000000000003 109.497 -173.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 73.3 mt -103.26 133.18 20.46 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 107.817 -1.179 . . . . 71.140000000000001 107.817 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.61 110.84 0.47 Allowed 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 123.424 2.749 . . . . 71.140000000000001 113.755 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 97.54 -4.58 61.91 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.322 -0.854 . . . . 74.230000000000004 112.045 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -120.15 96.82 5.32 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.831 0.824 . . . . 72.310000000000002 108.841 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -85.05 28.91 0.67 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.506 0.669 . . . . 74.299999999999997 110.7 -171.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 0.443 ' HB2' ' CE2' ' A' ' 349' ' ' TYR . 15.2 m -90.45 164.71 14.17 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.105 0.479 . . . . 64.409999999999997 111.106 -175.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 24.6 mm -79.54 125.01 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 108.428 -0.953 . . . . 75.109999999999999 108.428 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 370' ' ' LYS . 47.7 m-85 -123.71 130.22 52.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.089 0.471 . . . . 73.450000000000003 111.801 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.17 117.1 6.31 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 CA-C-N 115.432 -0.804 . . . . 73.140000000000001 109.254 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.2 m -100.06 -18.16 17.13 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.484 0.659 . . . . 75.439999999999998 110.476 -175.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.502 ' NZ ' ' HB2' ' A' ' 352' ' ' LYS . 2.3 ttmp? -166.57 153.05 8.81 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.047 -1.094 . . . . 72.329999999999998 108.047 -175.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 64.8 mt -126.87 119.86 54.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 107.037 -1.468 . . . . 70.030000000000001 107.037 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 42.8 mm -86.28 125.94 40.68 Favored 'Isoleucine or valine' 0 C--O 1.259 1.568 0 C-N-CA 123.234 0.614 . . . . 75.409999999999997 109.72 -175.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.31 147.6 47.69 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 108.285 -1.005 . . . . 73.219999999999999 108.285 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.438 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.49 -19.06 56.03 Favored Glycine 0 C--N 1.281 -2.487 0 N-CA-C 109.714 -1.355 . . . . 70.430000000000007 109.714 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . 0.489 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -72.93 149.85 43.51 Favored Glycine 1 N--CA 1.395 -4.095 0 N-CA-C 109.515 -1.434 . . . . 64.129999999999995 109.515 173.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -56.95 -36.84 70.73 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.132 -0.692 . . . . 74.319999999999993 109.132 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.491 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.81 -13.04 60.28 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 113.263 0.838 . . . . 51.32 113.263 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -94.14 -31.4 14.18 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.369 -0.974 . . . . 74.129999999999995 108.369 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.438 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 75.1 mmtt -84.69 -58.2 2.82 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.738 -0.785 . . . . 74.099999999999994 110.676 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.46 -42.17 13.81 Favored 'General case' 0 CA--C 1.467 -2.225 0 CA-C-O 121.887 0.851 . . . . 74.319999999999993 111.124 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.508 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -42.66 -23.1 0.17 Allowed Glycine 0 CA--C 1.482 -2.024 0 N-CA-C 120.328 2.891 . . . . 74.430000000000007 120.328 -158.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.508 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.84 32.48 0.4 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 119.037 1.418 . . . . 73.140000000000001 111.658 -178.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 48.5 tp -99.69 152.78 19.69 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.519 -1.219 . . . . 73.25 109.83 -171.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -117.14 144.65 44.47 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.478 0.656 . . . . 70.209999999999994 110.677 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.9 mt -66.12 120.81 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 106.958 -1.497 . . . . 72.219999999999999 106.958 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.56 -7.46 20.27 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 120.803 -0.713 . . . . 75.310000000000002 112.157 -176.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -70.14 137.54 51.14 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-O 121.17 0.509 . . . . 70.129999999999995 111.742 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.575 ' HB2' ' CE1' ' A' ' 349' ' ' TYR . 36.1 tttp -92.07 119.14 31.48 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.281 -0.872 . . . . 74.040000000000006 110.118 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.461 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 93.8 mt -79.08 114.71 18.24 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.293 -0.632 . . . . 75.329999999999998 109.293 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.443 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 3.3 tt -82.49 -39.84 21.92 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.205 -1.776 . . . . 74.329999999999998 106.205 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.92 166.86 21.29 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.538 -0.756 . . . . 53.439999999999998 112.331 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.0 p -132.74 116.69 27.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 107.493 -1.299 . . . . 62.030000000000001 107.493 171.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 63.22 29.58 15.94 Favored 'General case' 0 CA--C 1.469 -2.145 0 CA-C-O 123.943 1.83 . . . . 71.239999999999995 109.672 -172.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 66.39 11.8 8.23 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 109.556 -3.475 . . . . 74.420000000000002 113.182 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 49.8 t -78.57 119.31 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 106.214 -1.773 . . . . 74.109999999999999 106.214 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -59.45 124.62 20.64 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 114.328 1.233 . . . . 70.340000000000003 114.328 -173.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 6.6 mp -101.76 11.15 39.24 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 124.921 1.288 . . . . 64.030000000000001 108.973 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.443 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 24.0 mm-40 -78.43 112.23 15.25 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.258 -1.337 . . . . 75.25 108.682 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 61.06 83.55 0.14 Allowed 'General case' 0 CA--C 1.544 0.719 0 O-C-N 124.51 1.131 . . . . 71.430000000000007 111.721 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 19.3 m -153.13 162.83 2.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.061 -1.427 . . . . 74.519999999999996 107.975 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 2.0 m -78.64 143.32 36.46 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.726 -0.842 . . . . 72.409999999999997 108.726 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 388' ' ' VAL . 86.4 t60 -51.95 -49.66 62.73 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 120.872 0.367 . . . . 75.450000000000003 111.695 -175.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.477 ' HG3' ' OG1' ' B' ' 143' ' ' THR . 70.6 tt0 -61.05 -36.55 79.9 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.119 -0.946 . . . . 73.150000000000006 110.7 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 383' ' ' THR . 48.6 tt0 -73.75 -34.04 64.56 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.417 -1.265 . . . . 71.209999999999994 108.799 -174.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.522 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -71.83 -48.16 48.1 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.744 -1.117 . . . . 71.010000000000005 110.137 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 384' ' ' HIS . 19.3 t -58.52 -45.37 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.409 -0.589 . . . . 75.120000000000005 109.409 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 66.0 m -61.34 -31.72 71.59 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 116.08 -0.509 . . . . 65.099999999999994 111.348 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.65 84.16 Favored 'General case' 0 C--N 1.343 0.313 0 O-C-N 122.019 -0.426 . . . . 70.340000000000003 110.312 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.3 mp -79.08 -23.99 43.79 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 120.199 -0.6 . . . . 75.109999999999999 110.915 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 61.5 mttm -75.91 -32.19 59.51 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.528 0.566 . . . . 75.340000000000003 112.528 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -74.83 32.55 0.09 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.364 1.065 . . . . 72.25 113.761 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 1.7 p -124.77 158.45 33.28 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 109.968 -0.382 . . . . 71.200000000000003 109.968 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 62.8 m -148.53 125.84 11.55 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.535 -0.543 . . . . 73.530000000000001 109.535 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 26.6 t70 60.98 0.17 0.36 Allowed 'General case' 0 C--O 1.2 -1.513 0 C-N-CA 126.578 1.951 . . . . 72.349999999999994 114.954 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -158.38 119.12 3.36 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 120.276 -1.515 . . . . 74.319999999999993 110.333 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 93.7 t -142.21 117.93 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 122.553 0.341 . . . . 73.109999999999999 111.678 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . 0.523 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 17.8 m-85 -90.07 96.53 10.72 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.123 -1.066 . . . . 65.109999999999999 108.123 167.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 tt -83.35 130.82 35.08 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.097 -0.705 . . . . 73.219999999999999 109.097 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 38.8 tttp -121.19 112.62 18.88 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 109.954 -0.387 . . . . 74.299999999999997 109.954 -173.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 53.7 t -104.92 144.58 14.52 Favored 'Isoleucine or valine' 0 C--O 1.263 1.788 0 C-N-CA 123.753 0.821 . . . . 73.319999999999993 110.882 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -121.58 157.75 30.07 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 104.95 -2.241 . . . . 65.400000000000006 104.95 172.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.497 ' HA ' ' HE2' ' A' ' 404' ' ' LYS . 9.5 mmpt? -83.5 152.91 64.73 Favored Pre-proline 0 C--N 1.285 -2.208 0 C-N-CA 119.184 -1.006 . . . . 74.120000000000005 109.051 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . 0.563 ' HA ' ' OH ' ' A' ' 349' ' ' TYR . 2.2 Cg_endo -48.74 117.43 2.71 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 123.271 2.647 . . . . 75.319999999999993 113.632 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.4 -38.33 22.1 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 114.681 1.363 . . . . 74.510000000000005 114.681 -174.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -95.65 34.28 4.98 Favored Glycine 0 C--N 1.292 -1.864 0 C-N-CA 120.074 -1.06 . . . . 72.530000000000001 114.242 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 19.5 p -168.31 -175.68 2.65 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.571 -0.529 . . . . 72.329999999999998 109.571 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -76.98 130.99 38.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.051 -1.833 . . . . 75.439999999999998 106.051 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 404' ' ' LYS . 3.0 p-80 -107.03 143.56 34.97 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 115.409 1.633 . . . . 62.009999999999998 115.409 -172.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 . . . . . 0 N--CA 1.432 -1.34 0 N-CA-C 105.593 -2.003 . . . . 72.140000000000001 105.593 178.149 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.508 0 N-CA-C 109.002 -0.74 . . . . 72.230000000000004 109.002 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 69.62 -37.12 0.36 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 124.771 1.228 . . . . 75.040000000000006 111.381 -173.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.477 ' OG1' ' HG3' ' A' ' 385' ' ' GLU . 9.0 p -70.6 155.74 40.34 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 106.419 -1.696 . . . . 74.299999999999997 106.419 169.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . 0.453 ' O ' ' HD2' ' A' ' 384' ' ' HIS . 2.7 mmp_? -152.71 153.69 33.75 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.301 -1.0 . . . . 74.239999999999995 108.301 -172.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -87.04 169.85 12.05 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.016 0.436 . . . . 75.420000000000002 111.637 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . 0.487 ' HA ' ' OD1' ' A' ' 339' ' ' ASN 0.355 13.0 mmt180 65.96 20.91 11.35 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 125.43 1.492 . . . . 75.099999999999994 114.962 -178.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -144.86 170.24 16.5 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.621 -1.622 . . . . 65.099999999999994 106.621 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.489 ' CD ' ' HZ2' ' A' ' 352' ' ' LYS . 12.5 pt-20 -95.04 146.3 24.36 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 107.406 -1.331 . . . . 74.230000000000004 107.406 174.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 15.0 m -134.14 132.39 39.81 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 120.424 -0.51 . . . . 74.530000000000001 109.701 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -75.58 136.36 40.52 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 109.671 -0.492 . . . . 75.400000000000006 109.671 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 C--N 1.296 -1.73 0 CA-C-O 117.107 -1.425 . . . . 71.230000000000004 112.107 -179.888 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 109.331 -0.618 . . . . 72.140000000000001 109.331 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.33 119.8 11.67 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 122.247 1.022 . . . . 72.019999999999996 109.203 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 65.3 mt -98.47 106.56 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.895 0 CA-C-N 113.689 -1.596 . . . . 74.299999999999997 109.736 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -76.5 104.01 6.79 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 104.408 -2.442 . . . . 73.540000000000006 104.408 165.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 359' ' ' ALA . 0.6 OUTLIER -109.25 136.23 49.05 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 113.751 -1.568 . . . . 75.439999999999998 106.976 -173.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 21.9 mm -95.03 137.14 24.08 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 C-N-CA 119.36 -0.936 . . . . 71.319999999999993 109.292 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.533 ' HD3' ' HA ' ' A' ' 395' ' ' SER . 1.2 ttpm? -68.16 177.64 2.18 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-O 121.106 0.479 . . . . 74.209999999999994 109.835 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . 0.432 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -150.68 -173.88 21.2 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.229 -1.148 . . . . 65.150000000000006 110.229 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.47 -41.02 21.6 Favored 'Trans proline' 0 N--CA 1.482 0.831 0 C-N-CA 122.955 2.436 . . . . 74.030000000000001 112.178 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.35 -14.54 46.1 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 123.31 1.529 . . . . 70.129999999999995 107.656 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 98.74 -143.75 16.81 Favored Glycine 0 C--N 1.256 -3.885 0 CA-C-N 113.38 -1.736 . . . . 71.040000000000006 109.437 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.1 mp -74.76 -46.24 38.48 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 117.679 0.739 . . . . 73.030000000000001 111.105 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 83.41 53.15 3.51 Favored Glycine 0 C--O 1.22 -0.72 0 C-N-CA 120.173 -1.013 . . . . 73.439999999999998 115.364 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 49.0 p90 -151.82 172.98 15.33 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.185 -0.672 . . . . 71.329999999999998 109.185 173.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.463 ' OG ' ' HG2' ' B' ' 150' ' ' GLN . 3.9 m -123.38 136.1 54.47 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.951 -0.388 . . . . 62.219999999999999 109.951 -177.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 16.4 pt -120.57 156.55 23.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 116.318 -0.401 . . . . 74.299999999999997 110.146 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -148.02 133.3 18.46 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.96 -1.126 . . . . 73.040000000000006 107.96 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 157.83 -177.43 34.59 Favored Glycine 0 C--N 1.273 -2.922 0 N-CA-C 108.5 -1.84 . . . . 75.420000000000002 108.5 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.11 175.47 13.98 Favored Glycine 0 C--N 1.272 -2.986 0 N-CA-C 108.054 -2.018 . . . . 54.549999999999997 108.054 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.8 100.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.49 0.662 . . . . 75.409999999999997 110.769 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 80.71 2.45 89.96 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 115.164 -0.926 . . . . 61.229999999999997 113.445 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.426 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 62.2 t30 -107.69 11.81 28.06 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.057 -1.09 . . . . 73.430000000000007 108.057 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.88 134.27 56.48 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 115.624 1.713 . . . . 73.420000000000002 115.624 -173.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -71.62 -34.97 70.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.005 -1.452 . . . . 73.430000000000007 109.515 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 41.8 mm -104.75 118.89 55.23 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.998 -0.546 . . . . 75.510000000000005 110.299 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.94 110.17 0.59 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.745 2.297 . . . . 73.340000000000003 111.489 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.33 -28.23 9.87 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.95 -0.643 . . . . 71.010000000000005 111.832 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -106.77 102.51 11.87 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.766 -0.827 . . . . 64.239999999999995 108.766 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -82.66 38.11 0.55 Allowed 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 123.721 0.809 . . . . 73.140000000000001 112.208 -170.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 75.2 m -103.2 178.44 4.56 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 113.268 0.84 . . . . 74.329999999999998 113.268 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.415 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 25.7 mm -93.96 131.32 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 114.853 -1.067 . . . . 74.129999999999995 108.128 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 369' ' ' ASP . 28.9 m-85 -124.11 135.14 53.32 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 112.691 0.626 . . . . 74.120000000000005 112.691 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.69 116.57 5.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.072 -1.084 . . . . 74.400000000000006 108.072 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' THR . . . . . 0.401 HG21 ' HZ1' ' A' ' 352' ' ' LYS . 28.3 m -107.57 -20.41 13.25 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 120.852 0.358 . . . . 74.120000000000005 111.537 -175.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 331' ' ' PHE . 47.0 mmtm -149.34 159.06 44.61 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 107.524 -1.287 . . . . 75.510000000000005 107.524 177.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . 0.408 HG23 ' HB2' ' A' ' 360' ' ' HIS . 75.9 mt -140.54 124.97 18.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 107.049 -1.463 . . . . 73.319999999999993 107.049 172.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 39.2 mm -85.62 116.49 28.89 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 N-CA-C 108.15 -1.055 . . . . 74.049999999999997 108.15 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.506 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 1.1 pp20? -66.23 147.53 53.18 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 107.257 -1.386 . . . . 73.099999999999994 107.257 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.69 -26.66 19.11 Favored Glycine 0 C--N 1.288 -2.123 0 N-CA-C 109.691 -1.364 . . . . 63.420000000000002 109.691 -175.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -69.98 156.83 53.49 Favored Glycine 0 C--O 1.272 2.489 0 N-CA-C 110.914 -0.874 . . . . 75.209999999999994 110.914 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -57.6 -41.17 80.71 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 109.792 -0.448 . . . . 65.439999999999998 109.792 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.645 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.99 -4.88 43.6 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 113.394 0.887 . . . . 73.25 113.394 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . 0.506 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 69.6 t60 -94.8 -38.18 10.88 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.641 -0.824 . . . . 71.219999999999999 109.136 172.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -83.42 -57.2 3.35 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.976 -0.689 . . . . 74.530000000000001 111.362 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -85.54 -30.81 23.09 Favored 'General case' 0 CA--C 1.463 -2.383 0 CA-C-O 121.672 0.749 . . . . 75.310000000000002 109.588 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -43.31 -32.66 1.81 Allowed Glycine 0 CA--C 1.475 -2.413 0 CA-C-N 113.239 -1.801 . . . . 71.040000000000006 117.22 -168.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? 45.09 36.85 2.21 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 124.626 0.839 . . . . 75.519999999999996 110.408 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 29.9 tp -119.78 158.56 26.29 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 113.79 -1.55 . . . . 73.540000000000006 109.339 -168.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.75 145.23 49.63 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 115.82 -0.627 . . . . 71.540000000000006 109.936 -174.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 81.1 mt -66.77 119.23 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 108.991 -0.744 . . . . 74.299999999999997 108.991 175.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.76 3.33 20.25 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.984 -0.627 . . . . 71.329999999999998 111.996 -175.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 8.0 m-20 -73.25 133.02 43.83 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.818 0.673 . . . . 74.340000000000003 112.818 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 44.5 tttp -92.9 114.83 27.5 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.444 1.098 . . . . 73.099999999999994 108.473 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 83.9 mt -83.61 112.07 19.68 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.848 -0.427 . . . . 74.310000000000002 109.848 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.4 tt -83.7 -40.71 18.55 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.531 -1.213 . . . . 74.329999999999998 107.918 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -162.6 145.82 11.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.689 -0.687 . . . . 71.200000000000003 109.72 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.56 130.19 49.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 109.377 -0.601 . . . . 74.120000000000005 109.377 175.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 44.93 67.27 0.73 Allowed 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 125.652 1.581 . . . . 71.019999999999996 110.343 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 66.43 -26.69 0.11 Allowed 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 114.771 1.397 . . . . 75.299999999999997 114.771 -176.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 42.5 t -78.84 125.7 38.41 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 O-C-N 121.651 -0.656 . . . . 73.439999999999998 110.487 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -74.92 130.04 38.71 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 122.481 0.312 . . . . 74.0 110.521 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.6 0.09 22.34 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.474 0.546 . . . . 74.530000000000001 112.474 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -68.36 106.71 2.59 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.43 -0.582 . . . . 72.420000000000002 109.43 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 62.85 73.82 0.45 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 122.678 1.228 . . . . 72.519999999999996 113.077 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.56 169.71 16.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.515 -1.221 . . . . 72.209999999999994 107.834 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.513 ' OG1' ' HG2' ' A' ' 386' ' ' GLU . 3.0 p -76.63 147.85 37.3 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.639 -0.874 . . . . 74.329999999999998 108.639 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . 0.594 ' O ' HG22 ' A' ' 388' ' ' VAL . 10.6 t-80 -57.52 -37.04 72.37 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.496 0.665 . . . . 74.540000000000006 109.446 -172.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -56.45 -44.05 80.12 Favored 'General case' 0 N--CA 1.403 -2.8 0 CA-C-N 113.88 -1.509 . . . . 72.420000000000002 112.826 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.513 ' HG2' ' OG1' ' A' ' 383' ' ' THR . 20.0 mm-40 -75.28 -29.33 60.1 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 109.189 -0.671 . . . . 74.310000000000002 109.189 -176.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.449 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -67.33 -58.12 5.38 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.489 -1.232 . . . . 64.140000000000001 109.086 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 384' ' ' HIS . 17.8 t -59.27 -41.42 83.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 N-CA-C 109.447 -0.575 . . . . 65.340000000000003 109.447 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 35.1 m -61.46 -35.63 78.16 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 115.977 -0.556 . . . . 71.129999999999995 111.477 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -69.07 -38.02 78.82 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 122.341 -0.224 . . . . 63.130000000000003 110.583 176.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 387' ' ' ALA . 6.1 mp -72.16 -28.92 63.55 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.419 -0.513 . . . . 71.230000000000004 110.596 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 61.5 mttm -73.91 -34.88 64.55 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 120.602 -0.439 . . . . 75.510000000000005 112.106 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -84.77 62.39 7.37 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.785 0.802 . . . . 71.430000000000007 110.877 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 22.5 p -125.6 152.44 45.13 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.311 -0.859 . . . . 73.430000000000007 109.282 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' SER . . . . . 0.533 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 50.4 m -146.83 90.11 1.88 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 122.218 1.009 . . . . 70.129999999999995 111.072 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . 0.265 22.1 m-20 62.2 14.35 6.6 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 111.951 -2.386 . . . . 73.310000000000002 115.208 170.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -157.77 107.6 2.15 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 108.034 -1.098 . . . . 71.430000000000007 108.034 173.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 43.7 t -114.73 123.73 70.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.787 -0.819 . . . . 63.340000000000003 108.787 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.74 95.7 6.83 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 105.108 -2.182 . . . . 73.299999999999997 105.108 174.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 8.0 tt -102.22 104.02 14.56 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-O 121.376 0.608 . . . . 72.530000000000001 109.582 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -93.61 112.03 23.83 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.138 -1.43 . . . . 70.420000000000002 107.138 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 4.7 p -119.16 146.17 24.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.209 -0.905 . . . . 75.25 110.557 -173.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -125.17 158.38 34.1 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.298 -1.001 . . . . 72.329999999999998 108.298 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -92.92 152.94 41.94 Favored Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 106.958 -1.497 . . . . 64.430000000000007 106.958 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -75.46 78.29 3.06 Favored 'Trans proline' 0 C--O 1.248 1.007 0 C-N-CA 121.46 1.44 . . . . 74.120000000000005 110.5 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 31.1 m -77.39 74.39 3.96 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 122.439 1.114 . . . . 74.319999999999993 112.304 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -168.08 18.79 0.08 OUTLIER Glycine 0 C--N 1.304 -1.209 0 CA-C-N 113.661 -1.608 . . . . 63.210000000000001 109.743 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 26.0 t -168.89 -168.31 0.85 Allowed 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 105.635 -1.987 . . . . 62.240000000000002 105.635 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -80.74 89.7 5.78 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.447 0.642 . . . . 74.209999999999994 109.494 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -86.91 143.78 27.25 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.127 -0.942 . . . . 75.040000000000006 110.895 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 78.7 m80 . . . . . 0 C--N 1.294 -1.838 0 N-CA-C 107.095 -1.446 . . . . 72.239999999999995 107.095 179.333 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.455 -2.71 0 N-CA-C 107.89 -1.152 . . . . 61.039999999999999 107.89 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . 0.532 ' HG2' ' H ' ' B' ' 143' ' ' THR . 36.4 ttt180 -162.03 177.09 10.07 Favored 'General case' 0 N--CA 1.395 -3.191 0 N-CA-C 106.36 -1.719 . . . . 75.430000000000007 106.36 -173.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.532 ' H ' ' HG2' ' B' ' 142' ' ' ARG . 33.4 p -67.24 178.81 1.37 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.783 1.233 . . . . 74.310000000000002 110.363 176.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' B' ' 144' ' ' ARG . 34.8 mtt180 -152.12 151.3 30.89 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.146 -0.687 . . . . 73.019999999999996 109.146 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -85.28 175.1 9.12 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.018 -0.992 . . . . 65.329999999999998 108.962 170.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . 0.255 3.6 mpt_? 65.33 14.44 9.43 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.53 1.132 . . . . 54.399999999999999 113.617 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . 0.454 ' C ' HD21 ' B' ' 147' ' ' ASN . 0.2 OUTLIER -155.29 163.87 39.55 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 107.988 -1.116 . . . . 73.540000000000006 107.988 173.494 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -85.56 156.61 20.67 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.733 -0.839 . . . . 74.150000000000006 108.733 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 49.0 m -144.17 141.0 29.68 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.9 -0.5 . . . . 75.120000000000005 110.265 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . 0.463 ' HG2' ' OG ' ' A' ' 332' ' ' SER . 77.7 mt-30 -85.35 149.22 25.6 Favored 'General case' 0 CA--C 1.454 -2.742 0 CA-C-O 121.445 0.64 . . . . 73.25 111.631 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . 0.272 22.0 m . . . . . 1 N--CA 1.374 -4.253 0 CA-C-O 117.453 -1.261 . . . . 73.439999999999998 110.443 174.59 . . . . . . . . 2 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 CA--C 1.494 -1.193 0 N-CA-C 106.559 -1.645 . . . . 75.230000000000004 106.559 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.435 ' HG3' ' HH ' ' A' ' 399' ' ' TYR 0.429 1.8 pm0 -114.61 134.4 55.09 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 116.319 1.97 . . . . 74.519999999999996 116.319 -174.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 73.7 mt -124.43 112.88 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-N 112.573 -2.103 . . . . 74.430000000000007 109.186 -173.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -79.66 124.97 29.05 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.416 -1.327 . . . . 70.340000000000003 107.416 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 45.2 mt -114.48 144.33 43.51 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.072 -1.084 . . . . 75.019999999999996 108.072 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 54.3 mt -105.86 110.79 32.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 108.504 -0.925 . . . . 73.219999999999999 108.504 171.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.624 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 9.6 tmtt? -55.68 158.78 3.33 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 124.568 1.168 . . . . 74.400000000000006 111.601 177.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -144.37 -166.66 11.59 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 111.435 -0.666 . . . . 62.109999999999999 111.435 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.81 -15.08 46.22 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 123.324 2.683 . . . . 74.219999999999999 112.991 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -112.67 19.58 17.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.048 0.928 . . . . 74.329999999999998 109.248 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.92 -127.3 8.0 Favored Glycine 0 CA--C 1.497 -1.032 0 CA-C-N 114.994 -1.003 . . . . 54.420000000000002 111.31 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.425 HD12 ' OG1' ' A' ' 394' ' ' THR . 4.0 mp -104.89 -22.72 13.11 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.224 -1.028 . . . . 73.519999999999996 108.224 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 73.72 50.98 9.93 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 114.807 -1.088 . . . . 63.329999999999998 115.606 171.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' B' ' 150' ' ' GLN . 28.8 p90 -154.43 149.79 27.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.442 -0.577 . . . . 74.239999999999995 109.442 172.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.482 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 7.5 m -105.01 128.3 53.25 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.95 0.405 . . . . 74.530000000000001 109.919 -175.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 30.3 pt -122.82 151.58 27.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.596 -0.729 . . . . 73.439999999999998 111.03 -175.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -140.9 137.16 32.97 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 105.55 -2.018 . . . . 74.040000000000006 105.55 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 347' ' ' SER . . . 147.45 162.54 10.07 Favored Glycine 0 C--N 1.281 -2.49 0 N-CA-C 109.771 -1.332 . . . . 65.400000000000006 109.771 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.53 177.34 14.88 Favored Glycine 0 C--N 1.284 -2.345 0 N-CA-C 108.718 -1.753 . . . . 74.340000000000003 108.718 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 99.2 t -55.8 108.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 117.522 0.661 . . . . 73.200000000000003 109.971 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 86.45 -11.1 64.53 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.648 -0.706 . . . . 75.329999999999998 112.712 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.483 ' OD1' ' HA ' ' B' ' 145' ' ' GLN . 0.2 OUTLIER -106.39 9.74 31.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.051 -1.463 . . . . 63.210000000000001 107.051 179.162 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.95 121.66 4.97 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.939 1.296 . . . . 72.549999999999997 111.969 -175.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -82.28 -27.03 32.61 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.942 -1.026 . . . . 71.219999999999999 109.132 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.577 HD13 ' CE1' ' A' ' 349' ' ' TYR . 2.9 mp -116.52 131.48 23.84 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 106.779 -1.563 . . . . 75.200000000000003 106.779 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.53 107.01 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.571 2.18 . . . . 71.340000000000003 112.909 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 102.22 0.91 51.02 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.621 -0.718 . . . . 75.109999999999999 112.861 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.494 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 22.0 t70 -129.67 101.38 5.88 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.398 0.618 . . . . 72.519999999999996 109.617 -177.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . 0.432 ' HB2' ' OE2' ' A' ' 381' ' ' GLU . 32.6 m-80 -87.1 38.01 0.79 Allowed 'General case' 0 CA--C 1.5 -0.96 0 O-C-N 121.556 -0.715 . . . . 74.099999999999994 110.684 -174.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 0.509 ' O ' ' HA3' ' A' ' 335' ' ' GLY . 14.3 m -86.3 157.43 19.91 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.703 0.763 . . . . 75.420000000000002 111.202 -176.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 38.4 mm -75.63 122.82 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.563 0 N-CA-C 106.606 -1.627 . . . . 74.140000000000001 106.606 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.577 ' CE1' HD13 ' A' ' 342' ' ' ILE . 3.5 t80 -124.0 133.78 53.6 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 108.319 -0.993 . . . . 74.109999999999999 108.319 -173.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 43.9 t -74.82 109.78 8.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.851 -0.613 . . . . 73.310000000000002 109.581 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' THR . . . . . 0.553 ' O ' ' HD2' ' A' ' 352' ' ' LYS . 8.6 m -90.78 -36.73 14.1 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.975 -0.557 . . . . 74.439999999999998 109.976 -178.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.558 ' HZ1' ' CD ' ' B' ' 148' ' ' GLU . 1.2 mptm? -144.6 156.46 44.14 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.099 -0.704 . . . . 74.140000000000001 109.099 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 71.6 mt -125.35 129.51 73.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 106.284 -1.747 . . . . 73.230000000000004 106.284 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 47.2 mm -85.64 141.83 13.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 123.525 0.516 . . . . 73.310000000000002 110.186 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.03 120.87 8.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.286 1.034 . . . . 72.140000000000001 112.584 -174.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 72.59 14.49 77.68 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 115.281 -0.872 . . . . 64.5 112.97 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -73.54 168.42 53.95 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.213 -1.155 . . . . 74.340000000000003 110.213 176.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -58.76 -39.11 80.03 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 117.312 0.556 . . . . 72.329999999999998 110.346 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.599 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -72.58 -15.16 61.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.225 0.536 . . . . 65.530000000000001 111.94 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -95.19 -23.56 17.22 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.959 -0.756 . . . . 74.450000000000003 108.959 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 4.0 tmmt? -95.76 -60.16 1.71 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.649 0.738 . . . . 75.310000000000002 111.062 -175.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -86.94 -31.14 20.82 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.336 1.065 . . . . 74.310000000000002 109.426 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.777 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -53.61 -50.41 53.66 Favored Glycine 0 CA--C 1.481 -2.072 0 N-CA-C 119.135 2.414 . . . . 61.329999999999998 119.135 -167.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.777 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 43.8 34.17 0.83 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.253 1.025 . . . . 74.400000000000006 109.676 -167.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 21.7 tp -92.2 158.27 16.25 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 113.547 -1.66 . . . . 71.450000000000003 109.752 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -117.07 144.3 44.8 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.726 0.774 . . . . 71.099999999999994 110.845 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 71.0 mt -65.85 119.99 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 106.108 -1.812 . . . . 72.329999999999998 106.108 167.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.409 ' HA2' ' CE2' ' A' ' 349' ' ' TYR . . . 115.46 3.45 20.72 Favored Glycine 0 C--N 1.295 -1.699 0 C-N-CA 119.669 -1.253 . . . . 50.240000000000002 112.16 -173.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.8 137.19 40.36 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 113.139 0.792 . . . . 74.030000000000001 113.139 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -100.47 115.28 29.71 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.13 -1.063 . . . . 71.530000000000001 108.13 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 60.5 mt -84.67 115.51 22.7 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.236 0.541 . . . . 74.519999999999996 110.246 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.77 -37.11 27.68 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.837 -1.529 . . . . 63.539999999999999 107.695 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.34 157.25 19.85 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.79 -0.641 . . . . 71.219999999999999 111.216 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.88 122.93 43.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 107.569 -1.271 . . . . 74.219999999999999 107.569 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 62.2 29.32 17.44 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 124.036 1.874 . . . . 55.530000000000001 108.853 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 67.21 10.42 7.7 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 109.515 -3.493 . . . . 73.129999999999995 113.479 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.9 t -79.94 124.49 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 106.576 -1.639 . . . . 74.129999999999995 106.576 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -64.35 127.51 31.79 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.009 0.744 . . . . 75.5 113.009 -175.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 6.9 mp -106.31 6.71 30.83 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 123.865 0.866 . . . . 74.219999999999999 110.973 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -76.91 122.97 25.6 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.16 -1.792 . . . . 71.349999999999994 106.16 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . 0.432 ' OE2' ' HB2' ' A' ' 346' ' ' ASN 0.32 1.5 mp0 48.52 83.09 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 116.062 1.875 . . . . 74.109999999999999 116.062 -172.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 15.8 m -149.85 157.82 6.12 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-N 113.428 -1.714 . . . . 72.439999999999998 107.735 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.8 m -81.16 140.73 34.81 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.424 -0.954 . . . . 75.230000000000004 108.424 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . 0.557 ' O ' HG22 ' A' ' 388' ' ' VAL . 82.6 t60 -50.93 -46.18 60.77 Favored 'General case' 0 C--O 1.207 -1.168 0 N-CA-C 112.993 0.738 . . . . 74.430000000000007 112.993 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.423 ' HA ' ' OG1' ' B' ' 143' ' ' THR . 4.0 tp10 -59.24 -40.45 85.98 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.966 0.888 . . . . 73.109999999999999 109.677 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.0 tt0 -72.52 -39.76 67.33 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.074 -1.421 . . . . 72.200000000000003 108.856 -173.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -71.35 -46.17 61.17 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.449 -1.251 . . . . 63.350000000000001 110.997 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 384' ' ' HIS . 57.9 t -59.98 -41.64 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 109.872 -0.418 . . . . 74.049999999999997 109.872 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 62.2 m -58.9 -35.63 73.35 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 123.443 0.464 . . . . 73.510000000000005 110.478 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.31 -34.54 78.57 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 122.075 -0.391 . . . . 74.209999999999994 110.82 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 5.9 mp -80.74 -30.3 36.21 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 120.426 -0.509 . . . . 74.230000000000004 110.943 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.453 ' HD2' ' OE ' ' B' ' 141' ' ' PCA . 51.7 mttm -73.91 -23.54 59.56 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.23 0.456 . . . . 75.25 112.23 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -77.69 49.41 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.371 0.605 . . . . 71.030000000000001 110.562 175.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' THR . . . . . 0.425 ' OG1' HD12 ' A' ' 329' ' ' LEU . 21.5 p -124.77 142.35 51.48 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 109.472 -0.566 . . . . 75.319999999999993 109.472 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 62.1 m -144.48 99.09 3.31 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 122.571 1.177 . . . . 72.010000000000005 112.076 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . 0.624 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 7.7 m-20 65.58 12.36 8.16 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 111.023 -2.808 . . . . 73.030000000000001 112.819 168.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -160.76 129.37 4.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.332 -1.729 . . . . 74.450000000000003 106.332 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.7 t -139.53 141.74 34.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 107.668 -1.234 . . . . 72.219999999999999 107.668 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . 0.435 ' HH ' ' HG3' ' A' ' 319' ' ' GLU . 28.2 t80 -118.5 95.93 5.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.756 -1.572 . . . . 75.420000000000002 106.756 174.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.58 130.72 35.85 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 122.785 0.434 . . . . 73.120000000000005 110.571 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -116.21 108.97 16.8 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.178 -1.045 . . . . 72.510000000000005 108.178 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 7.9 p -113.38 155.39 14.6 Favored 'Isoleucine or valine' 0 C--O 1.269 2.113 0 CA-C-N 116.035 -0.53 . . . . 74.219999999999999 110.449 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -136.62 157.58 46.44 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.422 -1.325 . . . . 74.329999999999998 107.422 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' A' ' 404' ' ' LYS . 9.7 mmpt? -88.59 153.39 50.3 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 107.302 -1.37 . . . . 73.530000000000001 107.302 176.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . 0.463 ' HG3' ' OH ' ' A' ' 349' ' ' TYR . 29.2 Cg_endo -64.42 120.09 7.3 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 108.171 -1.511 . . . . 65.349999999999994 108.171 173.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 12.7 m -67.06 84.37 0.13 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.997 0.903 . . . . 74.540000000000006 112.668 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -168.14 165.09 38.52 Favored Glycine 0 N--CA 1.414 -2.788 0 N-CA-C 108.128 -1.989 . . . . 71.230000000000004 108.128 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 12.1 m -83.48 22.65 1.02 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 117.958 0.879 . . . . 55.219999999999999 110.682 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -128.58 26.51 5.62 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.14 -1.059 . . . . 65.219999999999999 108.14 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -87.76 144.76 26.45 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.744 -0.662 . . . . 75.019999999999996 112.082 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 . . . . . 0 C--N 1.297 -1.677 0 N-CA-C 106.116 -1.809 . . . . 74.140000000000001 106.116 171.813 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . 0.453 ' OE ' ' HD2' ' A' ' 392' ' ' LYS . . . . . . . . 0 CA--C 1.48 -1.716 0 CA-C-O 121.299 0.571 . . . . 73.530000000000001 110.072 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 68.97 18.36 8.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 113.305 -1.771 . . . . 75.540000000000006 109.085 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.466 ' HB ' ' CD2' ' A' ' 384' ' ' HIS . 4.8 p -97.77 122.43 40.85 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 114.746 -1.115 . . . . 71.340000000000003 109.533 -176.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -153.8 171.67 18.55 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 107.99 -1.115 . . . . 75.439999999999998 107.99 -173.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . 0.483 ' HA ' ' OD1' ' A' ' 339' ' ' ASN . 20.9 mp0 -53.97 147.4 12.45 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.955 1.095 . . . . 74.329999999999998 113.955 -172.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 67.04 28.66 8.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 113.424 -1.716 . . . . 74.319999999999993 113.765 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . 0.479 ' C ' HD21 ' B' ' 147' ' ' ASN . 0.1 OUTLIER -143.19 152.55 41.89 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 118.297 -1.361 . . . . 71.510000000000005 111.991 173.038 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.558 ' CD ' ' HZ1' ' A' ' 352' ' ' LYS . 11.9 pt-20 -96.33 145.69 25.39 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.668 -1.234 . . . . 75.439999999999998 107.668 172.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 65.7 m -147.4 144.23 28.53 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.992 -0.443 . . . . 74.340000000000003 110.011 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 331' ' ' PHE . 12.7 tt0 -76.34 136.08 39.55 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.096 0.474 . . . . 73.310000000000002 110.593 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 4.3 m . . . . . 0 C--N 1.292 -1.912 0 CA-C-N 115.59 -0.732 . . . . 72.319999999999993 110.309 173.013 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 C--O 1.202 -1.442 0 N-CA-C 106.242 -1.762 . . . . 71.439999999999998 106.242 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 401' ' ' LYS 0.343 1.8 pm0 -118.24 136.94 53.36 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 114.919 1.452 . . . . 64.420000000000002 114.919 -174.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 363' ' ' GLY . 75.3 mt -126.23 114.38 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 CA-C-N 113.214 -1.812 . . . . 73.25 110.048 -172.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.463 ' HG3' ' CZ ' ' A' ' 397' ' ' PHE . 0.9 OUTLIER -79.71 136.43 36.77 Favored 'General case' 0 C--N 1.279 -2.498 0 N-CA-C 107.718 -1.216 . . . . 71.319999999999993 107.718 172.046 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.529 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 97.0 mt -131.63 157.26 44.15 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.581 -0.525 . . . . 74.439999999999998 109.581 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 324' ' ' LYS . 2.4 mp -106.27 140.97 22.65 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 N-CA-C 106.006 -1.85 . . . . 74.200000000000003 106.006 171.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.468 ' HG2' ' H ' ' A' ' 325' ' ' GLY . 1.3 ttpm? -75.36 177.85 6.3 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.007 -1.108 . . . . 73.129999999999995 108.007 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . 0.468 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -160.91 -172.26 27.97 Favored Glycine 0 C--N 1.284 -2.325 0 N-CA-C 110.848 -0.901 . . . . 73.530000000000001 110.848 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.12 -13.95 28.74 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.879 2.386 . . . . 73.519999999999996 112.064 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.531 ' HB3' ' HZ1' ' A' ' 327' ' ' LYS . 9.0 mtpm? -115.18 20.08 15.2 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 115.973 -0.558 . . . . 74.129999999999995 110.996 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.44 -127.12 7.96 Favored Glycine 0 C--N 1.299 -1.492 0 N-CA-C 110.643 -0.983 . . . . 61.100000000000001 110.643 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.9 mp -105.83 -27.19 11.4 Favored 'General case' 0 C--O 1.268 2.054 0 N-CA-C 108.235 -1.024 . . . . 74.140000000000001 108.235 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 86.08 49.45 4.24 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 114.054 -1.43 . . . . 72.400000000000006 115.695 173.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -155.07 145.06 21.67 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 117.097 0.449 . . . . 75.230000000000004 111.144 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 14.5 m -96.34 126.38 41.5 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 124.005 0.922 . . . . 73.430000000000007 109.233 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 28.0 pt -117.11 144.37 25.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 116.28 -0.418 . . . . 73.319999999999993 111.377 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' B' ' 148' ' ' GLU . . . -130.99 136.16 48.27 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.414 -1.698 . . . . 73.329999999999998 106.414 174.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.556 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 145.12 161.45 9.06 Favored Glycine 0 C--N 1.268 -3.241 0 N-CA-C 109.685 -1.366 . . . . 72.120000000000005 109.685 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.82 173.49 13.22 Favored Glycine 0 N--CA 1.418 -2.512 0 N-CA-C 107.245 -2.342 . . . . 63.100000000000001 107.245 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 66.3 t -53.11 107.49 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 118.137 0.969 . . . . 72.239999999999995 110.554 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.45 -18.47 57.34 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.109 -0.951 . . . . 71.239999999999995 112.586 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.556 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 60.1 t30 -106.5 18.2 22.27 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.655 -0.498 . . . . 74.219999999999999 109.655 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.68 120.09 4.86 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.828 -0.624 . . . . 75.129999999999995 111.297 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -76.96 -40.24 47.63 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.431 -0.804 . . . . 74.340000000000003 109.803 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.2 mm -104.29 120.72 49.85 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 115.736 -0.665 . . . . 75.010000000000005 109.715 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.6 106.61 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 123.28 2.653 . . . . 74.010000000000005 112.349 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 107.96 -3.42 33.72 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 115.475 -0.784 . . . . 74.519999999999996 111.881 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.437 ' CG ' ' HH ' ' A' ' 349' ' ' TYR . 12.7 t70 -132.38 98.0 4.26 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.569 -0.9 . . . . 72.109999999999999 108.569 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -83.37 38.05 0.59 Allowed 'General case' 0 CA--C 1.553 1.068 0 CA-C-O 121.953 0.882 . . . . 75.439999999999998 111.89 -170.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 73.7 m -102.12 178.46 4.6 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.682 -0.69 . . . . 72.310000000000002 112.765 -178.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.413 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 31.3 mm -88.94 129.37 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 114.969 -1.014 . . . . 70.25 108.644 -178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 35.6 m-85 -124.06 140.43 52.98 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.195 0.521 . . . . 75.120000000000005 111.691 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 42.7 t -78.94 111.0 15.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.132 -0.94 . . . . 73.239999999999995 109.243 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 25.7 m -88.28 -30.46 19.62 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.198 0.523 . . . . 74.030000000000001 110.882 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.417 ' HD3' ' N ' ' A' ' 353' ' ' ILE . 9.1 tmtt? -155.36 137.83 15.0 Favored 'General case' 0 C--O 1.203 -1.385 0 N-CA-C 108.284 -1.006 . . . . 73.040000000000006 108.284 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . 0.417 ' N ' ' HD3' ' A' ' 352' ' ' LYS . 74.1 mt -109.17 129.73 63.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.632 -1.247 . . . . 73.549999999999997 107.632 174.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 49.7 mm -77.47 126.33 37.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.358 0.599 . . . . 75.209999999999994 110.037 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 355' ' ' GLU . 1.4 pm0 -62.31 127.04 29.45 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 114.39 -1.277 . . . . 75.310000000000002 110.739 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.56 -19.56 53.72 Favored Glycine 0 N--CA 1.426 -1.994 0 CA-C-N 115.021 -0.99 . . . . 62.32 112.533 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -68.19 167.03 43.82 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 114.278 0.471 . . . . 72.200000000000003 114.278 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -61.26 -41.99 97.85 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.313 0.645 . . . . 52.240000000000002 111.132 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -75.11 -7.74 54.61 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 119.692 -0.803 . . . . 72.510000000000005 111.954 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -94.09 -30.53 14.62 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.928 -0.767 . . . . 73.400000000000006 108.928 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -89.65 -59.65 2.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.028 -0.533 . . . . 73.400000000000006 111.671 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -87.14 -38.96 15.96 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 108.608 -0.886 . . . . 72.200000000000003 108.608 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.521 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -44.68 -31.25 2.51 Favored Glycine 0 C--O 1.207 -1.57 0 N-CA-C 119.195 2.438 . . . . 71.340000000000003 119.195 -167.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.521 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 41.37 32.21 0.2 Allowed 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 118.803 1.302 . . . . 75.310000000000002 111.377 -174.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 43.7 tp -98.11 155.07 17.32 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.551 -1.204 . . . . 74.310000000000002 109.474 -170.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -125.08 150.98 46.27 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.344 0.592 . . . . 75.540000000000006 111.267 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 75.9 mt -65.95 122.98 17.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.297 -1.001 . . . . 72.340000000000003 108.297 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 113.25 -2.3 25.29 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.686 -0.769 . . . . 63.420000000000002 112.126 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 3.5 m-20 -72.13 136.68 46.59 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 112.83 0.678 . . . . 73.439999999999998 112.83 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.623 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 33.9 tttp -96.2 115.28 27.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.213 1.405 . . . . 74.120000000000005 109.648 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 68.3 mt -85.21 118.92 25.05 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.156 0.503 . . . . 74.329999999999998 109.693 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.3 tt -87.61 -39.38 15.11 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.074 -1.421 . . . . 65.219999999999999 108.093 -176.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -160.77 156.09 24.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.05 -0.523 . . . . 71.430000000000007 111.095 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.1 p -134.74 123.33 41.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 108.139 -1.06 . . . . 73.549999999999997 108.139 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 62.32 29.55 17.32 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 123.516 1.627 . . . . 74.400000000000006 108.282 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 67.0 18.87 10.61 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 110.449 -3.068 . . . . 72.519999999999996 112.331 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 50.7 t -88.91 128.22 41.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 106.505 -1.665 . . . . 75.120000000000005 106.505 172.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.9 p -64.4 124.75 22.58 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 113.126 0.788 . . . . 74.510000000000005 113.126 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.5 mp -108.27 -2.48 19.24 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.561 0.745 . . . . 71.420000000000002 111.224 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -68.2 107.6 2.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.952 -0.567 . . . . 64.0 109.605 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 60.66 74.91 0.43 Allowed 'General case' 0 CA--C 1.545 0.775 0 O-C-N 124.619 1.199 . . . . 72.519999999999996 113.296 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 24.1 m -135.05 167.09 26.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.183 -1.414 . . . . 72.329999999999998 107.183 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 51.6 p -79.73 141.22 36.56 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 118.918 0.781 . . . . 71.049999999999997 110.325 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . 0.477 ' O ' HG22 ' A' ' 388' ' ' VAL . 82.7 t60 -45.56 -49.27 14.12 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.672 0.99 . . . . 73.420000000000002 113.672 -174.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.487 ' HA ' ' OG1' ' B' ' 143' ' ' THR . 10.0 tp10 -61.33 -38.78 88.13 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.212 0.53 . . . . 73.530000000000001 111.54 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.0 tt0 -70.46 -35.05 73.1 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.511 -0.922 . . . . 75.299999999999997 108.511 -177.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.409 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -70.54 -53.91 14.24 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 114.441 -1.254 . . . . 61.219999999999999 110.582 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.487 HG12 HG23 ' B' ' 143' ' ' THR . 44.5 t -59.54 -43.36 90.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 C-N-CA 121.147 -0.221 . . . . 71.140000000000001 110.57 -177.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 53.8 m -62.04 -30.32 70.89 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 111.953 0.353 . . . . 75.109999999999999 111.953 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.13 -35.08 78.98 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 122.124 -0.36 . . . . 74.409999999999997 110.331 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.7 mp -80.57 -28.61 37.15 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 120.394 -0.523 . . . . 73.310000000000002 110.783 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 54.3 mttm -74.31 -24.23 59.19 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.576 -0.45 . . . . 74.510000000000005 111.536 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -82.16 65.2 7.18 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.347 1.07 . . . . 71.519999999999996 110.19 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 13.3 p -130.65 145.63 51.96 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 113.987 -1.46 . . . . 74.150000000000006 107.679 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 43.8 m -141.77 91.28 2.35 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 122.568 1.175 . . . . 75.329999999999998 111.25 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . 0.343 12.4 m-20 65.16 4.79 2.72 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 111.438 -2.619 . . . . 73.319999999999993 115.616 172.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . 0.463 ' CZ ' ' HG3' ' A' ' 321' ' ' LYS . 37.6 t80 -151.85 134.52 15.5 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 106.368 -1.716 . . . . 73.209999999999994 106.368 171.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.8 t -138.29 145.69 28.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.812 -1.181 . . . . 75.530000000000001 107.812 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -126.0 96.1 4.63 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.027 -1.101 . . . . 74.099999999999994 108.027 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 tt -92.63 132.84 36.54 Favored 'General case' 0 C--N 1.277 -2.546 0 C-N-CA 123.031 0.532 . . . . 75.040000000000006 110.739 -174.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 319' ' ' GLU . 65.8 mttm -114.31 118.72 34.7 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.152 -0.684 . . . . 73.230000000000004 109.152 174.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 3.6 p -118.58 149.04 21.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 CA-C-N 115.048 -0.978 . . . . 75.120000000000005 109.979 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.623 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.45 159.32 42.15 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 125.119 1.368 . . . . 72.239999999999995 107.337 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -84.93 154.43 60.96 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 109.267 -0.642 . . . . 75.140000000000001 109.267 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -46.55 119.33 3.11 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 124.204 3.269 . . . . 75.310000000000002 113.933 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 16.5 p -95.21 -12.03 27.02 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.415 -0.811 . . . . 73.230000000000004 111.963 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -102.47 22.52 37.23 Favored Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 120.713 -0.756 . . . . 64.519999999999996 111.735 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 13.9 t -167.96 -164.72 0.57 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.521 -1.659 . . . . 63.420000000000002 106.521 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -82.44 144.72 30.28 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.606 -1.257 . . . . 72.319999999999993 107.606 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -74.11 144.59 44.88 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.636 0.255 . . . . 73.340000000000003 110.644 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 . . . . . 0 C--N 1.297 -1.711 0 N-CA-C 106.76 -1.57 . . . . 71.430000000000007 106.76 175.358 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 120.959 0.409 . . . . 71.409999999999997 110.139 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -139.14 28.91 2.27 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.085 -1.08 . . . . 74.409999999999997 108.085 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.487 ' OG1' ' HA ' ' A' ' 385' ' ' GLU . 6.7 p -99.17 155.78 17.3 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 115.83 -0.623 . . . . 71.239999999999995 111.705 -175.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -153.8 134.95 14.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.051 -1.833 . . . . 74.040000000000006 106.051 -169.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 339' ' ' ASN . 13.3 pm0 -65.52 152.02 45.02 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.608 0.966 . . . . 72.129999999999995 113.608 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . 0.508 ' HA ' ' OD1' ' A' ' 339' ' ' ASN 0.275 64.3 mtm180 67.67 59.53 0.48 Allowed 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 126.789 2.036 . . . . 71.510000000000005 112.984 -174.208 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 173.93 157.8 0.14 Allowed 'General case' 0 C--O 1.245 0.833 0 CA-C-N 110.966 -2.833 . . . . 74.140000000000001 107.494 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 334' ' ' ALA . 0.9 OUTLIER -95.96 157.18 16.01 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.232 0.539 . . . . 74.310000000000002 110.948 174.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 51.6 m -147.84 146.85 29.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.726 -0.842 . . . . 74.409999999999997 108.726 174.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 1.2 tt0 -79.79 137.84 37.09 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 120.996 0.427 . . . . 74.519999999999996 110.952 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.426 -1.633 0 CA-C-N 115.711 -0.677 . . . . 74.209999999999994 110.767 174.501 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' MET . . . . . 0.593 ' SD ' ' HE3' ' A' ' 404' ' ' LYS . 27.5 ttt . . . . . 0 CA--C 1.495 -1.168 0 N-CA-C 107.041 -1.466 . . . . 74.319999999999993 107.041 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.325 2.3 pm0 -115.87 137.56 51.99 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-O 122.202 1.001 . . . . 75.540000000000006 113.658 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 363' ' ' GLY . 70.2 mt -128.62 130.49 68.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 113.225 -1.807 . . . . 73.0 108.155 -169.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -108.07 107.66 18.42 Favored 'General case' 0 N--CA 1.411 -2.387 0 N-CA-C 108.348 -0.982 . . . . 73.540000000000006 108.348 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 93.3 mt -105.65 160.07 15.48 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.346 -0.843 . . . . 74.439999999999998 110.055 -176.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.2 113.41 42.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 N-CA-C 108.148 -1.056 . . . . 74.450000000000003 108.148 171.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.506 ' HB3' ' H ' ' A' ' 396' ' ' ASP . 0.0 OUTLIER -67.13 140.87 57.56 Favored 'General case' 0 C--O 1.207 -1.168 0 N-CA-C 106.953 -1.499 . . . . 74.430000000000007 106.953 174.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . 0.502 ' N ' ' HD2' ' A' ' 324' ' ' LYS . . . -142.31 -161.2 8.67 Favored Glycine 0 C--N 1.27 -3.099 0 CA-C-O 119.946 -0.363 . . . . 75.420000000000002 112.498 -171.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.94 -12.92 37.43 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 123.829 3.02 . . . . 51.229999999999997 113.507 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -109.43 5.96 23.83 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.175 0.988 . . . . 71.409999999999997 108.932 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.99 -121.35 5.49 Favored Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 108.965 -1.654 . . . . 63.539999999999999 108.965 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.79 -26.2 11.38 Favored 'General case' 0 C--O 1.266 1.952 0 N-CA-C 107.844 -1.169 . . . . 75.219999999999999 107.844 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.41 43.49 6.54 Favored Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 113.707 -1.588 . . . . 63.109999999999999 114.675 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -155.22 151.1 27.72 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 117.056 0.428 . . . . 72.109999999999999 110.286 174.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 29.2 m -106.28 129.58 54.28 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 124.145 0.978 . . . . 74.439999999999998 109.578 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 14.8 pt -114.32 156.63 15.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.776 -0.647 . . . . 74.25 110.666 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -143.68 130.02 19.89 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.896 -1.89 . . . . 73.319999999999993 105.896 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 149.67 153.21 5.98 Favored Glycine 0 C--N 1.27 -3.094 0 N-CA-C 109.012 -1.635 . . . . 62.229999999999997 109.012 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.82 173.1 13.09 Favored Glycine 0 C--N 1.283 -2.39 0 N-CA-C 106.558 -2.617 . . . . 62.020000000000003 106.558 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.8 t -45.75 106.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 118.597 1.198 . . . . 75.120000000000005 111.705 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 93.01 -23.92 27.05 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.541 -0.754 . . . . 64.0 112.27 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.53 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 32.7 t-20 -97.78 19.41 13.75 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.353 -0.98 . . . . 70.310000000000002 108.353 -177.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.1 118.7 3.09 Favored 'General case' 0 C--O 1.257 1.493 0 CA-C-O 121.263 0.554 . . . . 62.310000000000002 110.301 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -77.75 -43.59 30.35 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.075 -0.966 . . . . 73.439999999999998 109.052 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.439 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 39.3 mm -103.65 131.25 22.21 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 108.119 -1.067 . . . . 75.239999999999995 108.119 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.1 110.46 0.48 Allowed 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 123.173 2.582 . . . . 74.239999999999995 113.551 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.86 -3.6 65.11 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.407 -0.815 . . . . 73.310000000000002 112.189 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.439 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 29.2 t0 -119.64 99.69 6.81 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.716 -0.846 . . . . 73.329999999999998 108.716 -176.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -84.0 26.04 0.77 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.532 0.682 . . . . 73.219999999999999 110.845 -171.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 20.0 m -88.5 172.29 9.46 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.369 0.604 . . . . 72.540000000000006 111.762 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 18.3 mm -88.28 122.76 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 115.185 -0.916 . . . . 71.129999999999995 108.575 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 51.2 m-85 -123.62 131.93 53.74 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.031 0.443 . . . . 71.510000000000005 110.748 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.9 t -70.64 120.75 19.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.888 -0.597 . . . . 74.319999999999993 109.4 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 22.4 m -101.03 -23.16 14.56 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.102 0.477 . . . . 73.340000000000003 111.353 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -155.55 137.03 14.09 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 107.618 -1.253 . . . . 74.120000000000005 107.618 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 73.4 mt -108.94 126.03 65.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.099 -1.445 . . . . 74.540000000000006 107.099 172.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 49.7 mm -74.48 134.9 28.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.293 0.568 . . . . 64.420000000000002 109.853 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 355' ' ' GLU . 1.4 pm0 -62.39 120.84 11.81 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-O 122.45 1.119 . . . . 74.019999999999996 111.588 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 79.44 18.63 73.31 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-N 114.284 -1.325 . . . . 71.109999999999999 111.484 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.78 162.75 52.13 Favored Glycine 0 C--O 1.25 1.143 0 N-CA-C 111.783 -0.527 . . . . 75.409999999999997 111.783 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.61 98.97 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.892 -0.781 . . . . 75.329999999999998 108.892 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.457 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.64 -9.29 58.46 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.475 -0.89 . . . . 70.510000000000005 111.917 177.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -88.85 -29.19 19.86 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.596 -0.89 . . . . 74.239999999999995 108.596 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.595 ' NZ ' ' HA ' ' A' ' 361' ' ' LYS . 1.1 mmpm? -95.04 -57.65 2.37 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 113.13 0.789 . . . . 75.299999999999997 113.13 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -85.68 -43.05 13.75 Favored 'General case' 0 CA--C 1.457 -2.628 0 O-C-N 123.771 0.669 . . . . 72.109999999999999 110.647 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.56 ' O ' HD13 ' A' ' 320' ' ' ILE . . . -42.74 -25.5 0.33 Allowed Glycine 0 C--O 1.203 -1.79 0 N-CA-C 119.379 2.512 . . . . 73.310000000000002 119.379 -163.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.465 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.59 34.45 0.56 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 119.133 1.467 . . . . 73.129999999999995 111.265 -178.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . 0.566 HD11 ' N ' ' A' ' 366' ' ' GLN . 2.6 tm? -109.36 148.6 30.81 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.163 -1.38 . . . . 65.409999999999997 107.786 -170.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . 0.566 ' N ' HD11 ' A' ' 365' ' ' LEU . 0.0 OUTLIER -117.06 142.06 47.46 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.796 -0.446 . . . . 75.439999999999998 109.796 -178.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.76 121.3 8.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.111 -1.07 . . . . 64.299999999999997 108.111 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.35 -4.45 21.76 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 111.426 -0.67 . . . . 73.120000000000005 111.426 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.409 ' HB3' HG22 ' A' ' 402' ' ' VAL . 56.3 m-20 -75.63 136.28 40.45 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 113.193 0.812 . . . . 71.519999999999996 113.193 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 36.4 tttp -88.8 119.69 29.52 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 124.658 1.183 . . . . 74.209999999999994 111.135 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.41 124.84 32.46 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.885 -0.783 . . . . 75.329999999999998 108.885 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.466 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 5.3 tt -92.08 -40.16 11.22 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.336 -1.302 . . . . 74.219999999999999 107.965 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -159.86 160.94 34.27 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 116.017 -0.538 . . . . 71.319999999999993 111.733 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.55 117.33 27.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.413 -0.958 . . . . 74.25 108.413 171.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 58.54 36.17 25.04 Favored 'General case' 0 CA--C 1.485 -1.526 0 CA-C-O 123.4 1.571 . . . . 75.530000000000001 109.347 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 66.79 9.55 6.84 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 110.831 -2.895 . . . . 61.240000000000002 113.693 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.9 121.09 31.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.263 -1.754 . . . . 62.299999999999997 106.263 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.8 p -64.35 125.82 25.81 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 113.366 0.876 . . . . 74.409999999999997 113.366 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.1 mp -101.32 7.13 42.94 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.731 -1.122 . . . . 74.409999999999997 109.445 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.466 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 18.4 mm-40 -79.9 111.24 16.03 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.59 -1.186 . . . . 75.239999999999995 108.958 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 61.14 83.57 0.14 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.718 1.207 . . . . 72.329999999999998 112.232 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 19.7 m -153.58 165.21 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 125.563 1.545 . . . . 62.310000000000002 107.139 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.707 ' HB ' ' OE1' ' A' ' 386' ' ' GLU . 2.8 m -85.08 156.85 20.9 Favored 'General case' 0 C--O 1.258 1.539 0 N-CA-C 107.221 -1.4 . . . . 73.239999999999995 107.221 176.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . 0.523 ' O ' HG21 ' A' ' 388' ' ' VAL . 85.7 t60 -57.13 -40.73 77.7 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.303 0.573 . . . . 72.340000000000003 109.988 -170.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -54.68 -46.64 74.1 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 114.187 -1.37 . . . . 71.310000000000002 113.871 177.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.707 ' OE1' ' HB ' ' A' ' 383' ' ' THR . 1.8 mp0 -71.72 -32.14 67.45 Favored 'General case' 0 CA--C 1.476 -1.872 0 CA-C-N 118.711 0.687 . . . . 74.439999999999998 109.423 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.58 ' O ' HD11 ' A' ' 391' ' ' LEU . . . -64.46 -57.72 8.44 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 114.728 -1.124 . . . . 73.209999999999994 109.218 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.523 HG21 ' O ' ' A' ' 384' ' ' HIS . 21.7 t -61.35 -41.76 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 116.446 -0.343 . . . . 74.530000000000001 110.55 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 90.4 m -62.13 -34.35 76.2 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.071 -0.513 . . . . 64.530000000000001 111.433 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.08 80.05 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.522 -0.111 . . . . 71.5 110.859 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.58 HD11 ' O ' ' A' ' 387' ' ' ALA . 5.1 mp -79.66 -32.47 41.55 Favored 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 119.217 -0.993 . . . . 70.310000000000002 110.777 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -65.21 -35.41 80.97 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 112.663 0.616 . . . . 71.420000000000002 112.663 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -83.57 62.08 6.62 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.803 0.811 . . . . 74.400000000000006 110.926 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' THR . . . . . 0.414 ' HB ' HG21 ' A' ' 398' ' ' VAL . 41.9 p -132.28 149.52 52.35 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 107.526 -1.287 . . . . 73.340000000000003 107.526 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' SER . . . . . 0.429 ' HA ' ' HE3' ' A' ' 324' ' ' LYS . 34.9 p -141.96 100.99 3.85 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 118.461 -1.296 . . . . 72.329999999999998 112.578 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . 0.506 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 3.5 m-20 63.38 7.27 2.84 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 112.504 -2.135 . . . . 71.310000000000002 113.621 170.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -152.64 115.25 4.52 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 106.033 -1.84 . . . . 64.329999999999998 106.033 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 52.4 t -128.28 113.81 31.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 108.342 -0.984 . . . . 75.519999999999996 108.342 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -95.15 95.53 8.61 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.393 -1.336 . . . . 72.010000000000005 107.393 174.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.3 tt -89.97 139.02 31.01 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 116.147 -0.479 . . . . 72.319999999999993 109.748 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 40.6 tttp -126.84 111.7 14.48 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 108.403 -0.962 . . . . 73.25 108.403 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 369' ' ' ASP . 2.1 p -115.05 145.94 20.13 Favored 'Isoleucine or valine' 0 C--O 1.266 1.96 0 C-N-CA 123.732 0.813 . . . . 74.120000000000005 110.597 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.74 147.77 46.89 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 106.266 -1.753 . . . . 75.510000000000005 106.266 174.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.593 ' HE3' ' SD ' ' A' ' 318' ' ' MET . 0.0 OUTLIER -95.82 156.0 37.78 Favored Pre-proline 0 C--N 1.293 -1.881 0 C-N-CA 119.774 -0.77 . . . . 74.310000000000002 109.102 178.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -71.31 63.78 2.76 Favored 'Trans proline' 0 CA--C 1.549 1.237 0 C-N-CA 122.096 1.864 . . . . 73.010000000000005 114.011 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 26.7 m -85.32 88.19 7.47 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 107.755 -1.202 . . . . 75.519999999999996 107.755 177.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 134.96 -18.87 3.98 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 108.733 -1.747 . . . . 70.150000000000006 108.733 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 47.3 t -109.41 -169.61 1.51 Allowed 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 106.787 -1.56 . . . . 74.439999999999998 106.787 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -81.64 92.94 6.65 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.308 0.575 . . . . 61.039999999999999 111.11 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -95.08 142.04 28.0 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.628 -0.878 . . . . 75.450000000000003 108.628 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 . . . . . 0 C--N 1.296 -1.74 0 N-CA-C 103.598 -2.741 . . . . 75.310000000000002 103.598 -179.043 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.807 0 N-CA-C 108.101 -1.074 . . . . 74.209999999999994 108.101 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . 0.407 HH21 ' CD ' ' B' ' 148' ' ' GLU . 87.3 mtm-85 -92.76 20.61 6.32 Favored 'General case' 0 C--O 1.209 -1.045 0 O-C-N 123.398 0.436 . . . . 74.150000000000006 110.92 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 61.5 p -65.53 104.26 0.98 Allowed 'General case' 0 C--O 1.246 0.883 0 N-CA-C 109.331 -0.618 . . . . 74.030000000000001 109.331 -174.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . 0.492 ' HA ' ' HE ' ' B' ' 144' ' ' ARG . 0.3 OUTLIER -159.67 169.78 22.98 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 106.38 -1.711 . . . . 71.140000000000001 106.38 -174.147 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -85.05 154.27 22.19 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.625 -0.509 . . . . 70.329999999999998 109.625 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 66.02 13.29 9.0 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 125.748 1.619 . . . . 64.420000000000002 113.489 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . 0.424 ' C ' HD21 ' B' ' 147' ' ' ASN . 0.2 OUTLIER -143.96 170.54 15.73 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.634 -0.427 . . . . 72.319999999999993 110.521 179.349 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.407 ' CD ' HH21 ' B' ' 142' ' ' ARG . 0.0 OUTLIER -95.51 166.62 11.77 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.185 0.517 . . . . 74.400000000000006 111.8 -177.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 40.7 m -146.06 123.97 12.01 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.736 -0.665 . . . . 75.049999999999997 109.608 166.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -68.25 130.14 42.02 Favored 'General case' 0 C--O 1.257 1.468 0 N-CA-C 108.563 -0.903 . . . . 72.319999999999993 108.563 172.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.296 -1.726 0 CA-C-O 117.228 -1.368 . . . . 74.510000000000005 109.09 178.168 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 CA--C 1.485 -1.521 0 N-CA-C 106.309 -1.738 . . . . 75.439999999999998 106.309 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.477 2.0 pm0 -119.09 127.09 53.06 Favored 'General case' 0 N--CA 1.406 -2.641 0 N-CA-C 116.936 2.198 . . . . 65.310000000000002 116.936 -174.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.403 HG21 ' CD ' ' A' ' 364' ' ' LYS . 64.5 mt -102.54 106.17 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.623 0 CA-C-N 111.524 -2.58 . . . . 74.400000000000006 109.715 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.484 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 28.9 ttpt -80.81 110.72 16.59 Favored 'General case' 0 N--CA 1.41 -2.427 0 N-CA-C 106.319 -1.734 . . . . 75.209999999999994 106.319 170.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.435 ' HA ' ' OD2' ' A' ' 362' ' ' ASP . 0.6 OUTLIER -110.33 145.7 37.01 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 113.944 -1.48 . . . . 73.349999999999994 109.734 -171.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 39.0 mm -105.2 116.8 49.71 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-O 121.306 0.574 . . . . 75.310000000000002 110.606 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.589 ' HD2' ' N ' ' A' ' 396' ' ' ASP . 9.7 tmtt? -65.89 156.78 32.38 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.948 -1.024 . . . . 73.400000000000006 110.783 175.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -140.44 -165.97 10.5 Favored Glycine 0 C--N 1.303 -1.284 0 N-CA-C 110.748 -0.941 . . . . 73.209999999999994 110.748 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.91 -21.51 64.0 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 122.877 2.385 . . . . 71.409999999999997 112.59 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -91.61 -9.97 42.18 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.132 0.968 . . . . 74.230000000000004 110.449 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 97.42 -112.76 4.54 Favored Glycine 0 C--N 1.272 -3.014 0 N-CA-C 108.381 -1.887 . . . . 75.010000000000005 108.381 -171.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.13 -35.64 6.26 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 117.89 0.845 . . . . 70.129999999999995 109.589 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 84.48 50.72 4.14 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.841 -1.171 . . . . 72.420000000000002 114.903 175.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 54.4 p90 -155.07 163.04 40.83 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 117.146 0.473 . . . . 73.310000000000002 110.239 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 66.2 m -108.78 132.72 53.7 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 109.757 -0.46 . . . . 73.010000000000005 109.757 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 19.3 pt -122.84 149.6 26.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 109.863 -0.421 . . . . 70.120000000000005 109.863 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.7 129.3 16.04 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.537 -0.912 . . . . 74.329999999999998 108.537 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 165.1 -178.24 40.23 Favored Glycine 0 C--N 1.283 -2.393 0 N-CA-C 108.63 -1.788 . . . . 74.430000000000007 108.63 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.03 173.22 13.22 Favored Glycine 0 C--N 1.279 -2.592 0 N-CA-C 108.466 -1.853 . . . . 54.219999999999999 108.466 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 90.6 t -56.15 100.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 117.682 0.741 . . . . 74.329999999999998 110.623 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 88.33 -2.08 84.79 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.373 -0.83 . . . . 54.520000000000003 112.616 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.457 ' CG ' ' H ' ' B' ' 146' ' ' ARG . 63.2 t30 -109.02 3.55 22.23 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.575 0.702 . . . . 74.310000000000002 109.644 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER -61.39 127.29 30.76 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 115.042 1.497 . . . . 73.299999999999997 115.042 -174.299 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -66.67 -32.25 73.45 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.876 -1.511 . . . . 73.450000000000003 110.809 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 43.3 mm -104.64 114.61 63.83 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 116.319 -0.4 . . . . 74.340000000000003 110.033 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.23 111.19 0.78 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.888 2.392 . . . . 74.120000000000005 111.789 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.07 -22.98 20.09 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.84 -0.695 . . . . 65.239999999999995 111.607 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -112.39 106.97 15.61 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.175 -0.676 . . . . 71.109999999999999 109.175 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -85.22 63.04 7.87 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.502 0.668 . . . . 75.010000000000005 111.095 -173.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 0.461 ' HB2' ' CE1' ' A' ' 349' ' ' TYR . 7.2 m -119.06 177.68 4.78 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 119.588 -0.845 . . . . 73.140000000000001 111.861 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 26.0 mm -98.15 131.67 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 N-CA-C 106.052 -1.833 . . . . 71.310000000000002 106.052 176.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' A' ' 347' ' ' SER . 42.7 m-85 -123.72 132.55 53.85 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.574 0.583 . . . . 71.030000000000001 112.574 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.16 112.46 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.865 -1.062 . . . . 72.420000000000002 108.527 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.1 m -92.8 -28.69 16.41 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.458 0.647 . . . . 72.420000000000002 109.973 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 331' ' ' PHE . 54.3 tttm -155.89 153.57 29.87 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 108.249 -1.019 . . . . 72.319999999999993 108.249 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 86.9 mt -118.22 144.23 26.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 104.873 -2.269 . . . . 71.420000000000002 104.873 169.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 39.6 mm -79.92 129.68 37.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.69 -0.485 . . . . 74.329999999999998 109.69 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 355' ' ' GLU . 1.4 pm0 -63.78 105.02 0.75 Allowed 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.461 -1.245 . . . . 74.209999999999994 111.265 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.97 -2.35 63.9 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 114.521 -1.218 . . . . 74.299999999999997 112.387 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -69.99 172.04 41.15 Favored Glycine 0 C--O 1.244 0.76 0 O-C-N 123.697 0.293 . . . . 74.140000000000001 112.65 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -57.34 -44.12 84.02 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 122.976 0.511 . . . . 64.329999999999998 110.894 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.47 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.26 -9.87 58.94 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.726 0.639 . . . . 73.329999999999998 112.726 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -94.57 -24.3 17.29 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.19 -1.041 . . . . 75.239999999999995 108.19 177.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -89.93 -60.13 2.01 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-O 121.579 0.704 . . . . 73.430000000000007 110.054 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . 0.435 ' OD2' ' HA ' ' A' ' 322' ' ' LEU . 24.1 t70 -87.5 -44.66 11.13 Favored 'General case' 0 CA--C 1.46 -2.502 0 CA-C-N 114.588 -1.187 . . . . 72.409999999999997 111.485 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -42.82 -24.97 0.28 Allowed Glycine 0 CA--C 1.491 -1.46 0 N-CA-C 119.711 2.645 . . . . 75.200000000000003 119.711 -162.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.469 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 41.68 37.12 0.68 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 118.556 1.178 . . . . 74.430000000000007 111.34 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 39.8 tp -108.22 158.16 17.69 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.33 -1.304 . . . . 75.340000000000003 110.355 -169.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -121.26 143.66 49.04 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.646 0.736 . . . . 73.430000000000007 110.756 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.48 126.35 25.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.235 -1.395 . . . . 73.340000000000003 107.235 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.91 -1.36 30.19 Favored Glycine 0 C--N 1.302 -1.307 0 C-N-CA 120.574 -0.822 . . . . 73.010000000000005 111.965 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 5.1 m-20 -66.46 132.07 47.45 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 113.239 0.829 . . . . 65.129999999999995 113.239 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 39.9 tttp -92.19 114.28 26.79 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.68 1.192 . . . . 73.310000000000002 108.752 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 91.7 mt -85.14 116.38 23.47 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.533 -0.467 . . . . 72.519999999999996 110.224 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.1 tt -88.02 -39.13 14.91 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.999 -1.482 . . . . 74.400000000000006 106.999 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -166.95 156.0 10.47 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.648 -0.705 . . . . 75.549999999999997 110.204 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.81 122.74 39.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.968 -0.753 . . . . 75.25 108.968 173.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 60.89 35.32 19.29 Favored 'General case' 0 CA--C 1.482 -1.655 0 CA-C-O 123.713 1.72 . . . . 73.099999999999994 108.895 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 67.6 7.09 5.39 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 110.174 -3.194 . . . . 73.040000000000006 113.396 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 60.7 t -79.87 123.78 37.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 107.014 -1.476 . . . . 74.209999999999994 107.014 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.7 p -63.92 124.2 20.94 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.093 0.775 . . . . 71.510000000000005 113.093 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.74 -6.09 13.88 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.637 0.775 . . . . 70.120000000000005 110.216 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -72.58 105.07 4.08 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.337 -1.356 . . . . 73.329999999999998 107.337 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . 0.269 20.1 tt0 60.3 78.88 0.26 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.371 1.468 . . . . 73.209999999999994 113.829 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 30.5 m -147.04 175.15 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 107.592 -1.262 . . . . 72.409999999999997 107.592 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 75.0 p -81.06 155.22 26.43 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.442 -0.948 . . . . 64.299999999999997 108.442 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . 0.565 ' O ' HG22 ' A' ' 388' ' ' VAL . 8.6 t-160 -58.93 -41.26 86.91 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.226 -0.657 . . . . 74.239999999999995 109.226 -172.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -51.03 -44.94 61.13 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.659 -1.155 . . . . 72.519999999999996 113.492 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.2 -33.37 74.3 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.547 0.689 . . . . 75.409999999999997 109.268 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -74.08 -58.8 3.06 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.488 -1.233 . . . . 75.430000000000007 110.417 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 384' ' ' HIS . 15.7 t -58.31 -40.18 76.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 O-C-N 123.292 0.37 . . . . 63.310000000000002 110.314 -176.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 95.6 m -63.26 -36.81 84.9 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.298 -0.41 . . . . 72.030000000000001 110.751 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.57 -34.75 77.68 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.396 -0.19 . . . . 74.230000000000004 110.739 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.49 -32.49 60.58 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 120.67 -0.412 . . . . 74.439999999999998 110.704 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 57.7 mttm -72.99 -26.44 61.34 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 120.57 -0.452 . . . . 62.240000000000002 112.145 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -80.83 48.88 1.13 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.988 -0.551 . . . . 72.400000000000006 110.619 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' THR . . . . . 0.416 ' HB ' HG22 ' A' ' 398' ' ' VAL . 41.7 p -124.43 147.93 47.96 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.438 -0.579 . . . . 73.439999999999998 109.438 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 65.9 m -147.4 99.08 3.09 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 122.512 1.149 . . . . 70.209999999999994 112.003 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . 0.589 ' N ' ' HD2' ' A' ' 324' ' ' LYS . 8.4 m-20 65.26 13.02 8.5 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 111.195 -2.73 . . . . 73.549999999999997 113.218 168.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -165.72 129.08 2.16 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 106.863 -1.532 . . . . 74.099999999999994 106.863 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.416 HG22 ' HB ' ' A' ' 394' ' ' THR . 38.9 t -142.39 142.75 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 122.735 0.414 . . . . 73.329999999999998 110.361 -177.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . 0.484 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 13.0 m-85 -118.68 95.6 4.91 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.811 -0.811 . . . . 73.150000000000006 108.811 168.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.4 tt -93.7 121.3 34.99 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 123.383 0.673 . . . . 75.109999999999999 109.744 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -103.31 107.7 18.62 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.7 -0.852 . . . . 74.129999999999995 108.7 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 10.2 p -114.63 157.35 15.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 CA-C-N 114.815 -1.084 . . . . 72.209999999999994 110.194 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -135.98 158.6 44.01 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.868 -1.53 . . . . 71.420000000000002 106.868 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.47 ' HA ' ' HE2' ' A' ' 404' ' ' LYS . 10.9 mmpt? -79.91 153.46 75.17 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 108.54 -0.911 . . . . 75.019999999999996 108.54 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -57.09 129.46 34.5 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.315 2.01 . . . . 72.430000000000007 113.157 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 6.6 m -70.67 88.36 0.7 Allowed 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.591 -1.186 . . . . 75.109999999999999 110.83 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 167.74 -171.29 42.19 Favored Glycine 0 N--CA 1.41 -3.054 0 C-N-CA 120.392 -0.909 . . . . 64.140000000000001 110.982 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 28.6 t -81.12 -13.49 58.64 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.471 -0.566 . . . . 73.150000000000006 109.471 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -101.87 94.41 5.8 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.328 -1.36 . . . . 64.400000000000006 107.328 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -133.8 143.85 48.64 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 116.036 -0.529 . . . . 75.230000000000004 111.056 -178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 . . . . . 0 C--N 1.303 -1.44 0 N-CA-C 106.382 -1.71 . . . . 74.040000000000006 106.382 -178.905 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -0.989 0 N-CA-C 108.135 -1.061 . . . . 72.109999999999999 108.135 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 26.5 mtp-105 -100.19 -178.32 3.79 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.635 -1.246 . . . . 73.209999999999994 107.635 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.404 HG22 HG23 ' B' ' 149' ' ' THR . 72.7 p -53.59 152.06 5.41 Favored 'General case' 0 C--N 1.317 -0.815 0 O-C-N 124.715 1.259 . . . . 71.340000000000003 108.568 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -152.5 151.69 31.02 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 119.121 0.873 . . . . 74.319999999999993 113.333 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -85.34 156.14 21.03 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.422 -1.717 . . . . 75.5 112.238 177.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . 0.457 ' H ' ' CG ' ' A' ' 339' ' ' ASN 0.256 38.6 mtm-85 67.15 34.09 5.2 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 125.625 1.57 . . . . 74.209999999999994 112.152 -174.666 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -168.12 171.41 9.54 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 111.382 -2.645 . . . . 72.140000000000001 106.067 173.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.03 161.55 15.08 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 107.44 -1.318 . . . . 75.349999999999994 107.44 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.404 HG23 HG22 ' B' ' 143' ' ' THR . 32.9 m -142.42 104.01 4.34 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 108.353 -0.98 . . . . 72.209999999999994 108.353 170.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -60.11 132.19 53.17 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.183 -1.372 . . . . 71.109999999999999 110.899 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.442 ' HA ' ' NZ ' ' A' ' 392' ' ' LYS . 17.8 m . . . . . 0 C--O 1.262 1.75 0 CA-C-N 116.082 -0.508 . . . . 71.5 111.163 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 51.8 tpp . . . . . 0 CA--C 1.512 -0.503 0 N-CA-C 108.327 -0.99 . . . . 63.420000000000002 108.327 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.474 2.0 pm0 -117.67 128.67 55.14 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 116.744 2.127 . . . . 70.340000000000003 116.744 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.51 HG23 ' HZ2' ' A' ' 364' ' ' LYS . 70.8 mt -117.33 106.75 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 CA-C-N 111.74 -2.482 . . . . 75.409999999999997 109.793 -174.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 398' ' ' VAL . 40.7 ttmt -85.74 132.6 34.1 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.458 -1.312 . . . . 64.450000000000003 107.458 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.484 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 74.1 mt -129.02 152.12 48.97 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.02 -1.104 . . . . 74.120000000000005 108.02 178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 35.7 mm -106.2 112.34 39.01 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.589 0 N-CA-C 107.781 -1.192 . . . . 73.019999999999996 107.781 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.482 ' HB3' ' H ' ' A' ' 396' ' ' ASP . 0.0 OUTLIER -59.86 135.88 57.83 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 108.608 -0.886 . . . . 75.109999999999999 108.608 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . 0.433 ' N ' ' HD2' ' A' ' 324' ' ' LYS . . . -134.4 -161.12 9.43 Favored Glycine 0 C--N 1.287 -2.158 0 CA-C-N 116.281 -0.418 . . . . 43.219999999999999 113.008 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -62.08 -22.94 75.11 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 123.894 3.062 . . . . 71.109999999999999 114.033 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -109.03 18.06 21.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.255 0.55 . . . . 73.120000000000005 109.93 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.86 -119.19 4.86 Favored Glycine 0 CA--C 1.492 -1.379 0 N-CA-C 109.967 -1.253 . . . . 74.510000000000005 109.967 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.27 -30.5 8.69 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.55 -1.278 . . . . 64.530000000000001 107.55 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.12 50.2 4.19 Favored Glycine 0 N--CA 1.432 -1.57 0 CA-C-N 114.532 -1.213 . . . . 75.329999999999998 115.403 171.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -154.88 159.87 40.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 117.061 0.43 . . . . 74.209999999999994 110.797 172.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.52 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 5.8 m -110.07 127.92 55.13 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 109.139 -0.689 . . . . 73.409999999999997 109.139 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 10.1 pt -117.72 154.15 19.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 122.495 0.318 . . . . 75.349999999999994 111.02 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.62 120.38 7.56 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.774 -1.565 . . . . 73.400000000000006 106.774 174.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 156.97 154.52 7.08 Favored Glycine 0 C--N 1.293 -1.831 0 N-CA-C 110.829 -0.908 . . . . 63.229999999999997 110.829 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.55 -177.27 19.36 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 108.484 -1.846 . . . . 60.109999999999999 108.484 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 86.1 t -53.52 108.53 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 117.972 0.886 . . . . 74.140000000000001 111.245 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 88.83 -16.99 53.26 Favored Glycine 0 C--O 1.219 -0.813 0 CA-C-N 115.271 -0.877 . . . . 74.430000000000007 112.419 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.48 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -107.27 9.61 30.01 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.913 -0.773 . . . . 74.010000000000005 108.913 -178.154 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.97 126.26 13.88 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 123.557 0.743 . . . . 70.25 112.26 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -82.34 -45.26 15.13 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.09 -0.959 . . . . 72.040000000000006 110.107 -173.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.7 122.11 45.87 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 108.246 -1.02 . . . . 75.310000000000002 108.246 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.81 105.16 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 123.156 2.571 . . . . 73.129999999999995 112.607 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.82 -6.25 29.37 Favored Glycine 0 N--CA 1.431 -1.64 0 CA-C-N 115.352 -0.84 . . . . 60.229999999999997 112.099 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -127.19 98.92 5.46 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.478 -0.934 . . . . 52.32 108.478 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -82.4 33.63 0.41 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.991 -1.004 . . . . 72.219999999999999 111.827 -170.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 66.7 m -100.35 173.25 6.68 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.807 -0.633 . . . . 74.030000000000001 112.033 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.3 mm -86.27 129.64 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 107.574 -1.269 . . . . 74.439999999999998 107.574 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 27.1 m-85 -123.78 139.48 53.94 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-N 118.384 0.538 . . . . 71.239999999999995 111.572 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 45.3 t -77.04 115.37 18.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.547 -0.751 . . . . 72.549999999999997 109.514 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 24.8 m -91.45 -28.91 17.33 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.973 -0.558 . . . . 70.420000000000002 110.263 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 85.0 mttt -152.52 160.39 43.23 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 109.268 -0.641 . . . . 72.120000000000005 109.268 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 80.0 mt -125.34 135.02 65.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 106.198 -1.779 . . . . 72.150000000000006 106.198 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 44.3 mm -85.27 137.54 20.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 C-N-CA 122.429 0.292 . . . . 71.340000000000003 111.159 -173.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.97 127.84 32.35 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.709 0.766 . . . . 72.140000000000001 112.795 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 70.18 9.86 64.57 Favored Glycine 0 C--N 1.315 -0.626 0 CA-C-N 115.558 -0.746 . . . . 74.129999999999995 112.706 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -74.74 160.63 53.02 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 110.836 -0.906 . . . . 72.140000000000001 110.836 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -59.69 -42.02 92.04 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 109.733 -0.469 . . . . 75.109999999999999 109.733 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.552 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -72.3 -10.67 60.08 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.172 -0.611 . . . . 75.439999999999998 112.431 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -93.99 -29.58 15.17 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.635 -0.876 . . . . 61.43 108.635 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -94.17 -60.49 1.72 Allowed 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 122.955 1.359 . . . . 72.030000000000001 110.398 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -87.45 -25.66 23.64 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 112.47 -2.15 . . . . 74.219999999999999 110.467 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -44.11 -50.34 7.69 Favored Glycine 0 C--N 1.273 -2.967 0 N-CA-C 120.301 2.88 . . . . 65.109999999999999 120.301 -170.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 363' ' ' GLY 0.256 0.0 OUTLIER 47.99 31.29 2.34 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.383 1.592 . . . . 72.030000000000001 110.973 -164.521 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 9.8 tt -112.03 150.12 31.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.027 -0.988 . . . . 73.219999999999999 109.202 -170.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -122.21 152.43 40.0 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.294 0.569 . . . . 75.299999999999997 111.076 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 75.4 mt -65.96 129.26 30.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 107.0 -1.481 . . . . 74.329999999999998 107.0 170.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 107.72 3.34 34.63 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.471 -0.871 . . . . 62.030000000000001 112.172 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.495 ' CG ' ' HZ3' ' A' ' 404' ' ' LYS . 1.4 m-20 -72.89 128.52 35.74 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.261 0.837 . . . . 73.310000000000002 113.261 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 42.1 tttp -92.78 114.52 27.1 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.788 1.235 . . . . 75.540000000000006 109.492 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.43 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 85.8 mt -80.53 111.92 17.4 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 120.961 0.41 . . . . 75.230000000000004 110.082 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.2 tt -86.75 -39.41 15.99 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.491 -1.231 . . . . 75.030000000000001 107.694 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.55 155.69 17.6 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.772 -0.649 . . . . 74.129999999999995 110.677 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.5 p -133.4 122.36 44.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.116 -1.068 . . . . 74.530000000000001 108.116 173.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 62.26 30.52 17.57 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-O 123.873 1.797 . . . . 52.43 108.445 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.8 t30 66.32 16.89 10.58 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 109.831 -3.35 . . . . 64.319999999999993 112.556 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.95 125.28 40.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 106.557 -1.646 . . . . 74.129999999999995 106.557 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.1 p -61.62 123.3 17.53 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 113.557 0.947 . . . . 73.409999999999997 113.557 -175.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.28 -2.51 20.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.309 -0.86 . . . . 75.400000000000006 110.941 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -66.84 106.83 1.99 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.752 -0.658 . . . . 75.420000000000002 109.396 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 63.97 74.36 0.41 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 122.643 1.211 . . . . 74.519999999999996 113.591 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 21.4 m -137.29 169.5 19.37 Favored 'Isoleucine or valine' 0 C--O 1.249 1.03 0 N-CA-C 105.913 -1.884 . . . . 73.439999999999998 105.913 174.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.513 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 50.5 p -78.66 138.71 38.43 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.274 -0.97 . . . . 74.340000000000003 108.998 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . 0.584 ' O ' HG22 ' A' ' 388' ' ' VAL . 85.8 t60 -47.49 -51.06 21.69 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.31 0.855 . . . . 74.530000000000001 113.31 -173.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.635 ' OE1' ' HA ' ' B' ' 144' ' ' ARG . 19.5 tt0 -65.04 -29.61 70.52 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.484 0.659 . . . . 74.25 110.663 -175.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.513 ' HB3' ' O ' ' A' ' 383' ' ' THR . 49.8 tt0 -72.87 -39.11 66.73 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.367 -0.975 . . . . 72.510000000000005 108.367 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.462 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -67.59 -46.52 72.36 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.759 -1.109 . . . . 70.200000000000003 109.96 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 384' ' ' HIS . 24.8 t -57.87 -43.55 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 109.681 -0.489 . . . . 51.399999999999999 109.681 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 85.0 m -57.95 -38.14 75.45 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 123.49 0.494 . . . . 74.519999999999996 110.681 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.05 -33.37 75.89 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.193 -0.317 . . . . 70.140000000000001 110.959 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.7 mp -81.73 -26.58 34.44 Favored 'General case' 0 C--O 1.211 -0.949 0 C-N-CA 120.494 -0.482 . . . . 62.509999999999998 111.28 176.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.429 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 62.2 mttm -75.82 -27.33 57.86 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.698 -0.401 . . . . 75.120000000000005 111.968 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -80.27 43.67 0.64 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.844 -0.616 . . . . 74.049999999999997 110.623 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 77.4 p -124.19 144.03 50.17 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.813 -0.81 . . . . 72.099999999999994 108.813 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' SER . . . . . 0.463 ' HA ' ' HE3' ' A' ' 324' ' ' LYS . 65.4 m -146.02 116.92 7.73 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.568 0.699 . . . . 74.5 111.095 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . 0.482 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 3.3 m-20 55.77 14.52 1.33 Allowed 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 127.882 2.473 . . . . 75.340000000000003 114.903 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -163.17 126.15 2.71 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.452 -1.314 . . . . 73.340000000000003 107.452 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 321' ' ' LYS . 46.8 t -138.46 124.0 23.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.271 -1.011 . . . . 75.129999999999995 108.271 177.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -106.43 95.9 6.08 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.948 -1.871 . . . . 63.32 105.948 173.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.452 ' CD2' ' HB ' ' A' ' 402' ' ' VAL . 7.6 tt -95.14 114.58 26.39 Favored 'General case' 0 C--N 1.258 -3.374 0 N-CA-C 109.051 -0.722 . . . . 73.239999999999995 109.051 -176.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -99.58 108.66 21.11 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.795 -1.557 . . . . 72.150000000000006 106.795 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 369' ' ' ASP . 10.3 p -115.73 162.2 13.93 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.753 0 N-CA-C 108.223 -1.028 . . . . 74.019999999999996 108.223 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.9 148.83 47.26 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.58 -0.896 . . . . 73.450000000000003 108.58 173.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.495 ' HZ3' ' CG ' ' A' ' 369' ' ' ASP . 10.7 mmpt? -64.57 157.27 74.07 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 108.276 -1.009 . . . . 73.420000000000002 108.276 169.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 407' ' ' GLY . 7.7 Cg_exo -65.7 133.13 32.97 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 121.852 1.701 . . . . 74.150000000000006 112.814 -170.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 1.2 m -62.26 5.01 0.11 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 125.929 1.692 . . . . 71.409999999999997 113.775 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 405' ' ' PRO . . . -95.19 12.76 67.88 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 110.178 -1.169 . . . . 71.209999999999994 110.178 176.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 22.7 t -163.66 -164.73 0.94 Allowed 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 105.823 -1.917 . . . . 74.430000000000007 105.823 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -72.36 103.08 3.32 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.985 0.422 . . . . 74.230000000000004 110.532 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -71.31 137.65 48.68 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.457 -0.792 . . . . 72.340000000000003 110.465 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 78.5 m80 . . . . . 0 C--N 1.3 -1.563 0 N-CA-C 106.593 -1.632 . . . . 74.549999999999997 106.593 -179.136 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.711 0 N-CA-C 106.791 -1.559 . . . . 74.299999999999997 106.791 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -87.97 -6.33 58.07 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 118.415 0.552 . . . . 73.420000000000002 111.778 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.468 ' HA ' ' CG2' ' B' ' 149' ' ' THR . 0.9 OUTLIER -119.52 118.44 31.06 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 123.502 0.501 . . . . 75.319999999999993 111.038 176.27 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . 0.635 ' HA ' ' OE1' ' A' ' 385' ' ' GLU . 1.2 mmp_? -157.12 157.76 35.09 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.794 1.238 . . . . 74.209999999999994 108.554 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -85.9 155.18 21.04 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 116.049 -0.523 . . . . 74.420000000000002 111.063 174.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 67.2 32.2 6.21 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.441 1.496 . . . . 75.519999999999996 112.753 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -160.49 178.47 9.51 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-N 113.558 -1.655 . . . . 71.040000000000006 107.558 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.48 ' CD ' ' HZ2' ' A' ' 352' ' ' LYS . 11.3 pt-20 -89.28 144.85 25.78 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.29 -1.004 . . . . 63.109999999999999 108.29 176.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.468 ' CG2' ' HA ' ' B' ' 143' ' ' THR . 16.9 m -134.41 135.2 42.42 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 116.233 -0.44 . . . . 74.319999999999993 111.628 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -85.86 130.51 34.53 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-N 116.001 -0.545 . . . . 74.420000000000002 110.472 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.293 -1.861 0 CA-C-N 116.289 -0.414 . . . . 74.420000000000002 110.05 171.508 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 C--O 1.21 -1.016 0 N-CA-C 108.04 -1.096 . . . . 63.119999999999997 108.04 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.336 1.8 pm0 -103.45 131.86 50.2 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-O 123.012 1.387 . . . . 72.530000000000001 114.411 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 78.3 mt -113.93 106.49 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.97 0 CA-C-N 111.987 -2.37 . . . . 74.140000000000001 110.35 -172.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -85.55 105.9 16.48 Favored 'General case' 0 N--CA 1.402 -2.854 0 N-CA-C 104.324 -2.472 . . . . 75.209999999999994 104.324 170.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 359' ' ' ALA . 0.4 OUTLIER -106.5 144.59 32.96 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 113.802 -1.545 . . . . 75.120000000000005 109.299 -171.349 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.1 mp -98.34 111.24 27.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 108.75 -0.833 . . . . 75.0 108.75 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -76.32 149.91 36.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.489 -0.778 . . . . 75.530000000000001 109.979 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -141.2 -160.07 8.16 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.466 -0.874 . . . . 62.039999999999999 112.23 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.35 -12.77 34.43 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.334 2.69 . . . . 72.549999999999997 113.362 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -102.35 8.72 40.18 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.302 -0.629 . . . . 74.129999999999995 109.302 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.74 -128.2 8.45 Favored Glycine 0 CA--C 1.477 -2.338 0 N-CA-C 108.764 -1.735 . . . . 53.399999999999999 108.764 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.5 mp -98.52 -39.16 8.87 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.582 -2.007 . . . . 72.409999999999997 105.582 172.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.36 56.03 2.48 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 114.776 -1.102 . . . . 72.109999999999999 114.154 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -154.39 158.98 40.85 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.104 -0.702 . . . . 75.0 109.104 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 10.9 m -107.32 128.82 54.79 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.165 -1.05 . . . . 74.299999999999997 108.165 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 25.2 pt -114.71 151.87 16.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 109.998 -0.371 . . . . 74.319999999999993 109.998 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -147.57 121.86 9.61 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.147 -1.427 . . . . 72.329999999999998 107.147 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 154.71 163.19 11.77 Favored Glycine 0 C--N 1.282 -2.437 0 N-CA-C 110.784 -0.926 . . . . 75.150000000000006 110.784 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.58 -174.16 21.14 Favored Glycine 0 CA--C 1.479 -2.195 0 N-CA-C 108.069 -2.012 . . . . 54.140000000000001 108.069 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.43 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 68.3 t -54.08 103.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 117.545 0.672 . . . . 75.0 110.921 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 82.33 -7.79 63.27 Favored Glycine 0 C--O 1.217 -0.934 0 CA-C-N 115.419 -0.81 . . . . 73.310000000000002 112.98 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.36 0.06 26.62 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.206 -1.035 . . . . 75.430000000000007 108.206 -178.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.78 140.38 14.96 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 115.642 1.719 . . . . 74.010000000000005 115.642 -174.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -85.42 -33.64 21.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.439 -1.255 . . . . 73.430000000000007 109.078 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.406 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 46.4 mm -104.81 122.7 42.5 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.67 -0.695 . . . . 74.329999999999998 109.716 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.82 108.52 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.543 2.162 . . . . 62.219999999999999 111.412 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.29 -19.3 24.73 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.57 -0.824 . . . . 74.209999999999994 112.092 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 19.4 t70 -114.79 99.96 7.88 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.861 -1.163 . . . . 74.129999999999995 107.861 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' A' ' 337' ' ' VAL . 59.3 t30 -80.97 33.09 0.32 Allowed 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 124.018 0.927 . . . . 71.040000000000006 112.437 -169.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 68.1 m -100.01 176.97 5.24 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.772 0.656 . . . . 73.420000000000002 112.772 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.5 mm -92.2 132.66 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 107.513 -1.291 . . . . 73.209999999999994 107.513 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 32.9 m-85 -124.1 137.49 54.56 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 112.62 0.6 . . . . 74.230000000000004 112.62 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 49.9 t -70.59 117.59 13.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 115.159 -0.928 . . . . 72.310000000000002 108.606 176.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.0 m -97.26 -29.87 13.3 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.515 0.674 . . . . 72.400000000000006 110.248 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -155.39 152.36 28.98 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 107.285 -1.376 . . . . 74.409999999999997 107.285 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 80.3 mt -121.42 109.56 25.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 106.357 -1.72 . . . . 70.209999999999994 106.357 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 41.7 mm -52.21 133.73 14.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 O-C-N 124.711 1.257 . . . . 74.409999999999997 112.221 -171.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.1 pm0 -55.2 114.51 1.81 Allowed 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 125.361 1.464 . . . . 74.239999999999995 111.833 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 72.67 22.78 78.81 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 114.351 -1.295 . . . . 51.420000000000002 111.781 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.33 164.36 53.44 Favored Glycine 0 C--O 1.254 1.363 0 N-CA-C 111.466 -0.654 . . . . 74.540000000000006 111.466 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.13 96.46 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.983 -0.747 . . . . 64.219999999999999 108.983 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.472 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.69 -11.03 59.92 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.986 -0.552 . . . . 73.519999999999996 112.067 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -86.52 -30.52 21.88 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.711 -1.218 . . . . 74.510000000000005 107.711 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.58 ' NZ ' ' HA ' ' A' ' 361' ' ' LYS . 1.2 mmpm? -95.52 -57.82 2.29 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.657 0.984 . . . . 75.230000000000004 113.657 176.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -85.41 -39.2 17.83 Favored 'General case' 0 CA--C 1.467 -2.25 0 C-N-CA 123.542 0.737 . . . . 64.299999999999997 111.164 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -42.68 -23.95 0.21 Allowed Glycine 0 C--N 1.3 -1.421 0 N-CA-C 119.316 2.486 . . . . 73.450000000000003 119.316 -166.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.463 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.4 38.3 1.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 118.576 1.188 . . . . 75.0 111.241 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 55.8 tp -112.86 157.59 21.23 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.25 -1.341 . . . . 74.420000000000002 110.099 -170.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -120.41 143.74 48.3 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 121.524 0.678 . . . . 73.519999999999996 111.174 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.6 125.16 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 107.116 -1.439 . . . . 75.219999999999999 107.116 169.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.75 1.19 32.31 Favored Glycine 0 C--N 1.309 -0.935 0 C-N-CA 120.567 -0.825 . . . . 71.439999999999998 112.183 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 71.6 m-20 -75.49 138.27 41.47 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 112.698 0.629 . . . . 73.109999999999999 112.698 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.559 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 45.2 tttp -94.27 115.32 27.55 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.154 1.381 . . . . 75.319999999999993 108.994 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 95.7 mt -79.86 111.24 16.0 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.951 0.405 . . . . 71.400000000000006 109.999 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 403' ' ' ALA . 4.0 tt -83.09 -40.09 20.29 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.71 -1.589 . . . . 74.450000000000003 106.71 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.25 157.38 25.51 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.163 -0.926 . . . . 62.0 109.639 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . 0.454 HG11 ' HG ' ' A' ' 391' ' ' LEU . 7.6 p -147.31 137.27 16.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.59 -0.893 . . . . 75.319999999999993 108.59 173.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 59.51 38.38 22.47 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 108.066 -1.087 . . . . 73.209999999999994 108.066 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.03 -8.06 0.45 Allowed 'General case' 0 CA--C 1.57 1.723 0 C-N-CA 125.846 1.658 . . . . 54.43 113.278 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.32 130.65 35.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.981 -0.748 . . . . 74.140000000000001 108.981 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.0 p -72.21 129.68 39.03 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 122.756 0.423 . . . . 73.230000000000004 111.35 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.38 -3.7 16.91 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.766 0.654 . . . . 73.319999999999993 112.766 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -65.23 107.19 1.51 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.588 -0.523 . . . . 73.109999999999999 109.588 174.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 63.67 72.33 0.47 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 122.742 1.258 . . . . 54.25 113.359 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.59 164.35 31.15 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 N-CA-C 105.764 -1.939 . . . . 75.349999999999994 105.764 173.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.67 ' HB ' ' OE1' ' A' ' 386' ' ' GLU . 1.4 m -82.81 146.43 28.94 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.406 -1.331 . . . . 72.409999999999997 107.406 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . 0.607 ' O ' HG22 ' A' ' 388' ' ' VAL . 67.9 t60 -51.05 -32.73 22.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.526 -0.761 . . . . 75.510000000000005 112.961 -173.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.456 ' OE1' ' HA ' ' B' ' 144' ' ' ARG . 7.3 tp10 -65.08 -42.66 93.89 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.519 -0.549 . . . . 75.25 109.519 -177.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.67 ' OE1' ' HB ' ' A' ' 383' ' ' THR . 1.8 mp0 -73.22 -32.46 64.77 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 108.864 -0.791 . . . . 63.100000000000001 108.864 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.507 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -62.32 -53.88 48.66 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.709 -1.132 . . . . 72.540000000000006 109.251 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 384' ' ' HIS . 33.2 t -57.34 -44.19 83.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 N-CA-C 109.746 -0.465 . . . . 72.519999999999996 109.746 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 80.6 m -57.51 -41.11 80.15 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 116.065 -0.516 . . . . 73.25 111.035 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -63.36 -38.04 89.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.729 0.3 . . . . 74.200000000000003 110.844 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.6 mp -76.47 -21.3 56.04 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 120.23 -0.588 . . . . 74.420000000000002 110.978 176.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.476 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 54.5 mttm -83.95 -27.27 28.62 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 113.474 0.916 . . . . 74.010000000000005 113.474 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -76.11 35.15 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.075 0.95 . . . . 73.219999999999999 112.681 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 8.1 p -124.76 161.05 27.25 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 122.899 0.48 . . . . 75.340000000000003 110.028 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 24.9 p -160.53 125.86 3.88 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.325 -0.62 . . . . 72.409999999999997 109.325 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 61.69 0.14 0.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 125.92 1.688 . . . . 75.450000000000003 113.757 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -168.12 137.49 2.49 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.589 -0.893 . . . . 75.310000000000002 108.589 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 62.1 t -136.66 125.71 36.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.614 -1.254 . . . . 72.329999999999998 107.614 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -101.21 95.59 6.63 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.144 -2.169 . . . . 74.140000000000001 105.144 173.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.3 tt -101.02 140.78 34.84 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 109.46 -0.57 . . . . 71.530000000000001 109.46 -176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -128.11 113.09 15.3 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.85 -0.426 . . . . 74.439999999999998 109.85 -175.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 54.1 t -105.19 145.26 13.7 Favored 'Isoleucine or valine' 0 C--O 1.269 2.12 0 C-N-CA 124.256 1.022 . . . . 73.140000000000001 111.03 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.559 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -117.17 156.39 27.75 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 104.618 -2.364 . . . . 63.520000000000003 104.618 169.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 410' ' ' HIS . 7.7 mmpt? -84.98 151.97 58.26 Favored Pre-proline 0 C--N 1.285 -2.228 0 C-N-CA 118.677 -1.209 . . . . 74.140000000000001 107.991 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.95 111.72 0.82 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.866 2.377 . . . . 63.219999999999999 112.111 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 6.9 m -87.98 -10.32 50.77 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.563 -0.744 . . . . 75.5 111.031 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.52 16.57 37.49 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 120.129 -1.034 . . . . 72.310000000000002 112.816 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 64.2 m -160.17 -179.42 7.73 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.982 -1.118 . . . . 74.310000000000002 107.982 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -76.67 124.84 28.25 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.82 -1.548 . . . . 74.019999999999996 106.82 176.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 404' ' ' LYS . 30.2 p80 -95.74 146.05 24.83 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 120.971 -0.291 . . . . 65.319999999999993 111.63 -176.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 . . . . . 0 N--CA 1.419 -2.023 0 N-CA-C 104.389 -2.448 . . . . 74.340000000000003 104.389 166.955 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.453 -2.788 0 N-CA-C 108.47 -0.937 . . . . 72.219999999999999 108.47 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -91.63 131.69 36.85 Favored 'General case' 0 N--CA 1.394 -3.233 0 O-C-N 125.148 1.53 . . . . 75.319999999999993 108.753 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.532 ' O ' ' HG2' ' B' ' 144' ' ' ARG . 40.2 p -116.53 156.01 27.66 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.821 -1.177 . . . . 75.400000000000006 107.821 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' B' ' 143' ' ' THR . 6.7 mmp_? 175.37 164.86 0.31 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 127.725 2.41 . . . . 72.349999999999994 108.051 172.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -86.26 171.77 10.99 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 123.565 0.541 . . . . 75.200000000000003 111.069 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 65.81 18.47 11.14 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.344 1.858 . . . . 73.299999999999997 113.669 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . 0.465 ' C ' HD21 ' B' ' 147' ' ' ASN . 0.2 OUTLIER -152.32 178.27 9.69 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-N 116.026 -0.534 . . . . 71.030000000000001 109.62 -179.16 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -90.4 146.27 24.29 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.996 -0.742 . . . . 71.420000000000002 108.996 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 88.9 m -134.64 138.03 44.14 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.91 -0.587 . . . . 71.129999999999995 110.16 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -83.66 132.81 34.85 Favored 'General case' 0 C--O 1.254 1.319 0 N-CA-C 109.801 -0.444 . . . . 73.340000000000003 109.801 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.296 -1.742 0 CA-C-O 116.767 -1.587 . . . . 75.239999999999995 112.63 -179.477 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' MET . . . . . 0.515 ' SD ' ' HE3' ' A' ' 404' ' ' LYS . 26.1 ttt . . . . . 0 CA--C 1.495 -1.156 0 N-CA-C 106.941 -1.503 . . . . 75.239999999999995 106.941 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.339 2.0 pm0 -115.58 132.17 56.71 Favored 'General case' 0 N--CA 1.408 -2.562 0 N-CA-C 115.013 1.486 . . . . 64.299999999999997 115.013 -175.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.599 HD13 ' O ' ' A' ' 363' ' ' GLY . 58.6 mt -116.63 111.75 36.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.351 0 CA-C-N 112.402 -2.181 . . . . 71.040000000000006 107.966 -173.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -82.71 110.5 17.81 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.207 -1.034 . . . . 64.219999999999999 108.207 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 92.6 mt -111.02 156.32 21.44 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.54 0.525 . . . . 72.340000000000003 110.327 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.6 mp -105.04 115.4 46.84 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 107.925 -1.139 . . . . 72.519999999999996 107.925 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 394' ' ' THR . 22.7 tptm -68.57 122.16 17.91 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.485 -0.78 . . . . 65.329999999999998 109.318 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -133.55 -154.42 7.39 Favored Glycine 0 C--N 1.306 -1.104 0 C-N-CA 120.61 -0.805 . . . . 74.219999999999999 113.274 -173.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.85 -40.3 39.56 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 124.79 3.66 . . . . 71.420000000000002 115.49 -175.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -109.09 16.48 22.51 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.248 0.547 . . . . 75.200000000000003 110.044 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.41 -118.22 4.6 Favored Glycine 0 N--CA 1.424 -2.124 0 CA-C-N 114.892 -1.049 . . . . 63.210000000000001 110.983 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.0 mp -96.02 -30.32 13.64 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.565 -1.272 . . . . 72.230000000000004 107.565 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.49 44.93 5.98 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 114.853 -1.067 . . . . 45.399999999999999 114.487 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . 0.4 ' HA ' ' H ' ' A' ' 354' ' ' ILE . 50.7 p90 -152.43 156.7 40.0 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.823 -0.806 . . . . 71.340000000000003 108.823 172.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 46.3 m -113.66 136.66 52.59 Favored 'General case' 0 C--N 1.282 -2.348 0 O-C-N 123.663 0.602 . . . . 75.239999999999995 110.829 -175.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 20.2 pt -120.26 149.6 23.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.409 -0.814 . . . . 72.209999999999994 112.435 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -145.15 114.59 7.15 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.285 -1.746 . . . . 61.240000000000002 106.285 174.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 164.19 164.18 18.83 Favored Glycine 0 C--N 1.285 -2.291 0 N-CA-C 109.015 -1.634 . . . . 74.340000000000003 109.015 -178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.01 178.93 15.94 Favored Glycine 0 CA--C 1.479 -2.214 0 N-CA-C 108.113 -1.995 . . . . 62.420000000000002 108.113 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 88.8 t -53.23 108.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 117.766 0.783 . . . . 73.230000000000004 110.738 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.65 -23.64 33.1 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.269 -0.878 . . . . 72.439999999999998 112.509 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.615 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 58.8 t30 -105.91 18.63 21.82 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.696 -0.483 . . . . 74.430000000000007 109.696 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.89 123.88 10.07 Favored 'General case' 0 C--O 1.257 1.476 0 C-N-CA 123.553 0.741 . . . . 73.040000000000006 110.518 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -81.4 -40.1 23.96 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.146 -0.934 . . . . 74.099999999999994 109.977 -176.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 35.9 mm -103.65 126.11 32.9 Favored Pre-proline 0 C--N 1.309 -1.176 0 N-CA-C 109.2 -0.667 . . . . 72.349999999999994 109.2 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.14 102.73 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 123.108 2.539 . . . . 73.030000000000001 112.66 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.71 -7.2 29.75 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.828 -0.624 . . . . 75.200000000000003 112.033 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.422 ' CG ' ' HH ' ' A' ' 349' ' ' TYR . 13.2 t70 -123.92 96.84 5.1 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.049 -1.093 . . . . 74.129999999999995 108.049 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -83.03 36.92 0.52 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.587 -1.188 . . . . 72.109999999999999 112.08 -169.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 74.7 m -99.47 178.11 4.97 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.675 -0.693 . . . . 71.450000000000003 112.11 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.455 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 11.0 mm -88.72 131.6 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 107.899 -1.149 . . . . 73.340000000000003 107.899 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 26.8 m-85 -124.12 138.06 54.48 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 113.507 0.929 . . . . 65.420000000000002 113.507 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.1 t -71.14 115.54 11.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 114.787 -1.097 . . . . 72.129999999999995 108.48 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 22.6 m -100.56 -25.98 13.99 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.4 0.619 . . . . 73.349999999999994 110.848 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.89 142.25 22.49 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.229 -1.397 . . . . 74.120000000000005 107.229 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 74.3 mt -109.64 107.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 106.023 -1.843 . . . . 73.420000000000002 106.023 172.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.4 ' H ' ' HA ' ' A' ' 331' ' ' PHE . 46.4 mm -57.9 127.22 16.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 O-C-N 124.478 1.111 . . . . 65.230000000000004 112.585 -170.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.538 ' CD ' ' H ' ' A' ' 355' ' ' GLU . 1.1 pm0 -57.12 117.67 4.26 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 113.314 -1.766 . . . . 72.239999999999995 111.053 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 90.01 5.31 70.85 Favored Glycine 0 C--O 1.22 -0.747 0 CA-C-N 115.02 -0.991 . . . . 73.209999999999994 111.96 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.3 158.08 48.82 Favored Glycine 0 C--O 1.255 1.443 0 C-N-CA 121.548 -0.358 . . . . 74.239999999999995 112.808 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.88 -40.1 95.75 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.972 -0.751 . . . . 74.439999999999998 108.972 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.465 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.44 -9.82 58.91 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.9 -0.591 . . . . 52.420000000000002 111.504 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -87.22 -30.43 20.97 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.315 -0.995 . . . . 65.430000000000007 108.315 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.463 ' HA ' ' CE ' ' A' ' 361' ' ' LYS . 0.0 OUTLIER -95.83 -57.23 2.42 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 114.101 1.148 . . . . 74.409999999999997 114.101 176.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -85.2 -39.45 17.8 Favored 'General case' 0 CA--C 1.462 -2.414 0 O-C-N 123.58 0.55 . . . . 64.239999999999995 110.604 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.599 ' O ' HD13 ' A' ' 320' ' ' ILE . . . -42.72 -23.14 0.17 Allowed Glycine 0 C--O 1.199 -2.037 0 N-CA-C 119.199 2.44 . . . . 71.030000000000001 119.199 -164.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.463 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 43.68 32.22 0.54 Allowed 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 119.135 1.467 . . . . 75.439999999999998 111.872 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 43.9 tp -105.01 153.5 21.37 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 125.184 1.393 . . . . 75.310000000000002 109.246 -171.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -116.95 146.07 43.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.065 0.459 . . . . 74.049999999999997 111.224 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 74.9 mt -66.54 124.21 21.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.719 -1.215 . . . . 70.099999999999994 107.719 170.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.65 1.19 30.73 Favored Glycine 0 C--N 1.312 -0.774 0 N-CA-C 111.175 -0.77 . . . . 65.219999999999999 111.175 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 73.2 m-20 -75.71 138.75 41.5 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.981 1.104 . . . . 74.209999999999994 113.981 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.628 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 40.8 tttp -94.2 115.83 28.15 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.499 1.52 . . . . 73.109999999999999 110.043 -177.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 96.5 mt -80.28 112.61 17.77 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.954 -0.758 . . . . 72.030000000000001 108.954 176.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.4 tt -83.88 -37.57 22.24 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.952 -1.499 . . . . 63.119999999999997 106.952 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -162.68 158.0 22.55 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.568 -0.742 . . . . 75.340000000000003 111.186 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.8 p -133.82 125.45 49.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.629 -1.249 . . . . 75.540000000000006 107.629 171.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 59.55 36.62 22.86 Favored 'General case' 0 CA--C 1.47 -2.119 0 CA-C-O 124.287 1.994 . . . . 64.400000000000006 110.727 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.3 t30 61.99 13.2 5.44 Favored 'General case' 0 C--N 1.268 -2.935 0 CA-C-N 108.958 -3.746 . . . . 72.219999999999999 113.272 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.9 t -86.91 123.86 40.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 107.419 -1.326 . . . . 73.340000000000003 107.419 175.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.6 p -63.14 125.22 23.34 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.023 0.749 . . . . 72.329999999999998 113.023 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.57 3.68 27.26 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 123.843 0.857 . . . . 75.340000000000003 111.247 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -66.58 112.64 4.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.756 -0.656 . . . . 75.530000000000001 110.238 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 60.1 49.82 7.1 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 122.722 1.249 . . . . 72.340000000000003 112.98 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.31 169.55 4.01 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 N-CA-C 107.937 -1.135 . . . . 74.310000000000002 107.937 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.48 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 76.5 p -81.64 141.13 33.95 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.845 -0.742 . . . . 75.109999999999999 109.755 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . 0.56 ' O ' HG23 ' A' ' 388' ' ' VAL . 75.2 t60 -46.02 -45.33 15.85 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.267 0.84 . . . . 74.239999999999995 113.267 -176.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' B' ' 143' ' ' THR . 59.9 tt0 -62.33 -39.15 92.12 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 120.937 0.399 . . . . 73.420000000000002 111.122 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' A' ' 383' ' ' THR . 61.4 tt0 -69.53 -34.63 74.51 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 124.321 1.048 . . . . 72.430000000000007 108.559 -176.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.506 ' O ' HD13 ' A' ' 391' ' ' LEU . . . -73.37 -53.9 9.63 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.823 -1.081 . . . . 75.109999999999999 110.633 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 384' ' ' HIS . 21.1 t -58.15 -41.38 80.61 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 109.862 -0.421 . . . . 70.209999999999994 109.862 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 31.0 m -63.24 -31.67 72.87 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 116.224 -0.444 . . . . 74.140000000000001 110.938 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -69.35 -41.09 77.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.15 -0.315 . . . . 54.329999999999998 110.15 177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 387' ' ' ALA . 5.3 mp -73.85 -23.99 59.7 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 119.937 -0.705 . . . . 75.510000000000005 110.406 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 54.9 mttm -79.12 -32.47 44.51 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 113.488 0.921 . . . . 74.219999999999999 113.488 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -84.01 64.5 8.2 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.949 0.88 . . . . 73.409999999999997 111.836 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' THR . . . . . 0.515 ' O ' ' HG2' ' A' ' 324' ' ' LYS . 12.4 p -148.62 149.46 31.56 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.422 -1.263 . . . . 74.230000000000004 108.38 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 26.8 p -148.62 128.02 13.08 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.271 -0.64 . . . . 74.409999999999997 109.271 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 31.8 t70 59.8 -1.22 0.17 Allowed 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 126.29 1.836 . . . . 71.409999999999997 114.406 177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -159.73 120.8 3.16 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 120.607 -1.308 . . . . 74.420000000000002 110.718 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 80.4 t -136.15 145.13 31.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 124.281 1.032 . . . . 74.519999999999996 108.365 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.24 96.41 4.91 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.289 -1.374 . . . . 74.030000000000001 107.289 173.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 4.8 tt -83.98 118.26 23.91 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.885 -1.154 . . . . 74.340000000000003 107.885 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -108.09 107.34 17.96 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.928 -1.138 . . . . 73.209999999999994 107.928 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 3.0 p -111.3 148.69 14.41 Favored 'Isoleucine or valine' 0 C--O 1.267 1.998 0 CA-C-N 115.408 -0.814 . . . . 63.240000000000002 109.626 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.628 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.71 157.83 45.85 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 104.325 -2.472 . . . . 74.319999999999993 104.325 172.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.515 ' HE3' ' SD ' ' A' ' 318' ' ' MET . 0.0 OUTLIER -95.6 153.4 39.46 Favored Pre-proline 0 C--N 1.276 -2.599 0 C-N-CA 118.302 -1.359 . . . . 75.019999999999996 107.477 174.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -35.56 100.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 125.145 3.897 . . . . 75.299999999999997 115.913 -173.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 13.2 p -96.21 -17.9 20.45 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.657 -1.156 . . . . 74.420000000000002 112.194 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -92.63 -4.13 65.95 Favored Glycine 0 N--CA 1.422 -2.291 0 C-N-CA 120.157 -1.021 . . . . 65.219999999999999 113.179 -176.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 22.2 t -167.53 -169.11 1.14 Allowed 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.871 -0.789 . . . . 75.549999999999997 108.871 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . 0.488 ' CE1' ' HB3' ' A' ' 411' ' ' HIS . 33.0 t-80 -81.26 157.05 25.29 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.895 -1.15 . . . . 71.329999999999998 107.895 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -89.27 46.52 1.39 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.789 0.804 . . . . 74.510000000000005 110.438 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.488 ' HB3' ' CE1' ' A' ' 409' ' ' HIS . 27.9 t-80 . . . . . 0 C--O 1.27 2.133 0 N-CA-C 105.198 -2.149 . . . . 61.140000000000001 105.198 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . 0.49 ' C ' ' H ' ' B' ' 143' ' ' THR . . . . . . . . 0 C--O 1.218 -0.568 0 N-CA-C 109.977 -0.379 . . . . 74.319999999999993 109.977 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . 0.521 ' HA ' ' NE ' ' B' ' 142' ' ' ARG . 4.3 mmp_? 69.1 -19.08 0.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 126.034 1.733 . . . . 75.140000000000001 113.357 -178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.547 ' O ' ' HD2' ' B' ' 144' ' ' ARG 0.266 15.1 p -55.02 135.56 48.73 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 126.287 1.835 . . . . 60.549999999999997 107.242 168.043 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . 0.547 ' HD2' ' O ' ' B' ' 143' ' ' THR . 17.8 mmm180 -149.89 -164.53 2.04 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 119.806 1.185 . . . . 73.319999999999993 109.97 -173.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . 0.451 ' HA ' ' HB2' ' A' ' 339' ' ' ASN . 0.2 OUTLIER -69.3 144.34 53.58 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.392 0.615 . . . . 75.329999999999998 112.034 -173.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . 0.466 ' H ' ' CG ' ' A' ' 339' ' ' ASN 0.257 27.0 mmt180 65.66 39.55 4.84 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 126.061 1.744 . . . . 73.400000000000006 113.662 178.21 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . 0.476 ' C ' HD21 ' B' ' 147' ' ' ASN . 0.1 OUTLIER -143.66 148.93 36.51 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.567 -1.197 . . . . 71.030000000000001 108.759 173.001 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.65 151.94 19.14 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.628 -1.619 . . . . 73.219999999999999 106.628 173.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 53.8 m -147.37 129.62 15.65 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 120.534 -0.466 . . . . 73.439999999999998 110.66 174.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -67.07 129.51 40.13 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.941 -0.762 . . . . 72.230000000000004 108.941 173.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--N 1.297 -1.71 0 N-CA-C 113.404 0.89 . . . . 73.219999999999999 113.404 -179.173 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 56.8 tpp . . . . . 0 CA--C 1.487 -1.458 0 N-CA-C 106.032 -1.84 . . . . 74.340000000000003 106.032 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.426 1.8 pm0 -122.07 128.64 51.59 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 116.692 2.108 . . . . 70.239999999999995 116.692 -174.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.414 HD11 ' O ' ' A' ' 363' ' ' GLY . 89.8 mt -105.23 106.57 20.76 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.623 0 CA-C-N 111.452 -2.613 . . . . 75.109999999999999 109.305 -176.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -77.68 113.89 15.98 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 103.883 -2.636 . . . . 74.040000000000006 103.883 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.06 147.68 31.99 Favored 'General case' 0 C--N 1.266 -3.023 0 O-C-N 124.478 1.111 . . . . 61.509999999999998 109.234 -171.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 68.3 mt -106.03 134.99 46.0 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.881 0 N-CA-C 108.114 -1.069 . . . . 72.030000000000001 108.114 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 395' ' ' SER . 1.2 ttpm? -74.24 177.99 5.44 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.83 -0.804 . . . . 74.409999999999997 108.83 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . 0.406 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -155.86 -172.52 23.44 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 120.374 -0.917 . . . . 74.030000000000001 110.943 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.38 -26.16 20.82 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 122.895 2.397 . . . . 65.25 112.277 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -88.92 -8.56 53.98 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 122.469 1.128 . . . . 74.340000000000003 108.886 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 95.93 -135.55 12.38 Favored Glycine 0 CA--C 1.482 -1.985 0 CA-C-N 113.618 -1.628 . . . . 74.329999999999998 109.355 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.8 mp -83.71 -45.5 13.32 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.429 -1.693 . . . . 75.319999999999993 106.429 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 83.32 53.74 3.35 Favored Glycine 0 N--CA 1.421 -2.316 0 CA-C-N 114.645 -1.161 . . . . 74.319999999999993 114.348 170.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -154.4 164.48 38.57 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 116.736 0.268 . . . . 73.209999999999994 110.334 172.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 10.2 m -112.54 129.35 56.39 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.632 -0.507 . . . . 61.530000000000001 109.632 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.9 pt -118.75 153.33 20.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 109.927 -0.397 . . . . 75.25 109.927 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -142.22 136.57 30.01 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.288 -1.745 . . . . 73.140000000000001 106.288 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 347' ' ' SER . . . 144.81 157.44 7.22 Favored Glycine 0 C--N 1.282 -2.428 0 N-CA-C 109.288 -1.525 . . . . 43.32 109.288 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 137.74 175.5 13.91 Favored Glycine 0 C--N 1.282 -2.453 0 N-CA-C 108.386 -1.886 . . . . 73.010000000000005 108.386 -175.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.501 HG23 ' OE2' ' A' ' 381' ' ' GLU . 68.7 t -50.7 110.89 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 117.719 0.76 . . . . 64.109999999999999 109.655 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 81.4 -17.04 14.95 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 121.267 -0.492 . . . . 54.420000000000002 113.298 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.28 3.65 38.37 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.592 -1.262 . . . . 62.43 107.592 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.4 HE22 ' HA ' ' A' ' 343' ' ' PRO . 0.0 OUTLIER -49.57 126.21 13.03 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.595 1.158 . . . . 75.319999999999993 111.288 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -76.83 -37.27 55.97 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.22 -0.9 . . . . 64.450000000000003 109.97 -175.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 2.8 mp -104.82 126.76 30.35 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 109.344 -0.613 . . . . 72.340000000000003 109.344 177.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.4 ' HA ' HE22 ' A' ' 340' ' ' GLN . 18.7 Cg_endo -59.38 105.99 0.28 Allowed 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.842 2.362 . . . . 75.040000000000006 112.816 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 105.83 -1.22 38.82 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 115.553 -0.749 . . . . 52.140000000000001 111.931 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.497 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 60.4 t0 -130.85 103.55 6.63 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 108.087 -1.079 . . . . 72.219999999999999 108.087 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -76.91 65.05 2.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.501 1.143 . . . . 74.450000000000003 108.924 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 0.46 ' O ' ' HA3' ' A' ' 335' ' ' GLY . 5.2 p -97.09 134.6 40.22 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 113.289 -1.778 . . . . 74.209999999999994 112.38 -176.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 44.3 mm -80.94 119.14 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 N-CA-C 104.488 -2.412 . . . . 74.329999999999998 104.488 168.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -123.89 137.92 54.56 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 120.161 -0.616 . . . . 71.420000000000002 109.724 -169.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 49.5 t -78.58 111.41 15.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.266 -0.642 . . . . 65.430000000000007 109.266 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.5 m -96.42 -28.84 14.26 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.068 -0.515 . . . . 75.540000000000006 110.928 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.554 ' HZ1' ' CD ' ' B' ' 148' ' ' GLU . 55.4 mttp -151.61 163.11 39.8 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 109.637 -0.505 . . . . 75.420000000000002 109.637 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . 0.418 HG21 ' HB2' ' A' ' 360' ' ' HIS . 73.1 mt -131.54 127.48 59.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 106.644 -1.613 . . . . 74.129999999999995 106.644 174.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 50.6 mm -85.51 141.75 14.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 123.678 0.791 . . . . 72.299999999999997 111.466 -172.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.5 133.66 50.24 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.551 0.691 . . . . 74.439999999999998 112.339 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 70.88 7.46 62.05 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 120.598 -0.81 . . . . 75.049999999999997 112.454 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -67.39 148.89 50.41 Favored Glycine 0 N--CA 1.414 -2.807 0 N-CA-C 110.289 -1.124 . . . . 74.5 110.289 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.42 -34.27 77.38 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.432 -0.581 . . . . 63.119999999999997 109.432 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.484 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -76.1 -14.97 60.18 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.209 -0.597 . . . . 71.219999999999999 111.707 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . 0.536 ' CD2' ' HZ1' ' A' ' 361' ' ' LYS . 39.6 t60 -84.14 -27.79 27.88 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.695 0.759 . . . . 72.409999999999997 109.18 177.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.536 ' HZ1' ' CD2' ' A' ' 360' ' ' HIS . 19.3 mmtm -96.69 -58.28 2.08 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 114.835 1.42 . . . . 74.0 114.835 173.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -85.81 -41.57 14.93 Favored 'General case' 0 CA--C 1.465 -2.309 0 C-N-CA 122.796 0.438 . . . . 74.409999999999997 111.155 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -43.02 -25.0 0.31 Allowed Glycine 0 CA--C 1.491 -1.413 0 N-CA-C 118.79 2.276 . . . . 64.239999999999995 118.79 -165.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.467 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 43.72 36.21 1.23 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.42 1.088 . . . . 74.230000000000004 111.167 -179.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 39.5 tp -115.69 152.89 32.33 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 114.168 -1.378 . . . . 72.310000000000002 108.368 -171.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -123.84 155.56 37.8 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.751 0.786 . . . . 75.200000000000003 111.605 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 80.3 mt -66.12 125.47 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 107.204 -1.406 . . . . 73.109999999999999 107.204 173.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.34 -6.83 21.0 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.04 -1.076 . . . . 61.310000000000002 111.949 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -75.8 142.37 42.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.487 0.551 . . . . 63.299999999999997 112.487 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 76.4 tttt -101.64 131.21 47.99 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.931 -0.766 . . . . 74.209999999999994 108.931 176.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 68.8 mt -95.81 120.77 36.68 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.964 0.411 . . . . 74.129999999999995 110.812 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 40.0 mt -83.41 -39.73 20.25 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.433 -1.258 . . . . 74.200000000000003 109.736 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.23 157.93 26.47 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 120.015 -0.674 . . . . 62.229999999999997 112.088 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 14.7 p -134.28 121.69 38.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 107.984 -1.117 . . . . 71.340000000000003 107.984 172.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 399' ' ' TYR . 79.1 m-20 64.4 27.79 13.62 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 123.909 1.814 . . . . 75.420000000000002 108.641 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.2 t30 66.17 16.4 10.43 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 109.791 -3.368 . . . . 72.319999999999993 111.835 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.8 t -83.84 125.44 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.171 -1.788 . . . . 75.109999999999999 106.171 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.7 p -62.96 125.49 24.16 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 124.012 0.82 . . . . 63.439999999999998 113.008 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.21 1.1 32.59 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.229 -0.896 . . . . 73.340000000000003 110.892 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -75.3 115.05 14.54 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.644 -0.873 . . . . 72.200000000000003 108.644 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . 0.501 ' OE2' HG23 ' A' ' 337' ' ' VAL . 19.7 tp10 62.22 83.42 0.15 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.557 1.17 . . . . 62.200000000000003 112.117 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 23.9 m -153.21 165.8 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 113.24 -1.8 . . . . 75.519999999999996 107.606 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.464 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.0 OUTLIER -82.15 143.61 31.32 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.184 -1.043 . . . . 73.510000000000005 108.184 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . 0.521 ' O ' HG22 ' A' ' 388' ' ' VAL . 86.1 t60 -50.6 -53.27 31.93 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 112.394 0.516 . . . . 72.420000000000002 112.394 -174.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.69 -27.35 68.28 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.129 -0.941 . . . . 73.010000000000005 111.217 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.9 tt0 -75.0 -34.47 61.97 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.796 -1.187 . . . . 74.030000000000001 107.796 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.43 ' O ' HD13 ' A' ' 391' ' ' LEU . . . -73.08 -45.35 57.74 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.655 -1.157 . . . . 75.129999999999995 109.737 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 384' ' ' HIS . 15.4 t -56.95 -42.92 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.937 -0.764 . . . . 74.049999999999997 108.937 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 62.6 m -61.15 -36.3 79.41 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 116.016 -0.538 . . . . 71.310000000000002 110.936 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.74 80.91 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.333 -0.23 . . . . 71.349999999999994 110.512 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 387' ' ' ALA . 5.7 mp -78.03 -31.56 50.49 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 120.456 -0.498 . . . . 74.349999999999994 111.024 176.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -71.27 -25.75 62.59 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 120.569 -0.453 . . . . 73.299999999999997 112.167 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -82.68 65.39 7.78 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.227 1.013 . . . . 72.010000000000005 110.468 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 17.6 p -132.78 146.1 51.56 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.248 -1.342 . . . . 74.510000000000005 108.394 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 47.9 m -145.92 91.58 2.1 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.583 1.182 . . . . 73.400000000000006 111.426 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . 0.426 ' HA ' ' CB ' ' A' ' 324' ' ' LYS 0.346 14.4 m-20 65.08 4.44 2.55 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 111.427 -2.624 . . . . 70.349999999999994 116.075 170.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -156.39 130.32 8.48 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 106.987 -1.486 . . . . 73.439999999999998 106.987 170.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 27.6 t -138.09 149.3 24.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 124.187 0.995 . . . . 74.140000000000001 109.063 -172.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . 0.408 ' HB2' ' HA ' ' A' ' 375' ' ' ASN . 75.6 m-85 -116.34 95.9 5.28 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.248 -1.019 . . . . 74.340000000000003 108.248 170.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.5 tt -95.39 119.37 33.77 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.106 0.479 . . . . 75.530000000000001 109.999 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -102.4 110.41 22.35 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.793 -1.188 . . . . 71.209999999999994 107.793 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 3.0 p -110.87 144.51 18.69 Favored 'Isoleucine or valine' 0 C--O 1.274 2.356 0 C-N-CA 124.232 1.013 . . . . 73.439999999999998 111.526 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -137.64 159.93 40.62 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 125.907 1.683 . . . . 72.200000000000003 109.022 176.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.503 ' HG3' ' C ' ' A' ' 411' ' ' HIS . 0.4 OUTLIER -77.69 155.9 80.7 Favored Pre-proline 0 C--N 1.295 -1.788 0 N-CA-C 109.234 -0.654 . . . . 71.329999999999998 109.234 173.37 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -47.69 121.04 5.18 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 123.456 2.77 . . . . 74.439999999999998 111.675 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 7.0 m -84.2 -38.05 21.07 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.82 -1.082 . . . . 71.420000000000002 111.721 -172.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -101.57 38.68 3.05 Favored Glycine 0 C--N 1.292 -1.916 0 C-N-CA 120.096 -1.05 . . . . 72.430000000000007 113.08 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 33.2 t -165.7 -170.22 1.74 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.165 -1.421 . . . . 75.0 107.165 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -73.86 140.28 45.62 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 107.23 -1.396 . . . . 75.150000000000006 107.23 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -79.61 127.7 32.49 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 112.704 0.631 . . . . 75.209999999999994 112.704 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.503 ' C ' ' HG3' ' A' ' 404' ' ' LYS . 88.1 m-70 . . . . . 0 C--N 1.309 -1.171 0 N-CA-C 107.046 -1.465 . . . . 70.310000000000002 107.046 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 107.625 -1.25 . . . . 72.230000000000004 107.625 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -162.92 159.19 23.38 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 105.912 -1.885 . . . . 73.310000000000002 105.912 -175.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 36.6 p -69.8 151.87 45.25 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.026 -1.472 . . . . 72.430000000000007 107.026 175.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . 0.505 ' HA ' ' NE ' ' B' ' 144' ' ' ARG . 3.3 mmp_? -152.24 137.75 17.72 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 119.085 0.857 . . . . 74.129999999999995 111.588 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -86.54 162.77 17.86 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 113.822 -1.536 . . . . 64.120000000000005 108.58 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 67.44 18.97 10.1 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.501 1.52 . . . . 74.219999999999999 112.519 -174.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -157.11 179.23 9.49 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.805 0.842 . . . . 71.140000000000001 108.913 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.554 ' CD ' ' HZ1' ' A' ' 352' ' ' LYS . 13.2 pt-20 -91.78 144.96 24.96 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.155 -0.683 . . . . 71.310000000000002 109.155 177.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 86.6 m -134.63 142.69 46.96 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.722 -0.473 . . . . 72.030000000000001 109.722 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.87 145.4 36.27 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 122.942 0.497 . . . . 75.329999999999998 111.041 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 14.0 m . . . . . 0 C--O 1.261 1.676 0 CA-C-N 115.738 -0.665 . . . . 73.129999999999995 111.282 175.262 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 CA--C 1.495 -1.16 0 N-CA-C 107.192 -1.41 . . . . 64.200000000000003 107.192 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.323 2.0 pm0 -115.79 133.88 55.58 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-O 122.23 1.014 . . . . 74.109999999999999 113.364 -176.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.438 HD13 ' O ' ' A' ' 363' ' ' GLY . 77.3 mt -129.89 116.56 38.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 113.217 -1.81 . . . . 73.030000000000001 110.27 -168.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -75.92 134.7 40.18 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.028 -0.73 . . . . 74.239999999999995 109.028 172.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.502 ' HA ' ' OD2' ' A' ' 362' ' ' ASP . 95.5 mt -131.78 152.15 51.16 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 123.556 0.535 . . . . 74.310000000000002 110.217 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.44 110.64 31.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.14 -1.059 . . . . 73.510000000000005 108.14 171.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.472 ' NZ ' ' HA ' ' A' ' 392' ' ' LYS . 79.1 tttt -76.94 130.23 37.24 Favored 'General case' 0 C--O 1.201 -1.457 0 C-N-CA 119.687 -0.805 . . . . 70.140000000000001 110.112 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -133.85 -163.77 10.47 Favored Glycine 0 C--N 1.298 -1.58 0 C-N-CA 119.766 -1.207 . . . . 62.149999999999999 111.905 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.64 -12.9 33.49 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 123.775 2.983 . . . . 73.409999999999997 113.782 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.471 ' HZ2' ' HA3' ' A' ' 356' ' ' GLY . 79.1 tttt -103.53 6.99 37.75 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 122.316 1.055 . . . . 75.430000000000007 108.805 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.21 -151.02 28.01 Favored Glycine 0 CA--C 1.493 -1.331 0 CA-C-N 114.303 -1.317 . . . . 62.229999999999997 110.213 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.6 mp -88.11 -16.51 33.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.747 -1.575 . . . . 74.230000000000004 106.747 166.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 79.16 39.28 19.93 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 113.921 -1.491 . . . . 73.430000000000007 114.892 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 52.2 p90 -151.45 165.75 33.2 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 117.596 0.698 . . . . 75.319999999999993 110.487 175.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 12.2 m -121.62 136.0 54.96 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 109.706 -0.479 . . . . 70.040000000000006 109.706 -178.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' B' ' 148' ' ' GLU . 17.9 pt -119.9 152.73 22.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 122.514 0.326 . . . . 74.420000000000002 111.761 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.2 114.65 5.56 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 104.997 -2.223 . . . . 74.019999999999996 104.997 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.67 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 162.3 156.21 8.35 Favored Glycine 0 C--N 1.286 -2.222 0 N-CA-C 109.709 -1.356 . . . . 73.319999999999993 109.709 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.68 -174.81 20.88 Favored Glycine 0 CA--C 1.484 -1.873 0 N-CA-C 108.908 -1.677 . . . . 74.329999999999998 108.908 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 96.1 t -51.68 108.47 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 117.498 0.649 . . . . 72.120000000000005 111.673 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 91.37 -21.57 34.44 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.114 -0.948 . . . . 61.140000000000001 112.773 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.67 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 57.6 t30 -107.08 26.88 9.59 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.24 -0.652 . . . . 72.310000000000002 109.24 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.29 119.6 5.8 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.888 -0.596 . . . . 60.229999999999997 110.674 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -78.9 -41.5 29.52 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.304 -0.862 . . . . 72.409999999999997 109.865 -175.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 43.5 mm -103.91 123.36 41.31 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 108.918 -0.771 . . . . 74.230000000000004 108.918 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.95 105.39 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.161 2.574 . . . . 74.209999999999994 112.419 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.97 -5.14 28.93 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.477 -0.783 . . . . 64.450000000000003 111.935 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.447 ' CG ' ' HH ' ' A' ' 349' ' ' TYR . 13.7 t70 -129.29 99.46 5.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.766 0.793 . . . . 74.129999999999995 108.973 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -82.8 35.33 0.46 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.384 1.074 . . . . 72.239999999999995 111.458 -171.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 0.445 ' CB ' ' HE3' ' A' ' 370' ' ' LYS . 68.2 m -104.79 177.89 4.72 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 113.035 0.754 . . . . 72.239999999999995 113.035 -176.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.7 129.43 39.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.337 -0.847 . . . . 73.430000000000007 109.319 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 37.3 m-85 -124.26 136.73 54.36 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 113.47 0.915 . . . . 74.319999999999993 113.47 -177.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.4 t -71.65 117.2 14.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.688 -1.142 . . . . 74.409999999999997 108.51 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.4 m -106.28 -18.16 14.08 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.799 0.333 . . . . 71.420000000000002 111.581 -175.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.593 ' HG2' ' OE1' ' B' ' 148' ' ' GLU . 44.0 mmtm -149.89 154.95 39.17 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 108.609 -0.886 . . . . 72.140000000000001 108.609 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . 0.425 ' CG2' ' HB2' ' A' ' 360' ' ' HIS . 57.0 mt -138.89 121.23 17.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 107.232 -1.395 . . . . 71.219999999999999 107.232 172.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 41.6 mm -86.0 133.15 30.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.385 -1.339 . . . . 73.5 107.385 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.43 144.83 56.64 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.627 -1.62 . . . . 73.239999999999995 106.627 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.471 ' HA3' ' HZ2' ' A' ' 327' ' ' LYS . . . 92.08 -12.79 68.65 Favored Glycine 0 CA--C 1.475 -2.415 0 C-N-CA 119.36 -1.4 . . . . 55.149999999999999 110.672 178.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -67.98 148.34 49.03 Favored Glycine 1 N--CA 1.396 -4.005 0 N-CA-C 108.716 -1.754 . . . . 73.439999999999998 108.716 172.722 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.48 77.08 Favored 'General case' 0 C--O 1.2 -1.532 0 N-CA-C 109.834 -0.432 . . . . 70.420000000000002 109.834 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.492 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -73.82 -11.74 60.47 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.671 -0.812 . . . . 74.219999999999999 112.486 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . 0.425 ' HB2' ' CG2' ' A' ' 353' ' ' ILE . 70.9 t60 -88.01 -43.95 11.35 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.423 -0.584 . . . . 71.430000000000007 109.423 177.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.429 ' HE2' ' N ' ' A' ' 356' ' ' GLY . 73.4 mmtt -86.42 -57.83 2.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.143 0.973 . . . . 72.400000000000006 110.947 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . 0.502 ' OD2' ' HA ' ' A' ' 322' ' ' LEU . 35.2 t0 -81.75 -33.83 30.77 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 125.075 1.35 . . . . 74.430000000000007 109.38 -175.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.637 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -84.6 -16.91 65.03 Favored Glycine 0 C--N 1.289 -2.074 0 N-CA-C 117.37 1.708 . . . . 55.509999999999998 117.37 -169.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.637 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.31 34.23 0.49 Allowed 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 118.054 0.927 . . . . 72.109999999999999 112.619 -177.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 33.0 tp -83.78 157.58 22.04 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.199 0.999 . . . . 72.5 111.453 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -118.1 142.24 47.62 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.279 0.561 . . . . 73.109999999999999 111.414 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 84.3 mt -66.49 121.97 16.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 107.254 -1.387 . . . . 73.129999999999995 107.254 169.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 113.76 -1.72 24.56 Favored Glycine 0 C--N 1.309 -0.917 0 N-CA-C 110.936 -0.866 . . . . 72.209999999999994 110.936 -174.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.401 ' HB3' HG23 ' A' ' 402' ' ' VAL . 2.4 m-20 -73.14 138.32 45.69 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.265 0.469 . . . . 74.329999999999998 112.265 176.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 64.1 tttt -99.95 115.99 30.95 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.164 -0.925 . . . . 63.43 110.369 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 82.1 mt -82.13 112.94 19.63 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.455 -0.572 . . . . 71.329999999999998 109.455 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.5 tt -82.31 -37.36 25.89 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.079 -1.418 . . . . 73.120000000000005 107.343 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -162.85 157.45 21.34 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.057 -0.974 . . . . 72.120000000000005 109.122 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 10.0 p -142.86 121.85 8.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-O 121.138 0.494 . . . . 72.129999999999995 109.704 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 66.9 t30 44.56 78.86 0.05 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 126.246 1.818 . . . . 75.530000000000001 111.745 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 65.94 -29.42 0.13 Allowed 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 114.681 1.364 . . . . 74.400000000000006 114.681 -175.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 28.2 t -83.96 124.56 39.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 O-C-N 121.471 -0.768 . . . . 74.420000000000002 110.969 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 11.6 p -75.19 132.5 41.18 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.789 -0.449 . . . . 73.329999999999998 109.789 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.8 mp -108.51 -4.67 17.05 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.067 0.766 . . . . 75.200000000000003 113.067 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -63.55 113.87 3.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.572 0.225 . . . . 62.399999999999999 111.376 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 59.57 39.91 20.93 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 122.807 1.289 . . . . 74.239999999999995 112.989 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 31.4 m -104.27 166.16 3.15 Favored 'Isoleucine or valine' 0 C--O 1.257 1.494 0 N-CA-C 106.644 -1.613 . . . . 72.409999999999997 106.644 171.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.522 ' HB ' ' OE1' ' A' ' 386' ' ' GLU . 0.4 OUTLIER -81.13 149.08 29.31 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 117.808 -1.557 . . . . 73.049999999999997 107.381 178.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . 0.594 ' O ' HG23 ' A' ' 388' ' ' VAL . 79.8 t60 -53.77 -27.92 31.64 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 114.32 1.23 . . . . 74.129999999999995 114.32 -172.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.561 ' HB2' ' CG ' ' B' ' 144' ' ' ARG . 34.9 tt0 -65.87 -41.63 91.38 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 117.796 0.271 . . . . 74.120000000000005 110.293 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.522 ' OE1' ' HB ' ' A' ' 383' ' ' THR . 1.9 mp0 -68.38 -33.15 73.75 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 109.063 -0.718 . . . . 74.420000000000002 109.063 -177.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.566 ' O ' HD11 ' A' ' 391' ' ' LEU . . . -64.96 -58.15 6.88 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.392 -1.276 . . . . 65.019999999999996 109.058 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 384' ' ' HIS . 40.6 t -54.58 -43.35 64.53 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 0 O-C-N 123.401 0.438 . . . . 74.140000000000001 110.146 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 93.1 m -59.17 -37.5 77.5 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.355 0.662 . . . . 74.310000000000002 111.911 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -68.51 -40.64 80.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.996 0.427 . . . . 72.450000000000003 110.077 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.566 HD11 ' O ' ' A' ' 387' ' ' ALA . 5.1 mp -75.37 -19.95 59.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.201 0.524 . . . . 63.509999999999998 111.036 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.475 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 54.8 mttm -80.18 -41.53 25.1 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 113.429 0.9 . . . . 70.409999999999997 113.429 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -84.99 65.68 9.36 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.918 0.866 . . . . 73.510000000000005 111.427 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 1.3 p -145.01 148.92 34.28 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.565 -1.198 . . . . 74.519999999999996 109.296 177.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 22.0 m -145.37 120.28 9.98 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.841 -0.8 . . . . 75.140000000000001 108.841 178.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 56.1 0.98 0.06 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 127.381 2.272 . . . . 74.510000000000005 116.49 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . 0.437 ' HE2' ' CE2' ' A' ' 399' ' ' TYR . 6.0 t80 -158.73 125.12 4.62 Favored 'General case' 0 N--CA 1.437 -1.077 0 O-C-N 121.297 -0.877 . . . . 72.439999999999998 109.805 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.2 t -141.37 145.86 24.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.17 -1.048 . . . . 75.209999999999994 108.17 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . 0.437 ' CE2' ' HE2' ' A' ' 397' ' ' PHE . 21.1 m-85 -115.22 97.35 6.15 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.053 -0.721 . . . . 74.530000000000001 109.053 172.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 8.0 tt -87.01 134.42 33.49 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 110.271 -0.27 . . . . 73.019999999999996 110.271 -177.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -121.83 108.19 13.18 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.494 -0.928 . . . . 73.329999999999998 108.494 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.401 HG23 ' HB3' ' A' ' 369' ' ' ASP . 7.3 p -116.37 151.99 18.13 Favored 'Isoleucine or valine' 0 C--O 1.268 2.055 0 CA-C-O 121.561 0.696 . . . . 74.439999999999998 111.225 -175.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.86 158.66 43.95 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 125.153 1.381 . . . . 72.420000000000002 108.089 176.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.55 159.12 72.67 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 108.435 -0.95 . . . . 75.200000000000003 108.435 173.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . 0.5 ' HA ' ' OH ' ' A' ' 349' ' ' TYR . 18.9 Cg_endo -52.67 105.52 0.12 Allowed 'Trans proline' 0 C--N 1.365 1.43 0 C-N-CA 123.634 2.889 . . . . 74.150000000000006 114.407 -172.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 5.8 m -73.61 -35.38 65.34 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.364 -0.834 . . . . 75.209999999999994 112.088 -171.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -80.91 31.91 2.49 Favored Glycine 0 C--N 1.292 -1.906 0 CA-C-N 116.027 -0.533 . . . . 71.319999999999993 113.483 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' SER . . . . . 0.481 ' OG ' ' HB2' ' A' ' 405' ' ' PRO . 54.4 p -168.29 -172.68 1.79 Allowed 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.965 -1.124 . . . . 71.310000000000002 107.965 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -77.13 105.9 8.51 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.154 -0.684 . . . . 73.25 109.154 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . 0.459 ' HB3' ' O ' ' A' ' 405' ' ' PRO . 26.9 p-80 -107.48 142.45 37.32 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.22 -0.9 . . . . 74.439999999999998 111.032 -177.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 . . . . . 0 N--CA 1.423 -1.802 0 N-CA-C 104.005 -2.591 . . . . 73.519999999999996 104.005 177.389 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.878 0 N-CA-C 107.203 -1.406 . . . . 72.099999999999994 107.203 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . 0.427 ' HB3' ' OE1' ' A' ' 385' ' ' GLU . 19.8 mtp180 -120.2 130.43 54.54 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.141 -1.429 . . . . 74.120000000000005 107.141 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 2.9 p -70.48 99.73 1.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 123.655 0.597 . . . . 75.299999999999997 111.497 -175.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . 0.561 ' CG ' ' HB2' ' A' ' 385' ' ' GLU . 52.2 mtt180 -154.5 -49.35 0.09 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 117.591 -1.644 . . . . 74.0 114.171 173.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . 0.656 26.2 mt-30 -96.52 119.58 35.27 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 121.088 3.736 . . . . 72.120000000000005 121.088 -173.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . 0.401 ' HA ' ' OD1' ' A' ' 339' ' ' ASN . 0.1 OUTLIER 47.28 44.45 15.95 Favored 'General case' 0 CA--C 1.488 -1.412 0 O-C-N 124.244 0.965 . . . . 71.430000000000007 111.461 176.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . 0.415 ' C ' HD21 ' B' ' 147' ' ' ASN . 0.2 OUTLIER -142.76 136.73 29.17 Favored 'General case' 0 N--CA 1.402 -2.857 0 CA-C-N 114.155 -1.384 . . . . 72.129999999999995 108.361 -176.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . 0.593 ' OE1' ' HG2' ' A' ' 352' ' ' LYS . 15.6 pt-20 -96.23 140.94 30.18 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 108.515 -0.92 . . . . 71.310000000000002 108.515 174.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 332' ' ' SER . 87.7 m -134.13 135.98 43.53 Favored 'General case' 0 C--N 1.282 -2.368 0 C-N-CA 120.745 -0.382 . . . . 70.109999999999999 111.625 -176.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -80.57 124.09 28.67 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.313 -0.995 . . . . 72.120000000000005 108.313 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 C--N 1.282 -2.337 0 N-CA-C 115.435 1.643 . . . . 73.040000000000006 115.435 -174.576 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 CA--C 1.492 -1.263 0 N-CA-C 106.721 -1.585 . . . . 74.319999999999993 106.721 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.405 2.0 pm0 -115.82 130.78 56.98 Favored 'General case' 0 C--N 1.266 -3.046 0 CA-C-O 122.784 1.278 . . . . 73.099999999999994 114.408 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 69.0 mt -122.54 112.98 36.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.456 0 CA-C-N 112.482 -2.144 . . . . 73.430000000000007 110.698 -169.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.413 ' HD2' ' C ' ' A' ' 321' ' ' LYS . 0.4 OUTLIER -73.57 127.71 33.5 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 106.982 -1.488 . . . . 75.219999999999999 106.982 171.356 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.541 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 98.3 mt -120.54 154.24 35.61 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.829 -1.175 . . . . 74.010000000000005 107.829 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 324' ' ' LYS . 47.0 mt -107.43 150.58 9.89 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.028 0 N-CA-C 106.448 -1.686 . . . . 73.040000000000006 106.448 171.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.507 ' O ' HG22 ' A' ' 323' ' ' ILE . 1.0 OUTLIER -76.26 178.67 6.28 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.07 -1.455 . . . . 74.239999999999995 107.07 173.103 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -164.93 -166.98 24.79 Favored Glycine 0 C--N 1.287 -2.193 0 C-N-CA 118.373 -1.87 . . . . 72.239999999999995 113.627 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.56 -35.23 23.35 Favored 'Trans proline' 0 C--O 1.213 -0.753 0 C-N-CA 123.772 2.982 . . . . 73.409999999999997 112.41 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.407 ' NZ ' ' HA3' ' A' ' 356' ' ' GLY . 44.4 mttp -99.8 19.76 15.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.349 -0.611 . . . . 65.400000000000006 109.349 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.65 -123.97 6.5 Favored Glycine 0 CA--C 1.485 -1.84 0 N-CA-C 107.992 -2.043 . . . . 65.349999999999994 107.992 -176.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.43 HD13 ' OG1' ' A' ' 394' ' ' THR . 9.4 mp -93.13 -29.03 15.96 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.265 -1.383 . . . . 63.509999999999998 107.265 174.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . 0.446 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 77.49 39.82 24.83 Favored Glycine 0 N--CA 1.427 -1.92 0 CA-C-N 113.512 -1.676 . . . . 64.230000000000004 114.414 172.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -143.59 149.88 38.02 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 119.941 -0.703 . . . . 75.420000000000002 109.919 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 9.9 m -105.52 127.41 53.0 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 115.413 -0.812 . . . . 75.099999999999994 110.18 -176.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 22.6 pt -115.8 143.72 25.08 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-N 115.314 -0.857 . . . . 73.450000000000003 110.305 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -130.13 114.64 15.98 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.771 -1.566 . . . . 74.120000000000005 106.771 175.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 167.75 166.23 26.48 Favored Glycine 0 N--CA 1.408 -3.171 0 N-CA-C 110.609 -0.996 . . . . 63.240000000000002 110.609 177.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.12 177.12 14.72 Favored Glycine 0 N--CA 1.411 -2.995 0 N-CA-C 106.933 -2.467 . . . . 70.540000000000006 106.933 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.448 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 56.7 t -56.6 99.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 117.858 0.829 . . . . 75.319999999999993 110.035 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.22 -10.92 69.55 Favored Glycine 0 N--CA 1.432 -1.594 0 CA-C-O 119.148 -0.807 . . . . 44.43 114.237 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.57 HD21 ' CD2' ' A' ' 384' ' ' HIS . 63.5 t30 -106.88 10.28 30.64 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 118.767 1.284 . . . . 52.409999999999997 109.252 175.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.95 122.48 10.18 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 114.462 1.282 . . . . 71.230000000000004 114.462 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -66.87 -35.15 79.37 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.021 -1.445 . . . . 75.129999999999995 109.412 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.5 mm -104.89 120.02 51.45 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 115.68 -0.691 . . . . 72.540000000000006 109.649 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.83 109.03 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.765 2.31 . . . . 74.230000000000004 111.574 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.12 -14.84 28.39 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.576 -0.821 . . . . 73.109999999999999 111.961 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -119.49 98.03 5.94 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 106.887 -1.523 . . . . 74.540000000000006 106.887 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 337' ' ' VAL . 62.2 t30 -80.66 34.84 0.34 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.007 0.923 . . . . 72.319999999999993 112.531 -169.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 66.7 m -97.89 178.73 5.03 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.66 0.743 . . . . 75.430000000000007 112.751 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.475 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 18.2 mm -94.17 129.84 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 CA-C-N 114.777 -1.101 . . . . 74.120000000000005 108.062 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 30.1 m-85 -124.05 134.4 53.42 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 112.632 0.605 . . . . 71.140000000000001 112.632 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.69 111.65 3.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.022 -1.473 . . . . 73.150000000000006 107.022 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 45.6 m -106.97 -24.08 12.12 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.367 0.603 . . . . 74.400000000000006 111.965 -173.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 57.7 mttp -149.34 149.74 31.37 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.818 -1.178 . . . . 74.230000000000004 107.818 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 65.7 mt -128.87 120.77 52.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.395 -0.965 . . . . 73.329999999999998 108.395 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 31.2 mm -86.65 129.28 38.63 Favored 'Isoleucine or valine' 0 C--O 1.261 1.688 0 C-N-CA 123.34 0.656 . . . . 75.109999999999999 109.693 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.91 147.13 53.93 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 107.333 -1.358 . . . . 74.409999999999997 107.333 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . 0.455 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.51 -15.25 63.57 Favored Glycine 0 C--N 1.278 -2.659 0 N-CA-C 109.657 -1.377 . . . . 71.140000000000001 109.657 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . 0.446 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -72.05 139.04 27.68 Favored Glycine 1 N--CA 1.392 -4.255 0 N-CA-C 107.922 -2.071 . . . . 72.239999999999995 107.922 170.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -65.24 -25.38 67.65 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 109.48 -0.563 . . . . 61.25 109.48 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.64 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.87 -10.41 59.41 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 120.392 -0.523 . . . . 74.140000000000001 111.767 176.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -94.66 -35.24 12.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.125 -1.065 . . . . 72.400000000000006 108.125 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.455 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 75.5 mmtt -81.95 -58.56 2.92 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 120.125 -0.63 . . . . 73.420000000000002 111.173 -178.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -86.2 -35.12 20.26 Favored 'General case' 0 CA--C 1.472 -2.046 0 CA-C-O 122.028 0.918 . . . . 62.420000000000002 109.09 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.732 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -44.17 -29.22 1.54 Allowed Glycine 0 CA--C 1.487 -1.659 0 N-CA-C 119.924 2.729 . . . . 61.409999999999997 119.924 -165.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.732 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 39.98 34.75 0.2 Allowed 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 124.767 1.227 . . . . 74.519999999999996 111.92 -175.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 55.1 tp -107.03 153.55 22.43 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.597 -1.183 . . . . 74.109999999999999 109.362 -172.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -123.55 151.19 43.15 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.467 0.651 . . . . 73.230000000000004 112.18 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.14 125.76 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 108.1 -1.074 . . . . 74.209999999999994 108.1 172.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 114.99 -6.26 21.93 Favored Glycine 0 C--N 1.315 -0.623 0 C-N-CA 121.101 -0.571 . . . . 71.439999999999998 112.131 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.421 ' HB3' HG23 ' A' ' 402' ' ' VAL . 10.1 m-20 -75.02 137.09 41.27 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.208 0.818 . . . . 74.219999999999999 113.208 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.586 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 35.6 tttp -96.0 115.65 27.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.409 1.483 . . . . 75.319999999999993 109.477 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 68.1 mt -85.87 115.9 23.78 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.307 0.575 . . . . 71.120000000000005 110.224 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.1 tt -83.5 -37.77 22.66 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 113.692 -1.594 . . . . 74.209999999999994 107.273 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.81 155.86 21.94 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.157 -0.929 . . . . 75.099999999999994 109.467 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . 0.469 HG12 ' HG ' ' A' ' 391' ' ' LEU . 7.6 p -134.76 117.63 23.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 109.015 -0.735 . . . . 73.239999999999995 109.015 174.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 9.7 t30 44.91 74.79 0.12 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 125.836 1.655 . . . . 73.209999999999994 111.852 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 67.63 -23.57 0.12 Allowed 'General case' 0 CA--C 1.57 1.718 0 C-N-CA 125.386 1.474 . . . . 61.119999999999997 114.13 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 20.3 t -85.97 127.72 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 121.203 -0.936 . . . . 74.150000000000006 110.494 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -75.35 133.12 41.3 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 122.937 0.495 . . . . 75.540000000000006 110.833 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.9 mp -114.12 -4.7 13.11 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.899 1.074 . . . . 75.200000000000003 113.899 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -67.03 104.9 1.5 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.903 -0.406 . . . . 74.400000000000006 109.903 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 65.03 82.83 0.18 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.892 1.277 . . . . 73.519999999999996 113.812 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 20.6 m -143.42 163.88 15.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 106.156 -1.794 . . . . 73.219999999999999 106.156 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.9 m -79.81 149.07 31.15 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 119.17 0.895 . . . . 73.349999999999994 108.879 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . 0.57 ' CD2' HD21 ' A' ' 339' ' ' ASN . 45.2 t-80 -46.45 -48.44 18.95 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.231 0.826 . . . . 74.439999999999998 113.231 -174.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.426 ' OE2' ' HD3' ' B' ' 142' ' ' ARG . 18.7 tp10 -60.84 -39.24 88.34 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.021 0.438 . . . . 73.040000000000006 110.447 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -69.29 -39.8 78.11 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.389 -0.967 . . . . 72.430000000000007 108.389 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.18 -58.3 7.68 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.354 -1.294 . . . . 71.030000000000001 110.257 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 384' ' ' HIS . 40.5 t -55.63 -40.36 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 123.464 0.477 . . . . 74.140000000000001 110.606 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 88.8 m -60.25 -38.05 82.31 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.389 -0.369 . . . . 64.239999999999995 111.813 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.28 86.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.67 0.272 . . . . 73.510000000000005 110.797 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.469 ' HG ' HG12 ' A' ' 374' ' ' VAL . 5.5 mp -77.83 -37.74 47.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.179 -0.608 . . . . 74.209999999999994 109.891 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 54.2 mttm -62.97 -31.79 72.98 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 113.642 0.978 . . . . 74.109999999999999 113.642 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -83.81 64.49 8.08 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.975 0.893 . . . . 74.140000000000001 111.67 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' THR . . . . . 0.43 ' OG1' HD13 ' A' ' 329' ' ' LEU . 13.3 p -132.36 153.91 50.29 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.77 -1.105 . . . . 72.099999999999994 109.288 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 41.8 m -143.77 96.73 2.95 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.429 1.109 . . . . 74.340000000000003 111.143 178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . 0.489 ' O ' HG21 ' A' ' 323' ' ' ILE 0.4 9.0 m-20 57.57 6.06 0.38 Allowed 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 128.303 2.641 . . . . 71.349999999999994 118.063 172.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . 0.433 ' HE2' ' CZ ' ' A' ' 399' ' ' TYR . 31.2 t80 -156.31 127.75 7.14 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.004 -1.48 . . . . 70.329999999999998 107.004 171.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 24.1 t -138.69 142.82 33.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 123.269 0.627 . . . . 75.239999999999995 109.738 -174.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . 0.433 ' CZ ' ' HE2' ' A' ' 397' ' ' PHE . 87.1 m-85 -111.6 96.41 6.07 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.837 -0.801 . . . . 73.319999999999993 108.837 172.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.6 tt -89.27 135.29 33.66 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.568 -0.707 . . . . 72.549999999999997 110.58 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -117.77 108.65 15.63 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.41 -0.959 . . . . 74.349999999999994 108.41 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 369' ' ' ASP . 3.6 p -113.77 151.86 15.54 Favored 'Isoleucine or valine' 0 C--O 1.266 1.935 0 CA-C-O 121.977 0.894 . . . . 64.439999999999998 110.842 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.586 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -135.28 157.91 45.7 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 104.362 -2.459 . . . . 71.409999999999997 104.362 174.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 410' ' ' HIS . 62.1 mttm -95.88 153.16 39.33 Favored Pre-proline 0 C--N 1.274 -2.69 0 C-N-CA 118.159 -1.417 . . . . 75.340000000000003 111.39 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . 0.43 ' HA ' ' OH ' ' A' ' 349' ' ' TYR . 3.9 Cg_exo -37.15 111.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 125.054 3.836 . . . . 74.140000000000001 115.74 -175.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 1.5 p -95.48 -5.66 42.42 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.953 -1.021 . . . . 74.420000000000002 113.155 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -101.74 3.26 52.86 Favored Glycine 0 N--CA 1.438 -1.233 0 C-N-CA 120.01 -1.091 . . . . 74.219999999999999 112.492 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 68.4 m -161.33 -170.67 2.72 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.612 -1.255 . . . . 72.209999999999994 107.612 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -72.3 147.54 46.26 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.076 -0.713 . . . . 70.530000000000001 109.076 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 404' ' ' LYS . 3.1 p-80 -119.59 144.63 47.0 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 113.377 0.88 . . . . 73.409999999999997 113.377 -175.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 . . . . . 0 N--CA 1.433 -1.277 0 N-CA-C 106.137 -1.801 . . . . 73.310000000000002 106.137 179.751 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.459 -2.523 0 N-CA-C 108.092 -1.077 . . . . 71.219999999999999 108.092 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . 0.426 ' HD3' ' OE2' ' A' ' 385' ' ' GLU . 46.8 ttt-85 -167.59 -53.22 0.02 OUTLIER 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 105.19 -2.152 . . . . 74.519999999999996 105.19 -169.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.437 HG22 ' HB ' ' A' ' 388' ' ' VAL . 34.8 p -97.51 178.83 5.06 Favored 'General case' 0 C--O 1.263 1.787 0 N-CA-C 102.386 -3.19 . . . . 70.540000000000006 102.386 164.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -151.78 97.4 2.35 Favored 'General case' 0 C--O 1.167 -3.248 0 CA-C-N 120.371 1.442 . . . . 73.299999999999997 107.799 -173.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . 0.533 ' HG3' ' HB2' ' A' ' 339' ' ' ASN . 28.9 tt0 -57.57 144.47 37.14 Favored 'General case' 0 C--N 1.258 -3.399 0 N-CA-C 113.493 0.923 . . . . 74.040000000000006 113.493 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . 0.478 ' HA ' ' OD1' ' A' ' 339' ' ' ASN . 0.2 OUTLIER 68.18 68.67 0.33 Allowed 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 125.215 1.406 . . . . 72.549999999999997 109.564 -162.771 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 177.44 164.99 0.59 Allowed 'General case' 0 CA--C 1.486 -1.511 0 CA-C-N 113.067 -1.878 . . . . 71.319999999999993 107.717 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.58 150.3 21.28 Favored 'General case' 0 N--CA 1.408 -2.537 0 C-N-CA 118.616 -1.234 . . . . 74.450000000000003 107.804 162.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 332' ' ' SER . 97.2 m -132.23 132.04 42.7 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.38 -0.6 . . . . 73.329999999999998 109.38 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -74.16 131.59 41.42 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-N 115.608 -0.723 . . . . 72.019999999999996 110.65 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 C--N 1.286 -2.193 0 CA-C-N 115.099 -0.955 . . . . 70.299999999999997 108.686 173.307 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' MET . . . . . 0.491 ' HB3' ' O ' ' A' ' 402' ' ' VAL . 24.0 ttt . . . . . 0 C--O 1.193 -1.872 0 N-CA-C 105.814 -1.921 . . . . 75.510000000000005 105.814 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.355 2.0 pm0 -117.23 135.99 53.39 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 115.605 1.705 . . . . 75.120000000000005 115.605 -174.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.429 HD11 ' O ' ' A' ' 363' ' ' GLY . 91.4 mt -116.48 110.2 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.298 0 CA-C-N 112.637 -2.074 . . . . 74.230000000000004 108.98 -176.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -74.3 125.67 28.97 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.101 -1.444 . . . . 75.340000000000003 107.101 171.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 6.0 mt -122.91 149.39 44.3 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.107 -0.952 . . . . 63.130000000000003 110.518 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 37.8 mm -106.55 114.62 46.21 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 109.064 -0.717 . . . . 74.030000000000001 109.064 173.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.645 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 8.7 tmtt? -64.82 152.94 41.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.216 -0.661 . . . . 74.329999999999998 109.216 173.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . 0.402 ' N ' ' HD3' ' A' ' 324' ' ' LYS . . . -143.42 -159.5 8.0 Favored Glycine 0 C--N 1.296 -1.646 0 C-N-CA 120.615 -0.802 . . . . 63.350000000000001 111.678 -177.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.56 -12.71 27.15 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.947 2.431 . . . . 73.540000000000006 112.493 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -103.58 5.02 36.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.168 0.985 . . . . 75.209999999999994 108.818 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.02 -114.6 3.92 Favored Glycine 0 CA--C 1.488 -1.632 0 N-CA-C 108.283 -1.927 . . . . 74.310000000000002 108.283 -176.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.22 -35.55 5.59 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.829 -1.174 . . . . 75.310000000000002 107.829 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.43 50.59 3.98 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.194 -0.912 . . . . 74.400000000000006 115.218 172.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . 0.448 ' O ' HG22 ' B' ' 151' ' ' VAL . 25.7 p90 -154.73 144.5 21.58 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.076 0.465 . . . . 73.129999999999995 110.199 172.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 17.3 m -92.76 125.99 37.64 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.41 -0.813 . . . . 73.099999999999994 109.454 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 49.9 pt -113.09 144.18 21.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 108.502 -0.925 . . . . 73.340000000000003 108.502 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -138.83 131.66 29.29 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.753 -1.203 . . . . 74.319999999999993 107.753 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 144.77 164.12 10.41 Favored Glycine 0 C--N 1.28 -2.583 0 N-CA-C 109.606 -1.397 . . . . 61.149999999999999 109.606 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.09 177.16 14.76 Favored Glycine 0 CA--C 1.479 -2.206 0 N-CA-C 108.13 -1.988 . . . . 54.119999999999997 108.13 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 84.2 t -51.15 107.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 117.634 0.717 . . . . 62.439999999999998 110.954 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 91.34 -18.93 50.08 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.166 -0.925 . . . . 71.030000000000001 112.227 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.585 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 65.6 t30 -105.96 19.71 20.11 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.282 -0.636 . . . . 74.329999999999998 109.282 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.04 125.6 14.16 Favored 'General case' 0 C--O 1.251 1.167 0 CA-C-N 115.793 -0.64 . . . . 72.109999999999999 111.13 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -79.19 -49.11 13.07 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.127 -0.942 . . . . 75.409999999999997 109.768 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 55.7 mt -103.45 125.58 34.53 Favored Pre-proline 0 C--N 1.304 -1.407 0 CA-C-N 115.839 -0.619 . . . . 65.450000000000003 109.711 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -48.96 109.34 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 123.347 2.698 . . . . 73.129999999999995 112.638 177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 102.49 -2.24 49.81 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.387 -0.824 . . . . 73.400000000000006 112.265 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.531 ' CG ' ' HH ' ' A' ' 349' ' ' TYR . 11.9 t70 -128.93 96.89 4.47 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.747 -0.834 . . . . 72.0 108.747 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -83.07 33.03 0.44 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.927 0.87 . . . . 72.099999999999994 111.624 -171.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 0.438 ' HG ' ' CD ' ' A' ' 380' ' ' GLU . 56.7 m -98.96 178.08 5.05 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.798 -0.637 . . . . 75.120000000000005 111.933 -177.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 9.1 mm -90.81 132.83 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.995 -1.113 . . . . 73.349999999999994 107.995 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.531 ' HH ' ' CG ' ' A' ' 345' ' ' ASP . 39.6 m-85 -125.17 138.69 54.14 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 112.725 0.639 . . . . 74.150000000000006 112.725 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 50.9 t -68.05 118.03 11.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.296 -1.002 . . . . 75.409999999999997 108.296 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 17.4 m -105.27 -26.15 12.14 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.065 0.46 . . . . 73.340000000000003 111.285 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -156.7 138.08 13.88 Favored 'General case' 0 C--O 1.2 -1.544 0 N-CA-C 107.198 -1.408 . . . . 74.409999999999997 107.198 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 73.6 mt -110.37 128.35 66.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.342 -1.355 . . . . 74.430000000000007 107.342 172.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 50.1 mm -73.95 134.62 29.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.143 0.497 . . . . 74.530000000000001 109.848 -175.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' A' ' 355' ' ' GLU . 1.5 pm0 -62.68 125.55 24.33 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 124.482 1.113 . . . . 73.129999999999995 110.915 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 74.37 17.96 79.81 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.581 -1.191 . . . . 53.509999999999998 110.949 -175.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.76 160.37 50.39 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 111.512 -0.635 . . . . 75.230000000000004 111.512 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.06 94.49 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.519 -0.919 . . . . 74.209999999999994 108.519 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.43 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -74.64 -5.93 45.82 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.251 -0.431 . . . . 71.239999999999995 111.75 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -93.77 -33.96 13.39 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.575 -0.898 . . . . 75.140000000000001 108.575 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -91.25 -59.75 2.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 123.215 1.483 . . . . 75.400000000000006 109.838 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -87.13 -34.13 19.2 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 112.422 -2.172 . . . . 70.030000000000001 111.004 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.638 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -58.05 -33.64 70.01 Favored Glycine 0 C--O 1.199 -2.035 0 N-CA-C 117.453 1.741 . . . . 71.510000000000005 117.453 -174.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.638 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.62 33.34 0.45 Allowed 'General case' 0 N--CA 1.508 2.426 0 CA-C-N 118.457 1.129 . . . . 75.340000000000003 111.109 -173.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 58.9 tp -99.34 155.65 17.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.415 -1.266 . . . . 75.400000000000006 109.696 -171.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -117.07 146.42 43.12 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.111 0.481 . . . . 75.439999999999998 110.296 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.2 mt -66.22 120.82 14.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 107.506 -1.294 . . . . 73.219999999999999 107.506 171.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.44 -6.62 20.85 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 120.818 -0.706 . . . . 70.219999999999999 112.535 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.39 142.36 43.1 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 112.712 0.634 . . . . 74.239999999999995 112.712 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 9.2 ttmm -88.36 122.47 31.91 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 123.315 0.646 . . . . 73.219999999999999 110.02 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.471 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 3.5 mp -81.15 104.98 12.01 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.334 -1.728 . . . . 75.230000000000004 106.334 174.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.403 ' O ' HD21 ' A' ' 372' ' ' LEU . 5.7 tt -80.24 -37.74 32.38 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.053 -1.462 . . . . 74.409999999999997 107.053 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 401' ' ' LYS . . . -160.98 157.66 26.7 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.371 -0.831 . . . . 70.209999999999994 110.513 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 14.6 p -133.42 127.53 53.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.929 -1.137 . . . . 61.310000000000002 107.929 173.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 63.67 31.55 14.39 Favored 'General case' 0 C--O 1.206 -1.221 0 CA-C-O 124.011 1.862 . . . . 71.25 107.739 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 65.86 4.49 2.98 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 111.211 -2.722 . . . . 74.439999999999998 113.938 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 46.4 t -80.23 123.12 36.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.06 -1.089 . . . . 74.040000000000006 108.06 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.5 p -58.98 122.92 14.89 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.719 1.007 . . . . 75.140000000000001 113.719 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.42 -1.97 20.98 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 124.434 1.094 . . . . 65.329999999999998 111.356 177.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.438 ' CD ' ' HG ' ' A' ' 347' ' ' SER . 11.3 mm-40 -64.77 108.53 1.76 Allowed 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.554 -0.536 . . . . 73.450000000000003 109.554 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 61.78 71.07 0.56 Allowed 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 122.527 1.156 . . . . 75.430000000000007 112.909 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.0 168.77 23.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 106.989 -1.486 . . . . 74.209999999999994 106.989 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.7 m -76.52 139.33 40.71 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.559 -0.904 . . . . 72.420000000000002 108.559 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . 0.596 ' O ' HG22 ' A' ' 388' ' ' VAL . 84.8 t60 -48.42 -48.82 36.91 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.77 0.655 . . . . 75.540000000000006 112.77 -175.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -59.54 -42.58 92.65 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.936 -0.765 . . . . 75.019999999999996 108.936 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 383' ' ' THR . 49.3 tt0 -67.71 -32.44 73.08 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.213 -1.358 . . . . 71.010000000000005 109.115 -174.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.512 ' O ' HD11 ' A' ' 391' ' ' LEU . . . -73.78 -50.51 20.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.828 -1.078 . . . . 75.129999999999995 110.289 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 384' ' ' HIS . 15.8 t -59.62 -46.99 92.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 109.819 -0.437 . . . . 71.439999999999998 109.819 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 42.7 m -62.78 -29.97 71.11 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.553 -0.748 . . . . 72.540000000000006 112.164 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.94 -34.53 78.33 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.124 -0.36 . . . . 71.349999999999994 110.248 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.512 HD11 ' O ' ' A' ' 387' ' ' ALA . 5.5 mp -79.03 -33.61 44.62 Favored 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 120.253 -0.579 . . . . 73.120000000000005 110.738 176.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -67.23 -29.32 68.93 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.413 0.523 . . . . 72.540000000000006 112.413 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -80.21 48.14 0.97 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.44 0.638 . . . . 54.439999999999998 112.156 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' THR . . . . . 0.4 ' HB ' HG23 ' A' ' 398' ' ' VAL . 32.4 p -124.54 146.93 48.72 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.311 -0.996 . . . . 70.120000000000005 108.311 176.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.6 t -141.04 98.69 3.43 Favored 'General case' 0 N--CA 1.409 -2.509 0 C-N-CA 117.711 -1.596 . . . . 70.439999999999998 110.935 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . 0.645 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 6.2 m-20 65.63 16.13 10.36 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 110.89 -2.868 . . . . 64.049999999999997 112.951 166.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -161.65 115.54 1.92 Allowed 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.471 -1.307 . . . . 73.209999999999994 107.471 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.4 HG23 ' HB ' ' A' ' 394' ' ' THR . 28.8 t -133.74 151.04 32.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 123.034 0.534 . . . . 65.209999999999994 110.518 -175.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -126.24 99.79 6.03 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.723 -1.214 . . . . 70.219999999999999 107.723 171.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.2 tt -91.75 119.5 31.64 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.525 -1.287 . . . . 75.239999999999995 107.525 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 373' ' ' ALA . 24.0 ttmm -103.64 107.89 18.93 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.693 -1.225 . . . . 74.25 107.693 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 318' ' ' MET . 1.9 p -107.58 149.99 10.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 CA-C-O 121.744 0.783 . . . . 71.120000000000005 110.498 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.52 159.6 41.31 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.82 -1.082 . . . . 70.049999999999997 108.14 176.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.94 153.88 84.85 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 109.079 -0.712 . . . . 71.120000000000005 109.079 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . 0.523 ' HA ' ' OH ' ' A' ' 349' ' ' TYR . 10.7 Cg_endo -55.01 120.25 7.86 Favored 'Trans proline' 0 C--O 1.212 -0.79 0 C-N-CA 123.021 2.481 . . . . 72.439999999999998 112.524 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 4.8 m -96.61 9.67 40.85 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.625 0.726 . . . . 72.239999999999995 111.102 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -89.44 -156.93 32.45 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.699 -0.762 . . . . 73.109999999999999 113.981 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 12.5 m -68.91 -27.23 65.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.994 0.902 . . . . 72.530000000000001 108.963 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -107.92 101.11 10.41 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 106.032 -1.84 . . . . 71.030000000000001 106.032 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -121.04 143.8 48.87 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 123.473 0.483 . . . . 74.530000000000001 112.067 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.423 ' H ' ' HG2' ' A' ' 405' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.056 0 C-N-CA 126.432 1.893 . . . . 75.049999999999997 107.392 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.473 -1.989 0 N-CA-C 107.779 -1.193 . . . . 74.219999999999999 107.779 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . 0.523 ' HD3' ' O ' ' B' ' 142' ' ' ARG . 2.4 tmt_? -133.45 -16.06 2.41 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 124.122 0.889 . . . . 72.109999999999999 108.62 -173.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.439 HG22 HG21 ' B' ' 149' ' ' THR . 17.9 p -84.24 114.03 21.53 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 107.798 -1.186 . . . . 73.219999999999999 107.798 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -154.88 143.93 20.98 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.629 -0.878 . . . . 75.400000000000006 108.629 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -70.58 165.64 22.33 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.111 0.481 . . . . 75.049999999999997 111.601 176.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 66.57 28.44 9.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.803 1.641 . . . . 73.099999999999994 112.407 -174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -166.37 177.95 6.47 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 114.786 -1.097 . . . . 70.420000000000002 109.063 175.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.36 165.11 12.73 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.507 -0.923 . . . . 65.450000000000003 108.507 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.467 ' HA ' ' NH1' ' B' ' 142' ' ' ARG . 27.6 m -147.14 129.06 15.39 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.409 -0.589 . . . . 74.219999999999999 109.409 170.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 41.6 tt0 -71.14 131.27 43.32 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-O 121.088 0.471 . . . . 70.420000000000002 110.771 175.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 331' ' ' PHE . 17.4 m . . . . . 0 C--N 1.301 -1.527 0 CA-C-O 116.786 -1.578 . . . . 73.349999999999994 111.627 176.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 64.4 ttp . . . . . 0 CA--C 1.5 -0.951 0 N-CA-C 107.451 -1.314 . . . . 71.209999999999994 107.451 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.297 1.6 pm0 -89.88 133.22 34.87 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 114.514 1.302 . . . . 72.420000000000002 114.514 -177.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 77.9 mt -120.16 114.95 45.75 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.677 0 CA-C-N 112.135 -2.302 . . . . 74.549999999999997 108.789 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -81.43 121.29 26.06 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.235 -1.024 . . . . 73.239999999999995 108.235 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.531 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 95.5 mt -118.4 150.06 40.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 124.363 1.039 . . . . 64.239999999999995 108.807 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 42.9 mm -106.37 116.75 50.78 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 N-CA-C 109.286 -0.635 . . . . 73.340000000000003 109.286 173.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 396' ' ' ASP . 12.1 tmtt? -71.13 153.63 42.37 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 107.707 -1.22 . . . . 74.430000000000007 107.707 171.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . 0.414 ' O ' ' HE2' ' A' ' 324' ' ' LYS . . . -153.05 -154.94 6.91 Favored Glycine 0 C--N 1.302 -1.321 0 C-N-CA 119.625 -1.274 . . . . 42.399999999999999 113.291 -174.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.86 -22.59 36.2 Favored 'Trans proline' 0 C--O 1.217 -0.558 0 C-N-CA 123.165 2.577 . . . . 72.109999999999999 113.939 -175.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -106.07 20.57 18.74 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 122.224 1.011 . . . . 75.299999999999997 108.618 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.71 -133.61 11.96 Favored Glycine 0 CA--C 1.477 -2.298 0 CA-C-N 114.034 -1.439 . . . . 62.020000000000003 109.649 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 14.6 tp -109.26 -34.96 6.41 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 106.903 -1.517 . . . . 74.109999999999999 106.903 175.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . 0.467 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 86.32 47.18 5.02 Favored Glycine 0 N--CA 1.429 -1.822 0 CA-C-N 113.746 -1.57 . . . . 75.540000000000006 116.72 171.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -152.48 150.19 29.35 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 117.928 0.864 . . . . 74.549999999999997 112.23 169.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 6.5 m -104.71 129.34 52.93 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.197 -0.91 . . . . 62.32 109.263 -177.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 47.9 pt -113.75 150.96 15.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 115.544 -0.753 . . . . 73.420000000000002 108.994 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.503 ' HA ' ' CE1' ' A' ' 384' ' ' HIS . . . -146.3 130.68 17.64 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.343 -1.354 . . . . 74.540000000000006 107.343 175.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.531 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 145.05 160.24 8.46 Favored Glycine 0 C--N 1.283 -2.372 0 N-CA-C 110.705 -0.958 . . . . 71.310000000000002 110.705 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.9 -175.26 20.69 Favored Glycine 0 N--CA 1.424 -2.122 0 N-CA-C 108.253 -1.939 . . . . 70.439999999999998 108.253 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 91.0 t -51.07 105.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 O-C-N 124.358 0.681 . . . . 73.049999999999997 111.392 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 87.38 -14.92 56.65 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.449 -0.796 . . . . 71.109999999999999 112.74 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.531 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -105.41 12.72 31.22 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.873 -1.158 . . . . 71.420000000000002 107.873 -177.618 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.432 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -53.31 126.65 21.89 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.614 0.766 . . . . 63.210000000000001 111.749 -176.476 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . 0.542 ' HB3' ' CD2' ' A' ' 349' ' ' TYR . 15.7 t60 -86.64 -38.0 17.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.63 -0.714 . . . . 75.319999999999993 110.003 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 37.9 mm -102.62 118.78 57.77 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 109.929 -0.397 . . . . 75.0 109.929 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.07 110.62 0.46 Allowed 'Trans proline' 0 C--O 1.252 1.183 0 C-N-CA 123.093 2.529 . . . . 74.400000000000006 111.411 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 108.29 -5.62 33.79 Favored Glycine 0 N--CA 1.429 -1.814 0 CA-C-N 115.143 -0.935 . . . . 71.030000000000001 112.159 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -131.67 104.33 6.87 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.183 -0.673 . . . . 64.430000000000007 109.183 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . 0.432 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 66.3 t30 -83.92 37.91 0.62 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.282 1.039 . . . . 65.140000000000001 110.612 -173.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 50.1 m -103.95 177.65 4.78 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.96 -1.018 . . . . 74.439999999999998 112.235 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 4.5 mm -93.16 138.6 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.428 -0.953 . . . . 75.519999999999996 108.428 -177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.542 ' CD2' ' HB3' ' A' ' 341' ' ' HIS . 95.8 m-85 -129.84 141.86 50.76 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 112.309 0.485 . . . . 63.210000000000001 112.309 -178.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 56.8 t -74.37 115.5 15.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 107.747 -1.205 . . . . 73.439999999999998 107.747 175.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.9 m -98.85 -24.2 15.08 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 121.388 0.613 . . . . 73.109999999999999 110.473 -175.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 332' ' ' SER . 33.3 ttmt -158.8 150.13 20.58 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 107.801 -1.185 . . . . 74.329999999999998 107.801 -173.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 60.1 mt -130.7 116.26 34.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 107.08 -1.452 . . . . 74.239999999999995 107.08 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 46.2 mm -84.99 124.68 40.13 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 C-N-CA 123.481 0.712 . . . . 73.129999999999995 110.491 -171.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.485 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 0.6 OUTLIER -60.53 147.26 42.05 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.873 -0.788 . . . . 72.530000000000001 108.873 -177.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 94.2 -24.63 26.12 Favored Glycine 0 CA--C 1.478 -2.265 0 N-CA-C 109.486 -1.446 . . . . 71.319999999999993 109.486 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . 0.467 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -68.53 142.86 39.52 Favored Glycine 1 N--CA 1.395 -4.053 0 N-CA-C 108.0 -2.04 . . . . 52.229999999999997 108.0 172.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 362' ' ' ASP . . . -63.87 -32.56 74.13 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.296 -0.631 . . . . 74.439999999999998 109.296 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.625 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.11 -4.62 39.71 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 120.7 -0.4 . . . . 73.319999999999993 111.744 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . 0.485 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 17.1 t60 -94.68 -49.2 5.73 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.694 -0.854 . . . . 74.420000000000002 108.694 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -79.27 -50.42 10.94 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.386 -0.825 . . . . 72.519999999999996 111.928 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . 0.646 ' O ' ' HE2' ' A' ' 364' ' ' LYS . 11.4 t70 -85.76 -34.89 21.06 Favored 'General case' 0 CA--C 1.465 -2.303 0 C-N-CA 124.085 0.954 . . . . 75.430000000000007 109.888 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -42.39 -25.64 0.3 Allowed Glycine 0 CA--C 1.486 -1.763 0 N-CA-C 119.96 2.744 . . . . 74.140000000000001 119.96 -161.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.646 ' HE2' ' O ' ' A' ' 362' ' ' ASP . 0.0 OUTLIER 47.03 31.16 1.46 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.356 1.078 . . . . 70.109999999999999 111.069 178.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 48.6 tp -113.6 150.87 32.47 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 114.597 -1.183 . . . . 73.099999999999994 109.336 -170.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -122.88 148.44 45.43 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.388 0.614 . . . . 74.230000000000004 111.186 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.6 mt -65.97 126.05 24.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.272 -1.01 . . . . 65.430000000000007 108.272 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.64 -18.6 14.97 Favored Glycine 0 C--N 1.313 -0.748 0 N-CA-C 111.645 -0.582 . . . . 55.229999999999997 111.645 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -62.93 130.84 46.53 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-O 121.16 0.505 . . . . 72.010000000000005 111.827 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.535 ' HB2' ' CE1' ' A' ' 349' ' ' TYR . 50.9 tttt -88.84 127.01 35.62 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.562 -0.745 . . . . 74.150000000000006 110.581 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 3.3 mp -81.3 107.03 13.74 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.891 -1.522 . . . . 74.409999999999997 106.891 177.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.496 HD13 ' HB1' ' A' ' 403' ' ' ALA . 3.4 tt -80.31 -43.31 21.47 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 106.273 -1.751 . . . . 73.200000000000003 106.273 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -157.45 154.56 28.95 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.075 -0.966 . . . . 65.519999999999996 110.1 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.77 120.6 42.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 108.525 -0.917 . . . . 74.030000000000001 108.525 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 63.51 30.51 15.17 Favored 'General case' 0 CA--C 1.484 -1.574 0 CA-C-O 123.978 1.847 . . . . 71.109999999999999 108.321 -174.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.9 t30 66.57 16.15 10.32 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 109.793 -3.367 . . . . 75.049999999999997 112.605 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.88 124.36 39.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 106.271 -1.752 . . . . 74.099999999999994 106.271 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.9 p -65.08 125.36 24.69 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.893 0.701 . . . . 72.349999999999994 112.893 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.21 5.94 28.19 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 123.809 0.843 . . . . 74.319999999999993 111.108 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.429 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 28.4 mm-40 -68.48 111.66 4.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.227 -0.657 . . . . 73.150000000000006 109.227 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 56.09 67.9 0.94 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.572 1.177 . . . . 74.310000000000002 113.22 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.72 167.63 23.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 107.112 -1.44 . . . . 65.140000000000001 107.112 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.6 m -74.89 142.41 44.06 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.29 -1.004 . . . . 74.120000000000005 108.29 -177.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . 0.624 ' O ' HG22 ' A' ' 388' ' ' VAL . 86.3 t60 -52.93 -49.38 66.13 Favored 'General case' 0 C--O 1.213 -0.843 0 N-CA-C 112.252 0.464 . . . . 75.430000000000007 112.252 -176.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.414 ' HG3' ' OG1' ' B' ' 143' ' ' THR . 26.8 tt0 -61.64 -30.34 70.64 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.447 0.641 . . . . 73.109999999999999 111.435 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.5 tt0 -75.01 -35.74 61.96 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.044 -0.98 . . . . 75.030000000000001 108.426 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -75.09 -38.84 61.09 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.059 -0.973 . . . . 55.43 110.585 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.624 HG22 ' O ' ' A' ' 384' ' ' HIS . 11.7 t -65.08 -42.33 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 109.011 -0.737 . . . . 64.519999999999996 109.011 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 60.9 m -60.32 -40.79 91.85 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 123.417 0.448 . . . . 72.450000000000003 110.08 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -62.26 -35.43 78.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.628 -0.26 . . . . 62.409999999999997 111.479 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 57.4 tp -82.34 -22.75 35.4 Favored 'General case' 0 N--CA 1.394 -3.272 0 C-N-CA 122.823 0.449 . . . . 74.129999999999995 109.904 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 61.1 mttm -77.96 -21.63 50.7 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 120.869 0.366 . . . . 75.140000000000001 111.033 176.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -76.18 47.37 0.45 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.498 -0.774 . . . . 75.319999999999993 110.411 174.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' THR . . . . . 0.429 ' HB ' HG23 ' A' ' 398' ' ' VAL . 22.5 p -124.61 133.55 53.23 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.087 -1.079 . . . . 75.109999999999999 108.087 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' SER . . . . . 0.532 ' HA ' ' HD2' ' A' ' 324' ' ' LYS . 50.8 m -139.15 97.73 3.36 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.814 -1.154 . . . . 73.310000000000002 111.798 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . 0.593 ' HA ' ' O ' ' A' ' 324' ' ' LYS . 5.8 m-20 60.68 18.57 8.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 111.415 -2.63 . . . . 73.219999999999999 112.816 171.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -166.69 130.13 1.93 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.389 -1.278 . . . . 74.120000000000005 107.567 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 22.0 t -145.24 143.43 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 122.832 0.453 . . . . 75.140000000000001 111.086 -176.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -117.04 96.78 5.61 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.378 -0.971 . . . . 63.240000000000002 108.378 167.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.89 113.95 25.74 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.97 -0.752 . . . . 72.099999999999994 108.97 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -93.06 109.7 21.18 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.546 -1.279 . . . . 74.329999999999998 107.546 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 69.2 t -104.49 148.18 9.51 Favored 'Isoleucine or valine' 0 C--O 1.258 1.551 0 CA-C-O 121.368 0.604 . . . . 72.129999999999995 110.091 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.25 158.94 43.22 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 125.083 1.353 . . . . 75.540000000000006 107.543 176.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.409 ' HG3' ' C ' ' A' ' 411' ' ' HIS . 0.4 OUTLIER -81.55 153.31 70.79 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.826 -1.175 . . . . 74.329999999999998 107.826 173.237 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -49.34 123.26 9.93 Favored 'Trans proline' 0 N--CA 1.44 -1.647 0 C-N-CA 122.968 2.445 . . . . 64.140000000000001 112.199 177.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 2.6 m -95.74 20.65 9.49 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.022 -1.444 . . . . 75.150000000000006 109.663 -175.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -98.51 -140.92 11.72 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-N 115.242 -0.89 . . . . 64.319999999999993 111.988 -178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 16.4 m -92.08 10.55 28.72 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.263 0.554 . . . . 71.439999999999998 110.74 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -142.64 147.46 35.8 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 106.975 -1.491 . . . . 75.239999999999995 106.975 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -129.51 132.73 46.96 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 123.234 0.334 . . . . 72.530000000000001 110.159 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.409 ' C ' ' HG3' ' A' ' 404' ' ' LYS . 91.2 m-70 . . . . . 0 C--N 1.31 -1.132 0 N-CA-C 107.73 -1.211 . . . . 74.430000000000007 107.73 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.488 0 N-CA-C 110.609 -0.145 . . . . 73.519999999999996 110.609 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . 0.432 ' HE ' ' HB3' ' B' ' 142' ' ' ARG . 10.1 mtp180 69.32 178.27 0.26 Allowed 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.291 1.043 . . . . 74.439999999999998 113.149 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.414 ' OG1' ' HG3' ' A' ' 385' ' ' GLU . 17.5 p -96.97 152.74 18.42 Favored 'General case' 0 N--CA 1.405 -2.679 0 CA-C-N 113.211 -1.813 . . . . 72.109999999999999 106.796 175.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . 0.41 HH21 ' CD ' ' A' ' 385' ' ' GLU . 3.7 mmp_? -153.88 141.79 20.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 109.107 -0.701 . . . . 72.030000000000001 109.107 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -86.72 166.89 14.94 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 123.525 0.515 . . . . 75.109999999999999 111.035 176.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 67.72 21.33 9.28 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.063 1.745 . . . . 72.010000000000005 112.34 -174.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -155.54 178.86 9.75 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.897 -1.047 . . . . 70.200000000000003 108.52 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -92.21 149.97 21.16 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.393 -0.966 . . . . 74.030000000000001 108.393 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 20.1 m -134.8 129.76 35.06 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.204 -0.665 . . . . 65.129999999999995 109.204 174.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 50.2 tt0 -85.29 139.98 31.18 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 112.631 0.604 . . . . 73.299999999999997 112.631 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 51.0 t . . . . . 0 C--N 1.312 -1.04 0 N-CA-C 106.641 -1.614 . . . . 74.450000000000003 106.641 172.625 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.487 -1.479 0 N-CA-C 108.93 -0.767 . . . . 75.150000000000006 108.93 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -132.84 121.19 22.56 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 108.171 -1.048 . . . . 71.239999999999995 108.171 171.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 64.5 mt -98.1 105.75 17.71 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.033 0 CA-C-N 114.275 -1.33 . . . . 74.420000000000002 108.531 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -89.24 102.43 15.09 Favored 'General case' 0 N--CA 1.38 -3.971 0 N-CA-C 105.105 -2.183 . . . . 74.219999999999999 105.105 169.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.417 ' HA ' ' OD2' ' A' ' 362' ' ' ASP . 0.5 OUTLIER -106.31 138.83 41.79 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 112.486 -2.143 . . . . 72.140000000000001 108.092 -170.15 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 25.8 mm -98.53 114.83 37.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 CA-C-O 121.344 0.593 . . . . 75.019999999999996 110.161 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -75.3 148.7 39.13 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.425 -0.807 . . . . 73.430000000000007 110.3 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -135.38 -161.09 9.2 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.857 -0.687 . . . . 75.140000000000001 111.86 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.64 -16.59 33.87 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.041 2.494 . . . . 75.409999999999997 113.333 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -101.66 10.23 40.33 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.318 1.056 . . . . 71.209999999999994 108.633 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.77 -128.67 8.7 Favored Glycine 0 CA--C 1.478 -2.234 0 CA-C-N 114.3 -1.318 . . . . 74.540000000000006 110.741 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.3 mp -101.35 -44.65 5.57 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 105.918 -1.882 . . . . 75.329999999999998 105.918 174.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 80.36 49.37 5.89 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 114.852 -1.067 . . . . 73.219999999999999 114.514 172.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -151.41 147.74 27.25 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.842 -0.429 . . . . 74.099999999999994 109.842 174.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 4.2 m -97.93 124.59 42.44 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 108.436 -0.95 . . . . 72.400000000000006 108.436 -176.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 46.4 pt -113.48 153.09 15.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 108.611 -0.885 . . . . 75.519999999999996 108.611 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.92 129.35 15.85 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.077 -0.712 . . . . 74.319999999999993 109.077 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 152.35 165.55 13.33 Favored Glycine 0 C--N 1.282 -2.433 0 N-CA-C 110.208 -1.157 . . . . 74.129999999999995 110.208 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 136.69 -176.83 20.14 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 107.663 -2.175 . . . . 72.540000000000006 107.663 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.403 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 58.6 t -54.32 100.5 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.249 1.042 0 CA-C-O 122.096 0.951 . . . . 75.019999999999996 112.495 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 80.84 4.49 90.39 Favored Glycine 0 C--O 1.21 -1.404 0 CA-C-N 115.121 -0.945 . . . . 62.130000000000003 112.002 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.533 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -106.46 11.66 30.5 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.782 -1.562 . . . . 74.409999999999997 106.782 178.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -49.8 122.67 6.79 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.839 1.256 . . . . 72.129999999999995 112.701 -175.633 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -79.27 -38.52 35.24 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.307 -0.86 . . . . 73.129999999999995 109.572 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.6 123.97 38.54 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 108.564 -0.902 . . . . 70.430000000000007 108.564 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.36 107.51 0.21 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.971 2.447 . . . . 75.099999999999994 112.293 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.89 -8.97 29.66 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-N 115.26 -0.882 . . . . 75.409999999999997 112.591 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . 0.438 ' HB2' ' OG ' ' A' ' 408' ' ' SER . 3.1 t70 -125.22 106.94 10.25 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.39 -0.924 . . . . 72.540000000000006 110.288 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . 0.423 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 61.9 t30 -80.37 28.19 0.32 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.734 1.214 . . . . 73.150000000000006 111.747 -171.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 0.625 ' OG ' ' HE2' ' A' ' 370' ' ' LYS . 24.9 m -99.28 175.63 5.81 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.841 -0.618 . . . . 61.439999999999998 112.134 -175.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.487 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 6.0 mm -89.72 132.2 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 108.016 -1.105 . . . . 74.030000000000001 108.016 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.583 ' CE2' ' HB2' ' A' ' 370' ' ' LYS . 68.0 m-85 -128.01 149.57 50.3 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.948 0.404 . . . . 73.140000000000001 111.868 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.69 123.72 32.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.482 -0.933 . . . . 74.420000000000002 108.482 175.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 33.2 m -108.11 -28.47 9.5 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.932 0.396 . . . . 73.030000000000001 111.474 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 50.9 mtmt -152.27 151.96 31.58 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.862 -0.792 . . . . 74.200000000000003 108.862 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 68.4 mt -129.41 121.98 54.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.623 -1.621 . . . . 74.430000000000007 106.623 174.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 50.0 mm -78.16 142.01 14.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 123.408 0.683 . . . . 75.450000000000003 112.173 -170.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.98 122.64 12.78 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.698 1.199 . . . . 75.239999999999995 112.28 -174.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 72.31 12.25 76.39 Favored Glycine 0 C--N 1.306 -1.087 0 CA-C-N 115.605 -0.725 . . . . 61.149999999999999 112.966 177.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -74.27 164.26 54.65 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 110.735 -0.946 . . . . 62.43 110.735 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.53 98.08 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.172 -0.677 . . . . 72.319999999999993 109.172 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.566 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.58 -4.6 40.91 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.134 -0.485 . . . . 74.400000000000006 112.015 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -94.11 -32.69 13.66 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.849 -0.797 . . . . 75.340000000000003 108.849 176.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -95.8 -58.17 2.17 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.997 -0.681 . . . . 74.25 112.332 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . 0.417 ' OD2' ' HA ' ' A' ' 322' ' ' LEU . 27.7 t70 -86.18 -21.97 27.22 Favored 'General case' 0 CA--C 1.473 -2.019 0 CA-C-N 115.726 -0.67 . . . . 63.009999999999998 110.366 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -43.0 -34.9 2.13 Favored Glycine 0 CA--C 1.479 -2.172 0 CA-C-O 117.751 -1.583 . . . . 33.409999999999997 116.144 -172.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? 42.8 40.37 2.07 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.937 0.875 . . . . 64.439999999999998 110.15 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 60.3 tp -133.45 154.39 50.83 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 113.588 -1.642 . . . . 75.519999999999996 108.977 -167.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -122.66 152.33 40.62 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.736 0.779 . . . . 74.420000000000002 111.141 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.7 mt -65.71 123.68 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 108.024 -1.102 . . . . 73.439999999999998 108.024 174.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.17 -6.16 21.58 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.684 -0.769 . . . . 62.130000000000003 112.342 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -74.23 141.62 45.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.026 0.75 . . . . 70.239999999999995 113.026 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.638 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 47.1 tttm -96.08 118.43 32.65 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 123.978 0.911 . . . . 64.219999999999999 110.31 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 3.0 mp -78.85 114.46 17.8 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.674 -1.232 . . . . 73.510000000000005 107.674 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.508 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 5.7 tt -86.84 -43.01 12.8 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.943 -1.132 . . . . 72.519999999999996 107.943 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -157.2 150.64 24.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.046 -0.524 . . . . 75.329999999999998 111.024 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 9.8 p -133.59 123.8 46.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 109.006 -0.739 . . . . 75.409999999999997 109.006 173.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 60.95 31.86 19.96 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-O 124.145 1.926 . . . . 75.409999999999997 109.536 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 67.23 12.36 8.9 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 109.08 -3.691 . . . . 73.25 112.903 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 54.9 t -82.29 125.3 39.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 106.697 -1.594 . . . . 74.129999999999995 106.697 173.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.8 p -66.74 126.55 29.36 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 123.61 0.569 . . . . 73.530000000000001 112.267 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.02 6.07 30.88 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.714 0.806 . . . . 72.209999999999994 110.725 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . 0.508 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 13.6 mm-40 -70.81 107.43 3.99 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.217 -0.901 . . . . 74.409999999999997 109.253 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 57.8 71.59 0.57 Allowed 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.371 1.081 . . . . 73.109999999999999 113.36 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.69 172.53 15.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.023 -1.473 . . . . 72.109999999999999 107.023 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 81.0 p -81.23 146.69 30.33 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.066 -1.054 . . . . 74.0 108.769 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -52.33 -31.45 33.32 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 112.937 0.717 . . . . 63.539999999999999 112.937 -176.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.524 ' HA ' ' OG1' ' B' ' 143' ' ' THR . 14.0 tp10 -64.5 -40.85 96.42 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-O 120.625 0.25 . . . . 74.319999999999993 110.875 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.62 -40.22 80.44 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.637 -0.875 . . . . 74.140000000000001 108.637 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -62.42 -59.04 5.54 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.5 -1.227 . . . . 74.030000000000001 110.629 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.444 ' O ' ' HG2' ' A' ' 392' ' ' LYS . 90.4 t -57.3 -44.91 84.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 O-C-N 123.212 0.32 . . . . 73.099999999999994 111.546 -177.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 55.4 m -60.65 -34.12 73.82 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 111.927 0.343 . . . . 71.439999999999998 111.927 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.8 77.88 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 110.277 -0.268 . . . . 65.019999999999996 110.277 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.9 mp -79.28 -28.73 42.32 Favored 'General case' 0 C--O 1.218 -0.57 0 C-N-CA 120.339 -0.544 . . . . 74.439999999999998 110.792 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 388' ' ' VAL . 73.0 mmtt -61.94 -41.61 98.17 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 120.608 0.242 . . . . 73.329999999999998 111.014 176.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -77.46 70.7 3.88 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 122.561 1.172 . . . . 74.140000000000001 111.021 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 12.9 p -142.45 155.46 45.08 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 113.241 -1.8 . . . . 65.319999999999993 108.561 178.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 32.5 p -166.45 115.81 0.92 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.591 -0.522 . . . . 61.32 109.591 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.8 t70 64.39 0.07 1.0 Allowed 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 125.365 1.466 . . . . 74.439999999999998 112.043 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -163.48 137.87 6.04 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.532 -0.914 . . . . 72.530000000000001 108.532 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 48.0 t -139.51 120.62 15.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 106.437 -1.69 . . . . 75.400000000000006 106.437 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.22 95.13 5.76 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.134 -1.432 . . . . 61.329999999999998 107.134 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.4 tt -108.94 111.12 22.63 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-O 121.038 0.447 . . . . 73.319999999999993 110.439 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.24 121.25 30.43 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.013 -1.106 . . . . 73.299999999999997 108.013 176.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 2.1 p -115.9 137.33 49.92 Favored 'Isoleucine or valine' 0 C--O 1.258 1.534 0 C-N-CA 123.578 0.751 . . . . 74.019999999999996 110.045 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.638 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.48 158.72 43.77 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.364 -0.976 . . . . 61.43 108.364 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.436 ' HG3' ' C ' ' A' ' 411' ' ' HIS . 0.4 OUTLIER -78.43 153.77 79.04 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 108.723 -0.843 . . . . 63.43 108.723 175.255 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . 0.415 ' HG2' ' HA ' ' A' ' 410' ' ' HIS . 50.0 Cg_exo -35.41 125.21 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.914 3.743 . . . . 74.400000000000006 114.025 177.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 28.1 m -86.68 -38.12 17.32 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.577 -1.192 . . . . 75.310000000000002 111.291 -173.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -125.83 31.12 4.21 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 119.349 -1.405 . . . . 62.340000000000003 112.92 -175.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' SER . . . . . 0.438 ' OG ' ' HB2' ' A' ' 345' ' ' ASP . 33.9 p -154.55 -167.54 2.64 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.843 -0.428 . . . . 70.109999999999999 109.843 -178.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -71.03 109.56 5.2 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.93 -0.766 . . . . 74.439999999999998 108.93 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . 0.415 ' HA ' ' HG2' ' A' ' 405' ' ' PRO . 3.3 p-80 -71.14 132.84 45.63 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 115.163 1.542 . . . . 75.120000000000005 115.163 -176.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.436 ' C ' ' HG3' ' A' ' 404' ' ' LYS . 40.3 t-80 . . . . . 0 N--CA 1.435 -1.219 0 C-N-CA 126.293 1.837 . . . . 74.319999999999993 106.072 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . 0.512 ' H1 ' HG21 ' B' ' 143' ' ' THR . . . . . . . . 0 CA--C 1.488 -1.421 0 CA-C-O 121.229 0.538 . . . . 72.329999999999998 110.058 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . 0.464 ' O ' ' HD2' ' B' ' 142' ' ' ARG . 0.6 OUTLIER 68.91 45.88 0.92 Allowed 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 123.547 1.641 . . . . 72.519999999999996 108.691 173.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.524 ' OG1' ' HA ' ' A' ' 385' ' ' GLU . 72.9 p -88.54 -176.4 5.28 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 112.409 -2.178 . . . . 73.319999999999993 106.684 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . 0.613 ' HB2' HD22 ' B' ' 147' ' ' ASN . 52.0 mtm180 -148.19 126.78 12.46 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.694 -1.595 . . . . 63.409999999999997 106.694 -172.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . 0.411 ' HA ' ' OD1' ' A' ' 339' ' ' ASN . 9.3 pt20 -86.64 164.92 16.53 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 113.452 0.908 . . . . 75.420000000000002 113.452 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . 0.466 ' HD2' ' N ' ' B' ' 146' ' ' ARG . 1.0 OUTLIER 66.92 29.01 8.44 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.491 1.916 . . . . 75.219999999999999 111.112 -175.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . 0.613 HD22 ' HB2' ' B' ' 144' ' ' ARG . 0.2 OUTLIER -164.74 -179.13 5.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.182 -1.372 . . . . 62.409999999999997 107.991 179.415 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.42 152.3 19.79 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 123.427 0.454 . . . . 63.240000000000002 112.208 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 41.9 m -142.51 141.82 32.15 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.886 -0.509 . . . . 75.010000000000005 109.862 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -77.16 152.99 34.62 Favored 'General case' 0 CA--C 1.462 -2.44 0 C-N-CA 123.918 0.887 . . . . 74.129999999999995 113.193 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.392 -3.354 0 C-N-CA 118.37 -1.332 . . . . 71.349999999999994 110.847 169.433 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 53.6 ttm . . . . . 0 C--O 1.205 -1.256 0 N-CA-C 106.107 -1.812 . . . . 64.230000000000004 106.107 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.428 1.9 pm0 -114.59 130.89 56.82 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 116.787 2.143 . . . . 62.219999999999999 116.787 -173.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.428 HG21 ' CD ' ' A' ' 364' ' ' LYS . 72.5 mt -111.88 112.66 41.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-N 111.573 -2.558 . . . . 75.140000000000001 108.83 -176.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . 0.629 ' HD3' ' CE1' ' A' ' 399' ' ' TYR . 30.6 ttpt -82.97 125.08 31.01 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.42 -0.955 . . . . 72.319999999999993 108.42 173.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.546 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 96.3 mt -119.29 154.06 34.08 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 124.904 1.377 . . . . 73.230000000000004 108.762 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.402 HG23 ' O ' ' A' ' 396' ' ' ASP . 49.5 mt -106.44 145.55 14.06 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.121 0 N-CA-C 106.467 -1.679 . . . . 71.299999999999997 106.467 169.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 395' ' ' SER . 1.3 ttpm? -75.26 177.81 6.25 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.732 -1.211 . . . . 73.219999999999999 107.732 177.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . 0.423 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -160.78 -167.91 21.93 Favored Glycine 0 C--N 1.289 -2.067 0 C-N-CA 119.949 -1.119 . . . . 72.200000000000003 111.665 -177.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.27 -29.23 32.58 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 123.166 2.578 . . . . 75.310000000000002 112.405 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -106.39 25.29 11.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.241 0.543 . . . . 75.209999999999994 110.041 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.99 -125.52 7.13 Favored Glycine 0 CA--C 1.485 -1.793 0 N-CA-C 109.442 -1.463 . . . . 62.130000000000003 109.442 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.7 mp -97.49 -30.84 12.66 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.288 -1.745 . . . . 72.140000000000001 106.288 173.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.99 48.7 4.54 Favored Glycine 0 N--CA 1.429 -1.798 0 CA-C-N 114.057 -1.429 . . . . 75.549999999999997 115.041 173.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -153.23 166.43 32.58 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.504 -0.554 . . . . 72.319999999999993 109.504 172.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 9.5 m -117.9 136.78 53.24 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 120.597 -0.441 . . . . 75.140000000000001 110.18 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.0 pt -119.06 152.46 21.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 122.496 0.319 . . . . 71.340000000000003 110.948 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -141.73 135.05 29.4 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.106 -1.813 . . . . 75.25 106.106 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 144.59 156.54 6.86 Favored Glycine 0 C--N 1.277 -2.696 0 N-CA-C 109.53 -1.428 . . . . 65.209999999999994 109.53 -176.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.23 178.5 15.61 Favored Glycine 0 C--N 1.281 -2.519 0 N-CA-C 107.321 -2.311 . . . . 72.319999999999993 107.321 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 83.6 t -45.48 106.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 117.839 0.82 . . . . 72.299999999999997 111.994 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 84.91 -13.56 53.17 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.216 -0.902 . . . . 73.329999999999998 112.499 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.502 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 63.2 t30 -105.23 21.15 17.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.012 -0.736 . . . . 64.349999999999994 109.012 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.07 121.48 5.51 Favored 'General case' 0 C--O 1.256 1.436 0 CA-C-N 115.116 -0.947 . . . . 74.329999999999998 110.467 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -79.39 -43.4 23.49 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.11 -0.95 . . . . 73.129999999999995 108.734 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 37.4 mm -103.24 129.89 24.66 Favored Pre-proline 0 C--N 1.301 -1.503 0 CA-C-N 115.053 -0.976 . . . . 75.510000000000005 109.018 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.57 110.14 0.46 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 123.27 2.647 . . . . 73.530000000000001 113.292 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 97.83 -6.36 62.38 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.556 -0.747 . . . . 71.040000000000006 112.468 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -121.24 98.61 6.06 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.392 -0.966 . . . . 71.450000000000003 108.392 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -81.66 26.87 0.47 Allowed 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 124.362 1.065 . . . . 74.109999999999999 111.219 -170.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 0.516 ' CB ' ' HE3' ' A' ' 370' ' ' LYS . 55.1 m -93.94 173.57 7.6 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.16 0.8 . . . . 73.450000000000003 113.16 -174.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 34.5 mm -86.01 126.06 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.915 -1.039 . . . . 62.329999999999998 109.685 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.472 ' OH ' ' HA ' ' A' ' 405' ' ' PRO . 43.1 m-85 -124.01 132.69 53.72 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.199 0.523 . . . . 75.450000000000003 111.858 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.56 114.11 4.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 108.348 -0.982 . . . . 74.120000000000005 108.348 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 22.6 m -102.94 -20.95 14.05 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 120.865 0.364 . . . . 74.5 111.401 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 45.9 mmtm -150.71 159.46 44.51 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.342 -1.355 . . . . 75.310000000000002 107.342 177.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 61.3 mt -138.73 119.45 15.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 106.249 -1.76 . . . . 74.0 106.249 172.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 40.3 mm -86.07 118.01 31.79 Favored 'Isoleucine or valine' 0 C--O 1.255 1.387 0 N-CA-C 108.494 -0.928 . . . . 75.129999999999995 108.494 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.486 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 0.1 OUTLIER -65.62 147.42 53.43 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.181 -1.414 . . . . 74.5 107.181 -176.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.24 -16.62 60.92 Favored Glycine 0 C--N 1.289 -2.054 0 N-CA-C 109.275 -1.53 . . . . 71.310000000000002 109.275 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -75.09 150.43 40.78 Favored Glycine 0 N--CA 1.4 -3.738 0 N-CA-C 106.726 -2.55 . . . . 54.43 106.726 170.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -60.84 -35.03 75.52 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.854 -0.424 . . . . 60.030000000000001 109.854 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.54 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.35 -9.08 58.24 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 112.914 0.709 . . . . 64.409999999999997 112.914 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . 0.486 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 30.2 t-80 -94.95 -39.24 10.3 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.334 -0.947 . . . . 73.319999999999993 108.575 175.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -76.84 -57.19 3.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.861 -0.608 . . . . 75.219999999999999 110.949 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -85.84 -42.15 14.39 Favored 'General case' 0 CA--C 1.476 -1.882 0 C-N-CA 124.221 1.008 . . . . 74.430000000000007 111.32 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.554 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -43.07 -20.56 0.09 OUTLIER Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 120.651 3.02 . . . . 52.439999999999998 120.651 -162.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.554 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.86 33.45 0.5 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 118.522 1.161 . . . . 74.230000000000004 111.921 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 41.6 tp -107.94 155.49 20.26 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.718 1.207 . . . . 71.439999999999998 109.706 -171.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -124.89 145.34 49.87 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.405 0.621 . . . . 73.200000000000003 111.641 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 83.9 mt -66.15 123.23 18.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 107.69 -1.226 . . . . 75.409999999999997 107.69 171.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.73 -7.92 19.69 Favored Glycine 0 C--N 1.311 -0.841 0 C-N-CA 121.173 -0.536 . . . . 71.439999999999998 111.835 -175.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -68.68 137.14 53.9 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 112.563 0.579 . . . . 70.209999999999994 112.563 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.516 ' HE3' ' CB ' ' A' ' 347' ' ' SER . 72.4 tttt -98.71 116.83 31.8 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.288 -0.869 . . . . 72.519999999999996 109.957 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 71.4 mt -83.96 114.5 21.74 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.226 0.536 . . . . 75.209999999999994 109.679 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.5 tt -81.0 -39.38 25.98 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.159 -1.382 . . . . 74.209999999999994 107.457 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -165.67 158.56 15.53 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.504 -0.771 . . . . 71.140000000000001 110.174 -177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 14.2 p -134.17 124.15 45.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.287 -1.005 . . . . 72.219999999999999 108.287 174.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 62.18 30.81 17.76 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 123.719 1.723 . . . . 64.200000000000003 109.268 -176.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 67.48 9.64 7.17 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 109.999 -3.273 . . . . 74.299999999999997 113.201 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.43 122.27 36.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 106.472 -1.677 . . . . 73.129999999999995 106.472 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.3 p -61.21 125.84 25.2 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.235 0.828 . . . . 74.109999999999999 113.235 -176.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.6 -1.36 22.98 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.662 0.785 . . . . 71.319999999999993 110.71 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -73.45 113.88 11.05 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.405 -0.961 . . . . 72.120000000000005 108.405 172.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 63.75 83.87 0.16 Allowed 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 124.587 1.179 . . . . 71.319999999999993 111.919 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 23.5 m -153.15 164.62 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.234 -1.348 . . . . 74.109999999999999 108.705 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.495 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.6 m -83.0 139.61 33.19 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.258 -1.016 . . . . 73.430000000000007 108.258 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 388' ' ' VAL . 81.5 t60 -49.53 -47.47 48.96 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.031 0.752 . . . . 72.109999999999999 113.031 -175.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -43.42 91.83 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.75 -0.833 . . . . 65.519999999999996 108.75 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' A' ' 383' ' ' THR . 47.8 tt0 -67.5 -31.39 71.48 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.031 -1.44 . . . . 73.319999999999993 108.974 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . 0.483 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -75.37 -49.92 17.55 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 114.7 -1.136 . . . . 74.209999999999994 110.456 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 384' ' ' HIS . 19.2 t -59.61 -46.47 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 N-CA-C 109.713 -0.477 . . . . 64.540000000000006 109.713 -178.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 52.0 m -62.12 -29.49 70.37 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.522 -0.763 . . . . 73.310000000000002 112.041 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.86 -31.92 72.85 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.689 -0.632 . . . . 70.420000000000002 110.4 175.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.6 mp -82.2 -31.6 30.26 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 120.599 -0.44 . . . . 74.340000000000003 110.875 176.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -71.12 -27.82 63.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.074 0.398 . . . . 75.439999999999998 112.074 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -78.16 55.18 1.46 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.547 0.689 . . . . 64.209999999999994 110.641 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 22.1 p -127.46 152.54 47.42 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 109.122 -0.696 . . . . 74.439999999999998 109.122 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 51.1 m -144.47 90.37 2.08 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.444 1.116 . . . . 73.049999999999997 111.628 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . 0.402 ' O ' HG23 ' A' ' 323' ' ' ILE 0.267 9.1 m-20 61.96 17.2 8.76 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 111.636 -2.529 . . . . 62.539999999999999 115.329 170.074 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -161.61 122.15 2.67 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.075 -1.454 . . . . 73.439999999999998 107.075 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.7 t -140.1 143.45 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 122.509 0.323 . . . . 70.430000000000007 110.488 -175.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . 0.629 ' CE1' ' HD3' ' A' ' 321' ' ' LYS . 4.5 m-85 -117.64 96.45 5.39 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.265 0.555 . . . . 71.530000000000001 109.696 170.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.9 tt -88.67 123.21 32.9 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.675 -0.693 . . . . 63.450000000000003 109.683 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -107.37 107.78 18.84 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.358 -0.979 . . . . 75.129999999999995 108.358 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.39 153.31 10.0 Favored 'Isoleucine or valine' 0 C--O 1.274 2.387 0 CA-C-N 115.403 -0.817 . . . . 73.319999999999993 110.231 -177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -136.41 157.61 46.39 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 105.945 -1.872 . . . . 64.230000000000004 105.945 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -85.98 153.99 57.71 Favored Pre-proline 0 C--N 1.284 -2.25 0 C-N-CA 119.792 -0.763 . . . . 73.120000000000005 109.719 178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . 0.472 ' HA ' ' OH ' ' A' ' 349' ' ' TYR . 1.3 Cg_endo -42.38 120.39 1.64 Allowed 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 124.238 3.292 . . . . 74.150000000000006 114.089 -177.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 5.9 m -90.61 -7.68 52.1 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.065 -0.97 . . . . 61.450000000000003 111.017 -175.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -114.94 22.03 12.95 Favored Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 120.368 -0.92 . . . . 62.310000000000002 111.809 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 69.8 m -160.26 -172.56 3.63 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.753 -1.203 . . . . 55.219999999999999 107.753 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -78.68 151.58 32.13 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.37 -1.344 . . . . 73.530000000000001 107.37 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -77.77 130.7 37.05 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 123.216 0.323 . . . . 70.439999999999998 110.479 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 49.8 m80 . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 106.5 -1.667 . . . . 73.230000000000004 106.5 179.393 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.232 0 N-CA-C 107.136 -1.431 . . . . 75.25 107.136 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -122.42 -61.65 1.45 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 123.68 0.613 . . . . 73.340000000000003 110.73 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.482 ' CG2' HG23 ' B' ' 149' ' ' THR . 76.1 p -66.36 101.01 0.69 Allowed 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 107.949 -1.13 . . . . 74.329999999999998 107.949 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -164.9 160.07 18.93 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.659 -1.237 . . . . 71.230000000000004 107.659 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -83.08 163.28 21.01 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 120.892 0.377 . . . . 73.420000000000002 110.429 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 66.46 18.7 10.87 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.919 1.688 . . . . 74.109999999999999 112.894 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -152.99 172.12 17.32 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.242 0.544 . . . . 71.099999999999994 111.67 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -95.06 158.45 15.46 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.022 -0.99 . . . . 74.400000000000006 109.466 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.482 HG23 ' CG2' ' B' ' 143' ' ' THR . 23.0 m -144.93 138.58 26.98 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 116.567 -0.288 . . . . 71.549999999999997 110.329 175.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 13.9 tm0? -78.69 140.04 38.41 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.008 -0.542 . . . . 74.340000000000003 111.161 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.266 1.926 0 CA-C-N 115.476 -0.784 . . . . 64.510000000000005 112.275 178.8 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 CA--C 1.485 -1.52 0 N-CA-C 106.207 -1.775 . . . . 72.329999999999998 106.207 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.359 2.2 pm0 -121.46 131.0 53.91 Favored 'General case' 0 C--N 1.267 -2.981 0 N-CA-C 114.732 1.382 . . . . 73.219999999999999 114.732 -175.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 74.8 mt -116.96 113.7 43.66 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 CA-C-N 112.516 -2.129 . . . . 75.140000000000001 109.558 -172.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -92.81 112.4 24.34 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.323 -0.992 . . . . 64.319999999999993 108.323 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' LEU . . . . . 0.636 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 81.6 mt -107.27 152.85 23.57 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 124.363 1.039 . . . . 75.5 109.068 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 40.5 mt -106.16 126.46 61.72 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 107.917 -1.142 . . . . 74.239999999999995 107.917 169.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -75.04 156.49 36.1 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.337 -0.392 . . . . 73.540000000000006 110.473 -175.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -148.57 -154.86 6.45 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.705 -0.759 . . . . 43.229999999999997 113.151 -174.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.27 -46.85 27.62 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 124.039 3.159 . . . . 71.239999999999995 115.024 -173.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -98.47 25.82 6.03 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.265 0.555 . . . . 75.129999999999995 110.601 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.81 -124.32 6.67 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 114.987 -1.006 . . . . 72.120000000000005 111.958 177.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.417 HD13 HG12 ' B' ' 151' ' ' VAL . 8.2 mp -90.89 -39.78 12.11 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.526 -1.287 . . . . 71.400000000000006 107.526 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 87.08 47.99 4.53 Favored Glycine 0 N--CA 1.402 -3.613 0 CA-C-N 113.937 -1.483 . . . . 72.230000000000004 113.261 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 329' ' ' LEU . 48.9 p90 -155.47 147.17 23.13 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.327 0.584 . . . . 74.439999999999998 111.526 170.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 51.1 m -96.17 132.16 41.88 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.175 -0.921 . . . . 71.140000000000001 109.151 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 46.9 pt -120.45 141.91 38.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 109.941 -0.392 . . . . 71.450000000000003 109.941 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -139.58 125.59 19.81 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.768 -1.197 . . . . 64.209999999999994 107.768 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 150.22 161.65 10.03 Favored Glycine 0 C--N 1.282 -2.438 0 N-CA-C 110.469 -1.052 . . . . 63.109999999999999 110.469 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.05 -179.81 17.14 Favored Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 107.221 -2.352 . . . . 72.329999999999998 107.221 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 98.4 t -52.2 108.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 118.078 0.939 . . . . 72.439999999999998 110.778 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 94.78 -21.58 42.69 Favored Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.321 -0.854 . . . . 75.219999999999999 112.092 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' ASN . . . . . 0.622 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 32.1 t-20 -105.75 13.43 29.68 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.06 -0.719 . . . . 64.430000000000007 109.06 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.91 120.57 4.46 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 121.513 0.673 . . . . 75.319999999999993 111.098 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -77.79 -45.07 25.6 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.029 -0.987 . . . . 74.540000000000006 109.451 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 40.4 mm -103.35 124.14 39.21 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-N 115.309 -0.86 . . . . 74.349999999999994 109.16 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.66 108.01 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 123.247 2.631 . . . . 71.200000000000003 112.512 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 105.39 -4.12 40.4 Favored Glycine 0 N--CA 1.432 -1.599 0 CA-C-N 115.459 -0.791 . . . . 53.109999999999999 112.002 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -128.9 96.93 4.49 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.451 -0.944 . . . . 74.150000000000006 108.451 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -83.7 36.94 0.56 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.859 -1.064 . . . . 65.420000000000002 111.778 -170.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 72.0 m -98.66 177.34 5.34 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 115.613 -0.721 . . . . 70.5 111.249 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.509 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 4.1 mm -91.54 138.85 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 N-CA-C 106.33 -1.73 . . . . 75.310000000000002 106.33 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 369' ' ' ASP . 22.4 m-85 -127.5 139.25 52.91 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 118.34 0.518 . . . . 75.140000000000001 111.639 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.24 123.46 22.87 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 N-CA-C 108.955 -0.757 . . . . 64.319999999999993 108.955 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.1 m -102.35 -28.5 12.21 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.383 0.611 . . . . 73.409999999999997 110.529 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.458 ' HZ1' HD11 ' A' ' 354' ' ' ILE . 60.8 tttm -155.62 147.72 23.5 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.245 -1.02 . . . . 73.030000000000001 108.245 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 76.5 mt -107.74 139.7 28.78 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 N-CA-C 105.412 -2.07 . . . . 74.219999999999999 105.412 169.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.458 HD11 ' HZ1' ' A' ' 352' ' ' LYS . 44.9 mm -85.17 129.74 37.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.147 0.499 . . . . 74.209999999999994 110.799 -174.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 355' ' ' GLU . 0.5 OUTLIER -57.62 115.75 2.97 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 125.586 1.554 . . . . 71.209999999999994 111.105 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 84.24 7.98 84.27 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.725 -0.75 . . . . 43.329999999999998 111.807 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -75.9 160.2 51.36 Favored Glycine 0 C--O 1.259 1.67 0 N-CA-C 111.769 -0.532 . . . . 71.420000000000002 111.769 177.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.29 -42.21 99.06 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.184 -0.672 . . . . 64.310000000000002 109.184 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.489 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -72.97 -6.74 47.4 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.852 -0.613 . . . . 74.420000000000002 111.427 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -92.66 -33.92 14.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.592 0.71 . . . . 61.310000000000002 109.473 177.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.636 ' NZ ' ' HA ' ' A' ' 361' ' ' LYS . 0.7 OUTLIER -92.9 -54.65 3.66 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.902 0.704 . . . . 64.319999999999993 112.902 177.6 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' ASP . . . . . 0.722 ' O ' ' HE2' ' A' ' 364' ' ' LYS . 23.3 t70 -85.33 -37.22 20.19 Favored 'General case' 0 CA--C 1.461 -2.458 0 O-C-N 124.16 0.912 . . . . 61.340000000000003 110.625 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' GLY . . . . . 0.636 ' HA2' ' CD2' ' A' ' 322' ' ' LEU . . . -41.2 -28.11 0.27 Allowed Glycine 0 CA--C 1.483 -1.966 0 N-CA-C 120.37 2.908 . . . . 63.130000000000003 120.37 -160.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.722 ' HE2' ' O ' ' A' ' 362' ' ' ASP . 0.0 OUTLIER 46.26 32.66 1.56 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 118.442 1.121 . . . . 72.040000000000006 110.877 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 43.0 tp -115.4 155.55 27.2 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.776 1.231 . . . . 74.120000000000005 109.103 -170.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -120.62 149.04 43.09 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.388 0.613 . . . . 75.010000000000005 111.165 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.0 mt -66.17 122.65 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 107.454 -1.313 . . . . 74.200000000000003 107.454 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.57 -9.12 19.65 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.476 -0.869 . . . . 54.039999999999999 113.013 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 4.2 m-20 -61.47 142.32 57.09 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.233 0.827 . . . . 75.400000000000006 113.233 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.5 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 43.3 tttp -93.27 115.01 27.61 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.491 1.117 . . . . 74.329999999999998 109.452 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 4.2 mp -79.9 112.81 17.55 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.873 -0.788 . . . . 75.310000000000002 108.873 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 403' ' ' ALA . 5.8 tt -87.14 -40.16 14.87 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.057 -1.09 . . . . 74.219999999999999 108.057 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.99 157.3 23.45 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.883 -0.599 . . . . 75.209999999999994 110.891 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.28 123.11 42.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 108.624 -0.88 . . . . 72.519999999999996 108.624 173.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . 0.409 ' HA ' ' HB3' ' A' ' 399' ' ' TYR . 91.8 m-20 60.49 31.59 20.33 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-O 124.089 1.899 . . . . 75.129999999999995 109.235 -174.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.7 t30 66.26 15.84 10.23 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 109.48 -3.509 . . . . 73.140000000000001 112.509 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 55.2 t -84.08 125.98 40.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 106.522 -1.658 . . . . 73.530000000000001 106.522 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.8 p -61.66 123.69 18.62 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 123.605 0.762 . . . . 74.439999999999998 113.053 -176.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.6 mp -110.81 -4.79 15.11 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.653 0.781 . . . . 72.0 111.387 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -65.65 106.29 1.44 Allowed 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.661 -0.496 . . . . 72.510000000000005 109.661 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 60.37 73.17 0.49 Allowed 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 124.616 1.198 . . . . 60.340000000000003 113.223 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.24 171.02 18.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 107.155 -1.424 . . . . 65.0 107.155 175.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.456 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.8 m -76.96 142.52 39.98 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.613 -0.884 . . . . 74.25 108.613 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' HIS . . . . . 0.526 ' O ' HG22 ' A' ' 388' ' ' VAL . 82.4 t60 -51.17 -47.75 62.07 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 111.446 0.165 . . . . 74.120000000000005 111.446 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' GLU . . . . . 0.712 ' HA ' ' OG1' ' B' ' 143' ' ' THR . 7.4 tp10 -58.7 -37.39 75.98 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.835 0.826 . . . . 63.539999999999999 110.814 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 383' ' ' THR . 53.1 tt0 -73.85 -38.93 64.33 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.427 -1.26 . . . . 63.149999999999999 108.532 -174.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -70.19 -51.66 29.35 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.858 -1.065 . . . . 75.140000000000001 110.335 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 384' ' ' HIS . 40.4 t -59.28 -40.69 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.717 -0.22 . . . . 72.030000000000001 110.936 -177.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 90.5 m -60.23 -35.5 75.61 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 116.689 -0.232 . . . . 74.510000000000005 110.99 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.37 -37.98 84.05 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.587 0.232 . . . . 72.040000000000006 110.649 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.86 -32.01 59.54 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.248 -0.581 . . . . 74.340000000000003 110.841 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 57.6 mttm -67.52 -36.09 80.36 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 112.619 0.6 . . . . 75.340000000000003 112.619 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -81.1 70.62 7.97 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.38 1.086 . . . . 74.310000000000002 110.786 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 7.9 p -139.56 157.78 45.23 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 113.745 -1.571 . . . . 73.439999999999998 109.433 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 20.1 p -162.61 122.26 2.31 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.117 -0.698 . . . . 75.420000000000002 109.117 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 59.81 1.42 0.31 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.516 1.526 . . . . 74.450000000000003 114.446 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -162.35 128.22 3.47 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 108.835 -0.802 . . . . 73.109999999999999 108.835 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 47.6 t -140.32 111.94 4.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.766 -0.828 . . . . 75.030000000000001 108.766 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' TYR . . . . . 0.409 ' HB3' ' HA ' ' A' ' 375' ' ' ASN . 84.2 t80 -94.07 96.44 9.66 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.481 -0.933 . . . . 74.310000000000002 108.481 177.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 4.3 tt -92.25 120.61 32.97 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 108.656 -0.868 . . . . 72.329999999999998 108.656 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -106.09 110.16 22.33 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.509 -1.293 . . . . 75.010000000000005 107.509 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 370' ' ' LYS . 2.7 p -113.0 149.2 15.52 Favored 'Isoleucine or valine' 0 C--O 1.274 2.374 0 CA-C-O 121.843 0.83 . . . . 74.040000000000006 111.394 -177.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -128.12 158.37 38.19 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.595 -1.184 . . . . 71.430000000000007 108.446 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' LYS . . . . . 0.662 ' HZ1' ' CD2' ' A' ' 410' ' ' HIS . 0.8 OUTLIER -82.76 164.64 45.94 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 109.145 -0.687 . . . . 74.129999999999995 109.145 177.73 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' PRO . . . . . 0.525 ' HD3' ' CE1' ' A' ' 410' ' ' HIS . 74.4 Cg_endo -76.86 125.24 7.95 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 121.388 1.392 . . . . 61.240000000000002 114.492 -168.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 2.5 m -61.45 -30.3 70.5 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.621 -1.172 . . . . 75.510000000000005 111.553 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -138.27 47.24 0.94 Allowed Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.0 -1.095 . . . . 63.229999999999997 112.831 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 23.1 t -166.26 -173.12 2.45 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.034 -1.469 . . . . 74.200000000000003 107.034 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -132.3 107.84 8.81 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 117.899 0.318 . . . . 74.439999999999998 111.24 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' HIS . . . . . 0.662 ' CD2' ' HZ1' ' A' ' 404' ' ' LYS . 1.6 p-80 -150.79 144.85 25.35 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.969 -1.493 . . . . 75.319999999999993 106.969 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 58.1 m80 . . . . . 0 C--N 1.297 -1.69 0 N-CA-C 108.574 -0.899 . . . . 73.219999999999999 108.574 -178.235 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.812 0 N-CA-C 107.323 -1.362 . . . . 72.340000000000003 107.323 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 142' ' ' ARG . . . . . 0.469 ' HD2' ' OE2' ' A' ' 385' ' ' GLU . 15.5 mmt180 -117.0 170.49 8.6 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 123.588 0.555 . . . . 74.439999999999998 110.699 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.712 ' OG1' ' HA ' ' A' ' 385' ' ' GLU . 24.0 p -98.51 152.86 19.09 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.522 -1.288 . . . . 73.109999999999999 107.522 -172.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -152.27 176.64 11.39 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.717 -1.586 . . . . 75.109999999999999 106.717 -173.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 18.6 pm0 -85.8 159.07 19.83 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-O 121.421 0.629 . . . . 73.430000000000007 112.51 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 66.31 19.14 11.01 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.397 1.879 . . . . 74.299999999999997 112.601 -177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -144.14 163.85 32.4 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.913 -0.585 . . . . 73.209999999999994 109.573 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.83 166.73 11.66 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.041 -0.527 . . . . 72.439999999999998 109.979 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.421 HG22 HG23 ' B' ' 143' ' ' THR . 86.5 m -144.44 126.04 15.04 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.544 -0.539 . . . . 63.340000000000003 109.544 168.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 20.9 tm0? -69.59 136.35 51.15 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.107 -0.952 . . . . 72.109999999999999 110.601 175.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.417 HG12 HD13 ' A' ' 329' ' ' LEU . 21.8 t . . . . . 0 C--N 1.305 -1.363 0 N-CA-C 107.724 -1.213 . . . . 73.129999999999995 107.724 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 CA--C 1.492 -1.275 0 N-CA-C 105.766 -1.938 . . . . 73.25 105.766 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -127.12 140.39 52.3 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 113.878 1.066 . . . . 70.31 113.878 -174.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 363' ' ' GLY . 84.0 mt -129.0 116.83 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 CA-C-N 113.504 -1.68 . . . . 62.12 109.19 -174.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.5 127.33 34.86 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.836 -0.801 . . . . 74.12 108.836 175.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 80.9 mt -122.8 152.5 40.62 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.062 -0.718 . . . . 74.22 109.062 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 32.4 mm -105.76 111.51 35.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.653 -1.24 . . . . 73.13 107.653 173.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.475 ' HE3' ' HA2' ' A' ' 328' ' ' GLY . 1.4 tmtp? -75.92 141.05 42.4 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.8 -0.444 . . . . 75.31 109.8 -176.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -149.14 -154.55 6.39 Favored Glycine 0 C--N 1.301 -1.413 0 C-N-CA 120.41 -0.9 . . . . 72.43 112.646 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.66 -12.85 35.76 Favored 'Trans proline' 0 N--CA 1.484 0.926 0 C-N-CA 123.594 2.863 . . . . 62.14 113.99 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.411 ' HZ3' ' HB3' ' A' ' 327' ' ' LYS . 6.9 mtpm? -107.39 10.66 29.51 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.427 -0.953 . . . . 62.21 108.427 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLY . . . . . 0.475 ' HA2' ' HE3' ' A' ' 324' ' ' LYS . . . 83.72 -133.87 12.26 Favored Glycine 0 CA--C 1.484 -1.881 0 CA-C-N 114.389 -1.278 . . . . 71.34 109.91 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.476 ' HB2' HG23 ' B' ' 151' ' ' VAL . 5.1 mp -93.38 -19.68 21.08 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.073 -1.454 . . . . 62.31 107.073 172.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' GLY . . . . . 0.466 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 85.51 40.05 7.99 Favored Glycine 0 N--CA 1.426 -1.996 0 CA-C-N 113.869 -1.514 . . . . 65.04 115.064 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -154.92 167.8 29.1 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 117.409 0.604 . . . . 65.44 110.324 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 2.8 m -121.76 132.75 54.78 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.492 -0.559 . . . . 74.23 109.492 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 388' ' ' VAL . 18.2 pt -113.68 154.98 14.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 116.234 -0.439 . . . . 75.14 110.978 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.45 115.38 5.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 124.68 1.238 . . . . 61.43 107.937 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 168.77 161.29 18.66 Favored Glycine 0 C--N 1.275 -2.823 0 N-CA-C 108.928 -1.669 . . . . 70.43 108.928 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.67 178.2 15.43 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 108.601 -1.8 . . . . 61.14 108.601 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.8 t -53.05 104.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.65 0.738 . . . . 72.21 110.933 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.65 -19.88 52.3 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.001 -0.999 . . . . 72.43 113.269 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.509 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 60.2 t30 -107.65 22.39 16.03 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 117.288 0.544 . . . . 73.11 110.246 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.401 HE22 ' HA ' ' A' ' 343' ' ' PRO . 0.0 OUTLIER -52.34 119.64 4.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.263 0.554 . . . . 72.42 110.801 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -73.25 -44.82 58.77 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.149 -0.932 . . . . 71.33 109.979 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 42.7 mm -104.66 125.34 34.22 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 108.766 -0.827 . . . . 73.24 108.766 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.401 ' HA ' HE22 ' A' ' 340' ' ' GLN . 73.0 Cg_exo -52.62 107.73 0.21 Allowed 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 123.21 2.607 . . . . 74.34 112.898 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 107.14 -7.63 37.83 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-N 115.281 -0.872 . . . . 53.23 112.362 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -125.03 98.74 5.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.941 -0.763 . . . . 55.21 108.941 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -83.05 33.67 0.45 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.878 0.871 . . . . 74.5 111.511 -171.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 16.4 m -95.06 171.44 8.75 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.157 -0.474 . . . . 62.34 111.006 -177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.416 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 27.6 mm -83.91 127.5 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 107.678 -1.23 . . . . 71.05 107.678 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 47.6 m-85 -123.88 136.68 54.51 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.328 0.585 . . . . 53.0 112.465 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.18 113.81 5.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.796 -1.187 . . . . 65.14 107.796 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 53.2 m -102.14 -23.9 14.0 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.236 0.541 . . . . 74.32 111.276 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 94.7 mttt -151.32 156.28 40.45 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.964 -1.124 . . . . 74.13 107.964 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.4 HG22 ' HB2' ' A' ' 360' ' ' HIS . 78.0 mt -130.47 128.95 64.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.309 -1.367 . . . . 71.2 107.309 176.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 49.4 mm -85.35 141.78 14.1 Favored 'Isoleucine or valine' 0 C--O 1.256 1.419 0 C-N-CA 123.315 0.646 . . . . 74.13 111.22 -171.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.19 127.83 34.13 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.201 1.0 . . . . 74.12 111.555 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 71.71 8.9 68.86 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.534 -0.757 . . . . 51.12 112.584 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' GLY . . . . . 0.466 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -70.46 159.75 53.63 Favored Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.831 -0.699 . . . . 71.34 111.498 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -59.15 -40.86 86.86 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.592 -0.522 . . . . 72.43 109.592 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.523 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -73.01 -13.13 61.16 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.262 0.553 . . . . 63.12 112.298 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' HIS . . . . . 0.4 ' HB2' HG22 ' A' ' 353' ' ' ILE . 10.7 t-80 -92.53 -25.74 18.24 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.899 0.857 . . . . 61.52 109.434 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.424 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 0.2 OUTLIER -96.57 -59.21 1.87 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 113.332 0.864 . . . . 74.43 113.332 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -86.14 -36.53 19.51 Favored 'General case' 0 CA--C 1.475 -1.913 0 N-CA-C 107.844 -1.169 . . . . 64.41 107.844 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.535 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -44.75 -35.15 4.16 Favored Glycine 0 C--O 1.201 -1.923 0 N-CA-C 118.677 2.231 . . . . 74.34 118.677 -166.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.535 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.58 29.86 0.19 Allowed 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 118.29 1.045 . . . . 62.03 111.198 -173.038 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 47.2 tp -97.64 151.8 19.73 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 125.009 1.324 . . . . 74.54 109.807 -169.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -121.1 149.19 43.13 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-O 121.409 0.623 . . . . 74.35 111.409 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 77.8 mt -65.89 121.7 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 107.622 -1.251 . . . . 55.02 107.622 172.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.4 -1.76 22.13 Favored Glycine 0 C--N 1.313 -0.734 0 C-N-CA 121.0 -0.619 . . . . 60.45 112.133 -175.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -75.16 137.11 41.1 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 113.087 0.773 . . . . 74.45 113.087 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 37.9 tttp -92.83 119.43 32.15 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 124.327 1.051 . . . . 73.01 110.453 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 78.6 mt -87.63 121.03 29.54 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 120.393 -0.523 . . . . 62.01 110.002 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.466 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 92.6 mt -82.19 -40.16 22.14 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.088 -1.415 . . . . 72.23 108.439 177.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -165.17 165.65 19.6 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.281 -0.872 . . . . 71.53 111.944 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' VAL . . . . . 0.497 HG12 HD11 ' A' ' 379' ' ' LEU . 10.2 p -133.79 119.58 33.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.863 -1.162 . . . . 65.5 107.863 171.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 375' ' ' ASN . . . . . 0.49 HD21 HG22 ' A' ' 394' ' ' THR . 84.8 m-20 63.14 28.65 16.05 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 123.95 1.833 . . . . 71.33 108.406 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 66.18 17.92 10.84 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 109.726 -3.397 . . . . 75.33 112.52 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.5 t -84.14 123.63 39.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.567 -1.642 . . . . 70.34 106.567 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 10.4 p -59.49 124.04 18.77 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.163 1.172 . . . . 73.33 114.163 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.566 HD21 HD11 ' A' ' 391' ' ' LEU . 5.8 mp -106.49 6.7 30.43 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.64 1.176 . . . . 72.24 110.119 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 380' ' ' GLU . . . . . 0.466 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 20.1 mm-40 -71.26 110.67 6.05 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.073 -0.967 . . . . 73.23 110.902 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 54.1 66.86 1.12 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.65 1.18 . . . . 60.45 112.715 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.36 171.72 16.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.629 -1.249 . . . . 74.35 107.629 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.448 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 2.3 m -75.79 144.78 41.17 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.661 -0.866 . . . . 32.14 108.661 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' HIS . . . . . 0.578 ' O ' HG23 ' A' ' 388' ' ' VAL . 10.0 t-160 -51.88 -49.78 62.3 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 111.601 0.223 . . . . 61.12 111.601 -176.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.22 -29.52 70.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.966 0.412 . . . . 65.35 111.848 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 383' ' ' THR . 60.7 tt0 -71.52 -40.27 70.22 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.688 -1.227 . . . . 63.13 107.688 -176.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -69.59 -50.55 43.5 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.864 -1.062 . . . . 65.3 110.178 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 384' ' ' HIS . 40.6 t -57.38 -37.16 55.74 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 O-C-N 123.032 0.208 . . . . 71.52 111.38 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 91.5 m -62.55 -34.34 76.73 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 116.653 -0.248 . . . . 74.34 111.108 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -70.06 -35.95 74.63 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.644 0.259 . . . . 71.54 110.363 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.566 HD11 HD21 ' A' ' 379' ' ' LEU . 5.6 mp -78.51 -27.93 46.17 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 120.164 -0.614 . . . . 71.42 110.599 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 53.5 mttm -71.42 -37.24 71.49 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.85 0.685 . . . . 55.45 112.85 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -82.45 65.83 7.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.282 1.039 . . . . 62.4 110.79 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.49 HG22 HD21 ' A' ' 375' ' ' ASN . 31.0 p -137.18 146.93 45.51 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.034 -1.439 . . . . 65.24 107.506 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 42.1 m -142.78 120.39 11.79 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.71 -0.478 . . . . 60.02 109.71 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 324' ' ' LYS . 3.9 m-20 58.46 0.95 0.15 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.691 1.996 . . . . 71.43 115.694 172.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -161.61 135.57 6.74 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.416 -0.957 . . . . 74.03 108.416 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 61.4 t -142.02 133.45 26.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.682 -0.859 . . . . 53.35 108.682 177.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -107.73 96.29 6.28 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.192 -1.781 . . . . 74.31 106.192 173.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.4 tt -86.36 129.67 34.77 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 120.949 0.404 . . . . 63.44 110.292 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -108.96 108.54 19.33 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.817 -1.179 . . . . 62.32 107.817 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 3.4 p -118.93 150.55 21.22 Favored 'Isoleucine or valine' 0 C--O 1.274 2.353 0 CA-C-O 121.784 0.802 . . . . 72.31 111.265 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.424 ' HB2' HD11 ' A' ' 372' ' ' LEU . . . -136.63 158.15 45.11 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 105.721 -1.955 . . . . 71.12 105.721 171.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.284 -2.248 0 N-CA-C 105.463 -2.051 . . . . 63.41 105.463 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 24.3 p30 . . . . . 0 CA--C 1.507 -0.707 0 N-CA-C 109.708 -0.479 . . . . 74.41 109.708 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -91.36 161.3 15.07 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.657 -0.868 . . . . 75.24 108.657 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 51.6 m -147.27 140.43 25.23 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.927 -0.483 . . . . 73.2 110.414 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -71.13 139.24 50.2 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.865 -0.607 . . . . 73.51 109.916 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 329' ' ' LEU . 12.4 m . . . . . 0 C--O 1.265 1.878 0 CA-C-N 115.79 -0.641 . . . . 71.23 112.065 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 C--O 1.203 -1.394 0 N-CA-C 106.373 -1.714 . . . . 73.14 106.373 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.472 1.9 pm0 -115.58 128.98 56.35 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 117.05 2.241 . . . . 72.34 117.05 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.601 HG23 ' HD3' ' A' ' 364' ' ' LYS . 66.9 mt -107.38 107.0 21.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 CA-C-N 111.425 -2.625 . . . . 75.33 108.552 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.51 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 29.4 ttpt -80.44 118.92 22.49 Favored 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 119.865 -0.734 . . . . 71.22 109.073 174.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.59 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 27.5 mt -113.05 148.07 35.93 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 113.904 -1.498 . . . . 72.44 110.316 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.0 mp -106.55 117.2 51.89 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.017 0 N-CA-C 107.119 -1.437 . . . . 72.45 107.119 169.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.682 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 10.2 tmtt? -63.03 151.57 39.45 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 108.639 -0.875 . . . . 75.21 108.639 171.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.429 ' O ' ' HE2' ' A' ' 324' ' ' LYS . . . -141.98 -160.58 8.39 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 119.832 -1.175 . . . . 64.04 113.365 -171.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.22 -30.62 45.82 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.155 2.57 . . . . 74.41 113.651 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -101.58 18.85 19.21 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 122.279 1.037 . . . . 75.31 108.791 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.34 -129.0 8.92 Favored Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 109.799 -1.32 . . . . 71.14 109.799 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.508 ' HB2' HG23 ' B' ' 151' ' ' VAL . 5.3 mp -96.98 -42.58 7.84 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.161 -1.792 . . . . 75.24 106.161 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' GLY . . . . . 0.517 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 84.41 50.19 4.36 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 114.754 -1.112 . . . . 52.33 114.806 171.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' PHE . . . . . 0.408 ' O ' HG22 ' B' ' 151' ' ' VAL . 50.2 p90 -151.25 150.71 30.9 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.413 -0.588 . . . . 60.11 109.413 173.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 6.4 m -104.15 129.15 51.87 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.601 -0.518 . . . . 72.11 109.601 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.3 pt -113.36 151.69 15.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-N 115.824 -0.625 . . . . 72.23 109.943 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.66 121.75 10.1 Favored 'General case' 0 N--CA 1.425 -1.713 0 O-C-N 124.226 0.954 . . . . 74.23 108.685 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 167.7 179.07 40.18 Favored Glycine 0 C--N 1.281 -2.498 0 N-CA-C 107.452 -2.259 . . . . 54.3 107.452 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 132.54 175.98 14.21 Favored Glycine 0 CA--C 1.474 -2.526 0 N-CA-C 108.712 -1.755 . . . . 44.34 108.712 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.457 HG22 ' OE2' ' A' ' 381' ' ' GLU . 93.4 t -51.0 100.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 O-C-N 124.432 0.725 . . . . 62.41 111.437 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 88.13 -7.47 81.35 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.593 -0.731 . . . . 62.12 112.312 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.449 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 65.6 t30 -106.3 16.56 24.66 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.066 -0.716 . . . . 63.14 109.066 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.463 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -49.57 125.88 12.33 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.52 1.128 . . . . 73.22 111.835 -177.297 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -80.3 -44.11 20.12 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.18 -0.918 . . . . 54.03 109.429 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.5 mm -103.62 125.28 35.24 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 115.846 -0.615 . . . . 63.03 109.357 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.33 108.8 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.553 2.836 . . . . 75.41 113.416 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 101.87 -4.92 53.26 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.512 -0.767 . . . . 71.44 111.936 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -124.99 96.7 4.96 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.322 -0.992 . . . . 73.32 108.322 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' ASN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 51.7 t30 -81.01 29.04 0.34 Allowed 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 124.343 1.057 . . . . 74.23 111.781 -170.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 73.0 m -93.34 177.97 5.87 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.726 0.774 . . . . 75.45 112.755 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.5 mm -91.21 129.33 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 114.609 -1.178 . . . . 72.21 108.32 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 28.9 m-85 -123.54 132.47 53.91 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.193 0.52 . . . . 74.32 112.197 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 52.9 t -67.1 109.84 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.581 -1.266 . . . . 75.51 107.581 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.4 m -99.83 -22.07 15.48 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.207 0.527 . . . . 72.11 110.711 -175.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 31.8 mmtp -148.25 154.27 39.83 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.375 -1.343 . . . . 72.11 107.375 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.462 HG22 ' HB2' ' A' ' 360' ' ' HIS . 65.5 mt -131.72 107.59 13.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 106.815 -1.55 . . . . 70.11 106.815 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 38.7 mm -78.73 129.6 37.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 123.731 0.813 . . . . 74.34 109.788 -171.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.533 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 0.6 OUTLIER -63.83 146.25 54.29 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.429 -1.323 . . . . 63.11 107.429 -178.246 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.598 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.05 -19.53 53.66 Favored Glycine 0 C--N 1.28 -2.529 0 N-CA-C 109.299 -1.521 . . . . 35.22 109.299 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 357' ' ' GLY . . . . . 0.517 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -69.29 142.37 37.28 Favored Glycine 1 N--CA 1.384 -4.811 0 N-CA-C 107.968 -2.053 . . . . 72.44 107.968 172.034 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 362' ' ' ASP . . . -62.97 -32.65 74.04 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.826 -0.805 . . . . 74.42 108.826 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.585 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.72 -6.28 49.75 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.981 -0.554 . . . . 52.02 112.132 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' HIS . . . . . 0.533 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 19.5 t60 -94.19 -39.4 10.57 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.432 -0.951 . . . . 73.14 108.432 175.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.598 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 73.7 mmtt -82.7 -57.65 3.23 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.599 0.714 . . . . 62.23 110.79 -178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 358' ' ' ALA . 10.9 t70 -85.86 -34.85 20.9 Favored 'General case' 0 CA--C 1.468 -2.187 0 C-N-CA 125.182 1.393 . . . . 71.15 111.112 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.59 ' HA2' ' CD2' ' A' ' 322' ' ' LEU . . . -42.71 -23.97 0.22 Allowed Glycine 0 C--N 1.287 -2.186 0 N-CA-C 120.862 3.105 . . . . 35.44 120.862 -162.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.601 ' HD3' HG23 ' A' ' 320' ' ' ILE . 0.0 OUTLIER 41.47 36.99 0.6 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.802 1.301 . . . . 74.51 111.54 -178.45 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 50.3 tp -114.21 156.06 24.97 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.536 1.134 . . . . 64.25 109.891 -170.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -122.19 142.66 50.19 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.434 0.635 . . . . 74.04 111.678 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.39 121.53 15.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.507 -1.294 . . . . 71.1 107.507 169.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 114.55 -0.61 23.43 Favored Glycine 0 C--N 1.314 -0.687 0 N-CA-C 111.656 -0.578 . . . . 50.24 111.656 -176.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.478 ' HB3' HG21 ' A' ' 402' ' ' VAL . 83.2 m-20 -76.27 136.77 39.64 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.196 0.813 . . . . 73.12 113.196 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.666 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 37.7 tttp -94.86 116.61 28.93 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.99 1.316 . . . . 72.12 108.948 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 83.6 mt -83.25 113.45 20.69 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 109.779 -0.452 . . . . 72.3 109.779 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 403' ' ' ALA . 3.9 tt -81.49 -39.67 24.4 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.08 -1.452 . . . . 74.23 107.08 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.41 159.18 21.99 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.493 -0.776 . . . . 63.14 110.644 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' VAL . . . . . 0.438 HG12 HD11 ' A' ' 379' ' ' LEU . 13.5 p -133.75 121.09 39.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.07 -1.085 . . . . 60.15 108.07 172.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' ASN . . . . . 0.542 HD21 HG22 ' A' ' 394' ' ' THR . 89.1 m-20 62.83 29.85 16.63 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 123.987 1.851 . . . . 74.03 108.652 -174.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 67.42 10.39 7.71 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 109.652 -3.431 . . . . 71.34 113.355 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 50.3 t -78.74 124.56 37.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.585 -1.635 . . . . 64.44 106.585 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.5 p -61.51 124.62 21.17 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.677 0.992 . . . . 65.54 113.677 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.438 HD11 HG12 ' A' ' 374' ' ' VAL . 8.5 mp -109.18 3.48 21.88 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.027 0.931 . . . . 71.32 110.836 176.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -78.15 115.97 18.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.34 -0.985 . . . . 72.32 108.34 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' GLU . . . . . 0.457 ' OE2' HG22 ' A' ' 337' ' ' VAL . 17.1 tp10 62.83 83.34 0.16 Allowed 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 124.607 1.192 . . . . 75.32 111.625 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 18.4 m -153.81 160.36 2.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 113.966 -1.47 . . . . 64.54 109.171 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.5 m -81.65 145.14 30.73 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.443 -1.317 . . . . 73.51 107.443 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' HIS . . . . . 0.618 ' O ' HG23 ' A' ' 388' ' ' VAL . 7.3 t-160 -52.1 -48.27 64.85 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 112.533 0.568 . . . . 74.22 112.533 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -57.86 -37.34 73.72 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.653 0.74 . . . . 74.32 110.896 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 383' ' ' THR . 55.5 tt0 -70.54 -35.8 73.34 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.942 -1.026 . . . . 75.04 108.484 -174.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.407 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -75.47 -50.94 14.21 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.662 -1.154 . . . . 61.35 111.052 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 384' ' ' HIS . 20.7 t -57.64 -40.75 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 110.022 -0.362 . . . . 72.22 110.022 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 94.8 m -58.55 -40.01 81.83 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.101 -0.499 . . . . 65.52 110.749 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -63.65 -33.22 75.15 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.477 0.18 . . . . 60.01 110.972 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.8 mp -81.44 -28.92 34.0 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 120.388 -0.525 . . . . 51.01 110.943 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -74.74 -24.18 58.67 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.213 0.449 . . . . 64.41 112.213 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -78.62 46.39 0.65 Allowed 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 123.428 0.691 . . . . 73.53 110.692 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.542 HG22 HD21 ' A' ' 375' ' ' ASN . 34.0 p -124.57 143.49 50.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.056 0.455 . . . . 65.01 110.061 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 324' ' ' LYS . 49.3 m -142.49 100.98 3.8 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 122.32 1.057 . . . . 62.43 112.171 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.682 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 5.3 m-20 60.47 15.85 5.9 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 128.232 2.613 . . . . 60.01 113.897 169.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -165.91 126.53 1.79 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.035 -1.098 . . . . 60.33 108.035 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 25.1 t -145.61 146.6 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 123.296 0.638 . . . . 72.24 110.642 -175.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.51 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 20.4 m-85 -118.56 96.68 5.39 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.465 0.706 . . . . 74.0 109.191 169.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.8 tt -88.34 121.5 30.8 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.34 -0.615 . . . . 62.34 109.34 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -104.64 108.42 19.86 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.256 -1.016 . . . . 73.51 108.256 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 369' ' ' ASP . 5.6 p -106.41 150.48 8.98 Favored 'Isoleucine or valine' 0 C--O 1.276 2.5 0 CA-C-O 121.651 0.739 . . . . 74.04 110.247 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.666 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.7 159.58 41.39 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 125.966 1.706 . . . . 71.12 107.149 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 7.1 mmpt? . . . . . 0 C--N 1.287 -2.126 0 N-CA-C 108.803 -0.814 . . . . 73.55 108.803 174.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 N--CA 1.425 -1.712 0 N-CA-C 108.052 -1.092 . . . . 75.11 108.052 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -90.47 158.03 17.26 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 124.159 0.912 . . . . 74.42 108.54 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 55.2 m -145.85 138.16 25.47 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.796 -0.446 . . . . 51.23 109.796 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -81.52 132.35 35.31 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 109.525 -0.546 . . . . 61.21 109.525 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.508 HG23 ' HB2' ' A' ' 329' ' ' LEU . 7.9 m . . . . . 0 C--N 1.291 -1.957 0 CA-C-N 116.026 -0.534 . . . . 64.41 111.291 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 CA--C 1.493 -1.247 0 N-CA-C 107.427 -1.323 . . . . 75.33 107.427 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.298 1.6 pm0 -115.34 133.85 55.65 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-O 122.847 1.308 . . . . 73.23 114.087 -175.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.536 HG23 ' HE2' ' A' ' 364' ' ' LYS . 86.6 mt -123.62 106.59 17.41 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.732 0 CA-C-N 112.662 -2.063 . . . . 53.2 110.025 -173.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.524 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 30.2 ttpt -81.07 130.5 35.05 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.931 -1.137 . . . . 73.34 107.931 170.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.403 HD21 ' HA2' ' A' ' 363' ' ' GLY . 10.3 mt -129.97 156.76 43.91 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 124.805 1.316 . . . . 74.43 110.396 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 39.0 mm -106.5 117.57 52.52 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.762 0 N-CA-C 107.696 -1.224 . . . . 75.25 107.696 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.576 ' HG2' ' N ' ' A' ' 325' ' ' GLY . 17.5 tttm -71.69 160.92 31.8 Favored 'General case' 0 C--O 1.206 -1.185 0 N-CA-C 107.933 -1.136 . . . . 74.01 107.933 174.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.576 ' N ' ' HG2' ' A' ' 324' ' ' LYS . . . -149.33 -164.34 11.57 Favored Glycine 0 C--N 1.29 -1.981 0 N-CA-C 110.315 -1.114 . . . . 20.24 110.315 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.31 -12.84 27.86 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.892 2.394 . . . . 74.34 111.493 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -97.61 6.72 47.64 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 122.078 0.942 . . . . 65.43 108.968 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.03 -134.79 13.05 Favored Glycine 0 CA--C 1.491 -1.412 0 N-CA-C 109.824 -1.31 . . . . 74.45 109.824 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.78 -27.11 12.88 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.157 -1.423 . . . . 75.42 107.157 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 86.02 48.12 4.75 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.366 -1.288 . . . . 60.23 115.216 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -154.46 171.34 19.52 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 110.043 -0.354 . . . . 74.41 110.043 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.7 m -127.96 128.4 44.99 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.093 -0.706 . . . . 61.15 109.093 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 21.4 pt -113.79 157.92 14.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 115.84 -0.618 . . . . 75.31 110.622 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.39 125.96 10.98 Favored 'General case' 0 N--CA 1.428 -1.559 0 O-C-N 124.36 1.037 . . . . 63.12 108.454 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 164.13 -177.0 40.03 Favored Glycine 0 C--N 1.284 -2.333 0 N-CA-C 108.581 -1.808 . . . . 72.21 108.581 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.19 177.05 14.68 Favored Glycine 0 CA--C 1.482 -1.987 0 N-CA-C 109.833 -1.307 . . . . 71.25 109.833 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.454 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 92.8 t -57.76 103.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 O-C-N 124.121 0.542 . . . . 71.13 110.202 175.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 92.96 -14.08 66.11 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.375 -0.83 . . . . 72.32 112.101 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.511 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 65.0 t30 -106.02 21.56 17.11 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.553 -0.536 . . . . 73.42 109.553 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.67 123.5 7.96 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 115.104 -0.953 . . . . 72.23 111.49 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -78.72 -40.85 32.45 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.032 -0.985 . . . . 73.34 108.916 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 37.0 mm -103.62 122.36 45.07 Favored Pre-proline 0 C--N 1.302 -1.488 0 CA-C-N 115.2 -0.909 . . . . 75.24 109.334 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -52.2 108.11 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.429 2.752 . . . . 45.15 112.91 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 104.44 -2.6 42.97 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 115.178 -0.919 . . . . 61.35 112.308 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -127.14 103.66 7.55 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.747 0.784 . . . . 73.02 109.587 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' ASN . . . . . 0.454 ' OD1' ' HA ' ' A' ' 337' ' ' VAL . 65.9 t30 -83.32 38.02 0.59 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 125.038 1.335 . . . . 71.1 111.14 -171.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 21.5 m -110.9 177.86 4.53 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.723 -0.671 . . . . 75.13 112.346 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.416 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 35.0 mm -91.92 131.15 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.053 0.541 . . . . 74.43 109.702 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 36.6 m-85 -124.39 139.16 54.16 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.582 0.586 . . . . 72.44 112.582 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.24 115.05 10.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 108.256 -1.016 . . . . 71.55 108.256 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 31.6 m -101.06 -24.0 14.39 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.341 0.591 . . . . 71.32 111.308 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.63 147.93 23.7 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.792 -1.188 . . . . 72.33 107.792 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 85.1 mt -118.27 133.09 66.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 106.168 -1.79 . . . . 74.01 106.168 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 48.6 mm -75.83 130.87 35.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.315 0.579 . . . . 73.25 109.831 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.602 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.6 pm0 -60.09 122.36 14.2 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 125.006 1.322 . . . . 72.1 111.627 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 74.29 16.16 79.91 Favored Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 114.368 -1.287 . . . . 74.41 111.393 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.78 163.95 52.84 Favored Glycine 0 C--O 1.251 1.177 0 N-CA-C 110.97 -0.852 . . . . 15.32 110.97 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -64.33 -42.34 96.33 Favored 'General case' 0 C--O 1.207 -1.15 0 N-CA-C 108.816 -0.809 . . . . 44.34 108.816 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.425 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -71.49 -5.74 35.3 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 121.876 -0.515 . . . . 55.23 112.135 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -93.85 -36.12 12.39 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.67 -0.863 . . . . 63.33 108.67 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -92.62 -58.59 2.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.98 1.371 . . . . 52.45 110.221 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -85.9 -26.76 25.41 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.709 -2.041 . . . . 64.02 110.283 -170.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -56.69 -39.35 86.21 Favored Glycine 0 C--N 1.278 -2.641 0 CA-C-N 112.779 -2.01 . . . . 65.13 118.109 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.536 ' HE2' HG23 ' A' ' 320' ' ' ILE 0.255 0.0 OUTLIER 45.94 32.59 1.37 Allowed 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 119.113 1.456 . . . . 72.42 111.489 -170.56 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 48.3 tp -101.31 149.62 23.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.436 -1.257 . . . . 73.31 109.036 -172.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.95 147.74 42.86 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.285 0.564 . . . . 63.3 109.686 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 76.7 mt -66.03 123.3 18.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 106.927 -1.509 . . . . 74.12 106.927 170.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.54 -9.31 19.66 Favored Glycine 0 C--N 1.308 -1.005 0 C-N-CA 120.536 -0.84 . . . . 63.31 112.29 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -68.51 137.09 54.1 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 120.882 0.373 . . . . 74.44 111.504 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 2.1 ttmm -94.55 125.14 39.01 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.81 -0.632 . . . . 62.53 109.502 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 95.9 mt -81.45 112.36 18.63 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.671 -0.863 . . . . 62.4 108.671 176.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 403' ' ' ALA . 2.8 tt -80.5 -43.61 20.51 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.104 -2.184 . . . . 51.21 105.104 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -160.45 161.41 32.91 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.738 -1.119 . . . . 51.13 110.909 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.14 126.81 50.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.365 -1.346 . . . . 61.24 107.365 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.01 34.79 23.74 Favored 'General case' 0 CA--C 1.475 -1.925 0 CA-C-O 124.631 2.158 . . . . 43.01 110.339 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 60.42 17.33 7.11 Favored 'General case' 0 C--N 1.266 -3.058 1 CA-C-N 108.341 -4.027 . . . . 72.23 113.362 -177.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.4 t -89.04 125.86 42.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.64 -1.245 . . . . 70.14 107.64 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.4 p -57.58 123.42 15.53 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 123.847 0.859 . . . . 53.52 112.837 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 2.9 mp -107.32 -5.84 17.55 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.457 -0.792 . . . . 62.01 112.602 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -83.89 136.28 34.16 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.779 -0.768 . . . . 43.55 111.035 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 63.05 32.37 15.41 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.113 1.365 . . . . 71.53 114.469 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 33.2 m -112.07 169.15 4.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.257 -1.386 . . . . 71.14 107.257 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 82.6 p -79.26 150.46 31.54 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.359 -0.937 . . . . 73.54 108.937 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' HIS . . . . . 0.573 ' O ' HG23 ' A' ' 388' ' ' VAL . 6.8 t-160 -51.2 -37.25 45.63 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.212 0.449 . . . . 61.22 112.212 -175.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.33 -40.69 97.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 121.386 -0.126 . . . . 74.51 110.903 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -67.24 -37.15 83.08 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 109.188 -0.671 . . . . 72.35 109.188 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.523 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -68.66 -56.56 7.77 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 114.581 -1.19 . . . . 61.3 110.685 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 384' ' ' HIS . 27.4 t -58.98 -44.56 91.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 110.043 -0.354 . . . . 70.55 110.043 -177.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 87.3 m -60.29 -33.72 72.76 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.178 -0.465 . . . . 42.45 111.171 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.66 -38.03 86.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.425 -0.172 . . . . 74.33 110.757 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.4 mp -75.54 -30.12 59.63 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 119.914 -0.714 . . . . 64.12 110.219 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 55.0 mttm -72.31 -27.71 62.62 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 112.289 0.477 . . . . 74.02 112.289 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -80.07 51.36 1.35 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.047 0.927 . . . . 62.35 111.833 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 17.5 p -124.78 162.88 23.32 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 107.246 -1.39 . . . . 73.05 107.246 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 55.1 m -148.69 101.38 3.2 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.939 0.876 . . . . 74.35 110.669 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.571 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 0.8 OUTLIER 47.18 30.28 1.36 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 111.425 -2.625 . . . . 75.15 114.259 172.421 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -169.24 117.56 0.64 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 106.334 -1.728 . . . . 71.31 106.334 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.81 146.16 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.754 0.422 . . . . 73.14 111.036 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.524 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 28.0 m-85 -121.93 96.84 5.22 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.625 0.77 . . . . 72.31 108.975 171.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.45 ' CD2' HG23 ' A' ' 402' ' ' VAL . 7.0 tt -91.61 133.89 35.16 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.799 -0.637 . . . . 73.43 109.695 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -117.55 110.9 18.52 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.242 0.617 . . . . 60.15 110.651 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' A' ' 400' ' ' LEU . 53.7 t -104.99 143.13 16.8 Favored 'Isoleucine or valine' 0 C--O 1.27 2.162 0 C-N-CA 124.047 0.939 . . . . 64.41 110.525 177.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -125.76 154.52 42.41 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 103.957 -2.608 . . . . 73.43 103.957 167.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt . . . . . 0 C--N 1.285 -2.198 0 C-N-CA 119.303 -0.959 . . . . 71.1 111.085 -177.435 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 C--O 1.26 1.608 0 N-CA-C 106.478 -1.675 . . . . 74.04 106.478 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 148' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' B' ' 148' ' ' GLU . 0.1 OUTLIER -95.61 159.79 14.82 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 123.797 0.686 . . . . 74.03 110.074 -178.851 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 45.9 m -145.12 140.08 27.76 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.729 -0.607 . . . . 72.01 110.585 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -81.9 135.88 35.37 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.673 0.789 . . . . 73.44 110.393 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.42 HG12 HG13 ' A' ' 388' ' ' VAL . 15.3 m . . . . . 0 C--O 1.27 2.146 0 CA-C-N 116.077 -0.51 . . . . 64.15 111.641 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 C--O 1.209 -1.046 0 N-CA-C 108.233 -1.025 . . . . 63.3 108.233 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.285 2.0 pm0 -104.31 139.51 39.19 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 114.069 1.137 . . . . 73.34 114.069 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.471 HD13 ' O ' ' A' ' 363' ' ' GLY . 89.9 mt -128.66 122.53 57.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.168 -1.833 . . . . 62.13 107.986 -172.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.534 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 33.1 ttpt -94.79 109.67 21.62 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.38 -0.528 . . . . 42.24 110.622 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.429 HD21 ' HA2' ' A' ' 363' ' ' GLY . 88.0 mt -106.61 151.49 24.98 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.678 -1.147 . . . . 61.31 109.769 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 24.2 mm -105.25 111.22 33.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.038 -1.467 . . . . 75.31 107.038 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -75.98 130.55 38.6 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.355 -0.384 . . . . 70.33 111.548 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -133.09 -154.97 7.65 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 119.386 -1.388 . . . . 53.21 112.696 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.51 -13.26 35.03 Favored 'Trans proline' 0 N--CA 1.481 0.77 0 C-N-CA 123.411 2.741 . . . . 71.24 114.177 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -106.27 8.57 31.94 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.176 0.988 . . . . 62.23 108.386 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.02 -136.28 14.66 Favored Glycine 0 CA--C 1.492 -1.376 0 CA-C-N 113.844 -1.525 . . . . 34.13 110.497 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.457 ' HB2' HG23 ' B' ' 151' ' ' VAL . 4.0 mp -98.55 -26.26 14.47 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.746 -1.946 . . . . 73.52 105.746 171.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' GLY . . . . . 0.593 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 80.28 54.04 3.93 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 113.689 -1.596 . . . . 42.02 115.113 172.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -155.35 158.52 38.83 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.218 -1.03 . . . . 71.2 108.218 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 352' ' ' LYS . 14.9 m -113.08 133.64 54.9 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.388 -0.597 . . . . 74.42 109.388 -177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.3 pt -116.16 154.54 17.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 115.833 -0.622 . . . . 52.15 110.996 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -143.58 127.37 17.21 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.478 -1.675 . . . . 63.5 106.478 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 148.33 150.67 5.26 Favored Glycine 0 C--N 1.283 -2.416 0 N-CA-C 109.323 -1.511 . . . . 71.44 109.323 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.65 171.84 12.75 Favored Glycine 0 C--N 1.287 -2.189 0 N-CA-C 108.044 -2.022 . . . . 75.13 108.044 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.408 ' HA ' HD21 ' A' ' 346' ' ' ASN . 61.1 t -45.57 111.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.087 0.943 . . . . 60.44 111.58 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 94.05 -30.49 7.53 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.097 -0.956 . . . . 71.33 112.361 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.43 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 1.8 t-20 -105.46 26.75 9.08 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.808 -0.442 . . . . 72.3 109.808 -177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.83 123.93 8.91 Favored 'General case' 0 C--O 1.26 1.646 0 CA-C-N 116.017 -0.538 . . . . 75.45 109.793 177.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -75.81 -52.62 9.99 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.141 -0.936 . . . . 71.34 109.497 -173.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 73.3 mt -103.26 133.18 20.46 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 107.817 -1.179 . . . . 71.14 107.817 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.61 110.84 0.47 Allowed 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 123.424 2.749 . . . . 71.14 113.755 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 97.54 -4.58 61.91 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.322 -0.854 . . . . 61.43 112.045 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 23.8 t0 -120.15 96.82 5.32 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.831 0.824 . . . . 72.31 108.841 -177.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' ASN . . . . . 0.408 HD21 ' HA ' ' A' ' 337' ' ' VAL . 52.7 t30 -85.05 28.91 0.67 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.506 0.669 . . . . 74.3 110.7 -171.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.456 ' HB2' ' CE2' ' A' ' 349' ' ' TYR . 15.2 m -90.45 164.71 14.17 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.105 0.479 . . . . 63.52 111.106 -175.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 24.6 mm -79.54 125.01 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 108.428 -0.953 . . . . 75.11 108.428 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.589 ' CE1' ' HB2' ' A' ' 370' ' ' LYS . 47.7 m-85 -123.71 130.22 52.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.089 0.471 . . . . 73.45 111.801 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.17 117.1 6.31 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 CA-C-N 115.432 -0.804 . . . . 73.14 109.254 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.2 m -100.06 -18.16 17.13 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.484 0.659 . . . . 75.44 110.476 -175.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.566 ' HB2' ' HZ3' ' A' ' 352' ' ' LYS . 2.3 ttmp? -166.57 153.05 8.81 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.047 -1.094 . . . . 72.33 108.047 -175.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 64.8 mt -126.87 119.86 54.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 107.037 -1.468 . . . . 62.45 107.037 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 42.8 mm -86.28 125.94 40.68 Favored 'Isoleucine or valine' 0 C--O 1.259 1.568 0 C-N-CA 123.234 0.614 . . . . 74.54 109.72 -175.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.31 147.6 47.69 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 108.285 -1.005 . . . . 63.35 108.285 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.558 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.49 -19.06 56.03 Favored Glycine 0 C--N 1.281 -2.487 0 N-CA-C 109.714 -1.355 . . . . 41.22 109.714 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 357' ' ' GLY . . . . . 0.593 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -72.93 149.85 43.51 Favored Glycine 1 N--CA 1.395 -4.095 0 N-CA-C 109.515 -1.434 . . . . 62.21 109.515 173.616 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -56.95 -36.84 70.73 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.132 -0.692 . . . . 60.21 109.132 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.574 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.81 -13.04 60.28 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 113.263 0.838 . . . . 51.32 113.263 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -94.14 -31.4 14.18 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.369 -0.974 . . . . 72.32 108.369 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.558 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 75.1 mmtt -84.69 -58.2 2.82 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.738 -0.785 . . . . 64.12 110.676 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.46 -42.17 13.81 Favored 'General case' 0 CA--C 1.467 -2.225 0 CA-C-O 121.887 0.851 . . . . 74.32 111.124 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -42.66 -23.1 0.17 Allowed Glycine 0 CA--C 1.482 -2.024 0 N-CA-C 120.328 2.891 . . . . 74.43 120.328 -158.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.516 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.84 32.48 0.4 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 119.037 1.418 . . . . 54.14 111.658 -178.165 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 48.5 tp -99.69 152.78 19.69 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.519 -1.219 . . . . 73.25 109.83 -171.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -117.14 144.65 44.47 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.478 0.656 . . . . 64.1 110.677 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.9 mt -66.12 120.81 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 106.958 -1.497 . . . . 72.22 106.958 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.56 -7.46 20.27 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 120.803 -0.713 . . . . 51.41 112.157 -176.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -70.14 137.54 51.14 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-O 121.17 0.509 . . . . 70.13 111.742 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.589 ' HB2' ' CE1' ' A' ' 349' ' ' TYR . 36.1 tttp -92.07 119.14 31.48 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.281 -0.872 . . . . 71.1 110.118 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 93.8 mt -79.08 114.71 18.24 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.293 -0.632 . . . . 75.33 109.293 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.457 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 3.3 tt -82.49 -39.84 21.92 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.205 -1.776 . . . . 64.41 106.205 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.92 166.86 21.29 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.538 -0.756 . . . . 53.44 112.331 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' VAL . . . . . 0.524 HG12 HD11 ' A' ' 379' ' ' LEU . 12.0 p -132.74 116.69 27.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 107.493 -1.299 . . . . 43.21 107.493 171.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 63.22 29.58 15.94 Favored 'General case' 0 CA--C 1.469 -2.145 0 CA-C-O 123.943 1.83 . . . . 62.24 109.672 -172.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 66.39 11.8 8.23 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 109.556 -3.475 . . . . 74.42 113.182 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 49.8 t -78.57 119.31 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 106.214 -1.773 . . . . 74.11 106.214 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -59.45 124.62 20.64 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 114.328 1.233 . . . . 65.51 114.328 -173.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.524 HD11 HG12 ' A' ' 374' ' ' VAL . 6.6 mp -101.76 11.15 39.24 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 124.921 1.288 . . . . 54.43 108.973 174.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 380' ' ' GLU . . . . . 0.457 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 24.0 mm-40 -78.43 112.23 15.25 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.258 -1.337 . . . . 75.25 108.682 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 381' ' ' GLU . . . . . 0.405 ' CD ' HD22 ' A' ' 346' ' ' ASN . 19.0 tp10 61.06 83.55 0.14 Allowed 'General case' 0 CA--C 1.544 0.719 0 O-C-N 124.51 1.131 . . . . 63.44 111.721 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 19.3 m -153.13 162.83 2.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.061 -1.427 . . . . 74.52 107.975 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.419 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 2.0 m -78.64 143.32 36.46 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.726 -0.842 . . . . 72.41 108.726 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' HIS . . . . . 0.568 ' O ' HG23 ' A' ' 388' ' ' VAL . 86.4 t60 -51.95 -49.66 62.73 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 120.872 0.367 . . . . 75.45 111.695 -175.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -61.05 -36.55 79.9 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.119 -0.946 . . . . 63.01 110.7 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.419 ' HB3' ' O ' ' A' ' 383' ' ' THR . 48.6 tt0 -73.75 -34.04 64.56 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.417 -1.265 . . . . 63.03 108.799 -174.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.546 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -71.83 -48.16 48.1 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.744 -1.117 . . . . 64.22 110.137 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 384' ' ' HIS . 19.3 t -58.52 -45.37 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.409 -0.589 . . . . 71.53 109.409 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 66.0 m -61.34 -31.72 71.59 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 116.08 -0.509 . . . . 64.31 111.348 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.65 84.16 Favored 'General case' 0 C--N 1.343 0.313 0 O-C-N 122.019 -0.426 . . . . 23.44 110.312 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.3 mp -79.08 -23.99 43.79 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 120.199 -0.6 . . . . 75.11 110.915 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.481 ' HE2' HG12 ' A' ' 388' ' ' VAL . 61.5 mttm -75.91 -32.19 59.51 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.528 0.566 . . . . 71.2 112.528 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -74.83 32.55 0.09 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.364 1.065 . . . . 65.24 113.761 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 1.7 p -124.77 158.45 33.28 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 109.968 -0.382 . . . . 71.2 109.968 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 62.8 m -148.53 125.84 11.55 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.535 -0.543 . . . . 55.23 109.535 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 26.6 t70 60.98 0.17 0.36 Allowed 'General case' 0 C--O 1.2 -1.513 0 C-N-CA 126.578 1.951 . . . . 72.35 114.954 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -158.38 119.12 3.36 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 120.276 -1.515 . . . . 73.41 110.333 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 93.7 t -142.21 117.93 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 122.553 0.341 . . . . 62.53 111.678 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.534 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 17.8 m-85 -90.07 96.53 10.72 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.123 -1.066 . . . . 65.0 108.123 167.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 tt -83.35 130.82 35.08 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.097 -0.705 . . . . 73.22 109.097 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 38.8 tttp -121.19 112.62 18.88 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 109.954 -0.387 . . . . 74.3 109.954 -173.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 53.7 t -104.92 144.58 14.52 Favored 'Isoleucine or valine' 0 C--O 1.263 1.788 0 C-N-CA 123.753 0.821 . . . . 73.32 110.882 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -121.58 157.75 30.07 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 104.95 -2.241 . . . . 65.4 104.95 172.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 9.5 mmpt? . . . . . 0 C--N 1.285 -2.208 0 C-N-CA 119.184 -1.006 . . . . 74.12 109.051 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 N--CA 1.417 -2.098 0 N-CA-C 106.621 -1.622 . . . . 64.22 106.621 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.04 146.3 24.36 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 107.406 -1.331 . . . . 73.53 107.406 174.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 15.0 m -134.14 132.39 39.81 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 120.424 -0.51 . . . . 74.53 109.701 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -75.58 136.36 40.52 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 109.671 -0.492 . . . . 62.12 109.671 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.457 HG23 ' HB2' ' A' ' 329' ' ' LEU . 18.0 m . . . . . 0 C--N 1.296 -1.73 0 CA-C-O 117.107 -1.425 . . . . 65.51 112.107 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 109.331 -0.618 . . . . 62.22 109.331 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.33 119.8 11.67 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 122.247 1.022 . . . . 64.31 109.203 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 65.3 mt -98.47 106.56 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.895 0 CA-C-N 113.689 -1.596 . . . . 74.3 109.736 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -76.5 104.01 6.79 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 104.408 -2.442 . . . . 72.31 104.408 165.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 359' ' ' ALA . 0.6 OUTLIER -109.25 136.23 49.05 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 113.751 -1.568 . . . . 75.44 106.976 -173.4 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 21.9 mm -95.03 137.14 24.08 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 C-N-CA 119.36 -0.936 . . . . 71.32 109.292 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 395' ' ' SER . 1.2 ttpm? -68.16 177.64 2.18 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-O 121.106 0.479 . . . . 73.14 109.835 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.521 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -150.68 -173.88 21.2 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.229 -1.148 . . . . 65.02 110.229 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.47 -41.02 21.6 Favored 'Trans proline' 0 N--CA 1.482 0.831 0 C-N-CA 122.955 2.436 . . . . 62.3 112.178 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.35 -14.54 46.1 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 123.31 1.529 . . . . 61.24 107.656 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 98.74 -143.75 16.81 Favored Glycine 0 C--N 1.256 -3.885 0 CA-C-N 113.38 -1.736 . . . . 71.04 109.437 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.1 mp -74.76 -46.24 38.48 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 117.679 0.739 . . . . 61.41 111.105 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 83.41 53.15 3.51 Favored Glycine 0 C--O 1.22 -0.72 0 C-N-CA 120.173 -1.013 . . . . 52.5 115.364 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 49.0 p90 -151.82 172.98 15.33 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.185 -0.672 . . . . 71.24 109.185 173.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.486 ' OG ' ' HG2' ' B' ' 150' ' ' GLN . 3.9 m -123.38 136.1 54.47 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.951 -0.388 . . . . 44.13 109.951 -177.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 16.4 pt -120.57 156.55 23.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 116.318 -0.401 . . . . 71.34 110.146 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' B' ' 148' ' ' GLU . . . -148.02 133.3 18.46 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.96 -1.126 . . . . 63.35 107.96 175.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 157.83 -177.43 34.59 Favored Glycine 0 C--N 1.273 -2.922 0 N-CA-C 108.5 -1.84 . . . . 71.21 108.5 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.11 175.47 13.98 Favored Glycine 0 C--N 1.272 -2.986 0 N-CA-C 108.054 -2.018 . . . . 51.14 108.054 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.8 100.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.49 0.662 . . . . 62.21 110.769 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 80.71 2.45 89.96 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 115.164 -0.926 . . . . 55.24 113.445 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -107.69 11.81 28.06 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.057 -1.09 . . . . 73.43 108.057 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.88 134.27 56.48 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 115.624 1.713 . . . . 73.42 115.624 -173.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -71.62 -34.97 70.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.005 -1.452 . . . . 64.24 109.515 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 41.8 mm -104.75 118.89 55.23 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.998 -0.546 . . . . 75.51 110.299 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.94 110.17 0.59 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.745 2.297 . . . . 73.34 111.489 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.33 -28.23 9.87 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.95 -0.643 . . . . 71.01 111.832 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -106.77 102.51 11.87 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.766 -0.827 . . . . 64.24 108.766 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -82.66 38.11 0.55 Allowed 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 123.721 0.809 . . . . 73.14 112.208 -170.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 75.2 m -103.2 178.44 4.56 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 113.268 0.84 . . . . 74.33 113.268 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.459 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 25.7 mm -93.96 131.32 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 114.853 -1.067 . . . . 44.4 108.128 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 369' ' ' ASP . 28.9 m-85 -124.11 135.14 53.32 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 112.691 0.626 . . . . 73.03 112.691 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.69 116.57 5.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.072 -1.084 . . . . 62.34 108.072 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.3 m -107.57 -20.41 13.25 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 120.852 0.358 . . . . 74.12 111.537 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 331' ' ' PHE . 47.0 mmtm -149.34 159.06 44.61 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 107.524 -1.287 . . . . 75.51 107.524 177.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.441 HG22 ' HB2' ' A' ' 360' ' ' HIS . 75.9 mt -140.54 124.97 18.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 107.049 -1.463 . . . . 73.11 107.049 172.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 39.2 mm -85.62 116.49 28.89 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 N-CA-C 108.15 -1.055 . . . . 74.05 108.15 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.55 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 1.1 pp20? -66.23 147.53 53.18 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 107.257 -1.386 . . . . 73.1 107.257 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.485 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.69 -26.66 19.11 Favored Glycine 0 C--N 1.288 -2.123 0 N-CA-C 109.691 -1.364 . . . . 63.42 109.691 -175.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -69.98 156.83 53.49 Favored Glycine 0 C--O 1.272 2.489 0 N-CA-C 110.914 -0.874 . . . . 75.21 110.914 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -57.6 -41.17 80.71 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 109.792 -0.448 . . . . 53.42 109.792 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.655 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.99 -4.88 43.6 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 113.394 0.887 . . . . 73.25 113.394 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' HIS . . . . . 0.55 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 69.6 t60 -94.8 -38.18 10.88 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.641 -0.824 . . . . 54.04 109.136 172.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.485 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 72.7 mmtt -83.42 -57.2 3.35 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.976 -0.689 . . . . 73.23 111.362 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -85.54 -30.81 23.09 Favored 'General case' 0 CA--C 1.463 -2.383 0 CA-C-O 121.672 0.749 . . . . 70.34 109.588 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -43.31 -32.66 1.81 Allowed Glycine 0 CA--C 1.475 -2.413 0 CA-C-N 113.239 -1.801 . . . . 61.34 117.22 -168.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? 45.09 36.85 2.21 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 124.626 0.839 . . . . 74.41 110.408 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 29.9 tp -119.78 158.56 26.29 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 113.79 -1.55 . . . . 71.14 109.339 -168.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.75 145.23 49.63 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 115.82 -0.627 . . . . 71.54 109.936 -174.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 81.1 mt -66.77 119.23 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 108.991 -0.744 . . . . 71.24 108.991 175.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.76 3.33 20.25 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.984 -0.627 . . . . 71.33 111.996 -175.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 8.0 m-20 -73.25 133.02 43.83 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.818 0.673 . . . . 74.34 112.818 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 44.5 tttp -92.9 114.83 27.5 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.444 1.098 . . . . 70.42 108.473 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 83.9 mt -83.61 112.07 19.68 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.848 -0.427 . . . . 73.34 109.848 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.4 tt -83.7 -40.71 18.55 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.531 -1.213 . . . . 74.33 107.918 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -162.6 145.82 11.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.689 -0.687 . . . . 71.2 109.72 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.56 130.19 49.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 109.377 -0.601 . . . . 74.12 109.377 175.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 44.93 67.27 0.73 Allowed 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 125.652 1.581 . . . . 71.02 110.343 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 66.43 -26.69 0.11 Allowed 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 114.771 1.397 . . . . 75.3 114.771 -176.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 42.5 t -78.84 125.7 38.41 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 O-C-N 121.651 -0.656 . . . . 73.44 110.487 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -74.92 130.04 38.71 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 122.481 0.312 . . . . 74.0 110.521 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.6 0.09 22.34 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.474 0.546 . . . . 74.53 112.474 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -68.36 106.71 2.59 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.43 -0.582 . . . . 72.42 109.43 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 62.85 73.82 0.45 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 122.678 1.228 . . . . 60.23 113.077 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.56 169.71 16.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.515 -1.221 . . . . 71.24 107.834 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.518 ' OG1' ' HG2' ' A' ' 386' ' ' GLU . 3.0 p -76.63 147.85 37.3 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.639 -0.874 . . . . 65.12 108.639 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' HIS . . . . . 0.603 ' O ' HG23 ' A' ' 388' ' ' VAL . 10.6 t-80 -57.52 -37.04 72.37 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.496 0.665 . . . . 74.54 109.446 -172.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -56.45 -44.05 80.12 Favored 'General case' 0 N--CA 1.403 -2.8 0 CA-C-N 113.88 -1.509 . . . . 72.42 112.826 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.518 ' HG2' ' OG1' ' A' ' 383' ' ' THR . 20.0 mm-40 -75.28 -29.33 60.1 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 109.189 -0.671 . . . . 63.24 109.189 -176.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.421 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -67.33 -58.12 5.38 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.489 -1.232 . . . . 50.14 109.086 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 384' ' ' HIS . 17.8 t -59.27 -41.42 83.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 N-CA-C 109.447 -0.575 . . . . 53.5 109.447 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 35.1 m -61.46 -35.63 78.16 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 115.977 -0.556 . . . . 71.13 111.477 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -69.07 -38.02 78.82 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 122.341 -0.224 . . . . 43.24 110.583 176.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 387' ' ' ALA . 6.1 mp -72.16 -28.92 63.55 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.419 -0.513 . . . . 71.23 110.596 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 61.5 mttm -73.91 -34.88 64.55 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 120.602 -0.439 . . . . 72.32 112.106 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -84.77 62.39 7.37 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.785 0.802 . . . . 61.43 110.877 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 22.5 p -125.6 152.44 45.13 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.311 -0.859 . . . . 73.43 109.282 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' SER . . . . . 0.531 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 50.4 m -146.83 90.11 1.88 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 122.218 1.009 . . . . 70.13 111.072 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.497 ' H ' ' HB2' ' A' ' 324' ' ' LYS 0.265 22.1 m-20 62.2 14.35 6.6 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 111.951 -2.386 . . . . 73.31 115.208 170.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -157.77 107.6 2.15 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 108.034 -1.098 . . . . 70.54 108.034 173.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 43.7 t -114.73 123.73 70.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.787 -0.819 . . . . 34.04 108.787 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.74 95.7 6.83 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 105.108 -2.182 . . . . 65.13 105.108 174.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 8.0 tt -102.22 104.02 14.56 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-O 121.376 0.608 . . . . 72.53 109.582 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -93.61 112.03 23.83 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.138 -1.43 . . . . 52.15 107.138 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.426 HG21 ' HB3' ' A' ' 369' ' ' ASP . 4.7 p -119.16 146.17 24.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.209 -0.905 . . . . 62.22 110.557 -173.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.539 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -125.17 158.38 34.1 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.298 -1.001 . . . . 72.33 108.298 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? . . . . . 0 C--N 1.299 -1.611 0 N-CA-C 106.958 -1.497 . . . . 62.32 106.958 177.566 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 36.4 p30 . . . . . 0 CA--C 1.489 -1.376 0 N-CA-C 107.988 -1.116 . . . . 73.54 107.988 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 148' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 334' ' ' ALA . 15.3 pt-20 -85.56 156.61 20.67 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.733 -0.839 . . . . 72.44 108.733 176.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 49.0 m -144.17 141.0 29.68 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.9 -0.5 . . . . 52.41 110.265 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 150' ' ' GLN . . . . . 0.486 ' HG2' ' OG ' ' A' ' 332' ' ' SER . 77.7 mt-30 -85.35 149.22 25.6 Favored 'General case' 0 CA--C 1.454 -2.742 0 CA-C-O 121.445 0.64 . . . . 63.33 111.631 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . 0.272 22.0 m . . . . . 1 N--CA 1.374 -4.253 0 CA-C-O 117.453 -1.261 . . . . 73.44 110.443 174.59 . . . . . . . . 2 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 CA--C 1.494 -1.193 0 N-CA-C 106.559 -1.645 . . . . 75.23 106.559 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.429 1.8 pm0 -114.61 134.4 55.09 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 116.319 1.97 . . . . 74.52 116.319 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 73.7 mt -124.43 112.88 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-N 112.573 -2.103 . . . . 71.41 109.186 -173.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -79.66 124.97 29.05 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.416 -1.327 . . . . 70.34 107.416 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 45.2 mt -114.48 144.33 43.51 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.072 -1.084 . . . . 75.02 108.072 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 396' ' ' ASP . 54.3 mt -105.86 110.79 32.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 108.504 -0.925 . . . . 63.14 108.504 171.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.685 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 9.6 tmtt? -55.68 158.78 3.33 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 124.568 1.168 . . . . 64.12 111.601 177.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -144.37 -166.66 11.59 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 111.435 -0.666 . . . . 60.41 111.435 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.81 -15.08 46.22 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 123.324 2.683 . . . . 74.22 112.991 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 355' ' ' GLU . 37.0 ttpt -112.67 19.58 17.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.048 0.928 . . . . 74.33 109.248 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.92 -127.3 8.0 Favored Glycine 0 CA--C 1.497 -1.032 0 CA-C-N 114.994 -1.003 . . . . 54.42 111.31 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.537 ' HB2' HG23 ' B' ' 151' ' ' VAL . 4.0 mp -104.89 -22.72 13.11 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.224 -1.028 . . . . 73.52 108.224 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 73.72 50.98 9.93 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 114.807 -1.088 . . . . 63.33 115.606 171.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -154.43 149.79 27.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.442 -0.577 . . . . 65.25 109.442 172.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 7.5 m -105.01 128.3 53.25 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.95 0.405 . . . . 74.53 109.919 -175.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.404 ' HB ' HG23 ' A' ' 348' ' ' ILE . 30.3 pt -122.82 151.58 27.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.596 -0.729 . . . . 73.11 111.03 -175.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -140.9 137.16 32.97 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 105.55 -2.018 . . . . 72.42 105.55 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 347' ' ' SER . . . 147.45 162.54 10.07 Favored Glycine 0 C--N 1.281 -2.49 0 N-CA-C 109.771 -1.332 . . . . 64.5 109.771 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.53 177.34 14.88 Favored Glycine 0 C--N 1.284 -2.345 0 N-CA-C 108.718 -1.753 . . . . 34.13 108.718 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 99.2 t -55.8 108.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 117.522 0.661 . . . . 73.2 109.971 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 86.45 -11.1 64.53 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.648 -0.706 . . . . 71.33 112.712 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.409 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -106.39 9.74 31.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.051 -1.463 . . . . 63.21 107.051 179.162 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.95 121.66 4.97 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.939 1.296 . . . . 72.55 111.969 -175.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -82.28 -27.03 32.61 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.942 -1.026 . . . . 60.43 109.132 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.619 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 2.9 mp -116.52 131.48 23.84 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 106.779 -1.563 . . . . 75.2 106.779 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.53 107.01 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.571 2.18 . . . . 71.34 112.909 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 102.22 0.91 51.02 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.621 -0.718 . . . . 75.11 112.861 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.619 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 22.0 t70 -129.67 101.38 5.88 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.398 0.618 . . . . 72.45 109.617 -177.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' ASN . . . . . 0.418 ' HB2' ' OE2' ' A' ' 381' ' ' GLU . 32.6 m-80 -87.1 38.01 0.79 Allowed 'General case' 0 CA--C 1.5 -0.96 0 O-C-N 121.556 -0.715 . . . . 74.1 110.684 -174.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.487 ' O ' ' HA3' ' A' ' 335' ' ' GLY . 14.3 m -86.3 157.43 19.91 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.703 0.763 . . . . 72.31 111.202 -176.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.404 HG23 ' HB ' ' A' ' 333' ' ' ILE . 38.4 mm -75.63 122.82 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.563 0 N-CA-C 106.606 -1.627 . . . . 74.14 106.606 173.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 342' ' ' ILE . 3.5 t80 -124.0 133.78 53.6 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 108.319 -0.993 . . . . 72.23 108.319 -173.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.412 HG21 HD21 ' A' ' 365' ' ' LEU . 43.9 t -74.82 109.78 8.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.851 -0.613 . . . . 71.4 109.581 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.564 ' O ' ' HD2' ' A' ' 352' ' ' LYS . 8.6 m -90.78 -36.73 14.1 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.975 -0.557 . . . . 74.44 109.976 -178.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.564 ' HD2' ' O ' ' A' ' 351' ' ' THR . 1.2 mptm? -144.6 156.46 44.14 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.099 -0.704 . . . . 55.35 109.099 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 71.6 mt -125.35 129.51 73.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 106.284 -1.747 . . . . 64.31 106.284 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 47.2 mm -85.64 141.83 13.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 123.525 0.516 . . . . 65.32 110.186 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 327' ' ' LYS . 0.9 OUTLIER -57.03 120.87 8.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.286 1.034 . . . . 72.14 112.584 -174.528 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 72.59 14.49 77.68 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 115.281 -0.872 . . . . 52.1 112.97 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -73.54 168.42 53.95 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.213 -1.155 . . . . 43.24 110.213 176.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -58.76 -39.11 80.03 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 117.312 0.556 . . . . 63.43 110.346 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.61 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -72.58 -15.16 61.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.225 0.536 . . . . 52.05 111.94 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -95.19 -23.56 17.22 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.959 -0.756 . . . . 74.45 108.959 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 4.0 tmmt? -95.76 -60.16 1.71 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.649 0.738 . . . . 73.32 111.062 -175.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -86.94 -31.14 20.82 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.336 1.065 . . . . 74.31 109.426 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.786 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -53.61 -50.41 53.66 Favored Glycine 0 CA--C 1.481 -2.072 0 N-CA-C 119.135 2.414 . . . . 43.41 119.135 -167.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.786 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 43.8 34.17 0.83 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.253 1.025 . . . . 64.23 109.676 -167.688 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 365' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 350' ' ' VAL . 21.7 tp -92.2 158.27 16.25 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 113.547 -1.66 . . . . 53.14 109.752 -169.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -117.07 144.3 44.8 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.726 0.774 . . . . 71.1 110.845 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 71.0 mt -65.85 119.99 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 106.108 -1.812 . . . . 63.02 106.108 167.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.416 ' HA2' ' CE2' ' A' ' 349' ' ' TYR . . . 115.46 3.45 20.72 Favored Glycine 0 C--N 1.295 -1.699 0 C-N-CA 119.669 -1.253 . . . . 50.24 112.16 -173.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 7.2 m-20 -75.8 137.19 40.36 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 113.139 0.792 . . . . 60.12 113.139 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -100.47 115.28 29.71 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.13 -1.063 . . . . 71.53 108.13 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 60.5 mt -84.67 115.51 22.7 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.236 0.541 . . . . 63.33 110.246 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.77 -37.11 27.68 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.837 -1.529 . . . . 63.2 107.695 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 401' ' ' LYS . . . -163.34 157.25 19.85 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.79 -0.641 . . . . 71.22 111.216 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 374' ' ' VAL . . . . . 0.473 HG12 HD11 ' A' ' 379' ' ' LEU . 14.5 p -133.88 122.93 43.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 107.569 -1.271 . . . . 45.22 107.569 172.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' ASN . . . . . 0.548 HD21 HG22 ' A' ' 394' ' ' THR . 89.3 m-20 62.2 29.32 17.44 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 124.036 1.874 . . . . 55.53 108.853 -174.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 67.21 10.42 7.7 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 109.515 -3.493 . . . . 73.13 113.479 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.9 t -79.94 124.49 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 106.576 -1.639 . . . . 74.13 106.576 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -64.35 127.51 31.79 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.009 0.744 . . . . 75.5 113.009 -175.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.473 HD11 HG12 ' A' ' 374' ' ' VAL . 6.9 mp -106.31 6.71 30.83 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 123.865 0.866 . . . . 74.22 110.973 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -76.91 122.97 25.6 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.16 -1.792 . . . . 52.13 106.16 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' GLU . . . . . 0.418 ' OE2' ' HB2' ' A' ' 346' ' ' ASN 0.32 1.5 mp0 48.52 83.09 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 116.062 1.875 . . . . 73.25 116.062 -172.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 15.8 m -149.85 157.82 6.12 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-N 113.428 -1.714 . . . . 53.55 107.735 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.8 m -81.16 140.73 34.81 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.424 -0.954 . . . . 73.41 108.424 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' HIS . . . . . 0.561 ' O ' HG23 ' A' ' 388' ' ' VAL . 82.6 t60 -50.93 -46.18 60.77 Favored 'General case' 0 C--O 1.207 -1.168 0 N-CA-C 112.993 0.738 . . . . 74.13 112.993 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -59.24 -40.45 85.98 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.966 0.888 . . . . 63.42 109.677 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.0 tt0 -72.52 -39.76 67.33 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.074 -1.421 . . . . 72.2 108.856 -173.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.414 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -71.35 -46.17 61.17 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.449 -1.251 . . . . 44.13 110.997 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 384' ' ' HIS . 57.9 t -59.98 -41.64 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 109.872 -0.418 . . . . 71.42 109.872 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 62.2 m -58.9 -35.63 73.35 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 123.443 0.464 . . . . 73.51 110.478 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.31 -34.54 78.57 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 122.075 -0.391 . . . . 71.13 110.82 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.9 mp -80.74 -30.3 36.21 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 120.426 -0.509 . . . . 72.03 110.943 176.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.416 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 51.7 mttm -73.91 -23.54 59.56 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.23 0.456 . . . . 74.2 112.23 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -77.69 49.41 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.371 0.605 . . . . 71.03 110.562 175.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.548 HG22 HD21 ' A' ' 375' ' ' ASN . 21.5 p -124.77 142.35 51.48 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 109.472 -0.566 . . . . 74.55 109.472 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 62.1 m -144.48 99.09 3.31 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 122.571 1.177 . . . . 72.01 112.076 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.685 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 7.7 m-20 65.58 12.36 8.16 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 111.023 -2.808 . . . . 73.03 112.819 168.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -160.76 129.37 4.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.332 -1.729 . . . . 74.45 106.332 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.7 t -139.53 141.74 34.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 107.668 -1.234 . . . . 52.2 107.668 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -118.5 95.93 5.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.756 -1.572 . . . . 73.1 106.756 174.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.58 130.72 35.85 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 122.785 0.434 . . . . 53.35 110.571 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 373' ' ' ALA . 22.7 ttmm -116.21 108.97 16.8 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.178 -1.045 . . . . 72.51 108.178 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 369' ' ' ASP . 7.9 p -113.38 155.39 14.6 Favored 'Isoleucine or valine' 0 C--O 1.269 2.113 0 CA-C-N 116.035 -0.53 . . . . 65.54 110.449 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -136.62 157.58 46.44 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.422 -1.325 . . . . 72.22 107.422 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 9.7 mmpt? . . . . . 0 C--N 1.306 -1.312 0 N-CA-C 107.302 -1.37 . . . . 70.12 107.302 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 21.2 p30 . . . . . 0 CA--C 1.499 -1.0 0 N-CA-C 111.991 0.367 . . . . 62.03 111.991 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -96.33 145.69 25.39 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.668 -1.234 . . . . 75.44 107.668 172.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 65.7 m -147.4 144.23 28.53 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.992 -0.443 . . . . 74.34 110.011 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -76.34 136.08 39.55 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.096 0.474 . . . . 73.31 110.593 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.537 HG23 ' HB2' ' A' ' 329' ' ' LEU . 4.3 m . . . . . 0 C--N 1.292 -1.912 0 CA-C-N 115.59 -0.732 . . . . 72.12 110.309 173.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 C--O 1.202 -1.442 0 N-CA-C 106.242 -1.762 . . . . 53.21 106.242 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 319' ' ' GLU . . . . . 0.509 ' HB3' ' HG2' ' A' ' 401' ' ' LYS 0.343 1.8 pm0 -118.24 136.94 53.36 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 114.919 1.452 . . . . 64.42 114.919 -174.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 363' ' ' GLY . 75.3 mt -126.23 114.38 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 CA-C-N 113.214 -1.812 . . . . 73.25 110.048 -172.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.478 ' HG3' ' CZ ' ' A' ' 397' ' ' PHE . 0.9 OUTLIER -79.71 136.43 36.77 Favored 'General case' 0 C--N 1.279 -2.498 0 N-CA-C 107.718 -1.216 . . . . 63.2 107.718 172.046 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.59 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 97.0 mt -131.63 157.26 44.15 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.581 -0.525 . . . . 73.12 109.581 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 324' ' ' LYS . 2.4 mp -106.27 140.97 22.65 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 N-CA-C 106.006 -1.85 . . . . 74.2 106.006 171.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.521 ' HG2' ' H ' ' A' ' 325' ' ' GLY . 1.3 ttpm? -75.36 177.85 6.3 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.007 -1.108 . . . . 50.34 108.007 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.521 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -160.91 -172.26 27.97 Favored Glycine 0 C--N 1.284 -2.325 0 N-CA-C 110.848 -0.901 . . . . 73.53 110.848 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.12 -13.95 28.74 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.879 2.386 . . . . 73.52 112.064 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.433 ' HB3' ' NZ ' ' A' ' 327' ' ' LYS . 9.0 mtpm? -115.18 20.08 15.2 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 115.973 -0.558 . . . . 64.13 110.996 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.44 -127.12 7.96 Favored Glycine 0 C--N 1.299 -1.492 0 N-CA-C 110.643 -0.983 . . . . 61.1 110.643 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.441 ' HB2' HG23 ' B' ' 151' ' ' VAL . 4.9 mp -105.83 -27.19 11.4 Favored 'General case' 0 C--O 1.268 2.054 0 N-CA-C 108.235 -1.024 . . . . 61.0 108.235 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 86.08 49.45 4.24 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 114.054 -1.43 . . . . 34.15 115.695 173.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -155.07 145.06 21.67 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 117.097 0.449 . . . . 73.32 111.144 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 14.5 m -96.34 126.38 41.5 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 124.005 0.922 . . . . 65.01 109.233 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 28.0 pt -117.11 144.37 25.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 116.28 -0.418 . . . . 72.12 111.377 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' B' ' 148' ' ' GLU . . . -130.99 136.16 48.27 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.414 -1.698 . . . . 64.33 106.414 174.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 145.12 161.45 9.06 Favored Glycine 0 C--N 1.268 -3.241 0 N-CA-C 109.685 -1.366 . . . . 54.03 109.685 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.82 173.49 13.22 Favored Glycine 0 N--CA 1.418 -2.512 0 N-CA-C 107.245 -2.342 . . . . 63.1 107.245 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 66.3 t -53.11 107.49 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 118.137 0.969 . . . . 72.24 110.554 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.45 -18.47 57.34 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.109 -0.951 . . . . 62.22 112.586 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.512 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 60.1 t30 -106.5 18.2 22.27 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.655 -0.498 . . . . 74.22 109.655 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.4 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -51.68 120.09 4.86 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.828 -0.624 . . . . 75.13 111.297 -178.33 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -76.96 -40.24 47.63 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.431 -0.804 . . . . 52.23 109.803 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.2 mm -104.29 120.72 49.85 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 115.736 -0.665 . . . . 71.03 109.715 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.6 106.61 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 123.28 2.653 . . . . 64.11 112.349 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 107.96 -3.42 33.72 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 115.475 -0.784 . . . . 63.4 111.881 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -132.38 98.0 4.26 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.569 -0.9 . . . . 64.24 108.569 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' ASN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 64.4 t30 -83.37 38.05 0.59 Allowed 'General case' 0 CA--C 1.553 1.068 0 CA-C-O 121.953 0.882 . . . . 75.44 111.89 -170.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 73.7 m -102.12 178.46 4.6 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.682 -0.69 . . . . 72.31 112.765 -178.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 31.3 mm -88.94 129.37 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 114.969 -1.014 . . . . 51.22 108.644 -178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.555 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 35.6 m-85 -124.06 140.43 52.98 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.195 0.521 . . . . 74.2 111.691 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.415 HG21 HD21 ' A' ' 365' ' ' LEU . 42.7 t -78.94 111.0 15.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.132 -0.94 . . . . 60.31 109.243 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 25.7 m -88.28 -30.46 19.62 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.198 0.523 . . . . 74.03 110.882 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.428 ' HD3' ' N ' ' A' ' 353' ' ' ILE . 9.1 tmtt? -155.36 137.83 15.0 Favored 'General case' 0 C--O 1.203 -1.385 0 N-CA-C 108.284 -1.006 . . . . 71.23 108.284 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.428 ' N ' ' HD3' ' A' ' 352' ' ' LYS . 74.1 mt -109.17 129.73 63.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.632 -1.247 . . . . 65.41 107.632 174.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 49.7 mm -77.47 126.33 37.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.358 0.599 . . . . 73.45 110.037 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.561 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.4 pm0 -62.31 127.04 29.45 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 114.39 -1.277 . . . . 75.31 110.739 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.56 -19.56 53.72 Favored Glycine 0 N--CA 1.426 -1.994 0 CA-C-N 115.021 -0.99 . . . . 62.32 112.533 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -68.19 167.03 43.82 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 114.278 0.471 . . . . 64.05 114.278 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -61.26 -41.99 97.85 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.313 0.645 . . . . 52.24 111.132 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.425 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.11 -7.74 54.61 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 119.692 -0.803 . . . . 61.44 111.954 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -94.09 -30.53 14.62 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.928 -0.767 . . . . 73.4 108.928 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -89.65 -59.65 2.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.028 -0.533 . . . . 72.32 111.671 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -87.14 -38.96 15.96 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 108.608 -0.886 . . . . 54.21 108.608 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.56 ' HA2' HD21 ' A' ' 322' ' ' LEU . . . -44.68 -31.25 2.51 Favored Glycine 0 C--O 1.207 -1.57 0 N-CA-C 119.195 2.438 . . . . 42.54 119.195 -167.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.538 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 41.37 32.21 0.2 Allowed 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 118.803 1.302 . . . . 75.31 111.377 -174.669 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 365' ' ' LEU . . . . . 0.415 HD21 HG21 ' A' ' 350' ' ' VAL . 43.7 tp -98.11 155.07 17.32 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.551 -1.204 . . . . 73.43 109.474 -170.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -125.08 150.98 46.27 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.344 0.592 . . . . 75.54 111.267 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 75.9 mt -65.95 122.98 17.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.297 -1.001 . . . . 64.24 108.297 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 113.25 -2.3 25.29 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.686 -0.769 . . . . 22.34 112.126 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 3.5 m-20 -72.13 136.68 46.59 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 112.83 0.678 . . . . 73.44 112.83 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.627 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 33.9 tttp -96.2 115.28 27.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.213 1.405 . . . . 74.12 109.648 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 68.3 mt -85.21 118.92 25.05 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.156 0.503 . . . . 63.12 109.693 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.3 tt -87.61 -39.38 15.11 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.074 -1.421 . . . . 62.01 108.093 -176.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -160.77 156.09 24.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.05 -0.523 . . . . 64.33 111.095 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' VAL . . . . . 0.474 HG12 HD11 ' A' ' 379' ' ' LEU . 11.1 p -134.74 123.33 41.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 108.139 -1.06 . . . . 73.55 108.139 173.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 375' ' ' ASN . . . . . 0.573 HD21 HG22 ' A' ' 394' ' ' THR . 54.5 m-20 62.32 29.55 17.32 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 123.516 1.627 . . . . 74.4 108.282 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 67.0 18.87 10.61 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 110.449 -3.068 . . . . 72.52 112.331 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 50.7 t -88.91 128.22 41.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 106.505 -1.665 . . . . 75.12 106.505 172.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.9 p -64.4 124.75 22.58 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 113.126 0.788 . . . . 74.51 113.126 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.474 HD11 HG12 ' A' ' 374' ' ' VAL . 7.5 mp -108.27 -2.48 19.24 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.561 0.745 . . . . 70.42 111.224 177.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -68.2 107.6 2.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.952 -0.567 . . . . 64.0 109.605 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 60.66 74.91 0.43 Allowed 'General case' 0 CA--C 1.545 0.775 0 O-C-N 124.619 1.199 . . . . 72.52 113.296 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 387' ' ' ALA . 24.1 m -135.05 167.09 26.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.183 -1.414 . . . . 72.33 107.183 176.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 51.6 p -79.73 141.22 36.56 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 118.918 0.781 . . . . 63.32 110.325 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' HIS . . . . . 0.49 ' O ' HG23 ' A' ' 388' ' ' VAL . 82.7 t60 -45.56 -49.27 14.12 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.672 0.99 . . . . 71.21 113.672 -174.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -61.33 -38.78 88.13 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.212 0.53 . . . . 73.53 111.54 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.0 tt0 -70.46 -35.05 73.1 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.511 -0.922 . . . . 75.3 108.511 -177.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.435 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -70.54 -53.91 14.24 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 114.441 -1.254 . . . . 61.22 110.582 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 384' ' ' HIS . 44.5 t -59.54 -43.36 90.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 C-N-CA 121.147 -0.221 . . . . 61.15 110.57 -177.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 53.8 m -62.04 -30.32 70.89 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 111.953 0.353 . . . . 75.11 111.953 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.13 -35.08 78.98 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 122.124 -0.36 . . . . 53.53 110.331 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.7 mp -80.57 -28.61 37.15 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 120.394 -0.523 . . . . 71.14 110.783 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.427 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 54.3 mttm -74.31 -24.23 59.19 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.576 -0.45 . . . . 73.14 111.536 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -82.16 65.2 7.18 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.347 1.07 . . . . 71.52 110.19 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.573 HG22 HD21 ' A' ' 375' ' ' ASN . 13.3 p -130.65 145.63 51.96 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 113.987 -1.46 . . . . 71.31 107.679 177.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 395' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 43.8 m -141.77 91.28 2.35 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 122.568 1.175 . . . . 62.34 111.25 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.515 ' HA ' ' H ' ' A' ' 324' ' ' LYS 0.343 12.4 m-20 65.16 4.79 2.72 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 111.438 -2.619 . . . . 60.04 115.616 172.085 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 397' ' ' PHE . . . . . 0.478 ' CZ ' ' HG3' ' A' ' 321' ' ' LYS . 37.6 t80 -151.85 134.52 15.5 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 106.368 -1.716 . . . . 73.21 106.368 171.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.59 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.8 t -138.29 145.69 28.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.812 -1.181 . . . . 72.55 107.812 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -126.0 96.1 4.63 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.027 -1.101 . . . . 73.44 108.027 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 tt -92.63 132.84 36.54 Favored 'General case' 0 C--N 1.277 -2.546 0 C-N-CA 123.031 0.532 . . . . 75.04 110.739 -174.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.509 ' HG2' ' HB3' ' A' ' 319' ' ' GLU . 65.8 mttm -114.31 118.72 34.7 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.152 -0.684 . . . . 61.3 109.152 174.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 369' ' ' ASP . 3.6 p -118.58 149.04 21.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 CA-C-N 115.048 -0.978 . . . . 73.01 109.979 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.627 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.45 159.32 42.15 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 125.119 1.368 . . . . 63.0 107.337 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 12.6 mptt . . . . . 0 C--N 1.291 -1.947 0 N-CA-C 109.267 -0.642 . . . . 52.12 109.267 175.627 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 C--O 1.245 0.833 0 N-CA-C 107.494 -1.298 . . . . 74.14 107.494 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 148' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 334' ' ' ALA . 0.9 OUTLIER -95.96 157.18 16.01 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.232 0.539 . . . . 74.31 110.948 174.487 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 51.6 m -147.84 146.85 29.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.726 -0.842 . . . . 74.41 108.726 174.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 150' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 1.2 tt0 -79.79 137.84 37.09 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 120.996 0.427 . . . . 74.42 110.952 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 329' ' ' LEU . 15.7 m . . . . . 0 N--CA 1.426 -1.633 0 CA-C-N 115.711 -0.677 . . . . 74.21 110.767 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' MET . . . . . 0.605 ' SD ' ' HE3' ' A' ' 404' ' ' LYS . 27.5 ttt . . . . . 0 CA--C 1.495 -1.168 0 N-CA-C 107.041 -1.466 . . . . 63.34 107.041 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.325 2.3 pm0 -115.87 137.56 51.99 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-O 122.202 1.001 . . . . 74.21 113.658 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 363' ' ' GLY . 70.2 mt -128.62 130.49 68.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 113.225 -1.807 . . . . 63.22 108.155 -169.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -108.07 107.66 18.42 Favored 'General case' 0 N--CA 1.411 -2.387 0 N-CA-C 108.348 -0.982 . . . . 73.13 108.348 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.55 HD21 ' HA2' ' A' ' 363' ' ' GLY . 93.3 mt -105.65 160.07 15.48 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.346 -0.843 . . . . 74.44 110.055 -176.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.2 113.41 42.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 N-CA-C 108.148 -1.056 . . . . 72.54 108.148 171.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.609 ' HB3' ' H ' ' A' ' 396' ' ' ASP . 0.0 OUTLIER -67.13 140.87 57.56 Favored 'General case' 0 C--O 1.207 -1.168 0 N-CA-C 106.953 -1.499 . . . . 70.23 106.953 174.755 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.497 ' N ' ' HD2' ' A' ' 324' ' ' LYS . . . -142.31 -161.2 8.67 Favored Glycine 0 C--N 1.27 -3.099 0 CA-C-O 119.946 -0.363 . . . . 73.23 112.498 -171.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.94 -12.92 37.43 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 123.829 3.02 . . . . 51.23 113.507 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -109.43 5.96 23.83 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.175 0.988 . . . . 71.41 108.932 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.99 -121.35 5.49 Favored Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 108.965 -1.654 . . . . 63.54 108.965 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.79 -26.2 11.38 Favored 'General case' 0 C--O 1.266 1.952 0 N-CA-C 107.844 -1.169 . . . . 75.22 107.844 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.41 43.49 6.54 Favored Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 113.707 -1.588 . . . . 63.11 114.675 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -155.22 151.1 27.72 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 117.056 0.428 . . . . 72.11 110.286 174.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 29.2 m -106.28 129.58 54.28 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 124.145 0.978 . . . . 74.44 109.578 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 14.8 pt -114.32 156.63 15.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.776 -0.647 . . . . 74.25 110.666 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -143.68 130.02 19.89 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.896 -1.89 . . . . 61.31 105.896 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 149.67 153.21 5.98 Favored Glycine 0 C--N 1.27 -3.094 0 N-CA-C 109.012 -1.635 . . . . 54.45 109.012 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.82 173.1 13.09 Favored Glycine 0 C--N 1.283 -2.39 0 N-CA-C 106.558 -2.617 . . . . 62.02 106.558 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.46 ' HA ' HD21 ' A' ' 346' ' ' ASN . 61.8 t -45.75 106.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 118.597 1.198 . . . . 74.34 111.705 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 93.01 -23.92 27.05 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.541 -0.754 . . . . 64.0 112.27 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.482 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 32.7 t-20 -97.78 19.41 13.75 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.353 -0.98 . . . . 70.31 108.353 -177.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.1 118.7 3.09 Favored 'General case' 0 C--O 1.257 1.493 0 CA-C-O 121.263 0.554 . . . . 62.31 110.301 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -77.75 -43.59 30.35 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.075 -0.966 . . . . 73.44 109.052 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 39.3 mm -103.65 131.25 22.21 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 108.119 -1.067 . . . . 74.12 108.119 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.1 110.46 0.48 Allowed 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 123.173 2.582 . . . . 60.11 113.551 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.86 -3.6 65.11 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.407 -0.815 . . . . 24.21 112.189 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 29.2 t0 -119.64 99.69 6.81 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.716 -0.846 . . . . 72.14 108.716 -176.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' ASN . . . . . 0.46 HD21 ' HA ' ' A' ' 337' ' ' VAL . 51.7 t30 -84.0 26.04 0.77 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.532 0.682 . . . . 73.22 110.845 -171.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 20.0 m -88.5 172.29 9.46 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.369 0.604 . . . . 71.34 111.762 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 370' ' ' LYS . 18.3 mm -88.28 122.76 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 115.185 -0.916 . . . . 71.13 108.575 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 51.2 m-85 -123.62 131.93 53.74 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.031 0.443 . . . . 62.52 110.748 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.476 HG21 HD11 ' A' ' 365' ' ' LEU . 47.9 t -70.64 120.75 19.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.888 -0.597 . . . . 71.42 109.4 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 22.4 m -101.03 -23.16 14.56 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.102 0.477 . . . . 73.34 111.353 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -155.55 137.03 14.09 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 107.618 -1.253 . . . . 70.03 107.618 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' A' ' 360' ' ' HIS . 73.4 mt -108.94 126.03 65.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.099 -1.445 . . . . 71.4 107.099 172.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 49.7 mm -74.48 134.9 28.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.293 0.568 . . . . 54.1 109.853 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.569 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.4 pm0 -62.39 120.84 11.81 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-O 122.45 1.119 . . . . 72.15 111.588 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 79.44 18.63 73.31 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-N 114.284 -1.325 . . . . 71.11 111.484 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.78 162.75 52.13 Favored Glycine 0 C--O 1.25 1.143 0 N-CA-C 111.783 -0.527 . . . . 71.02 111.783 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.61 98.97 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.892 -0.781 . . . . 75.33 108.892 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.528 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.64 -9.29 58.46 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.475 -0.89 . . . . 70.51 111.917 177.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 360' ' ' HIS . . . . . 0.445 ' HB2' HG22 ' A' ' 353' ' ' ILE . 31.4 t-80 -88.85 -29.19 19.86 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.596 -0.89 . . . . 74.24 108.596 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.608 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 1.1 mmpm? -95.04 -57.65 2.37 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 113.13 0.789 . . . . 71.21 113.13 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -85.68 -43.05 13.75 Favored 'General case' 0 CA--C 1.457 -2.628 0 O-C-N 123.771 0.669 . . . . 72.11 110.647 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.576 ' O ' HD13 ' A' ' 320' ' ' ILE . . . -42.74 -25.5 0.33 Allowed Glycine 0 C--O 1.203 -1.79 0 N-CA-C 119.379 2.512 . . . . 73.31 119.379 -163.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.468 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.59 34.45 0.56 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 119.133 1.467 . . . . 71.21 111.265 -178.588 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 365' ' ' LEU . . . . . 0.553 HD13 ' N ' ' A' ' 366' ' ' GLN . 2.6 tm? -109.36 148.6 30.81 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.163 -1.38 . . . . 65.41 107.786 -170.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 366' ' ' GLN . . . . . 0.553 ' N ' HD13 ' A' ' 365' ' ' LEU . 26.3 mp0 -117.06 142.06 47.46 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.796 -0.446 . . . . 75.44 109.796 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.76 121.3 8.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.111 -1.07 . . . . 64.3 108.111 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.35 -4.45 21.76 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 111.426 -0.67 . . . . 54.42 111.426 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.574 ' HB3' HG21 ' A' ' 402' ' ' VAL . 56.3 m-20 -75.63 136.28 40.45 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 113.193 0.812 . . . . 71.52 113.193 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 36.4 tttp -88.8 119.69 29.52 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 124.658 1.183 . . . . 74.13 111.135 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.41 124.84 32.46 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.885 -0.783 . . . . 75.33 108.885 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.482 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 5.3 tt -92.08 -40.16 11.22 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.336 -1.302 . . . . 74.22 107.965 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -159.86 160.94 34.27 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 116.017 -0.538 . . . . 71.32 111.733 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' VAL . . . . . 0.557 HG12 HD11 ' A' ' 379' ' ' LEU . 13.9 p -133.55 117.33 27.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.413 -0.958 . . . . 74.25 108.413 171.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 58.54 36.17 25.04 Favored 'General case' 0 CA--C 1.485 -1.526 0 CA-C-O 123.4 1.571 . . . . 73.54 109.347 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 66.79 9.55 6.84 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 110.831 -2.895 . . . . 53.25 113.693 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.9 121.09 31.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.263 -1.754 . . . . 62.3 106.263 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.8 p -64.35 125.82 25.81 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 113.366 0.876 . . . . 74.41 113.366 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.557 HD11 HG12 ' A' ' 374' ' ' VAL . 7.1 mp -101.32 7.13 42.94 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.731 -1.122 . . . . 74.41 109.445 176.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 380' ' ' GLU . . . . . 0.482 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 18.4 mm-40 -79.9 111.24 16.03 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.59 -1.186 . . . . 75.24 108.958 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 61.14 83.57 0.14 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.718 1.207 . . . . 72.33 112.232 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 19.7 m -153.58 165.21 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 125.563 1.545 . . . . 61.23 107.139 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.707 ' HB ' ' OE1' ' A' ' 386' ' ' GLU . 2.8 m -85.08 156.85 20.9 Favored 'General case' 0 C--O 1.258 1.539 0 N-CA-C 107.221 -1.4 . . . . 73.24 107.221 176.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' HIS . . . . . 0.535 ' O ' HG23 ' A' ' 388' ' ' VAL . 85.7 t60 -57.13 -40.73 77.7 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.303 0.573 . . . . 72.34 109.988 -170.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -54.68 -46.64 74.1 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 114.187 -1.37 . . . . 71.31 113.871 177.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.707 ' OE1' ' HB ' ' A' ' 383' ' ' THR . 1.8 mp0 -71.72 -32.14 67.45 Favored 'General case' 0 CA--C 1.476 -1.872 0 CA-C-N 118.711 0.687 . . . . 73.32 109.423 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.6 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -64.46 -57.72 8.44 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 114.728 -1.124 . . . . 73.21 109.218 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 384' ' ' HIS . 21.7 t -61.35 -41.76 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 116.446 -0.343 . . . . 74.53 110.55 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 90.4 m -62.13 -34.35 76.2 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.071 -0.513 . . . . 62.44 111.433 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.08 80.05 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.522 -0.111 . . . . 71.5 110.859 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.1 mp -79.66 -32.47 41.55 Favored 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 119.217 -0.993 . . . . 61.35 110.777 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -65.21 -35.41 80.97 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 112.663 0.616 . . . . 71.42 112.663 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -83.57 62.08 6.62 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.803 0.811 . . . . 74.4 110.926 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.437 ' HB ' HG22 ' A' ' 398' ' ' VAL . 41.9 p -132.28 149.52 52.35 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 107.526 -1.287 . . . . 65.25 107.526 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' SER . . . . . 0.478 ' HA ' ' HE3' ' A' ' 324' ' ' LYS . 34.9 p -141.96 100.99 3.85 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 118.461 -1.296 . . . . 72.01 112.578 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.609 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 3.5 m-20 63.38 7.27 2.84 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 112.504 -2.135 . . . . 71.31 113.621 170.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -152.64 115.25 4.52 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 106.033 -1.84 . . . . 64.33 106.033 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 52.4 t -128.28 113.81 31.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 108.342 -0.984 . . . . 74.0 108.342 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -95.15 95.53 8.61 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.393 -1.336 . . . . 72.01 107.393 174.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.3 tt -89.97 139.02 31.01 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 116.147 -0.479 . . . . 72.32 109.748 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 40.6 tttp -126.84 111.7 14.48 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 108.403 -0.962 . . . . 73.25 108.403 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.574 HG21 ' HB3' ' A' ' 369' ' ' ASP . 2.1 p -115.05 145.94 20.13 Favored 'Isoleucine or valine' 0 C--O 1.266 1.96 0 C-N-CA 123.732 0.813 . . . . 61.13 110.597 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.74 147.77 46.89 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 106.266 -1.753 . . . . 75.51 106.266 174.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.605 ' HE3' ' SD ' ' A' ' 318' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.881 0 C-N-CA 119.774 -0.77 . . . . 61.35 109.102 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 26.4 p30 . . . . . 0 CA--C 1.504 -0.793 0 N-CA-C 110.521 -0.177 . . . . 72.32 110.521 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.51 166.62 11.77 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.185 0.517 . . . . 74.4 111.8 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 40.7 m -146.06 123.97 12.01 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.736 -0.665 . . . . 75.05 109.608 166.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -68.25 130.14 42.02 Favored 'General case' 0 C--O 1.257 1.468 0 N-CA-C 108.563 -0.903 . . . . 60.25 108.563 172.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.434 HG11 ' CB ' ' A' ' 391' ' ' LEU . 5.3 t . . . . . 0 C--N 1.296 -1.726 0 CA-C-O 117.228 -1.368 . . . . 74.51 109.09 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 CA--C 1.485 -1.521 0 N-CA-C 106.309 -1.738 . . . . 75.3 106.309 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.477 2.0 pm0 -119.09 127.09 53.06 Favored 'General case' 0 N--CA 1.406 -2.641 0 N-CA-C 116.936 2.198 . . . . 63.1 116.936 -174.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.45 HG23 ' HD3' ' A' ' 364' ' ' LYS . 64.5 mt -102.54 106.17 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.623 0 CA-C-N 111.524 -2.58 . . . . 52.41 109.715 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.492 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 28.9 ttpt -80.81 110.72 16.59 Favored 'General case' 0 N--CA 1.41 -2.427 0 N-CA-C 106.319 -1.734 . . . . 65.31 106.319 170.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.461 ' HA ' ' OD2' ' A' ' 362' ' ' ASP . 0.6 OUTLIER -110.33 145.7 37.01 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 113.944 -1.48 . . . . 73.35 109.734 -171.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 39.0 mm -105.2 116.8 49.71 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-O 121.306 0.574 . . . . 74.54 110.606 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.696 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 9.7 tmtt? -65.89 156.78 32.38 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.948 -1.024 . . . . 72.34 110.783 175.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -140.44 -165.97 10.5 Favored Glycine 0 C--N 1.303 -1.284 0 N-CA-C 110.748 -0.941 . . . . 73.21 110.748 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.91 -21.51 64.0 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 122.877 2.385 . . . . 71.41 112.59 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -91.61 -9.97 42.18 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.132 0.968 . . . . 64.44 110.449 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 97.42 -112.76 4.54 Favored Glycine 0 C--N 1.272 -3.014 0 N-CA-C 108.381 -1.887 . . . . 30.41 108.381 -171.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.13 -35.64 6.26 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 117.89 0.845 . . . . 53.52 109.589 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 84.48 50.72 4.14 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.841 -1.171 . . . . 72.42 114.903 175.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 54.4 p90 -155.07 163.04 40.83 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 117.146 0.473 . . . . 73.31 110.239 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 66.2 m -108.78 132.72 53.7 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 109.757 -0.46 . . . . 73.01 109.757 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 19.3 pt -122.84 149.6 26.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 109.863 -0.421 . . . . 70.12 109.863 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.7 129.3 16.04 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.537 -0.912 . . . . 74.33 108.537 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 165.1 -178.24 40.23 Favored Glycine 0 C--N 1.283 -2.393 0 N-CA-C 108.63 -1.788 . . . . 74.43 108.63 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.03 173.22 13.22 Favored Glycine 0 C--N 1.279 -2.592 0 N-CA-C 108.466 -1.853 . . . . 52.12 108.466 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 90.6 t -56.15 100.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 117.682 0.741 . . . . 74.33 110.623 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 88.33 -2.08 84.79 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.373 -0.83 . . . . 34.43 112.616 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -109.02 3.55 22.23 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.575 0.702 . . . . 74.31 109.644 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER -61.39 127.29 30.76 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 115.042 1.497 . . . . 73.3 115.042 -174.299 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -66.67 -32.25 73.45 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.876 -1.511 . . . . 73.45 110.809 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 43.3 mm -104.64 114.61 63.83 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 116.319 -0.4 . . . . 64.05 110.033 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.23 111.19 0.78 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.888 2.392 . . . . 53.41 111.789 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.07 -22.98 20.09 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.84 -0.695 . . . . 65.24 111.607 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -112.39 106.97 15.61 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.175 -0.676 . . . . 71.11 109.175 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -85.22 63.04 7.87 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.502 0.668 . . . . 73.12 111.095 -173.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.469 ' HB2' ' CE1' ' A' ' 349' ' ' TYR . 7.2 m -119.06 177.68 4.78 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 119.588 -0.845 . . . . 71.11 111.861 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 26.0 mm -98.15 131.67 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 N-CA-C 106.052 -1.833 . . . . 70.32 106.052 176.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 347' ' ' SER . 42.7 m-85 -123.72 132.55 53.85 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.574 0.583 . . . . 71.03 112.574 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.16 112.46 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.865 -1.062 . . . . 65.02 108.527 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.1 m -92.8 -28.69 16.41 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.458 0.647 . . . . 72.42 109.973 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 331' ' ' PHE . 54.3 tttm -155.89 153.57 29.87 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 108.249 -1.019 . . . . 72.32 108.249 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 86.9 mt -118.22 144.23 26.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 104.873 -2.269 . . . . 52.34 104.873 169.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 39.6 mm -79.92 129.68 37.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.69 -0.485 . . . . 74.23 109.69 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.4 pm0 -63.78 105.02 0.75 Allowed 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.461 -1.245 . . . . 71.54 111.265 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.97 -2.35 63.9 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 114.521 -1.218 . . . . 44.42 112.387 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -69.99 172.04 41.15 Favored Glycine 0 C--O 1.244 0.76 0 O-C-N 123.697 0.293 . . . . 73.01 112.65 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -57.34 -44.12 84.02 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 122.976 0.511 . . . . 54.13 110.894 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.54 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.26 -9.87 58.94 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.726 0.639 . . . . 73.33 112.726 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -94.57 -24.3 17.29 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.19 -1.041 . . . . 62.44 108.19 177.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -89.93 -60.13 2.01 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-O 121.579 0.704 . . . . 63.34 110.054 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' ASP . . . . . 0.461 ' OD2' ' HA ' ' A' ' 322' ' ' LEU . 24.1 t70 -87.5 -44.66 11.13 Favored 'General case' 0 CA--C 1.46 -2.502 0 CA-C-N 114.588 -1.187 . . . . 72.41 111.485 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -42.82 -24.97 0.28 Allowed Glycine 0 CA--C 1.491 -1.46 0 N-CA-C 119.711 2.645 . . . . 75.2 119.711 -162.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.482 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 41.68 37.12 0.68 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 118.556 1.178 . . . . 74.4 111.34 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 39.8 tp -108.22 158.16 17.69 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.33 -1.304 . . . . 74.21 110.355 -169.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -121.26 143.66 49.04 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.646 0.736 . . . . 70.31 110.756 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.48 126.35 25.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.235 -1.395 . . . . 73.34 107.235 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.91 -1.36 30.19 Favored Glycine 0 C--N 1.302 -1.307 0 C-N-CA 120.574 -0.822 . . . . 31.44 111.965 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 5.1 m-20 -66.46 132.07 47.45 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 113.239 0.829 . . . . 65.13 113.239 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 39.9 tttp -92.19 114.28 26.79 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.68 1.192 . . . . 73.31 108.752 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 91.7 mt -85.14 116.38 23.47 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.533 -0.467 . . . . 71.34 110.224 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.1 tt -88.02 -39.13 14.91 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.999 -1.482 . . . . 73.22 106.999 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -166.95 156.0 10.47 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.648 -0.705 . . . . 75.55 110.204 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.81 122.74 39.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.968 -0.753 . . . . 75.25 108.968 173.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 375' ' ' ASN . . . . . 0.556 HD21 HG22 ' A' ' 394' ' ' THR . 87.4 m-20 60.89 35.32 19.29 Favored 'General case' 0 CA--C 1.482 -1.655 0 CA-C-O 123.713 1.72 . . . . 72.52 108.895 -176.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 67.6 7.09 5.39 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 110.174 -3.194 . . . . 73.04 113.396 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 60.7 t -79.87 123.78 37.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 107.014 -1.476 . . . . 71.25 107.014 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.7 p -63.92 124.2 20.94 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.093 0.775 . . . . 71.51 113.093 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.74 -6.09 13.88 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.637 0.775 . . . . 70.11 110.216 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -72.58 105.07 4.08 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.337 -1.356 . . . . 53.45 107.337 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . 0.269 20.1 tt0 60.3 78.88 0.26 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.371 1.468 . . . . 73.21 113.829 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 30.5 m -147.04 175.15 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 107.592 -1.262 . . . . 72.41 107.592 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 75.0 p -81.06 155.22 26.43 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.442 -0.948 . . . . 64.3 108.442 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' HIS . . . . . 0.575 ' O ' HG23 ' A' ' 388' ' ' VAL . 8.6 t-160 -58.93 -41.26 86.91 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.226 -0.657 . . . . 73.01 109.226 -172.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -51.03 -44.94 61.13 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.659 -1.155 . . . . 72.52 113.492 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.2 -33.37 74.3 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.547 0.689 . . . . 74.32 109.268 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -74.08 -58.8 3.06 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.488 -1.233 . . . . 70.04 110.417 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 384' ' ' HIS . 15.7 t -58.31 -40.18 76.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 O-C-N 123.292 0.37 . . . . 62.22 110.314 -176.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 95.6 m -63.26 -36.81 84.9 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.298 -0.41 . . . . 72.03 110.751 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.57 -34.75 77.68 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.396 -0.19 . . . . 74.23 110.739 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.49 -32.49 60.58 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 120.67 -0.412 . . . . 74.44 110.704 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 57.7 mttm -72.99 -26.44 61.34 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 120.57 -0.452 . . . . 62.24 112.145 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -80.83 48.88 1.13 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.988 -0.551 . . . . 72.4 110.619 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.556 HG22 HD21 ' A' ' 375' ' ' ASN . 41.7 p -124.43 147.93 47.96 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.438 -0.579 . . . . 73.44 109.438 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 65.9 m -147.4 99.08 3.09 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 122.512 1.149 . . . . 63.3 112.003 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.696 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 8.4 m-20 65.26 13.02 8.5 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 111.195 -2.73 . . . . 73.55 113.218 168.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -165.72 129.08 2.16 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 106.863 -1.532 . . . . 74.1 106.863 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.45 HG22 ' HB ' ' A' ' 394' ' ' THR . 38.9 t -142.39 142.75 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 122.735 0.414 . . . . 72.03 110.361 -177.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.492 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 13.0 m-85 -118.68 95.6 4.91 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.811 -0.811 . . . . 73.15 108.811 168.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.4 tt -93.7 121.3 34.99 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 123.383 0.673 . . . . 55.25 109.744 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -103.31 107.7 18.62 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.7 -0.852 . . . . 74.13 108.7 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.42 HG21 ' HB3' ' A' ' 369' ' ' ASP . 10.2 p -114.63 157.35 15.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 CA-C-N 114.815 -1.084 . . . . 72.21 110.194 -176.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -135.98 158.6 44.01 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.868 -1.53 . . . . 71.42 106.868 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.641 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 10.9 mmpt? . . . . . 0 C--N 1.303 -1.424 0 N-CA-C 108.54 -0.911 . . . . 72.54 108.54 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 N--CA 1.426 -1.638 0 N-CA-C 106.067 -1.827 . . . . 72.14 106.067 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.03 161.55 15.08 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 107.44 -1.318 . . . . 73.21 107.44 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 32.9 m -142.42 104.01 4.34 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 108.353 -0.98 . . . . 72.14 108.353 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -60.11 132.19 53.17 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.183 -1.372 . . . . 71.11 110.899 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 331' ' ' PHE . 17.8 m . . . . . 0 C--O 1.262 1.75 0 CA-C-N 116.082 -0.508 . . . . 71.12 111.163 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 51.8 tpp . . . . . 0 CA--C 1.512 -0.503 0 N-CA-C 108.327 -0.99 . . . . 54.31 108.327 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.474 2.0 pm0 -117.67 128.67 55.14 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 116.744 2.127 . . . . 62.52 116.744 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.445 HG23 ' HZ3' ' A' ' 364' ' ' LYS . 70.8 mt -117.33 106.75 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 CA-C-N 111.74 -2.482 . . . . 75.41 109.793 -174.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 398' ' ' VAL . 40.7 ttmt -85.74 132.6 34.1 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.458 -1.312 . . . . 63.23 107.458 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 74.1 mt -129.02 152.12 48.97 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.02 -1.104 . . . . 74.12 108.02 178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 35.7 mm -106.2 112.34 39.01 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.589 0 N-CA-C 107.781 -1.192 . . . . 64.4 107.781 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.594 ' HB3' ' H ' ' A' ' 396' ' ' ASP . 0.0 OUTLIER -59.86 135.88 57.83 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 108.608 -0.886 . . . . 75.11 108.608 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.431 ' N ' ' HD2' ' A' ' 324' ' ' LYS . . . -134.4 -161.12 9.43 Favored Glycine 0 C--N 1.287 -2.158 0 CA-C-N 116.281 -0.418 . . . . 43.22 113.008 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -62.08 -22.94 75.11 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 123.894 3.062 . . . . 62.52 114.033 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -109.03 18.06 21.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.255 0.55 . . . . 43.44 109.93 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.86 -119.19 4.86 Favored Glycine 0 CA--C 1.492 -1.379 0 N-CA-C 109.967 -1.253 . . . . 64.43 109.967 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.27 -30.5 8.69 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.55 -1.278 . . . . 64.24 107.55 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.12 50.2 4.19 Favored Glycine 0 N--CA 1.432 -1.57 0 CA-C-N 114.532 -1.213 . . . . 75.33 115.403 171.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -154.88 159.87 40.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 117.061 0.43 . . . . 70.22 110.797 172.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.549 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 5.8 m -110.07 127.92 55.13 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 109.139 -0.689 . . . . 63.01 109.139 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 10.1 pt -117.72 154.15 19.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 122.495 0.318 . . . . 75.35 111.02 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.62 120.38 7.56 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.774 -1.565 . . . . 73.4 106.774 174.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 156.97 154.52 7.08 Favored Glycine 0 C--N 1.293 -1.831 0 N-CA-C 110.829 -0.908 . . . . 63.23 110.829 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.55 -177.27 19.36 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 108.484 -1.846 . . . . 54.34 108.484 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 86.1 t -53.52 108.53 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 117.972 0.886 . . . . 74.14 111.245 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 88.83 -16.99 53.26 Favored Glycine 0 C--O 1.219 -0.813 0 CA-C-N 115.271 -0.877 . . . . 74.43 112.419 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.463 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -107.27 9.61 30.01 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.913 -0.773 . . . . 74.01 108.913 -178.154 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.97 126.26 13.88 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 123.557 0.743 . . . . 70.25 112.26 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -82.34 -45.26 15.13 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.09 -0.959 . . . . 72.04 110.107 -173.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.7 122.11 45.87 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 108.246 -1.02 . . . . 75.31 108.246 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.81 105.16 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 123.156 2.571 . . . . 73.13 112.607 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.82 -6.25 29.37 Favored Glycine 0 N--CA 1.431 -1.64 0 CA-C-N 115.352 -0.84 . . . . 45.0 112.099 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -127.19 98.92 5.46 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.478 -0.934 . . . . 52.32 108.478 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -82.4 33.63 0.41 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.991 -1.004 . . . . 72.22 111.827 -170.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 66.7 m -100.35 173.25 6.68 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.807 -0.633 . . . . 74.03 112.033 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.3 mm -86.27 129.64 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 107.574 -1.269 . . . . 73.41 107.574 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 27.1 m-85 -123.78 139.48 53.94 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-N 118.384 0.538 . . . . 71.24 111.572 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 45.3 t -77.04 115.37 18.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.547 -0.751 . . . . 62.22 109.514 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 24.8 m -91.45 -28.91 17.33 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.973 -0.558 . . . . 70.42 110.263 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 85.0 mttt -152.52 160.39 43.23 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 109.268 -0.641 . . . . 72.12 109.268 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 80.0 mt -125.34 135.02 65.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 106.198 -1.779 . . . . 64.25 106.198 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 44.3 mm -85.27 137.54 20.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 C-N-CA 122.429 0.292 . . . . 71.34 111.159 -173.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.97 127.84 32.35 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.709 0.766 . . . . 61.34 112.795 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 70.18 9.86 64.57 Favored Glycine 0 C--N 1.315 -0.626 0 CA-C-N 115.558 -0.746 . . . . 72.52 112.706 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -74.74 160.63 53.02 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 110.836 -0.906 . . . . 60.32 110.836 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -59.69 -42.02 92.04 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 109.733 -0.469 . . . . 72.33 109.733 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.562 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -72.3 -10.67 60.08 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.172 -0.611 . . . . 70.43 112.431 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -93.99 -29.58 15.17 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.635 -0.876 . . . . 61.43 108.635 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -94.17 -60.49 1.72 Allowed 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 122.955 1.359 . . . . 55.01 110.398 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -87.45 -25.66 23.64 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 112.47 -2.15 . . . . 73.35 110.467 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -44.11 -50.34 7.69 Favored Glycine 0 C--N 1.273 -2.967 0 N-CA-C 120.301 2.88 . . . . 65.11 120.301 -170.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 363' ' ' GLY 0.256 0.0 OUTLIER 47.99 31.29 2.34 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.383 1.592 . . . . 63.04 110.973 -164.521 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 9.8 tt -112.03 150.12 31.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.027 -0.988 . . . . 63.12 109.202 -170.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -122.21 152.43 40.0 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.294 0.569 . . . . 75.3 111.076 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 75.4 mt -65.96 129.26 30.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 107.0 -1.481 . . . . 74.25 107.0 170.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 107.72 3.34 34.63 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.471 -0.871 . . . . 62.03 112.172 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.573 ' HB3' HG21 ' A' ' 402' ' ' VAL . 1.4 m-20 -72.89 128.52 35.74 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.261 0.837 . . . . 73.31 113.261 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 42.1 tttp -92.78 114.52 27.1 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.788 1.235 . . . . 75.54 109.492 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 85.8 mt -80.53 111.92 17.4 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 120.961 0.41 . . . . 61.32 110.082 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.2 tt -86.75 -39.41 15.99 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.491 -1.231 . . . . 74.43 107.694 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.55 155.69 17.6 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.772 -0.649 . . . . 74.13 110.677 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.5 p -133.4 122.36 44.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.116 -1.068 . . . . 74.53 108.116 173.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' ASN . . . . . 0.569 HD21 HG22 ' A' ' 394' ' ' THR . 84.7 m-20 62.26 30.52 17.57 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-O 123.873 1.797 . . . . 43.32 108.445 -174.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.8 t30 66.32 16.89 10.58 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 109.831 -3.35 . . . . 52.44 112.556 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.95 125.28 40.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 106.557 -1.646 . . . . 74.13 106.557 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.1 p -61.62 123.3 17.53 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 113.557 0.947 . . . . 73.41 113.557 -175.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.28 -2.51 20.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.309 -0.86 . . . . 74.3 110.941 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -66.84 106.83 1.99 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.752 -0.658 . . . . 72.52 109.396 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 63.97 74.36 0.41 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 122.643 1.211 . . . . 74.52 113.591 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 21.4 m -137.29 169.5 19.37 Favored 'Isoleucine or valine' 0 C--O 1.249 1.03 0 N-CA-C 105.913 -1.884 . . . . 72.21 105.913 174.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.518 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 50.5 p -78.66 138.71 38.43 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.274 -0.97 . . . . 74.34 108.998 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 384' ' ' HIS . . . . . 0.598 ' O ' HG23 ' A' ' 388' ' ' VAL . 85.8 t60 -47.49 -51.06 21.69 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.31 0.855 . . . . 72.41 113.31 -173.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -65.04 -29.61 70.52 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.484 0.659 . . . . 53.21 110.663 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 383' ' ' THR . 49.8 tt0 -72.87 -39.11 66.73 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.367 -0.975 . . . . 64.33 108.367 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.486 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -67.59 -46.52 72.36 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.759 -1.109 . . . . 70.03 109.96 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 384' ' ' HIS . 24.8 t -57.87 -43.55 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 109.681 -0.489 . . . . 25.3 109.681 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 85.0 m -57.95 -38.14 75.45 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 123.49 0.494 . . . . 74.52 110.681 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.05 -33.37 75.89 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.193 -0.317 . . . . 70.14 110.959 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.7 mp -81.73 -26.58 34.44 Favored 'General case' 0 C--O 1.211 -0.949 0 C-N-CA 120.494 -0.482 . . . . 53.03 111.28 176.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.441 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 62.2 mttm -75.82 -27.33 57.86 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.698 -0.401 . . . . 74.21 111.968 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -80.27 43.67 0.64 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.844 -0.616 . . . . 73.32 110.623 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.569 HG22 HD21 ' A' ' 375' ' ' ASN . 77.4 p -124.19 144.03 50.17 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.813 -0.81 . . . . 54.41 108.813 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 395' ' ' SER . . . . . 0.516 ' HA ' ' HE3' ' A' ' 324' ' ' LYS . 65.4 m -146.02 116.92 7.73 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.568 0.699 . . . . 71.4 111.095 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.594 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 3.3 m-20 55.77 14.52 1.33 Allowed 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 127.882 2.473 . . . . 75.34 114.903 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -163.17 126.15 2.71 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.452 -1.314 . . . . 73.34 107.452 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 46.8 t -138.46 124.0 23.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.271 -1.011 . . . . 75.13 108.271 177.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -106.43 95.9 6.08 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.948 -1.871 . . . . 63.32 105.948 173.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.458 ' CD2' ' HB ' ' A' ' 402' ' ' VAL . 7.6 tt -95.14 114.58 26.39 Favored 'General case' 0 C--N 1.258 -3.374 0 N-CA-C 109.051 -0.722 . . . . 73.12 109.051 -176.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -99.58 108.66 21.11 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.795 -1.557 . . . . 72.15 106.795 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.573 HG21 ' HB3' ' A' ' 369' ' ' ASP . 10.3 p -115.73 162.2 13.93 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.753 0 N-CA-C 108.223 -1.028 . . . . 74.02 108.223 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.9 148.83 47.26 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.58 -0.896 . . . . 73.45 108.58 173.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 10.7 mmpt? . . . . . 0 C--N 1.303 -1.443 0 N-CA-C 108.276 -1.009 . . . . 73.42 108.276 169.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 CA--C 1.492 -1.258 0 N-CA-C 107.558 -1.275 . . . . 71.04 107.558 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -89.28 144.85 25.78 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.29 -1.004 . . . . 63.11 108.29 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 149' ' ' THR . . . . . 0.454 HG21 HG11 ' A' ' 388' ' ' VAL . 16.9 m -134.41 135.2 42.42 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 116.233 -0.44 . . . . 63.44 111.628 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -85.86 130.51 34.53 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-N 116.001 -0.545 . . . . 74.42 110.472 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.293 -1.861 0 CA-C-N 116.289 -0.414 . . . . 71.45 110.05 171.508 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 C--O 1.21 -1.016 0 N-CA-C 108.04 -1.096 . . . . 43.04 108.04 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.336 1.8 pm0 -103.45 131.86 50.2 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-O 123.012 1.387 . . . . 72.53 114.411 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.45 HG23 ' HD3' ' A' ' 364' ' ' LYS . 78.3 mt -113.93 106.49 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.97 0 CA-C-N 111.987 -2.37 . . . . 73.32 110.35 -172.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -85.55 105.9 16.48 Favored 'General case' 0 N--CA 1.402 -2.854 0 N-CA-C 104.324 -2.472 . . . . 75.21 104.324 170.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.421 HD21 ' HA ' ' A' ' 359' ' ' ALA . 0.4 OUTLIER -106.5 144.59 32.96 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 113.802 -1.545 . . . . 71.45 109.299 -171.349 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.1 mp -98.34 111.24 27.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 108.75 -0.833 . . . . 64.34 108.75 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -76.32 149.91 36.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.489 -0.778 . . . . 72.32 109.979 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -141.2 -160.07 8.16 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.466 -0.874 . . . . 62.04 112.23 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.35 -12.77 34.43 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.334 2.69 . . . . 72.55 113.362 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -102.35 8.72 40.18 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.302 -0.629 . . . . 74.13 109.302 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.74 -128.2 8.45 Favored Glycine 0 CA--C 1.477 -2.338 0 N-CA-C 108.764 -1.735 . . . . 35.43 108.764 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.44 ' HB2' HG23 ' B' ' 151' ' ' VAL . 4.5 mp -98.52 -39.16 8.87 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.582 -2.007 . . . . 72.41 105.582 172.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.36 56.03 2.48 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 114.776 -1.102 . . . . 72.11 114.154 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 331' ' ' PHE . . . . . 0.414 ' HA ' ' H ' ' A' ' 354' ' ' ILE . 53.9 p90 -154.39 158.98 40.85 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.104 -0.702 . . . . 75.0 109.104 172.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' B' ' 149' ' ' THR . 10.9 m -107.32 128.82 54.79 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.165 -1.05 . . . . 74.3 108.165 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 25.2 pt -114.71 151.87 16.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 109.998 -0.371 . . . . 74.32 109.998 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -147.57 121.86 9.61 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.147 -1.427 . . . . 71.21 107.147 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 154.71 163.19 11.77 Favored Glycine 0 C--N 1.282 -2.437 0 N-CA-C 110.784 -0.926 . . . . 51.34 110.784 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.58 -174.16 21.14 Favored Glycine 0 CA--C 1.479 -2.195 0 N-CA-C 108.069 -2.012 . . . . 54.14 108.069 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.425 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 68.3 t -54.08 103.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 117.545 0.672 . . . . 54.24 110.921 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 82.33 -7.79 63.27 Favored Glycine 0 C--O 1.217 -0.934 0 CA-C-N 115.419 -0.81 . . . . 73.31 112.98 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.36 0.06 26.62 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.206 -1.035 . . . . 75.43 108.206 -178.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.449 ' HA ' ' HA2' ' A' ' 335' ' ' GLY . 0.0 OUTLIER -50.78 140.38 14.96 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 115.642 1.719 . . . . 61.25 115.642 -174.583 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -85.42 -33.64 21.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.439 -1.255 . . . . 73.43 109.078 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 46.4 mm -104.81 122.7 42.5 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.67 -0.695 . . . . 74.33 109.716 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.82 108.52 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.543 2.162 . . . . 62.22 111.412 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.29 -19.3 24.73 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.57 -0.824 . . . . 74.21 112.092 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 19.4 t70 -114.79 99.96 7.88 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.861 -1.163 . . . . 74.13 107.861 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 346' ' ' ASN . . . . . 0.425 ' OD1' ' HA ' ' A' ' 337' ' ' VAL . 59.3 t30 -80.97 33.09 0.32 Allowed 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 124.018 0.927 . . . . 64.44 112.437 -169.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 68.1 m -100.01 176.97 5.24 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.772 0.656 . . . . 71.42 112.772 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.5 mm -92.2 132.66 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 107.513 -1.291 . . . . 72.44 107.513 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 32.9 m-85 -124.1 137.49 54.56 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 112.62 0.6 . . . . 72.43 112.62 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 49.9 t -70.59 117.59 13.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 115.159 -0.928 . . . . 72.31 108.606 176.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.0 m -97.26 -29.87 13.3 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.515 0.674 . . . . 53.24 110.248 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -155.39 152.36 28.98 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 107.285 -1.376 . . . . 74.03 107.285 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 80.3 mt -121.42 109.56 25.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 106.357 -1.72 . . . . 70.21 106.357 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.414 ' H ' ' HA ' ' A' ' 331' ' ' PHE . 41.7 mm -52.21 133.73 14.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 O-C-N 124.711 1.257 . . . . 74.23 112.221 -171.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.536 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.1 pm0 -55.2 114.51 1.81 Allowed 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 125.361 1.464 . . . . 74.24 111.833 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 72.67 22.78 78.81 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 114.351 -1.295 . . . . 51.42 111.781 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.33 164.36 53.44 Favored Glycine 0 C--O 1.254 1.363 0 N-CA-C 111.466 -0.654 . . . . 74.54 111.466 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.13 96.46 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.983 -0.747 . . . . 61.32 108.983 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.541 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.69 -11.03 59.92 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.986 -0.552 . . . . 73.52 112.067 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -86.52 -30.52 21.88 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.711 -1.218 . . . . 74.51 107.711 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.588 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 1.2 mmpm? -95.52 -57.82 2.29 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.657 0.984 . . . . 75.23 113.657 176.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -85.41 -39.2 17.83 Favored 'General case' 0 CA--C 1.467 -2.25 0 C-N-CA 123.542 0.737 . . . . 55.02 111.164 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.541 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -42.68 -23.95 0.21 Allowed Glycine 0 C--N 1.3 -1.421 0 N-CA-C 119.316 2.486 . . . . 73.45 119.316 -166.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.476 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.4 38.3 1.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 118.576 1.188 . . . . 75.0 111.241 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 55.8 tp -112.86 157.59 21.23 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.25 -1.341 . . . . 74.34 110.099 -170.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -120.41 143.74 48.3 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 121.524 0.678 . . . . 73.52 111.174 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.6 125.16 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 107.116 -1.439 . . . . 75.22 107.116 169.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.75 1.19 32.31 Favored Glycine 0 C--N 1.309 -0.935 0 C-N-CA 120.567 -0.825 . . . . 51.31 112.183 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 71.6 m-20 -75.49 138.27 41.47 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 112.698 0.629 . . . . 54.02 112.698 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 45.2 tttp -94.27 115.32 27.55 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.154 1.381 . . . . 74.44 108.994 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 95.7 mt -79.86 111.24 16.0 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.951 0.405 . . . . 62.35 109.999 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 403' ' ' ALA . 4.0 tt -83.09 -40.09 20.29 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.71 -1.589 . . . . 74.45 106.71 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.25 157.38 25.51 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.163 -0.926 . . . . 62.0 109.639 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 374' ' ' VAL . . . . . 0.515 HG11 ' HG ' ' A' ' 391' ' ' LEU . 7.6 p -147.31 137.27 16.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.59 -0.893 . . . . 43.45 108.59 173.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 59.51 38.38 22.47 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 108.066 -1.087 . . . . 73.21 108.066 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 64.0 t30 67.03 -8.06 0.45 Allowed 'General case' 0 CA--C 1.57 1.723 0 C-N-CA 125.846 1.658 . . . . 53.23 113.278 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.32 130.65 35.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.981 -0.748 . . . . 71.35 108.981 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.0 p -72.21 129.68 39.03 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 122.756 0.423 . . . . 73.23 111.35 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.38 -3.7 16.91 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.766 0.654 . . . . 73.32 112.766 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -65.23 107.19 1.51 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.588 -0.523 . . . . 73.11 109.588 174.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 63.67 72.33 0.47 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 122.742 1.258 . . . . 54.25 113.359 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.59 164.35 31.15 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 N-CA-C 105.764 -1.939 . . . . 75.35 105.764 173.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.676 ' HB ' ' OE1' ' A' ' 386' ' ' GLU . 1.4 m -82.81 146.43 28.94 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.406 -1.331 . . . . 72.41 107.406 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 384' ' ' HIS . . . . . 0.617 ' O ' HG23 ' A' ' 388' ' ' VAL . 67.9 t60 -51.05 -32.73 22.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.526 -0.761 . . . . 75.51 112.961 -173.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.08 -42.66 93.89 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.519 -0.549 . . . . 75.25 109.519 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.676 ' OE1' ' HB ' ' A' ' 383' ' ' THR . 1.8 mp0 -73.22 -32.46 64.77 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 108.864 -0.791 . . . . 63.1 108.864 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.514 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -62.32 -53.88 48.66 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.709 -1.132 . . . . 43.12 109.251 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 384' ' ' HIS . 33.2 t -57.34 -44.19 83.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 N-CA-C 109.746 -0.465 . . . . 52.2 109.746 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 80.6 m -57.51 -41.11 80.15 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 116.065 -0.516 . . . . 73.25 111.035 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -63.36 -38.04 89.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.729 0.3 . . . . 71.24 110.844 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.515 ' HG ' HG11 ' A' ' 374' ' ' VAL . 5.6 mp -76.47 -21.3 56.04 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 120.23 -0.588 . . . . 62.13 110.978 176.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.496 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 54.5 mttm -83.95 -27.27 28.62 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 113.474 0.916 . . . . 54.02 113.474 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -76.11 35.15 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.075 0.95 . . . . 71.32 112.681 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 8.1 p -124.76 161.05 27.25 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 122.899 0.48 . . . . 75.34 110.028 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 24.9 p -160.53 125.86 3.88 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.325 -0.62 . . . . 72.41 109.325 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 61.69 0.14 0.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 125.92 1.688 . . . . 75.45 113.757 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -168.12 137.49 2.49 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.589 -0.893 . . . . 75.11 108.589 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 62.1 t -136.66 125.71 36.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.614 -1.254 . . . . 72.33 107.614 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -101.21 95.59 6.63 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.144 -2.169 . . . . 74.14 105.144 173.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.3 tt -101.02 140.78 34.84 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 109.46 -0.57 . . . . 71.53 109.46 -176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -128.11 113.09 15.3 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.85 -0.426 . . . . 74.44 109.85 -175.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 54.1 t -105.19 145.26 13.7 Favored 'Isoleucine or valine' 0 C--O 1.269 2.12 0 C-N-CA 124.256 1.022 . . . . 71.35 111.03 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -117.17 156.39 27.75 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 104.618 -2.364 . . . . 35.01 104.618 169.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? . . . . . 0 C--N 1.285 -2.228 0 C-N-CA 118.677 -1.209 . . . . 61.43 107.991 -179.594 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 30.5 p30 . . . . . 0 CA--C 1.489 -1.395 0 N-CA-C 109.62 -0.511 . . . . 71.03 109.62 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -90.4 146.27 24.29 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.996 -0.742 . . . . 71.24 108.996 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 149' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 332' ' ' SER . 88.9 m -134.64 138.03 44.14 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.91 -0.587 . . . . 71.13 110.16 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -83.66 132.81 34.85 Favored 'General case' 0 C--O 1.254 1.319 0 N-CA-C 109.801 -0.444 . . . . 73.34 109.801 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.44 HG23 ' HB2' ' A' ' 329' ' ' LEU . 15.1 m . . . . . 0 C--N 1.296 -1.742 0 CA-C-O 116.767 -1.587 . . . . 74.11 112.63 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' MET . . . . . 0.528 ' SD ' ' HE3' ' A' ' 404' ' ' LYS . 26.1 ttt . . . . . 0 CA--C 1.495 -1.156 0 N-CA-C 106.941 -1.503 . . . . 70.32 106.941 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 400' ' ' LEU 0.339 2.0 pm0 -115.58 132.17 56.71 Favored 'General case' 0 N--CA 1.408 -2.562 0 N-CA-C 115.013 1.486 . . . . 53.24 115.013 -175.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 363' ' ' GLY . 58.6 mt -116.63 111.75 36.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.351 0 CA-C-N 112.402 -2.181 . . . . 54.45 107.966 -173.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -82.71 110.5 17.81 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.207 -1.034 . . . . 64.22 108.207 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 92.6 mt -111.02 156.32 21.44 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.54 0.525 . . . . 61.11 110.327 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.6 mp -105.04 115.4 46.84 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 107.925 -1.139 . . . . 60.4 107.925 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 394' ' ' THR . 22.7 tptm -68.57 122.16 17.91 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.485 -0.78 . . . . 65.33 109.318 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -133.55 -154.42 7.39 Favored Glycine 0 C--N 1.306 -1.104 0 C-N-CA 120.61 -0.805 . . . . 71.43 113.274 -173.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.85 -40.3 39.56 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 124.79 3.66 . . . . 44.41 115.49 -175.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -109.09 16.48 22.51 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.248 0.547 . . . . 75.2 110.044 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.41 -118.22 4.6 Favored Glycine 0 N--CA 1.424 -2.124 0 CA-C-N 114.892 -1.049 . . . . 63.21 110.983 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.543 HD21 HG11 ' A' ' 398' ' ' VAL . 4.0 mp -96.02 -30.32 13.64 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.565 -1.272 . . . . 72.23 107.565 177.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.49 44.93 5.98 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 114.853 -1.067 . . . . 45.4 114.487 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 331' ' ' PHE . . . . . 0.487 ' HA ' ' H ' ' A' ' 354' ' ' ILE . 50.7 p90 -152.43 156.7 40.0 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.823 -0.806 . . . . 71.14 108.823 172.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' B' ' 149' ' ' THR . 46.3 m -113.66 136.66 52.59 Favored 'General case' 0 C--N 1.282 -2.348 0 O-C-N 123.663 0.602 . . . . 51.02 110.829 -175.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 20.2 pt -120.26 149.6 23.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.409 -0.814 . . . . 64.3 112.435 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -145.15 114.59 7.15 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.285 -1.746 . . . . 40.32 106.285 174.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 164.19 164.18 18.83 Favored Glycine 0 C--N 1.285 -2.291 0 N-CA-C 109.015 -1.634 . . . . 60.34 109.015 -178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.01 178.93 15.94 Favored Glycine 0 CA--C 1.479 -2.214 0 N-CA-C 108.113 -1.995 . . . . 52.21 108.113 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 88.8 t -53.23 108.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 117.766 0.783 . . . . 73.23 110.738 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.65 -23.64 33.1 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.269 -0.878 . . . . 72.44 112.509 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.598 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 58.8 t30 -105.91 18.63 21.82 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.696 -0.483 . . . . 72.32 109.696 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -50.89 123.88 10.07 Favored 'General case' 0 C--O 1.257 1.476 0 C-N-CA 123.553 0.741 . . . . 54.3 110.518 -178.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -81.4 -40.1 23.96 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.146 -0.934 . . . . 74.1 109.977 -176.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 35.9 mm -103.65 126.11 32.9 Favored Pre-proline 0 C--N 1.309 -1.176 0 N-CA-C 109.2 -0.667 . . . . 72.35 109.2 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.14 102.73 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 123.108 2.539 . . . . 63.32 112.66 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.71 -7.2 29.75 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.828 -0.624 . . . . 75.2 112.033 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -123.92 96.84 5.1 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.049 -1.093 . . . . 74.13 108.049 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 346' ' ' ASN . . . . . 0.414 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 65.3 t30 -83.03 36.92 0.52 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.587 -1.188 . . . . 72.11 112.08 -169.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 74.7 m -99.47 178.11 4.97 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.675 -0.693 . . . . 65.03 112.11 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 11.0 mm -88.72 131.6 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 107.899 -1.149 . . . . 73.34 107.899 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 26.8 m-85 -124.12 138.06 54.48 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 113.507 0.929 . . . . 64.34 113.507 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.1 t -71.14 115.54 11.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 114.787 -1.097 . . . . 72.13 108.48 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 22.6 m -100.56 -25.98 13.99 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.4 0.619 . . . . 73.35 110.848 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.89 142.25 22.49 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.229 -1.397 . . . . 72.33 107.229 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 74.3 mt -109.64 107.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 106.023 -1.843 . . . . 72.33 106.023 172.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.487 ' H ' ' HA ' ' A' ' 331' ' ' PHE . 46.4 mm -57.9 127.22 16.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 O-C-N 124.478 1.111 . . . . 65.23 112.585 -170.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.616 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.1 pm0 -57.12 117.67 4.26 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 113.314 -1.766 . . . . 72.24 111.053 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 90.01 5.31 70.85 Favored Glycine 0 C--O 1.22 -0.747 0 CA-C-N 115.02 -0.991 . . . . 54.31 111.96 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.3 158.08 48.82 Favored Glycine 0 C--O 1.255 1.443 0 C-N-CA 121.548 -0.358 . . . . 22.13 112.808 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.88 -40.1 95.75 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.972 -0.751 . . . . 74.44 108.972 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.548 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.44 -9.82 58.91 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.9 -0.591 . . . . 52.42 111.504 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -87.22 -30.43 20.97 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.315 -0.995 . . . . 60.52 108.315 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.478 ' HA ' ' CE ' ' A' ' 361' ' ' LYS . 0.0 OUTLIER -95.83 -57.23 2.42 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 114.101 1.148 . . . . 70.2 114.101 176.884 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -85.2 -39.45 17.8 Favored 'General case' 0 CA--C 1.462 -2.414 0 O-C-N 123.58 0.55 . . . . 64.24 110.604 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.604 ' O ' HD13 ' A' ' 320' ' ' ILE . . . -42.72 -23.14 0.17 Allowed Glycine 0 C--O 1.199 -2.037 0 N-CA-C 119.199 2.44 . . . . 71.03 119.199 -164.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.469 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 43.68 32.22 0.54 Allowed 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 119.135 1.467 . . . . 62.33 111.872 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 43.9 tp -105.01 153.5 21.37 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 125.184 1.393 . . . . 61.32 109.246 -171.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -116.95 146.07 43.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.065 0.459 . . . . 73.34 111.224 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 74.9 mt -66.54 124.21 21.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.719 -1.215 . . . . 70.1 107.719 170.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.65 1.19 30.73 Favored Glycine 0 C--N 1.312 -0.774 0 N-CA-C 111.175 -0.77 . . . . 65.22 111.175 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.51 ' HB3' HG21 ' A' ' 402' ' ' VAL . 73.2 m-20 -75.71 138.75 41.5 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.981 1.104 . . . . 65.25 113.981 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.631 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 40.8 tttp -94.2 115.83 28.15 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.499 1.52 . . . . 73.11 110.043 -177.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.49 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 96.5 mt -80.28 112.61 17.77 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.954 -0.758 . . . . 72.03 108.954 176.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.4 tt -83.88 -37.57 22.24 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.952 -1.499 . . . . 62.42 106.952 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -162.68 158.0 22.55 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.568 -0.742 . . . . 74.12 111.186 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' VAL . . . . . 0.408 HG12 HD11 ' A' ' 379' ' ' LEU . 13.8 p -133.82 125.45 49.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.629 -1.249 . . . . 75.42 107.629 171.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 59.55 36.62 22.86 Favored 'General case' 0 CA--C 1.47 -2.119 0 CA-C-O 124.287 1.994 . . . . 54.3 110.727 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.3 t30 61.99 13.2 5.44 Favored 'General case' 0 C--N 1.268 -2.935 0 CA-C-N 108.958 -3.746 . . . . 72.22 113.272 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.9 t -86.91 123.86 40.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 107.419 -1.326 . . . . 32.4 107.419 175.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.6 p -63.14 125.22 23.34 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.023 0.749 . . . . 72.33 113.023 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.408 HD11 HG12 ' A' ' 374' ' ' VAL . 7.2 mp -106.57 3.68 27.26 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 123.843 0.857 . . . . 73.14 111.247 178.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -66.58 112.64 4.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.756 -0.656 . . . . 73.45 110.238 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 60.1 49.82 7.1 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 122.722 1.249 . . . . 72.34 112.98 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.31 169.55 4.01 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 N-CA-C 107.937 -1.135 . . . . 51.31 107.937 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 76.5 p -81.64 141.13 33.95 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.845 -0.742 . . . . 75.0 109.755 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 384' ' ' HIS . . . . . 0.57 ' O ' HG23 ' A' ' 388' ' ' VAL . 75.2 t60 -46.02 -45.33 15.85 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.267 0.84 . . . . 74.24 113.267 -176.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -62.33 -39.15 92.12 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 120.937 0.399 . . . . 65.4 111.122 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 383' ' ' THR . 61.4 tt0 -69.53 -34.63 74.51 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 124.321 1.048 . . . . 72.43 108.559 -176.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.526 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -73.37 -53.9 9.63 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.823 -1.081 . . . . 75.11 110.633 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 384' ' ' HIS . 21.1 t -58.15 -41.38 80.61 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 109.862 -0.421 . . . . 54.3 109.862 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 31.0 m -63.24 -31.67 72.87 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 116.224 -0.444 . . . . 74.14 110.938 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -69.35 -41.09 77.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.15 -0.315 . . . . 52.22 110.15 177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.3 mp -73.85 -23.99 59.7 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 119.937 -0.705 . . . . 72.23 110.406 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 54.9 mttm -79.12 -32.47 44.51 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 113.488 0.921 . . . . 74.22 113.488 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -84.01 64.5 8.2 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.949 0.88 . . . . 73.41 111.836 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.54 ' O ' ' HG2' ' A' ' 324' ' ' LYS . 12.4 p -148.62 149.46 31.56 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.422 -1.263 . . . . 74.23 108.38 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 26.8 p -148.62 128.02 13.08 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.271 -0.64 . . . . 74.41 109.271 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.435 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 31.8 t70 59.8 -1.22 0.17 Allowed 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 126.29 1.836 . . . . 71.41 114.406 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -159.73 120.8 3.16 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 120.607 -1.308 . . . . 73.12 110.718 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.543 HG11 HD21 ' A' ' 329' ' ' LEU . 80.4 t -136.15 145.13 31.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 124.281 1.032 . . . . 74.52 108.365 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.24 96.41 4.91 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.289 -1.374 . . . . 74.03 107.289 173.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 319' ' ' GLU . 4.8 tt -83.98 118.26 23.91 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.885 -1.154 . . . . 74.34 107.885 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -108.09 107.34 17.96 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.928 -1.138 . . . . 65.42 107.928 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 369' ' ' ASP . 3.0 p -111.3 148.69 14.41 Favored 'Isoleucine or valine' 0 C--O 1.267 1.998 0 CA-C-N 115.408 -0.814 . . . . 63.11 109.626 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.631 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.71 157.83 45.85 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 104.325 -2.472 . . . . 74.32 104.325 172.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.528 ' HE3' ' SD ' ' A' ' 318' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.599 0 C-N-CA 118.302 -1.359 . . . . 75.02 107.477 174.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 18.4 p30 . . . . . 0 N--CA 1.435 -1.18 0 N-CA-C 108.759 -0.83 . . . . 71.03 108.759 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.65 151.94 19.14 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.628 -1.619 . . . . 73.22 106.628 173.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 149' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 332' ' ' SER . 53.8 m -147.37 129.62 15.65 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 120.534 -0.466 . . . . 73.44 110.66 174.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 150' ' ' GLN . . . . . 0.42 ' HG3' HG13 ' A' ' 354' ' ' ILE . 16.5 tt0 -67.07 129.51 40.13 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.941 -0.762 . . . . 72.23 108.941 173.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 331' ' ' PHE . 15.4 m . . . . . 0 C--N 1.297 -1.71 0 N-CA-C 113.404 0.89 . . . . 63.22 113.404 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 56.8 tpp . . . . . 0 CA--C 1.487 -1.458 0 N-CA-C 106.032 -1.84 . . . . 74.23 106.032 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.426 1.8 pm0 -122.07 128.64 51.59 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 116.692 2.108 . . . . 45.55 116.692 -174.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.503 HG23 ' HD3' ' A' ' 364' ' ' LYS . 89.8 mt -105.23 106.57 20.76 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.623 0 CA-C-N 111.452 -2.613 . . . . 73.11 109.305 -176.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -77.68 113.89 15.98 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 103.883 -2.636 . . . . 70.31 103.883 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.06 147.68 31.99 Favored 'General case' 0 C--N 1.266 -3.023 0 O-C-N 124.478 1.111 . . . . 61.01 109.234 -171.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 68.3 mt -106.03 134.99 46.0 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.881 0 N-CA-C 108.114 -1.069 . . . . 72.03 108.114 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.493 ' H ' ' HA ' ' A' ' 396' ' ' ASP . 1.2 ttpm? -74.24 177.99 5.44 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.83 -0.804 . . . . 74.41 108.83 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.441 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -155.86 -172.52 23.44 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 120.374 -0.917 . . . . 73.45 110.943 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.38 -26.16 20.82 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 122.895 2.397 . . . . 65.25 112.277 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -88.92 -8.56 53.98 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 122.469 1.128 . . . . 73.03 108.886 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 95.93 -135.55 12.38 Favored Glycine 0 CA--C 1.482 -1.985 0 CA-C-N 113.618 -1.628 . . . . 74.33 109.355 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.8 mp -83.71 -45.5 13.32 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.429 -1.693 . . . . 75.32 106.429 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 83.32 53.74 3.35 Favored Glycine 0 N--CA 1.421 -2.316 0 CA-C-N 114.645 -1.161 . . . . 74.32 114.348 170.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -154.4 164.48 38.57 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 116.736 0.268 . . . . 73.21 110.334 172.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.529 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 10.2 m -112.54 129.35 56.39 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.632 -0.507 . . . . 61.53 109.632 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.9 pt -118.75 153.33 20.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 109.927 -0.397 . . . . 74.15 109.927 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -142.22 136.57 30.01 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.288 -1.745 . . . . 63.32 106.288 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 347' ' ' SER . . . 144.81 157.44 7.22 Favored Glycine 0 C--N 1.282 -2.428 0 N-CA-C 109.288 -1.525 . . . . 34.1 109.288 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 137.74 175.5 13.91 Favored Glycine 0 C--N 1.282 -2.453 0 N-CA-C 108.386 -1.886 . . . . 73.01 108.386 -175.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.51 HG22 ' OE2' ' A' ' 381' ' ' GLU . 68.7 t -50.7 110.89 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 117.719 0.76 . . . . 42.31 109.655 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 81.4 -17.04 14.95 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 121.267 -0.492 . . . . 54.42 113.298 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 339' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.28 3.65 38.37 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.592 -1.262 . . . . 62.43 107.592 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.424 HE22 ' HA ' ' A' ' 343' ' ' PRO . 0.0 OUTLIER -49.57 126.21 13.03 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.595 1.158 . . . . 74.14 111.288 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -76.83 -37.27 55.97 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.22 -0.9 . . . . 64.45 109.97 -175.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 2.8 mp -104.82 126.76 30.35 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 109.344 -0.613 . . . . 64.51 109.344 177.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.424 ' HA ' HE22 ' A' ' 340' ' ' GLN . 18.7 Cg_endo -59.38 105.99 0.28 Allowed 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.842 2.362 . . . . 75.04 112.816 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 105.83 -1.22 38.82 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 115.553 -0.749 . . . . 43.43 111.931 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 60.4 t0 -130.85 103.55 6.63 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 108.087 -1.079 . . . . 72.22 108.087 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -76.91 65.05 2.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.501 1.143 . . . . 74.45 108.924 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.451 ' O ' ' HA3' ' A' ' 335' ' ' GLY . 5.2 p -97.09 134.6 40.22 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 113.289 -1.778 . . . . 74.21 112.38 -176.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 44.3 mm -80.94 119.14 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 N-CA-C 104.488 -2.412 . . . . 74.04 104.488 168.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 349' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -123.89 137.92 54.56 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 120.161 -0.616 . . . . 71.42 109.724 -169.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 49.5 t -78.58 111.41 15.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.266 -0.642 . . . . 44.5 109.266 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.5 m -96.42 -28.84 14.26 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.068 -0.515 . . . . 75.54 110.928 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 55.4 mttp -151.61 163.11 39.8 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 109.637 -0.505 . . . . 71.42 109.637 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.458 HG22 ' HB2' ' A' ' 360' ' ' HIS . 73.1 mt -131.54 127.48 59.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 106.644 -1.613 . . . . 72.44 106.644 174.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 50.6 mm -85.51 141.75 14.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 123.678 0.791 . . . . 70.12 111.466 -172.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.5 133.66 50.24 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.551 0.691 . . . . 74.44 112.339 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 70.88 7.46 62.05 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 120.598 -0.81 . . . . 75.05 112.454 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -67.39 148.89 50.41 Favored Glycine 0 N--CA 1.414 -2.807 0 N-CA-C 110.289 -1.124 . . . . 74.5 110.289 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.42 -34.27 77.38 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.432 -0.581 . . . . 43.31 109.432 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.574 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -76.1 -14.97 60.18 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.209 -0.597 . . . . 64.13 111.707 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 360' ' ' HIS . . . . . 0.458 ' HB2' HG22 ' A' ' 353' ' ' ILE . 39.6 t60 -84.14 -27.79 27.88 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.695 0.759 . . . . 72.41 109.18 177.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -96.69 -58.28 2.08 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 114.835 1.42 . . . . 53.51 114.835 173.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -85.81 -41.57 14.93 Favored 'General case' 0 CA--C 1.465 -2.309 0 C-N-CA 122.796 0.438 . . . . 74.41 111.155 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -43.02 -25.0 0.31 Allowed Glycine 0 CA--C 1.491 -1.413 0 N-CA-C 118.79 2.276 . . . . 63.54 118.79 -165.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.503 ' HD3' HG23 ' A' ' 320' ' ' ILE . 0.0 OUTLIER 43.72 36.21 1.23 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.42 1.088 . . . . 63.04 111.167 -179.3 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 39.5 tp -115.69 152.89 32.33 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 114.168 -1.378 . . . . 70.51 108.368 -171.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -123.84 155.56 37.8 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.751 0.786 . . . . 72.33 111.605 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 80.3 mt -66.12 125.47 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 107.204 -1.406 . . . . 71.42 107.204 173.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.34 -6.83 21.0 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.04 -1.076 . . . . 50.55 111.949 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -75.8 142.37 42.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.487 0.551 . . . . 63.1 112.487 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 76.4 tttt -101.64 131.21 47.99 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.931 -0.766 . . . . 73.14 108.931 176.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 68.8 mt -95.81 120.77 36.68 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.964 0.411 . . . . 74.13 110.812 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 403' ' ' ALA . 40.0 mt -83.41 -39.73 20.25 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.433 -1.258 . . . . 74.2 109.736 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.23 157.93 26.47 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 120.015 -0.674 . . . . 55.12 112.088 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' VAL . . . . . 0.493 HG12 HD11 ' A' ' 379' ' ' LEU . 14.7 p -134.28 121.69 38.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 107.984 -1.117 . . . . 54.44 107.984 172.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 375' ' ' ASN . . . . . 0.518 HD21 HG22 ' A' ' 394' ' ' THR . 79.1 m-20 64.4 27.79 13.62 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 123.909 1.814 . . . . 71.2 108.641 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.2 t30 66.17 16.4 10.43 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 109.791 -3.368 . . . . 72.32 111.835 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.8 t -83.84 125.44 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.171 -1.788 . . . . 72.31 106.171 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.7 p -62.96 125.49 24.16 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 124.012 0.82 . . . . 63.44 113.008 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.493 HD11 HG12 ' A' ' 374' ' ' VAL . 6.2 mp -103.21 1.1 32.59 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.229 -0.896 . . . . 73.34 110.892 177.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -75.3 115.05 14.54 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.644 -0.873 . . . . 72.2 108.644 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' GLU . . . . . 0.51 ' OE2' HG22 ' A' ' 337' ' ' VAL . 19.7 tp10 62.22 83.42 0.15 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.557 1.17 . . . . 62.2 112.117 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 337' ' ' VAL . 23.9 m -153.21 165.8 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 113.24 -1.8 . . . . 75.52 107.606 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.469 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.0 OUTLIER -82.15 143.61 31.32 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.184 -1.043 . . . . 73.22 108.184 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 384' ' ' HIS . . . . . 0.524 ' O ' HG23 ' A' ' 388' ' ' VAL . 86.1 t60 -50.6 -53.27 31.93 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 112.394 0.516 . . . . 72.42 112.394 -174.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.69 -27.35 68.28 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.129 -0.941 . . . . 70.44 111.217 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.9 tt0 -75.0 -34.47 61.97 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.796 -1.187 . . . . 72.42 107.796 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.46 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -73.08 -45.35 57.74 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.655 -1.157 . . . . 75.13 109.737 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 384' ' ' HIS . 15.4 t -56.95 -42.92 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.937 -0.764 . . . . 74.05 108.937 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 62.6 m -61.15 -36.3 79.41 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 116.016 -0.538 . . . . 63.42 110.936 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.74 80.91 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.333 -0.23 . . . . 70.24 110.512 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.7 mp -78.03 -31.56 50.49 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 120.456 -0.498 . . . . 74.35 111.024 176.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -71.27 -25.75 62.59 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 120.569 -0.453 . . . . 73.3 112.167 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -82.68 65.39 7.78 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.227 1.013 . . . . 72.01 110.468 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.518 HG22 HD21 ' A' ' 375' ' ' ASN . 17.6 p -132.78 146.1 51.56 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.248 -1.342 . . . . 53.22 108.394 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 395' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 47.9 m -145.92 91.58 2.1 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.583 1.182 . . . . 63.03 111.426 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.493 ' HA ' ' H ' ' A' ' 324' ' ' LYS 0.346 14.4 m-20 65.08 4.44 2.55 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 111.427 -2.624 . . . . 70.35 116.075 170.288 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -156.39 130.32 8.48 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 106.987 -1.486 . . . . 73.44 106.987 170.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 394' ' ' THR . 27.6 t -138.09 149.3 24.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 124.187 0.995 . . . . 54.11 109.063 -172.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -116.34 95.9 5.28 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.248 -1.019 . . . . 71.42 108.248 170.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.5 tt -95.39 119.37 33.77 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.106 0.479 . . . . 53.44 109.999 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -102.4 110.41 22.35 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.793 -1.188 . . . . 60.24 107.793 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 3.0 p -110.87 144.51 18.69 Favored 'Isoleucine or valine' 0 C--O 1.274 2.356 0 C-N-CA 124.232 1.013 . . . . 53.51 111.526 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -137.64 159.93 40.62 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 125.907 1.683 . . . . 72.2 109.022 176.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.295 -1.788 0 N-CA-C 109.234 -0.654 . . . . 63.01 109.234 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 CA--C 1.496 -1.101 0 N-CA-C 108.913 -0.773 . . . . 71.14 108.913 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.78 144.96 24.96 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.155 -0.683 . . . . 71.31 109.155 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 86.6 m -134.63 142.69 46.96 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.722 -0.473 . . . . 62.42 109.722 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.87 145.4 36.27 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 122.942 0.497 . . . . 74.42 111.041 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 14.0 m . . . . . 0 C--O 1.261 1.676 0 CA-C-N 115.738 -0.665 . . . . 73.13 111.282 175.262 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 CA--C 1.495 -1.16 0 N-CA-C 107.192 -1.41 . . . . 64.2 107.192 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.323 2.0 pm0 -115.79 133.88 55.58 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-O 122.23 1.014 . . . . 70.24 113.364 -176.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 363' ' ' GLY . 77.3 mt -129.89 116.56 38.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 113.217 -1.81 . . . . 60.31 110.27 -168.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.453 ' HE3' ' HB3' ' A' ' 321' ' ' LYS . 1.3 ttpp -75.92 134.7 40.18 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.028 -0.73 . . . . 74.24 109.028 172.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.517 ' HA ' ' OD2' ' A' ' 362' ' ' ASP . 95.5 mt -131.78 152.15 51.16 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 123.556 0.535 . . . . 72.12 110.217 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.44 110.64 31.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.14 -1.059 . . . . 70.45 108.14 171.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.481 ' NZ ' ' HA ' ' A' ' 392' ' ' LYS . 79.1 tttt -76.94 130.23 37.24 Favored 'General case' 0 C--O 1.201 -1.457 0 C-N-CA 119.687 -0.805 . . . . 63.54 110.112 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -133.85 -163.77 10.47 Favored Glycine 0 C--N 1.298 -1.58 0 C-N-CA 119.766 -1.207 . . . . 25.3 111.905 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.64 -12.9 33.49 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 123.775 2.983 . . . . 73.41 113.782 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -103.53 6.99 37.75 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 122.316 1.055 . . . . 63.33 108.805 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.21 -151.02 28.01 Favored Glycine 0 CA--C 1.493 -1.331 0 CA-C-N 114.303 -1.317 . . . . 51.13 110.213 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.6 mp -88.11 -16.51 33.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.747 -1.575 . . . . 71.14 106.747 166.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 330' ' ' GLY . . . . . 0.561 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 79.16 39.28 19.93 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 113.921 -1.491 . . . . 61.32 114.892 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 331' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 52.2 p90 -151.45 165.75 33.2 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 117.596 0.698 . . . . 55.45 110.487 175.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' B' ' 149' ' ' THR . 12.2 m -121.62 136.0 54.96 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 109.706 -0.479 . . . . 61.55 109.706 -178.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' B' ' 148' ' ' GLU . 17.9 pt -119.9 152.73 22.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 122.514 0.326 . . . . 51.43 111.761 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.2 114.65 5.56 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 104.997 -2.223 . . . . 74.02 104.997 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.66 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 162.3 156.21 8.35 Favored Glycine 0 C--N 1.286 -2.222 0 N-CA-C 109.709 -1.356 . . . . 73.32 109.709 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.68 -174.81 20.88 Favored Glycine 0 CA--C 1.484 -1.873 0 N-CA-C 108.908 -1.677 . . . . 42.35 108.908 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 96.1 t -51.68 108.47 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 117.498 0.649 . . . . 44.2 111.673 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 91.37 -21.57 34.44 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.114 -0.948 . . . . 61.14 112.773 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.66 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 57.6 t30 -107.08 26.88 9.59 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.24 -0.652 . . . . 72.31 109.24 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -55.29 119.6 5.8 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.888 -0.596 . . . . 55.34 110.674 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -78.9 -41.5 29.52 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.304 -0.862 . . . . 44.14 109.865 -175.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 43.5 mm -103.91 123.36 41.31 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 108.918 -0.771 . . . . 63.44 108.918 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.95 105.39 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.161 2.574 . . . . 74.21 112.419 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.97 -5.14 28.93 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.477 -0.783 . . . . 32.32 111.935 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -129.29 99.46 5.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.766 0.793 . . . . 72.42 108.973 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 346' ' ' ASN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 66.1 t30 -82.8 35.33 0.46 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.384 1.074 . . . . 71.41 111.458 -171.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.449 ' CB ' ' HE3' ' A' ' 370' ' ' LYS . 68.2 m -104.79 177.89 4.72 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 113.035 0.754 . . . . 71.05 113.035 -176.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.7 129.43 39.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.337 -0.847 . . . . 73.43 109.319 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 37.3 m-85 -124.26 136.73 54.36 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 113.47 0.915 . . . . 74.32 113.47 -177.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.424 HG21 HD21 ' A' ' 365' ' ' LEU . 60.4 t -71.65 117.2 14.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.688 -1.142 . . . . 74.41 108.51 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.4 m -106.28 -18.16 14.08 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.799 0.333 . . . . 52.21 111.581 -175.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.621 ' HG2' ' OE1' ' B' ' 148' ' ' GLU . 44.0 mmtm -149.89 154.95 39.17 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 108.609 -0.886 . . . . 72.14 108.609 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.427 ' CG2' ' HB2' ' A' ' 360' ' ' HIS . 57.0 mt -138.89 121.23 17.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 107.232 -1.395 . . . . 63.11 107.232 172.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 41.6 mm -86.0 133.15 30.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.385 -1.339 . . . . 71.24 107.385 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.43 144.83 56.64 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.627 -1.62 . . . . 73.24 106.627 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.47 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 92.08 -12.79 68.65 Favored Glycine 0 CA--C 1.475 -2.415 0 C-N-CA 119.36 -1.4 . . . . 55.15 110.672 178.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 357' ' ' GLY . . . . . 0.561 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -67.98 148.34 49.03 Favored Glycine 1 N--CA 1.396 -4.005 0 N-CA-C 108.716 -1.754 . . . . 71.41 108.716 172.722 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.48 77.08 Favored 'General case' 0 C--O 1.2 -1.532 0 N-CA-C 109.834 -0.432 . . . . 55.14 109.834 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.593 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -73.82 -11.74 60.47 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.671 -0.812 . . . . 74.22 112.486 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 360' ' ' HIS . . . . . 0.427 ' HB2' ' CG2' ' A' ' 353' ' ' ILE . 36.8 t-80 -88.01 -43.95 11.35 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.423 -0.584 . . . . 70.54 109.423 177.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.47 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 73.4 mmtt -86.42 -57.83 2.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.143 0.973 . . . . 63.05 110.947 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 362' ' ' ASP . . . . . 0.517 ' OD2' ' HA ' ' A' ' 322' ' ' LEU . 35.2 t0 -81.75 -33.83 30.77 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 125.075 1.35 . . . . 74.43 109.38 -175.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.654 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -84.6 -16.91 65.03 Favored Glycine 0 C--N 1.289 -2.074 0 N-CA-C 117.37 1.708 . . . . 55.51 117.37 -169.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.654 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.31 34.23 0.49 Allowed 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 118.054 0.927 . . . . 65.21 112.619 -177.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 365' ' ' LEU . . . . . 0.424 HD21 HG21 ' A' ' 350' ' ' VAL . 33.0 tp -83.78 157.58 22.04 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.199 0.999 . . . . 60.05 111.453 -170.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -118.1 142.24 47.62 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.279 0.561 . . . . 62.21 111.414 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 84.3 mt -66.49 121.97 16.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 107.254 -1.387 . . . . 72.43 107.254 169.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 113.76 -1.72 24.56 Favored Glycine 0 C--N 1.309 -0.917 0 N-CA-C 110.936 -0.866 . . . . 63.33 110.936 -174.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.513 ' HB3' HG21 ' A' ' 402' ' ' VAL . 2.4 m-20 -73.14 138.32 45.69 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.265 0.469 . . . . 63.23 112.265 176.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 64.1 tttt -99.95 115.99 30.95 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.164 -0.925 . . . . 61.42 110.369 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 82.1 mt -82.13 112.94 19.63 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.455 -0.572 . . . . 71.33 109.455 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.5 tt -82.31 -37.36 25.89 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.079 -1.418 . . . . 61.55 107.343 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -162.85 157.45 21.34 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.057 -0.974 . . . . 72.12 109.122 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' VAL . . . . . 0.491 HG11 ' HG ' ' A' ' 391' ' ' LEU . 10.0 p -142.86 121.85 8.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-O 121.138 0.494 . . . . 65.1 109.704 174.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 66.9 t30 44.56 78.86 0.05 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 126.246 1.818 . . . . 72.55 111.745 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 65.94 -29.42 0.13 Allowed 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 114.681 1.364 . . . . 74.4 114.681 -175.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 28.2 t -83.96 124.56 39.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 O-C-N 121.471 -0.768 . . . . 74.42 110.969 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 11.6 p -75.19 132.5 41.18 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.789 -0.449 . . . . 73.12 109.789 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.8 mp -108.51 -4.67 17.05 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.067 0.766 . . . . 73.24 113.067 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -63.55 113.87 3.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.572 0.225 . . . . 62.4 111.376 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 59.57 39.91 20.93 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 122.807 1.289 . . . . 73.43 112.989 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 31.4 m -104.27 166.16 3.15 Favored 'Isoleucine or valine' 0 C--O 1.257 1.494 0 N-CA-C 106.644 -1.613 . . . . 72.13 106.644 171.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.54 ' HB ' ' OE1' ' A' ' 386' ' ' GLU . 0.4 OUTLIER -81.13 149.08 29.31 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 117.808 -1.557 . . . . 72.32 107.381 178.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 384' ' ' HIS . . . . . 0.604 ' O ' HG23 ' A' ' 388' ' ' VAL . 79.8 t60 -53.77 -27.92 31.64 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 114.32 1.23 . . . . 74.13 114.32 -172.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.87 -41.63 91.38 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 117.796 0.271 . . . . 74.12 110.293 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.54 ' OE1' ' HB ' ' A' ' 383' ' ' THR . 1.9 mp0 -68.38 -33.15 73.75 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 109.063 -0.718 . . . . 65.21 109.063 -177.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.575 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -64.96 -58.15 6.88 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.392 -1.276 . . . . 54.41 109.058 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 384' ' ' HIS . 40.6 t -54.58 -43.35 64.53 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 0 O-C-N 123.401 0.438 . . . . 74.14 110.146 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 93.1 m -59.17 -37.5 77.5 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.355 0.662 . . . . 55.21 111.911 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -68.51 -40.64 80.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.996 0.427 . . . . 72.43 110.077 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.575 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.1 mp -75.37 -19.95 59.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.201 0.524 . . . . 52.32 111.036 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.495 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 54.8 mttm -80.18 -41.53 25.1 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 113.429 0.9 . . . . 65.23 113.429 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -84.99 65.68 9.36 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.918 0.866 . . . . 72.23 111.427 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 1.3 p -145.01 148.92 34.28 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.565 -1.198 . . . . 74.52 109.296 177.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 22.0 m -145.37 120.28 9.98 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.841 -0.8 . . . . 61.01 108.841 178.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 56.1 0.98 0.06 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 127.381 2.272 . . . . 74.51 116.49 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' PHE . . . . . 0.438 ' HE2' ' CE2' ' A' ' 399' ' ' TYR . 6.0 t80 -158.73 125.12 4.62 Favored 'General case' 0 N--CA 1.437 -1.077 0 O-C-N 121.297 -0.877 . . . . 72.44 109.805 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.2 t -141.37 145.86 24.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.17 -1.048 . . . . 64.13 108.17 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.438 ' CE2' ' HE2' ' A' ' 397' ' ' PHE . 21.1 m-85 -115.22 97.35 6.15 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.053 -0.721 . . . . 65.21 109.053 172.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 8.0 tt -87.01 134.42 33.49 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 110.271 -0.27 . . . . 71.55 110.271 -177.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -121.83 108.19 13.18 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.494 -0.928 . . . . 70.31 108.494 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.513 HG21 ' HB3' ' A' ' 369' ' ' ASP . 7.3 p -116.37 151.99 18.13 Favored 'Isoleucine or valine' 0 C--O 1.268 2.055 0 CA-C-O 121.561 0.696 . . . . 74.44 111.225 -175.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.86 158.66 43.95 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 125.153 1.381 . . . . 72.42 108.089 176.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.533 0 N-CA-C 108.435 -0.95 . . . . 70.1 108.435 173.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 27.4 p30 . . . . . 0 N--CA 1.402 -2.857 0 N-CA-C 108.361 -0.977 . . . . 72.13 108.361 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 148' ' ' GLU . . . . . 0.621 ' OE1' ' HG2' ' A' ' 352' ' ' LYS . 15.6 pt-20 -96.23 140.94 30.18 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 108.515 -0.92 . . . . 64.44 108.515 174.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 149' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 332' ' ' SER . 87.7 m -134.13 135.98 43.53 Favored 'General case' 0 C--N 1.282 -2.368 0 C-N-CA 120.745 -0.382 . . . . 62.4 111.625 -176.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -80.57 124.09 28.67 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.313 -0.995 . . . . 72.12 108.313 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 C--N 1.282 -2.337 0 N-CA-C 115.435 1.643 . . . . 73.04 115.435 -174.576 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 CA--C 1.492 -1.263 0 N-CA-C 106.721 -1.585 . . . . 61.13 106.721 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.405 2.0 pm0 -115.82 130.78 56.98 Favored 'General case' 0 C--N 1.266 -3.046 0 CA-C-O 122.784 1.278 . . . . 73.1 114.408 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 69.0 mt -122.54 112.98 36.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.456 0 CA-C-N 112.482 -2.144 . . . . 73.32 110.698 -169.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 321' ' ' LYS . 0.4 OUTLIER -73.57 127.71 33.5 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 106.982 -1.488 . . . . 73.31 106.982 171.356 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.572 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 98.3 mt -120.54 154.24 35.61 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.829 -1.175 . . . . 71.21 107.829 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 324' ' ' LYS . 47.0 mt -107.43 150.58 9.89 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.028 0 N-CA-C 106.448 -1.686 . . . . 71.33 106.448 171.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.516 ' O ' HG22 ' A' ' 323' ' ' ILE . 1.0 OUTLIER -76.26 178.67 6.28 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.07 -1.455 . . . . 73.22 107.07 173.103 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -164.93 -166.98 24.79 Favored Glycine 0 C--N 1.287 -2.193 0 C-N-CA 118.373 -1.87 . . . . 71.4 113.627 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.56 -35.23 23.35 Favored 'Trans proline' 0 C--O 1.213 -0.753 0 C-N-CA 123.772 2.982 . . . . 62.21 112.41 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.414 ' NZ ' ' HA3' ' A' ' 356' ' ' GLY . 44.4 mttp -99.8 19.76 15.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.349 -0.611 . . . . 65.4 109.349 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.65 -123.97 6.5 Favored Glycine 0 CA--C 1.485 -1.84 0 N-CA-C 107.992 -2.043 . . . . 65.35 107.992 -176.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.442 HD11 ' OG1' ' A' ' 394' ' ' THR . 9.4 mp -93.13 -29.03 15.96 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.265 -1.383 . . . . 63.51 107.265 174.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 330' ' ' GLY . . . . . 0.544 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 77.49 39.82 24.83 Favored Glycine 0 N--CA 1.427 -1.92 0 CA-C-N 113.512 -1.676 . . . . 53.33 114.414 172.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -143.59 149.88 38.02 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 119.941 -0.703 . . . . 75.42 109.919 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.604 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 9.9 m -105.52 127.41 53.0 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 115.413 -0.812 . . . . 75.1 110.18 -176.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 22.6 pt -115.8 143.72 25.08 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-N 115.314 -0.857 . . . . 73.45 110.305 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -130.13 114.64 15.98 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.771 -1.566 . . . . 63.42 106.771 175.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 167.75 166.23 26.48 Favored Glycine 0 N--CA 1.408 -3.171 0 N-CA-C 110.609 -0.996 . . . . 61.2 110.609 177.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.12 177.12 14.72 Favored Glycine 0 N--CA 1.411 -2.995 0 N-CA-C 106.933 -2.467 . . . . 70.54 106.933 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.45 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 56.7 t -56.6 99.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 117.858 0.829 . . . . 64.31 110.035 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.22 -10.92 69.55 Favored Glycine 0 N--CA 1.432 -1.594 0 CA-C-O 119.148 -0.807 . . . . 44.43 114.237 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -106.88 10.28 30.64 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 118.767 1.284 . . . . 43.41 109.252 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.459 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 1.3 pp0? -53.95 122.48 10.18 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 114.462 1.282 . . . . 71.23 114.462 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -66.87 -35.15 79.37 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.021 -1.445 . . . . 75.13 109.412 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.5 mm -104.89 120.02 51.45 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 115.68 -0.691 . . . . 70.14 109.649 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.83 109.03 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.765 2.31 . . . . 74.23 111.574 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.12 -14.84 28.39 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.576 -0.821 . . . . 73.11 111.961 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -119.49 98.03 5.94 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 106.887 -1.523 . . . . 71.42 106.887 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 346' ' ' ASN . . . . . 0.459 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 62.2 t30 -80.66 34.84 0.34 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.007 0.923 . . . . 72.13 112.531 -169.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 66.7 m -97.89 178.73 5.03 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.66 0.743 . . . . 75.43 112.751 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.514 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 18.2 mm -94.17 129.84 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 CA-C-N 114.777 -1.101 . . . . 54.51 108.062 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 30.1 m-85 -124.05 134.4 53.42 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 112.632 0.605 . . . . 63.23 112.632 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.69 111.65 3.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.022 -1.473 . . . . 73.15 107.022 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 45.6 m -106.97 -24.08 12.12 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.367 0.603 . . . . 71.23 111.965 -173.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.604 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 57.7 mttp -149.34 149.74 31.37 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.818 -1.178 . . . . 72.23 107.818 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 65.7 mt -128.87 120.77 52.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.395 -0.965 . . . . 73.33 108.395 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 31.2 mm -86.65 129.28 38.63 Favored 'Isoleucine or valine' 0 C--O 1.261 1.688 0 C-N-CA 123.34 0.656 . . . . 62.33 109.693 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.91 147.13 53.93 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 107.333 -1.358 . . . . 74.41 107.333 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 356' ' ' GLY . . . . . 0.579 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.51 -15.25 63.57 Favored Glycine 0 C--N 1.278 -2.659 0 N-CA-C 109.657 -1.377 . . . . 71.14 109.657 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 357' ' ' GLY . . . . . 0.544 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -72.05 139.04 27.68 Favored Glycine 1 N--CA 1.392 -4.255 0 N-CA-C 107.922 -2.071 . . . . 72.24 107.922 170.403 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -65.24 -25.38 67.65 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 109.48 -0.563 . . . . 61.25 109.48 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.659 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.87 -10.41 59.41 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 120.392 -0.523 . . . . 72.33 111.767 176.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -94.66 -35.24 12.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.125 -1.065 . . . . 72.4 108.125 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.579 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 75.5 mmtt -81.95 -58.56 2.92 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 120.125 -0.63 . . . . 73.42 111.173 -178.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -86.2 -35.12 20.26 Favored 'General case' 0 CA--C 1.472 -2.046 0 CA-C-O 122.028 0.918 . . . . 62.42 109.09 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.738 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -44.17 -29.22 1.54 Allowed Glycine 0 CA--C 1.487 -1.659 0 N-CA-C 119.924 2.729 . . . . 61.41 119.924 -165.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.738 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 39.98 34.75 0.2 Allowed 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 124.767 1.227 . . . . 65.12 111.92 -175.61 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 55.1 tp -107.03 153.55 22.43 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.597 -1.183 . . . . 74.11 109.362 -172.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -123.55 151.19 43.15 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.467 0.651 . . . . 73.23 112.18 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.14 125.76 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 108.1 -1.074 . . . . 74.21 108.1 172.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 114.99 -6.26 21.93 Favored Glycine 0 C--N 1.315 -0.623 0 C-N-CA 121.101 -0.571 . . . . 71.44 112.131 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.549 ' HB3' HG21 ' A' ' 402' ' ' VAL . 10.1 m-20 -75.02 137.09 41.27 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.208 0.818 . . . . 70.1 113.208 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.593 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 35.6 tttp -96.0 115.65 27.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.409 1.483 . . . . 75.32 109.477 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.408 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 68.1 mt -85.87 115.9 23.78 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.307 0.575 . . . . 62.55 110.224 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.1 tt -83.5 -37.77 22.66 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 113.692 -1.594 . . . . 74.21 107.273 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.81 155.86 21.94 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.157 -0.929 . . . . 75.1 109.467 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 374' ' ' VAL . . . . . 0.525 HG11 ' HG ' ' A' ' 391' ' ' LEU . 7.6 p -134.76 117.63 23.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 109.015 -0.735 . . . . 73.24 109.015 174.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 9.7 t30 44.91 74.79 0.12 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 125.836 1.655 . . . . 71.33 111.852 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 67.63 -23.57 0.12 Allowed 'General case' 0 CA--C 1.57 1.718 0 C-N-CA 125.386 1.474 . . . . 33.41 114.13 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 20.3 t -85.97 127.72 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 121.203 -0.936 . . . . 71.44 110.494 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -75.35 133.12 41.3 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 122.937 0.495 . . . . 75.54 110.833 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.435 HD21 HD11 ' A' ' 391' ' ' LEU . 7.9 mp -114.12 -4.7 13.11 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.899 1.074 . . . . 75.2 113.899 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -67.03 104.9 1.5 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.903 -0.406 . . . . 70.22 109.903 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 65.03 82.83 0.18 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.892 1.277 . . . . 73.52 113.812 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 20.6 m -143.42 163.88 15.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 106.156 -1.794 . . . . 34.23 106.156 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.9 m -79.81 149.07 31.15 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 119.17 0.895 . . . . 73.35 108.879 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' HIS . . . . . 0.515 ' O ' HG23 ' A' ' 388' ' ' VAL . 83.5 t60 -46.45 -48.44 18.95 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.231 0.826 . . . . 74.44 113.231 -174.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -60.84 -39.24 88.34 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.021 0.438 . . . . 63.15 110.447 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -69.29 -39.8 78.11 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.389 -0.967 . . . . 72.43 108.389 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.18 -58.3 7.68 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.354 -1.294 . . . . 62.41 110.257 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 384' ' ' HIS . 40.5 t -55.63 -40.36 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 123.464 0.477 . . . . 74.14 110.606 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 88.8 m -60.25 -38.05 82.31 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.389 -0.369 . . . . 52.14 111.813 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.28 86.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.67 0.272 . . . . 71.31 110.797 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.532 HD22 HG21 ' B' ' 151' ' ' VAL . 5.5 mp -77.83 -37.74 47.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.179 -0.608 . . . . 52.0 109.891 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 54.2 mttm -62.97 -31.79 72.98 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 113.642 0.978 . . . . 72.31 113.642 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -83.81 64.49 8.08 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.975 0.893 . . . . 74.14 111.67 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.446 ' HB ' HG22 ' A' ' 398' ' ' VAL . 13.3 p -132.36 153.91 50.29 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.77 -1.105 . . . . 72.1 109.288 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 41.8 m -143.77 96.73 2.95 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.429 1.109 . . . . 74.34 111.143 178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.509 ' HA ' ' H ' ' A' ' 324' ' ' LYS 0.4 9.0 m-20 57.57 6.06 0.38 Allowed 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 128.303 2.641 . . . . 71.35 118.063 172.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 397' ' ' PHE . . . . . 0.433 ' HE2' ' CZ ' ' A' ' 399' ' ' TYR . 31.2 t80 -156.31 127.75 7.14 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.004 -1.48 . . . . 64.22 107.004 171.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 24.1 t -138.69 142.82 33.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 123.269 0.627 . . . . 73.13 109.738 -174.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.433 ' CZ ' ' HE2' ' A' ' 397' ' ' PHE . 87.1 m-85 -111.6 96.41 6.07 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.837 -0.801 . . . . 73.32 108.837 172.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.505 HD13 HD11 ' A' ' 322' ' ' LEU . 6.6 tt -89.27 135.29 33.66 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.568 -0.707 . . . . 72.55 110.58 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -117.77 108.65 15.63 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.41 -0.959 . . . . 72.44 108.41 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 369' ' ' ASP . 3.6 p -113.77 151.86 15.54 Favored 'Isoleucine or valine' 0 C--O 1.266 1.935 0 CA-C-O 121.977 0.894 . . . . 64.44 110.842 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.593 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -135.28 157.91 45.7 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 104.362 -2.459 . . . . 71.41 104.362 174.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 62.1 mttm . . . . . 0 C--N 1.274 -2.69 0 C-N-CA 118.159 -1.417 . . . . 71.51 111.39 178.116 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 CA--C 1.486 -1.511 0 N-CA-C 107.717 -1.216 . . . . 71.32 107.717 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.58 150.3 21.28 Favored 'General case' 0 N--CA 1.408 -2.537 0 C-N-CA 118.616 -1.234 . . . . 72.31 107.804 162.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 149' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 332' ' ' SER . 97.2 m -132.23 132.04 42.7 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.38 -0.6 . . . . 73.33 109.38 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -74.16 131.59 41.42 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-N 115.608 -0.723 . . . . 72.02 110.65 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.532 HG21 HD22 ' A' ' 391' ' ' LEU . 45.4 t . . . . . 0 C--N 1.286 -2.193 0 CA-C-N 115.099 -0.955 . . . . 64.22 108.686 173.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' MET . . . . . 0.498 ' HB3' ' O ' ' A' ' 402' ' ' VAL . 24.0 ttt . . . . . 0 C--O 1.193 -1.872 0 N-CA-C 105.814 -1.921 . . . . 73.51 105.814 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.355 2.0 pm0 -117.23 135.99 53.39 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 115.605 1.705 . . . . 74.14 115.605 -174.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 363' ' ' GLY . 91.4 mt -116.48 110.2 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.298 0 CA-C-N 112.637 -2.074 . . . . 72.01 108.98 -176.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.401 ' HE2' ' CZ ' ' A' ' 399' ' ' TYR . 38.7 ttmt -74.3 125.67 28.97 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.101 -1.444 . . . . 75.34 107.101 171.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.406 HD21 ' CA ' ' A' ' 363' ' ' GLY . 6.0 mt -122.91 149.39 44.3 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.107 -0.952 . . . . 63.13 110.518 -175.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 37.8 mm -106.55 114.62 46.21 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 109.064 -0.717 . . . . 74.03 109.064 173.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.759 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 8.7 tmtt? -64.82 152.94 41.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.216 -0.661 . . . . 74.33 109.216 173.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -143.42 -159.5 8.0 Favored Glycine 0 C--N 1.296 -1.646 0 C-N-CA 120.615 -0.802 . . . . 63.35 111.678 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.56 -12.71 27.15 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.947 2.431 . . . . 62.41 112.493 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.434 ' HD2' ' HA2' ' A' ' 357' ' ' GLY . 40.6 ttmt -103.58 5.02 36.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.168 0.985 . . . . 73.33 108.818 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.02 -114.6 3.92 Favored Glycine 0 CA--C 1.488 -1.632 0 N-CA-C 108.283 -1.927 . . . . 74.31 108.283 -176.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.503 ' HB2' HG23 ' B' ' 151' ' ' VAL . 5.3 mp -112.22 -35.55 5.59 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.829 -1.174 . . . . 75.31 107.829 173.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.43 50.59 3.98 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.194 -0.912 . . . . 74.4 115.218 172.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 331' ' ' PHE . . . . . 0.513 ' O ' HG22 ' B' ' 151' ' ' VAL . 25.7 p90 -154.73 144.5 21.58 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.076 0.465 . . . . 73.13 110.199 172.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 17.3 m -92.76 125.99 37.64 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.41 -0.813 . . . . 71.34 109.454 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.479 HD12 HG21 ' A' ' 348' ' ' ILE . 49.9 pt -113.09 144.18 21.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 108.502 -0.925 . . . . 70.43 108.502 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -138.83 131.66 29.29 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.753 -1.203 . . . . 74.32 107.753 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 144.77 164.12 10.41 Favored Glycine 0 C--N 1.28 -2.583 0 N-CA-C 109.606 -1.397 . . . . 61.15 109.606 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.09 177.16 14.76 Favored Glycine 0 CA--C 1.479 -2.206 0 N-CA-C 108.13 -1.988 . . . . 43.41 108.13 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 84.2 t -51.15 107.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 117.634 0.717 . . . . 62.44 110.954 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 91.34 -18.93 50.08 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.166 -0.925 . . . . 64.34 112.227 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.567 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 65.6 t30 -105.96 19.71 20.11 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.282 -0.636 . . . . 62.31 109.282 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.04 125.6 14.16 Favored 'General case' 0 C--O 1.251 1.167 0 CA-C-N 115.793 -0.64 . . . . 72.11 111.13 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -79.19 -49.11 13.07 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.127 -0.942 . . . . 75.41 109.768 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 55.7 mt -103.45 125.58 34.53 Favored Pre-proline 0 C--N 1.304 -1.407 0 CA-C-N 115.839 -0.619 . . . . 62.15 109.711 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -48.96 109.34 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 123.347 2.698 . . . . 73.13 112.638 177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 102.49 -2.24 49.81 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.387 -0.824 . . . . 43.55 112.265 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -128.93 96.89 4.47 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.747 -0.834 . . . . 63.4 108.747 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -83.07 33.03 0.44 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.927 0.87 . . . . 72.1 111.624 -171.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 56.7 m -98.96 178.08 5.05 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.798 -0.637 . . . . 61.5 111.933 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 9.1 mm -90.81 132.83 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.995 -1.113 . . . . 61.33 107.995 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 39.6 m-85 -125.17 138.69 54.14 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 112.725 0.639 . . . . 65.11 112.725 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 50.9 t -68.05 118.03 11.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.296 -1.002 . . . . 75.41 108.296 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 17.4 m -105.27 -26.15 12.14 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.065 0.46 . . . . 73.34 111.285 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -156.7 138.08 13.88 Favored 'General case' 0 C--O 1.2 -1.544 0 N-CA-C 107.198 -1.408 . . . . 73.14 107.198 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 73.6 mt -110.37 128.35 66.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.342 -1.355 . . . . 70.15 107.342 172.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 50.1 mm -73.95 134.62 29.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.143 0.497 . . . . 74.53 109.848 -175.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.541 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.5 pm0 -62.68 125.55 24.33 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 124.482 1.113 . . . . 73.13 110.915 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 74.37 17.96 79.81 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.581 -1.191 . . . . 53.51 110.949 -175.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 357' ' ' GLY . . . . . 0.434 ' HA2' ' HD2' ' A' ' 327' ' ' LYS . . . -76.76 160.37 50.39 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 111.512 -0.635 . . . . 75.23 111.512 175.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.06 94.49 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.519 -0.919 . . . . 50.0 108.519 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.484 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -74.64 -5.93 45.82 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.251 -0.431 . . . . 71.24 111.75 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -93.77 -33.96 13.39 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.575 -0.898 . . . . 75.14 108.575 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -91.25 -59.75 2.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 123.215 1.483 . . . . 73.21 109.838 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -87.13 -34.13 19.2 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 112.422 -2.172 . . . . 70.03 111.004 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -58.05 -33.64 70.01 Favored Glycine 0 C--O 1.199 -2.035 0 N-CA-C 117.453 1.741 . . . . 62.51 117.453 -174.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.656 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.62 33.34 0.45 Allowed 'General case' 0 N--CA 1.508 2.426 0 CA-C-N 118.457 1.129 . . . . 75.34 111.109 -173.635 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 58.9 tp -99.34 155.65 17.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.415 -1.266 . . . . 75.4 109.696 -171.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -117.07 146.42 43.12 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.111 0.481 . . . . 54.42 110.296 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.2 mt -66.22 120.82 14.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 107.506 -1.294 . . . . 71.2 107.506 171.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.44 -6.62 20.85 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 120.818 -0.706 . . . . 53.21 112.535 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.447 ' HB3' HG21 ' A' ' 402' ' ' VAL . 4.7 m-20 -75.39 142.36 43.1 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 112.712 0.634 . . . . 74.24 112.712 177.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.532 ' HD2' ' HB3' ' A' ' 403' ' ' ALA . 9.2 ttmm -88.36 122.47 31.91 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 123.315 0.646 . . . . 73.22 110.02 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 3.5 mp -81.15 104.98 12.01 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.334 -1.728 . . . . 74.54 106.334 174.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 403' ' ' ALA . 5.7 tt -80.24 -37.74 32.38 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.053 -1.462 . . . . 63.13 107.053 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 401' ' ' LYS . . . -160.98 157.66 26.7 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.371 -0.831 . . . . 70.21 110.513 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 374' ' ' VAL . . . . . 0.437 HG21 ' HG ' ' A' ' 391' ' ' LEU . 14.6 p -133.42 127.53 53.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.929 -1.137 . . . . 61.31 107.929 173.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 63.67 31.55 14.39 Favored 'General case' 0 C--O 1.206 -1.221 0 CA-C-O 124.011 1.862 . . . . 71.25 107.739 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 65.86 4.49 2.98 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 111.211 -2.722 . . . . 74.44 113.938 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 46.4 t -80.23 123.12 36.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.06 -1.089 . . . . 62.24 108.06 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.5 p -58.98 122.92 14.89 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.719 1.007 . . . . 75.14 113.719 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.42 -1.97 20.98 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 124.434 1.094 . . . . 64.51 111.356 177.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -64.77 108.53 1.76 Allowed 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.554 -0.536 . . . . 73.45 109.554 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 61.78 71.07 0.56 Allowed 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 122.527 1.156 . . . . 75.43 112.909 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.0 168.77 23.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 106.989 -1.486 . . . . 74.21 106.989 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.7 m -76.52 139.33 40.71 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.559 -0.904 . . . . 72.42 108.559 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 384' ' ' HIS . . . . . 0.607 ' O ' HG23 ' A' ' 388' ' ' VAL . 84.8 t60 -48.42 -48.82 36.91 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.77 0.655 . . . . 73.4 112.77 -175.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -59.54 -42.58 92.65 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.936 -0.765 . . . . 75.02 108.936 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 383' ' ' THR . 49.3 tt0 -67.71 -32.44 73.08 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.213 -1.358 . . . . 71.01 109.115 -174.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.533 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -73.78 -50.51 20.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.828 -1.078 . . . . 32.25 110.289 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 384' ' ' HIS . 15.8 t -59.62 -46.99 92.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 109.819 -0.437 . . . . 71.44 109.819 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 42.7 m -62.78 -29.97 71.11 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.553 -0.748 . . . . 72.54 112.164 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.94 -34.53 78.33 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.124 -0.36 . . . . 71.35 110.248 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.5 mp -79.03 -33.61 44.62 Favored 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 120.253 -0.579 . . . . 73.12 110.738 176.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.443 ' HE2' HG12 ' A' ' 388' ' ' VAL . 62.0 mttm -67.23 -29.32 68.93 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.413 0.523 . . . . 72.54 112.413 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -80.21 48.14 0.97 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.44 0.638 . . . . 54.44 112.156 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.42 ' HB ' HG22 ' A' ' 398' ' ' VAL . 32.4 p -124.54 146.93 48.72 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.311 -0.996 . . . . 70.12 108.311 176.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.6 t -141.04 98.69 3.43 Favored 'General case' 0 N--CA 1.409 -2.509 0 C-N-CA 117.711 -1.596 . . . . 65.42 110.935 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.759 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 6.2 m-20 65.63 16.13 10.36 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 110.89 -2.868 . . . . 63.11 112.951 166.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -161.65 115.54 1.92 Allowed 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.471 -1.307 . . . . 73.21 107.471 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 394' ' ' THR . 28.8 t -133.74 151.04 32.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 123.034 0.534 . . . . 65.21 110.518 -175.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.401 ' CZ ' ' HE2' ' A' ' 321' ' ' LYS . 29.4 m-85 -126.24 99.79 6.03 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.723 -1.214 . . . . 63.12 107.723 171.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.2 tt -91.75 119.5 31.64 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.525 -1.287 . . . . 62.35 107.525 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 373' ' ' ALA . 24.0 ttmm -103.64 107.89 18.93 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.693 -1.225 . . . . 74.25 107.693 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.498 ' O ' ' HB3' ' A' ' 318' ' ' MET . 1.9 p -107.58 149.99 10.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 CA-C-O 121.744 0.783 . . . . 71.12 110.498 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.585 ' HB2' HD12 ' A' ' 372' ' ' LEU . . . -136.52 159.6 41.31 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.82 -1.082 . . . . 70.05 108.14 176.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' LYS . . . . . 0.421 ' HA ' ' HE3' ' A' ' 404' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.609 0 N-CA-C 109.079 -0.712 . . . . 51.22 109.079 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 CA--C 1.497 -1.094 0 N-CA-C 109.063 -0.717 . . . . 70.42 109.063 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.36 165.11 12.73 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.507 -0.923 . . . . 65.45 108.507 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 27.6 m -147.14 129.06 15.39 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.409 -0.589 . . . . 74.22 109.409 170.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 150' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 41.6 tt0 -71.14 131.27 43.32 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-O 121.088 0.471 . . . . 70.42 110.771 175.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 331' ' ' PHE . 17.4 m . . . . . 0 C--N 1.301 -1.527 0 CA-C-O 116.786 -1.578 . . . . 70.03 111.627 176.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 64.4 ttp . . . . . 0 CA--C 1.5 -0.951 0 N-CA-C 107.451 -1.314 . . . . 71.21 107.451 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.297 1.6 pm0 -89.88 133.22 34.87 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 114.514 1.302 . . . . 72.42 114.514 -177.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 77.9 mt -120.16 114.95 45.75 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.677 0 CA-C-N 112.135 -2.302 . . . . 74.55 108.789 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -81.43 121.29 26.06 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.235 -1.024 . . . . 73.24 108.235 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.546 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 95.5 mt -118.4 150.06 40.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 124.363 1.039 . . . . 61.22 108.807 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 42.9 mm -106.37 116.75 50.78 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 N-CA-C 109.286 -0.635 . . . . 72.21 109.286 173.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 396' ' ' ASP . 12.1 tmtt? -71.13 153.63 42.37 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 107.707 -1.22 . . . . 74.43 107.707 171.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.415 ' O ' ' HE2' ' A' ' 324' ' ' LYS . . . -153.05 -154.94 6.91 Favored Glycine 0 C--N 1.302 -1.321 0 C-N-CA 119.625 -1.274 . . . . 41.5 113.291 -174.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.86 -22.59 36.2 Favored 'Trans proline' 0 C--O 1.217 -0.558 0 C-N-CA 123.165 2.577 . . . . 72.11 113.939 -175.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -106.07 20.57 18.74 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 122.224 1.011 . . . . 64.53 108.618 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.71 -133.61 11.96 Favored Glycine 0 CA--C 1.477 -2.298 0 CA-C-N 114.034 -1.439 . . . . 62.02 109.649 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 329' ' ' LEU . 14.6 tp -109.26 -34.96 6.41 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 106.903 -1.517 . . . . 62.34 106.903 175.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 330' ' ' GLY . . . . . 0.527 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 86.32 47.18 5.02 Favored Glycine 0 N--CA 1.429 -1.822 0 CA-C-N 113.746 -1.57 . . . . 53.04 116.72 171.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -152.48 150.19 29.35 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 117.928 0.864 . . . . 74.55 112.23 169.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 6.5 m -104.71 129.34 52.93 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.197 -0.91 . . . . 53.12 109.263 -177.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.427 HD11 ' HA ' ' A' ' 388' ' ' VAL . 47.9 pt -113.75 150.96 15.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 115.544 -0.753 . . . . 54.24 108.994 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 334' ' ' ALA . . . . . 0.489 ' HA ' ' CE1' ' A' ' 384' ' ' HIS . . . -146.3 130.68 17.64 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.343 -1.354 . . . . 44.31 107.343 175.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 145.05 160.24 8.46 Favored Glycine 0 C--N 1.283 -2.372 0 N-CA-C 110.705 -0.958 . . . . 71.31 110.705 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.9 -175.26 20.69 Favored Glycine 0 N--CA 1.424 -2.122 0 N-CA-C 108.253 -1.939 . . . . 64.45 108.253 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 91.0 t -51.07 105.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 O-C-N 124.358 0.681 . . . . 73.05 111.392 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 87.38 -14.92 56.65 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.449 -0.796 . . . . 64.32 112.74 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.522 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -105.41 12.72 31.22 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.873 -1.158 . . . . 71.42 107.873 -177.618 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.502 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -53.31 126.65 21.89 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.614 0.766 . . . . 61.44 111.749 -176.476 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 341' ' ' HIS . . . . . 0.556 ' HB3' ' CD2' ' A' ' 349' ' ' TYR . 15.7 t60 -86.64 -38.0 17.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.63 -0.714 . . . . 75.32 110.003 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 37.9 mm -102.62 118.78 57.77 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 109.929 -0.397 . . . . 74.32 109.929 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.07 110.62 0.46 Allowed 'Trans proline' 0 C--O 1.252 1.183 0 C-N-CA 123.093 2.529 . . . . 70.32 111.411 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 108.29 -5.62 33.79 Favored Glycine 0 N--CA 1.429 -1.814 0 CA-C-N 115.143 -0.935 . . . . 64.55 112.159 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 345' ' ' ASP . . . . . 0.414 ' HB3' ' OH ' ' A' ' 349' ' ' TYR . 40.4 t0 -131.67 104.33 6.87 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.183 -0.673 . . . . 61.43 109.183 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 346' ' ' ASN . . . . . 0.502 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 66.3 t30 -83.92 37.91 0.62 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.282 1.039 . . . . 65.14 110.612 -173.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 50.1 m -103.95 177.65 4.78 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.96 -1.018 . . . . 74.42 112.235 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.418 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.5 mm -93.16 138.6 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.428 -0.953 . . . . 73.11 108.428 -177.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.556 ' CD2' ' HB3' ' A' ' 341' ' ' HIS . 95.8 m-85 -129.84 141.86 50.76 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 112.309 0.485 . . . . 35.52 112.309 -178.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 56.8 t -74.37 115.5 15.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 107.747 -1.205 . . . . 73.44 107.747 175.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.9 m -98.85 -24.2 15.08 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 121.388 0.613 . . . . 73.11 110.473 -175.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 332' ' ' SER . 33.3 ttmt -158.8 150.13 20.58 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 107.801 -1.185 . . . . 74.33 107.801 -173.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 60.1 mt -130.7 116.26 34.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 107.08 -1.452 . . . . 74.24 107.08 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 46.2 mm -84.99 124.68 40.13 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 C-N-CA 123.481 0.712 . . . . 73.13 110.491 -171.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.496 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 0.6 OUTLIER -60.53 147.26 42.05 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.873 -0.788 . . . . 72.53 108.873 -177.811 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 94.2 -24.63 26.12 Favored Glycine 0 CA--C 1.478 -2.265 0 N-CA-C 109.486 -1.446 . . . . 71.32 109.486 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 357' ' ' GLY . . . . . 0.527 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -68.53 142.86 39.52 Favored Glycine 1 N--CA 1.395 -4.053 0 N-CA-C 108.0 -2.04 . . . . 41.05 108.0 172.834 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 358' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 362' ' ' ASP . . . -63.87 -32.56 74.13 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.296 -0.631 . . . . 74.44 109.296 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.637 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.11 -4.62 39.71 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 120.7 -0.4 . . . . 73.32 111.744 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 360' ' ' HIS . . . . . 0.496 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 17.1 t60 -94.68 -49.2 5.73 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.694 -0.854 . . . . 73.01 108.694 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -79.27 -50.42 10.94 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.386 -0.825 . . . . 70.33 111.928 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 362' ' ' ASP . . . . . 0.659 ' O ' ' HE2' ' A' ' 364' ' ' LYS . 11.4 t70 -85.76 -34.89 21.06 Favored 'General case' 0 CA--C 1.465 -2.303 0 C-N-CA 124.085 0.954 . . . . 75.33 109.888 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -42.39 -25.64 0.3 Allowed Glycine 0 CA--C 1.486 -1.763 0 N-CA-C 119.96 2.744 . . . . 64.53 119.96 -161.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.659 ' HE2' ' O ' ' A' ' 362' ' ' ASP . 0.0 OUTLIER 47.03 31.16 1.46 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.356 1.078 . . . . 70.11 111.069 178.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 48.6 tp -113.6 150.87 32.47 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 114.597 -1.183 . . . . 64.45 109.336 -170.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -122.88 148.44 45.43 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.388 0.614 . . . . 73.52 111.186 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.6 mt -65.97 126.05 24.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.272 -1.01 . . . . 65.43 108.272 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.64 -18.6 14.97 Favored Glycine 0 C--N 1.313 -0.748 0 N-CA-C 111.645 -0.582 . . . . 55.23 111.645 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -62.93 130.84 46.53 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-O 121.16 0.505 . . . . 72.01 111.827 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.546 ' HB2' ' CE1' ' A' ' 349' ' ' TYR . 50.9 tttt -88.84 127.01 35.62 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.562 -0.745 . . . . 65.24 110.581 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 3.3 mp -81.3 107.03 13.74 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.891 -1.522 . . . . 74.11 106.891 177.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' A' ' 403' ' ' ALA . 3.4 tt -80.31 -43.31 21.47 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 106.273 -1.751 . . . . 53.41 106.273 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -157.45 154.56 28.95 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.075 -0.966 . . . . 62.34 110.1 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.77 120.6 42.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 108.525 -0.917 . . . . 71.33 108.525 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 375' ' ' ASN . . . . . 0.496 HD21 HG22 ' A' ' 394' ' ' THR . 81.5 m-20 63.51 30.51 15.17 Favored 'General case' 0 CA--C 1.484 -1.574 0 CA-C-O 123.978 1.847 . . . . 71.11 108.321 -174.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.9 t30 66.57 16.15 10.32 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 109.793 -3.367 . . . . 74.44 112.605 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.88 124.36 39.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 106.271 -1.752 . . . . 71.52 106.271 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.9 p -65.08 125.36 24.69 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.893 0.701 . . . . 72.35 112.893 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.21 5.94 28.19 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 123.809 0.843 . . . . 64.33 111.108 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' GLU . . . . . 0.453 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 28.4 mm-40 -68.48 111.66 4.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.227 -0.657 . . . . 73.15 109.227 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 56.09 67.9 0.94 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.572 1.177 . . . . 72.53 113.22 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.72 167.63 23.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 107.112 -1.44 . . . . 53.34 107.112 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.477 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.6 m -74.89 142.41 44.06 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.29 -1.004 . . . . 74.12 108.29 -177.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' HIS . . . . . 0.626 ' O ' HG23 ' A' ' 388' ' ' VAL . 86.3 t60 -52.93 -49.38 66.13 Favored 'General case' 0 C--O 1.213 -0.843 0 N-CA-C 112.252 0.464 . . . . 64.3 112.252 -176.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -61.64 -30.34 70.64 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.447 0.641 . . . . 73.11 111.435 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.5 tt0 -75.01 -35.74 61.96 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.044 -0.98 . . . . 75.03 108.426 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -75.09 -38.84 61.09 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.059 -0.973 . . . . 55.43 110.585 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 384' ' ' HIS . 11.7 t -65.08 -42.33 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 109.011 -0.737 . . . . 64.15 109.011 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 60.9 m -60.32 -40.79 91.85 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 123.417 0.448 . . . . 72.45 110.08 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -62.26 -35.43 78.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.628 -0.26 . . . . 62.41 111.479 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.473 ' HG ' HG11 ' B' ' 151' ' ' VAL . 57.4 tp -82.34 -22.75 35.4 Favored 'General case' 0 N--CA 1.394 -3.272 0 C-N-CA 122.823 0.449 . . . . 74.13 109.904 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 61.1 mttm -77.96 -21.63 50.7 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 120.869 0.366 . . . . 54.52 111.033 176.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -76.18 47.37 0.45 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.498 -0.774 . . . . 73.31 110.411 174.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.496 HG22 HD21 ' A' ' 375' ' ' ASN . 22.5 p -124.61 133.55 53.23 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.087 -1.079 . . . . 73.4 108.087 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 395' ' ' SER . . . . . 0.528 ' HA ' ' HD2' ' A' ' 324' ' ' LYS . 50.8 m -139.15 97.73 3.36 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.814 -1.154 . . . . 63.33 111.798 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.62 ' HA ' ' O ' ' A' ' 324' ' ' LYS . 5.8 m-20 60.68 18.57 8.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 111.415 -2.63 . . . . 64.43 112.816 171.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -166.69 130.13 1.93 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.389 -1.278 . . . . 71.41 107.567 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.482 HG22 ' HB ' ' A' ' 394' ' ' THR . 22.0 t -145.24 143.43 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 122.832 0.453 . . . . 75.14 111.086 -176.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -117.04 96.78 5.61 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.378 -0.971 . . . . 63.24 108.378 167.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.89 113.95 25.74 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.97 -0.752 . . . . 72.1 108.97 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -93.06 109.7 21.18 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.546 -1.279 . . . . 74.33 107.546 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 69.2 t -104.49 148.18 9.51 Favored 'Isoleucine or valine' 0 C--O 1.258 1.551 0 CA-C-O 121.368 0.604 . . . . 72.13 110.091 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.545 ' HB2' HD12 ' A' ' 372' ' ' LEU . . . -136.25 158.94 43.22 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 125.083 1.353 . . . . 43.32 107.543 176.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.293 -1.851 0 N-CA-C 107.826 -1.175 . . . . 71.11 107.826 173.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 CA--C 1.497 -1.084 0 N-CA-C 108.52 -0.919 . . . . 62.3 108.52 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -92.21 149.97 21.16 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.393 -0.966 . . . . 73.32 108.393 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 20.1 m -134.8 129.76 35.06 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.204 -0.665 . . . . 64.13 109.204 174.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 150' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 50.2 tt0 -85.29 139.98 31.18 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 112.631 0.604 . . . . 64.42 112.631 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.473 HG11 ' HG ' ' A' ' 391' ' ' LEU . 51.0 t . . . . . 0 C--N 1.312 -1.04 0 N-CA-C 106.641 -1.614 . . . . 74.45 106.641 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' MET . . . . . 0.417 ' HB2' HG13 ' A' ' 402' ' ' VAL . 0.4 OUTLIER . . . . . 0 CA--C 1.487 -1.479 0 N-CA-C 108.93 -0.767 . . . . 75.15 108.93 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -132.84 121.19 22.56 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 108.171 -1.048 . . . . 71.24 108.171 171.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 64.5 mt -98.1 105.75 17.71 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.033 0 CA-C-N 114.275 -1.33 . . . . 72.23 108.531 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -89.24 102.43 15.09 Favored 'General case' 0 N--CA 1.38 -3.971 0 N-CA-C 105.105 -2.183 . . . . 74.22 105.105 169.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.457 ' HA ' ' OD2' ' A' ' 362' ' ' ASP . 0.5 OUTLIER -106.31 138.83 41.79 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 112.486 -2.143 . . . . 63.13 108.092 -170.15 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 25.8 mm -98.53 114.83 37.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 CA-C-O 121.344 0.593 . . . . 70.5 110.161 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -75.3 148.7 39.13 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.425 -0.807 . . . . 73.43 110.3 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -135.38 -161.09 9.2 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.857 -0.687 . . . . 75.14 111.86 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.64 -16.59 33.87 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.041 2.494 . . . . 75.41 113.333 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -101.66 10.23 40.33 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.318 1.056 . . . . 61.4 108.633 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.77 -128.67 8.7 Favored Glycine 0 CA--C 1.478 -2.234 0 CA-C-N 114.3 -1.318 . . . . 72.23 110.741 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.444 HD13 HG12 ' B' ' 151' ' ' VAL . 5.3 mp -101.35 -44.65 5.57 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 105.918 -1.882 . . . . 75.33 105.918 174.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 80.36 49.37 5.89 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 114.852 -1.067 . . . . 73.22 114.514 172.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -151.41 147.74 27.25 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.842 -0.429 . . . . 72.22 109.842 174.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 4.2 m -97.93 124.59 42.44 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 108.436 -0.95 . . . . 72.4 108.436 -176.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 46.4 pt -113.48 153.09 15.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 108.611 -0.885 . . . . 53.52 108.611 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.92 129.35 15.85 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.077 -0.712 . . . . 71.15 109.077 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 152.35 165.55 13.33 Favored Glycine 0 C--N 1.282 -2.433 0 N-CA-C 110.208 -1.157 . . . . 61.31 110.208 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 136.69 -176.83 20.14 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 107.663 -2.175 . . . . 72.54 107.663 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.403 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 58.6 t -54.32 100.5 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.249 1.042 0 CA-C-O 122.096 0.951 . . . . 75.02 112.495 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 80.84 4.49 90.39 Favored Glycine 0 C--O 1.21 -1.404 0 CA-C-N 115.121 -0.945 . . . . 52.41 112.002 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.504 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -106.46 11.66 30.5 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.782 -1.562 . . . . 74.41 106.782 178.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 340' ' ' GLN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -49.8 122.67 6.79 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.839 1.256 . . . . 72.13 112.701 -175.633 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -79.27 -38.52 35.24 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.307 -0.86 . . . . 73.13 109.572 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.6 123.97 38.54 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 108.564 -0.902 . . . . 65.23 108.564 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.36 107.51 0.21 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.971 2.447 . . . . 63.1 112.293 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.89 -8.97 29.66 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-N 115.26 -0.882 . . . . 75.41 112.591 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -125.22 106.94 10.25 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.39 -0.924 . . . . 71.0 110.288 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 346' ' ' ASN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 61.9 t30 -80.37 28.19 0.32 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.734 1.214 . . . . 73.15 111.747 -171.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.635 ' OG ' ' HE2' ' A' ' 370' ' ' LYS . 24.9 m -99.28 175.63 5.81 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.841 -0.618 . . . . 61.44 112.134 -175.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.564 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 6.0 mm -89.72 132.2 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 108.016 -1.105 . . . . 73.44 108.016 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.596 ' CE2' ' HB2' ' A' ' 370' ' ' LYS . 68.0 m-85 -128.01 149.57 50.3 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.948 0.404 . . . . 72.24 111.868 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.69 123.72 32.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.482 -0.933 . . . . 74.42 108.482 175.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 33.2 m -108.11 -28.47 9.5 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.932 0.396 . . . . 54.35 111.474 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 50.9 mtmt -152.27 151.96 31.58 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.862 -0.792 . . . . 73.54 108.862 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.438 HG22 ' HB2' ' A' ' 360' ' ' HIS . 68.4 mt -129.41 121.98 54.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.623 -1.621 . . . . 74.24 106.623 174.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 50.0 mm -78.16 142.01 14.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 123.408 0.683 . . . . 75.45 112.173 -170.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.98 122.64 12.78 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.698 1.199 . . . . 75.24 112.28 -174.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 72.31 12.25 76.39 Favored Glycine 0 C--N 1.306 -1.087 0 CA-C-N 115.605 -0.725 . . . . 54.44 112.966 177.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -74.27 164.26 54.65 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 110.735 -0.946 . . . . 62.14 110.735 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.53 98.08 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.172 -0.677 . . . . 65.41 109.172 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.575 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.58 -4.6 40.91 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.134 -0.485 . . . . 63.13 112.015 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 360' ' ' HIS . . . . . 0.438 ' HB2' HG22 ' A' ' 353' ' ' ILE . 15.1 t60 -94.11 -32.69 13.66 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.849 -0.797 . . . . 75.34 108.849 176.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -95.8 -58.17 2.17 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.997 -0.681 . . . . 74.03 112.332 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 362' ' ' ASP . . . . . 0.457 ' OD2' ' HA ' ' A' ' 322' ' ' LEU . 27.7 t70 -86.18 -21.97 27.22 Favored 'General case' 0 CA--C 1.473 -2.019 0 CA-C-N 115.726 -0.67 . . . . 41.41 110.366 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -43.0 -34.9 2.13 Favored Glycine 0 CA--C 1.479 -2.172 0 CA-C-O 117.751 -1.583 . . . . 33.41 116.144 -172.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? 42.8 40.37 2.07 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.937 0.875 . . . . 60.41 110.15 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 60.3 tp -133.45 154.39 50.83 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 113.588 -1.642 . . . . 73.23 108.977 -167.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -122.66 152.33 40.62 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.736 0.779 . . . . 73.35 111.141 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.7 mt -65.71 123.68 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 108.024 -1.102 . . . . 60.42 108.024 174.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.17 -6.16 21.58 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.684 -0.769 . . . . 50.35 112.342 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.428 ' HB3' HG21 ' A' ' 402' ' ' VAL . 13.5 m-20 -74.23 141.62 45.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.026 0.75 . . . . 60.04 113.026 177.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.647 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 47.1 tttm -96.08 118.43 32.65 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 123.978 0.911 . . . . 63.44 110.31 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.475 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 3.0 mp -78.85 114.46 17.8 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.674 -1.232 . . . . 73.51 107.674 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.53 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 5.7 tt -86.84 -43.01 12.8 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.943 -1.132 . . . . 72.52 107.943 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -157.2 150.64 24.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.046 -0.524 . . . . 63.32 111.024 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 9.8 p -133.59 123.8 46.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 109.006 -0.739 . . . . 62.32 109.006 173.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 375' ' ' ASN . . . . . 0.583 HD21 HG22 ' A' ' 394' ' ' THR . 92.7 m-20 60.95 31.86 19.96 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-O 124.145 1.926 . . . . 75.41 109.536 -173.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 67.23 12.36 8.9 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 109.08 -3.691 . . . . 73.25 112.903 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 54.9 t -82.29 125.3 39.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 106.697 -1.594 . . . . 73.42 106.697 173.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.8 p -66.74 126.55 29.36 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 123.61 0.569 . . . . 73.53 112.267 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.02 6.07 30.88 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.714 0.806 . . . . 53.33 110.725 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' GLU . . . . . 0.53 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 13.6 mm-40 -70.81 107.43 3.99 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.217 -0.901 . . . . 74.41 109.253 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 57.8 71.59 0.57 Allowed 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.371 1.081 . . . . 73.11 113.36 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.69 172.53 15.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.023 -1.473 . . . . 44.04 107.023 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 81.0 p -81.23 146.69 30.33 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.066 -1.054 . . . . 61.34 108.769 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -52.33 -31.45 33.32 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 112.937 0.717 . . . . 62.32 112.937 -176.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -64.5 -40.85 96.42 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-O 120.625 0.25 . . . . 61.51 110.875 177.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.62 -40.22 80.44 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.637 -0.875 . . . . 71.14 108.637 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.425 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -62.42 -59.04 5.54 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.5 -1.227 . . . . 73.11 110.629 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 392' ' ' LYS . 90.4 t -57.3 -44.91 84.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 O-C-N 123.212 0.32 . . . . 73.1 111.546 -177.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 55.4 m -60.65 -34.12 73.82 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 111.927 0.343 . . . . 71.24 111.927 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.8 77.88 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 110.277 -0.268 . . . . 64.42 110.277 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.9 mp -79.28 -28.73 42.32 Favored 'General case' 0 C--O 1.218 -0.57 0 C-N-CA 120.339 -0.544 . . . . 64.44 110.792 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 388' ' ' VAL . 73.0 mmtt -61.94 -41.61 98.17 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 120.608 0.242 . . . . 73.33 111.014 176.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -77.46 70.7 3.88 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 122.561 1.172 . . . . 74.14 111.021 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.583 HG22 HD21 ' A' ' 375' ' ' ASN . 12.9 p -142.45 155.46 45.08 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 113.241 -1.8 . . . . 65.32 108.561 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 32.5 p -166.45 115.81 0.92 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.591 -0.522 . . . . 61.32 109.591 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.8 t70 64.39 0.07 1.0 Allowed 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 125.365 1.466 . . . . 74.44 112.043 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -163.48 137.87 6.04 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.532 -0.914 . . . . 72.53 108.532 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 48.0 t -139.51 120.62 15.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 106.437 -1.69 . . . . 71.53 106.437 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.22 95.13 5.76 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.134 -1.432 . . . . 61.21 107.134 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.4 tt -108.94 111.12 22.63 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-O 121.038 0.447 . . . . 73.32 110.439 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.24 121.25 30.43 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.013 -1.106 . . . . 54.11 108.013 176.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 369' ' ' ASP . 2.1 p -115.9 137.33 49.92 Favored 'Isoleucine or valine' 0 C--O 1.258 1.534 0 C-N-CA 123.578 0.751 . . . . 74.02 110.045 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.647 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.48 158.72 43.77 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.364 -0.976 . . . . 33.33 108.364 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.294 -1.811 0 N-CA-C 108.723 -0.843 . . . . 53.11 108.723 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.24 0.594 0 N-CA-C 107.991 -1.114 . . . . 62.41 107.991 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.42 152.3 19.79 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 123.427 0.454 . . . . 63.24 112.208 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 41.9 m -142.51 141.82 32.15 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.886 -0.509 . . . . 75.01 109.862 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -77.16 152.99 34.62 Favored 'General case' 0 CA--C 1.462 -2.44 0 C-N-CA 123.918 0.887 . . . . 73.41 113.193 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.444 HG12 HD13 ' A' ' 329' ' ' LEU . 6.6 t . . . . . 0 N--CA 1.392 -3.354 0 C-N-CA 118.37 -1.332 . . . . 63.22 110.847 169.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 53.6 ttm . . . . . 0 C--O 1.205 -1.256 0 N-CA-C 106.107 -1.812 . . . . 64.23 106.107 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.428 1.9 pm0 -114.59 130.89 56.82 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 116.787 2.143 . . . . 60.13 116.787 -173.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.489 HG23 ' HD3' ' A' ' 364' ' ' LYS . 72.5 mt -111.88 112.66 41.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-N 111.573 -2.558 . . . . 70.01 108.83 -176.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 321' ' ' LYS . . . . . 0.639 ' HD3' ' CE1' ' A' ' 399' ' ' TYR . 30.6 ttpt -82.97 125.08 31.01 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.42 -0.955 . . . . 72.32 108.42 173.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.567 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 96.3 mt -119.29 154.06 34.08 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 124.904 1.377 . . . . 73.23 108.762 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 396' ' ' ASP . 49.5 mt -106.44 145.55 14.06 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.121 0 N-CA-C 106.467 -1.679 . . . . 64.42 106.467 169.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.537 ' H ' ' HA ' ' A' ' 396' ' ' ASP . 1.3 ttpm? -75.26 177.81 6.25 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.732 -1.211 . . . . 72.05 107.732 177.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 325' ' ' GLY . . . . . 0.465 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -160.78 -167.91 21.93 Favored Glycine 0 C--N 1.289 -2.067 0 C-N-CA 119.949 -1.119 . . . . 63.11 111.665 -177.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.27 -29.23 32.58 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 123.166 2.578 . . . . 75.31 112.405 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -106.39 25.29 11.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.241 0.543 . . . . 71.4 110.041 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.99 -125.52 7.13 Favored Glycine 0 CA--C 1.485 -1.793 0 N-CA-C 109.442 -1.463 . . . . 62.13 109.442 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.423 ' HB2' HG23 ' B' ' 151' ' ' VAL . 5.7 mp -97.49 -30.84 12.66 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.288 -1.745 . . . . 62.21 106.288 173.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 330' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 85.99 48.7 4.54 Favored Glycine 0 N--CA 1.429 -1.798 0 CA-C-N 114.057 -1.429 . . . . 75.55 115.041 173.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 55.5 p90 -153.23 166.43 32.58 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.504 -0.554 . . . . 72.32 109.504 172.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 9.5 m -117.9 136.78 53.24 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 120.597 -0.441 . . . . 74.03 110.18 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.0 pt -119.06 152.46 21.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 122.496 0.319 . . . . 45.02 110.948 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -141.73 135.05 29.4 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.106 -1.813 . . . . 44.03 106.106 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 144.59 156.54 6.86 Favored Glycine 0 C--N 1.277 -2.696 0 N-CA-C 109.53 -1.428 . . . . 64.01 109.53 -176.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.23 178.5 15.61 Favored Glycine 0 C--N 1.281 -2.519 0 N-CA-C 107.321 -2.311 . . . . 54.24 107.321 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.458 ' HA ' HD21 ' A' ' 346' ' ' ASN . 83.6 t -45.48 106.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 117.839 0.82 . . . . 72.3 111.994 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 84.91 -13.56 53.17 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.216 -0.902 . . . . 54.53 112.499 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.48 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 63.2 t30 -105.23 21.15 17.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.012 -0.736 . . . . 64.35 109.012 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.07 121.48 5.51 Favored 'General case' 0 C--O 1.256 1.436 0 CA-C-N 115.116 -0.947 . . . . 74.33 110.467 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -79.39 -43.4 23.49 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.11 -0.95 . . . . 73.13 108.734 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 37.4 mm -103.24 129.89 24.66 Favored Pre-proline 0 C--N 1.301 -1.503 0 CA-C-N 115.053 -0.976 . . . . 75.51 109.018 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.57 110.14 0.46 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 123.27 2.647 . . . . 71.22 113.292 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 97.83 -6.36 62.38 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.556 -0.747 . . . . 71.04 112.468 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -121.24 98.61 6.06 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.392 -0.966 . . . . 71.45 108.392 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 346' ' ' ASN . . . . . 0.458 HD21 ' HA ' ' A' ' 337' ' ' VAL . 51.5 t30 -81.66 26.87 0.47 Allowed 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 124.362 1.065 . . . . 73.53 111.219 -170.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 347' ' ' SER . . . . . 0.515 ' CB ' ' HE3' ' A' ' 370' ' ' LYS . 55.1 m -93.94 173.57 7.6 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.16 0.8 . . . . 73.45 113.16 -174.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 34.5 mm -86.01 126.06 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.915 -1.039 . . . . 62.33 109.685 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 43.1 m-85 -124.01 132.69 53.72 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.199 0.523 . . . . 75.45 111.858 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.56 114.11 4.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 108.348 -0.982 . . . . 74.04 108.348 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 22.6 m -102.94 -20.95 14.05 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 120.865 0.364 . . . . 43.35 111.401 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 45.9 mmtm -150.71 159.46 44.51 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.342 -1.355 . . . . 75.31 107.342 177.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 61.3 mt -138.73 119.45 15.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 106.249 -1.76 . . . . 73.02 106.249 172.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 40.3 mm -86.07 118.01 31.79 Favored 'Isoleucine or valine' 0 C--O 1.255 1.387 0 N-CA-C 108.494 -0.928 . . . . 63.51 108.494 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.53 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 0.1 OUTLIER -65.62 147.42 53.43 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.181 -1.414 . . . . 71.33 107.181 -176.769 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.24 -16.62 60.92 Favored Glycine 0 C--N 1.289 -2.054 0 N-CA-C 109.275 -1.53 . . . . 71.31 109.275 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -75.09 150.43 40.78 Favored Glycine 0 N--CA 1.4 -3.738 0 N-CA-C 106.726 -2.55 . . . . 54.43 106.726 170.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -60.84 -35.03 75.52 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.854 -0.424 . . . . 33.42 109.854 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.557 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.35 -9.08 58.24 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 112.914 0.709 . . . . 64.41 112.914 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 360' ' ' HIS . . . . . 0.53 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 30.2 t-80 -94.95 -39.24 10.3 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.334 -0.947 . . . . 73.32 108.575 175.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -76.84 -57.19 3.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.861 -0.608 . . . . 62.01 110.949 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -85.84 -42.15 14.39 Favored 'General case' 0 CA--C 1.476 -1.882 0 C-N-CA 124.221 1.008 . . . . 74.43 111.32 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.569 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -43.07 -20.56 0.09 OUTLIER Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 120.651 3.02 . . . . 52.44 120.651 -162.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.569 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.86 33.45 0.5 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 118.522 1.161 . . . . 72.43 111.921 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 41.6 tp -107.94 155.49 20.26 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.718 1.207 . . . . 41.55 109.706 -171.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -124.89 145.34 49.87 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.405 0.621 . . . . 64.33 111.641 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 83.9 mt -66.15 123.23 18.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 107.69 -1.226 . . . . 73.02 107.69 171.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.73 -7.92 19.69 Favored Glycine 0 C--N 1.311 -0.841 0 C-N-CA 121.173 -0.536 . . . . 71.44 111.835 -175.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.401 ' HB3' HG21 ' A' ' 402' ' ' VAL . 19.0 m-20 -68.68 137.14 53.9 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 112.563 0.579 . . . . 70.21 112.563 177.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.515 ' HE3' ' CB ' ' A' ' 347' ' ' SER . 72.4 tttt -98.71 116.83 31.8 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.288 -0.869 . . . . 71.02 109.957 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 71.4 mt -83.96 114.5 21.74 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.226 0.536 . . . . 75.21 109.679 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.5 tt -81.0 -39.38 25.98 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.159 -1.382 . . . . 74.21 107.457 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.473 ' HB3' ' HD3' ' A' ' 401' ' ' LYS . . . -165.67 158.56 15.53 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.504 -0.771 . . . . 70.21 110.174 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' VAL . . . . . 0.417 HG12 HD11 ' A' ' 379' ' ' LEU . 14.2 p -134.17 124.15 45.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.287 -1.005 . . . . 70.3 108.287 174.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 375' ' ' ASN . . . . . 0.537 HD21 HG22 ' A' ' 394' ' ' THR . 88.4 m-20 62.18 30.81 17.76 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 123.719 1.723 . . . . 64.2 109.268 -176.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 67.48 9.64 7.17 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 109.999 -3.273 . . . . 74.3 113.201 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.43 122.27 36.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 106.472 -1.677 . . . . 73.13 106.472 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.3 p -61.21 125.84 25.2 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.235 0.828 . . . . 74.11 113.235 -176.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.417 HD11 HG12 ' A' ' 374' ' ' VAL . 7.6 mp -106.6 -1.36 22.98 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.662 0.785 . . . . 71.32 110.71 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -73.45 113.88 11.05 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.405 -0.961 . . . . 70.45 108.405 172.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 63.75 83.87 0.16 Allowed 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 124.587 1.179 . . . . 71.32 111.919 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 23.5 m -153.15 164.62 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.234 -1.348 . . . . 65.24 108.705 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.6 m -83.0 139.61 33.19 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.258 -1.016 . . . . 73.43 108.258 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 384' ' ' HIS . . . . . 0.558 ' O ' HG23 ' A' ' 388' ' ' VAL . 81.5 t60 -49.53 -47.47 48.96 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.031 0.752 . . . . 72.11 113.031 -175.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -43.42 91.83 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.75 -0.833 . . . . 62.1 108.75 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 383' ' ' THR . 47.8 tt0 -67.5 -31.39 71.48 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.031 -1.44 . . . . 73.32 108.974 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 387' ' ' ALA . . . . . 0.504 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -75.37 -49.92 17.55 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 114.7 -1.136 . . . . 74.21 110.456 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 384' ' ' HIS . 19.2 t -59.61 -46.47 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 N-CA-C 109.713 -0.477 . . . . 61.45 109.713 -178.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 52.0 m -62.12 -29.49 70.37 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.522 -0.763 . . . . 73.31 112.041 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.86 -31.92 72.85 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.689 -0.632 . . . . 52.11 110.4 175.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.6 mp -82.2 -31.6 30.26 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 120.599 -0.44 . . . . 73.23 110.875 176.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -71.12 -27.82 63.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.074 0.398 . . . . 75.44 112.074 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -78.16 55.18 1.46 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.547 0.689 . . . . 64.21 110.641 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.537 HG22 HD21 ' A' ' 375' ' ' ASN . 22.1 p -127.46 152.54 47.42 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 109.122 -0.696 . . . . 64.03 109.122 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 395' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 51.1 m -144.47 90.37 2.08 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.444 1.116 . . . . 73.05 111.628 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.537 ' HA ' ' H ' ' A' ' 324' ' ' LYS 0.267 9.1 m-20 61.96 17.2 8.76 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 111.636 -2.529 . . . . 62.31 115.329 170.074 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -161.61 122.15 2.67 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.075 -1.454 . . . . 73.44 107.075 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.7 t -140.1 143.45 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 122.509 0.323 . . . . 70.43 110.488 -175.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 399' ' ' TYR . . . . . 0.639 ' CE1' ' HD3' ' A' ' 321' ' ' LYS . 4.5 m-85 -117.64 96.45 5.39 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.265 0.555 . . . . 71.53 109.696 170.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.9 tt -88.67 123.21 32.9 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.675 -0.693 . . . . 61.34 109.683 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.473 ' HD3' ' HB3' ' A' ' 373' ' ' ALA . 26.7 mtpp -107.37 107.78 18.84 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.358 -0.979 . . . . 75.13 108.358 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' A' ' 369' ' ' ASP . 7.2 p -108.39 153.31 10.0 Favored 'Isoleucine or valine' 0 C--O 1.274 2.387 0 CA-C-N 115.403 -0.817 . . . . 73.11 110.231 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.41 157.61 46.39 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 105.945 -1.872 . . . . 64.23 105.945 174.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt . . . . . 0 C--N 1.284 -2.25 0 C-N-CA 119.792 -0.763 . . . . 73.12 109.719 178.488 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 N--CA 1.442 -0.861 0 CA-C-O 121.242 0.544 . . . . 71.1 111.67 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -95.06 158.45 15.46 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.022 -0.99 . . . . 72.3 109.466 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 23.0 m -144.93 138.58 26.98 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 116.567 -0.288 . . . . 71.32 110.329 175.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 150' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 13.9 tm0? -78.69 140.04 38.41 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.008 -0.542 . . . . 74.34 111.161 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 329' ' ' LEU . 18.1 m . . . . . 0 C--O 1.266 1.926 0 CA-C-N 115.476 -0.784 . . . . 64.51 112.275 178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 CA--C 1.485 -1.52 0 N-CA-C 106.207 -1.775 . . . . 72.33 106.207 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.359 2.2 pm0 -121.46 131.0 53.91 Favored 'General case' 0 C--N 1.267 -2.981 0 N-CA-C 114.732 1.382 . . . . 73.22 114.732 -175.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 74.8 mt -116.96 113.7 43.66 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 CA-C-N 112.516 -2.129 . . . . 64.15 109.558 -172.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -92.81 112.4 24.34 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.323 -0.992 . . . . 35.13 108.323 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 322' ' ' LEU . . . . . 0.653 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 81.6 mt -107.27 152.85 23.57 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 124.363 1.039 . . . . 75.5 109.068 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 40.5 mt -106.16 126.46 61.72 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 107.917 -1.142 . . . . 74.24 107.917 169.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.47 ' HB3' ' H ' ' A' ' 396' ' ' ASP . 85.6 tttt -75.04 156.49 36.1 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.337 -0.392 . . . . 71.23 110.473 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -148.57 -154.86 6.45 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.705 -0.759 . . . . 33.01 113.151 -174.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.27 -46.85 27.62 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 124.039 3.159 . . . . 71.24 115.024 -173.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -98.47 25.82 6.03 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.265 0.555 . . . . 72.24 110.601 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.81 -124.32 6.67 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 114.987 -1.006 . . . . 71.12 111.958 177.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.433 HD13 HG12 ' B' ' 151' ' ' VAL . 8.2 mp -90.89 -39.78 12.11 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.526 -1.287 . . . . 65.54 107.526 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 87.08 47.99 4.53 Favored Glycine 0 N--CA 1.402 -3.613 0 CA-C-N 113.937 -1.483 . . . . 72.23 113.261 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 331' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 329' ' ' LEU . 48.9 p90 -155.47 147.17 23.13 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.327 0.584 . . . . 74.33 111.526 170.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 51.1 m -96.17 132.16 41.88 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.175 -0.921 . . . . 63.23 109.151 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.411 ' HB ' HG22 ' A' ' 348' ' ' ILE . 46.9 pt -120.45 141.91 38.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 109.941 -0.392 . . . . 61.53 109.941 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -139.58 125.59 19.81 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.768 -1.197 . . . . 64.21 107.768 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 150.22 161.65 10.03 Favored Glycine 0 C--N 1.282 -2.438 0 N-CA-C 110.469 -1.052 . . . . 63.11 110.469 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.05 -179.81 17.14 Favored Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 107.221 -2.352 . . . . 72.33 107.221 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 98.4 t -52.2 108.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 118.078 0.939 . . . . 65.52 110.778 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 94.78 -21.58 42.69 Favored Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.321 -0.854 . . . . 42.0 112.092 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 339' ' ' ASN . . . . . 0.61 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 32.1 t-20 -105.75 13.43 29.68 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.06 -0.719 . . . . 40.04 109.06 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.91 120.57 4.46 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 121.513 0.673 . . . . 74.53 111.098 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -77.79 -45.07 25.6 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.029 -0.987 . . . . 63.15 109.451 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 40.4 mm -103.35 124.14 39.21 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-N 115.309 -0.86 . . . . 74.35 109.16 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.66 108.01 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 123.247 2.631 . . . . 70.15 112.512 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 105.39 -4.12 40.4 Favored Glycine 0 N--CA 1.432 -1.599 0 CA-C-N 115.459 -0.791 . . . . 52.14 112.002 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -128.9 96.93 4.49 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.451 -0.944 . . . . 55.45 108.451 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -83.7 36.94 0.56 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.859 -1.064 . . . . 65.42 111.778 -170.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 72.0 m -98.66 177.34 5.34 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 115.613 -0.721 . . . . 70.5 111.249 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.1 mm -91.54 138.85 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 N-CA-C 106.33 -1.73 . . . . 75.31 106.33 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 349' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 369' ' ' ASP . 22.4 m-85 -127.5 139.25 52.91 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 118.34 0.518 . . . . 75.14 111.639 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.24 123.46 22.87 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 N-CA-C 108.955 -0.757 . . . . 52.34 108.955 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.1 m -102.35 -28.5 12.21 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.383 0.611 . . . . 73.41 110.529 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.48 ' HZ2' HD13 ' A' ' 354' ' ' ILE . 60.8 tttm -155.62 147.72 23.5 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.245 -1.02 . . . . 73.03 108.245 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 353' ' ' ILE . . . . . 0.454 HG22 ' HB2' ' A' ' 360' ' ' HIS . 76.5 mt -107.74 139.7 28.78 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 N-CA-C 105.412 -2.07 . . . . 64.24 105.412 169.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.48 HD13 ' HZ2' ' A' ' 352' ' ' LYS . 44.9 mm -85.17 129.74 37.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.147 0.499 . . . . 72.1 110.799 -174.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 0.5 OUTLIER -57.62 115.75 2.97 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 125.586 1.554 . . . . 62.13 111.105 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 84.24 7.98 84.27 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.725 -0.75 . . . . 43.12 111.807 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -75.9 160.2 51.36 Favored Glycine 0 C--O 1.259 1.67 0 N-CA-C 111.769 -0.532 . . . . 71.42 111.769 177.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.29 -42.21 99.06 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.184 -0.672 . . . . 45.4 109.184 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.522 ' HA ' ' CA ' ' A' ' 363' ' ' GLY . . . -72.97 -6.74 47.4 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.852 -0.613 . . . . 74.42 111.427 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 360' ' ' HIS . . . . . 0.454 ' HB2' HG22 ' A' ' 353' ' ' ILE . 63.9 t60 -92.66 -33.92 14.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.592 0.71 . . . . 61.12 109.473 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.651 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 0.7 OUTLIER -92.9 -54.65 3.66 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.902 0.704 . . . . 62.52 112.902 177.6 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 362' ' ' ASP . . . . . 0.728 ' O ' ' HE2' ' A' ' 364' ' ' LYS . 23.3 t70 -85.33 -37.22 20.19 Favored 'General case' 0 CA--C 1.461 -2.458 0 O-C-N 124.16 0.912 . . . . 61.34 110.625 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 363' ' ' GLY . . . . . 0.653 ' HA2' ' CD2' ' A' ' 322' ' ' LEU . . . -41.2 -28.11 0.27 Allowed Glycine 0 CA--C 1.483 -1.966 0 N-CA-C 120.37 2.908 . . . . 62.23 120.37 -160.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.728 ' HE2' ' O ' ' A' ' 362' ' ' ASP . 0.0 OUTLIER 46.26 32.66 1.56 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 118.442 1.121 . . . . 72.04 110.877 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 43.0 tp -115.4 155.55 27.2 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.776 1.231 . . . . 74.12 109.103 -170.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -120.62 149.04 43.09 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.388 0.613 . . . . 71.21 111.165 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.0 mt -66.17 122.65 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 107.454 -1.313 . . . . 73.02 107.454 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.57 -9.12 19.65 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.476 -0.869 . . . . 41.34 113.013 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 4.2 m-20 -61.47 142.32 57.09 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.233 0.827 . . . . 75.4 113.233 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 43.3 tttp -93.27 115.01 27.61 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.491 1.117 . . . . 74.33 109.452 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 371' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 4.2 mp -79.9 112.81 17.55 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.873 -0.788 . . . . 71.21 108.873 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 372' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 403' ' ' ALA . 5.8 tt -87.14 -40.16 14.87 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.057 -1.09 . . . . 74.22 108.057 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 401' ' ' LYS . . . -161.99 157.3 23.45 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.883 -0.599 . . . . 75.21 110.891 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.28 123.11 42.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 108.624 -0.88 . . . . 63.42 108.624 173.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 375' ' ' ASN . . . . . 0.535 HD21 HG22 ' A' ' 394' ' ' THR . 91.8 m-20 60.49 31.59 20.33 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-O 124.089 1.899 . . . . 70.14 109.235 -174.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.7 t30 66.26 15.84 10.23 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 109.48 -3.509 . . . . 70.3 112.509 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 55.2 t -84.08 125.98 40.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 106.522 -1.658 . . . . 73.32 106.522 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.8 p -61.66 123.69 18.62 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 123.605 0.762 . . . . 74.44 113.053 -176.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 391' ' ' LEU . 7.6 mp -110.81 -4.79 15.11 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.653 0.781 . . . . 71.35 111.387 177.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -65.65 106.29 1.44 Allowed 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.661 -0.496 . . . . 72.51 109.661 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 60.37 73.17 0.49 Allowed 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 124.616 1.198 . . . . 60.34 113.223 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.24 171.02 18.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 107.155 -1.424 . . . . 52.52 107.155 175.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.8 m -76.96 142.52 39.98 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.613 -0.884 . . . . 74.25 108.613 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 384' ' ' HIS . . . . . 0.535 ' O ' HG23 ' A' ' 388' ' ' VAL . 82.4 t60 -51.17 -47.75 62.07 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 111.446 0.165 . . . . 52.13 111.446 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.7 -37.39 75.98 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.835 0.826 . . . . 60.42 110.814 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 383' ' ' THR . 53.1 tt0 -73.85 -38.93 64.33 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.427 -1.26 . . . . 63.15 108.532 -174.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -70.19 -51.66 29.35 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.858 -1.065 . . . . 60.12 110.335 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 384' ' ' HIS . 40.4 t -59.28 -40.69 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.717 -0.22 . . . . 72.03 110.936 -177.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 90.5 m -60.23 -35.5 75.61 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 116.689 -0.232 . . . . 74.51 110.99 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.37 -37.98 84.05 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.587 0.232 . . . . 52.25 110.649 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.421 HD11 HD21 ' A' ' 379' ' ' LEU . 6.2 mp -75.86 -32.01 59.54 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.248 -0.581 . . . . 72.13 110.841 176.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' LYS . . . . . 0.488 ' HG2' HG13 ' B' ' 151' ' ' VAL . 57.6 mttm -67.52 -36.09 80.36 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 112.619 0.6 . . . . 75.34 112.619 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -81.1 70.62 7.97 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.38 1.086 . . . . 72.51 110.786 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.535 HG22 HD21 ' A' ' 375' ' ' ASN . 7.9 p -139.56 157.78 45.23 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 113.745 -1.571 . . . . 73.44 109.433 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 20.1 p -162.61 122.26 2.31 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.117 -0.698 . . . . 63.34 109.117 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' ASP . . . . . 0.47 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 3.6 m-20 59.81 1.42 0.31 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.516 1.526 . . . . 72.43 114.446 175.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -162.35 128.22 3.47 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 108.835 -0.802 . . . . 62.45 108.835 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 47.6 t -140.32 111.94 4.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.766 -0.828 . . . . 61.45 108.766 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -94.07 96.44 9.66 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.481 -0.933 . . . . 74.21 108.481 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 4.3 tt -92.25 120.61 32.97 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 108.656 -0.868 . . . . 71.33 108.656 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 373' ' ' ALA . 25.1 ttmm -106.09 110.16 22.33 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.509 -1.293 . . . . 75.01 107.509 177.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 402' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 370' ' ' LYS . 2.7 p -113.0 149.2 15.52 Favored 'Isoleucine or valine' 0 C--O 1.274 2.374 0 CA-C-O 121.843 0.83 . . . . 74.04 111.394 -177.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -128.12 158.37 38.19 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.595 -1.184 . . . . 70.31 108.446 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.483 0 N-CA-C 109.145 -0.687 . . . . 74.13 109.145 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 CA--C 1.5 -0.978 0 N-CA-C 109.573 -0.529 . . . . 73.21 109.573 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.83 166.73 11.66 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.041 -0.527 . . . . 72.44 109.979 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 86.5 m -144.44 126.04 15.04 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.544 -0.539 . . . . 60.13 109.544 168.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 150' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 20.9 tm0? -69.59 136.35 51.15 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.107 -0.952 . . . . 64.22 110.601 175.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.488 HG13 ' HG2' ' A' ' 392' ' ' LYS . 21.8 t . . . . . 0 C--N 1.305 -1.363 0 N-CA-C 107.724 -1.213 . . . . 71.51 107.724 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 CA--C 1.492 -1.275 0 N-CA-C 105.766 -1.938 . . . . 73.25 105.766 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -127.12 140.39 52.3 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 113.878 1.066 . . . . 70.31 113.878 -174.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 363' ' ' GLY . 84.0 mt -129.0 116.83 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 CA-C-N 113.504 -1.68 . . . . 62.12 109.19 -174.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.5 127.33 34.86 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.836 -0.801 . . . . 74.12 108.836 175.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 80.9 mt -122.8 152.5 40.62 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.062 -0.718 . . . . 74.22 109.062 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 32.4 mm -105.76 111.51 35.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.653 -1.24 . . . . 73.13 107.653 173.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.475 ' HE3' ' HA2' ' A' ' 328' ' ' GLY . 1.4 tmtp? -75.92 141.05 42.4 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.8 -0.444 . . . . 75.31 109.8 -176.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -149.14 -154.55 6.39 Favored Glycine 0 C--N 1.301 -1.413 0 C-N-CA 120.41 -0.9 . . . . 72.43 112.646 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.66 -12.85 35.76 Favored 'Trans proline' 0 N--CA 1.484 0.926 0 C-N-CA 123.594 2.863 . . . . 62.14 113.99 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.411 ' HZ3' ' HB3' ' A' ' 327' ' ' LYS . 6.9 mtpm? -107.39 10.66 29.51 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.427 -0.953 . . . . 62.21 108.427 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLY . . . . . 0.475 ' HA2' ' HE3' ' A' ' 324' ' ' LYS . . . 83.72 -133.87 12.26 Favored Glycine 0 CA--C 1.484 -1.881 0 CA-C-N 114.389 -1.278 . . . . 71.34 109.91 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.476 ' HB2' HG23 ' B' ' 151' ' ' VAL . 5.1 mp -93.38 -19.68 21.08 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.073 -1.454 . . . . 62.31 107.073 172.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' GLY . . . . . 0.466 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 85.51 40.05 7.99 Favored Glycine 0 N--CA 1.426 -1.996 0 CA-C-N 113.869 -1.514 . . . . 65.04 115.064 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -154.92 167.8 29.1 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 117.409 0.604 . . . . 65.44 110.324 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 2.8 m -121.76 132.75 54.78 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.492 -0.559 . . . . 74.23 109.492 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 388' ' ' VAL . 18.2 pt -113.68 154.98 14.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 116.234 -0.439 . . . . 75.14 110.978 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.45 115.38 5.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 124.68 1.238 . . . . 61.43 107.937 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 168.77 161.29 18.66 Favored Glycine 0 C--N 1.275 -2.823 0 N-CA-C 108.928 -1.669 . . . . 70.43 108.928 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.67 178.2 15.43 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 108.601 -1.8 . . . . 61.14 108.601 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.8 t -53.05 104.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.65 0.738 . . . . 72.21 110.933 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.65 -19.88 52.3 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.001 -0.999 . . . . 72.43 113.269 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.509 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 60.2 t30 -107.65 22.39 16.03 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 117.288 0.544 . . . . 73.11 110.246 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.401 HE22 ' HA ' ' A' ' 343' ' ' PRO . 0.0 OUTLIER -52.34 119.64 4.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.263 0.554 . . . . 72.42 110.801 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -73.25 -44.82 58.77 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.149 -0.932 . . . . 71.33 109.979 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 42.7 mm -104.66 125.34 34.22 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 108.766 -0.827 . . . . 73.24 108.766 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.401 ' HA ' HE22 ' A' ' 340' ' ' GLN . 73.0 Cg_exo -52.62 107.73 0.21 Allowed 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 123.21 2.607 . . . . 74.34 112.898 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 107.14 -7.63 37.83 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-N 115.281 -0.872 . . . . 53.23 112.362 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -125.03 98.74 5.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.941 -0.763 . . . . 55.21 108.941 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -83.05 33.67 0.45 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.878 0.871 . . . . 74.5 111.511 -171.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 16.4 m -95.06 171.44 8.75 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.157 -0.474 . . . . 62.34 111.006 -177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.416 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 27.6 mm -83.91 127.5 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 107.678 -1.23 . . . . 71.05 107.678 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 47.6 m-85 -123.88 136.68 54.51 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.328 0.585 . . . . 53.0 112.465 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.18 113.81 5.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.796 -1.187 . . . . 65.14 107.796 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 53.2 m -102.14 -23.9 14.0 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.236 0.541 . . . . 74.32 111.276 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 94.7 mttt -151.32 156.28 40.45 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.964 -1.124 . . . . 74.13 107.964 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.4 HG22 ' HB2' ' A' ' 360' ' ' HIS . 78.0 mt -130.47 128.95 64.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.309 -1.367 . . . . 71.2 107.309 176.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 49.4 mm -85.35 141.78 14.1 Favored 'Isoleucine or valine' 0 C--O 1.256 1.419 0 C-N-CA 123.315 0.646 . . . . 74.13 111.22 -171.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.19 127.83 34.13 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.201 1.0 . . . . 74.12 111.555 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 71.71 8.9 68.86 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.534 -0.757 . . . . 51.12 112.584 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' GLY . . . . . 0.466 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -70.46 159.75 53.63 Favored Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.831 -0.699 . . . . 71.34 111.498 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -59.15 -40.86 86.86 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.592 -0.522 . . . . 72.43 109.592 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.523 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -73.01 -13.13 61.16 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.262 0.553 . . . . 63.12 112.298 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' HIS . . . . . 0.4 ' HB2' HG22 ' A' ' 353' ' ' ILE . 10.7 t-80 -92.53 -25.74 18.24 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.899 0.857 . . . . 61.52 109.434 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.424 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 0.2 OUTLIER -96.57 -59.21 1.87 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 113.332 0.864 . . . . 74.43 113.332 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -86.14 -36.53 19.51 Favored 'General case' 0 CA--C 1.475 -1.913 0 N-CA-C 107.844 -1.169 . . . . 64.41 107.844 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.535 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -44.75 -35.15 4.16 Favored Glycine 0 C--O 1.201 -1.923 0 N-CA-C 118.677 2.231 . . . . 74.34 118.677 -166.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.535 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.58 29.86 0.19 Allowed 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 118.29 1.045 . . . . 62.03 111.198 -173.038 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 47.2 tp -97.64 151.8 19.73 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 125.009 1.324 . . . . 74.54 109.807 -169.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -121.1 149.19 43.13 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-O 121.409 0.623 . . . . 74.35 111.409 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 77.8 mt -65.89 121.7 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 107.622 -1.251 . . . . 55.02 107.622 172.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.4 -1.76 22.13 Favored Glycine 0 C--N 1.313 -0.734 0 C-N-CA 121.0 -0.619 . . . . 60.45 112.133 -175.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -75.16 137.11 41.1 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 113.087 0.773 . . . . 74.45 113.087 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 37.9 tttp -92.83 119.43 32.15 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 124.327 1.051 . . . . 73.01 110.453 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 78.6 mt -87.63 121.03 29.54 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 120.393 -0.523 . . . . 62.01 110.002 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.466 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 92.6 mt -82.19 -40.16 22.14 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.088 -1.415 . . . . 72.23 108.439 177.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -165.17 165.65 19.6 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.281 -0.872 . . . . 71.53 111.944 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.497 HG12 HD11 ' A' ' 379' ' ' LEU . 10.2 p -133.79 119.58 33.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.863 -1.162 . . . . 65.5 107.863 171.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' ASN . . . . . 0.49 HD21 HG22 ' A' ' 394' ' ' THR . 84.8 m-20 63.14 28.65 16.05 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 123.95 1.833 . . . . 71.33 108.406 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 66.18 17.92 10.84 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 109.726 -3.397 . . . . 75.33 112.52 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.5 t -84.14 123.63 39.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.567 -1.642 . . . . 70.34 106.567 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 10.4 p -59.49 124.04 18.77 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.163 1.172 . . . . 73.33 114.163 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.566 HD21 HD11 ' A' ' 391' ' ' LEU . 5.8 mp -106.49 6.7 30.43 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.64 1.176 . . . . 72.24 110.119 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.466 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 20.1 mm-40 -71.26 110.67 6.05 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.073 -0.967 . . . . 73.23 110.902 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 54.1 66.86 1.12 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.65 1.18 . . . . 60.45 112.715 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.36 171.72 16.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.629 -1.249 . . . . 74.35 107.629 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.448 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 2.3 m -75.79 144.78 41.17 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.661 -0.866 . . . . 32.14 108.661 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.578 ' O ' HG23 ' A' ' 388' ' ' VAL . 10.0 t-160 -51.88 -49.78 62.3 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 111.601 0.223 . . . . 61.12 111.601 -176.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' B' ' 143' ' ' THR . 36.7 tt0 -65.22 -29.52 70.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.966 0.412 . . . . 65.35 111.848 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 383' ' ' THR . 60.7 tt0 -71.52 -40.27 70.22 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.688 -1.227 . . . . 63.13 107.688 -176.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -69.59 -50.55 43.5 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.864 -1.062 . . . . 65.3 110.178 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.743 HG21 HG21 ' B' ' 143' ' ' THR . 40.6 t -57.38 -37.16 55.74 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 O-C-N 123.032 0.208 . . . . 71.52 111.38 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 91.5 m -62.55 -34.34 76.73 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 116.653 -0.248 . . . . 74.34 111.108 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -70.06 -35.95 74.63 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.644 0.259 . . . . 71.54 110.363 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.566 HD11 HD21 ' A' ' 379' ' ' LEU . 5.6 mp -78.51 -27.93 46.17 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 120.164 -0.614 . . . . 71.42 110.599 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 53.5 mttm -71.42 -37.24 71.49 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.85 0.685 . . . . 55.45 112.85 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -82.45 65.83 7.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.282 1.039 . . . . 62.4 110.79 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.49 HG22 HD21 ' A' ' 375' ' ' ASN . 31.0 p -137.18 146.93 45.51 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.034 -1.439 . . . . 65.24 107.506 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 42.1 m -142.78 120.39 11.79 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.71 -0.478 . . . . 60.02 109.71 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 324' ' ' LYS . 3.9 m-20 58.46 0.95 0.15 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.691 1.996 . . . . 71.43 115.694 172.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -161.61 135.57 6.74 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.416 -0.957 . . . . 74.03 108.416 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 61.4 t -142.02 133.45 26.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.682 -0.859 . . . . 53.35 108.682 177.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -107.73 96.29 6.28 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.192 -1.781 . . . . 74.31 106.192 173.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.4 tt -86.36 129.67 34.77 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 120.949 0.404 . . . . 63.44 110.292 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -108.96 108.54 19.33 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.817 -1.179 . . . . 62.32 107.817 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 3.4 p -118.93 150.55 21.22 Favored 'Isoleucine or valine' 0 C--O 1.274 2.353 0 CA-C-O 121.784 0.802 . . . . 72.31 111.265 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.424 ' HB2' HD11 ' A' ' 372' ' ' LEU . . . -136.63 158.15 45.11 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 105.721 -1.955 . . . . 71.12 105.721 171.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.37 154.33 56.83 Favored Pre-proline 0 C--N 1.284 -2.248 0 N-CA-C 105.463 -2.051 . . . . 63.41 105.463 177.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' PRO . . . . . 0.416 ' HA ' ' OH ' ' A' ' 349' ' ' TYR . 3.2 Cg_exo -36.89 110.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 124.503 3.469 . . . . 73.23 113.688 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 9.9 m -95.3 -38.05 10.71 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 113.48 0.918 . . . . 64.2 113.48 -168.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -104.3 31.12 8.99 Favored Glycine 0 C--N 1.29 -2.024 0 C-N-CA 119.815 -1.183 . . . . 43.13 110.536 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 12.6 p -161.2 -164.49 1.17 Allowed 'General case' 0 N--CA 1.411 -2.387 0 CA-C-N 114.584 -0.808 . . . . 63.24 109.032 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -70.12 106.6 3.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.444 -0.576 . . . . 63.44 109.444 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -71.88 138.61 48.33 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 123.718 0.636 . . . . 62.13 112.437 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 . . . . . 0 N--CA 1.426 -1.626 0 N-CA-C 103.513 -2.773 . . . . 73.31 103.513 179.709 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 121.717 0.77 . . . . 64.11 110.013 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -95.98 -55.23 3.05 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.005 -1.85 . . . . 75.21 106.005 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.743 HG21 HG21 ' A' ' 388' ' ' VAL . 5.9 m -91.76 152.17 20.29 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 104.976 -2.231 . . . . 72.24 104.976 171.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 40.9 ttm105 -154.39 166.62 32.65 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.852 -1.139 . . . . 74.31 110.052 -163.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.1 157.66 20.63 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 123.614 0.571 . . . . 61.31 110.51 176.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.78 26.64 9.41 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.268 1.427 . . . . 63.23 112.487 -173.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 147' ' ' ASN . . . . . 0.41 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.2 OUTLIER -159.89 144.2 14.7 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.669 -0.696 . . . . 74.41 109.708 174.395 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -91.36 161.3 15.07 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.657 -0.868 . . . . 75.24 108.657 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 51.6 m -147.27 140.43 25.23 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.927 -0.483 . . . . 73.2 110.414 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -71.13 139.24 50.2 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.865 -0.607 . . . . 73.51 109.916 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 329' ' ' LEU . 12.4 m . . . . . 0 C--O 1.265 1.878 0 CA-C-N 115.79 -0.641 . . . . 71.23 112.065 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 C--O 1.203 -1.394 0 N-CA-C 106.373 -1.714 . . . . 73.14 106.373 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.472 1.9 pm0 -115.58 128.98 56.35 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 117.05 2.241 . . . . 72.34 117.05 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.601 HG23 ' HD3' ' A' ' 364' ' ' LYS . 66.9 mt -107.38 107.0 21.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 CA-C-N 111.425 -2.625 . . . . 75.33 108.552 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.51 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 29.4 ttpt -80.44 118.92 22.49 Favored 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 119.865 -0.734 . . . . 71.22 109.073 174.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.59 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 27.5 mt -113.05 148.07 35.93 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 113.904 -1.498 . . . . 72.44 110.316 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.0 mp -106.55 117.2 51.89 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.017 0 N-CA-C 107.119 -1.437 . . . . 72.45 107.119 169.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.682 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 10.2 tmtt? -63.03 151.57 39.45 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 108.639 -0.875 . . . . 75.21 108.639 171.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.429 ' O ' ' HE2' ' A' ' 324' ' ' LYS . . . -141.98 -160.58 8.39 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 119.832 -1.175 . . . . 64.04 113.365 -171.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.22 -30.62 45.82 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.155 2.57 . . . . 74.41 113.651 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -101.58 18.85 19.21 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 122.279 1.037 . . . . 75.31 108.791 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.34 -129.0 8.92 Favored Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 109.799 -1.32 . . . . 71.14 109.799 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.508 ' HB2' HG23 ' B' ' 151' ' ' VAL . 5.3 mp -96.98 -42.58 7.84 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.161 -1.792 . . . . 75.24 106.161 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' GLY . . . . . 0.517 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 84.41 50.19 4.36 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 114.754 -1.112 . . . . 52.33 114.806 171.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' PHE . . . . . 0.408 ' O ' HG22 ' B' ' 151' ' ' VAL . 50.2 p90 -151.25 150.71 30.9 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.413 -0.588 . . . . 60.11 109.413 173.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 6.4 m -104.15 129.15 51.87 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.601 -0.518 . . . . 72.11 109.601 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.3 pt -113.36 151.69 15.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-N 115.824 -0.625 . . . . 72.23 109.943 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.66 121.75 10.1 Favored 'General case' 0 N--CA 1.425 -1.713 0 O-C-N 124.226 0.954 . . . . 74.23 108.685 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 167.7 179.07 40.18 Favored Glycine 0 C--N 1.281 -2.498 0 N-CA-C 107.452 -2.259 . . . . 54.3 107.452 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 132.54 175.98 14.21 Favored Glycine 0 CA--C 1.474 -2.526 0 N-CA-C 108.712 -1.755 . . . . 44.34 108.712 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.457 HG22 ' OE2' ' A' ' 381' ' ' GLU . 93.4 t -51.0 100.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 O-C-N 124.432 0.725 . . . . 62.41 111.437 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 88.13 -7.47 81.35 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.593 -0.731 . . . . 62.12 112.312 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.449 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 65.6 t30 -106.3 16.56 24.66 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.066 -0.716 . . . . 63.14 109.066 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.463 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -49.57 125.88 12.33 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.52 1.128 . . . . 73.22 111.835 -177.297 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -80.3 -44.11 20.12 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.18 -0.918 . . . . 54.03 109.429 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.5 mm -103.62 125.28 35.24 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 115.846 -0.615 . . . . 63.03 109.357 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.33 108.8 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.553 2.836 . . . . 75.41 113.416 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 101.87 -4.92 53.26 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.512 -0.767 . . . . 71.44 111.936 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -124.99 96.7 4.96 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.322 -0.992 . . . . 73.32 108.322 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 51.7 t30 -81.01 29.04 0.34 Allowed 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 124.343 1.057 . . . . 74.23 111.781 -170.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 73.0 m -93.34 177.97 5.87 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.726 0.774 . . . . 75.45 112.755 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.5 mm -91.21 129.33 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 114.609 -1.178 . . . . 72.21 108.32 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 28.9 m-85 -123.54 132.47 53.91 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.193 0.52 . . . . 74.32 112.197 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 52.9 t -67.1 109.84 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.581 -1.266 . . . . 75.51 107.581 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.4 m -99.83 -22.07 15.48 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.207 0.527 . . . . 72.11 110.711 -175.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 31.8 mmtp -148.25 154.27 39.83 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.375 -1.343 . . . . 72.11 107.375 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.462 HG22 ' HB2' ' A' ' 360' ' ' HIS . 65.5 mt -131.72 107.59 13.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 106.815 -1.55 . . . . 70.11 106.815 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 38.7 mm -78.73 129.6 37.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 123.731 0.813 . . . . 74.34 109.788 -171.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.533 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 0.6 OUTLIER -63.83 146.25 54.29 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.429 -1.323 . . . . 63.11 107.429 -178.246 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.598 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.05 -19.53 53.66 Favored Glycine 0 C--N 1.28 -2.529 0 N-CA-C 109.299 -1.521 . . . . 35.22 109.299 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' GLY . . . . . 0.517 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -69.29 142.37 37.28 Favored Glycine 1 N--CA 1.384 -4.811 0 N-CA-C 107.968 -2.053 . . . . 72.44 107.968 172.034 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 362' ' ' ASP . . . -62.97 -32.65 74.04 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.826 -0.805 . . . . 74.42 108.826 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.585 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.72 -6.28 49.75 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.981 -0.554 . . . . 52.02 112.132 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' HIS . . . . . 0.533 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 19.5 t60 -94.19 -39.4 10.57 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.432 -0.951 . . . . 73.14 108.432 175.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.598 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 73.7 mmtt -82.7 -57.65 3.23 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.599 0.714 . . . . 62.23 110.79 -178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 358' ' ' ALA . 10.9 t70 -85.86 -34.85 20.9 Favored 'General case' 0 CA--C 1.468 -2.187 0 C-N-CA 125.182 1.393 . . . . 71.15 111.112 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.59 ' HA2' ' CD2' ' A' ' 322' ' ' LEU . . . -42.71 -23.97 0.22 Allowed Glycine 0 C--N 1.287 -2.186 0 N-CA-C 120.862 3.105 . . . . 35.44 120.862 -162.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.601 ' HD3' HG23 ' A' ' 320' ' ' ILE . 0.0 OUTLIER 41.47 36.99 0.6 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.802 1.301 . . . . 74.51 111.54 -178.45 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 50.3 tp -114.21 156.06 24.97 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.536 1.134 . . . . 64.25 109.891 -170.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -122.19 142.66 50.19 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.434 0.635 . . . . 74.04 111.678 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.39 121.53 15.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.507 -1.294 . . . . 71.1 107.507 169.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 114.55 -0.61 23.43 Favored Glycine 0 C--N 1.314 -0.687 0 N-CA-C 111.656 -0.578 . . . . 50.24 111.656 -176.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.478 ' HB3' HG21 ' A' ' 402' ' ' VAL . 83.2 m-20 -76.27 136.77 39.64 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.196 0.813 . . . . 73.12 113.196 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.666 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 37.7 tttp -94.86 116.61 28.93 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.99 1.316 . . . . 72.12 108.948 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 83.6 mt -83.25 113.45 20.69 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 109.779 -0.452 . . . . 72.3 109.779 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 403' ' ' ALA . 3.9 tt -81.49 -39.67 24.4 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.08 -1.452 . . . . 74.23 107.08 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.41 159.18 21.99 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.493 -0.776 . . . . 63.14 110.644 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.438 HG12 HD11 ' A' ' 379' ' ' LEU . 13.5 p -133.75 121.09 39.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.07 -1.085 . . . . 60.15 108.07 172.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' ASN . . . . . 0.542 HD21 HG22 ' A' ' 394' ' ' THR . 89.1 m-20 62.83 29.85 16.63 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 123.987 1.851 . . . . 74.03 108.652 -174.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 67.42 10.39 7.71 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 109.652 -3.431 . . . . 71.34 113.355 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 50.3 t -78.74 124.56 37.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.585 -1.635 . . . . 64.44 106.585 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.5 p -61.51 124.62 21.17 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.677 0.992 . . . . 65.54 113.677 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.438 HD11 HG12 ' A' ' 374' ' ' VAL . 8.5 mp -109.18 3.48 21.88 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.027 0.931 . . . . 71.32 110.836 176.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -78.15 115.97 18.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.34 -0.985 . . . . 72.32 108.34 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' GLU . . . . . 0.457 ' OE2' HG22 ' A' ' 337' ' ' VAL . 17.1 tp10 62.83 83.34 0.16 Allowed 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 124.607 1.192 . . . . 75.32 111.625 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 18.4 m -153.81 160.36 2.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 113.966 -1.47 . . . . 64.54 109.171 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.5 m -81.65 145.14 30.73 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.443 -1.317 . . . . 73.51 107.443 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.618 ' O ' HG23 ' A' ' 388' ' ' VAL . 7.3 t-160 -52.1 -48.27 64.85 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 112.533 0.568 . . . . 74.22 112.533 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.6 ' HA ' ' OG1' ' B' ' 143' ' ' THR . 6.9 tp10 -57.86 -37.34 73.72 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.653 0.74 . . . . 74.32 110.896 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 383' ' ' THR . 55.5 tt0 -70.54 -35.8 73.34 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.942 -1.026 . . . . 75.04 108.484 -174.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.407 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -75.47 -50.94 14.21 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.662 -1.154 . . . . 61.35 111.052 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 384' ' ' HIS . 20.7 t -57.64 -40.75 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 110.022 -0.362 . . . . 72.22 110.022 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 94.8 m -58.55 -40.01 81.83 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.101 -0.499 . . . . 65.52 110.749 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -63.65 -33.22 75.15 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.477 0.18 . . . . 60.01 110.972 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.8 mp -81.44 -28.92 34.0 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 120.388 -0.525 . . . . 51.01 110.943 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -74.74 -24.18 58.67 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.213 0.449 . . . . 64.41 112.213 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -78.62 46.39 0.65 Allowed 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 123.428 0.691 . . . . 73.53 110.692 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.542 HG22 HD21 ' A' ' 375' ' ' ASN . 34.0 p -124.57 143.49 50.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.056 0.455 . . . . 65.01 110.061 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 324' ' ' LYS . 49.3 m -142.49 100.98 3.8 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 122.32 1.057 . . . . 62.43 112.171 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.682 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 5.3 m-20 60.47 15.85 5.9 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 128.232 2.613 . . . . 60.01 113.897 169.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -165.91 126.53 1.79 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.035 -1.098 . . . . 60.33 108.035 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 25.1 t -145.61 146.6 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 123.296 0.638 . . . . 72.24 110.642 -175.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.51 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 20.4 m-85 -118.56 96.68 5.39 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.465 0.706 . . . . 74.0 109.191 169.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.8 tt -88.34 121.5 30.8 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.34 -0.615 . . . . 62.34 109.34 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -104.64 108.42 19.86 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.256 -1.016 . . . . 73.51 108.256 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 369' ' ' ASP . 5.6 p -106.41 150.48 8.98 Favored 'Isoleucine or valine' 0 C--O 1.276 2.5 0 CA-C-O 121.651 0.739 . . . . 74.04 110.247 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.666 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.7 159.58 41.39 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 125.966 1.706 . . . . 71.12 107.149 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 7.1 mmpt? -95.99 153.91 39.07 Favored Pre-proline 0 C--N 1.287 -2.126 0 N-CA-C 108.803 -0.814 . . . . 73.55 108.803 174.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' PRO . . . . . 0.4 ' HD2' ' HE2' ' A' ' 404' ' ' LYS . 1.4 Cg_endo -43.33 139.28 4.39 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 123.954 3.103 . . . . 64.11 114.756 -176.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 5.9 m -75.93 78.19 2.82 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.083 -1.417 . . . . 75.32 112.147 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 87.78 -47.17 3.53 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 116.009 1.164 . . . . 65.3 116.009 169.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 17.0 m -62.18 -22.83 66.22 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.992 0.901 . . . . 54.21 110.815 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -159.61 168.47 25.98 Favored 'General case' 0 N--CA 1.405 -2.689 0 N-CA-C 103.755 -2.683 . . . . 73.31 103.755 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -159.92 49.48 0.3 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 119.433 1.015 . . . . 65.32 110.349 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 . . . . . 0 C--N 1.297 -1.681 0 N-CA-C 105.785 -1.932 . . . . 73.44 105.785 -177.841 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.869 0 N-CA-C 108.535 -0.913 . . . . 71.24 108.535 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 69.19 28.26 4.99 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.541 1.137 . . . . 74.33 110.256 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.6 ' OG1' ' HA ' ' A' ' 385' ' ' GLU . 27.3 p -112.64 174.13 6.04 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.617 -1.623 . . . . 71.41 106.617 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -153.18 154.27 34.4 Favored 'General case' 0 CA--C 1.482 -1.636 0 O-C-N 121.163 -0.961 . . . . 75.22 108.712 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' GLN . . . . . 0.451 ' HB3' ' CB ' ' A' ' 384' ' ' HIS . 12.6 pt20 -86.6 173.91 9.24 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 115.938 -0.574 . . . . 74.23 111.191 172.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 146' ' ' ARG . . . . . 0.63 ' HA ' ' HE ' ' B' ' 146' ' ' ARG . 2.0 mmp_? 66.63 22.02 10.55 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.527 1.131 . . . . 75.14 111.472 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -160.92 167.62 26.24 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 113.653 -1.612 . . . . 75.11 108.052 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -90.47 158.03 17.26 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 124.159 0.912 . . . . 74.42 108.54 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 55.2 m -145.85 138.16 25.47 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.796 -0.446 . . . . 51.23 109.796 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -81.52 132.35 35.31 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 109.525 -0.546 . . . . 61.21 109.525 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.508 HG23 ' HB2' ' A' ' 329' ' ' LEU . 7.9 m . . . . . 0 C--N 1.291 -1.957 0 CA-C-N 116.026 -0.534 . . . . 64.41 111.291 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 CA--C 1.493 -1.247 0 N-CA-C 107.427 -1.323 . . . . 75.33 107.427 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.298 1.6 pm0 -115.34 133.85 55.65 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-O 122.847 1.308 . . . . 73.23 114.087 -175.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.536 HG23 ' HE2' ' A' ' 364' ' ' LYS . 86.6 mt -123.62 106.59 17.41 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.732 0 CA-C-N 112.662 -2.063 . . . . 53.2 110.025 -173.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.524 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 30.2 ttpt -81.07 130.5 35.05 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.931 -1.137 . . . . 73.34 107.931 170.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.403 HD21 ' HA2' ' A' ' 363' ' ' GLY . 10.3 mt -129.97 156.76 43.91 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 124.805 1.316 . . . . 74.43 110.396 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 39.0 mm -106.5 117.57 52.52 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.762 0 N-CA-C 107.696 -1.224 . . . . 75.25 107.696 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.576 ' HG2' ' N ' ' A' ' 325' ' ' GLY . 17.5 tttm -71.69 160.92 31.8 Favored 'General case' 0 C--O 1.206 -1.185 0 N-CA-C 107.933 -1.136 . . . . 74.01 107.933 174.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.576 ' N ' ' HG2' ' A' ' 324' ' ' LYS . . . -149.33 -164.34 11.57 Favored Glycine 0 C--N 1.29 -1.981 0 N-CA-C 110.315 -1.114 . . . . 20.24 110.315 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.31 -12.84 27.86 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.892 2.394 . . . . 74.34 111.493 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -97.61 6.72 47.64 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 122.078 0.942 . . . . 65.43 108.968 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.03 -134.79 13.05 Favored Glycine 0 CA--C 1.491 -1.412 0 N-CA-C 109.824 -1.31 . . . . 74.45 109.824 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.78 -27.11 12.88 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.157 -1.423 . . . . 75.42 107.157 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 86.02 48.12 4.75 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.366 -1.288 . . . . 60.23 115.216 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -154.46 171.34 19.52 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 110.043 -0.354 . . . . 74.41 110.043 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.7 m -127.96 128.4 44.99 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.093 -0.706 . . . . 61.15 109.093 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 21.4 pt -113.79 157.92 14.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 115.84 -0.618 . . . . 75.31 110.622 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.39 125.96 10.98 Favored 'General case' 0 N--CA 1.428 -1.559 0 O-C-N 124.36 1.037 . . . . 63.12 108.454 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 164.13 -177.0 40.03 Favored Glycine 0 C--N 1.284 -2.333 0 N-CA-C 108.581 -1.808 . . . . 72.21 108.581 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.19 177.05 14.68 Favored Glycine 0 CA--C 1.482 -1.987 0 N-CA-C 109.833 -1.307 . . . . 71.25 109.833 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.454 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 92.8 t -57.76 103.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 O-C-N 124.121 0.542 . . . . 71.13 110.202 175.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 92.96 -14.08 66.11 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.375 -0.83 . . . . 72.32 112.101 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.511 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 65.0 t30 -106.02 21.56 17.11 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.553 -0.536 . . . . 73.42 109.553 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.67 123.5 7.96 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 115.104 -0.953 . . . . 72.23 111.49 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -78.72 -40.85 32.45 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.032 -0.985 . . . . 73.34 108.916 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 37.0 mm -103.62 122.36 45.07 Favored Pre-proline 0 C--N 1.302 -1.488 0 CA-C-N 115.2 -0.909 . . . . 75.24 109.334 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -52.2 108.11 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.429 2.752 . . . . 45.15 112.91 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 104.44 -2.6 42.97 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 115.178 -0.919 . . . . 61.35 112.308 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -127.14 103.66 7.55 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.747 0.784 . . . . 73.02 109.587 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.454 ' OD1' ' HA ' ' A' ' 337' ' ' VAL . 65.9 t30 -83.32 38.02 0.59 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 125.038 1.335 . . . . 71.1 111.14 -171.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 21.5 m -110.9 177.86 4.53 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.723 -0.671 . . . . 75.13 112.346 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.416 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 35.0 mm -91.92 131.15 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.053 0.541 . . . . 74.43 109.702 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 36.6 m-85 -124.39 139.16 54.16 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.582 0.586 . . . . 72.44 112.582 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.24 115.05 10.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 108.256 -1.016 . . . . 71.55 108.256 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 31.6 m -101.06 -24.0 14.39 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.341 0.591 . . . . 71.32 111.308 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.63 147.93 23.7 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.792 -1.188 . . . . 72.33 107.792 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 85.1 mt -118.27 133.09 66.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 106.168 -1.79 . . . . 74.01 106.168 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 48.6 mm -75.83 130.87 35.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.315 0.579 . . . . 73.25 109.831 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.602 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.6 pm0 -60.09 122.36 14.2 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 125.006 1.322 . . . . 72.1 111.627 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 74.29 16.16 79.91 Favored Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 114.368 -1.287 . . . . 74.41 111.393 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.78 163.95 52.84 Favored Glycine 0 C--O 1.251 1.177 0 N-CA-C 110.97 -0.852 . . . . 15.32 110.97 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -64.33 -42.34 96.33 Favored 'General case' 0 C--O 1.207 -1.15 0 N-CA-C 108.816 -0.809 . . . . 44.34 108.816 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.425 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -71.49 -5.74 35.3 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 121.876 -0.515 . . . . 55.23 112.135 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -93.85 -36.12 12.39 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.67 -0.863 . . . . 63.33 108.67 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -92.62 -58.59 2.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.98 1.371 . . . . 52.45 110.221 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -85.9 -26.76 25.41 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.709 -2.041 . . . . 64.02 110.283 -170.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -56.69 -39.35 86.21 Favored Glycine 0 C--N 1.278 -2.641 0 CA-C-N 112.779 -2.01 . . . . 65.13 118.109 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.536 ' HE2' HG23 ' A' ' 320' ' ' ILE 0.255 0.0 OUTLIER 45.94 32.59 1.37 Allowed 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 119.113 1.456 . . . . 72.42 111.489 -170.56 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 48.3 tp -101.31 149.62 23.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.436 -1.257 . . . . 73.31 109.036 -172.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.95 147.74 42.86 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.285 0.564 . . . . 63.3 109.686 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 76.7 mt -66.03 123.3 18.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 106.927 -1.509 . . . . 74.12 106.927 170.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.54 -9.31 19.66 Favored Glycine 0 C--N 1.308 -1.005 0 C-N-CA 120.536 -0.84 . . . . 63.31 112.29 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -68.51 137.09 54.1 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 120.882 0.373 . . . . 74.44 111.504 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 2.1 ttmm -94.55 125.14 39.01 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.81 -0.632 . . . . 62.53 109.502 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 95.9 mt -81.45 112.36 18.63 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.671 -0.863 . . . . 62.4 108.671 176.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 403' ' ' ALA . 2.8 tt -80.5 -43.61 20.51 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.104 -2.184 . . . . 51.21 105.104 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -160.45 161.41 32.91 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.738 -1.119 . . . . 51.13 110.909 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.14 126.81 50.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.365 -1.346 . . . . 61.24 107.365 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.01 34.79 23.74 Favored 'General case' 0 CA--C 1.475 -1.925 0 CA-C-O 124.631 2.158 . . . . 43.01 110.339 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 60.42 17.33 7.11 Favored 'General case' 0 C--N 1.266 -3.058 1 CA-C-N 108.341 -4.027 . . . . 72.23 113.362 -177.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.4 t -89.04 125.86 42.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.64 -1.245 . . . . 70.14 107.64 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.4 p -57.58 123.42 15.53 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 123.847 0.859 . . . . 53.52 112.837 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 2.9 mp -107.32 -5.84 17.55 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.457 -0.792 . . . . 62.01 112.602 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -83.89 136.28 34.16 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.779 -0.768 . . . . 43.55 111.035 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 63.05 32.37 15.41 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.113 1.365 . . . . 71.53 114.469 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 33.2 m -112.07 169.15 4.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.257 -1.386 . . . . 71.14 107.257 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 82.6 p -79.26 150.46 31.54 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.359 -0.937 . . . . 73.54 108.937 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.573 ' O ' HG23 ' A' ' 388' ' ' VAL . 6.8 t-160 -51.2 -37.25 45.63 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.212 0.449 . . . . 61.22 112.212 -175.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.44 ' HA ' ' OG1' ' B' ' 143' ' ' THR . 0.5 OUTLIER -62.33 -40.69 97.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 121.386 -0.126 . . . . 74.51 110.903 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -67.24 -37.15 83.08 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 109.188 -0.671 . . . . 72.35 109.188 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.523 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -68.66 -56.56 7.77 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 114.581 -1.19 . . . . 61.3 110.685 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 384' ' ' HIS . 27.4 t -58.98 -44.56 91.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 110.043 -0.354 . . . . 70.55 110.043 -177.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 87.3 m -60.29 -33.72 72.76 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.178 -0.465 . . . . 42.45 111.171 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.66 -38.03 86.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.425 -0.172 . . . . 74.33 110.757 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.4 mp -75.54 -30.12 59.63 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 119.914 -0.714 . . . . 64.12 110.219 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 55.0 mttm -72.31 -27.71 62.62 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 112.289 0.477 . . . . 74.02 112.289 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -80.07 51.36 1.35 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.047 0.927 . . . . 62.35 111.833 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 17.5 p -124.78 162.88 23.32 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 107.246 -1.39 . . . . 73.05 107.246 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 55.1 m -148.69 101.38 3.2 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.939 0.876 . . . . 74.35 110.669 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.571 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 0.8 OUTLIER 47.18 30.28 1.36 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 111.425 -2.625 . . . . 75.15 114.259 172.421 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -169.24 117.56 0.64 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 106.334 -1.728 . . . . 71.31 106.334 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.81 146.16 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.754 0.422 . . . . 73.14 111.036 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.524 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 28.0 m-85 -121.93 96.84 5.22 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.625 0.77 . . . . 72.31 108.975 171.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.45 ' CD2' HG23 ' A' ' 402' ' ' VAL . 7.0 tt -91.61 133.89 35.16 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.799 -0.637 . . . . 73.43 109.695 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -117.55 110.9 18.52 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.242 0.617 . . . . 60.15 110.651 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' A' ' 400' ' ' LEU . 53.7 t -104.99 143.13 16.8 Favored 'Isoleucine or valine' 0 C--O 1.27 2.162 0 C-N-CA 124.047 0.939 . . . . 64.41 110.525 177.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -125.76 154.52 42.41 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 103.957 -2.608 . . . . 73.43 103.957 167.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -89.42 153.67 48.44 Favored Pre-proline 0 C--N 1.285 -2.198 0 C-N-CA 119.303 -0.959 . . . . 71.1 111.085 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' PRO . . . . . 0.548 ' HB2' ' O ' ' A' ' 409' ' ' HIS . 2.4 Cg_endo -45.14 132.84 11.53 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 123.3 2.666 . . . . 75.44 112.394 176.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 11.4 m -70.5 75.98 0.57 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 113.912 -1.495 . . . . 64.32 114.738 -171.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 77.73 -60.62 3.72 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 117.697 1.839 . . . . 71.21 117.697 166.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 33.4 p -61.81 -33.93 75.01 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.221 1.01 . . . . 73.25 110.086 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' HIS . . . . . 0.548 ' O ' ' HB2' ' A' ' 405' ' ' PRO . 64.2 m80 -128.13 142.31 51.23 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 104.747 -2.316 . . . . 74.44 104.747 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' HIS . . . . . 0.429 ' HA ' ' HG2' ' A' ' 405' ' ' PRO . 12.4 p-80 -151.91 135.53 16.2 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 123.253 0.346 . . . . 73.41 110.735 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 . . . . . 0 C--N 1.318 -0.791 0 N-CA-C 107.263 -1.384 . . . . 73.51 107.263 -179.297 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.569 0 N-CA-C 107.296 -1.372 . . . . 62.41 107.296 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 142' ' ' ARG . . . . . 0.477 ' HA ' HH11 ' B' ' 142' ' ' ARG . 9.7 mmm180 -108.93 147.11 32.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.558 -1.275 . . . . 75.42 107.558 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' A' ' 385' ' ' GLU . 15.8 p -117.14 154.77 30.49 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 119.824 -0.751 . . . . 73.23 109.392 -174.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 144' ' ' ARG . . . . . 0.448 ' HD3' ' HA ' ' B' ' 144' ' ' ARG . 57.1 mmt-85 -153.47 148.72 26.95 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 121.055 0.455 . . . . 74.15 111.147 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 145' ' ' GLN . . . . . 0.455 ' HB3' ' CB ' ' A' ' 384' ' ' HIS . 13.7 pt20 -86.92 170.9 11.22 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.162 -0.926 . . . . 70.53 111.399 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 146' ' ' ARG . . . . . 0.637 ' HA ' ' HE ' ' B' ' 146' ' ' ARG . 1.7 mmp_? 67.4 21.38 9.72 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 125.088 1.355 . . . . 64.13 110.881 -173.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -161.53 172.72 15.92 Favored 'General case' 0 C--O 1.26 1.608 0 CA-C-N 113.081 -1.872 . . . . 74.04 106.478 173.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' B' ' 148' ' ' GLU . 0.1 OUTLIER -95.61 159.79 14.82 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 123.797 0.686 . . . . 74.03 110.074 -178.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.415 HG21 HG22 ' B' ' 143' ' ' THR . 45.9 m -145.12 140.08 27.76 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.729 -0.607 . . . . 72.01 110.585 177.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -81.9 135.88 35.37 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.673 0.789 . . . . 73.44 110.393 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.42 HG12 HG13 ' A' ' 388' ' ' VAL . 15.3 m . . . . . 0 C--O 1.27 2.146 0 CA-C-N 116.077 -0.51 . . . . 64.15 111.641 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 C--O 1.209 -1.046 0 N-CA-C 108.233 -1.025 . . . . 63.3 108.233 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.285 2.0 pm0 -104.31 139.51 39.19 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 114.069 1.137 . . . . 73.34 114.069 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.471 HD13 ' O ' ' A' ' 363' ' ' GLY . 89.9 mt -128.66 122.53 57.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.168 -1.833 . . . . 62.13 107.986 -172.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.534 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 33.1 ttpt -94.79 109.67 21.62 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.38 -0.528 . . . . 42.24 110.622 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.429 HD21 ' HA2' ' A' ' 363' ' ' GLY . 88.0 mt -106.61 151.49 24.98 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.678 -1.147 . . . . 61.31 109.769 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 24.2 mm -105.25 111.22 33.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.038 -1.467 . . . . 75.31 107.038 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -75.98 130.55 38.6 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.355 -0.384 . . . . 70.33 111.548 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -133.09 -154.97 7.65 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 119.386 -1.388 . . . . 53.21 112.696 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.51 -13.26 35.03 Favored 'Trans proline' 0 N--CA 1.481 0.77 0 C-N-CA 123.411 2.741 . . . . 71.24 114.177 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -106.27 8.57 31.94 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.176 0.988 . . . . 62.23 108.386 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.02 -136.28 14.66 Favored Glycine 0 CA--C 1.492 -1.376 0 CA-C-N 113.844 -1.525 . . . . 34.13 110.497 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.457 ' HB2' HG23 ' B' ' 151' ' ' VAL . 4.0 mp -98.55 -26.26 14.47 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.746 -1.946 . . . . 73.52 105.746 171.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' GLY . . . . . 0.593 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 80.28 54.04 3.93 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 113.689 -1.596 . . . . 42.02 115.113 172.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -155.35 158.52 38.83 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.218 -1.03 . . . . 71.2 108.218 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 352' ' ' LYS . 14.9 m -113.08 133.64 54.9 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.388 -0.597 . . . . 74.42 109.388 -177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.3 pt -116.16 154.54 17.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 115.833 -0.622 . . . . 52.15 110.996 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -143.58 127.37 17.21 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.478 -1.675 . . . . 63.5 106.478 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 148.33 150.67 5.26 Favored Glycine 0 C--N 1.283 -2.416 0 N-CA-C 109.323 -1.511 . . . . 71.44 109.323 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.65 171.84 12.75 Favored Glycine 0 C--N 1.287 -2.189 0 N-CA-C 108.044 -2.022 . . . . 75.13 108.044 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.408 ' HA ' HD21 ' A' ' 346' ' ' ASN . 61.1 t -45.57 111.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.087 0.943 . . . . 60.44 111.58 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 94.05 -30.49 7.53 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.097 -0.956 . . . . 71.33 112.361 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' B' ' 146' ' ' ARG . 63.3 t30 -105.46 26.75 9.08 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.808 -0.442 . . . . 72.3 109.808 -177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.83 123.93 8.91 Favored 'General case' 0 C--O 1.26 1.646 0 CA-C-N 116.017 -0.538 . . . . 75.45 109.793 177.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -75.81 -52.62 9.99 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.141 -0.936 . . . . 71.34 109.497 -173.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 73.3 mt -103.26 133.18 20.46 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 107.817 -1.179 . . . . 71.14 107.817 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.61 110.84 0.47 Allowed 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 123.424 2.749 . . . . 71.14 113.755 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 97.54 -4.58 61.91 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.322 -0.854 . . . . 61.43 112.045 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 23.8 t0 -120.15 96.82 5.32 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.831 0.824 . . . . 72.31 108.841 -177.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.408 HD21 ' HA ' ' A' ' 337' ' ' VAL . 52.7 t30 -85.05 28.91 0.67 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.506 0.669 . . . . 74.3 110.7 -171.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.456 ' HB2' ' CE2' ' A' ' 349' ' ' TYR . 15.2 m -90.45 164.71 14.17 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.105 0.479 . . . . 63.52 111.106 -175.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 24.6 mm -79.54 125.01 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 108.428 -0.953 . . . . 75.11 108.428 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.589 ' CE1' ' HB2' ' A' ' 370' ' ' LYS . 47.7 m-85 -123.71 130.22 52.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.089 0.471 . . . . 73.45 111.801 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.17 117.1 6.31 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 CA-C-N 115.432 -0.804 . . . . 73.14 109.254 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.2 m -100.06 -18.16 17.13 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.484 0.659 . . . . 75.44 110.476 -175.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.566 ' HB2' ' HZ3' ' A' ' 352' ' ' LYS . 2.3 ttmp? -166.57 153.05 8.81 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.047 -1.094 . . . . 72.33 108.047 -175.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 64.8 mt -126.87 119.86 54.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 107.037 -1.468 . . . . 62.45 107.037 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 42.8 mm -86.28 125.94 40.68 Favored 'Isoleucine or valine' 0 C--O 1.259 1.568 0 C-N-CA 123.234 0.614 . . . . 74.54 109.72 -175.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.31 147.6 47.69 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 108.285 -1.005 . . . . 63.35 108.285 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.558 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.49 -19.06 56.03 Favored Glycine 0 C--N 1.281 -2.487 0 N-CA-C 109.714 -1.355 . . . . 41.22 109.714 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' GLY . . . . . 0.593 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -72.93 149.85 43.51 Favored Glycine 1 N--CA 1.395 -4.095 0 N-CA-C 109.515 -1.434 . . . . 62.21 109.515 173.616 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -56.95 -36.84 70.73 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.132 -0.692 . . . . 60.21 109.132 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.574 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.81 -13.04 60.28 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 113.263 0.838 . . . . 51.32 113.263 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -94.14 -31.4 14.18 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.369 -0.974 . . . . 72.32 108.369 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.558 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 75.1 mmtt -84.69 -58.2 2.82 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.738 -0.785 . . . . 64.12 110.676 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.46 -42.17 13.81 Favored 'General case' 0 CA--C 1.467 -2.225 0 CA-C-O 121.887 0.851 . . . . 74.32 111.124 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -42.66 -23.1 0.17 Allowed Glycine 0 CA--C 1.482 -2.024 0 N-CA-C 120.328 2.891 . . . . 74.43 120.328 -158.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.516 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.84 32.48 0.4 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 119.037 1.418 . . . . 54.14 111.658 -178.165 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 48.5 tp -99.69 152.78 19.69 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.519 -1.219 . . . . 73.25 109.83 -171.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -117.14 144.65 44.47 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.478 0.656 . . . . 64.1 110.677 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.9 mt -66.12 120.81 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 106.958 -1.497 . . . . 72.22 106.958 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.56 -7.46 20.27 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 120.803 -0.713 . . . . 51.41 112.157 -176.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -70.14 137.54 51.14 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-O 121.17 0.509 . . . . 70.13 111.742 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.589 ' HB2' ' CE1' ' A' ' 349' ' ' TYR . 36.1 tttp -92.07 119.14 31.48 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.281 -0.872 . . . . 71.1 110.118 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 93.8 mt -79.08 114.71 18.24 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.293 -0.632 . . . . 75.33 109.293 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.457 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 3.3 tt -82.49 -39.84 21.92 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.205 -1.776 . . . . 64.41 106.205 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.92 166.86 21.29 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.538 -0.756 . . . . 53.44 112.331 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.524 HG12 HD11 ' A' ' 379' ' ' LEU . 12.0 p -132.74 116.69 27.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 107.493 -1.299 . . . . 43.21 107.493 171.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 63.22 29.58 15.94 Favored 'General case' 0 CA--C 1.469 -2.145 0 CA-C-O 123.943 1.83 . . . . 62.24 109.672 -172.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 66.39 11.8 8.23 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 109.556 -3.475 . . . . 74.42 113.182 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 49.8 t -78.57 119.31 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 106.214 -1.773 . . . . 74.11 106.214 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -59.45 124.62 20.64 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 114.328 1.233 . . . . 65.51 114.328 -173.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.524 HD11 HG12 ' A' ' 374' ' ' VAL . 6.6 mp -101.76 11.15 39.24 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 124.921 1.288 . . . . 54.43 108.973 174.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.457 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 24.0 mm-40 -78.43 112.23 15.25 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.258 -1.337 . . . . 75.25 108.682 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 381' ' ' GLU . . . . . 0.405 ' CD ' HD22 ' A' ' 346' ' ' ASN . 19.0 tp10 61.06 83.55 0.14 Allowed 'General case' 0 CA--C 1.544 0.719 0 O-C-N 124.51 1.131 . . . . 63.44 111.721 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 19.3 m -153.13 162.83 2.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.061 -1.427 . . . . 74.52 107.975 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.419 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 2.0 m -78.64 143.32 36.46 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.726 -0.842 . . . . 72.41 108.726 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.568 ' O ' HG23 ' A' ' 388' ' ' VAL . 86.4 t60 -51.95 -49.66 62.73 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 120.872 0.367 . . . . 75.45 111.695 -175.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.498 ' HG3' ' OG1' ' B' ' 143' ' ' THR . 70.6 tt0 -61.05 -36.55 79.9 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.119 -0.946 . . . . 63.01 110.7 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.419 ' HB3' ' O ' ' A' ' 383' ' ' THR . 48.6 tt0 -73.75 -34.04 64.56 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.417 -1.265 . . . . 63.03 108.799 -174.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.546 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -71.83 -48.16 48.1 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.744 -1.117 . . . . 64.22 110.137 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 384' ' ' HIS . 19.3 t -58.52 -45.37 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.409 -0.589 . . . . 71.53 109.409 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 66.0 m -61.34 -31.72 71.59 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 116.08 -0.509 . . . . 64.31 111.348 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.65 84.16 Favored 'General case' 0 C--N 1.343 0.313 0 O-C-N 122.019 -0.426 . . . . 23.44 110.312 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.3 mp -79.08 -23.99 43.79 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 120.199 -0.6 . . . . 75.11 110.915 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.481 ' HE2' HG12 ' A' ' 388' ' ' VAL . 61.5 mttm -75.91 -32.19 59.51 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.528 0.566 . . . . 71.2 112.528 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -74.83 32.55 0.09 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.364 1.065 . . . . 65.24 113.761 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 1.7 p -124.77 158.45 33.28 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 109.968 -0.382 . . . . 71.2 109.968 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 62.8 m -148.53 125.84 11.55 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.535 -0.543 . . . . 55.23 109.535 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 26.6 t70 60.98 0.17 0.36 Allowed 'General case' 0 C--O 1.2 -1.513 0 C-N-CA 126.578 1.951 . . . . 72.35 114.954 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -158.38 119.12 3.36 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 120.276 -1.515 . . . . 73.41 110.333 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 93.7 t -142.21 117.93 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 122.553 0.341 . . . . 62.53 111.678 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.534 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 17.8 m-85 -90.07 96.53 10.72 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.123 -1.066 . . . . 65.0 108.123 167.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 tt -83.35 130.82 35.08 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.097 -0.705 . . . . 73.22 109.097 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 38.8 tttp -121.19 112.62 18.88 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 109.954 -0.387 . . . . 74.3 109.954 -173.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 53.7 t -104.92 144.58 14.52 Favored 'Isoleucine or valine' 0 C--O 1.263 1.788 0 C-N-CA 123.753 0.821 . . . . 73.32 110.882 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -121.58 157.75 30.07 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 104.95 -2.241 . . . . 65.4 104.95 172.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 9.5 mmpt? -83.5 152.91 64.73 Favored Pre-proline 0 C--N 1.285 -2.208 0 C-N-CA 119.184 -1.006 . . . . 74.12 109.051 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' PRO . . . . . 0.572 ' HA ' ' OH ' ' A' ' 349' ' ' TYR . 2.2 Cg_endo -48.74 117.43 2.71 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 123.271 2.647 . . . . 74.41 113.632 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.4 -38.33 22.1 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 114.681 1.363 . . . . 65.2 114.681 -174.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -95.65 34.28 4.98 Favored Glycine 0 C--N 1.292 -1.864 0 C-N-CA 120.074 -1.06 . . . . 72.53 114.242 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 19.5 p -168.31 -175.68 2.65 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.571 -0.529 . . . . 72.33 109.571 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -76.98 130.99 38.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.051 -1.833 . . . . 71.43 106.051 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' HIS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 404' ' ' LYS . 3.0 p-80 -107.03 143.56 34.97 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 115.409 1.633 . . . . 54.01 115.409 -172.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 . . . . . 0 N--CA 1.432 -1.34 0 N-CA-C 105.593 -2.003 . . . . 63.43 105.593 178.149 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.508 0 N-CA-C 109.002 -0.74 . . . . 72.23 109.002 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 69.62 -37.12 0.36 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 124.771 1.228 . . . . 75.04 111.381 -173.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.498 ' OG1' ' HG3' ' A' ' 385' ' ' GLU . 9.0 p -70.6 155.74 40.34 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 106.419 -1.696 . . . . 74.3 106.419 169.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 144' ' ' ARG . . . . . 0.45 ' O ' ' HD2' ' A' ' 384' ' ' HIS . 2.7 mmp_? -152.71 153.69 33.75 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.301 -1.0 . . . . 74.24 108.301 -172.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -87.04 169.85 12.05 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.016 0.436 . . . . 45.33 111.637 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' ARG . . . . . 0.451 ' HA ' ' OD1' ' A' ' 339' ' ' ASN 0.355 13.0 mmt180 65.96 20.91 11.35 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 125.43 1.492 . . . . 75.1 114.962 -178.708 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -144.86 170.24 16.5 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.621 -1.622 . . . . 64.22 106.621 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.04 146.3 24.36 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 107.406 -1.331 . . . . 73.53 107.406 174.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.435 HG21 HG22 ' B' ' 143' ' ' THR . 15.0 m -134.14 132.39 39.81 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 120.424 -0.51 . . . . 74.53 109.701 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -75.58 136.36 40.52 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 109.671 -0.492 . . . . 62.12 109.671 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.457 HG23 ' HB2' ' A' ' 329' ' ' LEU . 18.0 m . . . . . 0 C--N 1.296 -1.73 0 CA-C-O 117.107 -1.425 . . . . 65.51 112.107 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 109.331 -0.618 . . . . 62.22 109.331 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.33 119.8 11.67 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 122.247 1.022 . . . . 64.31 109.203 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 65.3 mt -98.47 106.56 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.895 0 CA-C-N 113.689 -1.596 . . . . 74.3 109.736 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -76.5 104.01 6.79 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 104.408 -2.442 . . . . 72.31 104.408 165.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 359' ' ' ALA . 0.6 OUTLIER -109.25 136.23 49.05 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 113.751 -1.568 . . . . 75.44 106.976 -173.4 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 21.9 mm -95.03 137.14 24.08 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 C-N-CA 119.36 -0.936 . . . . 71.32 109.292 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 395' ' ' SER . 1.2 ttpm? -68.16 177.64 2.18 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-O 121.106 0.479 . . . . 73.14 109.835 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.521 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -150.68 -173.88 21.2 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.229 -1.148 . . . . 65.02 110.229 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.47 -41.02 21.6 Favored 'Trans proline' 0 N--CA 1.482 0.831 0 C-N-CA 122.955 2.436 . . . . 62.3 112.178 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.35 -14.54 46.1 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 123.31 1.529 . . . . 61.24 107.656 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 98.74 -143.75 16.81 Favored Glycine 0 C--N 1.256 -3.885 0 CA-C-N 113.38 -1.736 . . . . 71.04 109.437 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.1 mp -74.76 -46.24 38.48 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 117.679 0.739 . . . . 61.41 111.105 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 83.41 53.15 3.51 Favored Glycine 0 C--O 1.22 -0.72 0 C-N-CA 120.173 -1.013 . . . . 52.5 115.364 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 49.0 p90 -151.82 172.98 15.33 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.185 -0.672 . . . . 71.24 109.185 173.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.486 ' OG ' ' HG2' ' B' ' 150' ' ' GLN . 3.9 m -123.38 136.1 54.47 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.951 -0.388 . . . . 44.13 109.951 -177.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 16.4 pt -120.57 156.55 23.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 116.318 -0.401 . . . . 71.34 110.146 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' B' ' 148' ' ' GLU . . . -148.02 133.3 18.46 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.96 -1.126 . . . . 63.35 107.96 175.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 157.83 -177.43 34.59 Favored Glycine 0 C--N 1.273 -2.922 0 N-CA-C 108.5 -1.84 . . . . 71.21 108.5 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.11 175.47 13.98 Favored Glycine 0 C--N 1.272 -2.986 0 N-CA-C 108.054 -2.018 . . . . 51.14 108.054 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.8 100.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.49 0.662 . . . . 62.21 110.769 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 80.71 2.45 89.96 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 115.164 -0.926 . . . . 55.24 113.445 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -107.69 11.81 28.06 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.057 -1.09 . . . . 73.43 108.057 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.88 134.27 56.48 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 115.624 1.713 . . . . 73.42 115.624 -173.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -71.62 -34.97 70.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.005 -1.452 . . . . 64.24 109.515 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 41.8 mm -104.75 118.89 55.23 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.998 -0.546 . . . . 75.51 110.299 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.94 110.17 0.59 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.745 2.297 . . . . 73.34 111.489 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.33 -28.23 9.87 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.95 -0.643 . . . . 71.01 111.832 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -106.77 102.51 11.87 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.766 -0.827 . . . . 64.24 108.766 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -82.66 38.11 0.55 Allowed 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 123.721 0.809 . . . . 73.14 112.208 -170.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 75.2 m -103.2 178.44 4.56 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 113.268 0.84 . . . . 74.33 113.268 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.459 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 25.7 mm -93.96 131.32 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 114.853 -1.067 . . . . 44.4 108.128 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 369' ' ' ASP . 28.9 m-85 -124.11 135.14 53.32 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 112.691 0.626 . . . . 73.03 112.691 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.69 116.57 5.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.072 -1.084 . . . . 62.34 108.072 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.3 m -107.57 -20.41 13.25 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 120.852 0.358 . . . . 74.12 111.537 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 331' ' ' PHE . 47.0 mmtm -149.34 159.06 44.61 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 107.524 -1.287 . . . . 75.51 107.524 177.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.441 HG22 ' HB2' ' A' ' 360' ' ' HIS . 75.9 mt -140.54 124.97 18.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 107.049 -1.463 . . . . 73.11 107.049 172.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 39.2 mm -85.62 116.49 28.89 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 N-CA-C 108.15 -1.055 . . . . 74.05 108.15 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.55 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 1.1 pp20? -66.23 147.53 53.18 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 107.257 -1.386 . . . . 73.1 107.257 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.485 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.69 -26.66 19.11 Favored Glycine 0 C--N 1.288 -2.123 0 N-CA-C 109.691 -1.364 . . . . 63.42 109.691 -175.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -69.98 156.83 53.49 Favored Glycine 0 C--O 1.272 2.489 0 N-CA-C 110.914 -0.874 . . . . 75.21 110.914 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -57.6 -41.17 80.71 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 109.792 -0.448 . . . . 53.42 109.792 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.655 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.99 -4.88 43.6 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 113.394 0.887 . . . . 73.25 113.394 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' HIS . . . . . 0.55 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 69.6 t60 -94.8 -38.18 10.88 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.641 -0.824 . . . . 54.04 109.136 172.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.485 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 72.7 mmtt -83.42 -57.2 3.35 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.976 -0.689 . . . . 73.23 111.362 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -85.54 -30.81 23.09 Favored 'General case' 0 CA--C 1.463 -2.383 0 CA-C-O 121.672 0.749 . . . . 70.34 109.588 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -43.31 -32.66 1.81 Allowed Glycine 0 CA--C 1.475 -2.413 0 CA-C-N 113.239 -1.801 . . . . 61.34 117.22 -168.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? 45.09 36.85 2.21 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 124.626 0.839 . . . . 74.41 110.408 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 29.9 tp -119.78 158.56 26.29 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 113.79 -1.55 . . . . 71.14 109.339 -168.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.75 145.23 49.63 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 115.82 -0.627 . . . . 71.54 109.936 -174.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 81.1 mt -66.77 119.23 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 108.991 -0.744 . . . . 71.24 108.991 175.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.76 3.33 20.25 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.984 -0.627 . . . . 71.33 111.996 -175.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 8.0 m-20 -73.25 133.02 43.83 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.818 0.673 . . . . 74.34 112.818 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 44.5 tttp -92.9 114.83 27.5 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.444 1.098 . . . . 70.42 108.473 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 83.9 mt -83.61 112.07 19.68 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.848 -0.427 . . . . 73.34 109.848 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.4 tt -83.7 -40.71 18.55 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.531 -1.213 . . . . 74.33 107.918 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -162.6 145.82 11.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.689 -0.687 . . . . 71.2 109.72 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.56 130.19 49.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 109.377 -0.601 . . . . 74.12 109.377 175.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 44.93 67.27 0.73 Allowed 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 125.652 1.581 . . . . 71.02 110.343 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 66.43 -26.69 0.11 Allowed 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 114.771 1.397 . . . . 75.3 114.771 -176.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 42.5 t -78.84 125.7 38.41 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 O-C-N 121.651 -0.656 . . . . 73.44 110.487 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -74.92 130.04 38.71 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 122.481 0.312 . . . . 74.0 110.521 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.6 0.09 22.34 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.474 0.546 . . . . 74.53 112.474 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -68.36 106.71 2.59 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.43 -0.582 . . . . 72.42 109.43 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 62.85 73.82 0.45 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 122.678 1.228 . . . . 60.23 113.077 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.56 169.71 16.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.515 -1.221 . . . . 71.24 107.834 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.518 ' OG1' ' HG2' ' A' ' 386' ' ' GLU . 3.0 p -76.63 147.85 37.3 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.639 -0.874 . . . . 65.12 108.639 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.603 ' O ' HG23 ' A' ' 388' ' ' VAL . 10.6 t-80 -57.52 -37.04 72.37 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.496 0.665 . . . . 74.54 109.446 -172.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -56.45 -44.05 80.12 Favored 'General case' 0 N--CA 1.403 -2.8 0 CA-C-N 113.88 -1.509 . . . . 72.42 112.826 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.518 ' HG2' ' OG1' ' A' ' 383' ' ' THR . 20.0 mm-40 -75.28 -29.33 60.1 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 109.189 -0.671 . . . . 63.24 109.189 -176.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.421 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -67.33 -58.12 5.38 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.489 -1.232 . . . . 50.14 109.086 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 384' ' ' HIS . 17.8 t -59.27 -41.42 83.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 N-CA-C 109.447 -0.575 . . . . 53.5 109.447 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 35.1 m -61.46 -35.63 78.16 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 115.977 -0.556 . . . . 71.13 111.477 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -69.07 -38.02 78.82 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 122.341 -0.224 . . . . 43.24 110.583 176.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 387' ' ' ALA . 6.1 mp -72.16 -28.92 63.55 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.419 -0.513 . . . . 71.23 110.596 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 61.5 mttm -73.91 -34.88 64.55 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 120.602 -0.439 . . . . 72.32 112.106 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -84.77 62.39 7.37 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.785 0.802 . . . . 61.43 110.877 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 22.5 p -125.6 152.44 45.13 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.311 -0.859 . . . . 73.43 109.282 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' SER . . . . . 0.531 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 50.4 m -146.83 90.11 1.88 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 122.218 1.009 . . . . 70.13 111.072 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.497 ' H ' ' HB2' ' A' ' 324' ' ' LYS 0.265 22.1 m-20 62.2 14.35 6.6 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 111.951 -2.386 . . . . 73.31 115.208 170.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -157.77 107.6 2.15 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 108.034 -1.098 . . . . 70.54 108.034 173.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 43.7 t -114.73 123.73 70.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.787 -0.819 . . . . 34.04 108.787 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.74 95.7 6.83 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 105.108 -2.182 . . . . 65.13 105.108 174.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 8.0 tt -102.22 104.02 14.56 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-O 121.376 0.608 . . . . 72.53 109.582 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -93.61 112.03 23.83 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.138 -1.43 . . . . 52.15 107.138 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.426 HG21 ' HB3' ' A' ' 369' ' ' ASP . 4.7 p -119.16 146.17 24.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.209 -0.905 . . . . 62.22 110.557 -173.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.539 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -125.17 158.38 34.1 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.298 -1.001 . . . . 72.33 108.298 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -92.92 152.94 41.94 Favored Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 106.958 -1.497 . . . . 62.32 106.958 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -75.46 78.29 3.06 Favored 'Trans proline' 0 C--O 1.248 1.007 0 C-N-CA 121.46 1.44 . . . . 74.12 110.5 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 31.1 m -77.39 74.39 3.96 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 122.439 1.114 . . . . 74.32 112.304 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -168.08 18.79 0.08 OUTLIER Glycine 0 C--N 1.304 -1.209 0 CA-C-N 113.661 -1.608 . . . . 63.21 109.743 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 26.0 t -168.89 -168.31 0.85 Allowed 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 105.635 -1.987 . . . . 54.04 105.635 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -80.74 89.7 5.78 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.447 0.642 . . . . 71.31 109.494 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -86.91 143.78 27.25 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.127 -0.942 . . . . 75.04 110.895 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 78.7 m80 . . . . . 0 C--N 1.294 -1.838 0 N-CA-C 107.095 -1.446 . . . . 61.15 107.095 179.333 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.455 -2.71 0 N-CA-C 107.89 -1.152 . . . . 52.12 107.89 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 142' ' ' ARG . . . . . 0.523 ' HG2' ' H ' ' B' ' 143' ' ' THR . 36.4 ttt180 -162.03 177.09 10.07 Favored 'General case' 0 N--CA 1.395 -3.191 0 N-CA-C 106.36 -1.719 . . . . 73.31 106.36 -173.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.523 ' H ' ' HG2' ' B' ' 142' ' ' ARG . 33.4 p -67.24 178.81 1.37 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.783 1.233 . . . . 64.2 110.363 176.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 144' ' ' ARG . . . . . 0.404 ' HD2' ' OD1' ' B' ' 147' ' ' ASN . 34.8 mtt180 -152.12 151.3 30.89 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.146 -0.687 . . . . 73.02 109.146 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -85.28 175.1 9.12 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.018 -0.992 . . . . 64.22 108.962 170.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . 0.255 3.6 mpt_? 65.33 14.44 9.43 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.53 1.132 . . . . 54.4 113.617 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 147' ' ' ASN . . . . . 0.472 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.2 OUTLIER -155.29 163.87 39.55 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 107.988 -1.116 . . . . 73.54 107.988 173.494 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 334' ' ' ALA . 15.3 pt-20 -85.56 156.61 20.67 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.733 -0.839 . . . . 72.44 108.733 176.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 49.0 m -144.17 141.0 29.68 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.9 -0.5 . . . . 52.41 110.265 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 150' ' ' GLN . . . . . 0.486 ' HG2' ' OG ' ' A' ' 332' ' ' SER . 77.7 mt-30 -85.35 149.22 25.6 Favored 'General case' 0 CA--C 1.454 -2.742 0 CA-C-O 121.445 0.64 . . . . 63.33 111.631 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . 0.272 22.0 m . . . . . 1 N--CA 1.374 -4.253 0 CA-C-O 117.453 -1.261 . . . . 73.44 110.443 174.59 . . . . . . . . 2 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 CA--C 1.494 -1.193 0 N-CA-C 106.559 -1.645 . . . . 75.23 106.559 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.429 1.8 pm0 -114.61 134.4 55.09 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 116.319 1.97 . . . . 74.52 116.319 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 73.7 mt -124.43 112.88 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-N 112.573 -2.103 . . . . 71.41 109.186 -173.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -79.66 124.97 29.05 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.416 -1.327 . . . . 70.34 107.416 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 45.2 mt -114.48 144.33 43.51 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.072 -1.084 . . . . 75.02 108.072 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 396' ' ' ASP . 54.3 mt -105.86 110.79 32.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 108.504 -0.925 . . . . 63.14 108.504 171.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.685 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 9.6 tmtt? -55.68 158.78 3.33 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 124.568 1.168 . . . . 64.12 111.601 177.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -144.37 -166.66 11.59 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 111.435 -0.666 . . . . 60.41 111.435 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.81 -15.08 46.22 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 123.324 2.683 . . . . 74.22 112.991 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 355' ' ' GLU . 37.0 ttpt -112.67 19.58 17.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.048 0.928 . . . . 74.33 109.248 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.92 -127.3 8.0 Favored Glycine 0 CA--C 1.497 -1.032 0 CA-C-N 114.994 -1.003 . . . . 54.42 111.31 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.537 ' HB2' HG23 ' B' ' 151' ' ' VAL . 4.0 mp -104.89 -22.72 13.11 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.224 -1.028 . . . . 73.52 108.224 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 73.72 50.98 9.93 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 114.807 -1.088 . . . . 63.33 115.606 171.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -154.43 149.79 27.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.442 -0.577 . . . . 65.25 109.442 172.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 7.5 m -105.01 128.3 53.25 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.95 0.405 . . . . 74.53 109.919 -175.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.404 ' HB ' HG23 ' A' ' 348' ' ' ILE . 30.3 pt -122.82 151.58 27.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.596 -0.729 . . . . 73.11 111.03 -175.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -140.9 137.16 32.97 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 105.55 -2.018 . . . . 72.42 105.55 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 347' ' ' SER . . . 147.45 162.54 10.07 Favored Glycine 0 C--N 1.281 -2.49 0 N-CA-C 109.771 -1.332 . . . . 64.5 109.771 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.53 177.34 14.88 Favored Glycine 0 C--N 1.284 -2.345 0 N-CA-C 108.718 -1.753 . . . . 34.13 108.718 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 99.2 t -55.8 108.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 117.522 0.661 . . . . 73.2 109.971 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 86.45 -11.1 64.53 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.648 -0.706 . . . . 71.33 112.712 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' B' ' 145' ' ' GLN . 0.2 OUTLIER -106.39 9.74 31.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.051 -1.463 . . . . 63.21 107.051 179.162 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.95 121.66 4.97 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.939 1.296 . . . . 72.55 111.969 -175.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -82.28 -27.03 32.61 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.942 -1.026 . . . . 60.43 109.132 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.619 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 2.9 mp -116.52 131.48 23.84 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 106.779 -1.563 . . . . 75.2 106.779 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.53 107.01 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.571 2.18 . . . . 71.34 112.909 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 102.22 0.91 51.02 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.621 -0.718 . . . . 75.11 112.861 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.619 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 22.0 t70 -129.67 101.38 5.88 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.398 0.618 . . . . 72.45 109.617 -177.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.418 ' HB2' ' OE2' ' A' ' 381' ' ' GLU . 32.6 m-80 -87.1 38.01 0.79 Allowed 'General case' 0 CA--C 1.5 -0.96 0 O-C-N 121.556 -0.715 . . . . 74.1 110.684 -174.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.487 ' O ' ' HA3' ' A' ' 335' ' ' GLY . 14.3 m -86.3 157.43 19.91 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.703 0.763 . . . . 72.31 111.202 -176.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.404 HG23 ' HB ' ' A' ' 333' ' ' ILE . 38.4 mm -75.63 122.82 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.563 0 N-CA-C 106.606 -1.627 . . . . 74.14 106.606 173.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 342' ' ' ILE . 3.5 t80 -124.0 133.78 53.6 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 108.319 -0.993 . . . . 72.23 108.319 -173.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.412 HG21 HD21 ' A' ' 365' ' ' LEU . 43.9 t -74.82 109.78 8.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.851 -0.613 . . . . 71.4 109.581 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.564 ' O ' ' HD2' ' A' ' 352' ' ' LYS . 8.6 m -90.78 -36.73 14.1 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.975 -0.557 . . . . 74.44 109.976 -178.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.564 ' HD2' ' O ' ' A' ' 351' ' ' THR . 1.2 mptm? -144.6 156.46 44.14 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.099 -0.704 . . . . 55.35 109.099 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 71.6 mt -125.35 129.51 73.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 106.284 -1.747 . . . . 64.31 106.284 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 47.2 mm -85.64 141.83 13.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 123.525 0.516 . . . . 65.32 110.186 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 327' ' ' LYS . 0.9 OUTLIER -57.03 120.87 8.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.286 1.034 . . . . 72.14 112.584 -174.528 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 72.59 14.49 77.68 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 115.281 -0.872 . . . . 52.1 112.97 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -73.54 168.42 53.95 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.213 -1.155 . . . . 43.24 110.213 176.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -58.76 -39.11 80.03 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 117.312 0.556 . . . . 63.43 110.346 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.61 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -72.58 -15.16 61.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.225 0.536 . . . . 52.05 111.94 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -95.19 -23.56 17.22 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.959 -0.756 . . . . 74.45 108.959 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 4.0 tmmt? -95.76 -60.16 1.71 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.649 0.738 . . . . 73.32 111.062 -175.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -86.94 -31.14 20.82 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.336 1.065 . . . . 74.31 109.426 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.786 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -53.61 -50.41 53.66 Favored Glycine 0 CA--C 1.481 -2.072 0 N-CA-C 119.135 2.414 . . . . 43.41 119.135 -167.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.786 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 43.8 34.17 0.83 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.253 1.025 . . . . 64.23 109.676 -167.688 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 365' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 350' ' ' VAL . 21.7 tp -92.2 158.27 16.25 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 113.547 -1.66 . . . . 53.14 109.752 -169.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -117.07 144.3 44.8 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.726 0.774 . . . . 71.1 110.845 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 71.0 mt -65.85 119.99 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 106.108 -1.812 . . . . 63.02 106.108 167.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.416 ' HA2' ' CE2' ' A' ' 349' ' ' TYR . . . 115.46 3.45 20.72 Favored Glycine 0 C--N 1.295 -1.699 0 C-N-CA 119.669 -1.253 . . . . 50.24 112.16 -173.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 7.2 m-20 -75.8 137.19 40.36 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 113.139 0.792 . . . . 60.12 113.139 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -100.47 115.28 29.71 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.13 -1.063 . . . . 71.53 108.13 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 60.5 mt -84.67 115.51 22.7 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.236 0.541 . . . . 63.33 110.246 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.77 -37.11 27.68 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.837 -1.529 . . . . 63.2 107.695 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 401' ' ' LYS . . . -163.34 157.25 19.85 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.79 -0.641 . . . . 71.22 111.216 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.473 HG12 HD11 ' A' ' 379' ' ' LEU . 14.5 p -133.88 122.93 43.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 107.569 -1.271 . . . . 45.22 107.569 172.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' ASN . . . . . 0.548 HD21 HG22 ' A' ' 394' ' ' THR . 89.3 m-20 62.2 29.32 17.44 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 124.036 1.874 . . . . 55.53 108.853 -174.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 67.21 10.42 7.7 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 109.515 -3.493 . . . . 73.13 113.479 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.9 t -79.94 124.49 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 106.576 -1.639 . . . . 74.13 106.576 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -64.35 127.51 31.79 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.009 0.744 . . . . 75.5 113.009 -175.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.473 HD11 HG12 ' A' ' 374' ' ' VAL . 6.9 mp -106.31 6.71 30.83 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 123.865 0.866 . . . . 74.22 110.973 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -76.91 122.97 25.6 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.16 -1.792 . . . . 52.13 106.16 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' GLU . . . . . 0.418 ' OE2' ' HB2' ' A' ' 346' ' ' ASN 0.32 1.5 mp0 48.52 83.09 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 116.062 1.875 . . . . 73.25 116.062 -172.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 15.8 m -149.85 157.82 6.12 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-N 113.428 -1.714 . . . . 53.55 107.735 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.8 m -81.16 140.73 34.81 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.424 -0.954 . . . . 73.41 108.424 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.561 ' O ' HG23 ' A' ' 388' ' ' VAL . 82.6 t60 -50.93 -46.18 60.77 Favored 'General case' 0 C--O 1.207 -1.168 0 N-CA-C 112.993 0.738 . . . . 74.13 112.993 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.43 ' HA ' ' OG1' ' B' ' 143' ' ' THR . 4.0 tp10 -59.24 -40.45 85.98 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.966 0.888 . . . . 63.42 109.677 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.0 tt0 -72.52 -39.76 67.33 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.074 -1.421 . . . . 72.2 108.856 -173.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.414 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -71.35 -46.17 61.17 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.449 -1.251 . . . . 44.13 110.997 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 384' ' ' HIS . 57.9 t -59.98 -41.64 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 109.872 -0.418 . . . . 71.42 109.872 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 62.2 m -58.9 -35.63 73.35 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 123.443 0.464 . . . . 73.51 110.478 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.31 -34.54 78.57 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 122.075 -0.391 . . . . 71.13 110.82 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.9 mp -80.74 -30.3 36.21 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 120.426 -0.509 . . . . 72.03 110.943 176.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.453 ' HD2' ' OE ' ' B' ' 141' ' ' PCA . 51.7 mttm -73.91 -23.54 59.56 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.23 0.456 . . . . 74.2 112.23 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -77.69 49.41 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.371 0.605 . . . . 71.03 110.562 175.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.548 HG22 HD21 ' A' ' 375' ' ' ASN . 21.5 p -124.77 142.35 51.48 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 109.472 -0.566 . . . . 74.55 109.472 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 62.1 m -144.48 99.09 3.31 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 122.571 1.177 . . . . 72.01 112.076 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.685 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 7.7 m-20 65.58 12.36 8.16 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 111.023 -2.808 . . . . 73.03 112.819 168.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -160.76 129.37 4.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.332 -1.729 . . . . 74.45 106.332 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.7 t -139.53 141.74 34.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 107.668 -1.234 . . . . 52.2 107.668 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -118.5 95.93 5.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.756 -1.572 . . . . 73.1 106.756 174.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.58 130.72 35.85 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 122.785 0.434 . . . . 53.35 110.571 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 373' ' ' ALA . 22.7 ttmm -116.21 108.97 16.8 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.178 -1.045 . . . . 72.51 108.178 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 369' ' ' ASP . 7.9 p -113.38 155.39 14.6 Favored 'Isoleucine or valine' 0 C--O 1.269 2.113 0 CA-C-N 116.035 -0.53 . . . . 65.54 110.449 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -136.62 157.58 46.44 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.422 -1.325 . . . . 72.22 107.422 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 9.7 mmpt? -88.59 153.39 50.3 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 107.302 -1.37 . . . . 70.12 107.302 176.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 405' ' ' PRO . . . . . 0.456 ' HG3' ' OH ' ' A' ' 349' ' ' TYR . 29.2 Cg_endo -64.42 120.09 7.3 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 108.171 -1.511 . . . . 63.1 108.171 173.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 12.7 m -67.06 84.37 0.13 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.997 0.903 . . . . 73.34 112.668 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -168.14 165.09 38.52 Favored Glycine 0 N--CA 1.414 -2.788 0 N-CA-C 108.128 -1.989 . . . . 44.04 108.128 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 12.1 m -83.48 22.65 1.02 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 117.958 0.879 . . . . 41.31 110.682 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -128.58 26.51 5.62 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.14 -1.059 . . . . 65.22 108.14 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -87.76 144.76 26.45 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.744 -0.662 . . . . 75.02 112.082 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 . . . . . 0 C--N 1.297 -1.677 0 N-CA-C 106.116 -1.809 . . . . 74.04 106.116 171.813 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 141' ' ' PCA . . . . . 0.47 ' N ' ' HG1' ' B' ' 143' ' ' THR . . . . . . . . 0 CA--C 1.48 -1.716 0 CA-C-O 121.299 0.571 . . . . 73.41 110.072 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 68.97 18.36 8.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 113.305 -1.771 . . . . 74.02 109.085 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.479 ' HB ' ' CD2' ' A' ' 384' ' ' HIS . 4.8 p -97.77 122.43 40.85 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 114.746 -1.115 . . . . 65.12 109.533 -176.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -153.8 171.67 18.55 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 107.99 -1.115 . . . . 73.31 107.99 -173.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' GLN . . . . . 0.506 ' HA ' ' OD1' ' A' ' 339' ' ' ASN . 20.9 mp0 -53.97 147.4 12.45 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.955 1.095 . . . . 74.33 113.955 -172.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 67.04 28.66 8.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 113.424 -1.716 . . . . 73.4 113.765 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 147' ' ' ASN . . . . . 0.513 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.1 OUTLIER -143.19 152.55 41.89 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 118.297 -1.361 . . . . 62.03 111.991 173.038 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -96.33 145.69 25.39 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.668 -1.234 . . . . 75.44 107.668 172.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 65.7 m -147.4 144.23 28.53 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.992 -0.443 . . . . 74.34 110.011 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -76.34 136.08 39.55 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.096 0.474 . . . . 73.31 110.593 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.537 HG23 ' HB2' ' A' ' 329' ' ' LEU . 4.3 m . . . . . 0 C--N 1.292 -1.912 0 CA-C-N 115.59 -0.732 . . . . 72.12 110.309 173.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 C--O 1.202 -1.442 0 N-CA-C 106.242 -1.762 . . . . 53.21 106.242 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.509 ' HB3' ' HG2' ' A' ' 401' ' ' LYS 0.343 1.8 pm0 -118.24 136.94 53.36 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 114.919 1.452 . . . . 64.42 114.919 -174.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 363' ' ' GLY . 75.3 mt -126.23 114.38 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 CA-C-N 113.214 -1.812 . . . . 73.25 110.048 -172.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.478 ' HG3' ' CZ ' ' A' ' 397' ' ' PHE . 0.9 OUTLIER -79.71 136.43 36.77 Favored 'General case' 0 C--N 1.279 -2.498 0 N-CA-C 107.718 -1.216 . . . . 63.2 107.718 172.046 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.59 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 97.0 mt -131.63 157.26 44.15 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.581 -0.525 . . . . 73.12 109.581 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 324' ' ' LYS . 2.4 mp -106.27 140.97 22.65 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 N-CA-C 106.006 -1.85 . . . . 74.2 106.006 171.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.521 ' HG2' ' H ' ' A' ' 325' ' ' GLY . 1.3 ttpm? -75.36 177.85 6.3 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.007 -1.108 . . . . 50.34 108.007 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.521 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -160.91 -172.26 27.97 Favored Glycine 0 C--N 1.284 -2.325 0 N-CA-C 110.848 -0.901 . . . . 73.53 110.848 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.12 -13.95 28.74 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.879 2.386 . . . . 73.52 112.064 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.433 ' HB3' ' NZ ' ' A' ' 327' ' ' LYS . 9.0 mtpm? -115.18 20.08 15.2 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 115.973 -0.558 . . . . 64.13 110.996 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.44 -127.12 7.96 Favored Glycine 0 C--N 1.299 -1.492 0 N-CA-C 110.643 -0.983 . . . . 61.1 110.643 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.441 ' HB2' HG23 ' B' ' 151' ' ' VAL . 4.9 mp -105.83 -27.19 11.4 Favored 'General case' 0 C--O 1.268 2.054 0 N-CA-C 108.235 -1.024 . . . . 61.0 108.235 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 86.08 49.45 4.24 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 114.054 -1.43 . . . . 34.15 115.695 173.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -155.07 145.06 21.67 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 117.097 0.449 . . . . 73.32 111.144 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 14.5 m -96.34 126.38 41.5 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 124.005 0.922 . . . . 65.01 109.233 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 28.0 pt -117.11 144.37 25.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 116.28 -0.418 . . . . 72.12 111.377 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' B' ' 148' ' ' GLU . . . -130.99 136.16 48.27 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.414 -1.698 . . . . 64.33 106.414 174.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 145.12 161.45 9.06 Favored Glycine 0 C--N 1.268 -3.241 0 N-CA-C 109.685 -1.366 . . . . 54.03 109.685 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.82 173.49 13.22 Favored Glycine 0 N--CA 1.418 -2.512 0 N-CA-C 107.245 -2.342 . . . . 63.1 107.245 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 66.3 t -53.11 107.49 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 118.137 0.969 . . . . 72.24 110.554 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.45 -18.47 57.34 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.109 -0.951 . . . . 62.22 112.586 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.512 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 60.1 t30 -106.5 18.2 22.27 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.655 -0.498 . . . . 74.22 109.655 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.4 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -51.68 120.09 4.86 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.828 -0.624 . . . . 75.13 111.297 -178.33 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -76.96 -40.24 47.63 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.431 -0.804 . . . . 52.23 109.803 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.2 mm -104.29 120.72 49.85 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 115.736 -0.665 . . . . 71.03 109.715 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.6 106.61 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 123.28 2.653 . . . . 64.11 112.349 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 107.96 -3.42 33.72 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 115.475 -0.784 . . . . 63.4 111.881 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -132.38 98.0 4.26 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.569 -0.9 . . . . 64.24 108.569 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 64.4 t30 -83.37 38.05 0.59 Allowed 'General case' 0 CA--C 1.553 1.068 0 CA-C-O 121.953 0.882 . . . . 75.44 111.89 -170.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 73.7 m -102.12 178.46 4.6 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.682 -0.69 . . . . 72.31 112.765 -178.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 31.3 mm -88.94 129.37 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 114.969 -1.014 . . . . 51.22 108.644 -178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.555 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 35.6 m-85 -124.06 140.43 52.98 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.195 0.521 . . . . 74.2 111.691 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.415 HG21 HD21 ' A' ' 365' ' ' LEU . 42.7 t -78.94 111.0 15.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.132 -0.94 . . . . 60.31 109.243 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 25.7 m -88.28 -30.46 19.62 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.198 0.523 . . . . 74.03 110.882 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.428 ' HD3' ' N ' ' A' ' 353' ' ' ILE . 9.1 tmtt? -155.36 137.83 15.0 Favored 'General case' 0 C--O 1.203 -1.385 0 N-CA-C 108.284 -1.006 . . . . 71.23 108.284 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.428 ' N ' ' HD3' ' A' ' 352' ' ' LYS . 74.1 mt -109.17 129.73 63.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.632 -1.247 . . . . 65.41 107.632 174.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 49.7 mm -77.47 126.33 37.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.358 0.599 . . . . 73.45 110.037 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.561 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.4 pm0 -62.31 127.04 29.45 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 114.39 -1.277 . . . . 75.31 110.739 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.56 -19.56 53.72 Favored Glycine 0 N--CA 1.426 -1.994 0 CA-C-N 115.021 -0.99 . . . . 62.32 112.533 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -68.19 167.03 43.82 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 114.278 0.471 . . . . 64.05 114.278 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -61.26 -41.99 97.85 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.313 0.645 . . . . 52.24 111.132 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.425 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.11 -7.74 54.61 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 119.692 -0.803 . . . . 61.44 111.954 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -94.09 -30.53 14.62 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.928 -0.767 . . . . 73.4 108.928 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -89.65 -59.65 2.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.028 -0.533 . . . . 72.32 111.671 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -87.14 -38.96 15.96 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 108.608 -0.886 . . . . 54.21 108.608 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.56 ' HA2' HD21 ' A' ' 322' ' ' LEU . . . -44.68 -31.25 2.51 Favored Glycine 0 C--O 1.207 -1.57 0 N-CA-C 119.195 2.438 . . . . 42.54 119.195 -167.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.538 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 41.37 32.21 0.2 Allowed 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 118.803 1.302 . . . . 75.31 111.377 -174.669 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 365' ' ' LEU . . . . . 0.415 HD21 HG21 ' A' ' 350' ' ' VAL . 43.7 tp -98.11 155.07 17.32 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.551 -1.204 . . . . 73.43 109.474 -170.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -125.08 150.98 46.27 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.344 0.592 . . . . 75.54 111.267 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 75.9 mt -65.95 122.98 17.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.297 -1.001 . . . . 64.24 108.297 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 113.25 -2.3 25.29 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.686 -0.769 . . . . 22.34 112.126 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 3.5 m-20 -72.13 136.68 46.59 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 112.83 0.678 . . . . 73.44 112.83 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.627 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 33.9 tttp -96.2 115.28 27.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.213 1.405 . . . . 74.12 109.648 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 68.3 mt -85.21 118.92 25.05 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.156 0.503 . . . . 63.12 109.693 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.3 tt -87.61 -39.38 15.11 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.074 -1.421 . . . . 62.01 108.093 -176.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -160.77 156.09 24.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.05 -0.523 . . . . 64.33 111.095 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.474 HG12 HD11 ' A' ' 379' ' ' LEU . 11.1 p -134.74 123.33 41.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 108.139 -1.06 . . . . 73.55 108.139 173.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' ASN . . . . . 0.573 HD21 HG22 ' A' ' 394' ' ' THR . 54.5 m-20 62.32 29.55 17.32 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 123.516 1.627 . . . . 74.4 108.282 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 67.0 18.87 10.61 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 110.449 -3.068 . . . . 72.52 112.331 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 50.7 t -88.91 128.22 41.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 106.505 -1.665 . . . . 75.12 106.505 172.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.9 p -64.4 124.75 22.58 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 113.126 0.788 . . . . 74.51 113.126 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.474 HD11 HG12 ' A' ' 374' ' ' VAL . 7.5 mp -108.27 -2.48 19.24 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.561 0.745 . . . . 70.42 111.224 177.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -68.2 107.6 2.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.952 -0.567 . . . . 64.0 109.605 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 60.66 74.91 0.43 Allowed 'General case' 0 CA--C 1.545 0.775 0 O-C-N 124.619 1.199 . . . . 72.52 113.296 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 387' ' ' ALA . 24.1 m -135.05 167.09 26.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.183 -1.414 . . . . 72.33 107.183 176.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 51.6 p -79.73 141.22 36.56 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 118.918 0.781 . . . . 63.32 110.325 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.49 ' O ' HG23 ' A' ' 388' ' ' VAL . 82.7 t60 -45.56 -49.27 14.12 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.672 0.99 . . . . 71.21 113.672 -174.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.508 ' HA ' ' OG1' ' B' ' 143' ' ' THR . 10.0 tp10 -61.33 -38.78 88.13 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.212 0.53 . . . . 73.53 111.54 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.0 tt0 -70.46 -35.05 73.1 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.511 -0.922 . . . . 75.3 108.511 -177.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.435 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -70.54 -53.91 14.24 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 114.441 -1.254 . . . . 61.22 110.582 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.569 HG11 HG21 ' B' ' 143' ' ' THR . 44.5 t -59.54 -43.36 90.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 C-N-CA 121.147 -0.221 . . . . 61.15 110.57 -177.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 53.8 m -62.04 -30.32 70.89 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 111.953 0.353 . . . . 75.11 111.953 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.13 -35.08 78.98 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 122.124 -0.36 . . . . 53.53 110.331 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.7 mp -80.57 -28.61 37.15 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 120.394 -0.523 . . . . 71.14 110.783 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.427 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 54.3 mttm -74.31 -24.23 59.19 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.576 -0.45 . . . . 73.14 111.536 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -82.16 65.2 7.18 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.347 1.07 . . . . 71.52 110.19 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.573 HG22 HD21 ' A' ' 375' ' ' ASN . 13.3 p -130.65 145.63 51.96 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 113.987 -1.46 . . . . 71.31 107.679 177.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 43.8 m -141.77 91.28 2.35 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 122.568 1.175 . . . . 62.34 111.25 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.515 ' HA ' ' H ' ' A' ' 324' ' ' LYS 0.343 12.4 m-20 65.16 4.79 2.72 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 111.438 -2.619 . . . . 60.04 115.616 172.085 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 397' ' ' PHE . . . . . 0.478 ' CZ ' ' HG3' ' A' ' 321' ' ' LYS . 37.6 t80 -151.85 134.52 15.5 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 106.368 -1.716 . . . . 73.21 106.368 171.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.59 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.8 t -138.29 145.69 28.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.812 -1.181 . . . . 72.55 107.812 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -126.0 96.1 4.63 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.027 -1.101 . . . . 73.44 108.027 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 tt -92.63 132.84 36.54 Favored 'General case' 0 C--N 1.277 -2.546 0 C-N-CA 123.031 0.532 . . . . 75.04 110.739 -174.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.509 ' HG2' ' HB3' ' A' ' 319' ' ' GLU . 65.8 mttm -114.31 118.72 34.7 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.152 -0.684 . . . . 61.3 109.152 174.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 369' ' ' ASP . 3.6 p -118.58 149.04 21.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 CA-C-N 115.048 -0.978 . . . . 73.01 109.979 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.627 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.45 159.32 42.15 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 125.119 1.368 . . . . 63.0 107.337 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -84.93 154.43 60.96 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 109.267 -0.642 . . . . 52.12 109.267 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -46.55 119.33 3.11 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 124.204 3.269 . . . . 75.31 113.933 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 16.5 p -95.21 -12.03 27.02 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.415 -0.811 . . . . 73.23 111.963 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -102.47 22.52 37.23 Favored Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 120.713 -0.756 . . . . 32.11 111.735 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 13.9 t -167.96 -164.72 0.57 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.521 -1.659 . . . . 63.42 106.521 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -82.44 144.72 30.28 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.606 -1.257 . . . . 72.32 107.606 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -74.11 144.59 44.88 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.636 0.255 . . . . 70.14 110.644 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 . . . . . 0 C--N 1.297 -1.711 0 N-CA-C 106.76 -1.57 . . . . 71.32 106.76 175.358 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 120.959 0.409 . . . . 51.22 110.139 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -139.14 28.91 2.27 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.085 -1.08 . . . . 74.41 108.085 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.569 HG21 HG11 ' A' ' 388' ' ' VAL . 6.7 p -99.17 155.78 17.3 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 115.83 -0.623 . . . . 65.33 111.705 -175.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -153.8 134.95 14.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.051 -1.833 . . . . 64.24 106.051 -169.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' GLN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 339' ' ' ASN . 13.3 pm0 -65.52 152.02 45.02 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.608 0.966 . . . . 54.22 113.608 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 146' ' ' ARG . . . . . 0.481 ' H ' ' CG ' ' A' ' 339' ' ' ASN 0.275 64.3 mtm180 67.67 59.53 0.48 Allowed 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 126.789 2.036 . . . . 63.4 112.984 -174.208 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 173.93 157.8 0.14 Allowed 'General case' 0 C--O 1.245 0.833 0 CA-C-N 110.966 -2.833 . . . . 74.14 107.494 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 334' ' ' ALA . 0.9 OUTLIER -95.96 157.18 16.01 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.232 0.539 . . . . 74.31 110.948 174.487 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 51.6 m -147.84 146.85 29.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.726 -0.842 . . . . 74.41 108.726 174.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 1.2 tt0 -79.79 137.84 37.09 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 120.996 0.427 . . . . 74.42 110.952 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 329' ' ' LEU . 15.7 m . . . . . 0 N--CA 1.426 -1.633 0 CA-C-N 115.711 -0.677 . . . . 74.21 110.767 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' MET . . . . . 0.605 ' SD ' ' HE3' ' A' ' 404' ' ' LYS . 27.5 ttt . . . . . 0 CA--C 1.495 -1.168 0 N-CA-C 107.041 -1.466 . . . . 63.34 107.041 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.325 2.3 pm0 -115.87 137.56 51.99 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-O 122.202 1.001 . . . . 74.21 113.658 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 363' ' ' GLY . 70.2 mt -128.62 130.49 68.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 113.225 -1.807 . . . . 63.22 108.155 -169.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -108.07 107.66 18.42 Favored 'General case' 0 N--CA 1.411 -2.387 0 N-CA-C 108.348 -0.982 . . . . 73.13 108.348 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.55 HD21 ' HA2' ' A' ' 363' ' ' GLY . 93.3 mt -105.65 160.07 15.48 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.346 -0.843 . . . . 74.44 110.055 -176.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.2 113.41 42.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 N-CA-C 108.148 -1.056 . . . . 72.54 108.148 171.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.609 ' HB3' ' H ' ' A' ' 396' ' ' ASP . 0.0 OUTLIER -67.13 140.87 57.56 Favored 'General case' 0 C--O 1.207 -1.168 0 N-CA-C 106.953 -1.499 . . . . 70.23 106.953 174.755 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.497 ' N ' ' HD2' ' A' ' 324' ' ' LYS . . . -142.31 -161.2 8.67 Favored Glycine 0 C--N 1.27 -3.099 0 CA-C-O 119.946 -0.363 . . . . 73.23 112.498 -171.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.94 -12.92 37.43 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 123.829 3.02 . . . . 51.23 113.507 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -109.43 5.96 23.83 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.175 0.988 . . . . 71.41 108.932 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.99 -121.35 5.49 Favored Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 108.965 -1.654 . . . . 63.54 108.965 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.79 -26.2 11.38 Favored 'General case' 0 C--O 1.266 1.952 0 N-CA-C 107.844 -1.169 . . . . 75.22 107.844 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.41 43.49 6.54 Favored Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 113.707 -1.588 . . . . 63.11 114.675 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -155.22 151.1 27.72 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 117.056 0.428 . . . . 72.11 110.286 174.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 29.2 m -106.28 129.58 54.28 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 124.145 0.978 . . . . 74.44 109.578 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 14.8 pt -114.32 156.63 15.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.776 -0.647 . . . . 74.25 110.666 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -143.68 130.02 19.89 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.896 -1.89 . . . . 61.31 105.896 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 149.67 153.21 5.98 Favored Glycine 0 C--N 1.27 -3.094 0 N-CA-C 109.012 -1.635 . . . . 54.45 109.012 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.82 173.1 13.09 Favored Glycine 0 C--N 1.283 -2.39 0 N-CA-C 106.558 -2.617 . . . . 62.02 106.558 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.46 ' HA ' HD21 ' A' ' 346' ' ' ASN . 61.8 t -45.75 106.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 118.597 1.198 . . . . 74.34 111.705 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 93.01 -23.92 27.05 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.541 -0.754 . . . . 64.0 112.27 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.482 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 32.7 t-20 -97.78 19.41 13.75 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.353 -0.98 . . . . 70.31 108.353 -177.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.1 118.7 3.09 Favored 'General case' 0 C--O 1.257 1.493 0 CA-C-O 121.263 0.554 . . . . 62.31 110.301 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -77.75 -43.59 30.35 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.075 -0.966 . . . . 73.44 109.052 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 39.3 mm -103.65 131.25 22.21 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 108.119 -1.067 . . . . 74.12 108.119 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.1 110.46 0.48 Allowed 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 123.173 2.582 . . . . 60.11 113.551 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.86 -3.6 65.11 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.407 -0.815 . . . . 24.21 112.189 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 29.2 t0 -119.64 99.69 6.81 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.716 -0.846 . . . . 72.14 108.716 -176.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.46 HD21 ' HA ' ' A' ' 337' ' ' VAL . 51.7 t30 -84.0 26.04 0.77 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.532 0.682 . . . . 73.22 110.845 -171.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 20.0 m -88.5 172.29 9.46 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.369 0.604 . . . . 71.34 111.762 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 370' ' ' LYS . 18.3 mm -88.28 122.76 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 115.185 -0.916 . . . . 71.13 108.575 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 51.2 m-85 -123.62 131.93 53.74 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.031 0.443 . . . . 62.52 110.748 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.476 HG21 HD11 ' A' ' 365' ' ' LEU . 47.9 t -70.64 120.75 19.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.888 -0.597 . . . . 71.42 109.4 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 22.4 m -101.03 -23.16 14.56 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.102 0.477 . . . . 73.34 111.353 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -155.55 137.03 14.09 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 107.618 -1.253 . . . . 70.03 107.618 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' A' ' 360' ' ' HIS . 73.4 mt -108.94 126.03 65.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.099 -1.445 . . . . 71.4 107.099 172.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 49.7 mm -74.48 134.9 28.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.293 0.568 . . . . 54.1 109.853 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.569 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.4 pm0 -62.39 120.84 11.81 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-O 122.45 1.119 . . . . 72.15 111.588 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 79.44 18.63 73.31 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-N 114.284 -1.325 . . . . 71.11 111.484 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.78 162.75 52.13 Favored Glycine 0 C--O 1.25 1.143 0 N-CA-C 111.783 -0.527 . . . . 71.02 111.783 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.61 98.97 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.892 -0.781 . . . . 75.33 108.892 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.528 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.64 -9.29 58.46 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.475 -0.89 . . . . 70.51 111.917 177.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 360' ' ' HIS . . . . . 0.445 ' HB2' HG22 ' A' ' 353' ' ' ILE . 31.4 t-80 -88.85 -29.19 19.86 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.596 -0.89 . . . . 74.24 108.596 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.608 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 1.1 mmpm? -95.04 -57.65 2.37 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 113.13 0.789 . . . . 71.21 113.13 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -85.68 -43.05 13.75 Favored 'General case' 0 CA--C 1.457 -2.628 0 O-C-N 123.771 0.669 . . . . 72.11 110.647 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.576 ' O ' HD13 ' A' ' 320' ' ' ILE . . . -42.74 -25.5 0.33 Allowed Glycine 0 C--O 1.203 -1.79 0 N-CA-C 119.379 2.512 . . . . 73.31 119.379 -163.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.468 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.59 34.45 0.56 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 119.133 1.467 . . . . 71.21 111.265 -178.588 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 365' ' ' LEU . . . . . 0.553 HD13 ' N ' ' A' ' 366' ' ' GLN . 2.6 tm? -109.36 148.6 30.81 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.163 -1.38 . . . . 65.41 107.786 -170.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' GLN . . . . . 0.553 ' N ' HD13 ' A' ' 365' ' ' LEU . 26.3 mp0 -117.06 142.06 47.46 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.796 -0.446 . . . . 75.44 109.796 -178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.76 121.3 8.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.111 -1.07 . . . . 64.3 108.111 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.35 -4.45 21.76 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 111.426 -0.67 . . . . 54.42 111.426 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.574 ' HB3' HG21 ' A' ' 402' ' ' VAL . 56.3 m-20 -75.63 136.28 40.45 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 113.193 0.812 . . . . 71.52 113.193 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 36.4 tttp -88.8 119.69 29.52 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 124.658 1.183 . . . . 74.13 111.135 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.41 124.84 32.46 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.885 -0.783 . . . . 75.33 108.885 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.482 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 5.3 tt -92.08 -40.16 11.22 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.336 -1.302 . . . . 74.22 107.965 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -159.86 160.94 34.27 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 116.017 -0.538 . . . . 71.32 111.733 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.557 HG12 HD11 ' A' ' 379' ' ' LEU . 13.9 p -133.55 117.33 27.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.413 -0.958 . . . . 74.25 108.413 171.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 58.54 36.17 25.04 Favored 'General case' 0 CA--C 1.485 -1.526 0 CA-C-O 123.4 1.571 . . . . 73.54 109.347 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 66.79 9.55 6.84 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 110.831 -2.895 . . . . 53.25 113.693 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.9 121.09 31.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.263 -1.754 . . . . 62.3 106.263 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.8 p -64.35 125.82 25.81 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 113.366 0.876 . . . . 74.41 113.366 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.557 HD11 HG12 ' A' ' 374' ' ' VAL . 7.1 mp -101.32 7.13 42.94 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.731 -1.122 . . . . 74.41 109.445 176.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.482 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 18.4 mm-40 -79.9 111.24 16.03 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.59 -1.186 . . . . 75.24 108.958 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 61.14 83.57 0.14 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.718 1.207 . . . . 72.33 112.232 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 19.7 m -153.58 165.21 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 125.563 1.545 . . . . 61.23 107.139 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.707 ' HB ' ' OE1' ' A' ' 386' ' ' GLU . 2.8 m -85.08 156.85 20.9 Favored 'General case' 0 C--O 1.258 1.539 0 N-CA-C 107.221 -1.4 . . . . 73.24 107.221 176.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.535 ' O ' HG23 ' A' ' 388' ' ' VAL . 85.7 t60 -57.13 -40.73 77.7 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.303 0.573 . . . . 72.34 109.988 -170.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -54.68 -46.64 74.1 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 114.187 -1.37 . . . . 71.31 113.871 177.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.707 ' OE1' ' HB ' ' A' ' 383' ' ' THR . 1.8 mp0 -71.72 -32.14 67.45 Favored 'General case' 0 CA--C 1.476 -1.872 0 CA-C-N 118.711 0.687 . . . . 73.32 109.423 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.6 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -64.46 -57.72 8.44 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 114.728 -1.124 . . . . 73.21 109.218 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 384' ' ' HIS . 21.7 t -61.35 -41.76 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 116.446 -0.343 . . . . 74.53 110.55 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 90.4 m -62.13 -34.35 76.2 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.071 -0.513 . . . . 62.44 111.433 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.08 80.05 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.522 -0.111 . . . . 71.5 110.859 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.1 mp -79.66 -32.47 41.55 Favored 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 119.217 -0.993 . . . . 61.35 110.777 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -65.21 -35.41 80.97 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 112.663 0.616 . . . . 71.42 112.663 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -83.57 62.08 6.62 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.803 0.811 . . . . 74.4 110.926 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.437 ' HB ' HG22 ' A' ' 398' ' ' VAL . 41.9 p -132.28 149.52 52.35 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 107.526 -1.287 . . . . 65.25 107.526 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' SER . . . . . 0.478 ' HA ' ' HE3' ' A' ' 324' ' ' LYS . 34.9 p -141.96 100.99 3.85 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 118.461 -1.296 . . . . 72.01 112.578 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.609 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 3.5 m-20 63.38 7.27 2.84 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 112.504 -2.135 . . . . 71.31 113.621 170.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -152.64 115.25 4.52 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 106.033 -1.84 . . . . 64.33 106.033 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 52.4 t -128.28 113.81 31.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 108.342 -0.984 . . . . 74.0 108.342 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -95.15 95.53 8.61 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.393 -1.336 . . . . 72.01 107.393 174.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.3 tt -89.97 139.02 31.01 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 116.147 -0.479 . . . . 72.32 109.748 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 40.6 tttp -126.84 111.7 14.48 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 108.403 -0.962 . . . . 73.25 108.403 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.574 HG21 ' HB3' ' A' ' 369' ' ' ASP . 2.1 p -115.05 145.94 20.13 Favored 'Isoleucine or valine' 0 C--O 1.266 1.96 0 C-N-CA 123.732 0.813 . . . . 61.13 110.597 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.74 147.77 46.89 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 106.266 -1.753 . . . . 75.51 106.266 174.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.605 ' HE3' ' SD ' ' A' ' 318' ' ' MET . 0.0 OUTLIER -95.82 156.0 37.78 Favored Pre-proline 0 C--N 1.293 -1.881 0 C-N-CA 119.774 -0.77 . . . . 61.35 109.102 178.686 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 405' ' ' PRO . . . . . 0.419 ' HG2' ' HB3' ' A' ' 410' ' ' HIS . 37.3 Cg_endo -71.31 63.78 2.76 Favored 'Trans proline' 0 CA--C 1.549 1.237 0 C-N-CA 122.096 1.864 . . . . 64.21 114.011 -176.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 26.7 m -85.32 88.19 7.47 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 107.755 -1.202 . . . . 25.32 107.755 177.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 134.96 -18.87 3.98 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 108.733 -1.747 . . . . 52.12 108.733 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 47.3 t -109.41 -169.61 1.51 Allowed 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 106.787 -1.56 . . . . 65.42 106.787 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -81.64 92.94 6.65 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.308 0.575 . . . . 52.13 111.11 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' HIS . . . . . 0.419 ' HB3' ' HG2' ' A' ' 405' ' ' PRO . 24.3 p-80 -95.08 142.04 28.0 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.628 -0.878 . . . . 71.42 108.628 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 . . . . . 0 C--N 1.296 -1.74 0 N-CA-C 103.598 -2.741 . . . . 75.31 103.598 -179.043 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.807 0 N-CA-C 108.101 -1.074 . . . . 73.32 108.101 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 142' ' ' ARG . . . . . 0.407 HH21 ' CD ' ' B' ' 148' ' ' GLU . 87.3 mtm-85 -92.76 20.61 6.32 Favored 'General case' 0 C--O 1.209 -1.045 0 O-C-N 123.398 0.436 . . . . 74.15 110.92 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 61.5 p -65.53 104.26 0.98 Allowed 'General case' 0 C--O 1.246 0.883 0 N-CA-C 109.331 -0.618 . . . . 63.23 109.331 -174.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' ARG . . . . . 0.537 ' HA ' ' HE ' ' B' ' 144' ' ' ARG . 0.3 OUTLIER -159.67 169.78 22.98 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 106.38 -1.711 . . . . 62.22 106.38 -174.147 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -85.05 154.27 22.19 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.625 -0.509 . . . . 70.33 109.625 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 66.02 13.29 9.0 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 125.748 1.619 . . . . 63.11 113.489 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' ASN . . . . . 0.469 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.2 OUTLIER -143.96 170.54 15.73 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.634 -0.427 . . . . 72.32 110.521 179.349 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.407 ' CD ' HH21 ' B' ' 142' ' ' ARG . 0.0 OUTLIER -95.51 166.62 11.77 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.185 0.517 . . . . 74.4 111.8 -177.451 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 40.7 m -146.06 123.97 12.01 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.736 -0.665 . . . . 75.05 109.608 166.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -68.25 130.14 42.02 Favored 'General case' 0 C--O 1.257 1.468 0 N-CA-C 108.563 -0.903 . . . . 60.25 108.563 172.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.434 HG11 ' CB ' ' A' ' 391' ' ' LEU . 5.3 t . . . . . 0 C--N 1.296 -1.726 0 CA-C-O 117.228 -1.368 . . . . 74.51 109.09 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 CA--C 1.485 -1.521 0 N-CA-C 106.309 -1.738 . . . . 75.3 106.309 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.477 2.0 pm0 -119.09 127.09 53.06 Favored 'General case' 0 N--CA 1.406 -2.641 0 N-CA-C 116.936 2.198 . . . . 63.1 116.936 -174.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.45 HG23 ' HD3' ' A' ' 364' ' ' LYS . 64.5 mt -102.54 106.17 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.623 0 CA-C-N 111.524 -2.58 . . . . 52.41 109.715 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.492 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 28.9 ttpt -80.81 110.72 16.59 Favored 'General case' 0 N--CA 1.41 -2.427 0 N-CA-C 106.319 -1.734 . . . . 65.31 106.319 170.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.461 ' HA ' ' OD2' ' A' ' 362' ' ' ASP . 0.6 OUTLIER -110.33 145.7 37.01 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 113.944 -1.48 . . . . 73.35 109.734 -171.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 39.0 mm -105.2 116.8 49.71 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-O 121.306 0.574 . . . . 74.54 110.606 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.696 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 9.7 tmtt? -65.89 156.78 32.38 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.948 -1.024 . . . . 72.34 110.783 175.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -140.44 -165.97 10.5 Favored Glycine 0 C--N 1.303 -1.284 0 N-CA-C 110.748 -0.941 . . . . 73.21 110.748 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.91 -21.51 64.0 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 122.877 2.385 . . . . 71.41 112.59 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -91.61 -9.97 42.18 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.132 0.968 . . . . 64.44 110.449 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 97.42 -112.76 4.54 Favored Glycine 0 C--N 1.272 -3.014 0 N-CA-C 108.381 -1.887 . . . . 30.41 108.381 -171.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.13 -35.64 6.26 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 117.89 0.845 . . . . 53.52 109.589 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 84.48 50.72 4.14 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.841 -1.171 . . . . 72.42 114.903 175.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 54.4 p90 -155.07 163.04 40.83 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 117.146 0.473 . . . . 73.31 110.239 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 66.2 m -108.78 132.72 53.7 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 109.757 -0.46 . . . . 73.01 109.757 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 19.3 pt -122.84 149.6 26.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 109.863 -0.421 . . . . 70.12 109.863 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.7 129.3 16.04 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.537 -0.912 . . . . 74.33 108.537 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 165.1 -178.24 40.23 Favored Glycine 0 C--N 1.283 -2.393 0 N-CA-C 108.63 -1.788 . . . . 74.43 108.63 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.03 173.22 13.22 Favored Glycine 0 C--N 1.279 -2.592 0 N-CA-C 108.466 -1.853 . . . . 52.12 108.466 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 90.6 t -56.15 100.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 117.682 0.741 . . . . 74.33 110.623 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 88.33 -2.08 84.79 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.373 -0.83 . . . . 34.43 112.616 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.525 ' CG ' ' H ' ' B' ' 146' ' ' ARG . 63.2 t30 -109.02 3.55 22.23 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.575 0.702 . . . . 74.31 109.644 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER -61.39 127.29 30.76 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 115.042 1.497 . . . . 73.3 115.042 -174.299 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -66.67 -32.25 73.45 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.876 -1.511 . . . . 73.45 110.809 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 43.3 mm -104.64 114.61 63.83 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 116.319 -0.4 . . . . 64.05 110.033 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.23 111.19 0.78 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.888 2.392 . . . . 53.41 111.789 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.07 -22.98 20.09 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.84 -0.695 . . . . 65.24 111.607 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -112.39 106.97 15.61 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.175 -0.676 . . . . 71.11 109.175 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -85.22 63.04 7.87 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.502 0.668 . . . . 73.12 111.095 -173.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.469 ' HB2' ' CE1' ' A' ' 349' ' ' TYR . 7.2 m -119.06 177.68 4.78 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 119.588 -0.845 . . . . 71.11 111.861 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 26.0 mm -98.15 131.67 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 N-CA-C 106.052 -1.833 . . . . 70.32 106.052 176.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 347' ' ' SER . 42.7 m-85 -123.72 132.55 53.85 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.574 0.583 . . . . 71.03 112.574 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.16 112.46 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.865 -1.062 . . . . 65.02 108.527 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.1 m -92.8 -28.69 16.41 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.458 0.647 . . . . 72.42 109.973 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 331' ' ' PHE . 54.3 tttm -155.89 153.57 29.87 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 108.249 -1.019 . . . . 72.32 108.249 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 86.9 mt -118.22 144.23 26.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 104.873 -2.269 . . . . 52.34 104.873 169.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 39.6 mm -79.92 129.68 37.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.69 -0.485 . . . . 74.23 109.69 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.4 pm0 -63.78 105.02 0.75 Allowed 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.461 -1.245 . . . . 71.54 111.265 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.97 -2.35 63.9 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 114.521 -1.218 . . . . 44.42 112.387 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -69.99 172.04 41.15 Favored Glycine 0 C--O 1.244 0.76 0 O-C-N 123.697 0.293 . . . . 73.01 112.65 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -57.34 -44.12 84.02 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 122.976 0.511 . . . . 54.13 110.894 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.54 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.26 -9.87 58.94 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.726 0.639 . . . . 73.33 112.726 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -94.57 -24.3 17.29 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.19 -1.041 . . . . 62.44 108.19 177.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -89.93 -60.13 2.01 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-O 121.579 0.704 . . . . 63.34 110.054 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' ASP . . . . . 0.461 ' OD2' ' HA ' ' A' ' 322' ' ' LEU . 24.1 t70 -87.5 -44.66 11.13 Favored 'General case' 0 CA--C 1.46 -2.502 0 CA-C-N 114.588 -1.187 . . . . 72.41 111.485 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -42.82 -24.97 0.28 Allowed Glycine 0 CA--C 1.491 -1.46 0 N-CA-C 119.711 2.645 . . . . 75.2 119.711 -162.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.482 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 41.68 37.12 0.68 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 118.556 1.178 . . . . 74.4 111.34 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 39.8 tp -108.22 158.16 17.69 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.33 -1.304 . . . . 74.21 110.355 -169.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -121.26 143.66 49.04 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.646 0.736 . . . . 70.31 110.756 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.48 126.35 25.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.235 -1.395 . . . . 73.34 107.235 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.91 -1.36 30.19 Favored Glycine 0 C--N 1.302 -1.307 0 C-N-CA 120.574 -0.822 . . . . 31.44 111.965 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 5.1 m-20 -66.46 132.07 47.45 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 113.239 0.829 . . . . 65.13 113.239 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 39.9 tttp -92.19 114.28 26.79 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.68 1.192 . . . . 73.31 108.752 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 91.7 mt -85.14 116.38 23.47 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.533 -0.467 . . . . 71.34 110.224 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.1 tt -88.02 -39.13 14.91 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.999 -1.482 . . . . 73.22 106.999 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -166.95 156.0 10.47 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.648 -0.705 . . . . 75.55 110.204 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.81 122.74 39.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.968 -0.753 . . . . 75.25 108.968 173.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' ASN . . . . . 0.556 HD21 HG22 ' A' ' 394' ' ' THR . 87.4 m-20 60.89 35.32 19.29 Favored 'General case' 0 CA--C 1.482 -1.655 0 CA-C-O 123.713 1.72 . . . . 72.52 108.895 -176.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 67.6 7.09 5.39 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 110.174 -3.194 . . . . 73.04 113.396 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 60.7 t -79.87 123.78 37.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 107.014 -1.476 . . . . 71.25 107.014 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.7 p -63.92 124.2 20.94 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.093 0.775 . . . . 71.51 113.093 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.74 -6.09 13.88 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.637 0.775 . . . . 70.11 110.216 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -72.58 105.07 4.08 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.337 -1.356 . . . . 53.45 107.337 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . 0.269 20.1 tt0 60.3 78.88 0.26 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.371 1.468 . . . . 73.21 113.829 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 30.5 m -147.04 175.15 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 107.592 -1.262 . . . . 72.41 107.592 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 75.0 p -81.06 155.22 26.43 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.442 -0.948 . . . . 64.3 108.442 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.575 ' O ' HG23 ' A' ' 388' ' ' VAL . 8.6 t-160 -58.93 -41.26 86.91 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.226 -0.657 . . . . 73.01 109.226 -172.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' B' ' 143' ' ' THR . 3.5 mp0 -51.03 -44.94 61.13 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.659 -1.155 . . . . 72.52 113.492 175.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.2 -33.37 74.3 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.547 0.689 . . . . 74.32 109.268 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -74.08 -58.8 3.06 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.488 -1.233 . . . . 70.04 110.417 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 384' ' ' HIS . 15.7 t -58.31 -40.18 76.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 O-C-N 123.292 0.37 . . . . 62.22 110.314 -176.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 95.6 m -63.26 -36.81 84.9 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.298 -0.41 . . . . 72.03 110.751 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.57 -34.75 77.68 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.396 -0.19 . . . . 74.23 110.739 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.49 -32.49 60.58 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 120.67 -0.412 . . . . 74.44 110.704 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 57.7 mttm -72.99 -26.44 61.34 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 120.57 -0.452 . . . . 62.24 112.145 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -80.83 48.88 1.13 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.988 -0.551 . . . . 72.4 110.619 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.556 HG22 HD21 ' A' ' 375' ' ' ASN . 41.7 p -124.43 147.93 47.96 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.438 -0.579 . . . . 73.44 109.438 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 65.9 m -147.4 99.08 3.09 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 122.512 1.149 . . . . 63.3 112.003 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.696 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 8.4 m-20 65.26 13.02 8.5 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 111.195 -2.73 . . . . 73.55 113.218 168.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -165.72 129.08 2.16 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 106.863 -1.532 . . . . 74.1 106.863 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.45 HG22 ' HB ' ' A' ' 394' ' ' THR . 38.9 t -142.39 142.75 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 122.735 0.414 . . . . 72.03 110.361 -177.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.492 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 13.0 m-85 -118.68 95.6 4.91 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.811 -0.811 . . . . 73.15 108.811 168.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.4 tt -93.7 121.3 34.99 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 123.383 0.673 . . . . 55.25 109.744 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -103.31 107.7 18.62 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.7 -0.852 . . . . 74.13 108.7 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.42 HG21 ' HB3' ' A' ' 369' ' ' ASP . 10.2 p -114.63 157.35 15.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 CA-C-N 114.815 -1.084 . . . . 72.21 110.194 -176.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -135.98 158.6 44.01 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.868 -1.53 . . . . 71.42 106.868 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.641 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 10.9 mmpt? -79.91 153.46 75.17 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 108.54 -0.911 . . . . 72.54 108.54 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -57.09 129.46 34.5 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.315 2.01 . . . . 72.43 113.157 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 6.6 m -70.67 88.36 0.7 Allowed 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.591 -1.186 . . . . 63.45 110.83 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 167.74 -171.29 42.19 Favored Glycine 0 N--CA 1.41 -3.054 0 C-N-CA 120.392 -0.909 . . . . 62.23 110.982 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 28.6 t -81.12 -13.49 58.64 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.471 -0.566 . . . . 73.15 109.471 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -101.87 94.41 5.8 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.328 -1.36 . . . . 64.15 107.328 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -133.8 143.85 48.64 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 116.036 -0.529 . . . . 60.3 111.056 -178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 . . . . . 0 C--N 1.303 -1.44 0 N-CA-C 106.382 -1.71 . . . . 74.04 106.382 -178.905 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -0.989 0 N-CA-C 108.135 -1.061 . . . . 62.23 108.135 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 26.5 mtp-105 -100.19 -178.32 3.79 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.635 -1.246 . . . . 73.12 107.635 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.489 HG22 HG21 ' B' ' 149' ' ' THR . 72.7 p -53.59 152.06 5.41 Favored 'General case' 0 C--N 1.317 -0.815 0 O-C-N 124.715 1.259 . . . . 52.31 108.568 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -152.5 151.69 31.02 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 119.121 0.873 . . . . 72.41 113.333 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' GLN . . . . . 0.421 ' H ' ' HG2' ' B' ' 145' ' ' GLN . 10.2 pt20 -85.34 156.14 21.03 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.422 -1.717 . . . . 75.5 112.238 177.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 146' ' ' ARG . . . . . 0.525 ' H ' ' CG ' ' A' ' 339' ' ' ASN 0.256 38.6 mtm-85 67.15 34.09 5.2 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 125.625 1.57 . . . . 74.21 112.152 -174.666 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -168.12 171.41 9.54 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 111.382 -2.645 . . . . 72.14 106.067 173.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.03 161.55 15.08 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 107.44 -1.318 . . . . 73.21 107.44 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.489 HG21 HG22 ' B' ' 143' ' ' THR . 32.9 m -142.42 104.01 4.34 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 108.353 -0.98 . . . . 72.14 108.353 170.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -60.11 132.19 53.17 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.183 -1.372 . . . . 71.11 110.899 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 331' ' ' PHE . 17.8 m . . . . . 0 C--O 1.262 1.75 0 CA-C-N 116.082 -0.508 . . . . 71.12 111.163 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 51.8 tpp . . . . . 0 CA--C 1.512 -0.503 0 N-CA-C 108.327 -0.99 . . . . 54.31 108.327 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.474 2.0 pm0 -117.67 128.67 55.14 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 116.744 2.127 . . . . 62.52 116.744 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.445 HG23 ' HZ3' ' A' ' 364' ' ' LYS . 70.8 mt -117.33 106.75 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 CA-C-N 111.74 -2.482 . . . . 75.41 109.793 -174.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 398' ' ' VAL . 40.7 ttmt -85.74 132.6 34.1 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.458 -1.312 . . . . 63.23 107.458 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 74.1 mt -129.02 152.12 48.97 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.02 -1.104 . . . . 74.12 108.02 178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 35.7 mm -106.2 112.34 39.01 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.589 0 N-CA-C 107.781 -1.192 . . . . 64.4 107.781 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.594 ' HB3' ' H ' ' A' ' 396' ' ' ASP . 0.0 OUTLIER -59.86 135.88 57.83 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 108.608 -0.886 . . . . 75.11 108.608 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.431 ' N ' ' HD2' ' A' ' 324' ' ' LYS . . . -134.4 -161.12 9.43 Favored Glycine 0 C--N 1.287 -2.158 0 CA-C-N 116.281 -0.418 . . . . 43.22 113.008 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -62.08 -22.94 75.11 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 123.894 3.062 . . . . 62.52 114.033 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -109.03 18.06 21.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.255 0.55 . . . . 43.44 109.93 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.86 -119.19 4.86 Favored Glycine 0 CA--C 1.492 -1.379 0 N-CA-C 109.967 -1.253 . . . . 64.43 109.967 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.27 -30.5 8.69 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.55 -1.278 . . . . 64.24 107.55 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.12 50.2 4.19 Favored Glycine 0 N--CA 1.432 -1.57 0 CA-C-N 114.532 -1.213 . . . . 75.33 115.403 171.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -154.88 159.87 40.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 117.061 0.43 . . . . 70.22 110.797 172.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.549 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 5.8 m -110.07 127.92 55.13 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 109.139 -0.689 . . . . 63.01 109.139 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 10.1 pt -117.72 154.15 19.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 122.495 0.318 . . . . 75.35 111.02 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.62 120.38 7.56 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.774 -1.565 . . . . 73.4 106.774 174.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 156.97 154.52 7.08 Favored Glycine 0 C--N 1.293 -1.831 0 N-CA-C 110.829 -0.908 . . . . 63.23 110.829 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.55 -177.27 19.36 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 108.484 -1.846 . . . . 54.34 108.484 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 86.1 t -53.52 108.53 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 117.972 0.886 . . . . 74.14 111.245 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 88.83 -16.99 53.26 Favored Glycine 0 C--O 1.219 -0.813 0 CA-C-N 115.271 -0.877 . . . . 74.43 112.419 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.463 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -107.27 9.61 30.01 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.913 -0.773 . . . . 74.01 108.913 -178.154 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.97 126.26 13.88 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 123.557 0.743 . . . . 70.25 112.26 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -82.34 -45.26 15.13 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.09 -0.959 . . . . 72.04 110.107 -173.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.7 122.11 45.87 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 108.246 -1.02 . . . . 75.31 108.246 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.81 105.16 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 123.156 2.571 . . . . 73.13 112.607 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.82 -6.25 29.37 Favored Glycine 0 N--CA 1.431 -1.64 0 CA-C-N 115.352 -0.84 . . . . 45.0 112.099 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -127.19 98.92 5.46 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.478 -0.934 . . . . 52.32 108.478 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -82.4 33.63 0.41 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.991 -1.004 . . . . 72.22 111.827 -170.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 66.7 m -100.35 173.25 6.68 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.807 -0.633 . . . . 74.03 112.033 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.3 mm -86.27 129.64 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 107.574 -1.269 . . . . 73.41 107.574 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 27.1 m-85 -123.78 139.48 53.94 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-N 118.384 0.538 . . . . 71.24 111.572 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 45.3 t -77.04 115.37 18.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.547 -0.751 . . . . 62.22 109.514 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 24.8 m -91.45 -28.91 17.33 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.973 -0.558 . . . . 70.42 110.263 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 85.0 mttt -152.52 160.39 43.23 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 109.268 -0.641 . . . . 72.12 109.268 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 80.0 mt -125.34 135.02 65.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 106.198 -1.779 . . . . 64.25 106.198 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 44.3 mm -85.27 137.54 20.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 C-N-CA 122.429 0.292 . . . . 71.34 111.159 -173.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.97 127.84 32.35 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.709 0.766 . . . . 61.34 112.795 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 70.18 9.86 64.57 Favored Glycine 0 C--N 1.315 -0.626 0 CA-C-N 115.558 -0.746 . . . . 72.52 112.706 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -74.74 160.63 53.02 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 110.836 -0.906 . . . . 60.32 110.836 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -59.69 -42.02 92.04 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 109.733 -0.469 . . . . 72.33 109.733 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.562 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -72.3 -10.67 60.08 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.172 -0.611 . . . . 70.43 112.431 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -93.99 -29.58 15.17 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.635 -0.876 . . . . 61.43 108.635 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -94.17 -60.49 1.72 Allowed 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 122.955 1.359 . . . . 55.01 110.398 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -87.45 -25.66 23.64 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 112.47 -2.15 . . . . 73.35 110.467 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -44.11 -50.34 7.69 Favored Glycine 0 C--N 1.273 -2.967 0 N-CA-C 120.301 2.88 . . . . 65.11 120.301 -170.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 363' ' ' GLY 0.256 0.0 OUTLIER 47.99 31.29 2.34 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.383 1.592 . . . . 63.04 110.973 -164.521 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 9.8 tt -112.03 150.12 31.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.027 -0.988 . . . . 63.12 109.202 -170.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -122.21 152.43 40.0 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.294 0.569 . . . . 75.3 111.076 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 75.4 mt -65.96 129.26 30.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 107.0 -1.481 . . . . 74.25 107.0 170.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 107.72 3.34 34.63 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.471 -0.871 . . . . 62.03 112.172 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.573 ' HB3' HG21 ' A' ' 402' ' ' VAL . 1.4 m-20 -72.89 128.52 35.74 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.261 0.837 . . . . 73.31 113.261 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 42.1 tttp -92.78 114.52 27.1 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.788 1.235 . . . . 75.54 109.492 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 85.8 mt -80.53 111.92 17.4 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 120.961 0.41 . . . . 61.32 110.082 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.2 tt -86.75 -39.41 15.99 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.491 -1.231 . . . . 74.43 107.694 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.55 155.69 17.6 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.772 -0.649 . . . . 74.13 110.677 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.5 p -133.4 122.36 44.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.116 -1.068 . . . . 74.53 108.116 173.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' ASN . . . . . 0.569 HD21 HG22 ' A' ' 394' ' ' THR . 84.7 m-20 62.26 30.52 17.57 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-O 123.873 1.797 . . . . 43.32 108.445 -174.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.8 t30 66.32 16.89 10.58 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 109.831 -3.35 . . . . 52.44 112.556 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.95 125.28 40.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 106.557 -1.646 . . . . 74.13 106.557 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.1 p -61.62 123.3 17.53 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 113.557 0.947 . . . . 73.41 113.557 -175.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.28 -2.51 20.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.309 -0.86 . . . . 74.3 110.941 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -66.84 106.83 1.99 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.752 -0.658 . . . . 72.52 109.396 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 63.97 74.36 0.41 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 122.643 1.211 . . . . 74.52 113.591 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 21.4 m -137.29 169.5 19.37 Favored 'Isoleucine or valine' 0 C--O 1.249 1.03 0 N-CA-C 105.913 -1.884 . . . . 72.21 105.913 174.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.518 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 50.5 p -78.66 138.71 38.43 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.274 -0.97 . . . . 74.34 108.998 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.598 ' O ' HG23 ' A' ' 388' ' ' VAL . 85.8 t60 -47.49 -51.06 21.69 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.31 0.855 . . . . 72.41 113.31 -173.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.617 ' OE1' ' HA ' ' B' ' 144' ' ' ARG . 19.5 tt0 -65.04 -29.61 70.52 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.484 0.659 . . . . 53.21 110.663 -175.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 383' ' ' THR . 49.8 tt0 -72.87 -39.11 66.73 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.367 -0.975 . . . . 64.33 108.367 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.486 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -67.59 -46.52 72.36 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.759 -1.109 . . . . 70.03 109.96 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 384' ' ' HIS . 24.8 t -57.87 -43.55 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 109.681 -0.489 . . . . 25.3 109.681 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 85.0 m -57.95 -38.14 75.45 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 123.49 0.494 . . . . 74.52 110.681 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.05 -33.37 75.89 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.193 -0.317 . . . . 70.14 110.959 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.7 mp -81.73 -26.58 34.44 Favored 'General case' 0 C--O 1.211 -0.949 0 C-N-CA 120.494 -0.482 . . . . 53.03 111.28 176.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.441 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 62.2 mttm -75.82 -27.33 57.86 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.698 -0.401 . . . . 74.21 111.968 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -80.27 43.67 0.64 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.844 -0.616 . . . . 73.32 110.623 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.569 HG22 HD21 ' A' ' 375' ' ' ASN . 77.4 p -124.19 144.03 50.17 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.813 -0.81 . . . . 54.41 108.813 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' SER . . . . . 0.516 ' HA ' ' HE3' ' A' ' 324' ' ' LYS . 65.4 m -146.02 116.92 7.73 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.568 0.699 . . . . 71.4 111.095 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.594 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 3.3 m-20 55.77 14.52 1.33 Allowed 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 127.882 2.473 . . . . 75.34 114.903 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -163.17 126.15 2.71 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.452 -1.314 . . . . 73.34 107.452 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 46.8 t -138.46 124.0 23.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.271 -1.011 . . . . 75.13 108.271 177.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -106.43 95.9 6.08 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.948 -1.871 . . . . 63.32 105.948 173.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.458 ' CD2' ' HB ' ' A' ' 402' ' ' VAL . 7.6 tt -95.14 114.58 26.39 Favored 'General case' 0 C--N 1.258 -3.374 0 N-CA-C 109.051 -0.722 . . . . 73.12 109.051 -176.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -99.58 108.66 21.11 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.795 -1.557 . . . . 72.15 106.795 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.573 HG21 ' HB3' ' A' ' 369' ' ' ASP . 10.3 p -115.73 162.2 13.93 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.753 0 N-CA-C 108.223 -1.028 . . . . 74.02 108.223 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.9 148.83 47.26 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.58 -0.896 . . . . 73.45 108.58 173.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 10.7 mmpt? -64.57 157.27 74.07 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 108.276 -1.009 . . . . 73.42 108.276 169.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -65.7 133.13 32.97 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 121.852 1.701 . . . . 61.25 112.814 -170.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 1.2 m -62.26 5.01 0.11 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 125.929 1.692 . . . . 70.1 113.775 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -95.19 12.76 67.88 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 110.178 -1.169 . . . . 51.54 110.178 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 22.7 t -163.66 -164.73 0.94 Allowed 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 105.823 -1.917 . . . . 74.43 105.823 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -72.36 103.08 3.32 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.985 0.422 . . . . 63.25 110.532 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -71.31 137.65 48.68 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.457 -0.792 . . . . 63.31 110.465 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 78.5 m80 . . . . . 0 C--N 1.3 -1.563 0 N-CA-C 106.593 -1.632 . . . . 74.55 106.593 -179.136 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.711 0 N-CA-C 106.791 -1.559 . . . . 74.3 106.791 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -87.97 -6.33 58.07 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 118.415 0.552 . . . . 73.12 111.778 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.517 ' HA ' ' CG2' ' B' ' 149' ' ' THR . 0.9 OUTLIER -119.52 118.44 31.06 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 123.502 0.501 . . . . 75.32 111.038 176.27 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 144' ' ' ARG . . . . . 0.617 ' HA ' ' OE1' ' A' ' 385' ' ' GLU . 1.2 mmp_? -157.12 157.76 35.09 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.794 1.238 . . . . 74.21 108.554 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -85.9 155.18 21.04 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 116.049 -0.523 . . . . 74.42 111.063 174.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 67.2 32.2 6.21 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.441 1.496 . . . . 74.44 112.753 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -160.49 178.47 9.51 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-N 113.558 -1.655 . . . . 71.04 107.558 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -89.28 144.85 25.78 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.29 -1.004 . . . . 63.11 108.29 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.517 ' CG2' ' HA ' ' B' ' 143' ' ' THR . 16.9 m -134.41 135.2 42.42 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 116.233 -0.44 . . . . 63.44 111.628 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -85.86 130.51 34.53 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-N 116.001 -0.545 . . . . 74.42 110.472 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.293 -1.861 0 CA-C-N 116.289 -0.414 . . . . 71.45 110.05 171.508 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 C--O 1.21 -1.016 0 N-CA-C 108.04 -1.096 . . . . 43.04 108.04 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.336 1.8 pm0 -103.45 131.86 50.2 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-O 123.012 1.387 . . . . 72.53 114.411 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.45 HG23 ' HD3' ' A' ' 364' ' ' LYS . 78.3 mt -113.93 106.49 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.97 0 CA-C-N 111.987 -2.37 . . . . 73.32 110.35 -172.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -85.55 105.9 16.48 Favored 'General case' 0 N--CA 1.402 -2.854 0 N-CA-C 104.324 -2.472 . . . . 75.21 104.324 170.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.421 HD21 ' HA ' ' A' ' 359' ' ' ALA . 0.4 OUTLIER -106.5 144.59 32.96 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 113.802 -1.545 . . . . 71.45 109.299 -171.349 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.1 mp -98.34 111.24 27.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 108.75 -0.833 . . . . 64.34 108.75 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -76.32 149.91 36.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.489 -0.778 . . . . 72.32 109.979 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -141.2 -160.07 8.16 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.466 -0.874 . . . . 62.04 112.23 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.35 -12.77 34.43 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.334 2.69 . . . . 72.55 113.362 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -102.35 8.72 40.18 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.302 -0.629 . . . . 74.13 109.302 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.74 -128.2 8.45 Favored Glycine 0 CA--C 1.477 -2.338 0 N-CA-C 108.764 -1.735 . . . . 35.43 108.764 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.44 ' HB2' HG23 ' B' ' 151' ' ' VAL . 4.5 mp -98.52 -39.16 8.87 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.582 -2.007 . . . . 72.41 105.582 172.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.36 56.03 2.48 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 114.776 -1.102 . . . . 72.11 114.154 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' PHE . . . . . 0.414 ' HA ' ' H ' ' A' ' 354' ' ' ILE . 53.9 p90 -154.39 158.98 40.85 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.104 -0.702 . . . . 75.0 109.104 172.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' B' ' 149' ' ' THR . 10.9 m -107.32 128.82 54.79 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.165 -1.05 . . . . 74.3 108.165 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 25.2 pt -114.71 151.87 16.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 109.998 -0.371 . . . . 74.32 109.998 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -147.57 121.86 9.61 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.147 -1.427 . . . . 71.21 107.147 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 154.71 163.19 11.77 Favored Glycine 0 C--N 1.282 -2.437 0 N-CA-C 110.784 -0.926 . . . . 51.34 110.784 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.58 -174.16 21.14 Favored Glycine 0 CA--C 1.479 -2.195 0 N-CA-C 108.069 -2.012 . . . . 54.14 108.069 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.425 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 68.3 t -54.08 103.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 117.545 0.672 . . . . 54.24 110.921 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 82.33 -7.79 63.27 Favored Glycine 0 C--O 1.217 -0.934 0 CA-C-N 115.419 -0.81 . . . . 73.31 112.98 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.36 0.06 26.62 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.206 -1.035 . . . . 75.43 108.206 -178.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.449 ' HA ' ' HA2' ' A' ' 335' ' ' GLY . 0.0 OUTLIER -50.78 140.38 14.96 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 115.642 1.719 . . . . 61.25 115.642 -174.583 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -85.42 -33.64 21.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.439 -1.255 . . . . 73.43 109.078 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 46.4 mm -104.81 122.7 42.5 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.67 -0.695 . . . . 74.33 109.716 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.82 108.52 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.543 2.162 . . . . 62.22 111.412 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.29 -19.3 24.73 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.57 -0.824 . . . . 74.21 112.092 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 19.4 t70 -114.79 99.96 7.88 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.861 -1.163 . . . . 74.13 107.861 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.425 ' OD1' ' HA ' ' A' ' 337' ' ' VAL . 59.3 t30 -80.97 33.09 0.32 Allowed 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 124.018 0.927 . . . . 64.44 112.437 -169.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 68.1 m -100.01 176.97 5.24 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.772 0.656 . . . . 71.42 112.772 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.5 mm -92.2 132.66 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 107.513 -1.291 . . . . 72.44 107.513 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 32.9 m-85 -124.1 137.49 54.56 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 112.62 0.6 . . . . 72.43 112.62 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 49.9 t -70.59 117.59 13.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 115.159 -0.928 . . . . 72.31 108.606 176.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.0 m -97.26 -29.87 13.3 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.515 0.674 . . . . 53.24 110.248 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -155.39 152.36 28.98 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 107.285 -1.376 . . . . 74.03 107.285 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 80.3 mt -121.42 109.56 25.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 106.357 -1.72 . . . . 70.21 106.357 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.414 ' H ' ' HA ' ' A' ' 331' ' ' PHE . 41.7 mm -52.21 133.73 14.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 O-C-N 124.711 1.257 . . . . 74.23 112.221 -171.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.536 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.1 pm0 -55.2 114.51 1.81 Allowed 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 125.361 1.464 . . . . 74.24 111.833 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 72.67 22.78 78.81 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 114.351 -1.295 . . . . 51.42 111.781 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.33 164.36 53.44 Favored Glycine 0 C--O 1.254 1.363 0 N-CA-C 111.466 -0.654 . . . . 74.54 111.466 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.13 96.46 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.983 -0.747 . . . . 61.32 108.983 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.541 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.69 -11.03 59.92 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.986 -0.552 . . . . 73.52 112.067 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -86.52 -30.52 21.88 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.711 -1.218 . . . . 74.51 107.711 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.588 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 1.2 mmpm? -95.52 -57.82 2.29 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.657 0.984 . . . . 75.23 113.657 176.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -85.41 -39.2 17.83 Favored 'General case' 0 CA--C 1.467 -2.25 0 C-N-CA 123.542 0.737 . . . . 55.02 111.164 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.541 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -42.68 -23.95 0.21 Allowed Glycine 0 C--N 1.3 -1.421 0 N-CA-C 119.316 2.486 . . . . 73.45 119.316 -166.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.476 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.4 38.3 1.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 118.576 1.188 . . . . 75.0 111.241 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 55.8 tp -112.86 157.59 21.23 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.25 -1.341 . . . . 74.34 110.099 -170.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -120.41 143.74 48.3 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 121.524 0.678 . . . . 73.52 111.174 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.6 125.16 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 107.116 -1.439 . . . . 75.22 107.116 169.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.75 1.19 32.31 Favored Glycine 0 C--N 1.309 -0.935 0 C-N-CA 120.567 -0.825 . . . . 51.31 112.183 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 71.6 m-20 -75.49 138.27 41.47 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 112.698 0.629 . . . . 54.02 112.698 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 45.2 tttp -94.27 115.32 27.55 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.154 1.381 . . . . 74.44 108.994 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 95.7 mt -79.86 111.24 16.0 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.951 0.405 . . . . 62.35 109.999 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 403' ' ' ALA . 4.0 tt -83.09 -40.09 20.29 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.71 -1.589 . . . . 74.45 106.71 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.25 157.38 25.51 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.163 -0.926 . . . . 62.0 109.639 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.515 HG11 ' HG ' ' A' ' 391' ' ' LEU . 7.6 p -147.31 137.27 16.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.59 -0.893 . . . . 43.45 108.59 173.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 59.51 38.38 22.47 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 108.066 -1.087 . . . . 73.21 108.066 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 64.0 t30 67.03 -8.06 0.45 Allowed 'General case' 0 CA--C 1.57 1.723 0 C-N-CA 125.846 1.658 . . . . 53.23 113.278 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.32 130.65 35.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.981 -0.748 . . . . 71.35 108.981 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.0 p -72.21 129.68 39.03 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 122.756 0.423 . . . . 73.23 111.35 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.38 -3.7 16.91 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.766 0.654 . . . . 73.32 112.766 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -65.23 107.19 1.51 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.588 -0.523 . . . . 73.11 109.588 174.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 63.67 72.33 0.47 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 122.742 1.258 . . . . 54.25 113.359 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.59 164.35 31.15 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 N-CA-C 105.764 -1.939 . . . . 75.35 105.764 173.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.676 ' HB ' ' OE1' ' A' ' 386' ' ' GLU . 1.4 m -82.81 146.43 28.94 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.406 -1.331 . . . . 72.41 107.406 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.617 ' O ' HG23 ' A' ' 388' ' ' VAL . 67.9 t60 -51.05 -32.73 22.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.526 -0.761 . . . . 75.51 112.961 -173.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.426 ' OE1' ' HA ' ' B' ' 144' ' ' ARG . 7.3 tp10 -65.08 -42.66 93.89 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.519 -0.549 . . . . 75.25 109.519 -177.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.676 ' OE1' ' HB ' ' A' ' 383' ' ' THR . 1.8 mp0 -73.22 -32.46 64.77 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 108.864 -0.791 . . . . 63.1 108.864 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.514 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -62.32 -53.88 48.66 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.709 -1.132 . . . . 43.12 109.251 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 384' ' ' HIS . 33.2 t -57.34 -44.19 83.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 N-CA-C 109.746 -0.465 . . . . 52.2 109.746 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 80.6 m -57.51 -41.11 80.15 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 116.065 -0.516 . . . . 73.25 111.035 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -63.36 -38.04 89.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.729 0.3 . . . . 71.24 110.844 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.515 ' HG ' HG11 ' A' ' 374' ' ' VAL . 5.6 mp -76.47 -21.3 56.04 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 120.23 -0.588 . . . . 62.13 110.978 176.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.496 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 54.5 mttm -83.95 -27.27 28.62 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 113.474 0.916 . . . . 54.02 113.474 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -76.11 35.15 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.075 0.95 . . . . 71.32 112.681 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 8.1 p -124.76 161.05 27.25 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 122.899 0.48 . . . . 75.34 110.028 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 24.9 p -160.53 125.86 3.88 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.325 -0.62 . . . . 72.41 109.325 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 61.69 0.14 0.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 125.92 1.688 . . . . 75.45 113.757 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -168.12 137.49 2.49 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.589 -0.893 . . . . 75.11 108.589 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 62.1 t -136.66 125.71 36.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.614 -1.254 . . . . 72.33 107.614 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -101.21 95.59 6.63 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.144 -2.169 . . . . 74.14 105.144 173.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.3 tt -101.02 140.78 34.84 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 109.46 -0.57 . . . . 71.53 109.46 -176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -128.11 113.09 15.3 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.85 -0.426 . . . . 74.44 109.85 -175.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 54.1 t -105.19 145.26 13.7 Favored 'Isoleucine or valine' 0 C--O 1.269 2.12 0 C-N-CA 124.256 1.022 . . . . 71.35 111.03 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -117.17 156.39 27.75 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 104.618 -2.364 . . . . 35.01 104.618 169.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 410' ' ' HIS . 7.7 mmpt? -84.98 151.97 58.26 Favored Pre-proline 0 C--N 1.285 -2.228 0 C-N-CA 118.677 -1.209 . . . . 61.43 107.991 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.95 111.72 0.82 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.866 2.377 . . . . 54.35 112.111 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 6.9 m -87.98 -10.32 50.77 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.563 -0.744 . . . . 71.53 111.031 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.52 16.57 37.49 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 120.129 -1.034 . . . . 72.31 112.816 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 64.2 m -160.17 -179.42 7.73 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.982 -1.118 . . . . 63.13 107.982 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -76.67 124.84 28.25 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.82 -1.548 . . . . 74.02 106.82 176.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' HIS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 404' ' ' LYS . 30.2 p80 -95.74 146.05 24.83 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 120.971 -0.291 . . . . 65.32 111.63 -176.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 . . . . . 0 N--CA 1.419 -2.023 0 N-CA-C 104.389 -2.448 . . . . 73.31 104.389 166.955 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.453 -2.788 0 N-CA-C 108.47 -0.937 . . . . 65.5 108.47 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -91.63 131.69 36.85 Favored 'General case' 0 N--CA 1.394 -3.233 0 O-C-N 125.148 1.53 . . . . 65.33 108.753 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.522 ' O ' ' HG2' ' B' ' 144' ' ' ARG . 40.2 p -116.53 156.01 27.66 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.821 -1.177 . . . . 75.4 107.821 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 144' ' ' ARG . . . . . 0.572 ' HA ' ' HE ' ' B' ' 144' ' ' ARG . 6.7 mmp_? 175.37 164.86 0.31 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 127.725 2.41 . . . . 72.35 108.051 172.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -86.26 171.77 10.99 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 123.565 0.541 . . . . 75.2 111.069 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 65.81 18.47 11.14 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.344 1.858 . . . . 63.41 113.669 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' ASN . . . . . 0.506 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.2 OUTLIER -152.32 178.27 9.69 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-N 116.026 -0.534 . . . . 71.03 109.62 -179.16 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -90.4 146.27 24.29 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.996 -0.742 . . . . 71.24 108.996 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 332' ' ' SER . 88.9 m -134.64 138.03 44.14 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.91 -0.587 . . . . 71.13 110.16 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -83.66 132.81 34.85 Favored 'General case' 0 C--O 1.254 1.319 0 N-CA-C 109.801 -0.444 . . . . 73.34 109.801 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.44 HG23 ' HB2' ' A' ' 329' ' ' LEU . 15.1 m . . . . . 0 C--N 1.296 -1.742 0 CA-C-O 116.767 -1.587 . . . . 74.11 112.63 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' MET . . . . . 0.528 ' SD ' ' HE3' ' A' ' 404' ' ' LYS . 26.1 ttt . . . . . 0 CA--C 1.495 -1.156 0 N-CA-C 106.941 -1.503 . . . . 70.32 106.941 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 400' ' ' LEU 0.339 2.0 pm0 -115.58 132.17 56.71 Favored 'General case' 0 N--CA 1.408 -2.562 0 N-CA-C 115.013 1.486 . . . . 53.24 115.013 -175.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 363' ' ' GLY . 58.6 mt -116.63 111.75 36.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.351 0 CA-C-N 112.402 -2.181 . . . . 54.45 107.966 -173.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -82.71 110.5 17.81 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.207 -1.034 . . . . 64.22 108.207 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 92.6 mt -111.02 156.32 21.44 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.54 0.525 . . . . 61.11 110.327 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.6 mp -105.04 115.4 46.84 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 107.925 -1.139 . . . . 60.4 107.925 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 394' ' ' THR . 22.7 tptm -68.57 122.16 17.91 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.485 -0.78 . . . . 65.33 109.318 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -133.55 -154.42 7.39 Favored Glycine 0 C--N 1.306 -1.104 0 C-N-CA 120.61 -0.805 . . . . 71.43 113.274 -173.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.85 -40.3 39.56 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 124.79 3.66 . . . . 44.41 115.49 -175.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -109.09 16.48 22.51 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.248 0.547 . . . . 75.2 110.044 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.41 -118.22 4.6 Favored Glycine 0 N--CA 1.424 -2.124 0 CA-C-N 114.892 -1.049 . . . . 63.21 110.983 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.543 HD21 HG11 ' A' ' 398' ' ' VAL . 4.0 mp -96.02 -30.32 13.64 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.565 -1.272 . . . . 72.23 107.565 177.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.49 44.93 5.98 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 114.853 -1.067 . . . . 45.4 114.487 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' PHE . . . . . 0.487 ' HA ' ' H ' ' A' ' 354' ' ' ILE . 50.7 p90 -152.43 156.7 40.0 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.823 -0.806 . . . . 71.14 108.823 172.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' B' ' 149' ' ' THR . 46.3 m -113.66 136.66 52.59 Favored 'General case' 0 C--N 1.282 -2.348 0 O-C-N 123.663 0.602 . . . . 51.02 110.829 -175.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 20.2 pt -120.26 149.6 23.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.409 -0.814 . . . . 64.3 112.435 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -145.15 114.59 7.15 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.285 -1.746 . . . . 40.32 106.285 174.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 164.19 164.18 18.83 Favored Glycine 0 C--N 1.285 -2.291 0 N-CA-C 109.015 -1.634 . . . . 60.34 109.015 -178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.01 178.93 15.94 Favored Glycine 0 CA--C 1.479 -2.214 0 N-CA-C 108.113 -1.995 . . . . 52.21 108.113 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 88.8 t -53.23 108.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 117.766 0.783 . . . . 73.23 110.738 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.65 -23.64 33.1 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.269 -0.878 . . . . 72.44 112.509 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.598 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 58.8 t30 -105.91 18.63 21.82 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.696 -0.483 . . . . 72.32 109.696 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -50.89 123.88 10.07 Favored 'General case' 0 C--O 1.257 1.476 0 C-N-CA 123.553 0.741 . . . . 54.3 110.518 -178.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -81.4 -40.1 23.96 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.146 -0.934 . . . . 74.1 109.977 -176.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 35.9 mm -103.65 126.11 32.9 Favored Pre-proline 0 C--N 1.309 -1.176 0 N-CA-C 109.2 -0.667 . . . . 72.35 109.2 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.14 102.73 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 123.108 2.539 . . . . 63.32 112.66 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.71 -7.2 29.75 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.828 -0.624 . . . . 75.2 112.033 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -123.92 96.84 5.1 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.049 -1.093 . . . . 74.13 108.049 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.414 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 65.3 t30 -83.03 36.92 0.52 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.587 -1.188 . . . . 72.11 112.08 -169.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 74.7 m -99.47 178.11 4.97 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.675 -0.693 . . . . 65.03 112.11 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 11.0 mm -88.72 131.6 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 107.899 -1.149 . . . . 73.34 107.899 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 26.8 m-85 -124.12 138.06 54.48 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 113.507 0.929 . . . . 64.34 113.507 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.1 t -71.14 115.54 11.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 114.787 -1.097 . . . . 72.13 108.48 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 22.6 m -100.56 -25.98 13.99 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.4 0.619 . . . . 73.35 110.848 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.89 142.25 22.49 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.229 -1.397 . . . . 72.33 107.229 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 74.3 mt -109.64 107.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 106.023 -1.843 . . . . 72.33 106.023 172.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.487 ' H ' ' HA ' ' A' ' 331' ' ' PHE . 46.4 mm -57.9 127.22 16.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 O-C-N 124.478 1.111 . . . . 65.23 112.585 -170.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.616 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.1 pm0 -57.12 117.67 4.26 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 113.314 -1.766 . . . . 72.24 111.053 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 90.01 5.31 70.85 Favored Glycine 0 C--O 1.22 -0.747 0 CA-C-N 115.02 -0.991 . . . . 54.31 111.96 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.3 158.08 48.82 Favored Glycine 0 C--O 1.255 1.443 0 C-N-CA 121.548 -0.358 . . . . 22.13 112.808 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.88 -40.1 95.75 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.972 -0.751 . . . . 74.44 108.972 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.548 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.44 -9.82 58.91 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.9 -0.591 . . . . 52.42 111.504 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -87.22 -30.43 20.97 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.315 -0.995 . . . . 60.52 108.315 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.478 ' HA ' ' CE ' ' A' ' 361' ' ' LYS . 0.0 OUTLIER -95.83 -57.23 2.42 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 114.101 1.148 . . . . 70.2 114.101 176.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -85.2 -39.45 17.8 Favored 'General case' 0 CA--C 1.462 -2.414 0 O-C-N 123.58 0.55 . . . . 64.24 110.604 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.604 ' O ' HD13 ' A' ' 320' ' ' ILE . . . -42.72 -23.14 0.17 Allowed Glycine 0 C--O 1.199 -2.037 0 N-CA-C 119.199 2.44 . . . . 71.03 119.199 -164.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.469 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 43.68 32.22 0.54 Allowed 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 119.135 1.467 . . . . 62.33 111.872 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 43.9 tp -105.01 153.5 21.37 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 125.184 1.393 . . . . 61.32 109.246 -171.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -116.95 146.07 43.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.065 0.459 . . . . 73.34 111.224 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 74.9 mt -66.54 124.21 21.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.719 -1.215 . . . . 70.1 107.719 170.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.65 1.19 30.73 Favored Glycine 0 C--N 1.312 -0.774 0 N-CA-C 111.175 -0.77 . . . . 65.22 111.175 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.51 ' HB3' HG21 ' A' ' 402' ' ' VAL . 73.2 m-20 -75.71 138.75 41.5 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.981 1.104 . . . . 65.25 113.981 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.631 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 40.8 tttp -94.2 115.83 28.15 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.499 1.52 . . . . 73.11 110.043 -177.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.49 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 96.5 mt -80.28 112.61 17.77 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.954 -0.758 . . . . 72.03 108.954 176.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.4 tt -83.88 -37.57 22.24 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.952 -1.499 . . . . 62.42 106.952 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -162.68 158.0 22.55 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.568 -0.742 . . . . 74.12 111.186 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.408 HG12 HD11 ' A' ' 379' ' ' LEU . 13.8 p -133.82 125.45 49.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.629 -1.249 . . . . 75.42 107.629 171.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 59.55 36.62 22.86 Favored 'General case' 0 CA--C 1.47 -2.119 0 CA-C-O 124.287 1.994 . . . . 54.3 110.727 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.3 t30 61.99 13.2 5.44 Favored 'General case' 0 C--N 1.268 -2.935 0 CA-C-N 108.958 -3.746 . . . . 72.22 113.272 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.9 t -86.91 123.86 40.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 107.419 -1.326 . . . . 32.4 107.419 175.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.6 p -63.14 125.22 23.34 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.023 0.749 . . . . 72.33 113.023 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.408 HD11 HG12 ' A' ' 374' ' ' VAL . 7.2 mp -106.57 3.68 27.26 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 123.843 0.857 . . . . 73.14 111.247 178.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -66.58 112.64 4.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.756 -0.656 . . . . 73.45 110.238 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 60.1 49.82 7.1 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 122.722 1.249 . . . . 72.34 112.98 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.31 169.55 4.01 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 N-CA-C 107.937 -1.135 . . . . 51.31 107.937 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 76.5 p -81.64 141.13 33.95 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.845 -0.742 . . . . 75.0 109.755 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.57 ' O ' HG23 ' A' ' 388' ' ' VAL . 75.2 t60 -46.02 -45.33 15.85 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.267 0.84 . . . . 74.24 113.267 -176.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.469 ' HB2' ' HD2' ' B' ' 144' ' ' ARG . 59.9 tt0 -62.33 -39.15 92.12 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 120.937 0.399 . . . . 65.4 111.122 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 383' ' ' THR . 61.4 tt0 -69.53 -34.63 74.51 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 124.321 1.048 . . . . 72.43 108.559 -176.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.526 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -73.37 -53.9 9.63 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.823 -1.081 . . . . 75.11 110.633 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 384' ' ' HIS . 21.1 t -58.15 -41.38 80.61 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 109.862 -0.421 . . . . 54.3 109.862 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 31.0 m -63.24 -31.67 72.87 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 116.224 -0.444 . . . . 74.14 110.938 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -69.35 -41.09 77.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.15 -0.315 . . . . 52.22 110.15 177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.3 mp -73.85 -23.99 59.7 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 119.937 -0.705 . . . . 72.23 110.406 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 54.9 mttm -79.12 -32.47 44.51 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 113.488 0.921 . . . . 74.22 113.488 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -84.01 64.5 8.2 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.949 0.88 . . . . 73.41 111.836 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.54 ' O ' ' HG2' ' A' ' 324' ' ' LYS . 12.4 p -148.62 149.46 31.56 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.422 -1.263 . . . . 74.23 108.38 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 26.8 p -148.62 128.02 13.08 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.271 -0.64 . . . . 74.41 109.271 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.435 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 31.8 t70 59.8 -1.22 0.17 Allowed 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 126.29 1.836 . . . . 71.41 114.406 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -159.73 120.8 3.16 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 120.607 -1.308 . . . . 73.12 110.718 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.543 HG11 HD21 ' A' ' 329' ' ' LEU . 80.4 t -136.15 145.13 31.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 124.281 1.032 . . . . 74.52 108.365 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.24 96.41 4.91 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.289 -1.374 . . . . 74.03 107.289 173.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 319' ' ' GLU . 4.8 tt -83.98 118.26 23.91 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.885 -1.154 . . . . 74.34 107.885 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -108.09 107.34 17.96 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.928 -1.138 . . . . 65.42 107.928 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 369' ' ' ASP . 3.0 p -111.3 148.69 14.41 Favored 'Isoleucine or valine' 0 C--O 1.267 1.998 0 CA-C-N 115.408 -0.814 . . . . 63.11 109.626 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.631 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.71 157.83 45.85 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 104.325 -2.472 . . . . 74.32 104.325 172.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.528 ' HE3' ' SD ' ' A' ' 318' ' ' MET . 0.0 OUTLIER -95.6 153.4 39.46 Favored Pre-proline 0 C--N 1.276 -2.599 0 C-N-CA 118.302 -1.359 . . . . 75.02 107.477 174.848 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 405' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' A' ' 410' ' ' HIS . 1.3 Cg_endo -35.56 100.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 125.145 3.897 . . . . 72.55 115.913 -173.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 13.2 p -96.21 -17.9 20.45 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.657 -1.156 . . . . 41.04 112.194 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -92.63 -4.13 65.95 Favored Glycine 0 N--CA 1.422 -2.291 0 C-N-CA 120.157 -1.021 . . . . 31.31 113.179 -176.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 22.2 t -167.53 -169.11 1.14 Allowed 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.871 -0.789 . . . . 75.55 108.871 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' HIS . . . . . 0.503 ' CE1' ' HB3' ' A' ' 411' ' ' HIS . 33.0 t-80 -81.26 157.05 25.29 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.895 -1.15 . . . . 71.32 107.895 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' HIS . . . . . 0.401 ' HB3' ' HG2' ' A' ' 405' ' ' PRO . 11.2 p-80 -89.27 46.52 1.39 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.789 0.804 . . . . 74.51 110.438 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.503 ' HB3' ' CE1' ' A' ' 409' ' ' HIS . 27.9 t-80 . . . . . 0 C--O 1.27 2.133 0 N-CA-C 105.198 -2.149 . . . . 61.14 105.198 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 141' ' ' PCA . . . . . 0.505 ' N ' ' HG1' ' B' ' 143' ' ' THR . . . . . . . . 0 C--O 1.218 -0.568 0 N-CA-C 109.977 -0.379 . . . . 74.32 109.977 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 142' ' ' ARG . . . . . 0.539 ' HA ' ' NE ' ' B' ' 142' ' ' ARG . 4.3 mmp_? 69.1 -19.08 0.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 126.034 1.733 . . . . 75.14 113.357 -178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.541 ' O ' ' HD2' ' B' ' 144' ' ' ARG 0.266 15.1 p -55.02 135.56 48.73 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 126.287 1.835 . . . . 53.13 107.242 168.043 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 144' ' ' ARG . . . . . 0.541 ' HD2' ' O ' ' B' ' 143' ' ' THR . 17.8 mmm180 -149.89 -164.53 2.04 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 119.806 1.185 . . . . 73.31 109.97 -173.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 145' ' ' GLN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 339' ' ' ASN . 0.2 OUTLIER -69.3 144.34 53.58 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.392 0.615 . . . . 74.44 112.034 -173.738 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 146' ' ' ARG . . . . . 0.507 ' H ' ' CG ' ' A' ' 339' ' ' ASN 0.257 27.0 mmt180 65.66 39.55 4.84 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 126.061 1.744 . . . . 73.4 113.662 178.21 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 147' ' ' ASN . . . . . 0.514 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.1 OUTLIER -143.66 148.93 36.51 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.567 -1.197 . . . . 71.03 108.759 173.001 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.65 151.94 19.14 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.628 -1.619 . . . . 73.22 106.628 173.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 332' ' ' SER . 53.8 m -147.37 129.62 15.65 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 120.534 -0.466 . . . . 73.44 110.66 174.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 150' ' ' GLN . . . . . 0.42 ' HG3' HG13 ' A' ' 354' ' ' ILE . 16.5 tt0 -67.07 129.51 40.13 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.941 -0.762 . . . . 72.23 108.941 173.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 331' ' ' PHE . 15.4 m . . . . . 0 C--N 1.297 -1.71 0 N-CA-C 113.404 0.89 . . . . 63.22 113.404 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 56.8 tpp . . . . . 0 CA--C 1.487 -1.458 0 N-CA-C 106.032 -1.84 . . . . 74.23 106.032 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.426 1.8 pm0 -122.07 128.64 51.59 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 116.692 2.108 . . . . 45.55 116.692 -174.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.503 HG23 ' HD3' ' A' ' 364' ' ' LYS . 89.8 mt -105.23 106.57 20.76 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.623 0 CA-C-N 111.452 -2.613 . . . . 73.11 109.305 -176.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -77.68 113.89 15.98 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 103.883 -2.636 . . . . 70.31 103.883 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.06 147.68 31.99 Favored 'General case' 0 C--N 1.266 -3.023 0 O-C-N 124.478 1.111 . . . . 61.01 109.234 -171.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 68.3 mt -106.03 134.99 46.0 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.881 0 N-CA-C 108.114 -1.069 . . . . 72.03 108.114 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.493 ' H ' ' HA ' ' A' ' 396' ' ' ASP . 1.2 ttpm? -74.24 177.99 5.44 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.83 -0.804 . . . . 74.41 108.83 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.441 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -155.86 -172.52 23.44 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 120.374 -0.917 . . . . 73.45 110.943 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.38 -26.16 20.82 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 122.895 2.397 . . . . 65.25 112.277 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -88.92 -8.56 53.98 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 122.469 1.128 . . . . 73.03 108.886 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 95.93 -135.55 12.38 Favored Glycine 0 CA--C 1.482 -1.985 0 CA-C-N 113.618 -1.628 . . . . 74.33 109.355 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.8 mp -83.71 -45.5 13.32 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.429 -1.693 . . . . 75.32 106.429 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 83.32 53.74 3.35 Favored Glycine 0 N--CA 1.421 -2.316 0 CA-C-N 114.645 -1.161 . . . . 74.32 114.348 170.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -154.4 164.48 38.57 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 116.736 0.268 . . . . 73.21 110.334 172.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.529 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 10.2 m -112.54 129.35 56.39 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.632 -0.507 . . . . 61.53 109.632 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.9 pt -118.75 153.33 20.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 109.927 -0.397 . . . . 74.15 109.927 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -142.22 136.57 30.01 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.288 -1.745 . . . . 63.32 106.288 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 347' ' ' SER . . . 144.81 157.44 7.22 Favored Glycine 0 C--N 1.282 -2.428 0 N-CA-C 109.288 -1.525 . . . . 34.1 109.288 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 137.74 175.5 13.91 Favored Glycine 0 C--N 1.282 -2.453 0 N-CA-C 108.386 -1.886 . . . . 73.01 108.386 -175.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.51 HG22 ' OE2' ' A' ' 381' ' ' GLU . 68.7 t -50.7 110.89 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 117.719 0.76 . . . . 42.31 109.655 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 81.4 -17.04 14.95 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 121.267 -0.492 . . . . 54.42 113.298 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.28 3.65 38.37 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.592 -1.262 . . . . 62.43 107.592 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.424 HE22 ' HA ' ' A' ' 343' ' ' PRO . 0.0 OUTLIER -49.57 126.21 13.03 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.595 1.158 . . . . 74.14 111.288 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -76.83 -37.27 55.97 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.22 -0.9 . . . . 64.45 109.97 -175.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 2.8 mp -104.82 126.76 30.35 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 109.344 -0.613 . . . . 64.51 109.344 177.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.424 ' HA ' HE22 ' A' ' 340' ' ' GLN . 18.7 Cg_endo -59.38 105.99 0.28 Allowed 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.842 2.362 . . . . 75.04 112.816 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 105.83 -1.22 38.82 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 115.553 -0.749 . . . . 43.43 111.931 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 60.4 t0 -130.85 103.55 6.63 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 108.087 -1.079 . . . . 72.22 108.087 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -76.91 65.05 2.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.501 1.143 . . . . 74.45 108.924 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.451 ' O ' ' HA3' ' A' ' 335' ' ' GLY . 5.2 p -97.09 134.6 40.22 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 113.289 -1.778 . . . . 74.21 112.38 -176.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 44.3 mm -80.94 119.14 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 N-CA-C 104.488 -2.412 . . . . 74.04 104.488 168.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -123.89 137.92 54.56 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 120.161 -0.616 . . . . 71.42 109.724 -169.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 49.5 t -78.58 111.41 15.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.266 -0.642 . . . . 44.5 109.266 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.5 m -96.42 -28.84 14.26 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.068 -0.515 . . . . 75.54 110.928 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 55.4 mttp -151.61 163.11 39.8 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 109.637 -0.505 . . . . 71.42 109.637 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.458 HG22 ' HB2' ' A' ' 360' ' ' HIS . 73.1 mt -131.54 127.48 59.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 106.644 -1.613 . . . . 72.44 106.644 174.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 50.6 mm -85.51 141.75 14.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 123.678 0.791 . . . . 70.12 111.466 -172.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.5 133.66 50.24 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.551 0.691 . . . . 74.44 112.339 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 70.88 7.46 62.05 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 120.598 -0.81 . . . . 75.05 112.454 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -67.39 148.89 50.41 Favored Glycine 0 N--CA 1.414 -2.807 0 N-CA-C 110.289 -1.124 . . . . 74.5 110.289 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.42 -34.27 77.38 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.432 -0.581 . . . . 43.31 109.432 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.574 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -76.1 -14.97 60.18 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.209 -0.597 . . . . 64.13 111.707 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 360' ' ' HIS . . . . . 0.458 ' HB2' HG22 ' A' ' 353' ' ' ILE . 39.6 t60 -84.14 -27.79 27.88 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.695 0.759 . . . . 72.41 109.18 177.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -96.69 -58.28 2.08 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 114.835 1.42 . . . . 53.51 114.835 173.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -85.81 -41.57 14.93 Favored 'General case' 0 CA--C 1.465 -2.309 0 C-N-CA 122.796 0.438 . . . . 74.41 111.155 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -43.02 -25.0 0.31 Allowed Glycine 0 CA--C 1.491 -1.413 0 N-CA-C 118.79 2.276 . . . . 63.54 118.79 -165.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.503 ' HD3' HG23 ' A' ' 320' ' ' ILE . 0.0 OUTLIER 43.72 36.21 1.23 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.42 1.088 . . . . 63.04 111.167 -179.3 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 39.5 tp -115.69 152.89 32.33 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 114.168 -1.378 . . . . 70.51 108.368 -171.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -123.84 155.56 37.8 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.751 0.786 . . . . 72.33 111.605 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 80.3 mt -66.12 125.47 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 107.204 -1.406 . . . . 71.42 107.204 173.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.34 -6.83 21.0 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.04 -1.076 . . . . 50.55 111.949 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -75.8 142.37 42.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.487 0.551 . . . . 63.1 112.487 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 76.4 tttt -101.64 131.21 47.99 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.931 -0.766 . . . . 73.14 108.931 176.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 68.8 mt -95.81 120.77 36.68 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.964 0.411 . . . . 74.13 110.812 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 403' ' ' ALA . 40.0 mt -83.41 -39.73 20.25 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.433 -1.258 . . . . 74.2 109.736 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.23 157.93 26.47 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 120.015 -0.674 . . . . 55.12 112.088 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.493 HG12 HD11 ' A' ' 379' ' ' LEU . 14.7 p -134.28 121.69 38.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 107.984 -1.117 . . . . 54.44 107.984 172.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' ASN . . . . . 0.518 HD21 HG22 ' A' ' 394' ' ' THR . 79.1 m-20 64.4 27.79 13.62 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 123.909 1.814 . . . . 71.2 108.641 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.2 t30 66.17 16.4 10.43 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 109.791 -3.368 . . . . 72.32 111.835 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.8 t -83.84 125.44 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.171 -1.788 . . . . 72.31 106.171 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.7 p -62.96 125.49 24.16 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 124.012 0.82 . . . . 63.44 113.008 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.493 HD11 HG12 ' A' ' 374' ' ' VAL . 6.2 mp -103.21 1.1 32.59 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.229 -0.896 . . . . 73.34 110.892 177.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -75.3 115.05 14.54 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.644 -0.873 . . . . 72.2 108.644 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' GLU . . . . . 0.51 ' OE2' HG22 ' A' ' 337' ' ' VAL . 19.7 tp10 62.22 83.42 0.15 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.557 1.17 . . . . 62.2 112.117 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 337' ' ' VAL . 23.9 m -153.21 165.8 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 113.24 -1.8 . . . . 75.52 107.606 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.469 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.0 OUTLIER -82.15 143.61 31.32 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.184 -1.043 . . . . 73.22 108.184 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.524 ' O ' HG23 ' A' ' 388' ' ' VAL . 86.1 t60 -50.6 -53.27 31.93 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 112.394 0.516 . . . . 72.42 112.394 -174.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.69 -27.35 68.28 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.129 -0.941 . . . . 70.44 111.217 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.9 tt0 -75.0 -34.47 61.97 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.796 -1.187 . . . . 72.42 107.796 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.46 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -73.08 -45.35 57.74 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.655 -1.157 . . . . 75.13 109.737 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 384' ' ' HIS . 15.4 t -56.95 -42.92 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.937 -0.764 . . . . 74.05 108.937 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 62.6 m -61.15 -36.3 79.41 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 116.016 -0.538 . . . . 63.42 110.936 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.74 80.91 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.333 -0.23 . . . . 70.24 110.512 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.7 mp -78.03 -31.56 50.49 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 120.456 -0.498 . . . . 74.35 111.024 176.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -71.27 -25.75 62.59 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 120.569 -0.453 . . . . 73.3 112.167 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -82.68 65.39 7.78 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.227 1.013 . . . . 72.01 110.468 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.518 HG22 HD21 ' A' ' 375' ' ' ASN . 17.6 p -132.78 146.1 51.56 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.248 -1.342 . . . . 53.22 108.394 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 47.9 m -145.92 91.58 2.1 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.583 1.182 . . . . 63.03 111.426 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.493 ' HA ' ' H ' ' A' ' 324' ' ' LYS 0.346 14.4 m-20 65.08 4.44 2.55 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 111.427 -2.624 . . . . 70.35 116.075 170.288 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -156.39 130.32 8.48 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 106.987 -1.486 . . . . 73.44 106.987 170.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 394' ' ' THR . 27.6 t -138.09 149.3 24.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 124.187 0.995 . . . . 54.11 109.063 -172.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -116.34 95.9 5.28 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.248 -1.019 . . . . 71.42 108.248 170.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.5 tt -95.39 119.37 33.77 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.106 0.479 . . . . 53.44 109.999 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -102.4 110.41 22.35 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.793 -1.188 . . . . 60.24 107.793 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 3.0 p -110.87 144.51 18.69 Favored 'Isoleucine or valine' 0 C--O 1.274 2.356 0 C-N-CA 124.232 1.013 . . . . 53.51 111.526 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -137.64 159.93 40.62 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 125.907 1.683 . . . . 72.2 109.022 176.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.515 ' HG3' ' C ' ' A' ' 411' ' ' HIS . 0.4 OUTLIER -77.69 155.9 80.7 Favored Pre-proline 0 C--N 1.295 -1.788 0 N-CA-C 109.234 -0.654 . . . . 63.01 109.234 173.37 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -47.69 121.04 5.18 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 123.456 2.77 . . . . 73.45 111.675 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 7.0 m -84.2 -38.05 21.07 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.82 -1.082 . . . . 71.42 111.721 -172.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -101.57 38.68 3.05 Favored Glycine 0 C--N 1.292 -1.916 0 C-N-CA 120.096 -1.05 . . . . 72.41 113.08 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 33.2 t -165.7 -170.22 1.74 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.165 -1.421 . . . . 75.0 107.165 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -73.86 140.28 45.62 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 107.23 -1.396 . . . . 75.15 107.23 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -79.61 127.7 32.49 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 112.704 0.631 . . . . 75.21 112.704 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.515 ' C ' ' HG3' ' A' ' 404' ' ' LYS . 88.1 m-70 . . . . . 0 C--N 1.309 -1.171 0 N-CA-C 107.046 -1.465 . . . . 70.31 107.046 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 107.625 -1.25 . . . . 72.23 107.625 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 142' ' ' ARG . . . . . 0.406 ' HD3' ' H ' ' B' ' 143' ' ' THR . 0.1 OUTLIER -162.92 159.19 23.38 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 105.912 -1.885 . . . . 73.31 105.912 -175.683 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.406 ' H ' ' HD3' ' B' ' 142' ' ' ARG . 36.6 p -69.8 151.87 45.25 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.026 -1.472 . . . . 72.43 107.026 175.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 144' ' ' ARG . . . . . 0.509 ' NE ' ' HA ' ' B' ' 144' ' ' ARG . 3.3 mmp_? -152.24 137.75 17.72 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 119.085 0.857 . . . . 73.42 111.588 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -86.54 162.77 17.86 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 113.822 -1.536 . . . . 64.12 108.58 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 67.44 18.97 10.1 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.501 1.52 . . . . 74.22 112.519 -174.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -157.11 179.23 9.49 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.805 0.842 . . . . 71.14 108.913 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.78 144.96 24.96 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.155 -0.683 . . . . 71.31 109.155 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 86.6 m -134.63 142.69 46.96 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.722 -0.473 . . . . 62.42 109.722 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.87 145.4 36.27 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 122.942 0.497 . . . . 74.42 111.041 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 14.0 m . . . . . 0 C--O 1.261 1.676 0 CA-C-N 115.738 -0.665 . . . . 73.13 111.282 175.262 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 CA--C 1.495 -1.16 0 N-CA-C 107.192 -1.41 . . . . 64.2 107.192 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.323 2.0 pm0 -115.79 133.88 55.58 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-O 122.23 1.014 . . . . 70.24 113.364 -176.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 363' ' ' GLY . 77.3 mt -129.89 116.56 38.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 113.217 -1.81 . . . . 60.31 110.27 -168.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.453 ' HE3' ' HB3' ' A' ' 321' ' ' LYS . 1.3 ttpp -75.92 134.7 40.18 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.028 -0.73 . . . . 74.24 109.028 172.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.517 ' HA ' ' OD2' ' A' ' 362' ' ' ASP . 95.5 mt -131.78 152.15 51.16 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 123.556 0.535 . . . . 72.12 110.217 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.44 110.64 31.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.14 -1.059 . . . . 70.45 108.14 171.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.481 ' NZ ' ' HA ' ' A' ' 392' ' ' LYS . 79.1 tttt -76.94 130.23 37.24 Favored 'General case' 0 C--O 1.201 -1.457 0 C-N-CA 119.687 -0.805 . . . . 63.54 110.112 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -133.85 -163.77 10.47 Favored Glycine 0 C--N 1.298 -1.58 0 C-N-CA 119.766 -1.207 . . . . 25.3 111.905 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.64 -12.9 33.49 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 123.775 2.983 . . . . 73.41 113.782 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -103.53 6.99 37.75 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 122.316 1.055 . . . . 63.33 108.805 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.21 -151.02 28.01 Favored Glycine 0 CA--C 1.493 -1.331 0 CA-C-N 114.303 -1.317 . . . . 51.13 110.213 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.6 mp -88.11 -16.51 33.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.747 -1.575 . . . . 71.14 106.747 166.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' GLY . . . . . 0.561 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 79.16 39.28 19.93 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 113.921 -1.491 . . . . 61.32 114.892 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 52.2 p90 -151.45 165.75 33.2 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 117.596 0.698 . . . . 55.45 110.487 175.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' B' ' 149' ' ' THR . 12.2 m -121.62 136.0 54.96 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 109.706 -0.479 . . . . 61.55 109.706 -178.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' B' ' 148' ' ' GLU . 17.9 pt -119.9 152.73 22.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 122.514 0.326 . . . . 51.43 111.761 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.2 114.65 5.56 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 104.997 -2.223 . . . . 74.02 104.997 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.66 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 162.3 156.21 8.35 Favored Glycine 0 C--N 1.286 -2.222 0 N-CA-C 109.709 -1.356 . . . . 73.32 109.709 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.68 -174.81 20.88 Favored Glycine 0 CA--C 1.484 -1.873 0 N-CA-C 108.908 -1.677 . . . . 42.35 108.908 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 96.1 t -51.68 108.47 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 117.498 0.649 . . . . 44.2 111.673 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 91.37 -21.57 34.44 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.114 -0.948 . . . . 61.14 112.773 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.66 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 57.6 t30 -107.08 26.88 9.59 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.24 -0.652 . . . . 72.31 109.24 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -55.29 119.6 5.8 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.888 -0.596 . . . . 55.34 110.674 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -78.9 -41.5 29.52 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.304 -0.862 . . . . 44.14 109.865 -175.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 43.5 mm -103.91 123.36 41.31 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 108.918 -0.771 . . . . 63.44 108.918 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.95 105.39 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.161 2.574 . . . . 74.21 112.419 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.97 -5.14 28.93 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.477 -0.783 . . . . 32.32 111.935 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -129.29 99.46 5.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.766 0.793 . . . . 72.42 108.973 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 66.1 t30 -82.8 35.33 0.46 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.384 1.074 . . . . 71.41 111.458 -171.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.449 ' CB ' ' HE3' ' A' ' 370' ' ' LYS . 68.2 m -104.79 177.89 4.72 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 113.035 0.754 . . . . 71.05 113.035 -176.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.7 129.43 39.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.337 -0.847 . . . . 73.43 109.319 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 37.3 m-85 -124.26 136.73 54.36 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 113.47 0.915 . . . . 74.32 113.47 -177.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.424 HG21 HD21 ' A' ' 365' ' ' LEU . 60.4 t -71.65 117.2 14.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.688 -1.142 . . . . 74.41 108.51 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.4 m -106.28 -18.16 14.08 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.799 0.333 . . . . 52.21 111.581 -175.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.621 ' HG2' ' OE1' ' B' ' 148' ' ' GLU . 44.0 mmtm -149.89 154.95 39.17 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 108.609 -0.886 . . . . 72.14 108.609 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.427 ' CG2' ' HB2' ' A' ' 360' ' ' HIS . 57.0 mt -138.89 121.23 17.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 107.232 -1.395 . . . . 63.11 107.232 172.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 41.6 mm -86.0 133.15 30.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.385 -1.339 . . . . 71.24 107.385 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.43 144.83 56.64 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.627 -1.62 . . . . 73.24 106.627 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.47 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 92.08 -12.79 68.65 Favored Glycine 0 CA--C 1.475 -2.415 0 C-N-CA 119.36 -1.4 . . . . 55.15 110.672 178.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 357' ' ' GLY . . . . . 0.561 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -67.98 148.34 49.03 Favored Glycine 1 N--CA 1.396 -4.005 0 N-CA-C 108.716 -1.754 . . . . 71.41 108.716 172.722 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.48 77.08 Favored 'General case' 0 C--O 1.2 -1.532 0 N-CA-C 109.834 -0.432 . . . . 55.14 109.834 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.593 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -73.82 -11.74 60.47 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.671 -0.812 . . . . 74.22 112.486 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' HIS . . . . . 0.427 ' HB2' ' CG2' ' A' ' 353' ' ' ILE . 36.8 t-80 -88.01 -43.95 11.35 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.423 -0.584 . . . . 70.54 109.423 177.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.47 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 73.4 mmtt -86.42 -57.83 2.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.143 0.973 . . . . 63.05 110.947 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' ASP . . . . . 0.517 ' OD2' ' HA ' ' A' ' 322' ' ' LEU . 35.2 t0 -81.75 -33.83 30.77 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 125.075 1.35 . . . . 74.43 109.38 -175.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.654 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -84.6 -16.91 65.03 Favored Glycine 0 C--N 1.289 -2.074 0 N-CA-C 117.37 1.708 . . . . 55.51 117.37 -169.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.654 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.31 34.23 0.49 Allowed 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 118.054 0.927 . . . . 65.21 112.619 -177.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 365' ' ' LEU . . . . . 0.424 HD21 HG21 ' A' ' 350' ' ' VAL . 33.0 tp -83.78 157.58 22.04 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.199 0.999 . . . . 60.05 111.453 -170.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -118.1 142.24 47.62 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.279 0.561 . . . . 62.21 111.414 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 84.3 mt -66.49 121.97 16.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 107.254 -1.387 . . . . 72.43 107.254 169.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 113.76 -1.72 24.56 Favored Glycine 0 C--N 1.309 -0.917 0 N-CA-C 110.936 -0.866 . . . . 63.33 110.936 -174.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.513 ' HB3' HG21 ' A' ' 402' ' ' VAL . 2.4 m-20 -73.14 138.32 45.69 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.265 0.469 . . . . 63.23 112.265 176.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 64.1 tttt -99.95 115.99 30.95 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.164 -0.925 . . . . 61.42 110.369 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 82.1 mt -82.13 112.94 19.63 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.455 -0.572 . . . . 71.33 109.455 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.5 tt -82.31 -37.36 25.89 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.079 -1.418 . . . . 61.55 107.343 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -162.85 157.45 21.34 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.057 -0.974 . . . . 72.12 109.122 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.491 HG11 ' HG ' ' A' ' 391' ' ' LEU . 10.0 p -142.86 121.85 8.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-O 121.138 0.494 . . . . 65.1 109.704 174.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 66.9 t30 44.56 78.86 0.05 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 126.246 1.818 . . . . 72.55 111.745 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 65.94 -29.42 0.13 Allowed 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 114.681 1.364 . . . . 74.4 114.681 -175.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 28.2 t -83.96 124.56 39.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 O-C-N 121.471 -0.768 . . . . 74.42 110.969 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 11.6 p -75.19 132.5 41.18 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.789 -0.449 . . . . 73.12 109.789 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.8 mp -108.51 -4.67 17.05 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.067 0.766 . . . . 73.24 113.067 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -63.55 113.87 3.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.572 0.225 . . . . 62.4 111.376 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 59.57 39.91 20.93 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 122.807 1.289 . . . . 73.43 112.989 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 31.4 m -104.27 166.16 3.15 Favored 'Isoleucine or valine' 0 C--O 1.257 1.494 0 N-CA-C 106.644 -1.613 . . . . 72.13 106.644 171.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.54 ' HB ' ' OE1' ' A' ' 386' ' ' GLU . 0.4 OUTLIER -81.13 149.08 29.31 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 117.808 -1.557 . . . . 72.32 107.381 178.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.604 ' O ' HG23 ' A' ' 388' ' ' VAL . 79.8 t60 -53.77 -27.92 31.64 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 114.32 1.23 . . . . 74.13 114.32 -172.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.601 ' HB2' ' CG ' ' B' ' 144' ' ' ARG . 34.9 tt0 -65.87 -41.63 91.38 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 117.796 0.271 . . . . 74.12 110.293 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.54 ' OE1' ' HB ' ' A' ' 383' ' ' THR . 1.9 mp0 -68.38 -33.15 73.75 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 109.063 -0.718 . . . . 65.21 109.063 -177.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.575 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -64.96 -58.15 6.88 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.392 -1.276 . . . . 54.41 109.058 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 384' ' ' HIS . 40.6 t -54.58 -43.35 64.53 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 0 O-C-N 123.401 0.438 . . . . 74.14 110.146 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 93.1 m -59.17 -37.5 77.5 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.355 0.662 . . . . 55.21 111.911 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -68.51 -40.64 80.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.996 0.427 . . . . 72.43 110.077 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.575 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.1 mp -75.37 -19.95 59.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.201 0.524 . . . . 52.32 111.036 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.495 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 54.8 mttm -80.18 -41.53 25.1 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 113.429 0.9 . . . . 65.23 113.429 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -84.99 65.68 9.36 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.918 0.866 . . . . 72.23 111.427 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 1.3 p -145.01 148.92 34.28 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.565 -1.198 . . . . 74.52 109.296 177.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 22.0 m -145.37 120.28 9.98 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.841 -0.8 . . . . 61.01 108.841 178.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 56.1 0.98 0.06 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 127.381 2.272 . . . . 74.51 116.49 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' PHE . . . . . 0.438 ' HE2' ' CE2' ' A' ' 399' ' ' TYR . 6.0 t80 -158.73 125.12 4.62 Favored 'General case' 0 N--CA 1.437 -1.077 0 O-C-N 121.297 -0.877 . . . . 72.44 109.805 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.2 t -141.37 145.86 24.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.17 -1.048 . . . . 64.13 108.17 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.438 ' CE2' ' HE2' ' A' ' 397' ' ' PHE . 21.1 m-85 -115.22 97.35 6.15 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.053 -0.721 . . . . 65.21 109.053 172.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 8.0 tt -87.01 134.42 33.49 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 110.271 -0.27 . . . . 71.55 110.271 -177.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -121.83 108.19 13.18 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.494 -0.928 . . . . 70.31 108.494 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.513 HG21 ' HB3' ' A' ' 369' ' ' ASP . 7.3 p -116.37 151.99 18.13 Favored 'Isoleucine or valine' 0 C--O 1.268 2.055 0 CA-C-O 121.561 0.696 . . . . 74.44 111.225 -175.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.86 158.66 43.95 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 125.153 1.381 . . . . 72.42 108.089 176.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.55 159.12 72.67 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 108.435 -0.95 . . . . 70.1 108.435 173.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 405' ' ' PRO . . . . . 0.496 ' HB2' ' OG ' ' A' ' 408' ' ' SER . 18.9 Cg_endo -52.67 105.52 0.12 Allowed 'Trans proline' 0 C--N 1.365 1.43 0 C-N-CA 123.634 2.889 . . . . 64.04 114.407 -172.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 5.8 m -73.61 -35.38 65.34 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.364 -0.834 . . . . 55.52 112.088 -171.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -80.91 31.91 2.49 Favored Glycine 0 C--N 1.292 -1.906 0 CA-C-N 116.027 -0.533 . . . . 71.32 113.483 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' SER . . . . . 0.496 ' OG ' ' HB2' ' A' ' 405' ' ' PRO . 54.4 p -168.29 -172.68 1.79 Allowed 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.965 -1.124 . . . . 71.31 107.965 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -77.13 105.9 8.51 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.154 -0.684 . . . . 73.25 109.154 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' HIS . . . . . 0.467 ' HB3' ' O ' ' A' ' 405' ' ' PRO . 26.9 p-80 -107.48 142.45 37.32 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.22 -0.9 . . . . 73.43 111.032 -177.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 . . . . . 0 N--CA 1.423 -1.802 0 N-CA-C 104.005 -2.591 . . . . 65.54 104.005 177.389 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.878 0 N-CA-C 107.203 -1.406 . . . . 72.1 107.203 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 142' ' ' ARG . . . . . 0.437 ' HB3' ' OE1' ' A' ' 385' ' ' GLU . 19.8 mtp180 -120.2 130.43 54.54 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.141 -1.429 . . . . 74.12 107.141 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.433 HG21 HG21 ' B' ' 149' ' ' THR . 2.9 p -70.48 99.73 1.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 123.655 0.597 . . . . 75.3 111.497 -175.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 144' ' ' ARG . . . . . 0.601 ' CG ' ' HB2' ' A' ' 385' ' ' GLU . 52.2 mtt180 -154.5 -49.35 0.09 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 117.591 -1.644 . . . . 73.01 114.171 173.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . 0.656 26.2 mt-30 -96.52 119.58 35.27 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 121.088 3.736 . . . . 71.21 121.088 -173.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 47.28 44.45 15.95 Favored 'General case' 0 CA--C 1.488 -1.412 0 O-C-N 124.244 0.965 . . . . 71.43 111.461 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 147' ' ' ASN . . . . . 0.439 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.2 OUTLIER -142.76 136.73 29.17 Favored 'General case' 0 N--CA 1.402 -2.857 0 CA-C-N 114.155 -1.384 . . . . 72.13 108.361 -176.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 148' ' ' GLU . . . . . 0.621 ' OE1' ' HG2' ' A' ' 352' ' ' LYS . 15.6 pt-20 -96.23 140.94 30.18 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 108.515 -0.92 . . . . 64.44 108.515 174.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 332' ' ' SER . 87.7 m -134.13 135.98 43.53 Favored 'General case' 0 C--N 1.282 -2.368 0 C-N-CA 120.745 -0.382 . . . . 62.4 111.625 -176.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -80.57 124.09 28.67 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.313 -0.995 . . . . 72.12 108.313 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 C--N 1.282 -2.337 0 N-CA-C 115.435 1.643 . . . . 73.04 115.435 -174.576 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 CA--C 1.492 -1.263 0 N-CA-C 106.721 -1.585 . . . . 61.13 106.721 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.405 2.0 pm0 -115.82 130.78 56.98 Favored 'General case' 0 C--N 1.266 -3.046 0 CA-C-O 122.784 1.278 . . . . 73.1 114.408 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 69.0 mt -122.54 112.98 36.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.456 0 CA-C-N 112.482 -2.144 . . . . 73.32 110.698 -169.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 321' ' ' LYS . 0.4 OUTLIER -73.57 127.71 33.5 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 106.982 -1.488 . . . . 73.31 106.982 171.356 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.572 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 98.3 mt -120.54 154.24 35.61 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.829 -1.175 . . . . 71.21 107.829 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 324' ' ' LYS . 47.0 mt -107.43 150.58 9.89 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.028 0 N-CA-C 106.448 -1.686 . . . . 71.33 106.448 171.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.516 ' O ' HG22 ' A' ' 323' ' ' ILE . 1.0 OUTLIER -76.26 178.67 6.28 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.07 -1.455 . . . . 73.22 107.07 173.103 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -164.93 -166.98 24.79 Favored Glycine 0 C--N 1.287 -2.193 0 C-N-CA 118.373 -1.87 . . . . 71.4 113.627 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.56 -35.23 23.35 Favored 'Trans proline' 0 C--O 1.213 -0.753 0 C-N-CA 123.772 2.982 . . . . 62.21 112.41 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.414 ' NZ ' ' HA3' ' A' ' 356' ' ' GLY . 44.4 mttp -99.8 19.76 15.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.349 -0.611 . . . . 65.4 109.349 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.65 -123.97 6.5 Favored Glycine 0 CA--C 1.485 -1.84 0 N-CA-C 107.992 -2.043 . . . . 65.35 107.992 -176.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.442 HD11 ' OG1' ' A' ' 394' ' ' THR . 9.4 mp -93.13 -29.03 15.96 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.265 -1.383 . . . . 63.51 107.265 174.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 330' ' ' GLY . . . . . 0.544 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 77.49 39.82 24.83 Favored Glycine 0 N--CA 1.427 -1.92 0 CA-C-N 113.512 -1.676 . . . . 53.33 114.414 172.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -143.59 149.88 38.02 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 119.941 -0.703 . . . . 75.42 109.919 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.604 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 9.9 m -105.52 127.41 53.0 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 115.413 -0.812 . . . . 75.1 110.18 -176.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 22.6 pt -115.8 143.72 25.08 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-N 115.314 -0.857 . . . . 73.45 110.305 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -130.13 114.64 15.98 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.771 -1.566 . . . . 63.42 106.771 175.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 167.75 166.23 26.48 Favored Glycine 0 N--CA 1.408 -3.171 0 N-CA-C 110.609 -0.996 . . . . 61.2 110.609 177.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.12 177.12 14.72 Favored Glycine 0 N--CA 1.411 -2.995 0 N-CA-C 106.933 -2.467 . . . . 70.54 106.933 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.45 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 56.7 t -56.6 99.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 117.858 0.829 . . . . 64.31 110.035 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.22 -10.92 69.55 Favored Glycine 0 N--CA 1.432 -1.594 0 CA-C-O 119.148 -0.807 . . . . 44.43 114.237 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.594 ' HB2' ' HG3' ' B' ' 145' ' ' GLN . 63.5 t30 -106.88 10.28 30.64 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 118.767 1.284 . . . . 43.41 109.252 175.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.459 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 1.3 pp0? -53.95 122.48 10.18 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 114.462 1.282 . . . . 71.23 114.462 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -66.87 -35.15 79.37 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.021 -1.445 . . . . 75.13 109.412 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.5 mm -104.89 120.02 51.45 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 115.68 -0.691 . . . . 70.14 109.649 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.83 109.03 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.765 2.31 . . . . 74.23 111.574 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.12 -14.84 28.39 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.576 -0.821 . . . . 73.11 111.961 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -119.49 98.03 5.94 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 106.887 -1.523 . . . . 71.42 106.887 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.459 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 62.2 t30 -80.66 34.84 0.34 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.007 0.923 . . . . 72.13 112.531 -169.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 66.7 m -97.89 178.73 5.03 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.66 0.743 . . . . 75.43 112.751 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.514 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 18.2 mm -94.17 129.84 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 CA-C-N 114.777 -1.101 . . . . 54.51 108.062 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 30.1 m-85 -124.05 134.4 53.42 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 112.632 0.605 . . . . 63.23 112.632 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.69 111.65 3.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.022 -1.473 . . . . 73.15 107.022 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 45.6 m -106.97 -24.08 12.12 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.367 0.603 . . . . 71.23 111.965 -173.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.604 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 57.7 mttp -149.34 149.74 31.37 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.818 -1.178 . . . . 72.23 107.818 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 65.7 mt -128.87 120.77 52.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.395 -0.965 . . . . 73.33 108.395 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 31.2 mm -86.65 129.28 38.63 Favored 'Isoleucine or valine' 0 C--O 1.261 1.688 0 C-N-CA 123.34 0.656 . . . . 62.33 109.693 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.91 147.13 53.93 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 107.333 -1.358 . . . . 74.41 107.333 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' GLY . . . . . 0.579 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.51 -15.25 63.57 Favored Glycine 0 C--N 1.278 -2.659 0 N-CA-C 109.657 -1.377 . . . . 71.14 109.657 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' GLY . . . . . 0.544 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -72.05 139.04 27.68 Favored Glycine 1 N--CA 1.392 -4.255 0 N-CA-C 107.922 -2.071 . . . . 72.24 107.922 170.403 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -65.24 -25.38 67.65 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 109.48 -0.563 . . . . 61.25 109.48 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.659 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.87 -10.41 59.41 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 120.392 -0.523 . . . . 72.33 111.767 176.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -94.66 -35.24 12.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.125 -1.065 . . . . 72.4 108.125 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.579 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 75.5 mmtt -81.95 -58.56 2.92 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 120.125 -0.63 . . . . 73.42 111.173 -178.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -86.2 -35.12 20.26 Favored 'General case' 0 CA--C 1.472 -2.046 0 CA-C-O 122.028 0.918 . . . . 62.42 109.09 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.738 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -44.17 -29.22 1.54 Allowed Glycine 0 CA--C 1.487 -1.659 0 N-CA-C 119.924 2.729 . . . . 61.41 119.924 -165.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.738 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 39.98 34.75 0.2 Allowed 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 124.767 1.227 . . . . 65.12 111.92 -175.61 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 55.1 tp -107.03 153.55 22.43 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.597 -1.183 . . . . 74.11 109.362 -172.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -123.55 151.19 43.15 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.467 0.651 . . . . 73.23 112.18 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.14 125.76 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 108.1 -1.074 . . . . 74.21 108.1 172.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 114.99 -6.26 21.93 Favored Glycine 0 C--N 1.315 -0.623 0 C-N-CA 121.101 -0.571 . . . . 71.44 112.131 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.549 ' HB3' HG21 ' A' ' 402' ' ' VAL . 10.1 m-20 -75.02 137.09 41.27 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.208 0.818 . . . . 70.1 113.208 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.593 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 35.6 tttp -96.0 115.65 27.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.409 1.483 . . . . 75.32 109.477 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.408 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 68.1 mt -85.87 115.9 23.78 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.307 0.575 . . . . 62.55 110.224 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.1 tt -83.5 -37.77 22.66 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 113.692 -1.594 . . . . 74.21 107.273 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.81 155.86 21.94 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.157 -0.929 . . . . 75.1 109.467 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.525 HG11 ' HG ' ' A' ' 391' ' ' LEU . 7.6 p -134.76 117.63 23.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 109.015 -0.735 . . . . 73.24 109.015 174.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 9.7 t30 44.91 74.79 0.12 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 125.836 1.655 . . . . 71.33 111.852 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 67.63 -23.57 0.12 Allowed 'General case' 0 CA--C 1.57 1.718 0 C-N-CA 125.386 1.474 . . . . 33.41 114.13 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 20.3 t -85.97 127.72 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 121.203 -0.936 . . . . 71.44 110.494 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -75.35 133.12 41.3 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 122.937 0.495 . . . . 75.54 110.833 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.435 HD21 HD11 ' A' ' 391' ' ' LEU . 7.9 mp -114.12 -4.7 13.11 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.899 1.074 . . . . 75.2 113.899 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -67.03 104.9 1.5 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.903 -0.406 . . . . 70.22 109.903 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 65.03 82.83 0.18 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.892 1.277 . . . . 73.52 113.812 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 20.6 m -143.42 163.88 15.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 106.156 -1.794 . . . . 34.23 106.156 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.9 m -79.81 149.07 31.15 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 119.17 0.895 . . . . 73.35 108.879 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.515 ' O ' HG23 ' A' ' 388' ' ' VAL . 83.5 t60 -46.45 -48.44 18.95 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.231 0.826 . . . . 74.44 113.231 -174.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.435 ' OE2' ' HD3' ' B' ' 142' ' ' ARG . 18.7 tp10 -60.84 -39.24 88.34 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.021 0.438 . . . . 63.15 110.447 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -69.29 -39.8 78.11 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.389 -0.967 . . . . 72.43 108.389 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.18 -58.3 7.68 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.354 -1.294 . . . . 62.41 110.257 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.522 ' HB ' HG21 ' B' ' 143' ' ' THR . 40.5 t -55.63 -40.36 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 123.464 0.477 . . . . 74.14 110.606 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 88.8 m -60.25 -38.05 82.31 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.389 -0.369 . . . . 52.14 111.813 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.28 86.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.67 0.272 . . . . 71.31 110.797 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.532 HD22 HG21 ' B' ' 151' ' ' VAL . 5.5 mp -77.83 -37.74 47.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.179 -0.608 . . . . 52.0 109.891 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 54.2 mttm -62.97 -31.79 72.98 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 113.642 0.978 . . . . 72.31 113.642 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -83.81 64.49 8.08 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.975 0.893 . . . . 74.14 111.67 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.446 ' HB ' HG22 ' A' ' 398' ' ' VAL . 13.3 p -132.36 153.91 50.29 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.77 -1.105 . . . . 72.1 109.288 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 41.8 m -143.77 96.73 2.95 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.429 1.109 . . . . 74.34 111.143 178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.509 ' HA ' ' H ' ' A' ' 324' ' ' LYS 0.4 9.0 m-20 57.57 6.06 0.38 Allowed 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 128.303 2.641 . . . . 71.35 118.063 172.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 397' ' ' PHE . . . . . 0.433 ' HE2' ' CZ ' ' A' ' 399' ' ' TYR . 31.2 t80 -156.31 127.75 7.14 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.004 -1.48 . . . . 64.22 107.004 171.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 24.1 t -138.69 142.82 33.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 123.269 0.627 . . . . 73.13 109.738 -174.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.433 ' CZ ' ' HE2' ' A' ' 397' ' ' PHE . 87.1 m-85 -111.6 96.41 6.07 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.837 -0.801 . . . . 73.32 108.837 172.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.505 HD13 HD11 ' A' ' 322' ' ' LEU . 6.6 tt -89.27 135.29 33.66 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.568 -0.707 . . . . 72.55 110.58 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -117.77 108.65 15.63 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.41 -0.959 . . . . 72.44 108.41 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 369' ' ' ASP . 3.6 p -113.77 151.86 15.54 Favored 'Isoleucine or valine' 0 C--O 1.266 1.935 0 CA-C-O 121.977 0.894 . . . . 64.44 110.842 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.593 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -135.28 157.91 45.7 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 104.362 -2.459 . . . . 71.41 104.362 174.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 410' ' ' HIS . 62.1 mttm -95.88 153.16 39.33 Favored Pre-proline 0 C--N 1.274 -2.69 0 C-N-CA 118.159 -1.417 . . . . 71.51 111.39 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -37.15 111.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 125.054 3.836 . . . . 74.14 115.74 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 1.5 p -95.48 -5.66 42.42 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.953 -1.021 . . . . 70.22 113.155 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -101.74 3.26 52.86 Favored Glycine 0 N--CA 1.438 -1.233 0 C-N-CA 120.01 -1.091 . . . . 71.12 112.492 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 68.4 m -161.33 -170.67 2.72 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.612 -1.255 . . . . 23.03 107.612 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -72.3 147.54 46.26 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.076 -0.713 . . . . 70.53 109.076 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' HIS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 404' ' ' LYS . 3.1 p-80 -119.59 144.63 47.0 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 113.377 0.88 . . . . 73.41 113.377 -175.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 . . . . . 0 N--CA 1.433 -1.277 0 N-CA-C 106.137 -1.801 . . . . 73.31 106.137 179.751 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.459 -2.523 0 N-CA-C 108.092 -1.077 . . . . 71.22 108.092 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 142' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' B' ' 142' ' ' ARG . 46.8 ttt-85 -167.59 -53.22 0.02 OUTLIER 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 105.19 -2.152 . . . . 74.52 105.19 -169.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.522 HG21 ' HB ' ' A' ' 388' ' ' VAL . 34.8 p -97.51 178.83 5.06 Favored 'General case' 0 C--O 1.263 1.787 0 N-CA-C 102.386 -3.19 . . . . 64.44 102.386 164.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -151.78 97.4 2.35 Favored 'General case' 0 C--O 1.167 -3.248 0 CA-C-N 120.371 1.442 . . . . 73.3 107.799 -173.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 145' ' ' GLN . . . . . 0.594 ' HG3' ' HB2' ' A' ' 339' ' ' ASN . 28.9 tt0 -57.57 144.47 37.14 Favored 'General case' 0 C--N 1.258 -3.399 0 N-CA-C 113.493 0.923 . . . . 71.44 113.493 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 146' ' ' ARG . . . . . 0.41 ' HA ' ' OD1' ' A' ' 339' ' ' ASN . 0.2 OUTLIER 68.18 68.67 0.33 Allowed 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 125.215 1.406 . . . . 61.42 109.564 -162.771 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 177.44 164.99 0.59 Allowed 'General case' 0 CA--C 1.486 -1.511 0 CA-C-N 113.067 -1.878 . . . . 71.32 107.717 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.58 150.3 21.28 Favored 'General case' 0 N--CA 1.408 -2.537 0 C-N-CA 118.616 -1.234 . . . . 72.31 107.804 162.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 332' ' ' SER . 97.2 m -132.23 132.04 42.7 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.38 -0.6 . . . . 73.33 109.38 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -74.16 131.59 41.42 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-N 115.608 -0.723 . . . . 72.02 110.65 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.532 HG21 HD22 ' A' ' 391' ' ' LEU . 45.4 t . . . . . 0 C--N 1.286 -2.193 0 CA-C-N 115.099 -0.955 . . . . 64.22 108.686 173.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' MET . . . . . 0.498 ' HB3' ' O ' ' A' ' 402' ' ' VAL . 24.0 ttt . . . . . 0 C--O 1.193 -1.872 0 N-CA-C 105.814 -1.921 . . . . 73.51 105.814 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.355 2.0 pm0 -117.23 135.99 53.39 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 115.605 1.705 . . . . 74.14 115.605 -174.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 363' ' ' GLY . 91.4 mt -116.48 110.2 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.298 0 CA-C-N 112.637 -2.074 . . . . 72.01 108.98 -176.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.401 ' HE2' ' CZ ' ' A' ' 399' ' ' TYR . 38.7 ttmt -74.3 125.67 28.97 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.101 -1.444 . . . . 75.34 107.101 171.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.406 HD21 ' CA ' ' A' ' 363' ' ' GLY . 6.0 mt -122.91 149.39 44.3 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.107 -0.952 . . . . 63.13 110.518 -175.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 37.8 mm -106.55 114.62 46.21 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 109.064 -0.717 . . . . 74.03 109.064 173.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.759 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 8.7 tmtt? -64.82 152.94 41.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.216 -0.661 . . . . 74.33 109.216 173.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -143.42 -159.5 8.0 Favored Glycine 0 C--N 1.296 -1.646 0 C-N-CA 120.615 -0.802 . . . . 63.35 111.678 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.56 -12.71 27.15 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.947 2.431 . . . . 62.41 112.493 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.434 ' HD2' ' HA2' ' A' ' 357' ' ' GLY . 40.6 ttmt -103.58 5.02 36.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.168 0.985 . . . . 73.33 108.818 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.02 -114.6 3.92 Favored Glycine 0 CA--C 1.488 -1.632 0 N-CA-C 108.283 -1.927 . . . . 74.31 108.283 -176.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.503 ' HB2' HG23 ' B' ' 151' ' ' VAL . 5.3 mp -112.22 -35.55 5.59 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.829 -1.174 . . . . 75.31 107.829 173.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.43 50.59 3.98 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.194 -0.912 . . . . 74.4 115.218 172.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' PHE . . . . . 0.513 ' O ' HG22 ' B' ' 151' ' ' VAL . 25.7 p90 -154.73 144.5 21.58 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.076 0.465 . . . . 73.13 110.199 172.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 17.3 m -92.76 125.99 37.64 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.41 -0.813 . . . . 71.34 109.454 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.479 HD12 HG21 ' A' ' 348' ' ' ILE . 49.9 pt -113.09 144.18 21.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 108.502 -0.925 . . . . 70.43 108.502 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -138.83 131.66 29.29 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.753 -1.203 . . . . 74.32 107.753 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 144.77 164.12 10.41 Favored Glycine 0 C--N 1.28 -2.583 0 N-CA-C 109.606 -1.397 . . . . 61.15 109.606 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.09 177.16 14.76 Favored Glycine 0 CA--C 1.479 -2.206 0 N-CA-C 108.13 -1.988 . . . . 43.41 108.13 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 84.2 t -51.15 107.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 117.634 0.717 . . . . 62.44 110.954 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 91.34 -18.93 50.08 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.166 -0.925 . . . . 64.34 112.227 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.567 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 65.6 t30 -105.96 19.71 20.11 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.282 -0.636 . . . . 62.31 109.282 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.04 125.6 14.16 Favored 'General case' 0 C--O 1.251 1.167 0 CA-C-N 115.793 -0.64 . . . . 72.11 111.13 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -79.19 -49.11 13.07 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.127 -0.942 . . . . 75.41 109.768 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 55.7 mt -103.45 125.58 34.53 Favored Pre-proline 0 C--N 1.304 -1.407 0 CA-C-N 115.839 -0.619 . . . . 62.15 109.711 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -48.96 109.34 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 123.347 2.698 . . . . 73.13 112.638 177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 102.49 -2.24 49.81 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.387 -0.824 . . . . 43.55 112.265 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -128.93 96.89 4.47 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.747 -0.834 . . . . 63.4 108.747 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -83.07 33.03 0.44 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.927 0.87 . . . . 72.1 111.624 -171.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 56.7 m -98.96 178.08 5.05 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.798 -0.637 . . . . 61.5 111.933 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 9.1 mm -90.81 132.83 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.995 -1.113 . . . . 61.33 107.995 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 39.6 m-85 -125.17 138.69 54.14 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 112.725 0.639 . . . . 65.11 112.725 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 50.9 t -68.05 118.03 11.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.296 -1.002 . . . . 75.41 108.296 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 17.4 m -105.27 -26.15 12.14 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.065 0.46 . . . . 73.34 111.285 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -156.7 138.08 13.88 Favored 'General case' 0 C--O 1.2 -1.544 0 N-CA-C 107.198 -1.408 . . . . 73.14 107.198 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 73.6 mt -110.37 128.35 66.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.342 -1.355 . . . . 70.15 107.342 172.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 50.1 mm -73.95 134.62 29.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.143 0.497 . . . . 74.53 109.848 -175.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.541 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.5 pm0 -62.68 125.55 24.33 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 124.482 1.113 . . . . 73.13 110.915 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 74.37 17.96 79.81 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.581 -1.191 . . . . 53.51 110.949 -175.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' GLY . . . . . 0.434 ' HA2' ' HD2' ' A' ' 327' ' ' LYS . . . -76.76 160.37 50.39 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 111.512 -0.635 . . . . 75.23 111.512 175.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.06 94.49 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.519 -0.919 . . . . 50.0 108.519 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.484 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -74.64 -5.93 45.82 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.251 -0.431 . . . . 71.24 111.75 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -93.77 -33.96 13.39 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.575 -0.898 . . . . 75.14 108.575 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -91.25 -59.75 2.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 123.215 1.483 . . . . 73.21 109.838 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -87.13 -34.13 19.2 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 112.422 -2.172 . . . . 70.03 111.004 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -58.05 -33.64 70.01 Favored Glycine 0 C--O 1.199 -2.035 0 N-CA-C 117.453 1.741 . . . . 62.51 117.453 -174.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.656 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.62 33.34 0.45 Allowed 'General case' 0 N--CA 1.508 2.426 0 CA-C-N 118.457 1.129 . . . . 75.34 111.109 -173.635 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 58.9 tp -99.34 155.65 17.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.415 -1.266 . . . . 75.4 109.696 -171.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -117.07 146.42 43.12 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.111 0.481 . . . . 54.42 110.296 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.2 mt -66.22 120.82 14.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 107.506 -1.294 . . . . 71.2 107.506 171.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.44 -6.62 20.85 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 120.818 -0.706 . . . . 53.21 112.535 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.447 ' HB3' HG21 ' A' ' 402' ' ' VAL . 4.7 m-20 -75.39 142.36 43.1 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 112.712 0.634 . . . . 74.24 112.712 177.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.532 ' HD2' ' HB3' ' A' ' 403' ' ' ALA . 9.2 ttmm -88.36 122.47 31.91 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 123.315 0.646 . . . . 73.22 110.02 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 3.5 mp -81.15 104.98 12.01 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.334 -1.728 . . . . 74.54 106.334 174.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 403' ' ' ALA . 5.7 tt -80.24 -37.74 32.38 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.053 -1.462 . . . . 63.13 107.053 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 401' ' ' LYS . . . -160.98 157.66 26.7 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.371 -0.831 . . . . 70.21 110.513 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.437 HG21 ' HG ' ' A' ' 391' ' ' LEU . 14.6 p -133.42 127.53 53.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.929 -1.137 . . . . 61.31 107.929 173.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 63.67 31.55 14.39 Favored 'General case' 0 C--O 1.206 -1.221 0 CA-C-O 124.011 1.862 . . . . 71.25 107.739 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 65.86 4.49 2.98 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 111.211 -2.722 . . . . 74.44 113.938 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 46.4 t -80.23 123.12 36.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.06 -1.089 . . . . 62.24 108.06 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.5 p -58.98 122.92 14.89 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.719 1.007 . . . . 75.14 113.719 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.42 -1.97 20.98 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 124.434 1.094 . . . . 64.51 111.356 177.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -64.77 108.53 1.76 Allowed 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.554 -0.536 . . . . 73.45 109.554 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 61.78 71.07 0.56 Allowed 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 122.527 1.156 . . . . 75.43 112.909 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.0 168.77 23.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 106.989 -1.486 . . . . 74.21 106.989 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.7 m -76.52 139.33 40.71 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.559 -0.904 . . . . 72.42 108.559 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.607 ' O ' HG23 ' A' ' 388' ' ' VAL . 84.8 t60 -48.42 -48.82 36.91 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.77 0.655 . . . . 73.4 112.77 -175.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -59.54 -42.58 92.65 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.936 -0.765 . . . . 75.02 108.936 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 383' ' ' THR . 49.3 tt0 -67.71 -32.44 73.08 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.213 -1.358 . . . . 71.01 109.115 -174.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.533 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -73.78 -50.51 20.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.828 -1.078 . . . . 32.25 110.289 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 384' ' ' HIS . 15.8 t -59.62 -46.99 92.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 109.819 -0.437 . . . . 71.44 109.819 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 42.7 m -62.78 -29.97 71.11 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.553 -0.748 . . . . 72.54 112.164 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.94 -34.53 78.33 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.124 -0.36 . . . . 71.35 110.248 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.5 mp -79.03 -33.61 44.62 Favored 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 120.253 -0.579 . . . . 73.12 110.738 176.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.443 ' HE2' HG12 ' A' ' 388' ' ' VAL . 62.0 mttm -67.23 -29.32 68.93 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.413 0.523 . . . . 72.54 112.413 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -80.21 48.14 0.97 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.44 0.638 . . . . 54.44 112.156 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.42 ' HB ' HG22 ' A' ' 398' ' ' VAL . 32.4 p -124.54 146.93 48.72 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.311 -0.996 . . . . 70.12 108.311 176.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.6 t -141.04 98.69 3.43 Favored 'General case' 0 N--CA 1.409 -2.509 0 C-N-CA 117.711 -1.596 . . . . 65.42 110.935 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.759 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 6.2 m-20 65.63 16.13 10.36 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 110.89 -2.868 . . . . 63.11 112.951 166.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -161.65 115.54 1.92 Allowed 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.471 -1.307 . . . . 73.21 107.471 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 394' ' ' THR . 28.8 t -133.74 151.04 32.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 123.034 0.534 . . . . 65.21 110.518 -175.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.401 ' CZ ' ' HE2' ' A' ' 321' ' ' LYS . 29.4 m-85 -126.24 99.79 6.03 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.723 -1.214 . . . . 63.12 107.723 171.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.2 tt -91.75 119.5 31.64 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.525 -1.287 . . . . 62.35 107.525 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 373' ' ' ALA . 24.0 ttmm -103.64 107.89 18.93 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.693 -1.225 . . . . 74.25 107.693 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.498 ' O ' ' HB3' ' A' ' 318' ' ' MET . 1.9 p -107.58 149.99 10.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 CA-C-O 121.744 0.783 . . . . 71.12 110.498 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.585 ' HB2' HD12 ' A' ' 372' ' ' LEU . . . -136.52 159.6 41.31 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.82 -1.082 . . . . 70.05 108.14 176.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.421 ' HA ' ' HE3' ' A' ' 404' ' ' LYS . 0.0 OUTLIER -75.94 153.88 84.85 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 109.079 -0.712 . . . . 51.22 109.079 179.247 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 405' ' ' PRO . . . . . 0.499 ' HA ' ' OH ' ' A' ' 349' ' ' TYR . 10.7 Cg_endo -55.01 120.25 7.86 Favored 'Trans proline' 0 C--O 1.212 -0.79 0 C-N-CA 123.021 2.481 . . . . 72.44 112.524 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 4.8 m -96.61 9.67 40.85 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.625 0.726 . . . . 72.24 111.102 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -89.44 -156.93 32.45 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.699 -0.762 . . . . 51.31 113.981 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 12.5 m -68.91 -27.23 65.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.994 0.902 . . . . 72.53 108.963 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -107.92 101.11 10.41 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 106.032 -1.84 . . . . 63.14 106.032 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -121.04 143.8 48.87 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 123.473 0.483 . . . . 74.53 112.067 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.469 ' H ' ' HG2' ' A' ' 405' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.056 0 C-N-CA 126.432 1.893 . . . . 75.05 107.392 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.473 -1.989 0 N-CA-C 107.779 -1.193 . . . . 74.22 107.779 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 142' ' ' ARG . . . . . 0.527 ' O ' ' HD3' ' B' ' 142' ' ' ARG . 2.4 tmt_? -133.45 -16.06 2.41 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 124.122 0.889 . . . . 71.45 108.62 -173.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.678 HG22 HG21 ' B' ' 149' ' ' THR . 17.9 p -84.24 114.03 21.53 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 107.798 -1.186 . . . . 71.25 107.798 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -154.88 143.93 20.98 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.629 -0.878 . . . . 74.33 108.629 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 145' ' ' GLN . . . . . 0.451 ' CD ' ' H ' ' B' ' 145' ' ' GLN . 5.0 pm0 -70.58 165.64 22.33 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.111 0.481 . . . . 74.43 111.601 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 66.57 28.44 9.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.803 1.641 . . . . 63.25 112.407 -174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -166.37 177.95 6.47 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 114.786 -1.097 . . . . 70.42 109.063 175.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.36 165.11 12.73 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.507 -0.923 . . . . 65.45 108.507 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.678 HG21 HG22 ' B' ' 143' ' ' THR . 27.6 m -147.14 129.06 15.39 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.409 -0.589 . . . . 74.22 109.409 170.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 150' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 41.6 tt0 -71.14 131.27 43.32 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-O 121.088 0.471 . . . . 70.42 110.771 175.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 331' ' ' PHE . 17.4 m . . . . . 0 C--N 1.301 -1.527 0 CA-C-O 116.786 -1.578 . . . . 70.03 111.627 176.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 64.4 ttp . . . . . 0 CA--C 1.5 -0.951 0 N-CA-C 107.451 -1.314 . . . . 71.21 107.451 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.297 1.6 pm0 -89.88 133.22 34.87 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 114.514 1.302 . . . . 72.42 114.514 -177.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 77.9 mt -120.16 114.95 45.75 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.677 0 CA-C-N 112.135 -2.302 . . . . 74.55 108.789 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -81.43 121.29 26.06 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.235 -1.024 . . . . 73.24 108.235 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.546 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 95.5 mt -118.4 150.06 40.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 124.363 1.039 . . . . 61.22 108.807 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 42.9 mm -106.37 116.75 50.78 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 N-CA-C 109.286 -0.635 . . . . 72.21 109.286 173.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 396' ' ' ASP . 12.1 tmtt? -71.13 153.63 42.37 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 107.707 -1.22 . . . . 74.43 107.707 171.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.415 ' O ' ' HE2' ' A' ' 324' ' ' LYS . . . -153.05 -154.94 6.91 Favored Glycine 0 C--N 1.302 -1.321 0 C-N-CA 119.625 -1.274 . . . . 41.5 113.291 -174.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.86 -22.59 36.2 Favored 'Trans proline' 0 C--O 1.217 -0.558 0 C-N-CA 123.165 2.577 . . . . 72.11 113.939 -175.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -106.07 20.57 18.74 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 122.224 1.011 . . . . 64.53 108.618 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.71 -133.61 11.96 Favored Glycine 0 CA--C 1.477 -2.298 0 CA-C-N 114.034 -1.439 . . . . 62.02 109.649 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 329' ' ' LEU . 14.6 tp -109.26 -34.96 6.41 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 106.903 -1.517 . . . . 62.34 106.903 175.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' GLY . . . . . 0.527 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 86.32 47.18 5.02 Favored Glycine 0 N--CA 1.429 -1.822 0 CA-C-N 113.746 -1.57 . . . . 53.04 116.72 171.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -152.48 150.19 29.35 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 117.928 0.864 . . . . 74.55 112.23 169.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 6.5 m -104.71 129.34 52.93 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.197 -0.91 . . . . 53.12 109.263 -177.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.427 HD11 ' HA ' ' A' ' 388' ' ' VAL . 47.9 pt -113.75 150.96 15.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 115.544 -0.753 . . . . 54.24 108.994 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.489 ' HA ' ' CE1' ' A' ' 384' ' ' HIS . . . -146.3 130.68 17.64 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.343 -1.354 . . . . 44.31 107.343 175.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 145.05 160.24 8.46 Favored Glycine 0 C--N 1.283 -2.372 0 N-CA-C 110.705 -0.958 . . . . 71.31 110.705 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.9 -175.26 20.69 Favored Glycine 0 N--CA 1.424 -2.122 0 N-CA-C 108.253 -1.939 . . . . 64.45 108.253 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 91.0 t -51.07 105.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 O-C-N 124.358 0.681 . . . . 73.05 111.392 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 87.38 -14.92 56.65 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.449 -0.796 . . . . 64.32 112.74 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.522 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -105.41 12.72 31.22 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.873 -1.158 . . . . 71.42 107.873 -177.618 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.502 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -53.31 126.65 21.89 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.614 0.766 . . . . 61.44 111.749 -176.476 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 341' ' ' HIS . . . . . 0.556 ' HB3' ' CD2' ' A' ' 349' ' ' TYR . 15.7 t60 -86.64 -38.0 17.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.63 -0.714 . . . . 75.32 110.003 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 37.9 mm -102.62 118.78 57.77 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 109.929 -0.397 . . . . 74.32 109.929 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.07 110.62 0.46 Allowed 'Trans proline' 0 C--O 1.252 1.183 0 C-N-CA 123.093 2.529 . . . . 70.32 111.411 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 108.29 -5.62 33.79 Favored Glycine 0 N--CA 1.429 -1.814 0 CA-C-N 115.143 -0.935 . . . . 64.55 112.159 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.414 ' HB3' ' OH ' ' A' ' 349' ' ' TYR . 40.4 t0 -131.67 104.33 6.87 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.183 -0.673 . . . . 61.43 109.183 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.502 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 66.3 t30 -83.92 37.91 0.62 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.282 1.039 . . . . 65.14 110.612 -173.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 50.1 m -103.95 177.65 4.78 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.96 -1.018 . . . . 74.42 112.235 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.418 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.5 mm -93.16 138.6 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.428 -0.953 . . . . 73.11 108.428 -177.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.556 ' CD2' ' HB3' ' A' ' 341' ' ' HIS . 95.8 m-85 -129.84 141.86 50.76 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 112.309 0.485 . . . . 35.52 112.309 -178.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 56.8 t -74.37 115.5 15.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 107.747 -1.205 . . . . 73.44 107.747 175.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.9 m -98.85 -24.2 15.08 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 121.388 0.613 . . . . 73.11 110.473 -175.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 332' ' ' SER . 33.3 ttmt -158.8 150.13 20.58 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 107.801 -1.185 . . . . 74.33 107.801 -173.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 60.1 mt -130.7 116.26 34.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 107.08 -1.452 . . . . 74.24 107.08 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 46.2 mm -84.99 124.68 40.13 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 C-N-CA 123.481 0.712 . . . . 73.13 110.491 -171.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.496 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 0.6 OUTLIER -60.53 147.26 42.05 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.873 -0.788 . . . . 72.53 108.873 -177.811 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 94.2 -24.63 26.12 Favored Glycine 0 CA--C 1.478 -2.265 0 N-CA-C 109.486 -1.446 . . . . 71.32 109.486 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' GLY . . . . . 0.527 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -68.53 142.86 39.52 Favored Glycine 1 N--CA 1.395 -4.053 0 N-CA-C 108.0 -2.04 . . . . 41.05 108.0 172.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 358' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 362' ' ' ASP . . . -63.87 -32.56 74.13 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.296 -0.631 . . . . 74.44 109.296 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.637 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.11 -4.62 39.71 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 120.7 -0.4 . . . . 73.32 111.744 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 360' ' ' HIS . . . . . 0.496 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 17.1 t60 -94.68 -49.2 5.73 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.694 -0.854 . . . . 73.01 108.694 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -79.27 -50.42 10.94 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.386 -0.825 . . . . 70.33 111.928 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' ASP . . . . . 0.659 ' O ' ' HE2' ' A' ' 364' ' ' LYS . 11.4 t70 -85.76 -34.89 21.06 Favored 'General case' 0 CA--C 1.465 -2.303 0 C-N-CA 124.085 0.954 . . . . 75.33 109.888 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -42.39 -25.64 0.3 Allowed Glycine 0 CA--C 1.486 -1.763 0 N-CA-C 119.96 2.744 . . . . 64.53 119.96 -161.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.659 ' HE2' ' O ' ' A' ' 362' ' ' ASP . 0.0 OUTLIER 47.03 31.16 1.46 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.356 1.078 . . . . 70.11 111.069 178.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 48.6 tp -113.6 150.87 32.47 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 114.597 -1.183 . . . . 64.45 109.336 -170.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -122.88 148.44 45.43 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.388 0.614 . . . . 73.52 111.186 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.6 mt -65.97 126.05 24.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.272 -1.01 . . . . 65.43 108.272 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.64 -18.6 14.97 Favored Glycine 0 C--N 1.313 -0.748 0 N-CA-C 111.645 -0.582 . . . . 55.23 111.645 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -62.93 130.84 46.53 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-O 121.16 0.505 . . . . 72.01 111.827 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.546 ' HB2' ' CE1' ' A' ' 349' ' ' TYR . 50.9 tttt -88.84 127.01 35.62 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.562 -0.745 . . . . 65.24 110.581 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 3.3 mp -81.3 107.03 13.74 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.891 -1.522 . . . . 74.11 106.891 177.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' A' ' 403' ' ' ALA . 3.4 tt -80.31 -43.31 21.47 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 106.273 -1.751 . . . . 53.41 106.273 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -157.45 154.56 28.95 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.075 -0.966 . . . . 62.34 110.1 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.77 120.6 42.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 108.525 -0.917 . . . . 71.33 108.525 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' ASN . . . . . 0.496 HD21 HG22 ' A' ' 394' ' ' THR . 81.5 m-20 63.51 30.51 15.17 Favored 'General case' 0 CA--C 1.484 -1.574 0 CA-C-O 123.978 1.847 . . . . 71.11 108.321 -174.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.9 t30 66.57 16.15 10.32 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 109.793 -3.367 . . . . 74.44 112.605 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.88 124.36 39.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 106.271 -1.752 . . . . 71.52 106.271 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.9 p -65.08 125.36 24.69 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.893 0.701 . . . . 72.35 112.893 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.21 5.94 28.19 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 123.809 0.843 . . . . 64.33 111.108 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.453 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 28.4 mm-40 -68.48 111.66 4.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.227 -0.657 . . . . 73.15 109.227 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 56.09 67.9 0.94 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.572 1.177 . . . . 72.53 113.22 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.72 167.63 23.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 107.112 -1.44 . . . . 53.34 107.112 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.477 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.6 m -74.89 142.41 44.06 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.29 -1.004 . . . . 74.12 108.29 -177.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.626 ' O ' HG23 ' A' ' 388' ' ' VAL . 86.3 t60 -52.93 -49.38 66.13 Favored 'General case' 0 C--O 1.213 -0.843 0 N-CA-C 112.252 0.464 . . . . 64.3 112.252 -176.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.419 ' HG3' ' OG1' ' B' ' 143' ' ' THR . 26.8 tt0 -61.64 -30.34 70.64 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.447 0.641 . . . . 73.11 111.435 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.5 tt0 -75.01 -35.74 61.96 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.044 -0.98 . . . . 75.03 108.426 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -75.09 -38.84 61.09 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.059 -0.973 . . . . 55.43 110.585 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 384' ' ' HIS . 11.7 t -65.08 -42.33 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 109.011 -0.737 . . . . 64.15 109.011 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 60.9 m -60.32 -40.79 91.85 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 123.417 0.448 . . . . 72.45 110.08 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -62.26 -35.43 78.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.628 -0.26 . . . . 62.41 111.479 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.473 ' HG ' HG11 ' B' ' 151' ' ' VAL . 57.4 tp -82.34 -22.75 35.4 Favored 'General case' 0 N--CA 1.394 -3.272 0 C-N-CA 122.823 0.449 . . . . 74.13 109.904 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 61.1 mttm -77.96 -21.63 50.7 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 120.869 0.366 . . . . 54.52 111.033 176.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -76.18 47.37 0.45 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.498 -0.774 . . . . 73.31 110.411 174.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.496 HG22 HD21 ' A' ' 375' ' ' ASN . 22.5 p -124.61 133.55 53.23 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.087 -1.079 . . . . 73.4 108.087 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' SER . . . . . 0.528 ' HA ' ' HD2' ' A' ' 324' ' ' LYS . 50.8 m -139.15 97.73 3.36 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.814 -1.154 . . . . 63.33 111.798 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.62 ' HA ' ' O ' ' A' ' 324' ' ' LYS . 5.8 m-20 60.68 18.57 8.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 111.415 -2.63 . . . . 64.43 112.816 171.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -166.69 130.13 1.93 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.389 -1.278 . . . . 71.41 107.567 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.482 HG22 ' HB ' ' A' ' 394' ' ' THR . 22.0 t -145.24 143.43 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 122.832 0.453 . . . . 75.14 111.086 -176.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -117.04 96.78 5.61 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.378 -0.971 . . . . 63.24 108.378 167.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.89 113.95 25.74 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.97 -0.752 . . . . 72.1 108.97 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -93.06 109.7 21.18 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.546 -1.279 . . . . 74.33 107.546 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 69.2 t -104.49 148.18 9.51 Favored 'Isoleucine or valine' 0 C--O 1.258 1.551 0 CA-C-O 121.368 0.604 . . . . 72.13 110.091 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.545 ' HB2' HD12 ' A' ' 372' ' ' LEU . . . -136.25 158.94 43.22 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 125.083 1.353 . . . . 43.32 107.543 176.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.42 ' HG3' ' C ' ' A' ' 411' ' ' HIS . 0.4 OUTLIER -81.55 153.31 70.79 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.826 -1.175 . . . . 71.11 107.826 173.237 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -49.34 123.26 9.93 Favored 'Trans proline' 0 N--CA 1.44 -1.647 0 C-N-CA 122.968 2.445 . . . . 64.14 112.199 177.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 2.6 m -95.74 20.65 9.49 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.022 -1.444 . . . . 75.15 109.663 -175.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -98.51 -140.92 11.72 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-N 115.242 -0.89 . . . . 43.41 111.988 -178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 16.4 m -92.08 10.55 28.72 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.263 0.554 . . . . 71.44 110.74 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -142.64 147.46 35.8 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 106.975 -1.491 . . . . 75.12 106.975 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -129.51 132.73 46.96 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 123.234 0.334 . . . . 72.53 110.159 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.42 ' C ' ' HG3' ' A' ' 404' ' ' LYS . 91.2 m-70 . . . . . 0 C--N 1.31 -1.132 0 N-CA-C 107.73 -1.211 . . . . 74.43 107.73 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.488 0 N-CA-C 110.609 -0.145 . . . . 73.52 110.609 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 142' ' ' ARG . . . . . 0.475 ' HE ' ' HB3' ' B' ' 142' ' ' ARG . 10.1 mtp180 69.32 178.27 0.26 Allowed 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.291 1.043 . . . . 74.44 113.149 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.419 ' OG1' ' HG3' ' A' ' 385' ' ' GLU . 17.5 p -96.97 152.74 18.42 Favored 'General case' 0 N--CA 1.405 -2.679 0 CA-C-N 113.211 -1.813 . . . . 72.11 106.796 175.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 144' ' ' ARG . . . . . 0.412 ' NE ' ' HA ' ' B' ' 144' ' ' ARG . 3.7 mmp_? -153.88 141.79 20.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 109.107 -0.701 . . . . 72.03 109.107 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -86.72 166.89 14.94 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 123.525 0.515 . . . . 75.11 111.035 176.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 67.72 21.33 9.28 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.063 1.745 . . . . 64.33 112.34 -174.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -155.54 178.86 9.75 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.897 -1.047 . . . . 62.3 108.52 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -92.21 149.97 21.16 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.393 -0.966 . . . . 73.32 108.393 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.414 HG21 HG22 ' B' ' 143' ' ' THR . 20.1 m -134.8 129.76 35.06 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.204 -0.665 . . . . 64.13 109.204 174.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 150' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 50.2 tt0 -85.29 139.98 31.18 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 112.631 0.604 . . . . 64.42 112.631 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.473 HG11 ' HG ' ' A' ' 391' ' ' LEU . 51.0 t . . . . . 0 C--N 1.312 -1.04 0 N-CA-C 106.641 -1.614 . . . . 74.45 106.641 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' MET . . . . . 0.417 ' HB2' HG13 ' A' ' 402' ' ' VAL . 0.4 OUTLIER . . . . . 0 CA--C 1.487 -1.479 0 N-CA-C 108.93 -0.767 . . . . 75.15 108.93 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -132.84 121.19 22.56 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 108.171 -1.048 . . . . 71.24 108.171 171.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 64.5 mt -98.1 105.75 17.71 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.033 0 CA-C-N 114.275 -1.33 . . . . 72.23 108.531 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -89.24 102.43 15.09 Favored 'General case' 0 N--CA 1.38 -3.971 0 N-CA-C 105.105 -2.183 . . . . 74.22 105.105 169.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.457 ' HA ' ' OD2' ' A' ' 362' ' ' ASP . 0.5 OUTLIER -106.31 138.83 41.79 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 112.486 -2.143 . . . . 63.13 108.092 -170.15 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 25.8 mm -98.53 114.83 37.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 CA-C-O 121.344 0.593 . . . . 70.5 110.161 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -75.3 148.7 39.13 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.425 -0.807 . . . . 73.43 110.3 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -135.38 -161.09 9.2 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.857 -0.687 . . . . 75.14 111.86 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.64 -16.59 33.87 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.041 2.494 . . . . 75.41 113.333 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -101.66 10.23 40.33 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.318 1.056 . . . . 61.4 108.633 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.77 -128.67 8.7 Favored Glycine 0 CA--C 1.478 -2.234 0 CA-C-N 114.3 -1.318 . . . . 72.23 110.741 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.444 HD13 HG12 ' B' ' 151' ' ' VAL . 5.3 mp -101.35 -44.65 5.57 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 105.918 -1.882 . . . . 75.33 105.918 174.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 80.36 49.37 5.89 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 114.852 -1.067 . . . . 73.22 114.514 172.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -151.41 147.74 27.25 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.842 -0.429 . . . . 72.22 109.842 174.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 4.2 m -97.93 124.59 42.44 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 108.436 -0.95 . . . . 72.4 108.436 -176.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 46.4 pt -113.48 153.09 15.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 108.611 -0.885 . . . . 53.52 108.611 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.92 129.35 15.85 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.077 -0.712 . . . . 71.15 109.077 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 152.35 165.55 13.33 Favored Glycine 0 C--N 1.282 -2.433 0 N-CA-C 110.208 -1.157 . . . . 61.31 110.208 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 136.69 -176.83 20.14 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 107.663 -2.175 . . . . 72.54 107.663 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.403 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 58.6 t -54.32 100.5 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.249 1.042 0 CA-C-O 122.096 0.951 . . . . 75.02 112.495 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 80.84 4.49 90.39 Favored Glycine 0 C--O 1.21 -1.404 0 CA-C-N 115.121 -0.945 . . . . 52.41 112.002 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.504 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -106.46 11.66 30.5 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.782 -1.562 . . . . 74.41 106.782 178.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 340' ' ' GLN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -49.8 122.67 6.79 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.839 1.256 . . . . 72.13 112.701 -175.633 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -79.27 -38.52 35.24 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.307 -0.86 . . . . 73.13 109.572 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.6 123.97 38.54 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 108.564 -0.902 . . . . 65.23 108.564 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.36 107.51 0.21 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.971 2.447 . . . . 63.1 112.293 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.89 -8.97 29.66 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-N 115.26 -0.882 . . . . 75.41 112.591 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' ASP . . . . . 0.448 ' HB2' ' OG ' ' A' ' 408' ' ' SER . 3.1 t70 -125.22 106.94 10.25 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.39 -0.924 . . . . 71.0 110.288 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 61.9 t30 -80.37 28.19 0.32 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.734 1.214 . . . . 73.15 111.747 -171.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.635 ' OG ' ' HE2' ' A' ' 370' ' ' LYS . 24.9 m -99.28 175.63 5.81 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.841 -0.618 . . . . 61.44 112.134 -175.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.564 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 6.0 mm -89.72 132.2 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 108.016 -1.105 . . . . 73.44 108.016 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.596 ' CE2' ' HB2' ' A' ' 370' ' ' LYS . 68.0 m-85 -128.01 149.57 50.3 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.948 0.404 . . . . 72.24 111.868 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.69 123.72 32.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.482 -0.933 . . . . 74.42 108.482 175.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 33.2 m -108.11 -28.47 9.5 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.932 0.396 . . . . 54.35 111.474 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 50.9 mtmt -152.27 151.96 31.58 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.862 -0.792 . . . . 73.54 108.862 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.438 HG22 ' HB2' ' A' ' 360' ' ' HIS . 68.4 mt -129.41 121.98 54.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.623 -1.621 . . . . 74.24 106.623 174.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 50.0 mm -78.16 142.01 14.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 123.408 0.683 . . . . 75.45 112.173 -170.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.98 122.64 12.78 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.698 1.199 . . . . 75.24 112.28 -174.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 72.31 12.25 76.39 Favored Glycine 0 C--N 1.306 -1.087 0 CA-C-N 115.605 -0.725 . . . . 54.44 112.966 177.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -74.27 164.26 54.65 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 110.735 -0.946 . . . . 62.14 110.735 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.53 98.08 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.172 -0.677 . . . . 65.41 109.172 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.575 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.58 -4.6 40.91 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.134 -0.485 . . . . 63.13 112.015 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 360' ' ' HIS . . . . . 0.438 ' HB2' HG22 ' A' ' 353' ' ' ILE . 15.1 t60 -94.11 -32.69 13.66 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.849 -0.797 . . . . 75.34 108.849 176.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -95.8 -58.17 2.17 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.997 -0.681 . . . . 74.03 112.332 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' ASP . . . . . 0.457 ' OD2' ' HA ' ' A' ' 322' ' ' LEU . 27.7 t70 -86.18 -21.97 27.22 Favored 'General case' 0 CA--C 1.473 -2.019 0 CA-C-N 115.726 -0.67 . . . . 41.41 110.366 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -43.0 -34.9 2.13 Favored Glycine 0 CA--C 1.479 -2.172 0 CA-C-O 117.751 -1.583 . . . . 33.41 116.144 -172.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? 42.8 40.37 2.07 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.937 0.875 . . . . 60.41 110.15 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 60.3 tp -133.45 154.39 50.83 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 113.588 -1.642 . . . . 73.23 108.977 -167.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -122.66 152.33 40.62 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.736 0.779 . . . . 73.35 111.141 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.7 mt -65.71 123.68 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 108.024 -1.102 . . . . 60.42 108.024 174.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.17 -6.16 21.58 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.684 -0.769 . . . . 50.35 112.342 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.428 ' HB3' HG21 ' A' ' 402' ' ' VAL . 13.5 m-20 -74.23 141.62 45.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.026 0.75 . . . . 60.04 113.026 177.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.647 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 47.1 tttm -96.08 118.43 32.65 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 123.978 0.911 . . . . 63.44 110.31 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.475 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 3.0 mp -78.85 114.46 17.8 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.674 -1.232 . . . . 73.51 107.674 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.53 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 5.7 tt -86.84 -43.01 12.8 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.943 -1.132 . . . . 72.52 107.943 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -157.2 150.64 24.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.046 -0.524 . . . . 63.32 111.024 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 9.8 p -133.59 123.8 46.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 109.006 -0.739 . . . . 62.32 109.006 173.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' ASN . . . . . 0.583 HD21 HG22 ' A' ' 394' ' ' THR . 92.7 m-20 60.95 31.86 19.96 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-O 124.145 1.926 . . . . 75.41 109.536 -173.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 67.23 12.36 8.9 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 109.08 -3.691 . . . . 73.25 112.903 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 54.9 t -82.29 125.3 39.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 106.697 -1.594 . . . . 73.42 106.697 173.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.8 p -66.74 126.55 29.36 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 123.61 0.569 . . . . 73.53 112.267 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.02 6.07 30.88 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.714 0.806 . . . . 53.33 110.725 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' GLU . . . . . 0.53 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 13.6 mm-40 -70.81 107.43 3.99 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.217 -0.901 . . . . 74.41 109.253 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 57.8 71.59 0.57 Allowed 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.371 1.081 . . . . 73.11 113.36 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.69 172.53 15.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.023 -1.473 . . . . 44.04 107.023 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 81.0 p -81.23 146.69 30.33 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.066 -1.054 . . . . 61.34 108.769 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -52.33 -31.45 33.32 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 112.937 0.717 . . . . 62.32 112.937 -176.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.529 ' HA ' ' OG1' ' B' ' 143' ' ' THR . 14.0 tp10 -64.5 -40.85 96.42 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-O 120.625 0.25 . . . . 61.51 110.875 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.62 -40.22 80.44 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.637 -0.875 . . . . 71.14 108.637 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.425 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -62.42 -59.04 5.54 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.5 -1.227 . . . . 73.11 110.629 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.477 ' HB ' HG21 ' B' ' 143' ' ' THR . 90.4 t -57.3 -44.91 84.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 O-C-N 123.212 0.32 . . . . 73.1 111.546 -177.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 55.4 m -60.65 -34.12 73.82 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 111.927 0.343 . . . . 71.24 111.927 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.8 77.88 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 110.277 -0.268 . . . . 64.42 110.277 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.9 mp -79.28 -28.73 42.32 Favored 'General case' 0 C--O 1.218 -0.57 0 C-N-CA 120.339 -0.544 . . . . 64.44 110.792 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 388' ' ' VAL . 73.0 mmtt -61.94 -41.61 98.17 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 120.608 0.242 . . . . 73.33 111.014 176.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -77.46 70.7 3.88 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 122.561 1.172 . . . . 74.14 111.021 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.583 HG22 HD21 ' A' ' 375' ' ' ASN . 12.9 p -142.45 155.46 45.08 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 113.241 -1.8 . . . . 65.32 108.561 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 32.5 p -166.45 115.81 0.92 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.591 -0.522 . . . . 61.32 109.591 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.8 t70 64.39 0.07 1.0 Allowed 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 125.365 1.466 . . . . 74.44 112.043 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -163.48 137.87 6.04 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.532 -0.914 . . . . 72.53 108.532 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 48.0 t -139.51 120.62 15.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 106.437 -1.69 . . . . 71.53 106.437 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.22 95.13 5.76 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.134 -1.432 . . . . 61.21 107.134 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.4 tt -108.94 111.12 22.63 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-O 121.038 0.447 . . . . 73.32 110.439 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.24 121.25 30.43 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.013 -1.106 . . . . 54.11 108.013 176.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 369' ' ' ASP . 2.1 p -115.9 137.33 49.92 Favored 'Isoleucine or valine' 0 C--O 1.258 1.534 0 C-N-CA 123.578 0.751 . . . . 74.02 110.045 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.647 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.48 158.72 43.77 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.364 -0.976 . . . . 33.33 108.364 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' LYS . . . . . 0.447 ' HG3' ' C ' ' A' ' 411' ' ' HIS . 0.4 OUTLIER -78.43 153.77 79.04 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 108.723 -0.843 . . . . 53.11 108.723 175.255 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 405' ' ' PRO . . . . . 0.457 ' HG2' ' HA ' ' A' ' 410' ' ' HIS . 50.0 Cg_exo -35.41 125.21 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.914 3.743 . . . . 64.23 114.025 177.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 28.1 m -86.68 -38.12 17.32 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.577 -1.192 . . . . 70.4 111.291 -173.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -125.83 31.12 4.21 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 119.349 -1.405 . . . . 62.34 112.92 -175.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' SER . . . . . 0.448 ' OG ' ' HB2' ' A' ' 345' ' ' ASP . 33.9 p -154.55 -167.54 2.64 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.843 -0.428 . . . . 70.11 109.843 -178.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -71.03 109.56 5.2 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.93 -0.766 . . . . 74.44 108.93 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' HIS . . . . . 0.457 ' HA ' ' HG2' ' A' ' 405' ' ' PRO . 3.3 p-80 -71.14 132.84 45.63 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 115.163 1.542 . . . . 75.12 115.163 -176.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.447 ' C ' ' HG3' ' A' ' 404' ' ' LYS . 40.3 t-80 . . . . . 0 N--CA 1.435 -1.219 0 C-N-CA 126.293 1.837 . . . . 74.32 106.072 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 141' ' ' PCA . . . . . 0.413 ' OE ' ' HG3' ' A' ' 392' ' ' LYS . . . . . . . . 0 CA--C 1.488 -1.421 0 CA-C-O 121.229 0.538 . . . . 60.24 110.058 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 142' ' ' ARG . . . . . 0.459 ' O ' ' HD2' ' B' ' 142' ' ' ARG . 0.6 OUTLIER 68.91 45.88 0.92 Allowed 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 123.547 1.641 . . . . 70.33 108.691 173.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 385' ' ' GLU . 72.9 p -88.54 -176.4 5.28 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 112.409 -2.178 . . . . 73.32 106.684 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 52.0 mtm180 -148.19 126.78 12.46 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.694 -1.595 . . . . 61.23 106.694 -172.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 145' ' ' GLN . . . . . 0.447 ' HA ' ' OD1' ' A' ' 339' ' ' ASN . 9.3 pt20 -86.64 164.92 16.53 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 113.452 0.908 . . . . 75.42 113.452 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 146' ' ' ARG . . . . . 0.464 ' H ' ' CG ' ' A' ' 339' ' ' ASN . 1.0 OUTLIER 66.92 29.01 8.44 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.491 1.916 . . . . 71.51 111.112 -175.907 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -164.74 -179.13 5.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.182 -1.372 . . . . 62.41 107.991 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.42 152.3 19.79 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 123.427 0.454 . . . . 63.24 112.208 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 41.9 m -142.51 141.82 32.15 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.886 -0.509 . . . . 75.01 109.862 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -77.16 152.99 34.62 Favored 'General case' 0 CA--C 1.462 -2.44 0 C-N-CA 123.918 0.887 . . . . 73.41 113.193 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.444 HG12 HD13 ' A' ' 329' ' ' LEU . 6.6 t . . . . . 0 N--CA 1.392 -3.354 0 C-N-CA 118.37 -1.332 . . . . 63.22 110.847 169.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 53.6 ttm . . . . . 0 C--O 1.205 -1.256 0 N-CA-C 106.107 -1.812 . . . . 64.23 106.107 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.428 1.9 pm0 -114.59 130.89 56.82 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 116.787 2.143 . . . . 60.13 116.787 -173.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.489 HG23 ' HD3' ' A' ' 364' ' ' LYS . 72.5 mt -111.88 112.66 41.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-N 111.573 -2.558 . . . . 70.01 108.83 -176.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 321' ' ' LYS . . . . . 0.639 ' HD3' ' CE1' ' A' ' 399' ' ' TYR . 30.6 ttpt -82.97 125.08 31.01 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.42 -0.955 . . . . 72.32 108.42 173.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.567 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 96.3 mt -119.29 154.06 34.08 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 124.904 1.377 . . . . 73.23 108.762 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 396' ' ' ASP . 49.5 mt -106.44 145.55 14.06 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.121 0 N-CA-C 106.467 -1.679 . . . . 64.42 106.467 169.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.537 ' H ' ' HA ' ' A' ' 396' ' ' ASP . 1.3 ttpm? -75.26 177.81 6.25 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.732 -1.211 . . . . 72.05 107.732 177.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' GLY . . . . . 0.465 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -160.78 -167.91 21.93 Favored Glycine 0 C--N 1.289 -2.067 0 C-N-CA 119.949 -1.119 . . . . 63.11 111.665 -177.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.27 -29.23 32.58 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 123.166 2.578 . . . . 75.31 112.405 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -106.39 25.29 11.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.241 0.543 . . . . 71.4 110.041 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.99 -125.52 7.13 Favored Glycine 0 CA--C 1.485 -1.793 0 N-CA-C 109.442 -1.463 . . . . 62.13 109.442 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.423 ' HB2' HG23 ' B' ' 151' ' ' VAL . 5.7 mp -97.49 -30.84 12.66 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.288 -1.745 . . . . 62.21 106.288 173.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 330' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 85.99 48.7 4.54 Favored Glycine 0 N--CA 1.429 -1.798 0 CA-C-N 114.057 -1.429 . . . . 75.55 115.041 173.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 55.5 p90 -153.23 166.43 32.58 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.504 -0.554 . . . . 72.32 109.504 172.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 9.5 m -117.9 136.78 53.24 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 120.597 -0.441 . . . . 74.03 110.18 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.0 pt -119.06 152.46 21.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 122.496 0.319 . . . . 45.02 110.948 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -141.73 135.05 29.4 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.106 -1.813 . . . . 44.03 106.106 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 144.59 156.54 6.86 Favored Glycine 0 C--N 1.277 -2.696 0 N-CA-C 109.53 -1.428 . . . . 64.01 109.53 -176.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.23 178.5 15.61 Favored Glycine 0 C--N 1.281 -2.519 0 N-CA-C 107.321 -2.311 . . . . 54.24 107.321 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.458 ' HA ' HD21 ' A' ' 346' ' ' ASN . 83.6 t -45.48 106.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 117.839 0.82 . . . . 72.3 111.994 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 84.91 -13.56 53.17 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.216 -0.902 . . . . 54.53 112.499 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.48 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 63.2 t30 -105.23 21.15 17.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.012 -0.736 . . . . 64.35 109.012 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.07 121.48 5.51 Favored 'General case' 0 C--O 1.256 1.436 0 CA-C-N 115.116 -0.947 . . . . 74.33 110.467 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -79.39 -43.4 23.49 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.11 -0.95 . . . . 73.13 108.734 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 37.4 mm -103.24 129.89 24.66 Favored Pre-proline 0 C--N 1.301 -1.503 0 CA-C-N 115.053 -0.976 . . . . 75.51 109.018 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.57 110.14 0.46 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 123.27 2.647 . . . . 71.22 113.292 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 97.83 -6.36 62.38 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.556 -0.747 . . . . 71.04 112.468 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -121.24 98.61 6.06 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.392 -0.966 . . . . 71.45 108.392 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.458 HD21 ' HA ' ' A' ' 337' ' ' VAL . 51.5 t30 -81.66 26.87 0.47 Allowed 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 124.362 1.065 . . . . 73.53 111.219 -170.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.515 ' CB ' ' HE3' ' A' ' 370' ' ' LYS . 55.1 m -93.94 173.57 7.6 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.16 0.8 . . . . 73.45 113.16 -174.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 34.5 mm -86.01 126.06 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.915 -1.039 . . . . 62.33 109.685 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 43.1 m-85 -124.01 132.69 53.72 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.199 0.523 . . . . 75.45 111.858 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.56 114.11 4.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 108.348 -0.982 . . . . 74.04 108.348 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 22.6 m -102.94 -20.95 14.05 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 120.865 0.364 . . . . 43.35 111.401 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 45.9 mmtm -150.71 159.46 44.51 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.342 -1.355 . . . . 75.31 107.342 177.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 61.3 mt -138.73 119.45 15.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 106.249 -1.76 . . . . 73.02 106.249 172.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 40.3 mm -86.07 118.01 31.79 Favored 'Isoleucine or valine' 0 C--O 1.255 1.387 0 N-CA-C 108.494 -0.928 . . . . 63.51 108.494 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.53 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 0.1 OUTLIER -65.62 147.42 53.43 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.181 -1.414 . . . . 71.33 107.181 -176.769 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.24 -16.62 60.92 Favored Glycine 0 C--N 1.289 -2.054 0 N-CA-C 109.275 -1.53 . . . . 71.31 109.275 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -75.09 150.43 40.78 Favored Glycine 0 N--CA 1.4 -3.738 0 N-CA-C 106.726 -2.55 . . . . 54.43 106.726 170.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -60.84 -35.03 75.52 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.854 -0.424 . . . . 33.42 109.854 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.557 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.35 -9.08 58.24 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 112.914 0.709 . . . . 64.41 112.914 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 360' ' ' HIS . . . . . 0.53 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 30.2 t-80 -94.95 -39.24 10.3 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.334 -0.947 . . . . 73.32 108.575 175.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -76.84 -57.19 3.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.861 -0.608 . . . . 62.01 110.949 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -85.84 -42.15 14.39 Favored 'General case' 0 CA--C 1.476 -1.882 0 C-N-CA 124.221 1.008 . . . . 74.43 111.32 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.569 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -43.07 -20.56 0.09 OUTLIER Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 120.651 3.02 . . . . 52.44 120.651 -162.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.569 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.86 33.45 0.5 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 118.522 1.161 . . . . 72.43 111.921 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 41.6 tp -107.94 155.49 20.26 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.718 1.207 . . . . 41.55 109.706 -171.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -124.89 145.34 49.87 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.405 0.621 . . . . 64.33 111.641 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 83.9 mt -66.15 123.23 18.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 107.69 -1.226 . . . . 73.02 107.69 171.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.73 -7.92 19.69 Favored Glycine 0 C--N 1.311 -0.841 0 C-N-CA 121.173 -0.536 . . . . 71.44 111.835 -175.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.401 ' HB3' HG21 ' A' ' 402' ' ' VAL . 19.0 m-20 -68.68 137.14 53.9 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 112.563 0.579 . . . . 70.21 112.563 177.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.515 ' HE3' ' CB ' ' A' ' 347' ' ' SER . 72.4 tttt -98.71 116.83 31.8 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.288 -0.869 . . . . 71.02 109.957 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 71.4 mt -83.96 114.5 21.74 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.226 0.536 . . . . 75.21 109.679 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.5 tt -81.0 -39.38 25.98 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.159 -1.382 . . . . 74.21 107.457 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.473 ' HB3' ' HD3' ' A' ' 401' ' ' LYS . . . -165.67 158.56 15.53 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.504 -0.771 . . . . 70.21 110.174 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.417 HG12 HD11 ' A' ' 379' ' ' LEU . 14.2 p -134.17 124.15 45.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.287 -1.005 . . . . 70.3 108.287 174.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' ASN . . . . . 0.537 HD21 HG22 ' A' ' 394' ' ' THR . 88.4 m-20 62.18 30.81 17.76 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 123.719 1.723 . . . . 64.2 109.268 -176.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 67.48 9.64 7.17 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 109.999 -3.273 . . . . 74.3 113.201 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.43 122.27 36.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 106.472 -1.677 . . . . 73.13 106.472 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.3 p -61.21 125.84 25.2 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.235 0.828 . . . . 74.11 113.235 -176.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.417 HD11 HG12 ' A' ' 374' ' ' VAL . 7.6 mp -106.6 -1.36 22.98 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.662 0.785 . . . . 71.32 110.71 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -73.45 113.88 11.05 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.405 -0.961 . . . . 70.45 108.405 172.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 63.75 83.87 0.16 Allowed 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 124.587 1.179 . . . . 71.32 111.919 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 23.5 m -153.15 164.62 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.234 -1.348 . . . . 65.24 108.705 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.6 m -83.0 139.61 33.19 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.258 -1.016 . . . . 73.43 108.258 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.558 ' O ' HG23 ' A' ' 388' ' ' VAL . 81.5 t60 -49.53 -47.47 48.96 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.031 0.752 . . . . 72.11 113.031 -175.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.422 ' HA ' ' HB ' ' B' ' 143' ' ' THR . 0.8 OUTLIER -59.09 -43.42 91.83 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.75 -0.833 . . . . 62.1 108.75 -178.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 383' ' ' THR . 47.8 tt0 -67.5 -31.39 71.48 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.031 -1.44 . . . . 73.32 108.974 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.504 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -75.37 -49.92 17.55 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 114.7 -1.136 . . . . 74.21 110.456 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 384' ' ' HIS . 19.2 t -59.61 -46.47 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 N-CA-C 109.713 -0.477 . . . . 61.45 109.713 -178.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 52.0 m -62.12 -29.49 70.37 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.522 -0.763 . . . . 73.31 112.041 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.86 -31.92 72.85 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.689 -0.632 . . . . 52.11 110.4 175.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.6 mp -82.2 -31.6 30.26 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 120.599 -0.44 . . . . 73.23 110.875 176.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -71.12 -27.82 63.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.074 0.398 . . . . 75.44 112.074 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -78.16 55.18 1.46 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.547 0.689 . . . . 64.21 110.641 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.537 HG22 HD21 ' A' ' 375' ' ' ASN . 22.1 p -127.46 152.54 47.42 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 109.122 -0.696 . . . . 64.03 109.122 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 51.1 m -144.47 90.37 2.08 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.444 1.116 . . . . 73.05 111.628 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.537 ' HA ' ' H ' ' A' ' 324' ' ' LYS 0.267 9.1 m-20 61.96 17.2 8.76 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 111.636 -2.529 . . . . 62.31 115.329 170.074 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -161.61 122.15 2.67 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.075 -1.454 . . . . 73.44 107.075 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.7 t -140.1 143.45 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 122.509 0.323 . . . . 70.43 110.488 -175.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' TYR . . . . . 0.639 ' CE1' ' HD3' ' A' ' 321' ' ' LYS . 4.5 m-85 -117.64 96.45 5.39 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.265 0.555 . . . . 71.53 109.696 170.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.9 tt -88.67 123.21 32.9 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.675 -0.693 . . . . 61.34 109.683 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.473 ' HD3' ' HB3' ' A' ' 373' ' ' ALA . 26.7 mtpp -107.37 107.78 18.84 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.358 -0.979 . . . . 75.13 108.358 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' A' ' 369' ' ' ASP . 7.2 p -108.39 153.31 10.0 Favored 'Isoleucine or valine' 0 C--O 1.274 2.387 0 CA-C-N 115.403 -0.817 . . . . 73.11 110.231 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.41 157.61 46.39 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 105.945 -1.872 . . . . 64.23 105.945 174.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -85.98 153.99 57.71 Favored Pre-proline 0 C--N 1.284 -2.25 0 C-N-CA 119.792 -0.763 . . . . 73.12 109.719 178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' PRO . . . . . 0.451 ' HA ' ' OH ' ' A' ' 349' ' ' TYR . 1.3 Cg_endo -42.38 120.39 1.64 Allowed 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 124.238 3.292 . . . . 73.12 114.089 -177.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 5.9 m -90.61 -7.68 52.1 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.065 -0.97 . . . . 61.45 111.017 -175.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -114.94 22.03 12.95 Favored Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 120.368 -0.92 . . . . 44.33 111.809 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 69.8 m -160.26 -172.56 3.63 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.753 -1.203 . . . . 55.22 107.753 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -78.68 151.58 32.13 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.37 -1.344 . . . . 73.53 107.37 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -77.77 130.7 37.05 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 123.216 0.323 . . . . 63.4 110.479 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 49.8 m80 . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 106.5 -1.667 . . . . 61.31 106.5 179.393 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.232 0 N-CA-C 107.136 -1.431 . . . . 75.25 107.136 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 142' ' ' ARG . . . . . 0.442 ' HB3' HG23 ' B' ' 149' ' ' THR . 2.7 mmt180 -122.42 -61.65 1.45 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 123.68 0.613 . . . . 73.34 110.73 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.708 HG22 HG21 ' B' ' 149' ' ' THR . 76.1 p -66.36 101.01 0.69 Allowed 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 107.949 -1.13 . . . . 74.33 107.949 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -164.9 160.07 18.93 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.659 -1.237 . . . . 71.23 107.659 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -83.08 163.28 21.01 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 120.892 0.377 . . . . 60.03 110.429 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 66.46 18.7 10.87 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.919 1.688 . . . . 61.55 112.894 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -152.99 172.12 17.32 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.242 0.544 . . . . 71.1 111.67 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -95.06 158.45 15.46 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.022 -0.99 . . . . 72.3 109.466 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.708 HG21 HG22 ' B' ' 143' ' ' THR . 23.0 m -144.93 138.58 26.98 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 116.567 -0.288 . . . . 71.32 110.329 175.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 150' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 13.9 tm0? -78.69 140.04 38.41 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.008 -0.542 . . . . 74.34 111.161 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 329' ' ' LEU . 18.1 m . . . . . 0 C--O 1.266 1.926 0 CA-C-N 115.476 -0.784 . . . . 64.51 112.275 178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 CA--C 1.485 -1.52 0 N-CA-C 106.207 -1.775 . . . . 72.33 106.207 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.359 2.2 pm0 -121.46 131.0 53.91 Favored 'General case' 0 C--N 1.267 -2.981 0 N-CA-C 114.732 1.382 . . . . 73.22 114.732 -175.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 74.8 mt -116.96 113.7 43.66 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 CA-C-N 112.516 -2.129 . . . . 64.15 109.558 -172.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -92.81 112.4 24.34 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.323 -0.992 . . . . 35.13 108.323 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' LEU . . . . . 0.653 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 81.6 mt -107.27 152.85 23.57 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 124.363 1.039 . . . . 75.5 109.068 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 40.5 mt -106.16 126.46 61.72 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 107.917 -1.142 . . . . 74.24 107.917 169.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.47 ' HB3' ' H ' ' A' ' 396' ' ' ASP . 85.6 tttt -75.04 156.49 36.1 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.337 -0.392 . . . . 71.23 110.473 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -148.57 -154.86 6.45 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.705 -0.759 . . . . 33.01 113.151 -174.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.27 -46.85 27.62 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 124.039 3.159 . . . . 71.24 115.024 -173.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -98.47 25.82 6.03 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.265 0.555 . . . . 72.24 110.601 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.81 -124.32 6.67 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 114.987 -1.006 . . . . 71.12 111.958 177.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.433 HD13 HG12 ' B' ' 151' ' ' VAL . 8.2 mp -90.89 -39.78 12.11 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.526 -1.287 . . . . 65.54 107.526 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 87.08 47.99 4.53 Favored Glycine 0 N--CA 1.402 -3.613 0 CA-C-N 113.937 -1.483 . . . . 72.23 113.261 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 329' ' ' LEU . 48.9 p90 -155.47 147.17 23.13 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.327 0.584 . . . . 74.33 111.526 170.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 51.1 m -96.17 132.16 41.88 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.175 -0.921 . . . . 63.23 109.151 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.411 ' HB ' HG22 ' A' ' 348' ' ' ILE . 46.9 pt -120.45 141.91 38.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 109.941 -0.392 . . . . 61.53 109.941 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -139.58 125.59 19.81 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.768 -1.197 . . . . 64.21 107.768 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 150.22 161.65 10.03 Favored Glycine 0 C--N 1.282 -2.438 0 N-CA-C 110.469 -1.052 . . . . 63.11 110.469 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.05 -179.81 17.14 Favored Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 107.221 -2.352 . . . . 72.33 107.221 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 98.4 t -52.2 108.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 118.078 0.939 . . . . 65.52 110.778 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 94.78 -21.58 42.69 Favored Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.321 -0.854 . . . . 42.0 112.092 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' ASN . . . . . 0.61 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 32.1 t-20 -105.75 13.43 29.68 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.06 -0.719 . . . . 40.04 109.06 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.91 120.57 4.46 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 121.513 0.673 . . . . 74.53 111.098 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -77.79 -45.07 25.6 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.029 -0.987 . . . . 63.15 109.451 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 40.4 mm -103.35 124.14 39.21 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-N 115.309 -0.86 . . . . 74.35 109.16 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.66 108.01 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 123.247 2.631 . . . . 70.15 112.512 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 105.39 -4.12 40.4 Favored Glycine 0 N--CA 1.432 -1.599 0 CA-C-N 115.459 -0.791 . . . . 52.14 112.002 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -128.9 96.93 4.49 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.451 -0.944 . . . . 55.45 108.451 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -83.7 36.94 0.56 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.859 -1.064 . . . . 65.42 111.778 -170.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 72.0 m -98.66 177.34 5.34 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 115.613 -0.721 . . . . 70.5 111.249 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.1 mm -91.54 138.85 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 N-CA-C 106.33 -1.73 . . . . 75.31 106.33 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 349' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 369' ' ' ASP . 22.4 m-85 -127.5 139.25 52.91 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 118.34 0.518 . . . . 75.14 111.639 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.24 123.46 22.87 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 N-CA-C 108.955 -0.757 . . . . 52.34 108.955 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.1 m -102.35 -28.5 12.21 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.383 0.611 . . . . 73.41 110.529 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.48 ' HZ2' HD13 ' A' ' 354' ' ' ILE . 60.8 tttm -155.62 147.72 23.5 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.245 -1.02 . . . . 73.03 108.245 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.454 HG22 ' HB2' ' A' ' 360' ' ' HIS . 76.5 mt -107.74 139.7 28.78 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 N-CA-C 105.412 -2.07 . . . . 64.24 105.412 169.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.48 HD13 ' HZ2' ' A' ' 352' ' ' LYS . 44.9 mm -85.17 129.74 37.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.147 0.499 . . . . 72.1 110.799 -174.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 0.5 OUTLIER -57.62 115.75 2.97 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 125.586 1.554 . . . . 62.13 111.105 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 84.24 7.98 84.27 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.725 -0.75 . . . . 43.12 111.807 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -75.9 160.2 51.36 Favored Glycine 0 C--O 1.259 1.67 0 N-CA-C 111.769 -0.532 . . . . 71.42 111.769 177.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.29 -42.21 99.06 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.184 -0.672 . . . . 45.4 109.184 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.522 ' HA ' ' CA ' ' A' ' 363' ' ' GLY . . . -72.97 -6.74 47.4 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.852 -0.613 . . . . 74.42 111.427 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 360' ' ' HIS . . . . . 0.454 ' HB2' HG22 ' A' ' 353' ' ' ILE . 63.9 t60 -92.66 -33.92 14.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.592 0.71 . . . . 61.12 109.473 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.651 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 0.7 OUTLIER -92.9 -54.65 3.66 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.902 0.704 . . . . 62.52 112.902 177.6 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 362' ' ' ASP . . . . . 0.728 ' O ' ' HE2' ' A' ' 364' ' ' LYS . 23.3 t70 -85.33 -37.22 20.19 Favored 'General case' 0 CA--C 1.461 -2.458 0 O-C-N 124.16 0.912 . . . . 61.34 110.625 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' GLY . . . . . 0.653 ' HA2' ' CD2' ' A' ' 322' ' ' LEU . . . -41.2 -28.11 0.27 Allowed Glycine 0 CA--C 1.483 -1.966 0 N-CA-C 120.37 2.908 . . . . 62.23 120.37 -160.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.728 ' HE2' ' O ' ' A' ' 362' ' ' ASP . 0.0 OUTLIER 46.26 32.66 1.56 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 118.442 1.121 . . . . 72.04 110.877 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 43.0 tp -115.4 155.55 27.2 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.776 1.231 . . . . 74.12 109.103 -170.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -120.62 149.04 43.09 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.388 0.613 . . . . 71.21 111.165 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.0 mt -66.17 122.65 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 107.454 -1.313 . . . . 73.02 107.454 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.57 -9.12 19.65 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.476 -0.869 . . . . 41.34 113.013 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 4.2 m-20 -61.47 142.32 57.09 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.233 0.827 . . . . 75.4 113.233 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 43.3 tttp -93.27 115.01 27.61 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.491 1.117 . . . . 74.33 109.452 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 4.2 mp -79.9 112.81 17.55 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.873 -0.788 . . . . 71.21 108.873 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 372' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 403' ' ' ALA . 5.8 tt -87.14 -40.16 14.87 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.057 -1.09 . . . . 74.22 108.057 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 401' ' ' LYS . . . -161.99 157.3 23.45 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.883 -0.599 . . . . 75.21 110.891 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.28 123.11 42.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 108.624 -0.88 . . . . 63.42 108.624 173.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' ASN . . . . . 0.535 HD21 HG22 ' A' ' 394' ' ' THR . 91.8 m-20 60.49 31.59 20.33 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-O 124.089 1.899 . . . . 70.14 109.235 -174.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.7 t30 66.26 15.84 10.23 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 109.48 -3.509 . . . . 70.3 112.509 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 55.2 t -84.08 125.98 40.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 106.522 -1.658 . . . . 73.32 106.522 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.8 p -61.66 123.69 18.62 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 123.605 0.762 . . . . 74.44 113.053 -176.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 391' ' ' LEU . 7.6 mp -110.81 -4.79 15.11 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.653 0.781 . . . . 71.35 111.387 177.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -65.65 106.29 1.44 Allowed 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.661 -0.496 . . . . 72.51 109.661 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 60.37 73.17 0.49 Allowed 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 124.616 1.198 . . . . 60.34 113.223 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.24 171.02 18.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 107.155 -1.424 . . . . 52.52 107.155 175.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.8 m -76.96 142.52 39.98 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.613 -0.884 . . . . 74.25 108.613 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 384' ' ' HIS . . . . . 0.535 ' O ' HG23 ' A' ' 388' ' ' VAL . 82.4 t60 -51.17 -47.75 62.07 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 111.446 0.165 . . . . 52.13 111.446 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' GLU . . . . . 0.715 ' HA ' ' OG1' ' B' ' 143' ' ' THR . 7.4 tp10 -58.7 -37.39 75.98 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.835 0.826 . . . . 60.42 110.814 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 383' ' ' THR . 53.1 tt0 -73.85 -38.93 64.33 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.427 -1.26 . . . . 63.15 108.532 -174.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -70.19 -51.66 29.35 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.858 -1.065 . . . . 60.12 110.335 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' VAL . . . . . 0.546 HG11 HG21 ' B' ' 143' ' ' THR . 40.4 t -59.28 -40.69 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.717 -0.22 . . . . 72.03 110.936 -177.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 90.5 m -60.23 -35.5 75.61 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 116.689 -0.232 . . . . 74.51 110.99 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.37 -37.98 84.05 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.587 0.232 . . . . 52.25 110.649 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.421 HD11 HD21 ' A' ' 379' ' ' LEU . 6.2 mp -75.86 -32.01 59.54 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.248 -0.581 . . . . 72.13 110.841 176.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' LYS . . . . . 0.488 ' HG2' HG13 ' B' ' 151' ' ' VAL . 57.6 mttm -67.52 -36.09 80.36 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 112.619 0.6 . . . . 75.34 112.619 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -81.1 70.62 7.97 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.38 1.086 . . . . 72.51 110.786 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.535 HG22 HD21 ' A' ' 375' ' ' ASN . 7.9 p -139.56 157.78 45.23 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 113.745 -1.571 . . . . 73.44 109.433 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 20.1 p -162.61 122.26 2.31 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.117 -0.698 . . . . 63.34 109.117 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' ASP . . . . . 0.47 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 3.6 m-20 59.81 1.42 0.31 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.516 1.526 . . . . 72.43 114.446 175.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -162.35 128.22 3.47 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 108.835 -0.802 . . . . 62.45 108.835 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 47.6 t -140.32 111.94 4.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.766 -0.828 . . . . 61.45 108.766 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -94.07 96.44 9.66 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.481 -0.933 . . . . 74.21 108.481 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 4.3 tt -92.25 120.61 32.97 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 108.656 -0.868 . . . . 71.33 108.656 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 373' ' ' ALA . 25.1 ttmm -106.09 110.16 22.33 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.509 -1.293 . . . . 75.01 107.509 177.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 402' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 370' ' ' LYS . 2.7 p -113.0 149.2 15.52 Favored 'Isoleucine or valine' 0 C--O 1.274 2.374 0 CA-C-O 121.843 0.83 . . . . 74.04 111.394 -177.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -128.12 158.37 38.19 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.595 -1.184 . . . . 70.31 108.446 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.76 164.64 45.94 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 109.145 -0.687 . . . . 74.13 109.145 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 405' ' ' PRO . . . . . 0.498 ' HD3' ' CE1' ' A' ' 410' ' ' HIS . 74.4 Cg_endo -76.86 125.24 7.95 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 121.388 1.392 . . . . 61.24 114.492 -168.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 2.5 m -61.45 -30.3 70.5 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.621 -1.172 . . . . 72.13 111.553 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -138.27 47.24 0.94 Allowed Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.0 -1.095 . . . . 55.04 112.831 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' SER . . . . . 0.418 ' HB3' ' HB2' ' A' ' 405' ' ' PRO . 23.1 t -166.26 -173.12 2.45 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.034 -1.469 . . . . 72.24 107.034 178.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -132.3 107.84 8.81 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 117.899 0.318 . . . . 73.22 111.24 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' HIS . . . . . 0.498 ' CE1' ' HD3' ' A' ' 405' ' ' PRO . 1.6 p-80 -150.79 144.85 25.35 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.969 -1.493 . . . . 75.32 106.969 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 58.1 m80 . . . . . 0 C--N 1.297 -1.69 0 N-CA-C 108.574 -0.899 . . . . 73.22 108.574 -178.235 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.812 0 N-CA-C 107.323 -1.362 . . . . 72.34 107.323 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 142' ' ' ARG . . . . . 0.488 ' HD2' ' OE2' ' A' ' 385' ' ' GLU . 15.5 mmt180 -117.0 170.49 8.6 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 123.588 0.555 . . . . 74.44 110.699 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.715 ' OG1' ' HA ' ' A' ' 385' ' ' GLU . 24.0 p -98.51 152.86 19.09 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.522 -1.288 . . . . 73.11 107.522 -172.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -152.27 176.64 11.39 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.717 -1.586 . . . . 70.31 106.717 -173.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 18.6 pm0 -85.8 159.07 19.83 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-O 121.421 0.629 . . . . 73.43 112.51 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 66.31 19.14 11.01 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.397 1.879 . . . . 74.3 112.601 -177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -144.14 163.85 32.4 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.913 -0.585 . . . . 73.21 109.573 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.83 166.73 11.66 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.041 -0.527 . . . . 72.44 109.979 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.564 HG21 HG22 ' B' ' 143' ' ' THR . 86.5 m -144.44 126.04 15.04 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.544 -0.539 . . . . 60.13 109.544 168.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 150' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 20.9 tm0? -69.59 136.35 51.15 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.107 -0.952 . . . . 64.22 110.601 175.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.488 HG13 ' HG2' ' A' ' 392' ' ' LYS . 21.8 t . . . . . 0 C--N 1.305 -1.363 0 N-CA-C 107.724 -1.213 . . . . 71.51 107.724 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 CA--C 1.492 -1.275 0 N-CA-C 105.766 -1.938 . . . . 73.25 105.766 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -127.12 140.39 52.3 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 113.878 1.066 . . . . 70.31 113.878 -174.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 363' ' ' GLY . 84.0 mt -129.0 116.83 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 CA-C-N 113.504 -1.68 . . . . 62.12 109.19 -174.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.5 127.33 34.86 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.836 -0.801 . . . . 74.12 108.836 175.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 80.9 mt -122.8 152.5 40.62 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.062 -0.718 . . . . 74.22 109.062 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 32.4 mm -105.76 111.51 35.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.653 -1.24 . . . . 73.13 107.653 173.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.475 ' HE3' ' HA2' ' A' ' 328' ' ' GLY . 1.4 tmtp? -75.92 141.05 42.4 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.8 -0.444 . . . . 75.31 109.8 -176.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -149.14 -154.55 6.39 Favored Glycine 0 C--N 1.301 -1.413 0 C-N-CA 120.41 -0.9 . . . . 72.43 112.646 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.66 -12.85 35.76 Favored 'Trans proline' 0 N--CA 1.484 0.926 0 C-N-CA 123.594 2.863 . . . . 62.14 113.99 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.411 ' HZ3' ' HB3' ' A' ' 327' ' ' LYS . 6.9 mtpm? -107.39 10.66 29.51 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.427 -0.953 . . . . 62.21 108.427 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . 0.475 ' HA2' ' HE3' ' A' ' 324' ' ' LYS . . . 83.72 -133.87 12.26 Favored Glycine 0 CA--C 1.484 -1.881 0 CA-C-N 114.389 -1.278 . . . . 71.34 109.91 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.476 ' HB2' HG23 ' B' ' 151' ' ' VAL . 5.1 mp -93.38 -19.68 21.08 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.073 -1.454 . . . . 62.31 107.073 172.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . 0.466 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 85.51 40.05 7.99 Favored Glycine 0 N--CA 1.426 -1.996 0 CA-C-N 113.869 -1.514 . . . . 65.04 115.064 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -154.92 167.8 29.1 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 117.409 0.604 . . . . 65.44 110.324 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 2.8 m -121.76 132.75 54.78 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.492 -0.559 . . . . 74.23 109.492 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 388' ' ' VAL . 18.2 pt -113.68 154.98 14.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 116.234 -0.439 . . . . 75.14 110.978 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.45 115.38 5.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 124.68 1.238 . . . . 61.43 107.937 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 168.77 161.29 18.66 Favored Glycine 0 C--N 1.275 -2.823 0 N-CA-C 108.928 -1.669 . . . . 70.43 108.928 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.67 178.2 15.43 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 108.601 -1.8 . . . . 61.14 108.601 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.8 t -53.05 104.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.65 0.738 . . . . 72.21 110.933 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.65 -19.88 52.3 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.001 -0.999 . . . . 72.43 113.269 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.509 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 60.2 t30 -107.65 22.39 16.03 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 117.288 0.544 . . . . 73.11 110.246 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.401 HE22 ' HA ' ' A' ' 343' ' ' PRO . 0.0 OUTLIER -52.34 119.64 4.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.263 0.554 . . . . 72.42 110.801 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -73.25 -44.82 58.77 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.149 -0.932 . . . . 71.33 109.979 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 42.7 mm -104.66 125.34 34.22 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 108.766 -0.827 . . . . 73.24 108.766 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.401 ' HA ' HE22 ' A' ' 340' ' ' GLN . 73.0 Cg_exo -52.62 107.73 0.21 Allowed 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 123.21 2.607 . . . . 74.34 112.898 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 107.14 -7.63 37.83 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-N 115.281 -0.872 . . . . 53.23 112.362 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -125.03 98.74 5.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.941 -0.763 . . . . 55.21 108.941 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -83.05 33.67 0.45 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.878 0.871 . . . . 74.5 111.511 -171.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 16.4 m -95.06 171.44 8.75 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.157 -0.474 . . . . 62.34 111.006 -177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.416 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 27.6 mm -83.91 127.5 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 107.678 -1.23 . . . . 71.05 107.678 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 47.6 m-85 -123.88 136.68 54.51 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.328 0.585 . . . . 53.0 112.465 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.18 113.81 5.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.796 -1.187 . . . . 65.14 107.796 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 53.2 m -102.14 -23.9 14.0 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.236 0.541 . . . . 74.32 111.276 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 94.7 mttt -151.32 156.28 40.45 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.964 -1.124 . . . . 74.13 107.964 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.4 HG22 ' HB2' ' A' ' 360' ' ' HIS . 78.0 mt -130.47 128.95 64.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.309 -1.367 . . . . 71.2 107.309 176.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 49.4 mm -85.35 141.78 14.1 Favored 'Isoleucine or valine' 0 C--O 1.256 1.419 0 C-N-CA 123.315 0.646 . . . . 74.13 111.22 -171.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.19 127.83 34.13 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.201 1.0 . . . . 74.12 111.555 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 71.71 8.9 68.86 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.534 -0.757 . . . . 51.12 112.584 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . 0.466 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -70.46 159.75 53.63 Favored Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.831 -0.699 . . . . 71.34 111.498 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -59.15 -40.86 86.86 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.592 -0.522 . . . . 72.43 109.592 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.523 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -73.01 -13.13 61.16 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.262 0.553 . . . . 63.12 112.298 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . 0.4 ' HB2' HG22 ' A' ' 353' ' ' ILE . 25.0 t60 -92.53 -25.74 18.24 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.899 0.857 . . . . 61.52 109.434 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.424 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 0.2 OUTLIER -96.57 -59.21 1.87 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 113.332 0.864 . . . . 74.43 113.332 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -86.14 -36.53 19.51 Favored 'General case' 0 CA--C 1.475 -1.913 0 N-CA-C 107.844 -1.169 . . . . 64.41 107.844 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.535 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -44.75 -35.15 4.16 Favored Glycine 0 C--O 1.201 -1.923 0 N-CA-C 118.677 2.231 . . . . 74.34 118.677 -166.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.535 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.58 29.86 0.19 Allowed 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 118.29 1.045 . . . . 62.03 111.198 -173.038 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 47.2 tp -97.64 151.8 19.73 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 125.009 1.324 . . . . 74.54 109.807 -169.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -121.1 149.19 43.13 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-O 121.409 0.623 . . . . 74.35 111.409 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 77.8 mt -65.89 121.7 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 107.622 -1.251 . . . . 55.02 107.622 172.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.4 -1.76 22.13 Favored Glycine 0 C--N 1.313 -0.734 0 C-N-CA 121.0 -0.619 . . . . 60.45 112.133 -175.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -75.16 137.11 41.1 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 113.087 0.773 . . . . 74.45 113.087 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 37.9 tttp -92.83 119.43 32.15 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 124.327 1.051 . . . . 73.01 110.453 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 78.6 mt -87.63 121.03 29.54 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 120.393 -0.523 . . . . 62.01 110.002 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.466 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 92.6 mt -82.19 -40.16 22.14 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.088 -1.415 . . . . 72.23 108.439 177.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -165.17 165.65 19.6 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.281 -0.872 . . . . 71.53 111.944 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . 0.497 HG12 HD11 ' A' ' 379' ' ' LEU . 10.2 p -133.79 119.58 33.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.863 -1.162 . . . . 65.5 107.863 171.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . 0.49 HD21 HG22 ' A' ' 394' ' ' THR . 84.8 m-20 63.14 28.65 16.05 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 123.95 1.833 . . . . 71.33 108.406 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 66.18 17.92 10.84 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 109.726 -3.397 . . . . 75.33 112.52 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.5 t -84.14 123.63 39.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.567 -1.642 . . . . 70.34 106.567 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 10.4 p -59.49 124.04 18.77 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.163 1.172 . . . . 73.33 114.163 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.566 HD21 HD11 ' A' ' 391' ' ' LEU . 5.8 mp -106.49 6.7 30.43 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.64 1.176 . . . . 72.24 110.119 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.466 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 20.1 mm-40 -71.26 110.67 6.05 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.073 -0.967 . . . . 73.23 110.902 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 54.1 66.86 1.12 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.65 1.18 . . . . 60.45 112.715 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.36 171.72 16.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.629 -1.249 . . . . 74.35 107.629 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.448 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 2.3 m -75.79 144.78 41.17 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.661 -0.866 . . . . 32.14 108.661 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . 0.578 ' O ' HG23 ' A' ' 388' ' ' VAL . 10.0 t-160 -51.88 -49.78 62.3 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 111.601 0.223 . . . . 61.12 111.601 -176.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -65.22 -29.52 70.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.966 0.412 . . . . 65.35 111.848 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 383' ' ' THR . 60.7 tt0 -71.52 -40.27 70.22 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.688 -1.227 . . . . 63.13 107.688 -176.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -69.59 -50.55 43.5 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.864 -1.062 . . . . 65.3 110.178 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 384' ' ' HIS . 40.6 t -57.38 -37.16 55.74 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 O-C-N 123.032 0.208 . . . . 71.52 111.38 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 91.5 m -62.55 -34.34 76.73 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 116.653 -0.248 . . . . 74.34 111.108 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -70.06 -35.95 74.63 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.644 0.259 . . . . 71.54 110.363 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.566 HD11 HD21 ' A' ' 379' ' ' LEU . 5.6 mp -78.51 -27.93 46.17 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 120.164 -0.614 . . . . 71.42 110.599 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 53.5 mttm -71.42 -37.24 71.49 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.85 0.685 . . . . 55.45 112.85 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -82.45 65.83 7.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.282 1.039 . . . . 62.4 110.79 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.49 HG22 HD21 ' A' ' 375' ' ' ASN . 31.0 p -137.18 146.93 45.51 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.034 -1.439 . . . . 65.24 107.506 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 42.1 m -142.78 120.39 11.79 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.71 -0.478 . . . . 60.02 109.71 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 324' ' ' LYS . 3.9 m-20 58.46 0.95 0.15 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.691 1.996 . . . . 71.43 115.694 172.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -161.61 135.57 6.74 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.416 -0.957 . . . . 74.03 108.416 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 61.4 t -142.02 133.45 26.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.682 -0.859 . . . . 53.35 108.682 177.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -107.73 96.29 6.28 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.192 -1.781 . . . . 74.31 106.192 173.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.4 tt -86.36 129.67 34.77 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 120.949 0.404 . . . . 63.44 110.292 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -108.96 108.54 19.33 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.817 -1.179 . . . . 62.32 107.817 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 3.4 p -118.93 150.55 21.22 Favored 'Isoleucine or valine' 0 C--O 1.274 2.353 0 CA-C-O 121.784 0.802 . . . . 72.31 111.265 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.424 ' HB2' HD11 ' A' ' 372' ' ' LEU . . . -136.63 158.15 45.11 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 105.721 -1.955 . . . . 71.12 105.721 171.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.284 -2.248 0 N-CA-C 105.463 -2.051 . . . . 63.41 105.463 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . 0.41 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.507 -0.707 0 N-CA-C 109.708 -0.479 . . . . 74.41 109.708 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -91.36 161.3 15.07 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.657 -0.868 . . . . 75.24 108.657 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 51.6 m -147.27 140.43 25.23 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.927 -0.483 . . . . 73.2 110.414 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -71.13 139.24 50.2 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.865 -0.607 . . . . 73.51 109.916 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 329' ' ' LEU . 12.4 m . . . . . 0 C--O 1.265 1.878 0 CA-C-N 115.79 -0.641 . . . . 71.23 112.065 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 C--O 1.203 -1.394 0 N-CA-C 106.373 -1.714 . . . . 73.14 106.373 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.472 1.9 pm0 -115.58 128.98 56.35 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 117.05 2.241 . . . . 72.34 117.05 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.601 HG23 ' HD3' ' A' ' 364' ' ' LYS . 66.9 mt -107.38 107.0 21.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 CA-C-N 111.425 -2.625 . . . . 75.33 108.552 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.51 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 29.4 ttpt -80.44 118.92 22.49 Favored 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 119.865 -0.734 . . . . 71.22 109.073 174.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.59 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 27.5 mt -113.05 148.07 35.93 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 113.904 -1.498 . . . . 72.44 110.316 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.0 mp -106.55 117.2 51.89 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.017 0 N-CA-C 107.119 -1.437 . . . . 72.45 107.119 169.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.682 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 10.2 tmtt? -63.03 151.57 39.45 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 108.639 -0.875 . . . . 75.21 108.639 171.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.429 ' O ' ' HE2' ' A' ' 324' ' ' LYS . . . -141.98 -160.58 8.39 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 119.832 -1.175 . . . . 64.04 113.365 -171.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.22 -30.62 45.82 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.155 2.57 . . . . 74.41 113.651 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -101.58 18.85 19.21 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 122.279 1.037 . . . . 75.31 108.791 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.34 -129.0 8.92 Favored Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 109.799 -1.32 . . . . 71.14 109.799 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.508 ' HB2' HG23 ' B' ' 151' ' ' VAL . 5.3 mp -96.98 -42.58 7.84 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.161 -1.792 . . . . 75.24 106.161 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . 0.517 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 84.41 50.19 4.36 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 114.754 -1.112 . . . . 52.33 114.806 171.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . 0.408 ' O ' HG22 ' B' ' 151' ' ' VAL . 50.2 p90 -151.25 150.71 30.9 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.413 -0.588 . . . . 60.11 109.413 173.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 6.4 m -104.15 129.15 51.87 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.601 -0.518 . . . . 72.11 109.601 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.3 pt -113.36 151.69 15.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-N 115.824 -0.625 . . . . 72.23 109.943 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.66 121.75 10.1 Favored 'General case' 0 N--CA 1.425 -1.713 0 O-C-N 124.226 0.954 . . . . 74.23 108.685 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 167.7 179.07 40.18 Favored Glycine 0 C--N 1.281 -2.498 0 N-CA-C 107.452 -2.259 . . . . 54.3 107.452 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 132.54 175.98 14.21 Favored Glycine 0 CA--C 1.474 -2.526 0 N-CA-C 108.712 -1.755 . . . . 44.34 108.712 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.457 HG22 ' OE2' ' A' ' 381' ' ' GLU . 93.4 t -51.0 100.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 O-C-N 124.432 0.725 . . . . 62.41 111.437 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 88.13 -7.47 81.35 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.593 -0.731 . . . . 62.12 112.312 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.449 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 65.6 t30 -106.3 16.56 24.66 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.066 -0.716 . . . . 63.14 109.066 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.463 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -49.57 125.88 12.33 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.52 1.128 . . . . 73.22 111.835 -177.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -80.3 -44.11 20.12 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.18 -0.918 . . . . 54.03 109.429 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.5 mm -103.62 125.28 35.24 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 115.846 -0.615 . . . . 63.03 109.357 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.33 108.8 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.553 2.836 . . . . 75.41 113.416 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 101.87 -4.92 53.26 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.512 -0.767 . . . . 71.44 111.936 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -124.99 96.7 4.96 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.322 -0.992 . . . . 73.32 108.322 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 51.7 t30 -81.01 29.04 0.34 Allowed 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 124.343 1.057 . . . . 74.23 111.781 -170.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 73.0 m -93.34 177.97 5.87 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.726 0.774 . . . . 75.45 112.755 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.5 mm -91.21 129.33 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 114.609 -1.178 . . . . 72.21 108.32 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 28.9 m-85 -123.54 132.47 53.91 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.193 0.52 . . . . 74.32 112.197 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 52.9 t -67.1 109.84 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.581 -1.266 . . . . 75.51 107.581 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.4 m -99.83 -22.07 15.48 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.207 0.527 . . . . 72.11 110.711 -175.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 31.8 mmtp -148.25 154.27 39.83 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.375 -1.343 . . . . 72.11 107.375 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.462 HG22 ' HB2' ' A' ' 360' ' ' HIS . 65.5 mt -131.72 107.59 13.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 106.815 -1.55 . . . . 70.11 106.815 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 38.7 mm -78.73 129.6 37.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 123.731 0.813 . . . . 74.34 109.788 -171.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.533 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 0.6 OUTLIER -63.83 146.25 54.29 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.429 -1.323 . . . . 63.11 107.429 -178.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.598 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.05 -19.53 53.66 Favored Glycine 0 C--N 1.28 -2.529 0 N-CA-C 109.299 -1.521 . . . . 35.22 109.299 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . 0.517 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -69.29 142.37 37.28 Favored Glycine 1 N--CA 1.384 -4.811 0 N-CA-C 107.968 -2.053 . . . . 72.44 107.968 172.034 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 362' ' ' ASP . . . -62.97 -32.65 74.04 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.826 -0.805 . . . . 74.42 108.826 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.585 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.72 -6.28 49.75 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.981 -0.554 . . . . 52.02 112.132 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . 0.533 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 19.5 t60 -94.19 -39.4 10.57 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.432 -0.951 . . . . 73.14 108.432 175.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.598 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 73.7 mmtt -82.7 -57.65 3.23 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.599 0.714 . . . . 62.23 110.79 -178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 358' ' ' ALA . 10.9 t70 -85.86 -34.85 20.9 Favored 'General case' 0 CA--C 1.468 -2.187 0 C-N-CA 125.182 1.393 . . . . 71.15 111.112 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.59 ' HA2' ' CD2' ' A' ' 322' ' ' LEU . . . -42.71 -23.97 0.22 Allowed Glycine 0 C--N 1.287 -2.186 0 N-CA-C 120.862 3.105 . . . . 35.44 120.862 -162.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.601 ' HD3' HG23 ' A' ' 320' ' ' ILE . 0.0 OUTLIER 41.47 36.99 0.6 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.802 1.301 . . . . 74.51 111.54 -178.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 50.3 tp -114.21 156.06 24.97 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.536 1.134 . . . . 64.25 109.891 -170.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -122.19 142.66 50.19 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.434 0.635 . . . . 74.04 111.678 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.39 121.53 15.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.507 -1.294 . . . . 71.1 107.507 169.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 114.55 -0.61 23.43 Favored Glycine 0 C--N 1.314 -0.687 0 N-CA-C 111.656 -0.578 . . . . 50.24 111.656 -176.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.478 ' HB3' HG21 ' A' ' 402' ' ' VAL . 83.2 m-20 -76.27 136.77 39.64 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.196 0.813 . . . . 73.12 113.196 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.666 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 37.7 tttp -94.86 116.61 28.93 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.99 1.316 . . . . 72.12 108.948 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 83.6 mt -83.25 113.45 20.69 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 109.779 -0.452 . . . . 72.3 109.779 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 403' ' ' ALA . 3.9 tt -81.49 -39.67 24.4 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.08 -1.452 . . . . 74.23 107.08 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.41 159.18 21.99 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.493 -0.776 . . . . 63.14 110.644 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . 0.438 HG12 HD11 ' A' ' 379' ' ' LEU . 13.5 p -133.75 121.09 39.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.07 -1.085 . . . . 60.15 108.07 172.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . 0.542 HD21 HG22 ' A' ' 394' ' ' THR . 89.1 m-20 62.83 29.85 16.63 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 123.987 1.851 . . . . 74.03 108.652 -174.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 67.42 10.39 7.71 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 109.652 -3.431 . . . . 71.34 113.355 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 50.3 t -78.74 124.56 37.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.585 -1.635 . . . . 64.44 106.585 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.5 p -61.51 124.62 21.17 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.677 0.992 . . . . 65.54 113.677 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.438 HD11 HG12 ' A' ' 374' ' ' VAL . 8.5 mp -109.18 3.48 21.88 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.027 0.931 . . . . 71.32 110.836 176.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -78.15 115.97 18.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.34 -0.985 . . . . 72.32 108.34 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . 0.457 ' OE2' HG22 ' A' ' 337' ' ' VAL . 17.1 tp10 62.83 83.34 0.16 Allowed 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 124.607 1.192 . . . . 75.32 111.625 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 18.4 m -153.81 160.36 2.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 113.966 -1.47 . . . . 64.54 109.171 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.5 m -81.65 145.14 30.73 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.443 -1.317 . . . . 73.51 107.443 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . 0.618 ' O ' HG23 ' A' ' 388' ' ' VAL . 7.3 t-160 -52.1 -48.27 64.85 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 112.533 0.568 . . . . 74.22 112.533 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -57.86 -37.34 73.72 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.653 0.74 . . . . 74.32 110.896 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 383' ' ' THR . 55.5 tt0 -70.54 -35.8 73.34 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.942 -1.026 . . . . 75.04 108.484 -174.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.407 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -75.47 -50.94 14.21 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.662 -1.154 . . . . 61.35 111.052 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 384' ' ' HIS . 20.7 t -57.64 -40.75 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 110.022 -0.362 . . . . 72.22 110.022 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 94.8 m -58.55 -40.01 81.83 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.101 -0.499 . . . . 65.52 110.749 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -63.65 -33.22 75.15 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.477 0.18 . . . . 60.01 110.972 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.8 mp -81.44 -28.92 34.0 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 120.388 -0.525 . . . . 51.01 110.943 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -74.74 -24.18 58.67 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.213 0.449 . . . . 64.41 112.213 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -78.62 46.39 0.65 Allowed 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 123.428 0.691 . . . . 73.53 110.692 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.542 HG22 HD21 ' A' ' 375' ' ' ASN . 34.0 p -124.57 143.49 50.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.056 0.455 . . . . 65.01 110.061 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 324' ' ' LYS . 49.3 m -142.49 100.98 3.8 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 122.32 1.057 . . . . 62.43 112.171 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.682 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 5.3 m-20 60.47 15.85 5.9 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 128.232 2.613 . . . . 60.01 113.897 169.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -165.91 126.53 1.79 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.035 -1.098 . . . . 60.33 108.035 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 25.1 t -145.61 146.6 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 123.296 0.638 . . . . 72.24 110.642 -175.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.51 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 20.4 m-85 -118.56 96.68 5.39 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.465 0.706 . . . . 74.0 109.191 169.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.8 tt -88.34 121.5 30.8 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.34 -0.615 . . . . 62.34 109.34 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -104.64 108.42 19.86 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.256 -1.016 . . . . 73.51 108.256 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 369' ' ' ASP . 5.6 p -106.41 150.48 8.98 Favored 'Isoleucine or valine' 0 C--O 1.276 2.5 0 CA-C-O 121.651 0.739 . . . . 74.04 110.247 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.666 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.7 159.58 41.39 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 125.966 1.706 . . . . 71.12 107.149 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 7.1 mmpt? . . . . . 0 C--N 1.287 -2.126 0 N-CA-C 108.803 -0.814 . . . . 73.55 108.803 174.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 N--CA 1.425 -1.712 0 N-CA-C 108.052 -1.092 . . . . 75.11 108.052 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -90.47 158.03 17.26 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 124.159 0.912 . . . . 74.42 108.54 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 55.2 m -145.85 138.16 25.47 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.796 -0.446 . . . . 51.23 109.796 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -81.52 132.35 35.31 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 109.525 -0.546 . . . . 61.21 109.525 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.508 HG23 ' HB2' ' A' ' 329' ' ' LEU . 7.9 m . . . . . 0 C--N 1.291 -1.957 0 CA-C-N 116.026 -0.534 . . . . 64.41 111.291 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 CA--C 1.493 -1.247 0 N-CA-C 107.427 -1.323 . . . . 75.33 107.427 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.298 1.6 pm0 -115.34 133.85 55.65 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-O 122.847 1.308 . . . . 73.23 114.087 -175.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.536 HG23 ' HE2' ' A' ' 364' ' ' LYS . 86.6 mt -123.62 106.59 17.41 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.732 0 CA-C-N 112.662 -2.063 . . . . 53.2 110.025 -173.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.524 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 30.2 ttpt -81.07 130.5 35.05 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.931 -1.137 . . . . 73.34 107.931 170.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.403 HD21 ' HA2' ' A' ' 363' ' ' GLY . 10.3 mt -129.97 156.76 43.91 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 124.805 1.316 . . . . 74.43 110.396 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 39.0 mm -106.5 117.57 52.52 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.762 0 N-CA-C 107.696 -1.224 . . . . 75.25 107.696 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.576 ' HG2' ' N ' ' A' ' 325' ' ' GLY . 17.5 tttm -71.69 160.92 31.8 Favored 'General case' 0 C--O 1.206 -1.185 0 N-CA-C 107.933 -1.136 . . . . 74.01 107.933 174.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.576 ' N ' ' HG2' ' A' ' 324' ' ' LYS . . . -149.33 -164.34 11.57 Favored Glycine 0 C--N 1.29 -1.981 0 N-CA-C 110.315 -1.114 . . . . 20.24 110.315 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.31 -12.84 27.86 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.892 2.394 . . . . 74.34 111.493 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -97.61 6.72 47.64 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 122.078 0.942 . . . . 65.43 108.968 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.03 -134.79 13.05 Favored Glycine 0 CA--C 1.491 -1.412 0 N-CA-C 109.824 -1.31 . . . . 74.45 109.824 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.78 -27.11 12.88 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.157 -1.423 . . . . 75.42 107.157 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 86.02 48.12 4.75 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.366 -1.288 . . . . 60.23 115.216 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -154.46 171.34 19.52 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 110.043 -0.354 . . . . 74.41 110.043 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.7 m -127.96 128.4 44.99 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.093 -0.706 . . . . 61.15 109.093 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 21.4 pt -113.79 157.92 14.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 115.84 -0.618 . . . . 75.31 110.622 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.39 125.96 10.98 Favored 'General case' 0 N--CA 1.428 -1.559 0 O-C-N 124.36 1.037 . . . . 63.12 108.454 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 164.13 -177.0 40.03 Favored Glycine 0 C--N 1.284 -2.333 0 N-CA-C 108.581 -1.808 . . . . 72.21 108.581 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.19 177.05 14.68 Favored Glycine 0 CA--C 1.482 -1.987 0 N-CA-C 109.833 -1.307 . . . . 71.25 109.833 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.454 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 92.8 t -57.76 103.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 O-C-N 124.121 0.542 . . . . 71.13 110.202 175.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 92.96 -14.08 66.11 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.375 -0.83 . . . . 72.32 112.101 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.511 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 65.0 t30 -106.02 21.56 17.11 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.553 -0.536 . . . . 73.42 109.553 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.67 123.5 7.96 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 115.104 -0.953 . . . . 72.23 111.49 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -78.72 -40.85 32.45 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.032 -0.985 . . . . 73.34 108.916 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 37.0 mm -103.62 122.36 45.07 Favored Pre-proline 0 C--N 1.302 -1.488 0 CA-C-N 115.2 -0.909 . . . . 75.24 109.334 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -52.2 108.11 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.429 2.752 . . . . 45.15 112.91 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 104.44 -2.6 42.97 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 115.178 -0.919 . . . . 61.35 112.308 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -127.14 103.66 7.55 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.747 0.784 . . . . 73.02 109.587 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . 0.454 ' OD1' ' HA ' ' A' ' 337' ' ' VAL . 65.9 t30 -83.32 38.02 0.59 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 125.038 1.335 . . . . 71.1 111.14 -171.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 21.5 m -110.9 177.86 4.53 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.723 -0.671 . . . . 75.13 112.346 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.416 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 35.0 mm -91.92 131.15 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.053 0.541 . . . . 74.43 109.702 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 36.6 m-85 -124.39 139.16 54.16 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.582 0.586 . . . . 72.44 112.582 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.24 115.05 10.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 108.256 -1.016 . . . . 71.55 108.256 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 31.6 m -101.06 -24.0 14.39 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.341 0.591 . . . . 71.32 111.308 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.63 147.93 23.7 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.792 -1.188 . . . . 72.33 107.792 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 85.1 mt -118.27 133.09 66.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 106.168 -1.79 . . . . 74.01 106.168 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 48.6 mm -75.83 130.87 35.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.315 0.579 . . . . 73.25 109.831 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.602 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.6 pm0 -60.09 122.36 14.2 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 125.006 1.322 . . . . 72.1 111.627 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 74.29 16.16 79.91 Favored Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 114.368 -1.287 . . . . 74.41 111.393 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.78 163.95 52.84 Favored Glycine 0 C--O 1.251 1.177 0 N-CA-C 110.97 -0.852 . . . . 15.32 110.97 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -64.33 -42.34 96.33 Favored 'General case' 0 C--O 1.207 -1.15 0 N-CA-C 108.816 -0.809 . . . . 44.34 108.816 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.425 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -71.49 -5.74 35.3 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 121.876 -0.515 . . . . 55.23 112.135 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -93.85 -36.12 12.39 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.67 -0.863 . . . . 63.33 108.67 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -92.62 -58.59 2.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.98 1.371 . . . . 52.45 110.221 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -85.9 -26.76 25.41 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.709 -2.041 . . . . 64.02 110.283 -170.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -56.69 -39.35 86.21 Favored Glycine 0 C--N 1.278 -2.641 0 CA-C-N 112.779 -2.01 . . . . 65.13 118.109 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.536 ' HE2' HG23 ' A' ' 320' ' ' ILE 0.255 0.0 OUTLIER 45.94 32.59 1.37 Allowed 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 119.113 1.456 . . . . 72.42 111.489 -170.56 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 48.3 tp -101.31 149.62 23.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.436 -1.257 . . . . 73.31 109.036 -172.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.95 147.74 42.86 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.285 0.564 . . . . 63.3 109.686 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 76.7 mt -66.03 123.3 18.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 106.927 -1.509 . . . . 74.12 106.927 170.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.54 -9.31 19.66 Favored Glycine 0 C--N 1.308 -1.005 0 C-N-CA 120.536 -0.84 . . . . 63.31 112.29 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -68.51 137.09 54.1 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 120.882 0.373 . . . . 74.44 111.504 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 2.1 ttmm -94.55 125.14 39.01 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.81 -0.632 . . . . 62.53 109.502 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 95.9 mt -81.45 112.36 18.63 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.671 -0.863 . . . . 62.4 108.671 176.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 403' ' ' ALA . 2.8 tt -80.5 -43.61 20.51 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.104 -2.184 . . . . 51.21 105.104 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -160.45 161.41 32.91 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.738 -1.119 . . . . 51.13 110.909 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.14 126.81 50.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.365 -1.346 . . . . 61.24 107.365 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.01 34.79 23.74 Favored 'General case' 0 CA--C 1.475 -1.925 0 CA-C-O 124.631 2.158 . . . . 43.01 110.339 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 60.42 17.33 7.11 Favored 'General case' 0 C--N 1.266 -3.058 1 CA-C-N 108.341 -4.027 . . . . 72.23 113.362 -177.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.4 t -89.04 125.86 42.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.64 -1.245 . . . . 70.14 107.64 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.4 p -57.58 123.42 15.53 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 123.847 0.859 . . . . 53.52 112.837 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 2.9 mp -107.32 -5.84 17.55 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.457 -0.792 . . . . 62.01 112.602 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -83.89 136.28 34.16 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.779 -0.768 . . . . 43.55 111.035 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 63.05 32.37 15.41 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.113 1.365 . . . . 71.53 114.469 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 33.2 m -112.07 169.15 4.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.257 -1.386 . . . . 71.14 107.257 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 82.6 p -79.26 150.46 31.54 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.359 -0.937 . . . . 73.54 108.937 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . 0.573 ' O ' HG23 ' A' ' 388' ' ' VAL . 6.8 t-160 -51.2 -37.25 45.63 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.212 0.449 . . . . 61.22 112.212 -175.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.33 -40.69 97.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 121.386 -0.126 . . . . 74.51 110.903 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -67.24 -37.15 83.08 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 109.188 -0.671 . . . . 72.35 109.188 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.523 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -68.66 -56.56 7.77 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 114.581 -1.19 . . . . 61.3 110.685 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 384' ' ' HIS . 27.4 t -58.98 -44.56 91.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 110.043 -0.354 . . . . 70.55 110.043 -177.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 87.3 m -60.29 -33.72 72.76 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.178 -0.465 . . . . 42.45 111.171 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.66 -38.03 86.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.425 -0.172 . . . . 74.33 110.757 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.4 mp -75.54 -30.12 59.63 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 119.914 -0.714 . . . . 64.12 110.219 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 55.0 mttm -72.31 -27.71 62.62 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 112.289 0.477 . . . . 74.02 112.289 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -80.07 51.36 1.35 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.047 0.927 . . . . 62.35 111.833 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 17.5 p -124.78 162.88 23.32 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 107.246 -1.39 . . . . 73.05 107.246 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 55.1 m -148.69 101.38 3.2 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.939 0.876 . . . . 74.35 110.669 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.571 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 0.8 OUTLIER 47.18 30.28 1.36 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 111.425 -2.625 . . . . 75.15 114.259 172.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -169.24 117.56 0.64 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 106.334 -1.728 . . . . 71.31 106.334 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.81 146.16 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.754 0.422 . . . . 73.14 111.036 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.524 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 28.0 m-85 -121.93 96.84 5.22 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.625 0.77 . . . . 72.31 108.975 171.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.45 ' CD2' HG23 ' A' ' 402' ' ' VAL . 7.0 tt -91.61 133.89 35.16 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.799 -0.637 . . . . 73.43 109.695 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -117.55 110.9 18.52 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.242 0.617 . . . . 60.15 110.651 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' A' ' 400' ' ' LEU . 53.7 t -104.99 143.13 16.8 Favored 'Isoleucine or valine' 0 C--O 1.27 2.162 0 C-N-CA 124.047 0.939 . . . . 64.41 110.525 177.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -125.76 154.52 42.41 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 103.957 -2.608 . . . . 73.43 103.957 167.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt . . . . . 0 C--N 1.285 -2.198 0 C-N-CA 119.303 -0.959 . . . . 71.1 111.085 -177.435 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 C--O 1.26 1.608 0 N-CA-C 106.478 -1.675 . . . . 74.04 106.478 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' B' ' 148' ' ' GLU . 0.1 OUTLIER -95.61 159.79 14.82 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 123.797 0.686 . . . . 74.03 110.074 -178.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 45.9 m -145.12 140.08 27.76 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.729 -0.607 . . . . 72.01 110.585 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -81.9 135.88 35.37 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.673 0.789 . . . . 73.44 110.393 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.42 HG12 HG13 ' A' ' 388' ' ' VAL . 15.3 m . . . . . 0 C--O 1.27 2.146 0 CA-C-N 116.077 -0.51 . . . . 64.15 111.641 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 C--O 1.209 -1.046 0 N-CA-C 108.233 -1.025 . . . . 63.3 108.233 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.285 2.0 pm0 -104.31 139.51 39.19 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 114.069 1.137 . . . . 73.34 114.069 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.471 HD13 ' O ' ' A' ' 363' ' ' GLY . 89.9 mt -128.66 122.53 57.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.168 -1.833 . . . . 62.13 107.986 -172.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.534 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 33.1 ttpt -94.79 109.67 21.62 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.38 -0.528 . . . . 42.24 110.622 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.429 HD21 ' HA2' ' A' ' 363' ' ' GLY . 88.0 mt -106.61 151.49 24.98 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.678 -1.147 . . . . 61.31 109.769 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 24.2 mm -105.25 111.22 33.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.038 -1.467 . . . . 75.31 107.038 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -75.98 130.55 38.6 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.355 -0.384 . . . . 70.33 111.548 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -133.09 -154.97 7.65 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 119.386 -1.388 . . . . 53.21 112.696 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.51 -13.26 35.03 Favored 'Trans proline' 0 N--CA 1.481 0.77 0 C-N-CA 123.411 2.741 . . . . 71.24 114.177 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -106.27 8.57 31.94 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.176 0.988 . . . . 62.23 108.386 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.02 -136.28 14.66 Favored Glycine 0 CA--C 1.492 -1.376 0 CA-C-N 113.844 -1.525 . . . . 34.13 110.497 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.457 ' HB2' HG23 ' B' ' 151' ' ' VAL . 4.0 mp -98.55 -26.26 14.47 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.746 -1.946 . . . . 73.52 105.746 171.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . 0.593 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 80.28 54.04 3.93 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 113.689 -1.596 . . . . 42.02 115.113 172.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -155.35 158.52 38.83 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.218 -1.03 . . . . 71.2 108.218 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 352' ' ' LYS . 14.9 m -113.08 133.64 54.9 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.388 -0.597 . . . . 74.42 109.388 -177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.3 pt -116.16 154.54 17.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 115.833 -0.622 . . . . 52.15 110.996 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -143.58 127.37 17.21 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.478 -1.675 . . . . 63.5 106.478 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 148.33 150.67 5.26 Favored Glycine 0 C--N 1.283 -2.416 0 N-CA-C 109.323 -1.511 . . . . 71.44 109.323 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.65 171.84 12.75 Favored Glycine 0 C--N 1.287 -2.189 0 N-CA-C 108.044 -2.022 . . . . 75.13 108.044 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.408 ' HA ' HD21 ' A' ' 346' ' ' ASN . 61.1 t -45.57 111.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.087 0.943 . . . . 60.44 111.58 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 94.05 -30.49 7.53 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.097 -0.956 . . . . 71.33 112.361 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.43 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 63.3 t30 -105.46 26.75 9.08 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.808 -0.442 . . . . 72.3 109.808 -177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.83 123.93 8.91 Favored 'General case' 0 C--O 1.26 1.646 0 CA-C-N 116.017 -0.538 . . . . 75.45 109.793 177.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -75.81 -52.62 9.99 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.141 -0.936 . . . . 71.34 109.497 -173.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 73.3 mt -103.26 133.18 20.46 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 107.817 -1.179 . . . . 71.14 107.817 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.61 110.84 0.47 Allowed 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 123.424 2.749 . . . . 71.14 113.755 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 97.54 -4.58 61.91 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.322 -0.854 . . . . 61.43 112.045 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 23.8 t0 -120.15 96.82 5.32 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.831 0.824 . . . . 72.31 108.841 -177.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . 0.408 HD21 ' HA ' ' A' ' 337' ' ' VAL . 52.7 t30 -85.05 28.91 0.67 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.506 0.669 . . . . 74.3 110.7 -171.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.456 ' HB2' ' CE2' ' A' ' 349' ' ' TYR . 15.2 m -90.45 164.71 14.17 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.105 0.479 . . . . 63.52 111.106 -175.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 24.6 mm -79.54 125.01 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 108.428 -0.953 . . . . 75.11 108.428 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.589 ' CE1' ' HB2' ' A' ' 370' ' ' LYS . 47.7 m-85 -123.71 130.22 52.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.089 0.471 . . . . 73.45 111.801 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.17 117.1 6.31 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 CA-C-N 115.432 -0.804 . . . . 73.14 109.254 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.2 m -100.06 -18.16 17.13 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.484 0.659 . . . . 75.44 110.476 -175.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.566 ' HB2' ' HZ3' ' A' ' 352' ' ' LYS . 2.3 ttmp? -166.57 153.05 8.81 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.047 -1.094 . . . . 72.33 108.047 -175.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 64.8 mt -126.87 119.86 54.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 107.037 -1.468 . . . . 62.45 107.037 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 42.8 mm -86.28 125.94 40.68 Favored 'Isoleucine or valine' 0 C--O 1.259 1.568 0 C-N-CA 123.234 0.614 . . . . 74.54 109.72 -175.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.31 147.6 47.69 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 108.285 -1.005 . . . . 63.35 108.285 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.558 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.49 -19.06 56.03 Favored Glycine 0 C--N 1.281 -2.487 0 N-CA-C 109.714 -1.355 . . . . 41.22 109.714 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . 0.593 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -72.93 149.85 43.51 Favored Glycine 1 N--CA 1.395 -4.095 0 N-CA-C 109.515 -1.434 . . . . 62.21 109.515 173.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -56.95 -36.84 70.73 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.132 -0.692 . . . . 60.21 109.132 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.574 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.81 -13.04 60.28 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 113.263 0.838 . . . . 51.32 113.263 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -94.14 -31.4 14.18 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.369 -0.974 . . . . 72.32 108.369 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.558 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 75.1 mmtt -84.69 -58.2 2.82 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.738 -0.785 . . . . 64.12 110.676 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.46 -42.17 13.81 Favored 'General case' 0 CA--C 1.467 -2.225 0 CA-C-O 121.887 0.851 . . . . 74.32 111.124 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -42.66 -23.1 0.17 Allowed Glycine 0 CA--C 1.482 -2.024 0 N-CA-C 120.328 2.891 . . . . 74.43 120.328 -158.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.516 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.84 32.48 0.4 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 119.037 1.418 . . . . 54.14 111.658 -178.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 48.5 tp -99.69 152.78 19.69 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.519 -1.219 . . . . 73.25 109.83 -171.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -117.14 144.65 44.47 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.478 0.656 . . . . 64.1 110.677 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.9 mt -66.12 120.81 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 106.958 -1.497 . . . . 72.22 106.958 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.56 -7.46 20.27 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 120.803 -0.713 . . . . 51.41 112.157 -176.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -70.14 137.54 51.14 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-O 121.17 0.509 . . . . 70.13 111.742 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.589 ' HB2' ' CE1' ' A' ' 349' ' ' TYR . 36.1 tttp -92.07 119.14 31.48 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.281 -0.872 . . . . 71.1 110.118 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 93.8 mt -79.08 114.71 18.24 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.293 -0.632 . . . . 75.33 109.293 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.457 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 3.3 tt -82.49 -39.84 21.92 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.205 -1.776 . . . . 64.41 106.205 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.92 166.86 21.29 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.538 -0.756 . . . . 53.44 112.331 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . 0.524 HG12 HD11 ' A' ' 379' ' ' LEU . 12.0 p -132.74 116.69 27.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 107.493 -1.299 . . . . 43.21 107.493 171.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 63.22 29.58 15.94 Favored 'General case' 0 CA--C 1.469 -2.145 0 CA-C-O 123.943 1.83 . . . . 62.24 109.672 -172.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 66.39 11.8 8.23 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 109.556 -3.475 . . . . 74.42 113.182 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 49.8 t -78.57 119.31 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 106.214 -1.773 . . . . 74.11 106.214 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -59.45 124.62 20.64 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 114.328 1.233 . . . . 65.51 114.328 -173.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.524 HD11 HG12 ' A' ' 374' ' ' VAL . 6.6 mp -101.76 11.15 39.24 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 124.921 1.288 . . . . 54.43 108.973 174.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.457 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 24.0 mm-40 -78.43 112.23 15.25 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.258 -1.337 . . . . 75.25 108.682 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . 0.405 ' CD ' HD22 ' A' ' 346' ' ' ASN . 19.0 tp10 61.06 83.55 0.14 Allowed 'General case' 0 CA--C 1.544 0.719 0 O-C-N 124.51 1.131 . . . . 63.44 111.721 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 19.3 m -153.13 162.83 2.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.061 -1.427 . . . . 74.52 107.975 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.419 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 2.0 m -78.64 143.32 36.46 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.726 -0.842 . . . . 72.41 108.726 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . 0.568 ' O ' HG23 ' A' ' 388' ' ' VAL . 86.4 t60 -51.95 -49.66 62.73 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 120.872 0.367 . . . . 75.45 111.695 -175.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -61.05 -36.55 79.9 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.119 -0.946 . . . . 63.01 110.7 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.419 ' HB3' ' O ' ' A' ' 383' ' ' THR . 48.6 tt0 -73.75 -34.04 64.56 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.417 -1.265 . . . . 63.03 108.799 -174.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.546 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -71.83 -48.16 48.1 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.744 -1.117 . . . . 64.22 110.137 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 384' ' ' HIS . 19.3 t -58.52 -45.37 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.409 -0.589 . . . . 71.53 109.409 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 66.0 m -61.34 -31.72 71.59 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 116.08 -0.509 . . . . 64.31 111.348 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.65 84.16 Favored 'General case' 0 C--N 1.343 0.313 0 O-C-N 122.019 -0.426 . . . . 23.44 110.312 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.3 mp -79.08 -23.99 43.79 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 120.199 -0.6 . . . . 75.11 110.915 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.481 ' HE2' HG12 ' A' ' 388' ' ' VAL . 61.5 mttm -75.91 -32.19 59.51 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.528 0.566 . . . . 71.2 112.528 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -74.83 32.55 0.09 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.364 1.065 . . . . 65.24 113.761 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 1.7 p -124.77 158.45 33.28 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 109.968 -0.382 . . . . 71.2 109.968 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 62.8 m -148.53 125.84 11.55 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.535 -0.543 . . . . 55.23 109.535 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 26.6 t70 60.98 0.17 0.36 Allowed 'General case' 0 C--O 1.2 -1.513 0 C-N-CA 126.578 1.951 . . . . 72.35 114.954 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -158.38 119.12 3.36 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 120.276 -1.515 . . . . 73.41 110.333 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 93.7 t -142.21 117.93 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 122.553 0.341 . . . . 62.53 111.678 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.534 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 17.8 m-85 -90.07 96.53 10.72 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.123 -1.066 . . . . 65.0 108.123 167.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 tt -83.35 130.82 35.08 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.097 -0.705 . . . . 73.22 109.097 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 38.8 tttp -121.19 112.62 18.88 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 109.954 -0.387 . . . . 74.3 109.954 -173.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 53.7 t -104.92 144.58 14.52 Favored 'Isoleucine or valine' 0 C--O 1.263 1.788 0 C-N-CA 123.753 0.821 . . . . 73.32 110.882 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -121.58 157.75 30.07 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 104.95 -2.241 . . . . 65.4 104.95 172.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 9.5 mmpt? . . . . . 0 C--N 1.285 -2.208 0 C-N-CA 119.184 -1.006 . . . . 74.12 109.051 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 N--CA 1.417 -2.098 0 N-CA-C 106.621 -1.622 . . . . 64.22 106.621 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.04 146.3 24.36 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 107.406 -1.331 . . . . 73.53 107.406 174.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 15.0 m -134.14 132.39 39.81 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 120.424 -0.51 . . . . 74.53 109.701 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -75.58 136.36 40.52 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 109.671 -0.492 . . . . 62.12 109.671 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.457 HG23 ' HB2' ' A' ' 329' ' ' LEU . 18.0 m . . . . . 0 C--N 1.296 -1.73 0 CA-C-O 117.107 -1.425 . . . . 65.51 112.107 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 109.331 -0.618 . . . . 62.22 109.331 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.33 119.8 11.67 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 122.247 1.022 . . . . 64.31 109.203 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 65.3 mt -98.47 106.56 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.895 0 CA-C-N 113.689 -1.596 . . . . 74.3 109.736 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -76.5 104.01 6.79 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 104.408 -2.442 . . . . 72.31 104.408 165.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 359' ' ' ALA . 0.6 OUTLIER -109.25 136.23 49.05 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 113.751 -1.568 . . . . 75.44 106.976 -173.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 21.9 mm -95.03 137.14 24.08 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 C-N-CA 119.36 -0.936 . . . . 71.32 109.292 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 395' ' ' SER . 1.2 ttpm? -68.16 177.64 2.18 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-O 121.106 0.479 . . . . 73.14 109.835 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.521 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -150.68 -173.88 21.2 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.229 -1.148 . . . . 65.02 110.229 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.47 -41.02 21.6 Favored 'Trans proline' 0 N--CA 1.482 0.831 0 C-N-CA 122.955 2.436 . . . . 62.3 112.178 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.35 -14.54 46.1 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 123.31 1.529 . . . . 61.24 107.656 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 98.74 -143.75 16.81 Favored Glycine 0 C--N 1.256 -3.885 0 CA-C-N 113.38 -1.736 . . . . 71.04 109.437 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.1 mp -74.76 -46.24 38.48 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 117.679 0.739 . . . . 61.41 111.105 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 83.41 53.15 3.51 Favored Glycine 0 C--O 1.22 -0.72 0 C-N-CA 120.173 -1.013 . . . . 52.5 115.364 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 49.0 p90 -151.82 172.98 15.33 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.185 -0.672 . . . . 71.24 109.185 173.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.486 ' OG ' ' HG2' ' B' ' 150' ' ' GLN . 3.9 m -123.38 136.1 54.47 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.951 -0.388 . . . . 44.13 109.951 -177.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 16.4 pt -120.57 156.55 23.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 116.318 -0.401 . . . . 71.34 110.146 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' B' ' 148' ' ' GLU . . . -148.02 133.3 18.46 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.96 -1.126 . . . . 63.35 107.96 175.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 157.83 -177.43 34.59 Favored Glycine 0 C--N 1.273 -2.922 0 N-CA-C 108.5 -1.84 . . . . 71.21 108.5 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.11 175.47 13.98 Favored Glycine 0 C--N 1.272 -2.986 0 N-CA-C 108.054 -2.018 . . . . 51.14 108.054 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.8 100.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.49 0.662 . . . . 62.21 110.769 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 80.71 2.45 89.96 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 115.164 -0.926 . . . . 55.24 113.445 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -107.69 11.81 28.06 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.057 -1.09 . . . . 73.43 108.057 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.88 134.27 56.48 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 115.624 1.713 . . . . 73.42 115.624 -173.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -71.62 -34.97 70.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.005 -1.452 . . . . 64.24 109.515 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 41.8 mm -104.75 118.89 55.23 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.998 -0.546 . . . . 75.51 110.299 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.94 110.17 0.59 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.745 2.297 . . . . 73.34 111.489 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.33 -28.23 9.87 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.95 -0.643 . . . . 71.01 111.832 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -106.77 102.51 11.87 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.766 -0.827 . . . . 64.24 108.766 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -82.66 38.11 0.55 Allowed 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 123.721 0.809 . . . . 73.14 112.208 -170.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 75.2 m -103.2 178.44 4.56 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 113.268 0.84 . . . . 74.33 113.268 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.459 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 25.7 mm -93.96 131.32 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 114.853 -1.067 . . . . 44.4 108.128 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 369' ' ' ASP . 28.9 m-85 -124.11 135.14 53.32 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 112.691 0.626 . . . . 73.03 112.691 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.69 116.57 5.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.072 -1.084 . . . . 62.34 108.072 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.3 m -107.57 -20.41 13.25 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 120.852 0.358 . . . . 74.12 111.537 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 331' ' ' PHE . 47.0 mmtm -149.34 159.06 44.61 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 107.524 -1.287 . . . . 75.51 107.524 177.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.441 HG22 ' HB2' ' A' ' 360' ' ' HIS . 75.9 mt -140.54 124.97 18.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 107.049 -1.463 . . . . 73.11 107.049 172.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 39.2 mm -85.62 116.49 28.89 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 N-CA-C 108.15 -1.055 . . . . 74.05 108.15 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.55 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 1.1 pp20? -66.23 147.53 53.18 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 107.257 -1.386 . . . . 73.1 107.257 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.485 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.69 -26.66 19.11 Favored Glycine 0 C--N 1.288 -2.123 0 N-CA-C 109.691 -1.364 . . . . 63.42 109.691 -175.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -69.98 156.83 53.49 Favored Glycine 0 C--O 1.272 2.489 0 N-CA-C 110.914 -0.874 . . . . 75.21 110.914 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -57.6 -41.17 80.71 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 109.792 -0.448 . . . . 53.42 109.792 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.655 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.99 -4.88 43.6 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 113.394 0.887 . . . . 73.25 113.394 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . 0.55 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 69.6 t60 -94.8 -38.18 10.88 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.641 -0.824 . . . . 54.04 109.136 172.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.485 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 72.7 mmtt -83.42 -57.2 3.35 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.976 -0.689 . . . . 73.23 111.362 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -85.54 -30.81 23.09 Favored 'General case' 0 CA--C 1.463 -2.383 0 CA-C-O 121.672 0.749 . . . . 70.34 109.588 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -43.31 -32.66 1.81 Allowed Glycine 0 CA--C 1.475 -2.413 0 CA-C-N 113.239 -1.801 . . . . 61.34 117.22 -168.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? 45.09 36.85 2.21 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 124.626 0.839 . . . . 74.41 110.408 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 29.9 tp -119.78 158.56 26.29 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 113.79 -1.55 . . . . 71.14 109.339 -168.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.75 145.23 49.63 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 115.82 -0.627 . . . . 71.54 109.936 -174.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 81.1 mt -66.77 119.23 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 108.991 -0.744 . . . . 71.24 108.991 175.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.76 3.33 20.25 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.984 -0.627 . . . . 71.33 111.996 -175.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 8.0 m-20 -73.25 133.02 43.83 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.818 0.673 . . . . 74.34 112.818 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 44.5 tttp -92.9 114.83 27.5 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.444 1.098 . . . . 70.42 108.473 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 83.9 mt -83.61 112.07 19.68 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.848 -0.427 . . . . 73.34 109.848 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.4 tt -83.7 -40.71 18.55 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.531 -1.213 . . . . 74.33 107.918 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -162.6 145.82 11.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.689 -0.687 . . . . 71.2 109.72 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.56 130.19 49.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 109.377 -0.601 . . . . 74.12 109.377 175.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 44.93 67.27 0.73 Allowed 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 125.652 1.581 . . . . 71.02 110.343 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 66.43 -26.69 0.11 Allowed 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 114.771 1.397 . . . . 75.3 114.771 -176.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 42.5 t -78.84 125.7 38.41 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 O-C-N 121.651 -0.656 . . . . 73.44 110.487 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -74.92 130.04 38.71 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 122.481 0.312 . . . . 74.0 110.521 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.6 0.09 22.34 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.474 0.546 . . . . 74.53 112.474 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -68.36 106.71 2.59 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.43 -0.582 . . . . 72.42 109.43 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 62.85 73.82 0.45 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 122.678 1.228 . . . . 60.23 113.077 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.56 169.71 16.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.515 -1.221 . . . . 71.24 107.834 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.518 ' OG1' ' HG2' ' A' ' 386' ' ' GLU . 3.0 p -76.63 147.85 37.3 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.639 -0.874 . . . . 65.12 108.639 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . 0.603 ' O ' HG23 ' A' ' 388' ' ' VAL . 10.6 t-80 -57.52 -37.04 72.37 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.496 0.665 . . . . 74.54 109.446 -172.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -56.45 -44.05 80.12 Favored 'General case' 0 N--CA 1.403 -2.8 0 CA-C-N 113.88 -1.509 . . . . 72.42 112.826 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.518 ' HG2' ' OG1' ' A' ' 383' ' ' THR . 20.0 mm-40 -75.28 -29.33 60.1 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 109.189 -0.671 . . . . 63.24 109.189 -176.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.421 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -67.33 -58.12 5.38 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.489 -1.232 . . . . 50.14 109.086 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 384' ' ' HIS . 17.8 t -59.27 -41.42 83.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 N-CA-C 109.447 -0.575 . . . . 53.5 109.447 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 35.1 m -61.46 -35.63 78.16 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 115.977 -0.556 . . . . 71.13 111.477 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -69.07 -38.02 78.82 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 122.341 -0.224 . . . . 43.24 110.583 176.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 387' ' ' ALA . 6.1 mp -72.16 -28.92 63.55 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.419 -0.513 . . . . 71.23 110.596 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 61.5 mttm -73.91 -34.88 64.55 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 120.602 -0.439 . . . . 72.32 112.106 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -84.77 62.39 7.37 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.785 0.802 . . . . 61.43 110.877 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 22.5 p -125.6 152.44 45.13 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.311 -0.859 . . . . 73.43 109.282 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . 0.531 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 50.4 m -146.83 90.11 1.88 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 122.218 1.009 . . . . 70.13 111.072 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.497 ' H ' ' HB2' ' A' ' 324' ' ' LYS 0.265 22.1 m-20 62.2 14.35 6.6 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 111.951 -2.386 . . . . 73.31 115.208 170.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -157.77 107.6 2.15 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 108.034 -1.098 . . . . 70.54 108.034 173.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 43.7 t -114.73 123.73 70.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.787 -0.819 . . . . 34.04 108.787 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.74 95.7 6.83 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 105.108 -2.182 . . . . 65.13 105.108 174.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 8.0 tt -102.22 104.02 14.56 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-O 121.376 0.608 . . . . 72.53 109.582 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -93.61 112.03 23.83 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.138 -1.43 . . . . 52.15 107.138 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.426 HG21 ' HB3' ' A' ' 369' ' ' ASP . 4.7 p -119.16 146.17 24.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.209 -0.905 . . . . 62.22 110.557 -173.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.539 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -125.17 158.38 34.1 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.298 -1.001 . . . . 72.33 108.298 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? . . . . . 0 C--N 1.299 -1.611 0 N-CA-C 106.958 -1.497 . . . . 62.32 106.958 177.566 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . 0.472 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.489 -1.376 0 N-CA-C 107.988 -1.116 . . . . 73.54 107.988 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 334' ' ' ALA . 15.3 pt-20 -85.56 156.61 20.67 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.733 -0.839 . . . . 72.44 108.733 176.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 49.0 m -144.17 141.0 29.68 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.9 -0.5 . . . . 52.41 110.265 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . 0.486 ' HG2' ' OG ' ' A' ' 332' ' ' SER . 77.7 mt-30 -85.35 149.22 25.6 Favored 'General case' 0 CA--C 1.454 -2.742 0 CA-C-O 121.445 0.64 . . . . 63.33 111.631 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . 0.272 22.0 m . . . . . 1 N--CA 1.374 -4.253 0 CA-C-O 117.453 -1.261 . . . . 73.44 110.443 174.59 . . . . . . . . 2 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 CA--C 1.494 -1.193 0 N-CA-C 106.559 -1.645 . . . . 75.23 106.559 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.429 1.8 pm0 -114.61 134.4 55.09 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 116.319 1.97 . . . . 74.52 116.319 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 73.7 mt -124.43 112.88 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-N 112.573 -2.103 . . . . 71.41 109.186 -173.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -79.66 124.97 29.05 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.416 -1.327 . . . . 70.34 107.416 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 45.2 mt -114.48 144.33 43.51 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.072 -1.084 . . . . 75.02 108.072 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 396' ' ' ASP . 54.3 mt -105.86 110.79 32.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 108.504 -0.925 . . . . 63.14 108.504 171.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.685 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 9.6 tmtt? -55.68 158.78 3.33 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 124.568 1.168 . . . . 64.12 111.601 177.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -144.37 -166.66 11.59 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 111.435 -0.666 . . . . 60.41 111.435 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.81 -15.08 46.22 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 123.324 2.683 . . . . 74.22 112.991 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 355' ' ' GLU . 37.0 ttpt -112.67 19.58 17.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.048 0.928 . . . . 74.33 109.248 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.92 -127.3 8.0 Favored Glycine 0 CA--C 1.497 -1.032 0 CA-C-N 114.994 -1.003 . . . . 54.42 111.31 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.537 ' HB2' HG23 ' B' ' 151' ' ' VAL . 4.0 mp -104.89 -22.72 13.11 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.224 -1.028 . . . . 73.52 108.224 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 73.72 50.98 9.93 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 114.807 -1.088 . . . . 63.33 115.606 171.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -154.43 149.79 27.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.442 -0.577 . . . . 65.25 109.442 172.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 7.5 m -105.01 128.3 53.25 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.95 0.405 . . . . 74.53 109.919 -175.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.404 ' HB ' HG23 ' A' ' 348' ' ' ILE . 30.3 pt -122.82 151.58 27.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.596 -0.729 . . . . 73.11 111.03 -175.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -140.9 137.16 32.97 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 105.55 -2.018 . . . . 72.42 105.55 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 347' ' ' SER . . . 147.45 162.54 10.07 Favored Glycine 0 C--N 1.281 -2.49 0 N-CA-C 109.771 -1.332 . . . . 64.5 109.771 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.53 177.34 14.88 Favored Glycine 0 C--N 1.284 -2.345 0 N-CA-C 108.718 -1.753 . . . . 34.13 108.718 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 99.2 t -55.8 108.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 117.522 0.661 . . . . 73.2 109.971 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 86.45 -11.1 64.53 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.648 -0.706 . . . . 71.33 112.712 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.409 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -106.39 9.74 31.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.051 -1.463 . . . . 63.21 107.051 179.162 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.95 121.66 4.97 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.939 1.296 . . . . 72.55 111.969 -175.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -82.28 -27.03 32.61 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.942 -1.026 . . . . 60.43 109.132 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.619 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 2.9 mp -116.52 131.48 23.84 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 106.779 -1.563 . . . . 75.2 106.779 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.53 107.01 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.571 2.18 . . . . 71.34 112.909 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 102.22 0.91 51.02 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.621 -0.718 . . . . 75.11 112.861 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.619 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 22.0 t70 -129.67 101.38 5.88 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.398 0.618 . . . . 72.45 109.617 -177.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . 0.418 ' HB2' ' OE2' ' A' ' 381' ' ' GLU . 32.6 m-80 -87.1 38.01 0.79 Allowed 'General case' 0 CA--C 1.5 -0.96 0 O-C-N 121.556 -0.715 . . . . 74.1 110.684 -174.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.487 ' O ' ' HA3' ' A' ' 335' ' ' GLY . 14.3 m -86.3 157.43 19.91 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.703 0.763 . . . . 72.31 111.202 -176.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.404 HG23 ' HB ' ' A' ' 333' ' ' ILE . 38.4 mm -75.63 122.82 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.563 0 N-CA-C 106.606 -1.627 . . . . 74.14 106.606 173.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 342' ' ' ILE . 3.5 t80 -124.0 133.78 53.6 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 108.319 -0.993 . . . . 72.23 108.319 -173.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.412 HG21 HD21 ' A' ' 365' ' ' LEU . 43.9 t -74.82 109.78 8.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.851 -0.613 . . . . 71.4 109.581 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.564 ' O ' ' HD2' ' A' ' 352' ' ' LYS . 8.6 m -90.78 -36.73 14.1 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.975 -0.557 . . . . 74.44 109.976 -178.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.564 ' HD2' ' O ' ' A' ' 351' ' ' THR . 1.2 mptm? -144.6 156.46 44.14 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.099 -0.704 . . . . 55.35 109.099 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 71.6 mt -125.35 129.51 73.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 106.284 -1.747 . . . . 64.31 106.284 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 47.2 mm -85.64 141.83 13.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 123.525 0.516 . . . . 65.32 110.186 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 327' ' ' LYS . 0.9 OUTLIER -57.03 120.87 8.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.286 1.034 . . . . 72.14 112.584 -174.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 72.59 14.49 77.68 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 115.281 -0.872 . . . . 52.1 112.97 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -73.54 168.42 53.95 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.213 -1.155 . . . . 43.24 110.213 176.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -58.76 -39.11 80.03 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 117.312 0.556 . . . . 63.43 110.346 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.61 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -72.58 -15.16 61.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.225 0.536 . . . . 52.05 111.94 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -95.19 -23.56 17.22 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.959 -0.756 . . . . 74.45 108.959 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 4.0 tmmt? -95.76 -60.16 1.71 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.649 0.738 . . . . 73.32 111.062 -175.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -86.94 -31.14 20.82 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.336 1.065 . . . . 74.31 109.426 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.786 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -53.61 -50.41 53.66 Favored Glycine 0 CA--C 1.481 -2.072 0 N-CA-C 119.135 2.414 . . . . 43.41 119.135 -167.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.786 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 43.8 34.17 0.83 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.253 1.025 . . . . 64.23 109.676 -167.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 350' ' ' VAL . 21.7 tp -92.2 158.27 16.25 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 113.547 -1.66 . . . . 53.14 109.752 -169.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -117.07 144.3 44.8 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.726 0.774 . . . . 71.1 110.845 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 71.0 mt -65.85 119.99 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 106.108 -1.812 . . . . 63.02 106.108 167.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.416 ' HA2' ' CE2' ' A' ' 349' ' ' TYR . . . 115.46 3.45 20.72 Favored Glycine 0 C--N 1.295 -1.699 0 C-N-CA 119.669 -1.253 . . . . 50.24 112.16 -173.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 7.2 m-20 -75.8 137.19 40.36 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 113.139 0.792 . . . . 60.12 113.139 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -100.47 115.28 29.71 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.13 -1.063 . . . . 71.53 108.13 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 60.5 mt -84.67 115.51 22.7 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.236 0.541 . . . . 63.33 110.246 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.77 -37.11 27.68 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.837 -1.529 . . . . 63.2 107.695 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 401' ' ' LYS . . . -163.34 157.25 19.85 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.79 -0.641 . . . . 71.22 111.216 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . 0.473 HG12 HD11 ' A' ' 379' ' ' LEU . 14.5 p -133.88 122.93 43.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 107.569 -1.271 . . . . 45.22 107.569 172.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . 0.548 HD21 HG22 ' A' ' 394' ' ' THR . 89.3 m-20 62.2 29.32 17.44 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 124.036 1.874 . . . . 55.53 108.853 -174.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 67.21 10.42 7.7 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 109.515 -3.493 . . . . 73.13 113.479 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.9 t -79.94 124.49 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 106.576 -1.639 . . . . 74.13 106.576 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -64.35 127.51 31.79 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.009 0.744 . . . . 75.5 113.009 -175.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.473 HD11 HG12 ' A' ' 374' ' ' VAL . 6.9 mp -106.31 6.71 30.83 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 123.865 0.866 . . . . 74.22 110.973 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -76.91 122.97 25.6 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.16 -1.792 . . . . 52.13 106.16 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . 0.418 ' OE2' ' HB2' ' A' ' 346' ' ' ASN 0.32 1.5 mp0 48.52 83.09 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 116.062 1.875 . . . . 73.25 116.062 -172.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 15.8 m -149.85 157.82 6.12 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-N 113.428 -1.714 . . . . 53.55 107.735 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.8 m -81.16 140.73 34.81 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.424 -0.954 . . . . 73.41 108.424 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . 0.561 ' O ' HG23 ' A' ' 388' ' ' VAL . 82.6 t60 -50.93 -46.18 60.77 Favored 'General case' 0 C--O 1.207 -1.168 0 N-CA-C 112.993 0.738 . . . . 74.13 112.993 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -59.24 -40.45 85.98 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.966 0.888 . . . . 63.42 109.677 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.0 tt0 -72.52 -39.76 67.33 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.074 -1.421 . . . . 72.2 108.856 -173.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.414 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -71.35 -46.17 61.17 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.449 -1.251 . . . . 44.13 110.997 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 384' ' ' HIS . 57.9 t -59.98 -41.64 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 109.872 -0.418 . . . . 71.42 109.872 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 62.2 m -58.9 -35.63 73.35 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 123.443 0.464 . . . . 73.51 110.478 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.31 -34.54 78.57 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 122.075 -0.391 . . . . 71.13 110.82 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.9 mp -80.74 -30.3 36.21 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 120.426 -0.509 . . . . 72.03 110.943 176.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.416 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 51.7 mttm -73.91 -23.54 59.56 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.23 0.456 . . . . 74.2 112.23 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -77.69 49.41 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.371 0.605 . . . . 71.03 110.562 175.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.548 HG22 HD21 ' A' ' 375' ' ' ASN . 21.5 p -124.77 142.35 51.48 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 109.472 -0.566 . . . . 74.55 109.472 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 62.1 m -144.48 99.09 3.31 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 122.571 1.177 . . . . 72.01 112.076 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.685 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 7.7 m-20 65.58 12.36 8.16 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 111.023 -2.808 . . . . 73.03 112.819 168.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -160.76 129.37 4.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.332 -1.729 . . . . 74.45 106.332 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.7 t -139.53 141.74 34.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 107.668 -1.234 . . . . 52.2 107.668 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -118.5 95.93 5.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.756 -1.572 . . . . 73.1 106.756 174.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.58 130.72 35.85 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 122.785 0.434 . . . . 53.35 110.571 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 373' ' ' ALA . 22.7 ttmm -116.21 108.97 16.8 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.178 -1.045 . . . . 72.51 108.178 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 369' ' ' ASP . 7.9 p -113.38 155.39 14.6 Favored 'Isoleucine or valine' 0 C--O 1.269 2.113 0 CA-C-N 116.035 -0.53 . . . . 65.54 110.449 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -136.62 157.58 46.44 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.422 -1.325 . . . . 72.22 107.422 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 9.7 mmpt? . . . . . 0 C--N 1.306 -1.312 0 N-CA-C 107.302 -1.37 . . . . 70.12 107.302 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . 0.513 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.499 -1.0 0 N-CA-C 111.991 0.367 . . . . 62.03 111.991 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -96.33 145.69 25.39 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.668 -1.234 . . . . 75.44 107.668 172.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 65.7 m -147.4 144.23 28.53 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.992 -0.443 . . . . 74.34 110.011 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -76.34 136.08 39.55 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.096 0.474 . . . . 73.31 110.593 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.537 HG23 ' HB2' ' A' ' 329' ' ' LEU . 4.3 m . . . . . 0 C--N 1.292 -1.912 0 CA-C-N 115.59 -0.732 . . . . 72.12 110.309 173.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 C--O 1.202 -1.442 0 N-CA-C 106.242 -1.762 . . . . 53.21 106.242 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . 0.509 ' HB3' ' HG2' ' A' ' 401' ' ' LYS 0.343 1.8 pm0 -118.24 136.94 53.36 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 114.919 1.452 . . . . 64.42 114.919 -174.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 363' ' ' GLY . 75.3 mt -126.23 114.38 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 CA-C-N 113.214 -1.812 . . . . 73.25 110.048 -172.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.478 ' HG3' ' CZ ' ' A' ' 397' ' ' PHE . 0.9 OUTLIER -79.71 136.43 36.77 Favored 'General case' 0 C--N 1.279 -2.498 0 N-CA-C 107.718 -1.216 . . . . 63.2 107.718 172.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.59 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 97.0 mt -131.63 157.26 44.15 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.581 -0.525 . . . . 73.12 109.581 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 324' ' ' LYS . 2.4 mp -106.27 140.97 22.65 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 N-CA-C 106.006 -1.85 . . . . 74.2 106.006 171.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.521 ' HG2' ' H ' ' A' ' 325' ' ' GLY . 1.3 ttpm? -75.36 177.85 6.3 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.007 -1.108 . . . . 50.34 108.007 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.521 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -160.91 -172.26 27.97 Favored Glycine 0 C--N 1.284 -2.325 0 N-CA-C 110.848 -0.901 . . . . 73.53 110.848 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.12 -13.95 28.74 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.879 2.386 . . . . 73.52 112.064 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.433 ' HB3' ' NZ ' ' A' ' 327' ' ' LYS . 9.0 mtpm? -115.18 20.08 15.2 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 115.973 -0.558 . . . . 64.13 110.996 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.44 -127.12 7.96 Favored Glycine 0 C--N 1.299 -1.492 0 N-CA-C 110.643 -0.983 . . . . 61.1 110.643 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.441 ' HB2' HG23 ' B' ' 151' ' ' VAL . 4.9 mp -105.83 -27.19 11.4 Favored 'General case' 0 C--O 1.268 2.054 0 N-CA-C 108.235 -1.024 . . . . 61.0 108.235 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 86.08 49.45 4.24 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 114.054 -1.43 . . . . 34.15 115.695 173.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -155.07 145.06 21.67 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 117.097 0.449 . . . . 73.32 111.144 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 14.5 m -96.34 126.38 41.5 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 124.005 0.922 . . . . 65.01 109.233 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 28.0 pt -117.11 144.37 25.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 116.28 -0.418 . . . . 72.12 111.377 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' B' ' 148' ' ' GLU . . . -130.99 136.16 48.27 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.414 -1.698 . . . . 64.33 106.414 174.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 145.12 161.45 9.06 Favored Glycine 0 C--N 1.268 -3.241 0 N-CA-C 109.685 -1.366 . . . . 54.03 109.685 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.82 173.49 13.22 Favored Glycine 0 N--CA 1.418 -2.512 0 N-CA-C 107.245 -2.342 . . . . 63.1 107.245 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 66.3 t -53.11 107.49 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 118.137 0.969 . . . . 72.24 110.554 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.45 -18.47 57.34 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.109 -0.951 . . . . 62.22 112.586 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.512 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 60.1 t30 -106.5 18.2 22.27 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.655 -0.498 . . . . 74.22 109.655 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.4 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -51.68 120.09 4.86 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.828 -0.624 . . . . 75.13 111.297 -178.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -76.96 -40.24 47.63 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.431 -0.804 . . . . 52.23 109.803 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.2 mm -104.29 120.72 49.85 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 115.736 -0.665 . . . . 71.03 109.715 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.6 106.61 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 123.28 2.653 . . . . 64.11 112.349 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 107.96 -3.42 33.72 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 115.475 -0.784 . . . . 63.4 111.881 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -132.38 98.0 4.26 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.569 -0.9 . . . . 64.24 108.569 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 64.4 t30 -83.37 38.05 0.59 Allowed 'General case' 0 CA--C 1.553 1.068 0 CA-C-O 121.953 0.882 . . . . 75.44 111.89 -170.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 73.7 m -102.12 178.46 4.6 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.682 -0.69 . . . . 72.31 112.765 -178.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 31.3 mm -88.94 129.37 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 114.969 -1.014 . . . . 51.22 108.644 -178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.555 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 35.6 m-85 -124.06 140.43 52.98 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.195 0.521 . . . . 74.2 111.691 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.415 HG21 HD21 ' A' ' 365' ' ' LEU . 42.7 t -78.94 111.0 15.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.132 -0.94 . . . . 60.31 109.243 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 25.7 m -88.28 -30.46 19.62 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.198 0.523 . . . . 74.03 110.882 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.428 ' HD3' ' N ' ' A' ' 353' ' ' ILE . 9.1 tmtt? -155.36 137.83 15.0 Favored 'General case' 0 C--O 1.203 -1.385 0 N-CA-C 108.284 -1.006 . . . . 71.23 108.284 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.428 ' N ' ' HD3' ' A' ' 352' ' ' LYS . 74.1 mt -109.17 129.73 63.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.632 -1.247 . . . . 65.41 107.632 174.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 49.7 mm -77.47 126.33 37.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.358 0.599 . . . . 73.45 110.037 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.561 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.4 pm0 -62.31 127.04 29.45 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 114.39 -1.277 . . . . 75.31 110.739 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.442 ' H ' ' CD2' ' A' ' 360' ' ' HIS . . . 95.56 -19.56 53.72 Favored Glycine 0 N--CA 1.426 -1.994 0 CA-C-N 115.021 -0.99 . . . . 62.32 112.533 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -68.19 167.03 43.82 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 114.278 0.471 . . . . 64.05 114.278 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -61.26 -41.99 97.85 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.313 0.645 . . . . 52.24 111.132 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.425 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.11 -7.74 54.61 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 119.692 -0.803 . . . . 61.44 111.954 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . 0.442 ' CD2' ' H ' ' A' ' 356' ' ' GLY . 18.7 t60 -94.09 -30.53 14.62 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.928 -0.767 . . . . 73.4 108.928 176.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -89.65 -59.65 2.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.028 -0.533 . . . . 72.32 111.671 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -87.14 -38.96 15.96 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 108.608 -0.886 . . . . 54.21 108.608 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.56 ' HA2' HD21 ' A' ' 322' ' ' LEU . . . -44.68 -31.25 2.51 Favored Glycine 0 C--O 1.207 -1.57 0 N-CA-C 119.195 2.438 . . . . 42.54 119.195 -167.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.538 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 41.37 32.21 0.2 Allowed 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 118.803 1.302 . . . . 75.31 111.377 -174.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . 0.415 HD21 HG21 ' A' ' 350' ' ' VAL . 43.7 tp -98.11 155.07 17.32 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.551 -1.204 . . . . 73.43 109.474 -170.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -125.08 150.98 46.27 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.344 0.592 . . . . 75.54 111.267 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 75.9 mt -65.95 122.98 17.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.297 -1.001 . . . . 64.24 108.297 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 113.25 -2.3 25.29 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.686 -0.769 . . . . 22.34 112.126 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 3.5 m-20 -72.13 136.68 46.59 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 112.83 0.678 . . . . 73.44 112.83 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.627 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 33.9 tttp -96.2 115.28 27.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.213 1.405 . . . . 74.12 109.648 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 68.3 mt -85.21 118.92 25.05 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.156 0.503 . . . . 63.12 109.693 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.3 tt -87.61 -39.38 15.11 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.074 -1.421 . . . . 62.01 108.093 -176.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -160.77 156.09 24.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.05 -0.523 . . . . 64.33 111.095 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . 0.474 HG12 HD11 ' A' ' 379' ' ' LEU . 11.1 p -134.74 123.33 41.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 108.139 -1.06 . . . . 73.55 108.139 173.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . 0.573 HD21 HG22 ' A' ' 394' ' ' THR . 54.5 m-20 62.32 29.55 17.32 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 123.516 1.627 . . . . 74.4 108.282 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 67.0 18.87 10.61 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 110.449 -3.068 . . . . 72.52 112.331 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 50.7 t -88.91 128.22 41.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 106.505 -1.665 . . . . 75.12 106.505 172.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.9 p -64.4 124.75 22.58 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 113.126 0.788 . . . . 74.51 113.126 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.474 HD11 HG12 ' A' ' 374' ' ' VAL . 7.5 mp -108.27 -2.48 19.24 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.561 0.745 . . . . 70.42 111.224 177.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -68.2 107.6 2.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.952 -0.567 . . . . 64.0 109.605 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 60.66 74.91 0.43 Allowed 'General case' 0 CA--C 1.545 0.775 0 O-C-N 124.619 1.199 . . . . 72.52 113.296 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 387' ' ' ALA . 24.1 m -135.05 167.09 26.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.183 -1.414 . . . . 72.33 107.183 176.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 51.6 p -79.73 141.22 36.56 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 118.918 0.781 . . . . 63.32 110.325 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . 0.49 ' O ' HG23 ' A' ' 388' ' ' VAL . 82.7 t60 -45.56 -49.27 14.12 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.672 0.99 . . . . 71.21 113.672 -174.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -61.33 -38.78 88.13 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.212 0.53 . . . . 73.53 111.54 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.0 tt0 -70.46 -35.05 73.1 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.511 -0.922 . . . . 75.3 108.511 -177.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.435 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -70.54 -53.91 14.24 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 114.441 -1.254 . . . . 61.22 110.582 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 384' ' ' HIS . 44.5 t -59.54 -43.36 90.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 C-N-CA 121.147 -0.221 . . . . 61.15 110.57 -177.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 53.8 m -62.04 -30.32 70.89 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 111.953 0.353 . . . . 75.11 111.953 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.13 -35.08 78.98 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 122.124 -0.36 . . . . 53.53 110.331 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.7 mp -80.57 -28.61 37.15 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 120.394 -0.523 . . . . 71.14 110.783 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.427 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 54.3 mttm -74.31 -24.23 59.19 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.576 -0.45 . . . . 73.14 111.536 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -82.16 65.2 7.18 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.347 1.07 . . . . 71.52 110.19 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.573 HG22 HD21 ' A' ' 375' ' ' ASN . 13.3 p -130.65 145.63 51.96 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 113.987 -1.46 . . . . 71.31 107.679 177.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 43.8 m -141.77 91.28 2.35 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 122.568 1.175 . . . . 62.34 111.25 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.515 ' HA ' ' H ' ' A' ' 324' ' ' LYS 0.343 12.4 m-20 65.16 4.79 2.72 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 111.438 -2.619 . . . . 60.04 115.616 172.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . 0.478 ' CZ ' ' HG3' ' A' ' 321' ' ' LYS . 37.6 t80 -151.85 134.52 15.5 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 106.368 -1.716 . . . . 73.21 106.368 171.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.59 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.8 t -138.29 145.69 28.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.812 -1.181 . . . . 72.55 107.812 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -126.0 96.1 4.63 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.027 -1.101 . . . . 73.44 108.027 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 tt -92.63 132.84 36.54 Favored 'General case' 0 C--N 1.277 -2.546 0 C-N-CA 123.031 0.532 . . . . 75.04 110.739 -174.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.509 ' HG2' ' HB3' ' A' ' 319' ' ' GLU . 65.8 mttm -114.31 118.72 34.7 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.152 -0.684 . . . . 61.3 109.152 174.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 369' ' ' ASP . 3.6 p -118.58 149.04 21.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 CA-C-N 115.048 -0.978 . . . . 73.01 109.979 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.627 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.45 159.32 42.15 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 125.119 1.368 . . . . 63.0 107.337 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 12.6 mptt . . . . . 0 C--N 1.291 -1.947 0 N-CA-C 109.267 -0.642 . . . . 52.12 109.267 175.627 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 C--O 1.245 0.833 0 N-CA-C 107.494 -1.298 . . . . 74.14 107.494 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 334' ' ' ALA . 0.9 OUTLIER -95.96 157.18 16.01 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.232 0.539 . . . . 74.31 110.948 174.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 51.6 m -147.84 146.85 29.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.726 -0.842 . . . . 74.41 108.726 174.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 1.2 tt0 -79.79 137.84 37.09 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 120.996 0.427 . . . . 74.42 110.952 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 329' ' ' LEU . 15.7 m . . . . . 0 N--CA 1.426 -1.633 0 CA-C-N 115.711 -0.677 . . . . 74.21 110.767 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . 0.605 ' SD ' ' HE3' ' A' ' 404' ' ' LYS . 27.5 ttt . . . . . 0 CA--C 1.495 -1.168 0 N-CA-C 107.041 -1.466 . . . . 63.34 107.041 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.325 2.3 pm0 -115.87 137.56 51.99 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-O 122.202 1.001 . . . . 74.21 113.658 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 363' ' ' GLY . 70.2 mt -128.62 130.49 68.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 113.225 -1.807 . . . . 63.22 108.155 -169.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -108.07 107.66 18.42 Favored 'General case' 0 N--CA 1.411 -2.387 0 N-CA-C 108.348 -0.982 . . . . 73.13 108.348 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.55 HD21 ' HA2' ' A' ' 363' ' ' GLY . 93.3 mt -105.65 160.07 15.48 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.346 -0.843 . . . . 74.44 110.055 -176.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.2 113.41 42.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 N-CA-C 108.148 -1.056 . . . . 72.54 108.148 171.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.609 ' HB3' ' H ' ' A' ' 396' ' ' ASP . 0.0 OUTLIER -67.13 140.87 57.56 Favored 'General case' 0 C--O 1.207 -1.168 0 N-CA-C 106.953 -1.499 . . . . 70.23 106.953 174.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.497 ' N ' ' HD2' ' A' ' 324' ' ' LYS . . . -142.31 -161.2 8.67 Favored Glycine 0 C--N 1.27 -3.099 0 CA-C-O 119.946 -0.363 . . . . 73.23 112.498 -171.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.94 -12.92 37.43 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 123.829 3.02 . . . . 51.23 113.507 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -109.43 5.96 23.83 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.175 0.988 . . . . 71.41 108.932 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.99 -121.35 5.49 Favored Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 108.965 -1.654 . . . . 63.54 108.965 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.79 -26.2 11.38 Favored 'General case' 0 C--O 1.266 1.952 0 N-CA-C 107.844 -1.169 . . . . 75.22 107.844 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.41 43.49 6.54 Favored Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 113.707 -1.588 . . . . 63.11 114.675 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -155.22 151.1 27.72 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 117.056 0.428 . . . . 72.11 110.286 174.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 29.2 m -106.28 129.58 54.28 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 124.145 0.978 . . . . 74.44 109.578 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 14.8 pt -114.32 156.63 15.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.776 -0.647 . . . . 74.25 110.666 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -143.68 130.02 19.89 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.896 -1.89 . . . . 61.31 105.896 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 149.67 153.21 5.98 Favored Glycine 0 C--N 1.27 -3.094 0 N-CA-C 109.012 -1.635 . . . . 54.45 109.012 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.82 173.1 13.09 Favored Glycine 0 C--N 1.283 -2.39 0 N-CA-C 106.558 -2.617 . . . . 62.02 106.558 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.46 ' HA ' HD21 ' A' ' 346' ' ' ASN . 61.8 t -45.75 106.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 118.597 1.198 . . . . 74.34 111.705 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 93.01 -23.92 27.05 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.541 -0.754 . . . . 64.0 112.27 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.482 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 32.7 t-20 -97.78 19.41 13.75 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.353 -0.98 . . . . 70.31 108.353 -177.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.1 118.7 3.09 Favored 'General case' 0 C--O 1.257 1.493 0 CA-C-O 121.263 0.554 . . . . 62.31 110.301 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -77.75 -43.59 30.35 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.075 -0.966 . . . . 73.44 109.052 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 39.3 mm -103.65 131.25 22.21 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 108.119 -1.067 . . . . 74.12 108.119 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.1 110.46 0.48 Allowed 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 123.173 2.582 . . . . 60.11 113.551 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.86 -3.6 65.11 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.407 -0.815 . . . . 24.21 112.189 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 29.2 t0 -119.64 99.69 6.81 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.716 -0.846 . . . . 72.14 108.716 -176.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . 0.46 HD21 ' HA ' ' A' ' 337' ' ' VAL . 51.7 t30 -84.0 26.04 0.77 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.532 0.682 . . . . 73.22 110.845 -171.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 20.0 m -88.5 172.29 9.46 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.369 0.604 . . . . 71.34 111.762 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 370' ' ' LYS . 18.3 mm -88.28 122.76 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 115.185 -0.916 . . . . 71.13 108.575 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 51.2 m-85 -123.62 131.93 53.74 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.031 0.443 . . . . 62.52 110.748 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.476 HG21 HD11 ' A' ' 365' ' ' LEU . 47.9 t -70.64 120.75 19.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.888 -0.597 . . . . 71.42 109.4 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 22.4 m -101.03 -23.16 14.56 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.102 0.477 . . . . 73.34 111.353 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -155.55 137.03 14.09 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 107.618 -1.253 . . . . 70.03 107.618 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' A' ' 360' ' ' HIS . 73.4 mt -108.94 126.03 65.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.099 -1.445 . . . . 71.4 107.099 172.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 49.7 mm -74.48 134.9 28.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.293 0.568 . . . . 54.1 109.853 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.569 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.4 pm0 -62.39 120.84 11.81 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-O 122.45 1.119 . . . . 72.15 111.588 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 79.44 18.63 73.31 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-N 114.284 -1.325 . . . . 71.11 111.484 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.78 162.75 52.13 Favored Glycine 0 C--O 1.25 1.143 0 N-CA-C 111.783 -0.527 . . . . 71.02 111.783 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.61 98.97 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.892 -0.781 . . . . 75.33 108.892 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.528 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.64 -9.29 58.46 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.475 -0.89 . . . . 70.51 111.917 177.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . 0.445 ' HB2' HG22 ' A' ' 353' ' ' ILE . 23.7 t60 -88.85 -29.19 19.86 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.596 -0.89 . . . . 74.24 108.596 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.608 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 1.1 mmpm? -95.04 -57.65 2.37 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 113.13 0.789 . . . . 71.21 113.13 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -85.68 -43.05 13.75 Favored 'General case' 0 CA--C 1.457 -2.628 0 O-C-N 123.771 0.669 . . . . 72.11 110.647 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.576 ' O ' HD13 ' A' ' 320' ' ' ILE . . . -42.74 -25.5 0.33 Allowed Glycine 0 C--O 1.203 -1.79 0 N-CA-C 119.379 2.512 . . . . 73.31 119.379 -163.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.468 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.59 34.45 0.56 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 119.133 1.467 . . . . 71.21 111.265 -178.588 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . 0.553 HD13 ' N ' ' A' ' 366' ' ' GLN . 2.6 tm? -109.36 148.6 30.81 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.163 -1.38 . . . . 65.41 107.786 -170.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . 0.553 ' N ' HD13 ' A' ' 365' ' ' LEU . 0.0 OUTLIER -117.06 142.06 47.46 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.796 -0.446 . . . . 75.44 109.796 -178.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.76 121.3 8.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.111 -1.07 . . . . 64.3 108.111 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.35 -4.45 21.76 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 111.426 -0.67 . . . . 54.42 111.426 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.574 ' HB3' HG21 ' A' ' 402' ' ' VAL . 56.3 m-20 -75.63 136.28 40.45 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 113.193 0.812 . . . . 71.52 113.193 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 36.4 tttp -88.8 119.69 29.52 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 124.658 1.183 . . . . 74.13 111.135 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.41 124.84 32.46 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.885 -0.783 . . . . 75.33 108.885 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.482 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 5.3 tt -92.08 -40.16 11.22 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.336 -1.302 . . . . 74.22 107.965 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -159.86 160.94 34.27 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 116.017 -0.538 . . . . 71.32 111.733 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . 0.557 HG12 HD11 ' A' ' 379' ' ' LEU . 13.9 p -133.55 117.33 27.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.413 -0.958 . . . . 74.25 108.413 171.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 58.54 36.17 25.04 Favored 'General case' 0 CA--C 1.485 -1.526 0 CA-C-O 123.4 1.571 . . . . 73.54 109.347 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 66.79 9.55 6.84 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 110.831 -2.895 . . . . 53.25 113.693 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.9 121.09 31.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.263 -1.754 . . . . 62.3 106.263 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.8 p -64.35 125.82 25.81 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 113.366 0.876 . . . . 74.41 113.366 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.557 HD11 HG12 ' A' ' 374' ' ' VAL . 7.1 mp -101.32 7.13 42.94 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.731 -1.122 . . . . 74.41 109.445 176.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.482 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 18.4 mm-40 -79.9 111.24 16.03 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.59 -1.186 . . . . 75.24 108.958 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 61.14 83.57 0.14 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.718 1.207 . . . . 72.33 112.232 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 19.7 m -153.58 165.21 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 125.563 1.545 . . . . 61.23 107.139 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.707 ' HB ' ' OE1' ' A' ' 386' ' ' GLU . 2.8 m -85.08 156.85 20.9 Favored 'General case' 0 C--O 1.258 1.539 0 N-CA-C 107.221 -1.4 . . . . 73.24 107.221 176.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . 0.535 ' O ' HG23 ' A' ' 388' ' ' VAL . 85.7 t60 -57.13 -40.73 77.7 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.303 0.573 . . . . 72.34 109.988 -170.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -54.68 -46.64 74.1 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 114.187 -1.37 . . . . 71.31 113.871 177.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.707 ' OE1' ' HB ' ' A' ' 383' ' ' THR . 1.8 mp0 -71.72 -32.14 67.45 Favored 'General case' 0 CA--C 1.476 -1.872 0 CA-C-N 118.711 0.687 . . . . 73.32 109.423 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.6 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -64.46 -57.72 8.44 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 114.728 -1.124 . . . . 73.21 109.218 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 384' ' ' HIS . 21.7 t -61.35 -41.76 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 116.446 -0.343 . . . . 74.53 110.55 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 90.4 m -62.13 -34.35 76.2 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.071 -0.513 . . . . 62.44 111.433 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.08 80.05 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.522 -0.111 . . . . 71.5 110.859 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.1 mp -79.66 -32.47 41.55 Favored 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 119.217 -0.993 . . . . 61.35 110.777 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -65.21 -35.41 80.97 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 112.663 0.616 . . . . 71.42 112.663 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -83.57 62.08 6.62 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.803 0.811 . . . . 74.4 110.926 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.437 ' HB ' HG22 ' A' ' 398' ' ' VAL . 41.9 p -132.28 149.52 52.35 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 107.526 -1.287 . . . . 65.25 107.526 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . 0.478 ' HA ' ' HE3' ' A' ' 324' ' ' LYS . 34.9 p -141.96 100.99 3.85 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 118.461 -1.296 . . . . 72.01 112.578 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.609 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 3.5 m-20 63.38 7.27 2.84 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 112.504 -2.135 . . . . 71.31 113.621 170.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -152.64 115.25 4.52 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 106.033 -1.84 . . . . 64.33 106.033 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 52.4 t -128.28 113.81 31.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 108.342 -0.984 . . . . 74.0 108.342 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -95.15 95.53 8.61 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.393 -1.336 . . . . 72.01 107.393 174.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.3 tt -89.97 139.02 31.01 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 116.147 -0.479 . . . . 72.32 109.748 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 40.6 tttp -126.84 111.7 14.48 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 108.403 -0.962 . . . . 73.25 108.403 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.574 HG21 ' HB3' ' A' ' 369' ' ' ASP . 2.1 p -115.05 145.94 20.13 Favored 'Isoleucine or valine' 0 C--O 1.266 1.96 0 C-N-CA 123.732 0.813 . . . . 61.13 110.597 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.74 147.77 46.89 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 106.266 -1.753 . . . . 75.51 106.266 174.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.605 ' HE3' ' SD ' ' A' ' 318' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.881 0 C-N-CA 119.774 -0.77 . . . . 61.35 109.102 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . 0.469 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.504 -0.793 0 N-CA-C 110.521 -0.177 . . . . 72.32 110.521 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.51 166.62 11.77 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.185 0.517 . . . . 74.4 111.8 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 40.7 m -146.06 123.97 12.01 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.736 -0.665 . . . . 75.05 109.608 166.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -68.25 130.14 42.02 Favored 'General case' 0 C--O 1.257 1.468 0 N-CA-C 108.563 -0.903 . . . . 60.25 108.563 172.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.434 HG11 ' CB ' ' A' ' 391' ' ' LEU . 5.3 t . . . . . 0 C--N 1.296 -1.726 0 CA-C-O 117.228 -1.368 . . . . 74.51 109.09 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 CA--C 1.485 -1.521 0 N-CA-C 106.309 -1.738 . . . . 75.3 106.309 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.477 2.0 pm0 -119.09 127.09 53.06 Favored 'General case' 0 N--CA 1.406 -2.641 0 N-CA-C 116.936 2.198 . . . . 63.1 116.936 -174.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.45 HG23 ' HD3' ' A' ' 364' ' ' LYS . 64.5 mt -102.54 106.17 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.623 0 CA-C-N 111.524 -2.58 . . . . 52.41 109.715 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.492 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 28.9 ttpt -80.81 110.72 16.59 Favored 'General case' 0 N--CA 1.41 -2.427 0 N-CA-C 106.319 -1.734 . . . . 65.31 106.319 170.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.461 ' HA ' ' OD2' ' A' ' 362' ' ' ASP . 0.6 OUTLIER -110.33 145.7 37.01 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 113.944 -1.48 . . . . 73.35 109.734 -171.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 39.0 mm -105.2 116.8 49.71 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-O 121.306 0.574 . . . . 74.54 110.606 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.696 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 9.7 tmtt? -65.89 156.78 32.38 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.948 -1.024 . . . . 72.34 110.783 175.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -140.44 -165.97 10.5 Favored Glycine 0 C--N 1.303 -1.284 0 N-CA-C 110.748 -0.941 . . . . 73.21 110.748 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.91 -21.51 64.0 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 122.877 2.385 . . . . 71.41 112.59 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -91.61 -9.97 42.18 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.132 0.968 . . . . 64.44 110.449 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 97.42 -112.76 4.54 Favored Glycine 0 C--N 1.272 -3.014 0 N-CA-C 108.381 -1.887 . . . . 30.41 108.381 -171.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.13 -35.64 6.26 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 117.89 0.845 . . . . 53.52 109.589 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 84.48 50.72 4.14 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.841 -1.171 . . . . 72.42 114.903 175.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 54.4 p90 -155.07 163.04 40.83 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 117.146 0.473 . . . . 73.31 110.239 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 66.2 m -108.78 132.72 53.7 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 109.757 -0.46 . . . . 73.01 109.757 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 19.3 pt -122.84 149.6 26.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 109.863 -0.421 . . . . 70.12 109.863 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.7 129.3 16.04 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.537 -0.912 . . . . 74.33 108.537 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 165.1 -178.24 40.23 Favored Glycine 0 C--N 1.283 -2.393 0 N-CA-C 108.63 -1.788 . . . . 74.43 108.63 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.03 173.22 13.22 Favored Glycine 0 C--N 1.279 -2.592 0 N-CA-C 108.466 -1.853 . . . . 52.12 108.466 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 90.6 t -56.15 100.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 117.682 0.741 . . . . 74.33 110.623 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 88.33 -2.08 84.79 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.373 -0.83 . . . . 34.43 112.616 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -109.02 3.55 22.23 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.575 0.702 . . . . 74.31 109.644 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER -61.39 127.29 30.76 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 115.042 1.497 . . . . 73.3 115.042 -174.299 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -66.67 -32.25 73.45 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.876 -1.511 . . . . 73.45 110.809 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 43.3 mm -104.64 114.61 63.83 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 116.319 -0.4 . . . . 64.05 110.033 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.23 111.19 0.78 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.888 2.392 . . . . 53.41 111.789 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.07 -22.98 20.09 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.84 -0.695 . . . . 65.24 111.607 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -112.39 106.97 15.61 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.175 -0.676 . . . . 71.11 109.175 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -85.22 63.04 7.87 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.502 0.668 . . . . 73.12 111.095 -173.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.469 ' HB2' ' CE1' ' A' ' 349' ' ' TYR . 7.2 m -119.06 177.68 4.78 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 119.588 -0.845 . . . . 71.11 111.861 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 26.0 mm -98.15 131.67 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 N-CA-C 106.052 -1.833 . . . . 70.32 106.052 176.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 347' ' ' SER . 42.7 m-85 -123.72 132.55 53.85 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.574 0.583 . . . . 71.03 112.574 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.16 112.46 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.865 -1.062 . . . . 65.02 108.527 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.1 m -92.8 -28.69 16.41 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.458 0.647 . . . . 72.42 109.973 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 331' ' ' PHE . 54.3 tttm -155.89 153.57 29.87 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 108.249 -1.019 . . . . 72.32 108.249 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 86.9 mt -118.22 144.23 26.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 104.873 -2.269 . . . . 52.34 104.873 169.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 39.6 mm -79.92 129.68 37.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.69 -0.485 . . . . 74.23 109.69 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.4 pm0 -63.78 105.02 0.75 Allowed 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.461 -1.245 . . . . 71.54 111.265 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.97 -2.35 63.9 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 114.521 -1.218 . . . . 44.42 112.387 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -69.99 172.04 41.15 Favored Glycine 0 C--O 1.244 0.76 0 O-C-N 123.697 0.293 . . . . 73.01 112.65 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -57.34 -44.12 84.02 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 122.976 0.511 . . . . 54.13 110.894 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.54 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.26 -9.87 58.94 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.726 0.639 . . . . 73.33 112.726 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -94.57 -24.3 17.29 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.19 -1.041 . . . . 62.44 108.19 177.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -89.93 -60.13 2.01 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-O 121.579 0.704 . . . . 63.34 110.054 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . 0.461 ' OD2' ' HA ' ' A' ' 322' ' ' LEU . 24.1 t70 -87.5 -44.66 11.13 Favored 'General case' 0 CA--C 1.46 -2.502 0 CA-C-N 114.588 -1.187 . . . . 72.41 111.485 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -42.82 -24.97 0.28 Allowed Glycine 0 CA--C 1.491 -1.46 0 N-CA-C 119.711 2.645 . . . . 75.2 119.711 -162.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.482 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 41.68 37.12 0.68 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 118.556 1.178 . . . . 74.4 111.34 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 39.8 tp -108.22 158.16 17.69 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.33 -1.304 . . . . 74.21 110.355 -169.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -121.26 143.66 49.04 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.646 0.736 . . . . 70.31 110.756 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.48 126.35 25.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.235 -1.395 . . . . 73.34 107.235 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.91 -1.36 30.19 Favored Glycine 0 C--N 1.302 -1.307 0 C-N-CA 120.574 -0.822 . . . . 31.44 111.965 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 5.1 m-20 -66.46 132.07 47.45 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 113.239 0.829 . . . . 65.13 113.239 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 39.9 tttp -92.19 114.28 26.79 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.68 1.192 . . . . 73.31 108.752 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 91.7 mt -85.14 116.38 23.47 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.533 -0.467 . . . . 71.34 110.224 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.1 tt -88.02 -39.13 14.91 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.999 -1.482 . . . . 73.22 106.999 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -166.95 156.0 10.47 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.648 -0.705 . . . . 75.55 110.204 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.81 122.74 39.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.968 -0.753 . . . . 75.25 108.968 173.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . 0.556 HD21 HG22 ' A' ' 394' ' ' THR . 87.4 m-20 60.89 35.32 19.29 Favored 'General case' 0 CA--C 1.482 -1.655 0 CA-C-O 123.713 1.72 . . . . 72.52 108.895 -176.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 67.6 7.09 5.39 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 110.174 -3.194 . . . . 73.04 113.396 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 60.7 t -79.87 123.78 37.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 107.014 -1.476 . . . . 71.25 107.014 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.7 p -63.92 124.2 20.94 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.093 0.775 . . . . 71.51 113.093 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.74 -6.09 13.88 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.637 0.775 . . . . 70.11 110.216 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -72.58 105.07 4.08 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.337 -1.356 . . . . 53.45 107.337 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . 0.269 20.1 tt0 60.3 78.88 0.26 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.371 1.468 . . . . 73.21 113.829 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 30.5 m -147.04 175.15 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 107.592 -1.262 . . . . 72.41 107.592 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 75.0 p -81.06 155.22 26.43 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.442 -0.948 . . . . 64.3 108.442 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . 0.575 ' O ' HG23 ' A' ' 388' ' ' VAL . 8.6 t-160 -58.93 -41.26 86.91 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.226 -0.657 . . . . 73.01 109.226 -172.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -51.03 -44.94 61.13 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.659 -1.155 . . . . 72.52 113.492 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.2 -33.37 74.3 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.547 0.689 . . . . 74.32 109.268 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -74.08 -58.8 3.06 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.488 -1.233 . . . . 70.04 110.417 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 384' ' ' HIS . 15.7 t -58.31 -40.18 76.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 O-C-N 123.292 0.37 . . . . 62.22 110.314 -176.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 95.6 m -63.26 -36.81 84.9 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.298 -0.41 . . . . 72.03 110.751 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.57 -34.75 77.68 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.396 -0.19 . . . . 74.23 110.739 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.49 -32.49 60.58 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 120.67 -0.412 . . . . 74.44 110.704 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 57.7 mttm -72.99 -26.44 61.34 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 120.57 -0.452 . . . . 62.24 112.145 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -80.83 48.88 1.13 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.988 -0.551 . . . . 72.4 110.619 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.556 HG22 HD21 ' A' ' 375' ' ' ASN . 41.7 p -124.43 147.93 47.96 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.438 -0.579 . . . . 73.44 109.438 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 65.9 m -147.4 99.08 3.09 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 122.512 1.149 . . . . 63.3 112.003 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.696 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 8.4 m-20 65.26 13.02 8.5 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 111.195 -2.73 . . . . 73.55 113.218 168.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -165.72 129.08 2.16 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 106.863 -1.532 . . . . 74.1 106.863 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.45 HG22 ' HB ' ' A' ' 394' ' ' THR . 38.9 t -142.39 142.75 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 122.735 0.414 . . . . 72.03 110.361 -177.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.492 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 13.0 m-85 -118.68 95.6 4.91 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.811 -0.811 . . . . 73.15 108.811 168.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.4 tt -93.7 121.3 34.99 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 123.383 0.673 . . . . 55.25 109.744 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -103.31 107.7 18.62 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.7 -0.852 . . . . 74.13 108.7 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.42 HG21 ' HB3' ' A' ' 369' ' ' ASP . 10.2 p -114.63 157.35 15.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 CA-C-N 114.815 -1.084 . . . . 72.21 110.194 -176.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -135.98 158.6 44.01 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.868 -1.53 . . . . 71.42 106.868 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.641 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 10.9 mmpt? . . . . . 0 C--N 1.303 -1.424 0 N-CA-C 108.54 -0.911 . . . . 72.54 108.54 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 N--CA 1.426 -1.638 0 N-CA-C 106.067 -1.827 . . . . 72.14 106.067 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.03 161.55 15.08 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 107.44 -1.318 . . . . 73.21 107.44 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 32.9 m -142.42 104.01 4.34 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 108.353 -0.98 . . . . 72.14 108.353 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -60.11 132.19 53.17 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.183 -1.372 . . . . 71.11 110.899 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 331' ' ' PHE . 17.8 m . . . . . 0 C--O 1.262 1.75 0 CA-C-N 116.082 -0.508 . . . . 71.12 111.163 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 51.8 tpp . . . . . 0 CA--C 1.512 -0.503 0 N-CA-C 108.327 -0.99 . . . . 54.31 108.327 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.474 2.0 pm0 -117.67 128.67 55.14 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 116.744 2.127 . . . . 62.52 116.744 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.445 HG23 ' HZ3' ' A' ' 364' ' ' LYS . 70.8 mt -117.33 106.75 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 CA-C-N 111.74 -2.482 . . . . 75.41 109.793 -174.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 398' ' ' VAL . 40.7 ttmt -85.74 132.6 34.1 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.458 -1.312 . . . . 63.23 107.458 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 74.1 mt -129.02 152.12 48.97 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.02 -1.104 . . . . 74.12 108.02 178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 35.7 mm -106.2 112.34 39.01 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.589 0 N-CA-C 107.781 -1.192 . . . . 64.4 107.781 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.594 ' HB3' ' H ' ' A' ' 396' ' ' ASP . 0.0 OUTLIER -59.86 135.88 57.83 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 108.608 -0.886 . . . . 75.11 108.608 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.431 ' N ' ' HD2' ' A' ' 324' ' ' LYS . . . -134.4 -161.12 9.43 Favored Glycine 0 C--N 1.287 -2.158 0 CA-C-N 116.281 -0.418 . . . . 43.22 113.008 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -62.08 -22.94 75.11 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 123.894 3.062 . . . . 62.52 114.033 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -109.03 18.06 21.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.255 0.55 . . . . 43.44 109.93 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.86 -119.19 4.86 Favored Glycine 0 CA--C 1.492 -1.379 0 N-CA-C 109.967 -1.253 . . . . 64.43 109.967 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.27 -30.5 8.69 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.55 -1.278 . . . . 64.24 107.55 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.12 50.2 4.19 Favored Glycine 0 N--CA 1.432 -1.57 0 CA-C-N 114.532 -1.213 . . . . 75.33 115.403 171.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -154.88 159.87 40.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 117.061 0.43 . . . . 70.22 110.797 172.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.549 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 5.8 m -110.07 127.92 55.13 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 109.139 -0.689 . . . . 63.01 109.139 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 10.1 pt -117.72 154.15 19.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 122.495 0.318 . . . . 75.35 111.02 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.62 120.38 7.56 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.774 -1.565 . . . . 73.4 106.774 174.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 156.97 154.52 7.08 Favored Glycine 0 C--N 1.293 -1.831 0 N-CA-C 110.829 -0.908 . . . . 63.23 110.829 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.55 -177.27 19.36 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 108.484 -1.846 . . . . 54.34 108.484 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 86.1 t -53.52 108.53 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 117.972 0.886 . . . . 74.14 111.245 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 88.83 -16.99 53.26 Favored Glycine 0 C--O 1.219 -0.813 0 CA-C-N 115.271 -0.877 . . . . 74.43 112.419 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.463 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -107.27 9.61 30.01 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.913 -0.773 . . . . 74.01 108.913 -178.154 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.97 126.26 13.88 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 123.557 0.743 . . . . 70.25 112.26 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -82.34 -45.26 15.13 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.09 -0.959 . . . . 72.04 110.107 -173.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.7 122.11 45.87 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 108.246 -1.02 . . . . 75.31 108.246 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.81 105.16 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 123.156 2.571 . . . . 73.13 112.607 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.82 -6.25 29.37 Favored Glycine 0 N--CA 1.431 -1.64 0 CA-C-N 115.352 -0.84 . . . . 45.0 112.099 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -127.19 98.92 5.46 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.478 -0.934 . . . . 52.32 108.478 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -82.4 33.63 0.41 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.991 -1.004 . . . . 72.22 111.827 -170.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 66.7 m -100.35 173.25 6.68 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.807 -0.633 . . . . 74.03 112.033 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.3 mm -86.27 129.64 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 107.574 -1.269 . . . . 73.41 107.574 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 27.1 m-85 -123.78 139.48 53.94 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-N 118.384 0.538 . . . . 71.24 111.572 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 45.3 t -77.04 115.37 18.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.547 -0.751 . . . . 62.22 109.514 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 24.8 m -91.45 -28.91 17.33 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.973 -0.558 . . . . 70.42 110.263 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 85.0 mttt -152.52 160.39 43.23 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 109.268 -0.641 . . . . 72.12 109.268 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 80.0 mt -125.34 135.02 65.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 106.198 -1.779 . . . . 64.25 106.198 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 44.3 mm -85.27 137.54 20.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 C-N-CA 122.429 0.292 . . . . 71.34 111.159 -173.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.97 127.84 32.35 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.709 0.766 . . . . 61.34 112.795 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 70.18 9.86 64.57 Favored Glycine 0 C--N 1.315 -0.626 0 CA-C-N 115.558 -0.746 . . . . 72.52 112.706 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -74.74 160.63 53.02 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 110.836 -0.906 . . . . 60.32 110.836 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -59.69 -42.02 92.04 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 109.733 -0.469 . . . . 72.33 109.733 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.562 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -72.3 -10.67 60.08 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.172 -0.611 . . . . 70.43 112.431 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -93.99 -29.58 15.17 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.635 -0.876 . . . . 61.43 108.635 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -94.17 -60.49 1.72 Allowed 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 122.955 1.359 . . . . 55.01 110.398 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -87.45 -25.66 23.64 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 112.47 -2.15 . . . . 73.35 110.467 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -44.11 -50.34 7.69 Favored Glycine 0 C--N 1.273 -2.967 0 N-CA-C 120.301 2.88 . . . . 65.11 120.301 -170.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 363' ' ' GLY 0.256 0.0 OUTLIER 47.99 31.29 2.34 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.383 1.592 . . . . 63.04 110.973 -164.521 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 9.8 tt -112.03 150.12 31.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.027 -0.988 . . . . 63.12 109.202 -170.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -122.21 152.43 40.0 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.294 0.569 . . . . 75.3 111.076 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 75.4 mt -65.96 129.26 30.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 107.0 -1.481 . . . . 74.25 107.0 170.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 107.72 3.34 34.63 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.471 -0.871 . . . . 62.03 112.172 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.573 ' HB3' HG21 ' A' ' 402' ' ' VAL . 1.4 m-20 -72.89 128.52 35.74 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.261 0.837 . . . . 73.31 113.261 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 42.1 tttp -92.78 114.52 27.1 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.788 1.235 . . . . 75.54 109.492 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 85.8 mt -80.53 111.92 17.4 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 120.961 0.41 . . . . 61.32 110.082 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.2 tt -86.75 -39.41 15.99 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.491 -1.231 . . . . 74.43 107.694 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.55 155.69 17.6 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.772 -0.649 . . . . 74.13 110.677 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.5 p -133.4 122.36 44.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.116 -1.068 . . . . 74.53 108.116 173.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . 0.569 HD21 HG22 ' A' ' 394' ' ' THR . 84.7 m-20 62.26 30.52 17.57 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-O 123.873 1.797 . . . . 43.32 108.445 -174.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.8 t30 66.32 16.89 10.58 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 109.831 -3.35 . . . . 52.44 112.556 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.95 125.28 40.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 106.557 -1.646 . . . . 74.13 106.557 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.1 p -61.62 123.3 17.53 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 113.557 0.947 . . . . 73.41 113.557 -175.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.28 -2.51 20.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.309 -0.86 . . . . 74.3 110.941 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -66.84 106.83 1.99 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.752 -0.658 . . . . 72.52 109.396 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 63.97 74.36 0.41 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 122.643 1.211 . . . . 74.52 113.591 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 21.4 m -137.29 169.5 19.37 Favored 'Isoleucine or valine' 0 C--O 1.249 1.03 0 N-CA-C 105.913 -1.884 . . . . 72.21 105.913 174.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.518 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 50.5 p -78.66 138.71 38.43 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.274 -0.97 . . . . 74.34 108.998 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . 0.598 ' O ' HG23 ' A' ' 388' ' ' VAL . 85.8 t60 -47.49 -51.06 21.69 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.31 0.855 . . . . 72.41 113.31 -173.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -65.04 -29.61 70.52 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.484 0.659 . . . . 53.21 110.663 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 383' ' ' THR . 49.8 tt0 -72.87 -39.11 66.73 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.367 -0.975 . . . . 64.33 108.367 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.486 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -67.59 -46.52 72.36 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.759 -1.109 . . . . 70.03 109.96 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 384' ' ' HIS . 24.8 t -57.87 -43.55 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 109.681 -0.489 . . . . 25.3 109.681 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 85.0 m -57.95 -38.14 75.45 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 123.49 0.494 . . . . 74.52 110.681 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.05 -33.37 75.89 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.193 -0.317 . . . . 70.14 110.959 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.7 mp -81.73 -26.58 34.44 Favored 'General case' 0 C--O 1.211 -0.949 0 C-N-CA 120.494 -0.482 . . . . 53.03 111.28 176.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.441 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 62.2 mttm -75.82 -27.33 57.86 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.698 -0.401 . . . . 74.21 111.968 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -80.27 43.67 0.64 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.844 -0.616 . . . . 73.32 110.623 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.569 HG22 HD21 ' A' ' 375' ' ' ASN . 77.4 p -124.19 144.03 50.17 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.813 -0.81 . . . . 54.41 108.813 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . 0.516 ' HA ' ' HE3' ' A' ' 324' ' ' LYS . 65.4 m -146.02 116.92 7.73 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.568 0.699 . . . . 71.4 111.095 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.594 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 3.3 m-20 55.77 14.52 1.33 Allowed 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 127.882 2.473 . . . . 75.34 114.903 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -163.17 126.15 2.71 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.452 -1.314 . . . . 73.34 107.452 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 46.8 t -138.46 124.0 23.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.271 -1.011 . . . . 75.13 108.271 177.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -106.43 95.9 6.08 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.948 -1.871 . . . . 63.32 105.948 173.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.458 ' CD2' ' HB ' ' A' ' 402' ' ' VAL . 7.6 tt -95.14 114.58 26.39 Favored 'General case' 0 C--N 1.258 -3.374 0 N-CA-C 109.051 -0.722 . . . . 73.12 109.051 -176.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -99.58 108.66 21.11 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.795 -1.557 . . . . 72.15 106.795 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.573 HG21 ' HB3' ' A' ' 369' ' ' ASP . 10.3 p -115.73 162.2 13.93 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.753 0 N-CA-C 108.223 -1.028 . . . . 74.02 108.223 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.9 148.83 47.26 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.58 -0.896 . . . . 73.45 108.58 173.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 10.7 mmpt? . . . . . 0 C--N 1.303 -1.443 0 N-CA-C 108.276 -1.009 . . . . 73.42 108.276 169.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 CA--C 1.492 -1.258 0 N-CA-C 107.558 -1.275 . . . . 71.04 107.558 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -89.28 144.85 25.78 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.29 -1.004 . . . . 63.11 108.29 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . 0.454 HG21 HG11 ' A' ' 388' ' ' VAL . 16.9 m -134.41 135.2 42.42 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 116.233 -0.44 . . . . 63.44 111.628 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -85.86 130.51 34.53 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-N 116.001 -0.545 . . . . 74.42 110.472 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.293 -1.861 0 CA-C-N 116.289 -0.414 . . . . 71.45 110.05 171.508 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 C--O 1.21 -1.016 0 N-CA-C 108.04 -1.096 . . . . 43.04 108.04 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.336 1.8 pm0 -103.45 131.86 50.2 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-O 123.012 1.387 . . . . 72.53 114.411 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.45 HG23 ' HD3' ' A' ' 364' ' ' LYS . 78.3 mt -113.93 106.49 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.97 0 CA-C-N 111.987 -2.37 . . . . 73.32 110.35 -172.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -85.55 105.9 16.48 Favored 'General case' 0 N--CA 1.402 -2.854 0 N-CA-C 104.324 -2.472 . . . . 75.21 104.324 170.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.421 HD21 ' HA ' ' A' ' 359' ' ' ALA . 0.4 OUTLIER -106.5 144.59 32.96 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 113.802 -1.545 . . . . 71.45 109.299 -171.349 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.1 mp -98.34 111.24 27.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 108.75 -0.833 . . . . 64.34 108.75 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -76.32 149.91 36.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.489 -0.778 . . . . 72.32 109.979 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -141.2 -160.07 8.16 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.466 -0.874 . . . . 62.04 112.23 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.35 -12.77 34.43 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.334 2.69 . . . . 72.55 113.362 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -102.35 8.72 40.18 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.302 -0.629 . . . . 74.13 109.302 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.74 -128.2 8.45 Favored Glycine 0 CA--C 1.477 -2.338 0 N-CA-C 108.764 -1.735 . . . . 35.43 108.764 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.44 ' HB2' HG23 ' B' ' 151' ' ' VAL . 4.5 mp -98.52 -39.16 8.87 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.582 -2.007 . . . . 72.41 105.582 172.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.36 56.03 2.48 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 114.776 -1.102 . . . . 72.11 114.154 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . 0.414 ' HA ' ' H ' ' A' ' 354' ' ' ILE . 53.9 p90 -154.39 158.98 40.85 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.104 -0.702 . . . . 75.0 109.104 172.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' B' ' 149' ' ' THR . 10.9 m -107.32 128.82 54.79 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.165 -1.05 . . . . 74.3 108.165 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 25.2 pt -114.71 151.87 16.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 109.998 -0.371 . . . . 74.32 109.998 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -147.57 121.86 9.61 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.147 -1.427 . . . . 71.21 107.147 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 154.71 163.19 11.77 Favored Glycine 0 C--N 1.282 -2.437 0 N-CA-C 110.784 -0.926 . . . . 51.34 110.784 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.58 -174.16 21.14 Favored Glycine 0 CA--C 1.479 -2.195 0 N-CA-C 108.069 -2.012 . . . . 54.14 108.069 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.425 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 68.3 t -54.08 103.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 117.545 0.672 . . . . 54.24 110.921 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 82.33 -7.79 63.27 Favored Glycine 0 C--O 1.217 -0.934 0 CA-C-N 115.419 -0.81 . . . . 73.31 112.98 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.36 0.06 26.62 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.206 -1.035 . . . . 75.43 108.206 -178.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.449 ' HA ' ' HA2' ' A' ' 335' ' ' GLY . 0.0 OUTLIER -50.78 140.38 14.96 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 115.642 1.719 . . . . 61.25 115.642 -174.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -85.42 -33.64 21.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.439 -1.255 . . . . 73.43 109.078 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 46.4 mm -104.81 122.7 42.5 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.67 -0.695 . . . . 74.33 109.716 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.82 108.52 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.543 2.162 . . . . 62.22 111.412 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.29 -19.3 24.73 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.57 -0.824 . . . . 74.21 112.092 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 19.4 t70 -114.79 99.96 7.88 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.861 -1.163 . . . . 74.13 107.861 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . 0.425 ' OD1' ' HA ' ' A' ' 337' ' ' VAL . 59.3 t30 -80.97 33.09 0.32 Allowed 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 124.018 0.927 . . . . 64.44 112.437 -169.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 68.1 m -100.01 176.97 5.24 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.772 0.656 . . . . 71.42 112.772 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.5 mm -92.2 132.66 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 107.513 -1.291 . . . . 72.44 107.513 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 32.9 m-85 -124.1 137.49 54.56 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 112.62 0.6 . . . . 72.43 112.62 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 49.9 t -70.59 117.59 13.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 115.159 -0.928 . . . . 72.31 108.606 176.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.0 m -97.26 -29.87 13.3 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.515 0.674 . . . . 53.24 110.248 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -155.39 152.36 28.98 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 107.285 -1.376 . . . . 74.03 107.285 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 80.3 mt -121.42 109.56 25.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 106.357 -1.72 . . . . 70.21 106.357 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.414 ' H ' ' HA ' ' A' ' 331' ' ' PHE . 41.7 mm -52.21 133.73 14.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 O-C-N 124.711 1.257 . . . . 74.23 112.221 -171.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.536 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.1 pm0 -55.2 114.51 1.81 Allowed 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 125.361 1.464 . . . . 74.24 111.833 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 72.67 22.78 78.81 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 114.351 -1.295 . . . . 51.42 111.781 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.33 164.36 53.44 Favored Glycine 0 C--O 1.254 1.363 0 N-CA-C 111.466 -0.654 . . . . 74.54 111.466 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.13 96.46 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.983 -0.747 . . . . 61.32 108.983 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.541 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.69 -11.03 59.92 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.986 -0.552 . . . . 73.52 112.067 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -86.52 -30.52 21.88 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.711 -1.218 . . . . 74.51 107.711 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.588 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 1.2 mmpm? -95.52 -57.82 2.29 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.657 0.984 . . . . 75.23 113.657 176.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -85.41 -39.2 17.83 Favored 'General case' 0 CA--C 1.467 -2.25 0 C-N-CA 123.542 0.737 . . . . 55.02 111.164 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.541 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -42.68 -23.95 0.21 Allowed Glycine 0 C--N 1.3 -1.421 0 N-CA-C 119.316 2.486 . . . . 73.45 119.316 -166.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.476 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.4 38.3 1.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 118.576 1.188 . . . . 75.0 111.241 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 55.8 tp -112.86 157.59 21.23 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.25 -1.341 . . . . 74.34 110.099 -170.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -120.41 143.74 48.3 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 121.524 0.678 . . . . 73.52 111.174 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.6 125.16 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 107.116 -1.439 . . . . 75.22 107.116 169.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.75 1.19 32.31 Favored Glycine 0 C--N 1.309 -0.935 0 C-N-CA 120.567 -0.825 . . . . 51.31 112.183 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 71.6 m-20 -75.49 138.27 41.47 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 112.698 0.629 . . . . 54.02 112.698 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 45.2 tttp -94.27 115.32 27.55 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.154 1.381 . . . . 74.44 108.994 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 95.7 mt -79.86 111.24 16.0 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.951 0.405 . . . . 62.35 109.999 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 403' ' ' ALA . 4.0 tt -83.09 -40.09 20.29 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.71 -1.589 . . . . 74.45 106.71 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.25 157.38 25.51 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.163 -0.926 . . . . 62.0 109.639 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . 0.515 HG11 ' HG ' ' A' ' 391' ' ' LEU . 7.6 p -147.31 137.27 16.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.59 -0.893 . . . . 43.45 108.59 173.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 59.51 38.38 22.47 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 108.066 -1.087 . . . . 73.21 108.066 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.03 -8.06 0.45 Allowed 'General case' 0 CA--C 1.57 1.723 0 C-N-CA 125.846 1.658 . . . . 53.23 113.278 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.32 130.65 35.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.981 -0.748 . . . . 71.35 108.981 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.0 p -72.21 129.68 39.03 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 122.756 0.423 . . . . 73.23 111.35 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.38 -3.7 16.91 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.766 0.654 . . . . 73.32 112.766 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -65.23 107.19 1.51 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.588 -0.523 . . . . 73.11 109.588 174.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 63.67 72.33 0.47 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 122.742 1.258 . . . . 54.25 113.359 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.59 164.35 31.15 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 N-CA-C 105.764 -1.939 . . . . 75.35 105.764 173.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.676 ' HB ' ' OE1' ' A' ' 386' ' ' GLU . 1.4 m -82.81 146.43 28.94 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.406 -1.331 . . . . 72.41 107.406 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . 0.617 ' O ' HG23 ' A' ' 388' ' ' VAL . 67.9 t60 -51.05 -32.73 22.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.526 -0.761 . . . . 75.51 112.961 -173.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.08 -42.66 93.89 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.519 -0.549 . . . . 75.25 109.519 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.676 ' OE1' ' HB ' ' A' ' 383' ' ' THR . 1.8 mp0 -73.22 -32.46 64.77 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 108.864 -0.791 . . . . 63.1 108.864 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.514 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -62.32 -53.88 48.66 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.709 -1.132 . . . . 43.12 109.251 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 384' ' ' HIS . 33.2 t -57.34 -44.19 83.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 N-CA-C 109.746 -0.465 . . . . 52.2 109.746 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 80.6 m -57.51 -41.11 80.15 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 116.065 -0.516 . . . . 73.25 111.035 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -63.36 -38.04 89.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.729 0.3 . . . . 71.24 110.844 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.515 ' HG ' HG11 ' A' ' 374' ' ' VAL . 5.6 mp -76.47 -21.3 56.04 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 120.23 -0.588 . . . . 62.13 110.978 176.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.496 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 54.5 mttm -83.95 -27.27 28.62 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 113.474 0.916 . . . . 54.02 113.474 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -76.11 35.15 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.075 0.95 . . . . 71.32 112.681 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 8.1 p -124.76 161.05 27.25 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 122.899 0.48 . . . . 75.34 110.028 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 24.9 p -160.53 125.86 3.88 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.325 -0.62 . . . . 72.41 109.325 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 61.69 0.14 0.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 125.92 1.688 . . . . 75.45 113.757 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -168.12 137.49 2.49 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.589 -0.893 . . . . 75.11 108.589 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 62.1 t -136.66 125.71 36.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.614 -1.254 . . . . 72.33 107.614 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -101.21 95.59 6.63 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.144 -2.169 . . . . 74.14 105.144 173.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.3 tt -101.02 140.78 34.84 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 109.46 -0.57 . . . . 71.53 109.46 -176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -128.11 113.09 15.3 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.85 -0.426 . . . . 74.44 109.85 -175.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 54.1 t -105.19 145.26 13.7 Favored 'Isoleucine or valine' 0 C--O 1.269 2.12 0 C-N-CA 124.256 1.022 . . . . 71.35 111.03 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -117.17 156.39 27.75 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 104.618 -2.364 . . . . 35.01 104.618 169.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? . . . . . 0 C--N 1.285 -2.228 0 C-N-CA 118.677 -1.209 . . . . 61.43 107.991 -179.594 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . 0.506 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.489 -1.395 0 N-CA-C 109.62 -0.511 . . . . 71.03 109.62 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -90.4 146.27 24.29 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.996 -0.742 . . . . 71.24 108.996 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 332' ' ' SER . 88.9 m -134.64 138.03 44.14 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.91 -0.587 . . . . 71.13 110.16 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -83.66 132.81 34.85 Favored 'General case' 0 C--O 1.254 1.319 0 N-CA-C 109.801 -0.444 . . . . 73.34 109.801 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.44 HG23 ' HB2' ' A' ' 329' ' ' LEU . 15.1 m . . . . . 0 C--N 1.296 -1.742 0 CA-C-O 116.767 -1.587 . . . . 74.11 112.63 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . 0.528 ' SD ' ' HE3' ' A' ' 404' ' ' LYS . 26.1 ttt . . . . . 0 CA--C 1.495 -1.156 0 N-CA-C 106.941 -1.503 . . . . 70.32 106.941 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 400' ' ' LEU 0.339 2.0 pm0 -115.58 132.17 56.71 Favored 'General case' 0 N--CA 1.408 -2.562 0 N-CA-C 115.013 1.486 . . . . 53.24 115.013 -175.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 363' ' ' GLY . 58.6 mt -116.63 111.75 36.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.351 0 CA-C-N 112.402 -2.181 . . . . 54.45 107.966 -173.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -82.71 110.5 17.81 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.207 -1.034 . . . . 64.22 108.207 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 92.6 mt -111.02 156.32 21.44 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.54 0.525 . . . . 61.11 110.327 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.6 mp -105.04 115.4 46.84 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 107.925 -1.139 . . . . 60.4 107.925 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 394' ' ' THR . 22.7 tptm -68.57 122.16 17.91 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.485 -0.78 . . . . 65.33 109.318 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -133.55 -154.42 7.39 Favored Glycine 0 C--N 1.306 -1.104 0 C-N-CA 120.61 -0.805 . . . . 71.43 113.274 -173.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.85 -40.3 39.56 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 124.79 3.66 . . . . 44.41 115.49 -175.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -109.09 16.48 22.51 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.248 0.547 . . . . 75.2 110.044 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.41 -118.22 4.6 Favored Glycine 0 N--CA 1.424 -2.124 0 CA-C-N 114.892 -1.049 . . . . 63.21 110.983 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.543 HD21 HG11 ' A' ' 398' ' ' VAL . 4.0 mp -96.02 -30.32 13.64 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.565 -1.272 . . . . 72.23 107.565 177.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.49 44.93 5.98 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 114.853 -1.067 . . . . 45.4 114.487 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . 0.487 ' HA ' ' H ' ' A' ' 354' ' ' ILE . 50.7 p90 -152.43 156.7 40.0 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.823 -0.806 . . . . 71.14 108.823 172.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' B' ' 149' ' ' THR . 46.3 m -113.66 136.66 52.59 Favored 'General case' 0 C--N 1.282 -2.348 0 O-C-N 123.663 0.602 . . . . 51.02 110.829 -175.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 20.2 pt -120.26 149.6 23.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.409 -0.814 . . . . 64.3 112.435 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -145.15 114.59 7.15 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.285 -1.746 . . . . 40.32 106.285 174.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 164.19 164.18 18.83 Favored Glycine 0 C--N 1.285 -2.291 0 N-CA-C 109.015 -1.634 . . . . 60.34 109.015 -178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.01 178.93 15.94 Favored Glycine 0 CA--C 1.479 -2.214 0 N-CA-C 108.113 -1.995 . . . . 52.21 108.113 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 88.8 t -53.23 108.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 117.766 0.783 . . . . 73.23 110.738 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.65 -23.64 33.1 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.269 -0.878 . . . . 72.44 112.509 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.598 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 58.8 t30 -105.91 18.63 21.82 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.696 -0.483 . . . . 72.32 109.696 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -50.89 123.88 10.07 Favored 'General case' 0 C--O 1.257 1.476 0 C-N-CA 123.553 0.741 . . . . 54.3 110.518 -178.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -81.4 -40.1 23.96 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.146 -0.934 . . . . 74.1 109.977 -176.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 35.9 mm -103.65 126.11 32.9 Favored Pre-proline 0 C--N 1.309 -1.176 0 N-CA-C 109.2 -0.667 . . . . 72.35 109.2 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.14 102.73 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 123.108 2.539 . . . . 63.32 112.66 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.71 -7.2 29.75 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.828 -0.624 . . . . 75.2 112.033 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -123.92 96.84 5.1 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.049 -1.093 . . . . 74.13 108.049 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . 0.414 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 65.3 t30 -83.03 36.92 0.52 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.587 -1.188 . . . . 72.11 112.08 -169.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 74.7 m -99.47 178.11 4.97 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.675 -0.693 . . . . 65.03 112.11 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 11.0 mm -88.72 131.6 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 107.899 -1.149 . . . . 73.34 107.899 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 26.8 m-85 -124.12 138.06 54.48 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 113.507 0.929 . . . . 64.34 113.507 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.1 t -71.14 115.54 11.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 114.787 -1.097 . . . . 72.13 108.48 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 22.6 m -100.56 -25.98 13.99 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.4 0.619 . . . . 73.35 110.848 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.89 142.25 22.49 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.229 -1.397 . . . . 72.33 107.229 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 74.3 mt -109.64 107.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 106.023 -1.843 . . . . 72.33 106.023 172.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.487 ' H ' ' HA ' ' A' ' 331' ' ' PHE . 46.4 mm -57.9 127.22 16.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 O-C-N 124.478 1.111 . . . . 65.23 112.585 -170.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.616 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.1 pm0 -57.12 117.67 4.26 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 113.314 -1.766 . . . . 72.24 111.053 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 90.01 5.31 70.85 Favored Glycine 0 C--O 1.22 -0.747 0 CA-C-N 115.02 -0.991 . . . . 54.31 111.96 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.3 158.08 48.82 Favored Glycine 0 C--O 1.255 1.443 0 C-N-CA 121.548 -0.358 . . . . 22.13 112.808 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.88 -40.1 95.75 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.972 -0.751 . . . . 74.44 108.972 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.548 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.44 -9.82 58.91 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.9 -0.591 . . . . 52.42 111.504 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -87.22 -30.43 20.97 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.315 -0.995 . . . . 60.52 108.315 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.478 ' HA ' ' CE ' ' A' ' 361' ' ' LYS . 0.0 OUTLIER -95.83 -57.23 2.42 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 114.101 1.148 . . . . 70.2 114.101 176.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -85.2 -39.45 17.8 Favored 'General case' 0 CA--C 1.462 -2.414 0 O-C-N 123.58 0.55 . . . . 64.24 110.604 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.604 ' O ' HD13 ' A' ' 320' ' ' ILE . . . -42.72 -23.14 0.17 Allowed Glycine 0 C--O 1.199 -2.037 0 N-CA-C 119.199 2.44 . . . . 71.03 119.199 -164.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.469 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 43.68 32.22 0.54 Allowed 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 119.135 1.467 . . . . 62.33 111.872 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 43.9 tp -105.01 153.5 21.37 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 125.184 1.393 . . . . 61.32 109.246 -171.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -116.95 146.07 43.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.065 0.459 . . . . 73.34 111.224 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 74.9 mt -66.54 124.21 21.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.719 -1.215 . . . . 70.1 107.719 170.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.65 1.19 30.73 Favored Glycine 0 C--N 1.312 -0.774 0 N-CA-C 111.175 -0.77 . . . . 65.22 111.175 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.51 ' HB3' HG21 ' A' ' 402' ' ' VAL . 73.2 m-20 -75.71 138.75 41.5 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.981 1.104 . . . . 65.25 113.981 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.631 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 40.8 tttp -94.2 115.83 28.15 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.499 1.52 . . . . 73.11 110.043 -177.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.49 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 96.5 mt -80.28 112.61 17.77 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.954 -0.758 . . . . 72.03 108.954 176.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.4 tt -83.88 -37.57 22.24 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.952 -1.499 . . . . 62.42 106.952 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -162.68 158.0 22.55 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.568 -0.742 . . . . 74.12 111.186 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . 0.408 HG12 HD11 ' A' ' 379' ' ' LEU . 13.8 p -133.82 125.45 49.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.629 -1.249 . . . . 75.42 107.629 171.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 59.55 36.62 22.86 Favored 'General case' 0 CA--C 1.47 -2.119 0 CA-C-O 124.287 1.994 . . . . 54.3 110.727 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.3 t30 61.99 13.2 5.44 Favored 'General case' 0 C--N 1.268 -2.935 0 CA-C-N 108.958 -3.746 . . . . 72.22 113.272 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.9 t -86.91 123.86 40.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 107.419 -1.326 . . . . 32.4 107.419 175.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.6 p -63.14 125.22 23.34 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.023 0.749 . . . . 72.33 113.023 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.408 HD11 HG12 ' A' ' 374' ' ' VAL . 7.2 mp -106.57 3.68 27.26 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 123.843 0.857 . . . . 73.14 111.247 178.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -66.58 112.64 4.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.756 -0.656 . . . . 73.45 110.238 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 60.1 49.82 7.1 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 122.722 1.249 . . . . 72.34 112.98 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.31 169.55 4.01 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 N-CA-C 107.937 -1.135 . . . . 51.31 107.937 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 76.5 p -81.64 141.13 33.95 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.845 -0.742 . . . . 75.0 109.755 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . 0.57 ' O ' HG23 ' A' ' 388' ' ' VAL . 75.2 t60 -46.02 -45.33 15.85 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.267 0.84 . . . . 74.24 113.267 -176.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -62.33 -39.15 92.12 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 120.937 0.399 . . . . 65.4 111.122 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 383' ' ' THR . 61.4 tt0 -69.53 -34.63 74.51 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 124.321 1.048 . . . . 72.43 108.559 -176.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.526 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -73.37 -53.9 9.63 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.823 -1.081 . . . . 75.11 110.633 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 384' ' ' HIS . 21.1 t -58.15 -41.38 80.61 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 109.862 -0.421 . . . . 54.3 109.862 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 31.0 m -63.24 -31.67 72.87 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 116.224 -0.444 . . . . 74.14 110.938 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -69.35 -41.09 77.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.15 -0.315 . . . . 52.22 110.15 177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.3 mp -73.85 -23.99 59.7 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 119.937 -0.705 . . . . 72.23 110.406 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 54.9 mttm -79.12 -32.47 44.51 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 113.488 0.921 . . . . 74.22 113.488 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -84.01 64.5 8.2 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.949 0.88 . . . . 73.41 111.836 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.54 ' O ' ' HG2' ' A' ' 324' ' ' LYS . 12.4 p -148.62 149.46 31.56 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.422 -1.263 . . . . 74.23 108.38 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 26.8 p -148.62 128.02 13.08 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.271 -0.64 . . . . 74.41 109.271 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.435 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 31.8 t70 59.8 -1.22 0.17 Allowed 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 126.29 1.836 . . . . 71.41 114.406 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -159.73 120.8 3.16 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 120.607 -1.308 . . . . 73.12 110.718 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.543 HG11 HD21 ' A' ' 329' ' ' LEU . 80.4 t -136.15 145.13 31.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 124.281 1.032 . . . . 74.52 108.365 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.24 96.41 4.91 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.289 -1.374 . . . . 74.03 107.289 173.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 319' ' ' GLU . 4.8 tt -83.98 118.26 23.91 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.885 -1.154 . . . . 74.34 107.885 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -108.09 107.34 17.96 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.928 -1.138 . . . . 65.42 107.928 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 369' ' ' ASP . 3.0 p -111.3 148.69 14.41 Favored 'Isoleucine or valine' 0 C--O 1.267 1.998 0 CA-C-N 115.408 -0.814 . . . . 63.11 109.626 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.631 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.71 157.83 45.85 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 104.325 -2.472 . . . . 74.32 104.325 172.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.528 ' HE3' ' SD ' ' A' ' 318' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.276 -2.599 0 C-N-CA 118.302 -1.359 . . . . 75.02 107.477 174.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . 0.514 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.435 -1.18 0 N-CA-C 108.759 -0.83 . . . . 71.03 108.759 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.65 151.94 19.14 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.628 -1.619 . . . . 73.22 106.628 173.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 332' ' ' SER . 53.8 m -147.37 129.62 15.65 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 120.534 -0.466 . . . . 73.44 110.66 174.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . 0.42 ' HG3' HG13 ' A' ' 354' ' ' ILE . 16.5 tt0 -67.07 129.51 40.13 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.941 -0.762 . . . . 72.23 108.941 173.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 331' ' ' PHE . 15.4 m . . . . . 0 C--N 1.297 -1.71 0 N-CA-C 113.404 0.89 . . . . 63.22 113.404 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 56.8 tpp . . . . . 0 CA--C 1.487 -1.458 0 N-CA-C 106.032 -1.84 . . . . 74.23 106.032 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.426 1.8 pm0 -122.07 128.64 51.59 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 116.692 2.108 . . . . 45.55 116.692 -174.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.503 HG23 ' HD3' ' A' ' 364' ' ' LYS . 89.8 mt -105.23 106.57 20.76 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.623 0 CA-C-N 111.452 -2.613 . . . . 73.11 109.305 -176.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -77.68 113.89 15.98 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 103.883 -2.636 . . . . 70.31 103.883 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.06 147.68 31.99 Favored 'General case' 0 C--N 1.266 -3.023 0 O-C-N 124.478 1.111 . . . . 61.01 109.234 -171.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 68.3 mt -106.03 134.99 46.0 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.881 0 N-CA-C 108.114 -1.069 . . . . 72.03 108.114 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.493 ' H ' ' HA ' ' A' ' 396' ' ' ASP . 1.2 ttpm? -74.24 177.99 5.44 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.83 -0.804 . . . . 74.41 108.83 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.441 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -155.86 -172.52 23.44 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 120.374 -0.917 . . . . 73.45 110.943 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.38 -26.16 20.82 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 122.895 2.397 . . . . 65.25 112.277 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -88.92 -8.56 53.98 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 122.469 1.128 . . . . 73.03 108.886 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 95.93 -135.55 12.38 Favored Glycine 0 CA--C 1.482 -1.985 0 CA-C-N 113.618 -1.628 . . . . 74.33 109.355 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.8 mp -83.71 -45.5 13.32 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.429 -1.693 . . . . 75.32 106.429 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 83.32 53.74 3.35 Favored Glycine 0 N--CA 1.421 -2.316 0 CA-C-N 114.645 -1.161 . . . . 74.32 114.348 170.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -154.4 164.48 38.57 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 116.736 0.268 . . . . 73.21 110.334 172.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.529 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 10.2 m -112.54 129.35 56.39 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.632 -0.507 . . . . 61.53 109.632 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.9 pt -118.75 153.33 20.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 109.927 -0.397 . . . . 74.15 109.927 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -142.22 136.57 30.01 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.288 -1.745 . . . . 63.32 106.288 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 347' ' ' SER . . . 144.81 157.44 7.22 Favored Glycine 0 C--N 1.282 -2.428 0 N-CA-C 109.288 -1.525 . . . . 34.1 109.288 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 137.74 175.5 13.91 Favored Glycine 0 C--N 1.282 -2.453 0 N-CA-C 108.386 -1.886 . . . . 73.01 108.386 -175.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.51 HG22 ' OE2' ' A' ' 381' ' ' GLU . 68.7 t -50.7 110.89 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 117.719 0.76 . . . . 42.31 109.655 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 81.4 -17.04 14.95 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 121.267 -0.492 . . . . 54.42 113.298 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.28 3.65 38.37 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.592 -1.262 . . . . 62.43 107.592 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.424 HE22 ' HA ' ' A' ' 343' ' ' PRO . 0.0 OUTLIER -49.57 126.21 13.03 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.595 1.158 . . . . 74.14 111.288 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -76.83 -37.27 55.97 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.22 -0.9 . . . . 64.45 109.97 -175.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 2.8 mp -104.82 126.76 30.35 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 109.344 -0.613 . . . . 64.51 109.344 177.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.424 ' HA ' HE22 ' A' ' 340' ' ' GLN . 18.7 Cg_endo -59.38 105.99 0.28 Allowed 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.842 2.362 . . . . 75.04 112.816 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 105.83 -1.22 38.82 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 115.553 -0.749 . . . . 43.43 111.931 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 60.4 t0 -130.85 103.55 6.63 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 108.087 -1.079 . . . . 72.22 108.087 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -76.91 65.05 2.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.501 1.143 . . . . 74.45 108.924 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.451 ' O ' ' HA3' ' A' ' 335' ' ' GLY . 5.2 p -97.09 134.6 40.22 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 113.289 -1.778 . . . . 74.21 112.38 -176.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 44.3 mm -80.94 119.14 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 N-CA-C 104.488 -2.412 . . . . 74.04 104.488 168.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -123.89 137.92 54.56 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 120.161 -0.616 . . . . 71.42 109.724 -169.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 49.5 t -78.58 111.41 15.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.266 -0.642 . . . . 44.5 109.266 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.5 m -96.42 -28.84 14.26 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.068 -0.515 . . . . 75.54 110.928 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 55.4 mttp -151.61 163.11 39.8 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 109.637 -0.505 . . . . 71.42 109.637 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.458 HG22 ' HB2' ' A' ' 360' ' ' HIS . 73.1 mt -131.54 127.48 59.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 106.644 -1.613 . . . . 72.44 106.644 174.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 50.6 mm -85.51 141.75 14.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 123.678 0.791 . . . . 70.12 111.466 -172.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.5 133.66 50.24 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.551 0.691 . . . . 74.44 112.339 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 70.88 7.46 62.05 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 120.598 -0.81 . . . . 75.05 112.454 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -67.39 148.89 50.41 Favored Glycine 0 N--CA 1.414 -2.807 0 N-CA-C 110.289 -1.124 . . . . 74.5 110.289 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.42 -34.27 77.38 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.432 -0.581 . . . . 43.31 109.432 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.574 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -76.1 -14.97 60.18 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.209 -0.597 . . . . 64.13 111.707 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . 0.458 ' HB2' HG22 ' A' ' 353' ' ' ILE . 39.6 t60 -84.14 -27.79 27.88 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.695 0.759 . . . . 72.41 109.18 177.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -96.69 -58.28 2.08 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 114.835 1.42 . . . . 53.51 114.835 173.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -85.81 -41.57 14.93 Favored 'General case' 0 CA--C 1.465 -2.309 0 C-N-CA 122.796 0.438 . . . . 74.41 111.155 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -43.02 -25.0 0.31 Allowed Glycine 0 CA--C 1.491 -1.413 0 N-CA-C 118.79 2.276 . . . . 63.54 118.79 -165.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.503 ' HD3' HG23 ' A' ' 320' ' ' ILE . 0.0 OUTLIER 43.72 36.21 1.23 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.42 1.088 . . . . 63.04 111.167 -179.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 39.5 tp -115.69 152.89 32.33 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 114.168 -1.378 . . . . 70.51 108.368 -171.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -123.84 155.56 37.8 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.751 0.786 . . . . 72.33 111.605 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 80.3 mt -66.12 125.47 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 107.204 -1.406 . . . . 71.42 107.204 173.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.34 -6.83 21.0 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.04 -1.076 . . . . 50.55 111.949 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -75.8 142.37 42.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.487 0.551 . . . . 63.1 112.487 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 76.4 tttt -101.64 131.21 47.99 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.931 -0.766 . . . . 73.14 108.931 176.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 68.8 mt -95.81 120.77 36.68 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.964 0.411 . . . . 74.13 110.812 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 403' ' ' ALA . 40.0 mt -83.41 -39.73 20.25 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.433 -1.258 . . . . 74.2 109.736 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.23 157.93 26.47 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 120.015 -0.674 . . . . 55.12 112.088 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . 0.493 HG12 HD11 ' A' ' 379' ' ' LEU . 14.7 p -134.28 121.69 38.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 107.984 -1.117 . . . . 54.44 107.984 172.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . 0.518 HD21 HG22 ' A' ' 394' ' ' THR . 79.1 m-20 64.4 27.79 13.62 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 123.909 1.814 . . . . 71.2 108.641 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.2 t30 66.17 16.4 10.43 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 109.791 -3.368 . . . . 72.32 111.835 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.8 t -83.84 125.44 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.171 -1.788 . . . . 72.31 106.171 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.7 p -62.96 125.49 24.16 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 124.012 0.82 . . . . 63.44 113.008 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.493 HD11 HG12 ' A' ' 374' ' ' VAL . 6.2 mp -103.21 1.1 32.59 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.229 -0.896 . . . . 73.34 110.892 177.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -75.3 115.05 14.54 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.644 -0.873 . . . . 72.2 108.644 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . 0.51 ' OE2' HG22 ' A' ' 337' ' ' VAL . 19.7 tp10 62.22 83.42 0.15 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.557 1.17 . . . . 62.2 112.117 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 337' ' ' VAL . 23.9 m -153.21 165.8 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 113.24 -1.8 . . . . 75.52 107.606 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.469 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.0 OUTLIER -82.15 143.61 31.32 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.184 -1.043 . . . . 73.22 108.184 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . 0.524 ' O ' HG23 ' A' ' 388' ' ' VAL . 86.1 t60 -50.6 -53.27 31.93 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 112.394 0.516 . . . . 72.42 112.394 -174.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.69 -27.35 68.28 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.129 -0.941 . . . . 70.44 111.217 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.9 tt0 -75.0 -34.47 61.97 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.796 -1.187 . . . . 72.42 107.796 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.46 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -73.08 -45.35 57.74 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.655 -1.157 . . . . 75.13 109.737 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 384' ' ' HIS . 15.4 t -56.95 -42.92 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.937 -0.764 . . . . 74.05 108.937 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 62.6 m -61.15 -36.3 79.41 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 116.016 -0.538 . . . . 63.42 110.936 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.74 80.91 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.333 -0.23 . . . . 70.24 110.512 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.7 mp -78.03 -31.56 50.49 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 120.456 -0.498 . . . . 74.35 111.024 176.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -71.27 -25.75 62.59 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 120.569 -0.453 . . . . 73.3 112.167 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -82.68 65.39 7.78 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.227 1.013 . . . . 72.01 110.468 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.518 HG22 HD21 ' A' ' 375' ' ' ASN . 17.6 p -132.78 146.1 51.56 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.248 -1.342 . . . . 53.22 108.394 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 47.9 m -145.92 91.58 2.1 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.583 1.182 . . . . 63.03 111.426 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.493 ' HA ' ' H ' ' A' ' 324' ' ' LYS 0.346 14.4 m-20 65.08 4.44 2.55 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 111.427 -2.624 . . . . 70.35 116.075 170.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -156.39 130.32 8.48 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 106.987 -1.486 . . . . 73.44 106.987 170.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 394' ' ' THR . 27.6 t -138.09 149.3 24.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 124.187 0.995 . . . . 54.11 109.063 -172.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -116.34 95.9 5.28 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.248 -1.019 . . . . 71.42 108.248 170.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.5 tt -95.39 119.37 33.77 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.106 0.479 . . . . 53.44 109.999 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -102.4 110.41 22.35 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.793 -1.188 . . . . 60.24 107.793 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 3.0 p -110.87 144.51 18.69 Favored 'Isoleucine or valine' 0 C--O 1.274 2.356 0 C-N-CA 124.232 1.013 . . . . 53.51 111.526 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -137.64 159.93 40.62 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 125.907 1.683 . . . . 72.2 109.022 176.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.295 -1.788 0 N-CA-C 109.234 -0.654 . . . . 63.01 109.234 173.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 CA--C 1.496 -1.101 0 N-CA-C 108.913 -0.773 . . . . 71.14 108.913 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.78 144.96 24.96 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.155 -0.683 . . . . 71.31 109.155 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 86.6 m -134.63 142.69 46.96 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.722 -0.473 . . . . 62.42 109.722 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.87 145.4 36.27 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 122.942 0.497 . . . . 74.42 111.041 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 14.0 m . . . . . 0 C--O 1.261 1.676 0 CA-C-N 115.738 -0.665 . . . . 73.13 111.282 175.262 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 CA--C 1.495 -1.16 0 N-CA-C 107.192 -1.41 . . . . 64.2 107.192 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.323 2.0 pm0 -115.79 133.88 55.58 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-O 122.23 1.014 . . . . 70.24 113.364 -176.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 363' ' ' GLY . 77.3 mt -129.89 116.56 38.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 113.217 -1.81 . . . . 60.31 110.27 -168.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.453 ' HE3' ' HB3' ' A' ' 321' ' ' LYS . 1.3 ttpp -75.92 134.7 40.18 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.028 -0.73 . . . . 74.24 109.028 172.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.517 ' HA ' ' OD2' ' A' ' 362' ' ' ASP . 95.5 mt -131.78 152.15 51.16 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 123.556 0.535 . . . . 72.12 110.217 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.44 110.64 31.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.14 -1.059 . . . . 70.45 108.14 171.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.481 ' NZ ' ' HA ' ' A' ' 392' ' ' LYS . 79.1 tttt -76.94 130.23 37.24 Favored 'General case' 0 C--O 1.201 -1.457 0 C-N-CA 119.687 -0.805 . . . . 63.54 110.112 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -133.85 -163.77 10.47 Favored Glycine 0 C--N 1.298 -1.58 0 C-N-CA 119.766 -1.207 . . . . 25.3 111.905 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.64 -12.9 33.49 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 123.775 2.983 . . . . 73.41 113.782 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -103.53 6.99 37.75 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 122.316 1.055 . . . . 63.33 108.805 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.21 -151.02 28.01 Favored Glycine 0 CA--C 1.493 -1.331 0 CA-C-N 114.303 -1.317 . . . . 51.13 110.213 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.6 mp -88.11 -16.51 33.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.747 -1.575 . . . . 71.14 106.747 166.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . 0.561 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 79.16 39.28 19.93 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 113.921 -1.491 . . . . 61.32 114.892 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 52.2 p90 -151.45 165.75 33.2 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 117.596 0.698 . . . . 55.45 110.487 175.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' B' ' 149' ' ' THR . 12.2 m -121.62 136.0 54.96 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 109.706 -0.479 . . . . 61.55 109.706 -178.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' B' ' 148' ' ' GLU . 17.9 pt -119.9 152.73 22.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 122.514 0.326 . . . . 51.43 111.761 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.2 114.65 5.56 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 104.997 -2.223 . . . . 74.02 104.997 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.66 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 162.3 156.21 8.35 Favored Glycine 0 C--N 1.286 -2.222 0 N-CA-C 109.709 -1.356 . . . . 73.32 109.709 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.68 -174.81 20.88 Favored Glycine 0 CA--C 1.484 -1.873 0 N-CA-C 108.908 -1.677 . . . . 42.35 108.908 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 96.1 t -51.68 108.47 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 117.498 0.649 . . . . 44.2 111.673 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 91.37 -21.57 34.44 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.114 -0.948 . . . . 61.14 112.773 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.66 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 57.6 t30 -107.08 26.88 9.59 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.24 -0.652 . . . . 72.31 109.24 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -55.29 119.6 5.8 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.888 -0.596 . . . . 55.34 110.674 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -78.9 -41.5 29.52 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.304 -0.862 . . . . 44.14 109.865 -175.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 43.5 mm -103.91 123.36 41.31 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 108.918 -0.771 . . . . 63.44 108.918 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.95 105.39 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.161 2.574 . . . . 74.21 112.419 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.97 -5.14 28.93 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.477 -0.783 . . . . 32.32 111.935 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -129.29 99.46 5.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.766 0.793 . . . . 72.42 108.973 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 66.1 t30 -82.8 35.33 0.46 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.384 1.074 . . . . 71.41 111.458 -171.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.449 ' CB ' ' HE3' ' A' ' 370' ' ' LYS . 68.2 m -104.79 177.89 4.72 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 113.035 0.754 . . . . 71.05 113.035 -176.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.7 129.43 39.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.337 -0.847 . . . . 73.43 109.319 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 37.3 m-85 -124.26 136.73 54.36 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 113.47 0.915 . . . . 74.32 113.47 -177.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.424 HG21 HD21 ' A' ' 365' ' ' LEU . 60.4 t -71.65 117.2 14.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.688 -1.142 . . . . 74.41 108.51 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.4 m -106.28 -18.16 14.08 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.799 0.333 . . . . 52.21 111.581 -175.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.621 ' HG2' ' OE1' ' B' ' 148' ' ' GLU . 44.0 mmtm -149.89 154.95 39.17 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 108.609 -0.886 . . . . 72.14 108.609 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.427 ' CG2' ' HB2' ' A' ' 360' ' ' HIS . 57.0 mt -138.89 121.23 17.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 107.232 -1.395 . . . . 63.11 107.232 172.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 41.6 mm -86.0 133.15 30.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.385 -1.339 . . . . 71.24 107.385 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.43 144.83 56.64 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.627 -1.62 . . . . 73.24 106.627 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.47 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 92.08 -12.79 68.65 Favored Glycine 0 CA--C 1.475 -2.415 0 C-N-CA 119.36 -1.4 . . . . 55.15 110.672 178.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . 0.561 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -67.98 148.34 49.03 Favored Glycine 1 N--CA 1.396 -4.005 0 N-CA-C 108.716 -1.754 . . . . 71.41 108.716 172.722 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.48 77.08 Favored 'General case' 0 C--O 1.2 -1.532 0 N-CA-C 109.834 -0.432 . . . . 55.14 109.834 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.593 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -73.82 -11.74 60.47 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.671 -0.812 . . . . 74.22 112.486 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . 0.427 ' HB2' ' CG2' ' A' ' 353' ' ' ILE . 70.9 t60 -88.01 -43.95 11.35 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.423 -0.584 . . . . 70.54 109.423 177.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.47 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 73.4 mmtt -86.42 -57.83 2.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.143 0.973 . . . . 63.05 110.947 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . 0.517 ' OD2' ' HA ' ' A' ' 322' ' ' LEU . 35.2 t0 -81.75 -33.83 30.77 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 125.075 1.35 . . . . 74.43 109.38 -175.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.654 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -84.6 -16.91 65.03 Favored Glycine 0 C--N 1.289 -2.074 0 N-CA-C 117.37 1.708 . . . . 55.51 117.37 -169.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.654 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.31 34.23 0.49 Allowed 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 118.054 0.927 . . . . 65.21 112.619 -177.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . 0.424 HD21 HG21 ' A' ' 350' ' ' VAL . 33.0 tp -83.78 157.58 22.04 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.199 0.999 . . . . 60.05 111.453 -170.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -118.1 142.24 47.62 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.279 0.561 . . . . 62.21 111.414 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 84.3 mt -66.49 121.97 16.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 107.254 -1.387 . . . . 72.43 107.254 169.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 113.76 -1.72 24.56 Favored Glycine 0 C--N 1.309 -0.917 0 N-CA-C 110.936 -0.866 . . . . 63.33 110.936 -174.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.513 ' HB3' HG21 ' A' ' 402' ' ' VAL . 2.4 m-20 -73.14 138.32 45.69 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.265 0.469 . . . . 63.23 112.265 176.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 64.1 tttt -99.95 115.99 30.95 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.164 -0.925 . . . . 61.42 110.369 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 82.1 mt -82.13 112.94 19.63 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.455 -0.572 . . . . 71.33 109.455 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.5 tt -82.31 -37.36 25.89 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.079 -1.418 . . . . 61.55 107.343 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -162.85 157.45 21.34 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.057 -0.974 . . . . 72.12 109.122 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . 0.491 HG11 ' HG ' ' A' ' 391' ' ' LEU . 10.0 p -142.86 121.85 8.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-O 121.138 0.494 . . . . 65.1 109.704 174.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 66.9 t30 44.56 78.86 0.05 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 126.246 1.818 . . . . 72.55 111.745 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 65.94 -29.42 0.13 Allowed 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 114.681 1.364 . . . . 74.4 114.681 -175.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 28.2 t -83.96 124.56 39.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 O-C-N 121.471 -0.768 . . . . 74.42 110.969 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 11.6 p -75.19 132.5 41.18 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.789 -0.449 . . . . 73.12 109.789 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.8 mp -108.51 -4.67 17.05 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.067 0.766 . . . . 73.24 113.067 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -63.55 113.87 3.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.572 0.225 . . . . 62.4 111.376 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 59.57 39.91 20.93 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 122.807 1.289 . . . . 73.43 112.989 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 31.4 m -104.27 166.16 3.15 Favored 'Isoleucine or valine' 0 C--O 1.257 1.494 0 N-CA-C 106.644 -1.613 . . . . 72.13 106.644 171.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.54 ' HB ' ' OE1' ' A' ' 386' ' ' GLU . 0.4 OUTLIER -81.13 149.08 29.31 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 117.808 -1.557 . . . . 72.32 107.381 178.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . 0.604 ' O ' HG23 ' A' ' 388' ' ' VAL . 79.8 t60 -53.77 -27.92 31.64 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 114.32 1.23 . . . . 74.13 114.32 -172.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -65.87 -41.63 91.38 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 117.796 0.271 . . . . 74.12 110.293 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.54 ' OE1' ' HB ' ' A' ' 383' ' ' THR . 1.9 mp0 -68.38 -33.15 73.75 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 109.063 -0.718 . . . . 65.21 109.063 -177.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.575 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -64.96 -58.15 6.88 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.392 -1.276 . . . . 54.41 109.058 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 384' ' ' HIS . 40.6 t -54.58 -43.35 64.53 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 0 O-C-N 123.401 0.438 . . . . 74.14 110.146 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 93.1 m -59.17 -37.5 77.5 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.355 0.662 . . . . 55.21 111.911 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -68.51 -40.64 80.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.996 0.427 . . . . 72.43 110.077 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.575 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.1 mp -75.37 -19.95 59.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.201 0.524 . . . . 52.32 111.036 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.495 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 54.8 mttm -80.18 -41.53 25.1 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 113.429 0.9 . . . . 65.23 113.429 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -84.99 65.68 9.36 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.918 0.866 . . . . 72.23 111.427 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 1.3 p -145.01 148.92 34.28 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.565 -1.198 . . . . 74.52 109.296 177.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 22.0 m -145.37 120.28 9.98 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.841 -0.8 . . . . 61.01 108.841 178.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 56.1 0.98 0.06 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 127.381 2.272 . . . . 74.51 116.49 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . 0.438 ' HE2' ' CE2' ' A' ' 399' ' ' TYR . 6.0 t80 -158.73 125.12 4.62 Favored 'General case' 0 N--CA 1.437 -1.077 0 O-C-N 121.297 -0.877 . . . . 72.44 109.805 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.2 t -141.37 145.86 24.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.17 -1.048 . . . . 64.13 108.17 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.438 ' CE2' ' HE2' ' A' ' 397' ' ' PHE . 21.1 m-85 -115.22 97.35 6.15 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.053 -0.721 . . . . 65.21 109.053 172.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 8.0 tt -87.01 134.42 33.49 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 110.271 -0.27 . . . . 71.55 110.271 -177.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -121.83 108.19 13.18 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.494 -0.928 . . . . 70.31 108.494 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.513 HG21 ' HB3' ' A' ' 369' ' ' ASP . 7.3 p -116.37 151.99 18.13 Favored 'Isoleucine or valine' 0 C--O 1.268 2.055 0 CA-C-O 121.561 0.696 . . . . 74.44 111.225 -175.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.86 158.66 43.95 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 125.153 1.381 . . . . 72.42 108.089 176.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.533 0 N-CA-C 108.435 -0.95 . . . . 70.1 108.435 173.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . 0.439 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.402 -2.857 0 N-CA-C 108.361 -0.977 . . . . 72.13 108.361 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . 0.621 ' OE1' ' HG2' ' A' ' 352' ' ' LYS . 15.6 pt-20 -96.23 140.94 30.18 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 108.515 -0.92 . . . . 64.44 108.515 174.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 332' ' ' SER . 87.7 m -134.13 135.98 43.53 Favored 'General case' 0 C--N 1.282 -2.368 0 C-N-CA 120.745 -0.382 . . . . 62.4 111.625 -176.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -80.57 124.09 28.67 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.313 -0.995 . . . . 72.12 108.313 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 C--N 1.282 -2.337 0 N-CA-C 115.435 1.643 . . . . 73.04 115.435 -174.576 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 CA--C 1.492 -1.263 0 N-CA-C 106.721 -1.585 . . . . 61.13 106.721 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.405 2.0 pm0 -115.82 130.78 56.98 Favored 'General case' 0 C--N 1.266 -3.046 0 CA-C-O 122.784 1.278 . . . . 73.1 114.408 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 69.0 mt -122.54 112.98 36.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.456 0 CA-C-N 112.482 -2.144 . . . . 73.32 110.698 -169.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 321' ' ' LYS . 0.4 OUTLIER -73.57 127.71 33.5 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 106.982 -1.488 . . . . 73.31 106.982 171.356 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.572 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 98.3 mt -120.54 154.24 35.61 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.829 -1.175 . . . . 71.21 107.829 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 324' ' ' LYS . 47.0 mt -107.43 150.58 9.89 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.028 0 N-CA-C 106.448 -1.686 . . . . 71.33 106.448 171.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.516 ' O ' HG22 ' A' ' 323' ' ' ILE . 1.0 OUTLIER -76.26 178.67 6.28 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.07 -1.455 . . . . 73.22 107.07 173.103 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -164.93 -166.98 24.79 Favored Glycine 0 C--N 1.287 -2.193 0 C-N-CA 118.373 -1.87 . . . . 71.4 113.627 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.56 -35.23 23.35 Favored 'Trans proline' 0 C--O 1.213 -0.753 0 C-N-CA 123.772 2.982 . . . . 62.21 112.41 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.414 ' NZ ' ' HA3' ' A' ' 356' ' ' GLY . 44.4 mttp -99.8 19.76 15.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.349 -0.611 . . . . 65.4 109.349 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.65 -123.97 6.5 Favored Glycine 0 CA--C 1.485 -1.84 0 N-CA-C 107.992 -2.043 . . . . 65.35 107.992 -176.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.442 HD11 ' OG1' ' A' ' 394' ' ' THR . 9.4 mp -93.13 -29.03 15.96 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.265 -1.383 . . . . 63.51 107.265 174.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . 0.544 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 77.49 39.82 24.83 Favored Glycine 0 N--CA 1.427 -1.92 0 CA-C-N 113.512 -1.676 . . . . 53.33 114.414 172.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -143.59 149.88 38.02 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 119.941 -0.703 . . . . 75.42 109.919 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.604 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 9.9 m -105.52 127.41 53.0 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 115.413 -0.812 . . . . 75.1 110.18 -176.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 22.6 pt -115.8 143.72 25.08 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-N 115.314 -0.857 . . . . 73.45 110.305 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -130.13 114.64 15.98 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.771 -1.566 . . . . 63.42 106.771 175.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 167.75 166.23 26.48 Favored Glycine 0 N--CA 1.408 -3.171 0 N-CA-C 110.609 -0.996 . . . . 61.2 110.609 177.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.12 177.12 14.72 Favored Glycine 0 N--CA 1.411 -2.995 0 N-CA-C 106.933 -2.467 . . . . 70.54 106.933 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.45 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 56.7 t -56.6 99.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 117.858 0.829 . . . . 64.31 110.035 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.22 -10.92 69.55 Favored Glycine 0 N--CA 1.432 -1.594 0 CA-C-O 119.148 -0.807 . . . . 44.43 114.237 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.593 HD22 ' CD2' ' A' ' 384' ' ' HIS . 63.5 t30 -106.88 10.28 30.64 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 118.767 1.284 . . . . 43.41 109.252 175.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.459 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -53.95 122.48 10.18 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 114.462 1.282 . . . . 71.23 114.462 -178.397 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -66.87 -35.15 79.37 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.021 -1.445 . . . . 75.13 109.412 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.5 mm -104.89 120.02 51.45 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 115.68 -0.691 . . . . 70.14 109.649 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.83 109.03 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.765 2.31 . . . . 74.23 111.574 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.12 -14.84 28.39 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.576 -0.821 . . . . 73.11 111.961 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -119.49 98.03 5.94 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 106.887 -1.523 . . . . 71.42 106.887 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . 0.459 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 62.2 t30 -80.66 34.84 0.34 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.007 0.923 . . . . 72.13 112.531 -169.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 66.7 m -97.89 178.73 5.03 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.66 0.743 . . . . 75.43 112.751 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.514 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 18.2 mm -94.17 129.84 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 CA-C-N 114.777 -1.101 . . . . 54.51 108.062 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 30.1 m-85 -124.05 134.4 53.42 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 112.632 0.605 . . . . 63.23 112.632 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.69 111.65 3.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.022 -1.473 . . . . 73.15 107.022 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 45.6 m -106.97 -24.08 12.12 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.367 0.603 . . . . 71.23 111.965 -173.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.604 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 57.7 mttp -149.34 149.74 31.37 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.818 -1.178 . . . . 72.23 107.818 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 65.7 mt -128.87 120.77 52.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.395 -0.965 . . . . 73.33 108.395 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 31.2 mm -86.65 129.28 38.63 Favored 'Isoleucine or valine' 0 C--O 1.261 1.688 0 C-N-CA 123.34 0.656 . . . . 62.33 109.693 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.91 147.13 53.93 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 107.333 -1.358 . . . . 74.41 107.333 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . 0.579 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.51 -15.25 63.57 Favored Glycine 0 C--N 1.278 -2.659 0 N-CA-C 109.657 -1.377 . . . . 71.14 109.657 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . 0.544 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -72.05 139.04 27.68 Favored Glycine 1 N--CA 1.392 -4.255 0 N-CA-C 107.922 -2.071 . . . . 72.24 107.922 170.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -65.24 -25.38 67.65 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 109.48 -0.563 . . . . 61.25 109.48 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.659 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.87 -10.41 59.41 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 120.392 -0.523 . . . . 72.33 111.767 176.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -94.66 -35.24 12.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.125 -1.065 . . . . 72.4 108.125 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.579 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 75.5 mmtt -81.95 -58.56 2.92 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 120.125 -0.63 . . . . 73.42 111.173 -178.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -86.2 -35.12 20.26 Favored 'General case' 0 CA--C 1.472 -2.046 0 CA-C-O 122.028 0.918 . . . . 62.42 109.09 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.738 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -44.17 -29.22 1.54 Allowed Glycine 0 CA--C 1.487 -1.659 0 N-CA-C 119.924 2.729 . . . . 61.41 119.924 -165.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.738 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 39.98 34.75 0.2 Allowed 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 124.767 1.227 . . . . 65.12 111.92 -175.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 55.1 tp -107.03 153.55 22.43 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.597 -1.183 . . . . 74.11 109.362 -172.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -123.55 151.19 43.15 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.467 0.651 . . . . 73.23 112.18 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.14 125.76 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 108.1 -1.074 . . . . 74.21 108.1 172.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 114.99 -6.26 21.93 Favored Glycine 0 C--N 1.315 -0.623 0 C-N-CA 121.101 -0.571 . . . . 71.44 112.131 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.549 ' HB3' HG21 ' A' ' 402' ' ' VAL . 10.1 m-20 -75.02 137.09 41.27 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.208 0.818 . . . . 70.1 113.208 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.593 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 35.6 tttp -96.0 115.65 27.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.409 1.483 . . . . 75.32 109.477 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.408 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 68.1 mt -85.87 115.9 23.78 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.307 0.575 . . . . 62.55 110.224 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.1 tt -83.5 -37.77 22.66 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 113.692 -1.594 . . . . 74.21 107.273 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.81 155.86 21.94 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.157 -0.929 . . . . 75.1 109.467 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . 0.525 HG11 ' HG ' ' A' ' 391' ' ' LEU . 7.6 p -134.76 117.63 23.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 109.015 -0.735 . . . . 73.24 109.015 174.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 9.7 t30 44.91 74.79 0.12 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 125.836 1.655 . . . . 71.33 111.852 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 67.63 -23.57 0.12 Allowed 'General case' 0 CA--C 1.57 1.718 0 C-N-CA 125.386 1.474 . . . . 33.41 114.13 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 20.3 t -85.97 127.72 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 121.203 -0.936 . . . . 71.44 110.494 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -75.35 133.12 41.3 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 122.937 0.495 . . . . 75.54 110.833 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.435 HD21 HD11 ' A' ' 391' ' ' LEU . 7.9 mp -114.12 -4.7 13.11 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.899 1.074 . . . . 75.2 113.899 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -67.03 104.9 1.5 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.903 -0.406 . . . . 70.22 109.903 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 65.03 82.83 0.18 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.892 1.277 . . . . 73.52 113.812 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 20.6 m -143.42 163.88 15.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 106.156 -1.794 . . . . 34.23 106.156 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.9 m -79.81 149.07 31.15 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 119.17 0.895 . . . . 73.35 108.879 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . 0.593 ' CD2' HD22 ' A' ' 339' ' ' ASN . 45.2 t-80 -46.45 -48.44 18.95 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.231 0.826 . . . . 74.44 113.231 -174.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -60.84 -39.24 88.34 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.021 0.438 . . . . 63.15 110.447 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -69.29 -39.8 78.11 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.389 -0.967 . . . . 72.43 108.389 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.18 -58.3 7.68 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.354 -1.294 . . . . 62.41 110.257 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 384' ' ' HIS . 40.5 t -55.63 -40.36 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 123.464 0.477 . . . . 74.14 110.606 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 88.8 m -60.25 -38.05 82.31 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.389 -0.369 . . . . 52.14 111.813 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.28 86.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.67 0.272 . . . . 71.31 110.797 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.532 HD22 HG21 ' B' ' 151' ' ' VAL . 5.5 mp -77.83 -37.74 47.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.179 -0.608 . . . . 52.0 109.891 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 54.2 mttm -62.97 -31.79 72.98 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 113.642 0.978 . . . . 72.31 113.642 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -83.81 64.49 8.08 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.975 0.893 . . . . 74.14 111.67 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.446 ' HB ' HG22 ' A' ' 398' ' ' VAL . 13.3 p -132.36 153.91 50.29 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.77 -1.105 . . . . 72.1 109.288 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 41.8 m -143.77 96.73 2.95 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.429 1.109 . . . . 74.34 111.143 178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.509 ' HA ' ' H ' ' A' ' 324' ' ' LYS 0.4 9.0 m-20 57.57 6.06 0.38 Allowed 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 128.303 2.641 . . . . 71.35 118.063 172.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . 0.433 ' HE2' ' CZ ' ' A' ' 399' ' ' TYR . 31.2 t80 -156.31 127.75 7.14 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.004 -1.48 . . . . 64.22 107.004 171.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 24.1 t -138.69 142.82 33.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 123.269 0.627 . . . . 73.13 109.738 -174.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.433 ' CZ ' ' HE2' ' A' ' 397' ' ' PHE . 87.1 m-85 -111.6 96.41 6.07 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.837 -0.801 . . . . 73.32 108.837 172.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.505 HD13 HD11 ' A' ' 322' ' ' LEU . 6.6 tt -89.27 135.29 33.66 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.568 -0.707 . . . . 72.55 110.58 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -117.77 108.65 15.63 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.41 -0.959 . . . . 72.44 108.41 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 369' ' ' ASP . 3.6 p -113.77 151.86 15.54 Favored 'Isoleucine or valine' 0 C--O 1.266 1.935 0 CA-C-O 121.977 0.894 . . . . 64.44 110.842 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.593 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -135.28 157.91 45.7 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 104.362 -2.459 . . . . 71.41 104.362 174.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 62.1 mttm . . . . . 0 C--N 1.274 -2.69 0 C-N-CA 118.159 -1.417 . . . . 71.51 111.39 178.116 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 CA--C 1.486 -1.511 0 N-CA-C 107.717 -1.216 . . . . 71.32 107.717 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.58 150.3 21.28 Favored 'General case' 0 N--CA 1.408 -2.537 0 C-N-CA 118.616 -1.234 . . . . 72.31 107.804 162.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 332' ' ' SER . 97.2 m -132.23 132.04 42.7 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.38 -0.6 . . . . 73.33 109.38 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -74.16 131.59 41.42 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-N 115.608 -0.723 . . . . 72.02 110.65 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.532 HG21 HD22 ' A' ' 391' ' ' LEU . 45.4 t . . . . . 0 C--N 1.286 -2.193 0 CA-C-N 115.099 -0.955 . . . . 64.22 108.686 173.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . 0.498 ' HB3' ' O ' ' A' ' 402' ' ' VAL . 24.0 ttt . . . . . 0 C--O 1.193 -1.872 0 N-CA-C 105.814 -1.921 . . . . 73.51 105.814 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.355 2.0 pm0 -117.23 135.99 53.39 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 115.605 1.705 . . . . 74.14 115.605 -174.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 363' ' ' GLY . 91.4 mt -116.48 110.2 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.298 0 CA-C-N 112.637 -2.074 . . . . 72.01 108.98 -176.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.401 ' HE2' ' CZ ' ' A' ' 399' ' ' TYR . 38.7 ttmt -74.3 125.67 28.97 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.101 -1.444 . . . . 75.34 107.101 171.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.406 HD21 ' CA ' ' A' ' 363' ' ' GLY . 6.0 mt -122.91 149.39 44.3 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.107 -0.952 . . . . 63.13 110.518 -175.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 37.8 mm -106.55 114.62 46.21 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 109.064 -0.717 . . . . 74.03 109.064 173.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.759 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 8.7 tmtt? -64.82 152.94 41.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.216 -0.661 . . . . 74.33 109.216 173.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -143.42 -159.5 8.0 Favored Glycine 0 C--N 1.296 -1.646 0 C-N-CA 120.615 -0.802 . . . . 63.35 111.678 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.56 -12.71 27.15 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.947 2.431 . . . . 62.41 112.493 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.434 ' HD2' ' HA2' ' A' ' 357' ' ' GLY . 40.6 ttmt -103.58 5.02 36.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.168 0.985 . . . . 73.33 108.818 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.02 -114.6 3.92 Favored Glycine 0 CA--C 1.488 -1.632 0 N-CA-C 108.283 -1.927 . . . . 74.31 108.283 -176.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.503 ' HB2' HG23 ' B' ' 151' ' ' VAL . 5.3 mp -112.22 -35.55 5.59 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.829 -1.174 . . . . 75.31 107.829 173.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.43 50.59 3.98 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.194 -0.912 . . . . 74.4 115.218 172.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . 0.513 ' O ' HG22 ' B' ' 151' ' ' VAL . 25.7 p90 -154.73 144.5 21.58 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.076 0.465 . . . . 73.13 110.199 172.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 17.3 m -92.76 125.99 37.64 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.41 -0.813 . . . . 71.34 109.454 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.479 HD12 HG21 ' A' ' 348' ' ' ILE . 49.9 pt -113.09 144.18 21.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 108.502 -0.925 . . . . 70.43 108.502 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -138.83 131.66 29.29 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.753 -1.203 . . . . 74.32 107.753 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 144.77 164.12 10.41 Favored Glycine 0 C--N 1.28 -2.583 0 N-CA-C 109.606 -1.397 . . . . 61.15 109.606 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.09 177.16 14.76 Favored Glycine 0 CA--C 1.479 -2.206 0 N-CA-C 108.13 -1.988 . . . . 43.41 108.13 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 84.2 t -51.15 107.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 117.634 0.717 . . . . 62.44 110.954 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 91.34 -18.93 50.08 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.166 -0.925 . . . . 64.34 112.227 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.567 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 65.6 t30 -105.96 19.71 20.11 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.282 -0.636 . . . . 62.31 109.282 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.04 125.6 14.16 Favored 'General case' 0 C--O 1.251 1.167 0 CA-C-N 115.793 -0.64 . . . . 72.11 111.13 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -79.19 -49.11 13.07 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.127 -0.942 . . . . 75.41 109.768 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 55.7 mt -103.45 125.58 34.53 Favored Pre-proline 0 C--N 1.304 -1.407 0 CA-C-N 115.839 -0.619 . . . . 62.15 109.711 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -48.96 109.34 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 123.347 2.698 . . . . 73.13 112.638 177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 102.49 -2.24 49.81 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.387 -0.824 . . . . 43.55 112.265 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -128.93 96.89 4.47 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.747 -0.834 . . . . 63.4 108.747 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -83.07 33.03 0.44 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.927 0.87 . . . . 72.1 111.624 -171.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 56.7 m -98.96 178.08 5.05 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.798 -0.637 . . . . 61.5 111.933 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 9.1 mm -90.81 132.83 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.995 -1.113 . . . . 61.33 107.995 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 39.6 m-85 -125.17 138.69 54.14 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 112.725 0.639 . . . . 65.11 112.725 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 50.9 t -68.05 118.03 11.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.296 -1.002 . . . . 75.41 108.296 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 17.4 m -105.27 -26.15 12.14 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.065 0.46 . . . . 73.34 111.285 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -156.7 138.08 13.88 Favored 'General case' 0 C--O 1.2 -1.544 0 N-CA-C 107.198 -1.408 . . . . 73.14 107.198 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 73.6 mt -110.37 128.35 66.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.342 -1.355 . . . . 70.15 107.342 172.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 50.1 mm -73.95 134.62 29.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.143 0.497 . . . . 74.53 109.848 -175.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.541 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.5 pm0 -62.68 125.55 24.33 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 124.482 1.113 . . . . 73.13 110.915 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 74.37 17.96 79.81 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.581 -1.191 . . . . 53.51 110.949 -175.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . 0.434 ' HA2' ' HD2' ' A' ' 327' ' ' LYS . . . -76.76 160.37 50.39 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 111.512 -0.635 . . . . 75.23 111.512 175.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.06 94.49 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.519 -0.919 . . . . 50.0 108.519 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.484 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -74.64 -5.93 45.82 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.251 -0.431 . . . . 71.24 111.75 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -93.77 -33.96 13.39 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.575 -0.898 . . . . 75.14 108.575 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -91.25 -59.75 2.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 123.215 1.483 . . . . 73.21 109.838 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -87.13 -34.13 19.2 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 112.422 -2.172 . . . . 70.03 111.004 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -58.05 -33.64 70.01 Favored Glycine 0 C--O 1.199 -2.035 0 N-CA-C 117.453 1.741 . . . . 62.51 117.453 -174.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.656 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.62 33.34 0.45 Allowed 'General case' 0 N--CA 1.508 2.426 0 CA-C-N 118.457 1.129 . . . . 75.34 111.109 -173.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 58.9 tp -99.34 155.65 17.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.415 -1.266 . . . . 75.4 109.696 -171.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -117.07 146.42 43.12 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.111 0.481 . . . . 54.42 110.296 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.2 mt -66.22 120.82 14.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 107.506 -1.294 . . . . 71.2 107.506 171.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.44 -6.62 20.85 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 120.818 -0.706 . . . . 53.21 112.535 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.447 ' HB3' HG21 ' A' ' 402' ' ' VAL . 4.7 m-20 -75.39 142.36 43.1 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 112.712 0.634 . . . . 74.24 112.712 177.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.532 ' HD2' ' HB3' ' A' ' 403' ' ' ALA . 9.2 ttmm -88.36 122.47 31.91 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 123.315 0.646 . . . . 73.22 110.02 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 3.5 mp -81.15 104.98 12.01 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.334 -1.728 . . . . 74.54 106.334 174.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 403' ' ' ALA . 5.7 tt -80.24 -37.74 32.38 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.053 -1.462 . . . . 63.13 107.053 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 401' ' ' LYS . . . -160.98 157.66 26.7 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.371 -0.831 . . . . 70.21 110.513 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . 0.437 HG21 ' HG ' ' A' ' 391' ' ' LEU . 14.6 p -133.42 127.53 53.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.929 -1.137 . . . . 61.31 107.929 173.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 63.67 31.55 14.39 Favored 'General case' 0 C--O 1.206 -1.221 0 CA-C-O 124.011 1.862 . . . . 71.25 107.739 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 65.86 4.49 2.98 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 111.211 -2.722 . . . . 74.44 113.938 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 46.4 t -80.23 123.12 36.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.06 -1.089 . . . . 62.24 108.06 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.5 p -58.98 122.92 14.89 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.719 1.007 . . . . 75.14 113.719 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.42 -1.97 20.98 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 124.434 1.094 . . . . 64.51 111.356 177.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -64.77 108.53 1.76 Allowed 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.554 -0.536 . . . . 73.45 109.554 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 61.78 71.07 0.56 Allowed 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 122.527 1.156 . . . . 75.43 112.909 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.0 168.77 23.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 106.989 -1.486 . . . . 74.21 106.989 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.7 m -76.52 139.33 40.71 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.559 -0.904 . . . . 72.42 108.559 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . 0.607 ' O ' HG23 ' A' ' 388' ' ' VAL . 84.8 t60 -48.42 -48.82 36.91 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.77 0.655 . . . . 73.4 112.77 -175.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -59.54 -42.58 92.65 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.936 -0.765 . . . . 75.02 108.936 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 383' ' ' THR . 49.3 tt0 -67.71 -32.44 73.08 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.213 -1.358 . . . . 71.01 109.115 -174.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.533 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -73.78 -50.51 20.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.828 -1.078 . . . . 32.25 110.289 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 384' ' ' HIS . 15.8 t -59.62 -46.99 92.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 109.819 -0.437 . . . . 71.44 109.819 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 42.7 m -62.78 -29.97 71.11 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.553 -0.748 . . . . 72.54 112.164 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.94 -34.53 78.33 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.124 -0.36 . . . . 71.35 110.248 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.5 mp -79.03 -33.61 44.62 Favored 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 120.253 -0.579 . . . . 73.12 110.738 176.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.443 ' HE2' HG12 ' A' ' 388' ' ' VAL . 62.0 mttm -67.23 -29.32 68.93 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.413 0.523 . . . . 72.54 112.413 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -80.21 48.14 0.97 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.44 0.638 . . . . 54.44 112.156 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.42 ' HB ' HG22 ' A' ' 398' ' ' VAL . 32.4 p -124.54 146.93 48.72 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.311 -0.996 . . . . 70.12 108.311 176.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.6 t -141.04 98.69 3.43 Favored 'General case' 0 N--CA 1.409 -2.509 0 C-N-CA 117.711 -1.596 . . . . 65.42 110.935 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.759 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 6.2 m-20 65.63 16.13 10.36 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 110.89 -2.868 . . . . 63.11 112.951 166.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -161.65 115.54 1.92 Allowed 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.471 -1.307 . . . . 73.21 107.471 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 394' ' ' THR . 28.8 t -133.74 151.04 32.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 123.034 0.534 . . . . 65.21 110.518 -175.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.401 ' CZ ' ' HE2' ' A' ' 321' ' ' LYS . 29.4 m-85 -126.24 99.79 6.03 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.723 -1.214 . . . . 63.12 107.723 171.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.2 tt -91.75 119.5 31.64 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.525 -1.287 . . . . 62.35 107.525 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 373' ' ' ALA . 24.0 ttmm -103.64 107.89 18.93 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.693 -1.225 . . . . 74.25 107.693 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.498 ' O ' ' HB3' ' A' ' 318' ' ' MET . 1.9 p -107.58 149.99 10.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 CA-C-O 121.744 0.783 . . . . 71.12 110.498 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.585 ' HB2' HD12 ' A' ' 372' ' ' LEU . . . -136.52 159.6 41.31 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.82 -1.082 . . . . 70.05 108.14 176.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . 0.421 ' HA ' ' HE3' ' A' ' 404' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.609 0 N-CA-C 109.079 -0.712 . . . . 51.22 109.079 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 CA--C 1.497 -1.094 0 N-CA-C 109.063 -0.717 . . . . 70.42 109.063 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.36 165.11 12.73 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.507 -0.923 . . . . 65.45 108.507 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 27.6 m -147.14 129.06 15.39 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.409 -0.589 . . . . 74.22 109.409 170.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 41.6 tt0 -71.14 131.27 43.32 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-O 121.088 0.471 . . . . 70.42 110.771 175.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 331' ' ' PHE . 17.4 m . . . . . 0 C--N 1.301 -1.527 0 CA-C-O 116.786 -1.578 . . . . 70.03 111.627 176.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 64.4 ttp . . . . . 0 CA--C 1.5 -0.951 0 N-CA-C 107.451 -1.314 . . . . 71.21 107.451 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.297 1.6 pm0 -89.88 133.22 34.87 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 114.514 1.302 . . . . 72.42 114.514 -177.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 77.9 mt -120.16 114.95 45.75 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.677 0 CA-C-N 112.135 -2.302 . . . . 74.55 108.789 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -81.43 121.29 26.06 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.235 -1.024 . . . . 73.24 108.235 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.546 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 95.5 mt -118.4 150.06 40.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 124.363 1.039 . . . . 61.22 108.807 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 42.9 mm -106.37 116.75 50.78 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 N-CA-C 109.286 -0.635 . . . . 72.21 109.286 173.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 396' ' ' ASP . 12.1 tmtt? -71.13 153.63 42.37 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 107.707 -1.22 . . . . 74.43 107.707 171.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.415 ' O ' ' HE2' ' A' ' 324' ' ' LYS . . . -153.05 -154.94 6.91 Favored Glycine 0 C--N 1.302 -1.321 0 C-N-CA 119.625 -1.274 . . . . 41.5 113.291 -174.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.86 -22.59 36.2 Favored 'Trans proline' 0 C--O 1.217 -0.558 0 C-N-CA 123.165 2.577 . . . . 72.11 113.939 -175.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -106.07 20.57 18.74 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 122.224 1.011 . . . . 64.53 108.618 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.71 -133.61 11.96 Favored Glycine 0 CA--C 1.477 -2.298 0 CA-C-N 114.034 -1.439 . . . . 62.02 109.649 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 329' ' ' LEU . 14.6 tp -109.26 -34.96 6.41 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 106.903 -1.517 . . . . 62.34 106.903 175.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . 0.527 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 86.32 47.18 5.02 Favored Glycine 0 N--CA 1.429 -1.822 0 CA-C-N 113.746 -1.57 . . . . 53.04 116.72 171.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -152.48 150.19 29.35 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 117.928 0.864 . . . . 74.55 112.23 169.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 6.5 m -104.71 129.34 52.93 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.197 -0.91 . . . . 53.12 109.263 -177.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.427 HD11 ' HA ' ' A' ' 388' ' ' VAL . 47.9 pt -113.75 150.96 15.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 115.544 -0.753 . . . . 54.24 108.994 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . 0.489 ' HA ' ' CE1' ' A' ' 384' ' ' HIS . . . -146.3 130.68 17.64 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.343 -1.354 . . . . 44.31 107.343 175.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 145.05 160.24 8.46 Favored Glycine 0 C--N 1.283 -2.372 0 N-CA-C 110.705 -0.958 . . . . 71.31 110.705 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.9 -175.26 20.69 Favored Glycine 0 N--CA 1.424 -2.122 0 N-CA-C 108.253 -1.939 . . . . 64.45 108.253 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 91.0 t -51.07 105.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 O-C-N 124.358 0.681 . . . . 73.05 111.392 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 87.38 -14.92 56.65 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.449 -0.796 . . . . 64.32 112.74 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.522 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -105.41 12.72 31.22 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.873 -1.158 . . . . 71.42 107.873 -177.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.502 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -53.31 126.65 21.89 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.614 0.766 . . . . 61.44 111.749 -176.476 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . 0.556 ' HB3' ' CD2' ' A' ' 349' ' ' TYR . 15.7 t60 -86.64 -38.0 17.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.63 -0.714 . . . . 75.32 110.003 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 37.9 mm -102.62 118.78 57.77 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 109.929 -0.397 . . . . 74.32 109.929 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.07 110.62 0.46 Allowed 'Trans proline' 0 C--O 1.252 1.183 0 C-N-CA 123.093 2.529 . . . . 70.32 111.411 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 108.29 -5.62 33.79 Favored Glycine 0 N--CA 1.429 -1.814 0 CA-C-N 115.143 -0.935 . . . . 64.55 112.159 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . 0.414 ' HB3' ' OH ' ' A' ' 349' ' ' TYR . 40.4 t0 -131.67 104.33 6.87 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.183 -0.673 . . . . 61.43 109.183 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . 0.502 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 66.3 t30 -83.92 37.91 0.62 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.282 1.039 . . . . 65.14 110.612 -173.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 50.1 m -103.95 177.65 4.78 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.96 -1.018 . . . . 74.42 112.235 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.418 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.5 mm -93.16 138.6 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.428 -0.953 . . . . 73.11 108.428 -177.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.556 ' CD2' ' HB3' ' A' ' 341' ' ' HIS . 95.8 m-85 -129.84 141.86 50.76 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 112.309 0.485 . . . . 35.52 112.309 -178.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 56.8 t -74.37 115.5 15.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 107.747 -1.205 . . . . 73.44 107.747 175.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.9 m -98.85 -24.2 15.08 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 121.388 0.613 . . . . 73.11 110.473 -175.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 332' ' ' SER . 33.3 ttmt -158.8 150.13 20.58 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 107.801 -1.185 . . . . 74.33 107.801 -173.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 60.1 mt -130.7 116.26 34.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 107.08 -1.452 . . . . 74.24 107.08 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 46.2 mm -84.99 124.68 40.13 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 C-N-CA 123.481 0.712 . . . . 73.13 110.491 -171.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.496 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 0.6 OUTLIER -60.53 147.26 42.05 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.873 -0.788 . . . . 72.53 108.873 -177.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 94.2 -24.63 26.12 Favored Glycine 0 CA--C 1.478 -2.265 0 N-CA-C 109.486 -1.446 . . . . 71.32 109.486 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . 0.527 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -68.53 142.86 39.52 Favored Glycine 1 N--CA 1.395 -4.053 0 N-CA-C 108.0 -2.04 . . . . 41.05 108.0 172.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 362' ' ' ASP . . . -63.87 -32.56 74.13 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.296 -0.631 . . . . 74.44 109.296 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.637 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.11 -4.62 39.71 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 120.7 -0.4 . . . . 73.32 111.744 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . 0.496 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 17.1 t60 -94.68 -49.2 5.73 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.694 -0.854 . . . . 73.01 108.694 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -79.27 -50.42 10.94 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.386 -0.825 . . . . 70.33 111.928 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . 0.659 ' O ' ' HE2' ' A' ' 364' ' ' LYS . 11.4 t70 -85.76 -34.89 21.06 Favored 'General case' 0 CA--C 1.465 -2.303 0 C-N-CA 124.085 0.954 . . . . 75.33 109.888 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -42.39 -25.64 0.3 Allowed Glycine 0 CA--C 1.486 -1.763 0 N-CA-C 119.96 2.744 . . . . 64.53 119.96 -161.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.659 ' HE2' ' O ' ' A' ' 362' ' ' ASP . 0.0 OUTLIER 47.03 31.16 1.46 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.356 1.078 . . . . 70.11 111.069 178.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 48.6 tp -113.6 150.87 32.47 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 114.597 -1.183 . . . . 64.45 109.336 -170.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -122.88 148.44 45.43 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.388 0.614 . . . . 73.52 111.186 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.6 mt -65.97 126.05 24.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.272 -1.01 . . . . 65.43 108.272 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.64 -18.6 14.97 Favored Glycine 0 C--N 1.313 -0.748 0 N-CA-C 111.645 -0.582 . . . . 55.23 111.645 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -62.93 130.84 46.53 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-O 121.16 0.505 . . . . 72.01 111.827 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.546 ' HB2' ' CE1' ' A' ' 349' ' ' TYR . 50.9 tttt -88.84 127.01 35.62 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.562 -0.745 . . . . 65.24 110.581 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 3.3 mp -81.3 107.03 13.74 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.891 -1.522 . . . . 74.11 106.891 177.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' A' ' 403' ' ' ALA . 3.4 tt -80.31 -43.31 21.47 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 106.273 -1.751 . . . . 53.41 106.273 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -157.45 154.56 28.95 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.075 -0.966 . . . . 62.34 110.1 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.77 120.6 42.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 108.525 -0.917 . . . . 71.33 108.525 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . 0.496 HD21 HG22 ' A' ' 394' ' ' THR . 81.5 m-20 63.51 30.51 15.17 Favored 'General case' 0 CA--C 1.484 -1.574 0 CA-C-O 123.978 1.847 . . . . 71.11 108.321 -174.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.9 t30 66.57 16.15 10.32 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 109.793 -3.367 . . . . 74.44 112.605 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.88 124.36 39.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 106.271 -1.752 . . . . 71.52 106.271 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.9 p -65.08 125.36 24.69 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.893 0.701 . . . . 72.35 112.893 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.21 5.94 28.19 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 123.809 0.843 . . . . 64.33 111.108 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.453 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 28.4 mm-40 -68.48 111.66 4.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.227 -0.657 . . . . 73.15 109.227 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 56.09 67.9 0.94 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.572 1.177 . . . . 72.53 113.22 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.72 167.63 23.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 107.112 -1.44 . . . . 53.34 107.112 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.477 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.6 m -74.89 142.41 44.06 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.29 -1.004 . . . . 74.12 108.29 -177.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . 0.626 ' O ' HG23 ' A' ' 388' ' ' VAL . 86.3 t60 -52.93 -49.38 66.13 Favored 'General case' 0 C--O 1.213 -0.843 0 N-CA-C 112.252 0.464 . . . . 64.3 112.252 -176.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -61.64 -30.34 70.64 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.447 0.641 . . . . 73.11 111.435 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.5 tt0 -75.01 -35.74 61.96 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.044 -0.98 . . . . 75.03 108.426 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -75.09 -38.84 61.09 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.059 -0.973 . . . . 55.43 110.585 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 384' ' ' HIS . 11.7 t -65.08 -42.33 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 109.011 -0.737 . . . . 64.15 109.011 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 60.9 m -60.32 -40.79 91.85 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 123.417 0.448 . . . . 72.45 110.08 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -62.26 -35.43 78.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.628 -0.26 . . . . 62.41 111.479 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.473 ' HG ' HG11 ' B' ' 151' ' ' VAL . 57.4 tp -82.34 -22.75 35.4 Favored 'General case' 0 N--CA 1.394 -3.272 0 C-N-CA 122.823 0.449 . . . . 74.13 109.904 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 61.1 mttm -77.96 -21.63 50.7 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 120.869 0.366 . . . . 54.52 111.033 176.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -76.18 47.37 0.45 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.498 -0.774 . . . . 73.31 110.411 174.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.496 HG22 HD21 ' A' ' 375' ' ' ASN . 22.5 p -124.61 133.55 53.23 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.087 -1.079 . . . . 73.4 108.087 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . 0.528 ' HA ' ' HD2' ' A' ' 324' ' ' LYS . 50.8 m -139.15 97.73 3.36 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.814 -1.154 . . . . 63.33 111.798 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.62 ' HA ' ' O ' ' A' ' 324' ' ' LYS . 5.8 m-20 60.68 18.57 8.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 111.415 -2.63 . . . . 64.43 112.816 171.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -166.69 130.13 1.93 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.389 -1.278 . . . . 71.41 107.567 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.482 HG22 ' HB ' ' A' ' 394' ' ' THR . 22.0 t -145.24 143.43 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 122.832 0.453 . . . . 75.14 111.086 -176.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -117.04 96.78 5.61 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.378 -0.971 . . . . 63.24 108.378 167.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.89 113.95 25.74 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.97 -0.752 . . . . 72.1 108.97 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -93.06 109.7 21.18 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.546 -1.279 . . . . 74.33 107.546 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 69.2 t -104.49 148.18 9.51 Favored 'Isoleucine or valine' 0 C--O 1.258 1.551 0 CA-C-O 121.368 0.604 . . . . 72.13 110.091 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.545 ' HB2' HD12 ' A' ' 372' ' ' LEU . . . -136.25 158.94 43.22 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 125.083 1.353 . . . . 43.32 107.543 176.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.293 -1.851 0 N-CA-C 107.826 -1.175 . . . . 71.11 107.826 173.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 CA--C 1.497 -1.084 0 N-CA-C 108.52 -0.919 . . . . 62.3 108.52 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -92.21 149.97 21.16 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.393 -0.966 . . . . 73.32 108.393 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 20.1 m -134.8 129.76 35.06 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.204 -0.665 . . . . 64.13 109.204 174.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 50.2 tt0 -85.29 139.98 31.18 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 112.631 0.604 . . . . 64.42 112.631 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.473 HG11 ' HG ' ' A' ' 391' ' ' LEU . 51.0 t . . . . . 0 C--N 1.312 -1.04 0 N-CA-C 106.641 -1.614 . . . . 74.45 106.641 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . 0.417 ' HB2' HG13 ' A' ' 402' ' ' VAL . 0.4 OUTLIER . . . . . 0 CA--C 1.487 -1.479 0 N-CA-C 108.93 -0.767 . . . . 75.15 108.93 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -132.84 121.19 22.56 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 108.171 -1.048 . . . . 71.24 108.171 171.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 64.5 mt -98.1 105.75 17.71 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.033 0 CA-C-N 114.275 -1.33 . . . . 72.23 108.531 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -89.24 102.43 15.09 Favored 'General case' 0 N--CA 1.38 -3.971 0 N-CA-C 105.105 -2.183 . . . . 74.22 105.105 169.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.457 ' HA ' ' OD2' ' A' ' 362' ' ' ASP . 0.5 OUTLIER -106.31 138.83 41.79 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 112.486 -2.143 . . . . 63.13 108.092 -170.15 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 25.8 mm -98.53 114.83 37.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 CA-C-O 121.344 0.593 . . . . 70.5 110.161 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -75.3 148.7 39.13 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.425 -0.807 . . . . 73.43 110.3 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -135.38 -161.09 9.2 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.857 -0.687 . . . . 75.14 111.86 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.64 -16.59 33.87 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.041 2.494 . . . . 75.41 113.333 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -101.66 10.23 40.33 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.318 1.056 . . . . 61.4 108.633 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.77 -128.67 8.7 Favored Glycine 0 CA--C 1.478 -2.234 0 CA-C-N 114.3 -1.318 . . . . 72.23 110.741 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.444 HD13 HG12 ' B' ' 151' ' ' VAL . 5.3 mp -101.35 -44.65 5.57 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 105.918 -1.882 . . . . 75.33 105.918 174.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 80.36 49.37 5.89 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 114.852 -1.067 . . . . 73.22 114.514 172.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -151.41 147.74 27.25 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.842 -0.429 . . . . 72.22 109.842 174.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 4.2 m -97.93 124.59 42.44 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 108.436 -0.95 . . . . 72.4 108.436 -176.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 46.4 pt -113.48 153.09 15.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 108.611 -0.885 . . . . 53.52 108.611 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.92 129.35 15.85 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.077 -0.712 . . . . 71.15 109.077 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 152.35 165.55 13.33 Favored Glycine 0 C--N 1.282 -2.433 0 N-CA-C 110.208 -1.157 . . . . 61.31 110.208 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 136.69 -176.83 20.14 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 107.663 -2.175 . . . . 72.54 107.663 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.403 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 58.6 t -54.32 100.5 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.249 1.042 0 CA-C-O 122.096 0.951 . . . . 75.02 112.495 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 80.84 4.49 90.39 Favored Glycine 0 C--O 1.21 -1.404 0 CA-C-N 115.121 -0.945 . . . . 52.41 112.002 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.504 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -106.46 11.66 30.5 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.782 -1.562 . . . . 74.41 106.782 178.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -49.8 122.67 6.79 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.839 1.256 . . . . 72.13 112.701 -175.633 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -79.27 -38.52 35.24 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.307 -0.86 . . . . 73.13 109.572 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.6 123.97 38.54 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 108.564 -0.902 . . . . 65.23 108.564 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.36 107.51 0.21 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.971 2.447 . . . . 63.1 112.293 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.89 -8.97 29.66 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-N 115.26 -0.882 . . . . 75.41 112.591 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -125.22 106.94 10.25 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.39 -0.924 . . . . 71.0 110.288 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 61.9 t30 -80.37 28.19 0.32 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.734 1.214 . . . . 73.15 111.747 -171.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.635 ' OG ' ' HE2' ' A' ' 370' ' ' LYS . 24.9 m -99.28 175.63 5.81 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.841 -0.618 . . . . 61.44 112.134 -175.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.564 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 6.0 mm -89.72 132.2 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 108.016 -1.105 . . . . 73.44 108.016 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.596 ' CE2' ' HB2' ' A' ' 370' ' ' LYS . 68.0 m-85 -128.01 149.57 50.3 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.948 0.404 . . . . 72.24 111.868 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.69 123.72 32.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.482 -0.933 . . . . 74.42 108.482 175.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 33.2 m -108.11 -28.47 9.5 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.932 0.396 . . . . 54.35 111.474 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 50.9 mtmt -152.27 151.96 31.58 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.862 -0.792 . . . . 73.54 108.862 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.438 HG22 ' HB2' ' A' ' 360' ' ' HIS . 68.4 mt -129.41 121.98 54.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.623 -1.621 . . . . 74.24 106.623 174.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 50.0 mm -78.16 142.01 14.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 123.408 0.683 . . . . 75.45 112.173 -170.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.98 122.64 12.78 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.698 1.199 . . . . 75.24 112.28 -174.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 72.31 12.25 76.39 Favored Glycine 0 C--N 1.306 -1.087 0 CA-C-N 115.605 -0.725 . . . . 54.44 112.966 177.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -74.27 164.26 54.65 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 110.735 -0.946 . . . . 62.14 110.735 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.53 98.08 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.172 -0.677 . . . . 65.41 109.172 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.575 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.58 -4.6 40.91 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.134 -0.485 . . . . 63.13 112.015 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . 0.438 ' HB2' HG22 ' A' ' 353' ' ' ILE . 15.1 t60 -94.11 -32.69 13.66 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.849 -0.797 . . . . 75.34 108.849 176.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -95.8 -58.17 2.17 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.997 -0.681 . . . . 74.03 112.332 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . 0.457 ' OD2' ' HA ' ' A' ' 322' ' ' LEU . 27.7 t70 -86.18 -21.97 27.22 Favored 'General case' 0 CA--C 1.473 -2.019 0 CA-C-N 115.726 -0.67 . . . . 41.41 110.366 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -43.0 -34.9 2.13 Favored Glycine 0 CA--C 1.479 -2.172 0 CA-C-O 117.751 -1.583 . . . . 33.41 116.144 -172.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? 42.8 40.37 2.07 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.937 0.875 . . . . 60.41 110.15 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 60.3 tp -133.45 154.39 50.83 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 113.588 -1.642 . . . . 73.23 108.977 -167.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -122.66 152.33 40.62 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.736 0.779 . . . . 73.35 111.141 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.7 mt -65.71 123.68 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 108.024 -1.102 . . . . 60.42 108.024 174.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.17 -6.16 21.58 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.684 -0.769 . . . . 50.35 112.342 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.428 ' HB3' HG21 ' A' ' 402' ' ' VAL . 13.5 m-20 -74.23 141.62 45.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.026 0.75 . . . . 60.04 113.026 177.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.647 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 47.1 tttm -96.08 118.43 32.65 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 123.978 0.911 . . . . 63.44 110.31 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.475 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 3.0 mp -78.85 114.46 17.8 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.674 -1.232 . . . . 73.51 107.674 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.53 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 5.7 tt -86.84 -43.01 12.8 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.943 -1.132 . . . . 72.52 107.943 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -157.2 150.64 24.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.046 -0.524 . . . . 63.32 111.024 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 9.8 p -133.59 123.8 46.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 109.006 -0.739 . . . . 62.32 109.006 173.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . 0.583 HD21 HG22 ' A' ' 394' ' ' THR . 92.7 m-20 60.95 31.86 19.96 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-O 124.145 1.926 . . . . 75.41 109.536 -173.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 67.23 12.36 8.9 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 109.08 -3.691 . . . . 73.25 112.903 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 54.9 t -82.29 125.3 39.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 106.697 -1.594 . . . . 73.42 106.697 173.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.8 p -66.74 126.55 29.36 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 123.61 0.569 . . . . 73.53 112.267 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.02 6.07 30.88 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.714 0.806 . . . . 53.33 110.725 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . 0.53 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 13.6 mm-40 -70.81 107.43 3.99 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.217 -0.901 . . . . 74.41 109.253 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 57.8 71.59 0.57 Allowed 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.371 1.081 . . . . 73.11 113.36 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.69 172.53 15.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.023 -1.473 . . . . 44.04 107.023 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 81.0 p -81.23 146.69 30.33 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.066 -1.054 . . . . 61.34 108.769 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -52.33 -31.45 33.32 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 112.937 0.717 . . . . 62.32 112.937 -176.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -64.5 -40.85 96.42 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-O 120.625 0.25 . . . . 61.51 110.875 177.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.62 -40.22 80.44 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.637 -0.875 . . . . 71.14 108.637 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.425 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -62.42 -59.04 5.54 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.5 -1.227 . . . . 73.11 110.629 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 392' ' ' LYS . 90.4 t -57.3 -44.91 84.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 O-C-N 123.212 0.32 . . . . 73.1 111.546 -177.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 55.4 m -60.65 -34.12 73.82 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 111.927 0.343 . . . . 71.24 111.927 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.8 77.88 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 110.277 -0.268 . . . . 64.42 110.277 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.9 mp -79.28 -28.73 42.32 Favored 'General case' 0 C--O 1.218 -0.57 0 C-N-CA 120.339 -0.544 . . . . 64.44 110.792 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 388' ' ' VAL . 73.0 mmtt -61.94 -41.61 98.17 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 120.608 0.242 . . . . 73.33 111.014 176.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -77.46 70.7 3.88 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 122.561 1.172 . . . . 74.14 111.021 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.583 HG22 HD21 ' A' ' 375' ' ' ASN . 12.9 p -142.45 155.46 45.08 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 113.241 -1.8 . . . . 65.32 108.561 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 32.5 p -166.45 115.81 0.92 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.591 -0.522 . . . . 61.32 109.591 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.8 t70 64.39 0.07 1.0 Allowed 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 125.365 1.466 . . . . 74.44 112.043 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -163.48 137.87 6.04 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.532 -0.914 . . . . 72.53 108.532 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 48.0 t -139.51 120.62 15.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 106.437 -1.69 . . . . 71.53 106.437 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.22 95.13 5.76 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.134 -1.432 . . . . 61.21 107.134 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.4 tt -108.94 111.12 22.63 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-O 121.038 0.447 . . . . 73.32 110.439 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.24 121.25 30.43 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.013 -1.106 . . . . 54.11 108.013 176.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 369' ' ' ASP . 2.1 p -115.9 137.33 49.92 Favored 'Isoleucine or valine' 0 C--O 1.258 1.534 0 C-N-CA 123.578 0.751 . . . . 74.02 110.045 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.647 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.48 158.72 43.77 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.364 -0.976 . . . . 33.33 108.364 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.294 -1.811 0 N-CA-C 108.723 -0.843 . . . . 53.11 108.723 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . 0.571 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.594 0 N-CA-C 107.991 -1.114 . . . . 62.41 107.991 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.42 152.3 19.79 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 123.427 0.454 . . . . 63.24 112.208 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 41.9 m -142.51 141.82 32.15 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.886 -0.509 . . . . 75.01 109.862 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -77.16 152.99 34.62 Favored 'General case' 0 CA--C 1.462 -2.44 0 C-N-CA 123.918 0.887 . . . . 73.41 113.193 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.444 HG12 HD13 ' A' ' 329' ' ' LEU . 6.6 t . . . . . 0 N--CA 1.392 -3.354 0 C-N-CA 118.37 -1.332 . . . . 63.22 110.847 169.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 53.6 ttm . . . . . 0 C--O 1.205 -1.256 0 N-CA-C 106.107 -1.812 . . . . 64.23 106.107 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.428 1.9 pm0 -114.59 130.89 56.82 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 116.787 2.143 . . . . 60.13 116.787 -173.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.489 HG23 ' HD3' ' A' ' 364' ' ' LYS . 72.5 mt -111.88 112.66 41.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-N 111.573 -2.558 . . . . 70.01 108.83 -176.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . 0.639 ' HD3' ' CE1' ' A' ' 399' ' ' TYR . 30.6 ttpt -82.97 125.08 31.01 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.42 -0.955 . . . . 72.32 108.42 173.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.567 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 96.3 mt -119.29 154.06 34.08 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 124.904 1.377 . . . . 73.23 108.762 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 396' ' ' ASP . 49.5 mt -106.44 145.55 14.06 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.121 0 N-CA-C 106.467 -1.679 . . . . 64.42 106.467 169.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.537 ' H ' ' HA ' ' A' ' 396' ' ' ASP . 1.3 ttpm? -75.26 177.81 6.25 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.732 -1.211 . . . . 72.05 107.732 177.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . 0.465 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -160.78 -167.91 21.93 Favored Glycine 0 C--N 1.289 -2.067 0 C-N-CA 119.949 -1.119 . . . . 63.11 111.665 -177.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.27 -29.23 32.58 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 123.166 2.578 . . . . 75.31 112.405 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -106.39 25.29 11.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.241 0.543 . . . . 71.4 110.041 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.99 -125.52 7.13 Favored Glycine 0 CA--C 1.485 -1.793 0 N-CA-C 109.442 -1.463 . . . . 62.13 109.442 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.423 ' HB2' HG23 ' B' ' 151' ' ' VAL . 5.7 mp -97.49 -30.84 12.66 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.288 -1.745 . . . . 62.21 106.288 173.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 85.99 48.7 4.54 Favored Glycine 0 N--CA 1.429 -1.798 0 CA-C-N 114.057 -1.429 . . . . 75.55 115.041 173.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 55.5 p90 -153.23 166.43 32.58 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.504 -0.554 . . . . 72.32 109.504 172.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 9.5 m -117.9 136.78 53.24 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 120.597 -0.441 . . . . 74.03 110.18 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.0 pt -119.06 152.46 21.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 122.496 0.319 . . . . 45.02 110.948 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -141.73 135.05 29.4 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.106 -1.813 . . . . 44.03 106.106 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 144.59 156.54 6.86 Favored Glycine 0 C--N 1.277 -2.696 0 N-CA-C 109.53 -1.428 . . . . 64.01 109.53 -176.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.23 178.5 15.61 Favored Glycine 0 C--N 1.281 -2.519 0 N-CA-C 107.321 -2.311 . . . . 54.24 107.321 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.458 ' HA ' HD21 ' A' ' 346' ' ' ASN . 83.6 t -45.48 106.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 117.839 0.82 . . . . 72.3 111.994 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 84.91 -13.56 53.17 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.216 -0.902 . . . . 54.53 112.499 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.48 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 63.2 t30 -105.23 21.15 17.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.012 -0.736 . . . . 64.35 109.012 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.07 121.48 5.51 Favored 'General case' 0 C--O 1.256 1.436 0 CA-C-N 115.116 -0.947 . . . . 74.33 110.467 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -79.39 -43.4 23.49 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.11 -0.95 . . . . 73.13 108.734 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 37.4 mm -103.24 129.89 24.66 Favored Pre-proline 0 C--N 1.301 -1.503 0 CA-C-N 115.053 -0.976 . . . . 75.51 109.018 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.57 110.14 0.46 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 123.27 2.647 . . . . 71.22 113.292 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 97.83 -6.36 62.38 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.556 -0.747 . . . . 71.04 112.468 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -121.24 98.61 6.06 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.392 -0.966 . . . . 71.45 108.392 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . 0.458 HD21 ' HA ' ' A' ' 337' ' ' VAL . 51.5 t30 -81.66 26.87 0.47 Allowed 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 124.362 1.065 . . . . 73.53 111.219 -170.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . 0.515 ' CB ' ' HE3' ' A' ' 370' ' ' LYS . 55.1 m -93.94 173.57 7.6 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.16 0.8 . . . . 73.45 113.16 -174.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 34.5 mm -86.01 126.06 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.915 -1.039 . . . . 62.33 109.685 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 43.1 m-85 -124.01 132.69 53.72 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.199 0.523 . . . . 75.45 111.858 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.56 114.11 4.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 108.348 -0.982 . . . . 74.04 108.348 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 22.6 m -102.94 -20.95 14.05 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 120.865 0.364 . . . . 43.35 111.401 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 45.9 mmtm -150.71 159.46 44.51 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.342 -1.355 . . . . 75.31 107.342 177.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 61.3 mt -138.73 119.45 15.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 106.249 -1.76 . . . . 73.02 106.249 172.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 40.3 mm -86.07 118.01 31.79 Favored 'Isoleucine or valine' 0 C--O 1.255 1.387 0 N-CA-C 108.494 -0.928 . . . . 63.51 108.494 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.53 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 0.1 OUTLIER -65.62 147.42 53.43 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.181 -1.414 . . . . 71.33 107.181 -176.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.24 -16.62 60.92 Favored Glycine 0 C--N 1.289 -2.054 0 N-CA-C 109.275 -1.53 . . . . 71.31 109.275 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -75.09 150.43 40.78 Favored Glycine 0 N--CA 1.4 -3.738 0 N-CA-C 106.726 -2.55 . . . . 54.43 106.726 170.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -60.84 -35.03 75.52 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.854 -0.424 . . . . 33.42 109.854 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.557 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.35 -9.08 58.24 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 112.914 0.709 . . . . 64.41 112.914 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . 0.53 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 30.2 t-80 -94.95 -39.24 10.3 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.334 -0.947 . . . . 73.32 108.575 175.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -76.84 -57.19 3.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.861 -0.608 . . . . 62.01 110.949 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -85.84 -42.15 14.39 Favored 'General case' 0 CA--C 1.476 -1.882 0 C-N-CA 124.221 1.008 . . . . 74.43 111.32 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.569 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -43.07 -20.56 0.09 OUTLIER Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 120.651 3.02 . . . . 52.44 120.651 -162.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.569 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.86 33.45 0.5 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 118.522 1.161 . . . . 72.43 111.921 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 41.6 tp -107.94 155.49 20.26 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.718 1.207 . . . . 41.55 109.706 -171.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -124.89 145.34 49.87 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.405 0.621 . . . . 64.33 111.641 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 83.9 mt -66.15 123.23 18.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 107.69 -1.226 . . . . 73.02 107.69 171.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.73 -7.92 19.69 Favored Glycine 0 C--N 1.311 -0.841 0 C-N-CA 121.173 -0.536 . . . . 71.44 111.835 -175.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.401 ' HB3' HG21 ' A' ' 402' ' ' VAL . 19.0 m-20 -68.68 137.14 53.9 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 112.563 0.579 . . . . 70.21 112.563 177.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.515 ' HE3' ' CB ' ' A' ' 347' ' ' SER . 72.4 tttt -98.71 116.83 31.8 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.288 -0.869 . . . . 71.02 109.957 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 71.4 mt -83.96 114.5 21.74 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.226 0.536 . . . . 75.21 109.679 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.5 tt -81.0 -39.38 25.98 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.159 -1.382 . . . . 74.21 107.457 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.473 ' HB3' ' HD3' ' A' ' 401' ' ' LYS . . . -165.67 158.56 15.53 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.504 -0.771 . . . . 70.21 110.174 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . 0.417 HG12 HD11 ' A' ' 379' ' ' LEU . 14.2 p -134.17 124.15 45.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.287 -1.005 . . . . 70.3 108.287 174.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . 0.537 HD21 HG22 ' A' ' 394' ' ' THR . 88.4 m-20 62.18 30.81 17.76 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 123.719 1.723 . . . . 64.2 109.268 -176.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 67.48 9.64 7.17 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 109.999 -3.273 . . . . 74.3 113.201 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.43 122.27 36.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 106.472 -1.677 . . . . 73.13 106.472 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.3 p -61.21 125.84 25.2 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.235 0.828 . . . . 74.11 113.235 -176.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.417 HD11 HG12 ' A' ' 374' ' ' VAL . 7.6 mp -106.6 -1.36 22.98 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.662 0.785 . . . . 71.32 110.71 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -73.45 113.88 11.05 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.405 -0.961 . . . . 70.45 108.405 172.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 63.75 83.87 0.16 Allowed 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 124.587 1.179 . . . . 71.32 111.919 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 23.5 m -153.15 164.62 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.234 -1.348 . . . . 65.24 108.705 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.6 m -83.0 139.61 33.19 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.258 -1.016 . . . . 73.43 108.258 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . 0.558 ' O ' HG23 ' A' ' 388' ' ' VAL . 81.5 t60 -49.53 -47.47 48.96 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.031 0.752 . . . . 72.11 113.031 -175.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -43.42 91.83 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.75 -0.833 . . . . 62.1 108.75 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 383' ' ' THR . 47.8 tt0 -67.5 -31.39 71.48 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.031 -1.44 . . . . 73.32 108.974 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . 0.504 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -75.37 -49.92 17.55 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 114.7 -1.136 . . . . 74.21 110.456 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 384' ' ' HIS . 19.2 t -59.61 -46.47 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 N-CA-C 109.713 -0.477 . . . . 61.45 109.713 -178.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 52.0 m -62.12 -29.49 70.37 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.522 -0.763 . . . . 73.31 112.041 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.86 -31.92 72.85 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.689 -0.632 . . . . 52.11 110.4 175.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.6 mp -82.2 -31.6 30.26 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 120.599 -0.44 . . . . 73.23 110.875 176.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -71.12 -27.82 63.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.074 0.398 . . . . 75.44 112.074 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -78.16 55.18 1.46 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.547 0.689 . . . . 64.21 110.641 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.537 HG22 HD21 ' A' ' 375' ' ' ASN . 22.1 p -127.46 152.54 47.42 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 109.122 -0.696 . . . . 64.03 109.122 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 51.1 m -144.47 90.37 2.08 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.444 1.116 . . . . 73.05 111.628 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.537 ' HA ' ' H ' ' A' ' 324' ' ' LYS 0.267 9.1 m-20 61.96 17.2 8.76 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 111.636 -2.529 . . . . 62.31 115.329 170.074 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -161.61 122.15 2.67 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.075 -1.454 . . . . 73.44 107.075 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.7 t -140.1 143.45 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 122.509 0.323 . . . . 70.43 110.488 -175.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . 0.639 ' CE1' ' HD3' ' A' ' 321' ' ' LYS . 4.5 m-85 -117.64 96.45 5.39 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.265 0.555 . . . . 71.53 109.696 170.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.9 tt -88.67 123.21 32.9 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.675 -0.693 . . . . 61.34 109.683 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.473 ' HD3' ' HB3' ' A' ' 373' ' ' ALA . 26.7 mtpp -107.37 107.78 18.84 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.358 -0.979 . . . . 75.13 108.358 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' A' ' 369' ' ' ASP . 7.2 p -108.39 153.31 10.0 Favored 'Isoleucine or valine' 0 C--O 1.274 2.387 0 CA-C-N 115.403 -0.817 . . . . 73.11 110.231 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.41 157.61 46.39 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 105.945 -1.872 . . . . 64.23 105.945 174.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt . . . . . 0 C--N 1.284 -2.25 0 C-N-CA 119.792 -0.763 . . . . 73.12 109.719 178.488 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 N--CA 1.442 -0.861 0 CA-C-O 121.242 0.544 . . . . 71.1 111.67 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -95.06 158.45 15.46 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.022 -0.99 . . . . 72.3 109.466 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 23.0 m -144.93 138.58 26.98 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 116.567 -0.288 . . . . 71.32 110.329 175.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 13.9 tm0? -78.69 140.04 38.41 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.008 -0.542 . . . . 74.34 111.161 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 329' ' ' LEU . 18.1 m . . . . . 0 C--O 1.266 1.926 0 CA-C-N 115.476 -0.784 . . . . 64.51 112.275 178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 CA--C 1.485 -1.52 0 N-CA-C 106.207 -1.775 . . . . 72.33 106.207 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.359 2.2 pm0 -121.46 131.0 53.91 Favored 'General case' 0 C--N 1.267 -2.981 0 N-CA-C 114.732 1.382 . . . . 73.22 114.732 -175.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 74.8 mt -116.96 113.7 43.66 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 CA-C-N 112.516 -2.129 . . . . 64.15 109.558 -172.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -92.81 112.4 24.34 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.323 -0.992 . . . . 35.13 108.323 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' LEU . . . . . 0.653 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 81.6 mt -107.27 152.85 23.57 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 124.363 1.039 . . . . 75.5 109.068 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 40.5 mt -106.16 126.46 61.72 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 107.917 -1.142 . . . . 74.24 107.917 169.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.47 ' HB3' ' H ' ' A' ' 396' ' ' ASP . 85.6 tttt -75.04 156.49 36.1 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.337 -0.392 . . . . 71.23 110.473 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -148.57 -154.86 6.45 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.705 -0.759 . . . . 33.01 113.151 -174.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.27 -46.85 27.62 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 124.039 3.159 . . . . 71.24 115.024 -173.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -98.47 25.82 6.03 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.265 0.555 . . . . 72.24 110.601 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.81 -124.32 6.67 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 114.987 -1.006 . . . . 71.12 111.958 177.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.433 HD13 HG12 ' B' ' 151' ' ' VAL . 8.2 mp -90.89 -39.78 12.11 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.526 -1.287 . . . . 65.54 107.526 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 87.08 47.99 4.53 Favored Glycine 0 N--CA 1.402 -3.613 0 CA-C-N 113.937 -1.483 . . . . 72.23 113.261 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 329' ' ' LEU . 48.9 p90 -155.47 147.17 23.13 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.327 0.584 . . . . 74.33 111.526 170.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 51.1 m -96.17 132.16 41.88 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.175 -0.921 . . . . 63.23 109.151 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.411 ' HB ' HG22 ' A' ' 348' ' ' ILE . 46.9 pt -120.45 141.91 38.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 109.941 -0.392 . . . . 61.53 109.941 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -139.58 125.59 19.81 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.768 -1.197 . . . . 64.21 107.768 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 150.22 161.65 10.03 Favored Glycine 0 C--N 1.282 -2.438 0 N-CA-C 110.469 -1.052 . . . . 63.11 110.469 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.05 -179.81 17.14 Favored Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 107.221 -2.352 . . . . 72.33 107.221 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 98.4 t -52.2 108.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 118.078 0.939 . . . . 65.52 110.778 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 94.78 -21.58 42.69 Favored Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.321 -0.854 . . . . 42.0 112.092 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' ASN . . . . . 0.61 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 32.1 t-20 -105.75 13.43 29.68 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.06 -0.719 . . . . 40.04 109.06 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.91 120.57 4.46 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 121.513 0.673 . . . . 74.53 111.098 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -77.79 -45.07 25.6 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.029 -0.987 . . . . 63.15 109.451 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 40.4 mm -103.35 124.14 39.21 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-N 115.309 -0.86 . . . . 74.35 109.16 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.66 108.01 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 123.247 2.631 . . . . 70.15 112.512 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 105.39 -4.12 40.4 Favored Glycine 0 N--CA 1.432 -1.599 0 CA-C-N 115.459 -0.791 . . . . 52.14 112.002 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -128.9 96.93 4.49 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.451 -0.944 . . . . 55.45 108.451 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -83.7 36.94 0.56 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.859 -1.064 . . . . 65.42 111.778 -170.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 72.0 m -98.66 177.34 5.34 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 115.613 -0.721 . . . . 70.5 111.249 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.1 mm -91.54 138.85 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 N-CA-C 106.33 -1.73 . . . . 75.31 106.33 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 369' ' ' ASP . 22.4 m-85 -127.5 139.25 52.91 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 118.34 0.518 . . . . 75.14 111.639 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.24 123.46 22.87 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 N-CA-C 108.955 -0.757 . . . . 52.34 108.955 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.1 m -102.35 -28.5 12.21 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.383 0.611 . . . . 73.41 110.529 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.48 ' HZ2' HD13 ' A' ' 354' ' ' ILE . 60.8 tttm -155.62 147.72 23.5 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.245 -1.02 . . . . 73.03 108.245 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' ILE . . . . . 0.454 HG22 ' HB2' ' A' ' 360' ' ' HIS . 76.5 mt -107.74 139.7 28.78 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 N-CA-C 105.412 -2.07 . . . . 64.24 105.412 169.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.48 HD13 ' HZ2' ' A' ' 352' ' ' LYS . 44.9 mm -85.17 129.74 37.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.147 0.499 . . . . 72.1 110.799 -174.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 0.5 OUTLIER -57.62 115.75 2.97 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 125.586 1.554 . . . . 62.13 111.105 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 84.24 7.98 84.27 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.725 -0.75 . . . . 43.12 111.807 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -75.9 160.2 51.36 Favored Glycine 0 C--O 1.259 1.67 0 N-CA-C 111.769 -0.532 . . . . 71.42 111.769 177.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.29 -42.21 99.06 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.184 -0.672 . . . . 45.4 109.184 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.522 ' HA ' ' CA ' ' A' ' 363' ' ' GLY . . . -72.97 -6.74 47.4 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.852 -0.613 . . . . 74.42 111.427 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' HIS . . . . . 0.454 ' HB2' HG22 ' A' ' 353' ' ' ILE . 63.9 t60 -92.66 -33.92 14.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.592 0.71 . . . . 61.12 109.473 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.651 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 0.7 OUTLIER -92.9 -54.65 3.66 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.902 0.704 . . . . 62.52 112.902 177.6 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' ASP . . . . . 0.728 ' O ' ' HE2' ' A' ' 364' ' ' LYS . 23.3 t70 -85.33 -37.22 20.19 Favored 'General case' 0 CA--C 1.461 -2.458 0 O-C-N 124.16 0.912 . . . . 61.34 110.625 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' GLY . . . . . 0.653 ' HA2' ' CD2' ' A' ' 322' ' ' LEU . . . -41.2 -28.11 0.27 Allowed Glycine 0 CA--C 1.483 -1.966 0 N-CA-C 120.37 2.908 . . . . 62.23 120.37 -160.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.728 ' HE2' ' O ' ' A' ' 362' ' ' ASP . 0.0 OUTLIER 46.26 32.66 1.56 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 118.442 1.121 . . . . 72.04 110.877 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 43.0 tp -115.4 155.55 27.2 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.776 1.231 . . . . 74.12 109.103 -170.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -120.62 149.04 43.09 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.388 0.613 . . . . 71.21 111.165 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.0 mt -66.17 122.65 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 107.454 -1.313 . . . . 73.02 107.454 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.57 -9.12 19.65 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.476 -0.869 . . . . 41.34 113.013 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 4.2 m-20 -61.47 142.32 57.09 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.233 0.827 . . . . 75.4 113.233 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 43.3 tttp -93.27 115.01 27.61 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.491 1.117 . . . . 74.33 109.452 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 4.2 mp -79.9 112.81 17.55 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.873 -0.788 . . . . 71.21 108.873 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 403' ' ' ALA . 5.8 tt -87.14 -40.16 14.87 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.057 -1.09 . . . . 74.22 108.057 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 401' ' ' LYS . . . -161.99 157.3 23.45 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.883 -0.599 . . . . 75.21 110.891 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.28 123.11 42.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 108.624 -0.88 . . . . 63.42 108.624 173.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . 0.535 HD21 HG22 ' A' ' 394' ' ' THR . 91.8 m-20 60.49 31.59 20.33 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-O 124.089 1.899 . . . . 70.14 109.235 -174.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.7 t30 66.26 15.84 10.23 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 109.48 -3.509 . . . . 70.3 112.509 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 55.2 t -84.08 125.98 40.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 106.522 -1.658 . . . . 73.32 106.522 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.8 p -61.66 123.69 18.62 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 123.605 0.762 . . . . 74.44 113.053 -176.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 391' ' ' LEU . 7.6 mp -110.81 -4.79 15.11 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.653 0.781 . . . . 71.35 111.387 177.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -65.65 106.29 1.44 Allowed 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.661 -0.496 . . . . 72.51 109.661 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 60.37 73.17 0.49 Allowed 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 124.616 1.198 . . . . 60.34 113.223 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.24 171.02 18.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 107.155 -1.424 . . . . 52.52 107.155 175.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.8 m -76.96 142.52 39.98 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.613 -0.884 . . . . 74.25 108.613 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' HIS . . . . . 0.535 ' O ' HG23 ' A' ' 388' ' ' VAL . 82.4 t60 -51.17 -47.75 62.07 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 111.446 0.165 . . . . 52.13 111.446 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.7 -37.39 75.98 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.835 0.826 . . . . 60.42 110.814 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 383' ' ' THR . 53.1 tt0 -73.85 -38.93 64.33 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.427 -1.26 . . . . 63.15 108.532 -174.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -70.19 -51.66 29.35 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.858 -1.065 . . . . 60.12 110.335 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 384' ' ' HIS . 40.4 t -59.28 -40.69 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.717 -0.22 . . . . 72.03 110.936 -177.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 90.5 m -60.23 -35.5 75.61 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 116.689 -0.232 . . . . 74.51 110.99 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.37 -37.98 84.05 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.587 0.232 . . . . 52.25 110.649 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.421 HD11 HD21 ' A' ' 379' ' ' LEU . 6.2 mp -75.86 -32.01 59.54 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.248 -0.581 . . . . 72.13 110.841 176.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' LYS . . . . . 0.488 ' HG2' HG13 ' B' ' 151' ' ' VAL . 57.6 mttm -67.52 -36.09 80.36 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 112.619 0.6 . . . . 75.34 112.619 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -81.1 70.62 7.97 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.38 1.086 . . . . 72.51 110.786 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.535 HG22 HD21 ' A' ' 375' ' ' ASN . 7.9 p -139.56 157.78 45.23 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 113.745 -1.571 . . . . 73.44 109.433 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 20.1 p -162.61 122.26 2.31 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.117 -0.698 . . . . 63.34 109.117 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' ASP . . . . . 0.47 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 3.6 m-20 59.81 1.42 0.31 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.516 1.526 . . . . 72.43 114.446 175.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -162.35 128.22 3.47 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 108.835 -0.802 . . . . 62.45 108.835 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 47.6 t -140.32 111.94 4.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.766 -0.828 . . . . 61.45 108.766 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -94.07 96.44 9.66 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.481 -0.933 . . . . 74.21 108.481 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 4.3 tt -92.25 120.61 32.97 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 108.656 -0.868 . . . . 71.33 108.656 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 373' ' ' ALA . 25.1 ttmm -106.09 110.16 22.33 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.509 -1.293 . . . . 75.01 107.509 177.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 370' ' ' LYS . 2.7 p -113.0 149.2 15.52 Favored 'Isoleucine or valine' 0 C--O 1.274 2.374 0 CA-C-O 121.843 0.83 . . . . 74.04 111.394 -177.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -128.12 158.37 38.19 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.595 -1.184 . . . . 70.31 108.446 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.483 0 N-CA-C 109.145 -0.687 . . . . 74.13 109.145 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 CA--C 1.5 -0.978 0 N-CA-C 109.573 -0.529 . . . . 73.21 109.573 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.83 166.73 11.66 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.041 -0.527 . . . . 72.44 109.979 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 86.5 m -144.44 126.04 15.04 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.544 -0.539 . . . . 60.13 109.544 168.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 150' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 20.9 tm0? -69.59 136.35 51.15 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.107 -0.952 . . . . 64.22 110.601 175.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.488 HG13 ' HG2' ' A' ' 392' ' ' LYS . 21.8 t . . . . . 0 C--N 1.305 -1.363 0 N-CA-C 107.724 -1.213 . . . . 71.51 107.724 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 CA--C 1.492 -1.275 0 N-CA-C 105.766 -1.938 . . . . 73.25 105.766 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -127.12 140.39 52.3 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 113.878 1.066 . . . . 70.31 113.878 -174.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 363' ' ' GLY . 84.0 mt -129.0 116.83 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 CA-C-N 113.504 -1.68 . . . . 62.12 109.19 -174.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.5 127.33 34.86 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 108.836 -0.801 . . . . 74.12 108.836 175.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 80.9 mt -122.8 152.5 40.62 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.062 -0.718 . . . . 74.22 109.062 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 32.4 mm -105.76 111.51 35.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.653 -1.24 . . . . 73.13 107.653 173.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.475 ' HE3' ' HA2' ' A' ' 328' ' ' GLY . 1.4 tmtp? -75.92 141.05 42.4 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.8 -0.444 . . . . 75.31 109.8 -176.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -149.14 -154.55 6.39 Favored Glycine 0 C--N 1.301 -1.413 0 C-N-CA 120.41 -0.9 . . . . 72.43 112.646 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.66 -12.85 35.76 Favored 'Trans proline' 0 N--CA 1.484 0.926 0 C-N-CA 123.594 2.863 . . . . 62.14 113.99 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.411 ' HZ3' ' HB3' ' A' ' 327' ' ' LYS . 6.9 mtpm? -107.39 10.66 29.51 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.427 -0.953 . . . . 62.21 108.427 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . 0.475 ' HA2' ' HE3' ' A' ' 324' ' ' LYS . . . 83.72 -133.87 12.26 Favored Glycine 0 CA--C 1.484 -1.881 0 CA-C-N 114.389 -1.278 . . . . 71.34 109.91 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.476 ' HB2' HG23 ' B' ' 151' ' ' VAL . 5.1 mp -93.38 -19.68 21.08 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.073 -1.454 . . . . 62.31 107.073 172.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . 0.466 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 85.51 40.05 7.99 Favored Glycine 0 N--CA 1.426 -1.996 0 CA-C-N 113.869 -1.514 . . . . 65.04 115.064 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -154.92 167.8 29.1 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 117.409 0.604 . . . . 65.44 110.324 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 2.8 m -121.76 132.75 54.78 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.492 -0.559 . . . . 74.23 109.492 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 388' ' ' VAL . 18.2 pt -113.68 154.98 14.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 116.234 -0.439 . . . . 75.14 110.978 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.45 115.38 5.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 124.68 1.238 . . . . 61.43 107.937 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 168.77 161.29 18.66 Favored Glycine 0 C--N 1.275 -2.823 0 N-CA-C 108.928 -1.669 . . . . 70.43 108.928 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.67 178.2 15.43 Favored Glycine 0 N--CA 1.414 -2.773 0 N-CA-C 108.601 -1.8 . . . . 61.14 108.601 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.8 t -53.05 104.47 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.65 0.738 . . . . 72.21 110.933 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.65 -19.88 52.3 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.001 -0.999 . . . . 72.43 113.269 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.509 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 60.2 t30 -107.65 22.39 16.03 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 117.288 0.544 . . . . 73.11 110.246 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.401 HE22 ' HA ' ' A' ' 343' ' ' PRO . 0.0 OUTLIER -52.34 119.64 4.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.263 0.554 . . . . 72.42 110.801 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -73.25 -44.82 58.77 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.149 -0.932 . . . . 71.33 109.979 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 42.7 mm -104.66 125.34 34.22 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 108.766 -0.827 . . . . 73.24 108.766 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.401 ' HA ' HE22 ' A' ' 340' ' ' GLN . 73.0 Cg_exo -52.62 107.73 0.21 Allowed 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 123.21 2.607 . . . . 74.34 112.898 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 107.14 -7.63 37.83 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-N 115.281 -0.872 . . . . 53.23 112.362 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -125.03 98.74 5.81 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.941 -0.763 . . . . 55.21 108.941 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -83.05 33.67 0.45 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.878 0.871 . . . . 74.5 111.511 -171.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 16.4 m -95.06 171.44 8.75 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.157 -0.474 . . . . 62.34 111.006 -177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.416 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 27.6 mm -83.91 127.5 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 107.678 -1.23 . . . . 71.05 107.678 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 47.6 m-85 -123.88 136.68 54.51 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.328 0.585 . . . . 53.0 112.465 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.18 113.81 5.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 107.796 -1.187 . . . . 65.14 107.796 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 53.2 m -102.14 -23.9 14.0 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.236 0.541 . . . . 74.32 111.276 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 94.7 mttt -151.32 156.28 40.45 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.964 -1.124 . . . . 74.13 107.964 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.4 HG22 ' HB2' ' A' ' 360' ' ' HIS . 78.0 mt -130.47 128.95 64.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.309 -1.367 . . . . 71.2 107.309 176.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 49.4 mm -85.35 141.78 14.1 Favored 'Isoleucine or valine' 0 C--O 1.256 1.419 0 C-N-CA 123.315 0.646 . . . . 74.13 111.22 -171.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.19 127.83 34.13 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.201 1.0 . . . . 74.12 111.555 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 71.71 8.9 68.86 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.534 -0.757 . . . . 51.12 112.584 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . 0.466 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -70.46 159.75 53.63 Favored Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.831 -0.699 . . . . 71.34 111.498 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -59.15 -40.86 86.86 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.592 -0.522 . . . . 72.43 109.592 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.523 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -73.01 -13.13 61.16 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.262 0.553 . . . . 63.12 112.298 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . 0.4 ' HB2' HG22 ' A' ' 353' ' ' ILE . 25.0 t60 -92.53 -25.74 18.24 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.899 0.857 . . . . 61.52 109.434 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.424 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 0.2 OUTLIER -96.57 -59.21 1.87 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 113.332 0.864 . . . . 74.43 113.332 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -86.14 -36.53 19.51 Favored 'General case' 0 CA--C 1.475 -1.913 0 N-CA-C 107.844 -1.169 . . . . 64.41 107.844 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.535 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -44.75 -35.15 4.16 Favored Glycine 0 C--O 1.201 -1.923 0 N-CA-C 118.677 2.231 . . . . 74.34 118.677 -166.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.535 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.58 29.86 0.19 Allowed 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 118.29 1.045 . . . . 62.03 111.198 -173.038 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 47.2 tp -97.64 151.8 19.73 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 125.009 1.324 . . . . 74.54 109.807 -169.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -121.1 149.19 43.13 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-O 121.409 0.623 . . . . 74.35 111.409 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 77.8 mt -65.89 121.7 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 N-CA-C 107.622 -1.251 . . . . 55.02 107.622 172.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.4 -1.76 22.13 Favored Glycine 0 C--N 1.313 -0.734 0 C-N-CA 121.0 -0.619 . . . . 60.45 112.133 -175.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -75.16 137.11 41.1 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 113.087 0.773 . . . . 74.45 113.087 176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 37.9 tttp -92.83 119.43 32.15 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 124.327 1.051 . . . . 73.01 110.453 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 78.6 mt -87.63 121.03 29.54 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 120.393 -0.523 . . . . 62.01 110.002 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.466 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 92.6 mt -82.19 -40.16 22.14 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.088 -1.415 . . . . 72.23 108.439 177.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -165.17 165.65 19.6 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.281 -0.872 . . . . 71.53 111.944 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.497 HG12 HD11 ' A' ' 379' ' ' LEU . 10.2 p -133.79 119.58 33.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.863 -1.162 . . . . 65.5 107.863 171.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . 0.49 HD21 HG22 ' A' ' 394' ' ' THR . 84.8 m-20 63.14 28.65 16.05 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 123.95 1.833 . . . . 71.33 108.406 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 66.18 17.92 10.84 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 109.726 -3.397 . . . . 75.33 112.52 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.5 t -84.14 123.63 39.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.567 -1.642 . . . . 70.34 106.567 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 10.4 p -59.49 124.04 18.77 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.163 1.172 . . . . 73.33 114.163 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.566 HD21 HD11 ' A' ' 391' ' ' LEU . 5.8 mp -106.49 6.7 30.43 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.64 1.176 . . . . 72.24 110.119 176.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.466 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 20.1 mm-40 -71.26 110.67 6.05 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.073 -0.967 . . . . 73.23 110.902 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 54.1 66.86 1.12 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.65 1.18 . . . . 60.45 112.715 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.36 171.72 16.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.629 -1.249 . . . . 74.35 107.629 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.448 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 2.3 m -75.79 144.78 41.17 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.661 -0.866 . . . . 32.14 108.661 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.578 ' O ' HG23 ' A' ' 388' ' ' VAL . 10.0 t-160 -51.88 -49.78 62.3 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 111.601 0.223 . . . . 61.12 111.601 -176.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' B' ' 143' ' ' THR . 36.7 tt0 -65.22 -29.52 70.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.966 0.412 . . . . 65.35 111.848 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 383' ' ' THR . 60.7 tt0 -71.52 -40.27 70.22 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.688 -1.227 . . . . 63.13 107.688 -176.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -69.59 -50.55 43.5 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.864 -1.062 . . . . 65.3 110.178 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.743 HG21 HG21 ' B' ' 143' ' ' THR . 40.6 t -57.38 -37.16 55.74 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 O-C-N 123.032 0.208 . . . . 71.52 111.38 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 91.5 m -62.55 -34.34 76.73 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 116.653 -0.248 . . . . 74.34 111.108 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -70.06 -35.95 74.63 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.644 0.259 . . . . 71.54 110.363 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.566 HD11 HD21 ' A' ' 379' ' ' LEU . 5.6 mp -78.51 -27.93 46.17 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 120.164 -0.614 . . . . 71.42 110.599 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 53.5 mttm -71.42 -37.24 71.49 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.85 0.685 . . . . 55.45 112.85 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -82.45 65.83 7.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.282 1.039 . . . . 62.4 110.79 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.49 HG22 HD21 ' A' ' 375' ' ' ASN . 31.0 p -137.18 146.93 45.51 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.034 -1.439 . . . . 65.24 107.506 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 42.1 m -142.78 120.39 11.79 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.71 -0.478 . . . . 60.02 109.71 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 324' ' ' LYS . 3.9 m-20 58.46 0.95 0.15 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.691 1.996 . . . . 71.43 115.694 172.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -161.61 135.57 6.74 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.416 -0.957 . . . . 74.03 108.416 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 61.4 t -142.02 133.45 26.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.682 -0.859 . . . . 53.35 108.682 177.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -107.73 96.29 6.28 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.192 -1.781 . . . . 74.31 106.192 173.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.4 tt -86.36 129.67 34.77 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 120.949 0.404 . . . . 63.44 110.292 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -108.96 108.54 19.33 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 107.817 -1.179 . . . . 62.32 107.817 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 3.4 p -118.93 150.55 21.22 Favored 'Isoleucine or valine' 0 C--O 1.274 2.353 0 CA-C-O 121.784 0.802 . . . . 72.31 111.265 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.424 ' HB2' HD11 ' A' ' 372' ' ' LEU . . . -136.63 158.15 45.11 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 105.721 -1.955 . . . . 71.12 105.721 171.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.37 154.33 56.83 Favored Pre-proline 0 C--N 1.284 -2.248 0 N-CA-C 105.463 -2.051 . . . . 63.41 105.463 177.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . 0.416 ' HA ' ' OH ' ' A' ' 349' ' ' TYR . 3.2 Cg_exo -36.89 110.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 124.503 3.469 . . . . 73.23 113.688 -177.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 9.9 m -95.3 -38.05 10.71 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 113.48 0.918 . . . . 64.2 113.48 -168.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -104.3 31.12 8.99 Favored Glycine 0 C--N 1.29 -2.024 0 C-N-CA 119.815 -1.183 . . . . 43.13 110.536 -177.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 12.6 p -161.2 -164.49 1.17 Allowed 'General case' 0 N--CA 1.411 -2.387 0 CA-C-N 114.584 -0.808 . . . . 63.24 109.032 -175.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -70.12 106.6 3.33 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.444 -0.576 . . . . 63.44 109.444 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -71.88 138.61 48.33 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 123.718 0.636 . . . . 62.13 112.437 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 . . . . . 0 N--CA 1.426 -1.626 0 N-CA-C 103.513 -2.773 . . . . 73.31 103.513 179.709 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 121.717 0.77 . . . . 64.11 110.013 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 -95.98 -55.23 3.05 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.005 -1.85 . . . . 75.21 106.005 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.743 HG21 HG21 ' A' ' 388' ' ' VAL . 5.9 m -91.76 152.17 20.29 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 104.976 -2.231 . . . . 72.24 104.976 171.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 40.9 ttm105 -154.39 166.62 32.65 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.852 -1.139 . . . . 74.31 110.052 -163.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.1 157.66 20.63 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 123.614 0.571 . . . . 61.31 110.51 176.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.78 26.64 9.41 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.268 1.427 . . . . 63.23 112.487 -173.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . 0.41 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.2 OUTLIER -159.89 144.2 14.7 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.669 -0.696 . . . . 74.41 109.708 174.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -91.36 161.3 15.07 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.657 -0.868 . . . . 75.24 108.657 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 51.6 m -147.27 140.43 25.23 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.927 -0.483 . . . . 73.2 110.414 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -71.13 139.24 50.2 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.865 -0.607 . . . . 73.51 109.916 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 329' ' ' LEU . 12.4 m . . . . . 0 C--O 1.265 1.878 0 CA-C-N 115.79 -0.641 . . . . 71.23 112.065 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 C--O 1.203 -1.394 0 N-CA-C 106.373 -1.714 . . . . 73.14 106.373 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.472 1.9 pm0 -115.58 128.98 56.35 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 117.05 2.241 . . . . 72.34 117.05 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.601 HG23 ' HD3' ' A' ' 364' ' ' LYS . 66.9 mt -107.38 107.0 21.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 CA-C-N 111.425 -2.625 . . . . 75.33 108.552 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.51 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 29.4 ttpt -80.44 118.92 22.49 Favored 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 119.865 -0.734 . . . . 71.22 109.073 174.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.59 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 27.5 mt -113.05 148.07 35.93 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 113.904 -1.498 . . . . 72.44 110.316 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.0 mp -106.55 117.2 51.89 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.017 0 N-CA-C 107.119 -1.437 . . . . 72.45 107.119 169.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.682 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 10.2 tmtt? -63.03 151.57 39.45 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 108.639 -0.875 . . . . 75.21 108.639 171.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.429 ' O ' ' HE2' ' A' ' 324' ' ' LYS . . . -141.98 -160.58 8.39 Favored Glycine 0 C--N 1.299 -1.517 0 C-N-CA 119.832 -1.175 . . . . 64.04 113.365 -171.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.22 -30.62 45.82 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.155 2.57 . . . . 74.41 113.651 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -101.58 18.85 19.21 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 122.279 1.037 . . . . 75.31 108.791 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.34 -129.0 8.92 Favored Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 109.799 -1.32 . . . . 71.14 109.799 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.508 ' HB2' HG23 ' B' ' 151' ' ' VAL . 5.3 mp -96.98 -42.58 7.84 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.161 -1.792 . . . . 75.24 106.161 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . 0.517 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 84.41 50.19 4.36 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 114.754 -1.112 . . . . 52.33 114.806 171.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . 0.408 ' O ' HG22 ' B' ' 151' ' ' VAL . 50.2 p90 -151.25 150.71 30.9 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.413 -0.588 . . . . 60.11 109.413 173.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 6.4 m -104.15 129.15 51.87 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.601 -0.518 . . . . 72.11 109.601 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.3 pt -113.36 151.69 15.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-N 115.824 -0.625 . . . . 72.23 109.943 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.66 121.75 10.1 Favored 'General case' 0 N--CA 1.425 -1.713 0 O-C-N 124.226 0.954 . . . . 74.23 108.685 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 167.7 179.07 40.18 Favored Glycine 0 C--N 1.281 -2.498 0 N-CA-C 107.452 -2.259 . . . . 54.3 107.452 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 132.54 175.98 14.21 Favored Glycine 0 CA--C 1.474 -2.526 0 N-CA-C 108.712 -1.755 . . . . 44.34 108.712 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.457 HG22 ' OE2' ' A' ' 381' ' ' GLU . 93.4 t -51.0 100.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 O-C-N 124.432 0.725 . . . . 62.41 111.437 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 88.13 -7.47 81.35 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.593 -0.731 . . . . 62.12 112.312 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.449 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 65.6 t30 -106.3 16.56 24.66 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.066 -0.716 . . . . 63.14 109.066 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.463 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -49.57 125.88 12.33 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.52 1.128 . . . . 73.22 111.835 -177.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -80.3 -44.11 20.12 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.18 -0.918 . . . . 54.03 109.429 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.5 mm -103.62 125.28 35.24 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 115.846 -0.615 . . . . 63.03 109.357 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.33 108.8 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.553 2.836 . . . . 75.41 113.416 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 101.87 -4.92 53.26 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-N 115.512 -0.767 . . . . 71.44 111.936 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -124.99 96.7 4.96 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.322 -0.992 . . . . 73.32 108.322 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 51.7 t30 -81.01 29.04 0.34 Allowed 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 124.343 1.057 . . . . 74.23 111.781 -170.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 73.0 m -93.34 177.97 5.87 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.726 0.774 . . . . 75.45 112.755 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.5 mm -91.21 129.33 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 114.609 -1.178 . . . . 72.21 108.32 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 28.9 m-85 -123.54 132.47 53.91 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.193 0.52 . . . . 74.32 112.197 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 52.9 t -67.1 109.84 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.581 -1.266 . . . . 75.51 107.581 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.4 m -99.83 -22.07 15.48 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.207 0.527 . . . . 72.11 110.711 -175.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 31.8 mmtp -148.25 154.27 39.83 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.375 -1.343 . . . . 72.11 107.375 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.462 HG22 ' HB2' ' A' ' 360' ' ' HIS . 65.5 mt -131.72 107.59 13.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 106.815 -1.55 . . . . 70.11 106.815 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 38.7 mm -78.73 129.6 37.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 123.731 0.813 . . . . 74.34 109.788 -171.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.533 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 0.6 OUTLIER -63.83 146.25 54.29 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.429 -1.323 . . . . 63.11 107.429 -178.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.598 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.05 -19.53 53.66 Favored Glycine 0 C--N 1.28 -2.529 0 N-CA-C 109.299 -1.521 . . . . 35.22 109.299 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . 0.517 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -69.29 142.37 37.28 Favored Glycine 1 N--CA 1.384 -4.811 0 N-CA-C 107.968 -2.053 . . . . 72.44 107.968 172.034 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 362' ' ' ASP . . . -62.97 -32.65 74.04 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.826 -0.805 . . . . 74.42 108.826 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.585 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.72 -6.28 49.75 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.981 -0.554 . . . . 52.02 112.132 178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . 0.533 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 19.5 t60 -94.19 -39.4 10.57 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.432 -0.951 . . . . 73.14 108.432 175.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.598 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 73.7 mmtt -82.7 -57.65 3.23 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.599 0.714 . . . . 62.23 110.79 -178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 358' ' ' ALA . 10.9 t70 -85.86 -34.85 20.9 Favored 'General case' 0 CA--C 1.468 -2.187 0 C-N-CA 125.182 1.393 . . . . 71.15 111.112 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.59 ' HA2' ' CD2' ' A' ' 322' ' ' LEU . . . -42.71 -23.97 0.22 Allowed Glycine 0 C--N 1.287 -2.186 0 N-CA-C 120.862 3.105 . . . . 35.44 120.862 -162.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.601 ' HD3' HG23 ' A' ' 320' ' ' ILE . 0.0 OUTLIER 41.47 36.99 0.6 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.802 1.301 . . . . 74.51 111.54 -178.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 50.3 tp -114.21 156.06 24.97 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 124.536 1.134 . . . . 64.25 109.891 -170.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -122.19 142.66 50.19 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.434 0.635 . . . . 74.04 111.678 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.5 mt -66.39 121.53 15.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.507 -1.294 . . . . 71.1 107.507 169.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 114.55 -0.61 23.43 Favored Glycine 0 C--N 1.314 -0.687 0 N-CA-C 111.656 -0.578 . . . . 50.24 111.656 -176.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.478 ' HB3' HG21 ' A' ' 402' ' ' VAL . 83.2 m-20 -76.27 136.77 39.64 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.196 0.813 . . . . 73.12 113.196 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.666 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 37.7 tttp -94.86 116.61 28.93 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.99 1.316 . . . . 72.12 108.948 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 83.6 mt -83.25 113.45 20.69 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 109.779 -0.452 . . . . 72.3 109.779 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 403' ' ' ALA . 3.9 tt -81.49 -39.67 24.4 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.08 -1.452 . . . . 74.23 107.08 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.41 159.18 21.99 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.493 -0.776 . . . . 63.14 110.644 -177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.438 HG12 HD11 ' A' ' 379' ' ' LEU . 13.5 p -133.75 121.09 39.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.07 -1.085 . . . . 60.15 108.07 172.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . 0.542 HD21 HG22 ' A' ' 394' ' ' THR . 89.1 m-20 62.83 29.85 16.63 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 123.987 1.851 . . . . 74.03 108.652 -174.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 67.42 10.39 7.71 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 109.652 -3.431 . . . . 71.34 113.355 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 50.3 t -78.74 124.56 37.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.585 -1.635 . . . . 64.44 106.585 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.5 p -61.51 124.62 21.17 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.677 0.992 . . . . 65.54 113.677 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.438 HD11 HG12 ' A' ' 374' ' ' VAL . 8.5 mp -109.18 3.48 21.88 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.027 0.931 . . . . 71.32 110.836 176.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -78.15 115.97 18.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.34 -0.985 . . . . 72.32 108.34 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . 0.457 ' OE2' HG22 ' A' ' 337' ' ' VAL . 17.1 tp10 62.83 83.34 0.16 Allowed 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 124.607 1.192 . . . . 75.32 111.625 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 18.4 m -153.81 160.36 2.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 113.966 -1.47 . . . . 64.54 109.171 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.5 m -81.65 145.14 30.73 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.443 -1.317 . . . . 73.51 107.443 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.618 ' O ' HG23 ' A' ' 388' ' ' VAL . 7.3 t-160 -52.1 -48.27 64.85 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 112.533 0.568 . . . . 74.22 112.533 -174.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.6 ' HA ' ' OG1' ' B' ' 143' ' ' THR . 6.9 tp10 -57.86 -37.34 73.72 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.653 0.74 . . . . 74.32 110.896 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 383' ' ' THR . 55.5 tt0 -70.54 -35.8 73.34 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.942 -1.026 . . . . 75.04 108.484 -174.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.407 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -75.47 -50.94 14.21 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.662 -1.154 . . . . 61.35 111.052 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 384' ' ' HIS . 20.7 t -57.64 -40.75 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 110.022 -0.362 . . . . 72.22 110.022 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 94.8 m -58.55 -40.01 81.83 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.101 -0.499 . . . . 65.52 110.749 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -63.65 -33.22 75.15 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.477 0.18 . . . . 60.01 110.972 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.8 mp -81.44 -28.92 34.0 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 120.388 -0.525 . . . . 51.01 110.943 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -74.74 -24.18 58.67 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 112.213 0.449 . . . . 64.41 112.213 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -78.62 46.39 0.65 Allowed 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 123.428 0.691 . . . . 73.53 110.692 176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.542 HG22 HD21 ' A' ' 375' ' ' ASN . 34.0 p -124.57 143.49 50.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.056 0.455 . . . . 65.01 110.061 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 324' ' ' LYS . 49.3 m -142.49 100.98 3.8 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 122.32 1.057 . . . . 62.43 112.171 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.682 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 5.3 m-20 60.47 15.85 5.9 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 128.232 2.613 . . . . 60.01 113.897 169.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -165.91 126.53 1.79 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.035 -1.098 . . . . 60.33 108.035 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 25.1 t -145.61 146.6 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 123.296 0.638 . . . . 72.24 110.642 -175.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.51 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 20.4 m-85 -118.56 96.68 5.39 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.465 0.706 . . . . 74.0 109.191 169.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.8 tt -88.34 121.5 30.8 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.34 -0.615 . . . . 62.34 109.34 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -104.64 108.42 19.86 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.256 -1.016 . . . . 73.51 108.256 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 369' ' ' ASP . 5.6 p -106.41 150.48 8.98 Favored 'Isoleucine or valine' 0 C--O 1.276 2.5 0 CA-C-O 121.651 0.739 . . . . 74.04 110.247 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.666 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.7 159.58 41.39 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 125.966 1.706 . . . . 71.12 107.149 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 7.1 mmpt? -95.99 153.91 39.07 Favored Pre-proline 0 C--N 1.287 -2.126 0 N-CA-C 108.803 -0.814 . . . . 73.55 108.803 174.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . 0.4 ' HD2' ' HE2' ' A' ' 404' ' ' LYS . 1.4 Cg_endo -43.33 139.28 4.39 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 123.954 3.103 . . . . 64.11 114.756 -176.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 5.9 m -75.93 78.19 2.82 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 114.083 -1.417 . . . . 75.32 112.147 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 87.78 -47.17 3.53 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 116.009 1.164 . . . . 65.3 116.009 169.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 17.0 m -62.18 -22.83 66.22 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.992 0.901 . . . . 54.21 110.815 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -159.61 168.47 25.98 Favored 'General case' 0 N--CA 1.405 -2.689 0 N-CA-C 103.755 -2.683 . . . . 73.31 103.755 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -159.92 49.48 0.3 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 119.433 1.015 . . . . 65.32 110.349 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 . . . . . 0 C--N 1.297 -1.681 0 N-CA-C 105.785 -1.932 . . . . 73.44 105.785 -177.841 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.869 0 N-CA-C 108.535 -0.913 . . . . 71.24 108.535 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 69.19 28.26 4.99 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.541 1.137 . . . . 74.33 110.256 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.6 ' OG1' ' HA ' ' A' ' 385' ' ' GLU . 27.3 p -112.64 174.13 6.04 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.617 -1.623 . . . . 71.41 106.617 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -153.18 154.27 34.4 Favored 'General case' 0 CA--C 1.482 -1.636 0 O-C-N 121.163 -0.961 . . . . 75.22 108.712 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . 0.451 ' HB3' ' CB ' ' A' ' 384' ' ' HIS . 12.6 pt20 -86.6 173.91 9.24 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 115.938 -0.574 . . . . 74.23 111.191 172.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . 0.63 ' HA ' ' HE ' ' B' ' 146' ' ' ARG . 2.0 mmp_? 66.63 22.02 10.55 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 124.527 1.131 . . . . 75.14 111.472 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -160.92 167.62 26.24 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 113.653 -1.612 . . . . 75.11 108.052 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -90.47 158.03 17.26 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 124.159 0.912 . . . . 74.42 108.54 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 55.2 m -145.85 138.16 25.47 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.796 -0.446 . . . . 51.23 109.796 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -81.52 132.35 35.31 Favored 'General case' 0 C--O 1.251 1.156 0 N-CA-C 109.525 -0.546 . . . . 61.21 109.525 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.508 HG23 ' HB2' ' A' ' 329' ' ' LEU . 7.9 m . . . . . 0 C--N 1.291 -1.957 0 CA-C-N 116.026 -0.534 . . . . 64.41 111.291 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 CA--C 1.493 -1.247 0 N-CA-C 107.427 -1.323 . . . . 75.33 107.427 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.298 1.6 pm0 -115.34 133.85 55.65 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-O 122.847 1.308 . . . . 73.23 114.087 -175.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.536 HG23 ' HE2' ' A' ' 364' ' ' LYS . 86.6 mt -123.62 106.59 17.41 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.732 0 CA-C-N 112.662 -2.063 . . . . 53.2 110.025 -173.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.524 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 30.2 ttpt -81.07 130.5 35.05 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.931 -1.137 . . . . 73.34 107.931 170.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.403 HD21 ' HA2' ' A' ' 363' ' ' GLY . 10.3 mt -129.97 156.76 43.91 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 124.805 1.316 . . . . 74.43 110.396 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 39.0 mm -106.5 117.57 52.52 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.762 0 N-CA-C 107.696 -1.224 . . . . 75.25 107.696 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.576 ' HG2' ' N ' ' A' ' 325' ' ' GLY . 17.5 tttm -71.69 160.92 31.8 Favored 'General case' 0 C--O 1.206 -1.185 0 N-CA-C 107.933 -1.136 . . . . 74.01 107.933 174.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.576 ' N ' ' HG2' ' A' ' 324' ' ' LYS . . . -149.33 -164.34 11.57 Favored Glycine 0 C--N 1.29 -1.981 0 N-CA-C 110.315 -1.114 . . . . 20.24 110.315 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.31 -12.84 27.86 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.892 2.394 . . . . 74.34 111.493 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -97.61 6.72 47.64 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 122.078 0.942 . . . . 65.43 108.968 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.03 -134.79 13.05 Favored Glycine 0 CA--C 1.491 -1.412 0 N-CA-C 109.824 -1.31 . . . . 74.45 109.824 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.78 -27.11 12.88 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.157 -1.423 . . . . 75.42 107.157 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 86.02 48.12 4.75 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.366 -1.288 . . . . 60.23 115.216 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -154.46 171.34 19.52 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 110.043 -0.354 . . . . 74.41 110.043 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.7 m -127.96 128.4 44.99 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.093 -0.706 . . . . 61.15 109.093 -176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 21.4 pt -113.79 157.92 14.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 115.84 -0.618 . . . . 75.31 110.622 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.39 125.96 10.98 Favored 'General case' 0 N--CA 1.428 -1.559 0 O-C-N 124.36 1.037 . . . . 63.12 108.454 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 164.13 -177.0 40.03 Favored Glycine 0 C--N 1.284 -2.333 0 N-CA-C 108.581 -1.808 . . . . 72.21 108.581 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.19 177.05 14.68 Favored Glycine 0 CA--C 1.482 -1.987 0 N-CA-C 109.833 -1.307 . . . . 71.25 109.833 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.454 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 92.8 t -57.76 103.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 O-C-N 124.121 0.542 . . . . 71.13 110.202 175.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 92.96 -14.08 66.11 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.375 -0.83 . . . . 72.32 112.101 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.511 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 65.0 t30 -106.02 21.56 17.11 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.553 -0.536 . . . . 73.42 109.553 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.67 123.5 7.96 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 115.104 -0.953 . . . . 72.23 111.49 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -78.72 -40.85 32.45 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.032 -0.985 . . . . 73.34 108.916 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 37.0 mm -103.62 122.36 45.07 Favored Pre-proline 0 C--N 1.302 -1.488 0 CA-C-N 115.2 -0.909 . . . . 75.24 109.334 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -52.2 108.11 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.429 2.752 . . . . 45.15 112.91 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 104.44 -2.6 42.97 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 115.178 -0.919 . . . . 61.35 112.308 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -127.14 103.66 7.55 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.747 0.784 . . . . 73.02 109.587 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.454 ' OD1' ' HA ' ' A' ' 337' ' ' VAL . 65.9 t30 -83.32 38.02 0.59 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 125.038 1.335 . . . . 71.1 111.14 -171.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 21.5 m -110.9 177.86 4.53 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.723 -0.671 . . . . 75.13 112.346 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.416 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 35.0 mm -91.92 131.15 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.053 0.541 . . . . 74.43 109.702 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 36.6 m-85 -124.39 139.16 54.16 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.582 0.586 . . . . 72.44 112.582 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.24 115.05 10.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 108.256 -1.016 . . . . 71.55 108.256 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 31.6 m -101.06 -24.0 14.39 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.341 0.591 . . . . 71.32 111.308 -175.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.63 147.93 23.7 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 107.792 -1.188 . . . . 72.33 107.792 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 85.1 mt -118.27 133.09 66.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 106.168 -1.79 . . . . 74.01 106.168 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 48.6 mm -75.83 130.87 35.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.315 0.579 . . . . 73.25 109.831 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.602 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.6 pm0 -60.09 122.36 14.2 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 125.006 1.322 . . . . 72.1 111.627 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 74.29 16.16 79.91 Favored Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 114.368 -1.287 . . . . 74.41 111.393 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.78 163.95 52.84 Favored Glycine 0 C--O 1.251 1.177 0 N-CA-C 110.97 -0.852 . . . . 15.32 110.97 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -64.33 -42.34 96.33 Favored 'General case' 0 C--O 1.207 -1.15 0 N-CA-C 108.816 -0.809 . . . . 44.34 108.816 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.425 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -71.49 -5.74 35.3 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 121.876 -0.515 . . . . 55.23 112.135 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -93.85 -36.12 12.39 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.67 -0.863 . . . . 63.33 108.67 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -92.62 -58.59 2.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.98 1.371 . . . . 52.45 110.221 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -85.9 -26.76 25.41 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.709 -2.041 . . . . 64.02 110.283 -170.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -56.69 -39.35 86.21 Favored Glycine 0 C--N 1.278 -2.641 0 CA-C-N 112.779 -2.01 . . . . 65.13 118.109 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.536 ' HE2' HG23 ' A' ' 320' ' ' ILE 0.255 0.0 OUTLIER 45.94 32.59 1.37 Allowed 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 119.113 1.456 . . . . 72.42 111.489 -170.56 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 48.3 tp -101.31 149.62 23.83 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.436 -1.257 . . . . 73.31 109.036 -172.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.95 147.74 42.86 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.285 0.564 . . . . 63.3 109.686 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 76.7 mt -66.03 123.3 18.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 106.927 -1.509 . . . . 74.12 106.927 170.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.54 -9.31 19.66 Favored Glycine 0 C--N 1.308 -1.005 0 C-N-CA 120.536 -0.84 . . . . 63.31 112.29 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -68.51 137.09 54.1 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 120.882 0.373 . . . . 74.44 111.504 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 2.1 ttmm -94.55 125.14 39.01 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.81 -0.632 . . . . 62.53 109.502 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 95.9 mt -81.45 112.36 18.63 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 108.671 -0.863 . . . . 62.4 108.671 176.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 403' ' ' ALA . 2.8 tt -80.5 -43.61 20.51 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.104 -2.184 . . . . 51.21 105.104 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -160.45 161.41 32.91 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.738 -1.119 . . . . 51.13 110.909 -176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.14 126.81 50.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.365 -1.346 . . . . 61.24 107.365 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.01 34.79 23.74 Favored 'General case' 0 CA--C 1.475 -1.925 0 CA-C-O 124.631 2.158 . . . . 43.01 110.339 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 60.42 17.33 7.11 Favored 'General case' 0 C--N 1.266 -3.058 1 CA-C-N 108.341 -4.027 . . . . 72.23 113.362 -177.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.4 t -89.04 125.86 42.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.64 -1.245 . . . . 70.14 107.64 175.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.4 p -57.58 123.42 15.53 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 123.847 0.859 . . . . 53.52 112.837 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 2.9 mp -107.32 -5.84 17.55 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.457 -0.792 . . . . 62.01 112.602 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -83.89 136.28 34.16 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.779 -0.768 . . . . 43.55 111.035 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 63.05 32.37 15.41 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.113 1.365 . . . . 71.53 114.469 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 33.2 m -112.07 169.15 4.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.257 -1.386 . . . . 71.14 107.257 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 82.6 p -79.26 150.46 31.54 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.359 -0.937 . . . . 73.54 108.937 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.573 ' O ' HG23 ' A' ' 388' ' ' VAL . 6.8 t-160 -51.2 -37.25 45.63 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.212 0.449 . . . . 61.22 112.212 -175.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.44 ' HA ' ' OG1' ' B' ' 143' ' ' THR . 0.5 OUTLIER -62.33 -40.69 97.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 121.386 -0.126 . . . . 74.51 110.903 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -67.24 -37.15 83.08 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 109.188 -0.671 . . . . 72.35 109.188 -177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.523 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -68.66 -56.56 7.77 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 114.581 -1.19 . . . . 61.3 110.685 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 384' ' ' HIS . 27.4 t -58.98 -44.56 91.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 110.043 -0.354 . . . . 70.55 110.043 -177.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 87.3 m -60.29 -33.72 72.76 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.178 -0.465 . . . . 42.45 111.171 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.66 -38.03 86.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.425 -0.172 . . . . 74.33 110.757 177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.4 mp -75.54 -30.12 59.63 Favored 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 119.914 -0.714 . . . . 64.12 110.219 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 55.0 mttm -72.31 -27.71 62.62 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 112.289 0.477 . . . . 74.02 112.289 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -80.07 51.36 1.35 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.047 0.927 . . . . 62.35 111.833 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 17.5 p -124.78 162.88 23.32 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 107.246 -1.39 . . . . 73.05 107.246 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 55.1 m -148.69 101.38 3.2 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.939 0.876 . . . . 74.35 110.669 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.571 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 0.8 OUTLIER 47.18 30.28 1.36 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 111.425 -2.625 . . . . 75.15 114.259 172.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -169.24 117.56 0.64 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 106.334 -1.728 . . . . 71.31 106.334 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.81 146.16 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.754 0.422 . . . . 73.14 111.036 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.524 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 28.0 m-85 -121.93 96.84 5.22 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.625 0.77 . . . . 72.31 108.975 171.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.45 ' CD2' HG23 ' A' ' 402' ' ' VAL . 7.0 tt -91.61 133.89 35.16 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 115.799 -0.637 . . . . 73.43 109.695 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -117.55 110.9 18.52 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.242 0.617 . . . . 60.15 110.651 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.45 HG23 ' CD2' ' A' ' 400' ' ' LEU . 53.7 t -104.99 143.13 16.8 Favored 'Isoleucine or valine' 0 C--O 1.27 2.162 0 C-N-CA 124.047 0.939 . . . . 64.41 110.525 177.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -125.76 154.52 42.41 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 103.957 -2.608 . . . . 73.43 103.957 167.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -89.42 153.67 48.44 Favored Pre-proline 0 C--N 1.285 -2.198 0 C-N-CA 119.303 -0.959 . . . . 71.1 111.085 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . 0.548 ' HB2' ' O ' ' A' ' 409' ' ' HIS . 2.4 Cg_endo -45.14 132.84 11.53 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 123.3 2.666 . . . . 75.44 112.394 176.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 11.4 m -70.5 75.98 0.57 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 113.912 -1.495 . . . . 64.32 114.738 -171.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 77.73 -60.62 3.72 Favored Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 117.697 1.839 . . . . 71.21 117.697 166.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 33.4 p -61.81 -33.93 75.01 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.221 1.01 . . . . 73.25 110.086 -173.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . 0.548 ' O ' ' HB2' ' A' ' 405' ' ' PRO . 64.2 m80 -128.13 142.31 51.23 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 104.747 -2.316 . . . . 74.44 104.747 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . 0.429 ' HA ' ' HG2' ' A' ' 405' ' ' PRO . 12.4 p-80 -151.91 135.53 16.2 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 123.253 0.346 . . . . 73.41 110.735 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 . . . . . 0 C--N 1.318 -0.791 0 N-CA-C 107.263 -1.384 . . . . 73.51 107.263 -179.297 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.569 0 N-CA-C 107.296 -1.372 . . . . 62.41 107.296 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . 0.477 ' HA ' HH11 ' B' ' 142' ' ' ARG . 9.7 mmm180 -108.93 147.11 32.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.558 -1.275 . . . . 75.42 107.558 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' A' ' 385' ' ' GLU . 15.8 p -117.14 154.77 30.49 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 119.824 -0.751 . . . . 73.23 109.392 -174.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . 0.448 ' HD3' ' HA ' ' B' ' 144' ' ' ARG . 57.1 mmt-85 -153.47 148.72 26.95 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 121.055 0.455 . . . . 74.15 111.147 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . 0.455 ' HB3' ' CB ' ' A' ' 384' ' ' HIS . 13.7 pt20 -86.92 170.9 11.22 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 115.162 -0.926 . . . . 70.53 111.399 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . 0.637 ' HA ' ' HE ' ' B' ' 146' ' ' ARG . 1.7 mmp_? 67.4 21.38 9.72 Favored 'General case' 0 CA--C 1.506 -0.713 0 C-N-CA 125.088 1.355 . . . . 64.13 110.881 -173.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -161.53 172.72 15.92 Favored 'General case' 0 C--O 1.26 1.608 0 CA-C-N 113.081 -1.872 . . . . 74.04 106.478 173.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' B' ' 148' ' ' GLU . 0.1 OUTLIER -95.61 159.79 14.82 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 123.797 0.686 . . . . 74.03 110.074 -178.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.415 HG21 HG22 ' B' ' 143' ' ' THR . 45.9 m -145.12 140.08 27.76 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.729 -0.607 . . . . 72.01 110.585 177.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -81.9 135.88 35.37 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.673 0.789 . . . . 73.44 110.393 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.42 HG12 HG13 ' A' ' 388' ' ' VAL . 15.3 m . . . . . 0 C--O 1.27 2.146 0 CA-C-N 116.077 -0.51 . . . . 64.15 111.641 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 C--O 1.209 -1.046 0 N-CA-C 108.233 -1.025 . . . . 63.3 108.233 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.285 2.0 pm0 -104.31 139.51 39.19 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 114.069 1.137 . . . . 73.34 114.069 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.471 HD13 ' O ' ' A' ' 363' ' ' GLY . 89.9 mt -128.66 122.53 57.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.168 -1.833 . . . . 62.13 107.986 -172.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.534 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 33.1 ttpt -94.79 109.67 21.62 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.38 -0.528 . . . . 42.24 110.622 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.429 HD21 ' HA2' ' A' ' 363' ' ' GLY . 88.0 mt -106.61 151.49 24.98 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.678 -1.147 . . . . 61.31 109.769 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 24.2 mm -105.25 111.22 33.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.038 -1.467 . . . . 75.31 107.038 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -75.98 130.55 38.6 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.355 -0.384 . . . . 70.33 111.548 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -133.09 -154.97 7.65 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 119.386 -1.388 . . . . 53.21 112.696 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.51 -13.26 35.03 Favored 'Trans proline' 0 N--CA 1.481 0.77 0 C-N-CA 123.411 2.741 . . . . 71.24 114.177 -174.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -106.27 8.57 31.94 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 122.176 0.988 . . . . 62.23 108.386 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.02 -136.28 14.66 Favored Glycine 0 CA--C 1.492 -1.376 0 CA-C-N 113.844 -1.525 . . . . 34.13 110.497 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.457 ' HB2' HG23 ' B' ' 151' ' ' VAL . 4.0 mp -98.55 -26.26 14.47 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.746 -1.946 . . . . 73.52 105.746 171.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . 0.593 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 80.28 54.04 3.93 Favored Glycine 0 N--CA 1.436 -1.366 0 CA-C-N 113.689 -1.596 . . . . 42.02 115.113 172.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -155.35 158.52 38.83 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 108.218 -1.03 . . . . 71.2 108.218 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' A' ' 352' ' ' LYS . 14.9 m -113.08 133.64 54.9 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.388 -0.597 . . . . 74.42 109.388 -177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.3 pt -116.16 154.54 17.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 115.833 -0.622 . . . . 52.15 110.996 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -143.58 127.37 17.21 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.478 -1.675 . . . . 63.5 106.478 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 148.33 150.67 5.26 Favored Glycine 0 C--N 1.283 -2.416 0 N-CA-C 109.323 -1.511 . . . . 71.44 109.323 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.65 171.84 12.75 Favored Glycine 0 C--N 1.287 -2.189 0 N-CA-C 108.044 -2.022 . . . . 75.13 108.044 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.408 ' HA ' HD21 ' A' ' 346' ' ' ASN . 61.1 t -45.57 111.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.087 0.943 . . . . 60.44 111.58 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 94.05 -30.49 7.53 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.097 -0.956 . . . . 71.33 112.361 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' B' ' 146' ' ' ARG . 63.3 t30 -105.46 26.75 9.08 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.808 -0.442 . . . . 72.3 109.808 -177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.83 123.93 8.91 Favored 'General case' 0 C--O 1.26 1.646 0 CA-C-N 116.017 -0.538 . . . . 75.45 109.793 177.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -75.81 -52.62 9.99 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.141 -0.936 . . . . 71.34 109.497 -173.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 73.3 mt -103.26 133.18 20.46 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 107.817 -1.179 . . . . 71.14 107.817 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.61 110.84 0.47 Allowed 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 123.424 2.749 . . . . 71.14 113.755 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 97.54 -4.58 61.91 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.322 -0.854 . . . . 61.43 112.045 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 23.8 t0 -120.15 96.82 5.32 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.831 0.824 . . . . 72.31 108.841 -177.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.408 HD21 ' HA ' ' A' ' 337' ' ' VAL . 52.7 t30 -85.05 28.91 0.67 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.506 0.669 . . . . 74.3 110.7 -171.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.456 ' HB2' ' CE2' ' A' ' 349' ' ' TYR . 15.2 m -90.45 164.71 14.17 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.105 0.479 . . . . 63.52 111.106 -175.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 24.6 mm -79.54 125.01 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 108.428 -0.953 . . . . 75.11 108.428 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.589 ' CE1' ' HB2' ' A' ' 370' ' ' LYS . 47.7 m-85 -123.71 130.22 52.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.089 0.471 . . . . 73.45 111.801 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.17 117.1 6.31 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 CA-C-N 115.432 -0.804 . . . . 73.14 109.254 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.2 m -100.06 -18.16 17.13 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.484 0.659 . . . . 75.44 110.476 -175.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.566 ' HB2' ' HZ3' ' A' ' 352' ' ' LYS . 2.3 ttmp? -166.57 153.05 8.81 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.047 -1.094 . . . . 72.33 108.047 -175.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 64.8 mt -126.87 119.86 54.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 107.037 -1.468 . . . . 62.45 107.037 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 42.8 mm -86.28 125.94 40.68 Favored 'Isoleucine or valine' 0 C--O 1.259 1.568 0 C-N-CA 123.234 0.614 . . . . 74.54 109.72 -175.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.31 147.6 47.69 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 108.285 -1.005 . . . . 63.35 108.285 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.558 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.49 -19.06 56.03 Favored Glycine 0 C--N 1.281 -2.487 0 N-CA-C 109.714 -1.355 . . . . 41.22 109.714 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . 0.593 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -72.93 149.85 43.51 Favored Glycine 1 N--CA 1.395 -4.095 0 N-CA-C 109.515 -1.434 . . . . 62.21 109.515 173.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -56.95 -36.84 70.73 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.132 -0.692 . . . . 60.21 109.132 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.574 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.81 -13.04 60.28 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 113.263 0.838 . . . . 51.32 113.263 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -94.14 -31.4 14.18 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.369 -0.974 . . . . 72.32 108.369 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.558 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 75.1 mmtt -84.69 -58.2 2.82 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 119.738 -0.785 . . . . 64.12 110.676 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -86.46 -42.17 13.81 Favored 'General case' 0 CA--C 1.467 -2.225 0 CA-C-O 121.887 0.851 . . . . 74.32 111.124 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -42.66 -23.1 0.17 Allowed Glycine 0 CA--C 1.482 -2.024 0 N-CA-C 120.328 2.891 . . . . 74.43 120.328 -158.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.516 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.84 32.48 0.4 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 119.037 1.418 . . . . 54.14 111.658 -178.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 48.5 tp -99.69 152.78 19.69 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.519 -1.219 . . . . 73.25 109.83 -171.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -117.14 144.65 44.47 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 121.478 0.656 . . . . 64.1 110.677 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.9 mt -66.12 120.81 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 106.958 -1.497 . . . . 72.22 106.958 170.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.56 -7.46 20.27 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 120.803 -0.713 . . . . 51.41 112.157 -176.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -70.14 137.54 51.14 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-O 121.17 0.509 . . . . 70.13 111.742 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.589 ' HB2' ' CE1' ' A' ' 349' ' ' TYR . 36.1 tttp -92.07 119.14 31.48 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.281 -0.872 . . . . 71.1 110.118 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 93.8 mt -79.08 114.71 18.24 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.293 -0.632 . . . . 75.33 109.293 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.457 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 3.3 tt -82.49 -39.84 21.92 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.205 -1.776 . . . . 64.41 106.205 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.92 166.86 21.29 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.538 -0.756 . . . . 53.44 112.331 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.524 HG12 HD11 ' A' ' 379' ' ' LEU . 12.0 p -132.74 116.69 27.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 107.493 -1.299 . . . . 43.21 107.493 171.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 63.22 29.58 15.94 Favored 'General case' 0 CA--C 1.469 -2.145 0 CA-C-O 123.943 1.83 . . . . 62.24 109.672 -172.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 66.39 11.8 8.23 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 109.556 -3.475 . . . . 74.42 113.182 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 49.8 t -78.57 119.31 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 N-CA-C 106.214 -1.773 . . . . 74.11 106.214 172.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -59.45 124.62 20.64 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 114.328 1.233 . . . . 65.51 114.328 -173.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.524 HD11 HG12 ' A' ' 374' ' ' VAL . 6.6 mp -101.76 11.15 39.24 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 124.921 1.288 . . . . 54.43 108.973 174.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.457 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 24.0 mm-40 -78.43 112.23 15.25 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.258 -1.337 . . . . 75.25 108.682 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . 0.405 ' CD ' HD22 ' A' ' 346' ' ' ASN . 19.0 tp10 61.06 83.55 0.14 Allowed 'General case' 0 CA--C 1.544 0.719 0 O-C-N 124.51 1.131 . . . . 63.44 111.721 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 19.3 m -153.13 162.83 2.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.061 -1.427 . . . . 74.52 107.975 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.419 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 2.0 m -78.64 143.32 36.46 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.726 -0.842 . . . . 72.41 108.726 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.568 ' O ' HG23 ' A' ' 388' ' ' VAL . 86.4 t60 -51.95 -49.66 62.73 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 120.872 0.367 . . . . 75.45 111.695 -175.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.498 ' HG3' ' OG1' ' B' ' 143' ' ' THR . 70.6 tt0 -61.05 -36.55 79.9 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.119 -0.946 . . . . 63.01 110.7 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.419 ' HB3' ' O ' ' A' ' 383' ' ' THR . 48.6 tt0 -73.75 -34.04 64.56 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.417 -1.265 . . . . 63.03 108.799 -174.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.546 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -71.83 -48.16 48.1 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.744 -1.117 . . . . 64.22 110.137 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 384' ' ' HIS . 19.3 t -58.52 -45.37 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 109.409 -0.589 . . . . 71.53 109.409 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 66.0 m -61.34 -31.72 71.59 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 116.08 -0.509 . . . . 64.31 111.348 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.65 84.16 Favored 'General case' 0 C--N 1.343 0.313 0 O-C-N 122.019 -0.426 . . . . 23.44 110.312 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.3 mp -79.08 -23.99 43.79 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 120.199 -0.6 . . . . 75.11 110.915 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.481 ' HE2' HG12 ' A' ' 388' ' ' VAL . 61.5 mttm -75.91 -32.19 59.51 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.528 0.566 . . . . 71.2 112.528 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -74.83 32.55 0.09 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.364 1.065 . . . . 65.24 113.761 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 1.7 p -124.77 158.45 33.28 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 109.968 -0.382 . . . . 71.2 109.968 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 62.8 m -148.53 125.84 11.55 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.535 -0.543 . . . . 55.23 109.535 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 26.6 t70 60.98 0.17 0.36 Allowed 'General case' 0 C--O 1.2 -1.513 0 C-N-CA 126.578 1.951 . . . . 72.35 114.954 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -158.38 119.12 3.36 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 120.276 -1.515 . . . . 73.41 110.333 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 93.7 t -142.21 117.93 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 122.553 0.341 . . . . 62.53 111.678 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.534 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 17.8 m-85 -90.07 96.53 10.72 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.123 -1.066 . . . . 65.0 108.123 167.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 tt -83.35 130.82 35.08 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.097 -0.705 . . . . 73.22 109.097 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 38.8 tttp -121.19 112.62 18.88 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 109.954 -0.387 . . . . 74.3 109.954 -173.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 53.7 t -104.92 144.58 14.52 Favored 'Isoleucine or valine' 0 C--O 1.263 1.788 0 C-N-CA 123.753 0.821 . . . . 73.32 110.882 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -121.58 157.75 30.07 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 104.95 -2.241 . . . . 65.4 104.95 172.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 9.5 mmpt? -83.5 152.91 64.73 Favored Pre-proline 0 C--N 1.285 -2.208 0 C-N-CA 119.184 -1.006 . . . . 74.12 109.051 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . 0.572 ' HA ' ' OH ' ' A' ' 349' ' ' TYR . 2.2 Cg_endo -48.74 117.43 2.71 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 123.271 2.647 . . . . 74.41 113.632 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.4 -38.33 22.1 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 114.681 1.363 . . . . 65.2 114.681 -174.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -95.65 34.28 4.98 Favored Glycine 0 C--N 1.292 -1.864 0 C-N-CA 120.074 -1.06 . . . . 72.53 114.242 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 19.5 p -168.31 -175.68 2.65 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.571 -0.529 . . . . 72.33 109.571 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -76.98 130.99 38.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.051 -1.833 . . . . 71.43 106.051 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 404' ' ' LYS . 3.0 p-80 -107.03 143.56 34.97 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 115.409 1.633 . . . . 54.01 115.409 -172.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 . . . . . 0 N--CA 1.432 -1.34 0 N-CA-C 105.593 -2.003 . . . . 63.43 105.593 178.149 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.508 0 N-CA-C 109.002 -0.74 . . . . 72.23 109.002 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 69.62 -37.12 0.36 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 124.771 1.228 . . . . 75.04 111.381 -173.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.498 ' OG1' ' HG3' ' A' ' 385' ' ' GLU . 9.0 p -70.6 155.74 40.34 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 106.419 -1.696 . . . . 74.3 106.419 169.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . 0.45 ' O ' ' HD2' ' A' ' 384' ' ' HIS . 2.7 mmp_? -152.71 153.69 33.75 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.301 -1.0 . . . . 74.24 108.301 -172.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -87.04 169.85 12.05 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.016 0.436 . . . . 45.33 111.637 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . 0.451 ' HA ' ' OD1' ' A' ' 339' ' ' ASN 0.355 13.0 mmt180 65.96 20.91 11.35 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 125.43 1.492 . . . . 75.1 114.962 -178.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -144.86 170.24 16.5 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.621 -1.622 . . . . 64.22 106.621 173.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.04 146.3 24.36 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 107.406 -1.331 . . . . 73.53 107.406 174.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.435 HG21 HG22 ' B' ' 143' ' ' THR . 15.0 m -134.14 132.39 39.81 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 120.424 -0.51 . . . . 74.53 109.701 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -75.58 136.36 40.52 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 109.671 -0.492 . . . . 62.12 109.671 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.457 HG23 ' HB2' ' A' ' 329' ' ' LEU . 18.0 m . . . . . 0 C--N 1.296 -1.73 0 CA-C-O 117.107 -1.425 . . . . 65.51 112.107 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 109.331 -0.618 . . . . 62.22 109.331 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.33 119.8 11.67 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 122.247 1.022 . . . . 64.31 109.203 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 65.3 mt -98.47 106.56 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.895 0 CA-C-N 113.689 -1.596 . . . . 74.3 109.736 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -76.5 104.01 6.79 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 104.408 -2.442 . . . . 72.31 104.408 165.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 359' ' ' ALA . 0.6 OUTLIER -109.25 136.23 49.05 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 113.751 -1.568 . . . . 75.44 106.976 -173.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 21.9 mm -95.03 137.14 24.08 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 C-N-CA 119.36 -0.936 . . . . 71.32 109.292 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 395' ' ' SER . 1.2 ttpm? -68.16 177.64 2.18 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-O 121.106 0.479 . . . . 73.14 109.835 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.521 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -150.68 -173.88 21.2 Favored Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 110.229 -1.148 . . . . 65.02 110.229 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.47 -41.02 21.6 Favored 'Trans proline' 0 N--CA 1.482 0.831 0 C-N-CA 122.955 2.436 . . . . 62.3 112.178 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.35 -14.54 46.1 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 123.31 1.529 . . . . 61.24 107.656 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 98.74 -143.75 16.81 Favored Glycine 0 C--N 1.256 -3.885 0 CA-C-N 113.38 -1.736 . . . . 71.04 109.437 -171.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.1 mp -74.76 -46.24 38.48 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 117.679 0.739 . . . . 61.41 111.105 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 83.41 53.15 3.51 Favored Glycine 0 C--O 1.22 -0.72 0 C-N-CA 120.173 -1.013 . . . . 52.5 115.364 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . 0.488 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 49.0 p90 -151.82 172.98 15.33 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.185 -0.672 . . . . 71.24 109.185 173.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.486 ' OG ' ' HG2' ' B' ' 150' ' ' GLN . 3.9 m -123.38 136.1 54.47 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.951 -0.388 . . . . 44.13 109.951 -177.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 16.4 pt -120.57 156.55 23.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 116.318 -0.401 . . . . 71.34 110.146 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' B' ' 148' ' ' GLU . . . -148.02 133.3 18.46 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.96 -1.126 . . . . 63.35 107.96 175.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 157.83 -177.43 34.59 Favored Glycine 0 C--N 1.273 -2.922 0 N-CA-C 108.5 -1.84 . . . . 71.21 108.5 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.11 175.47 13.98 Favored Glycine 0 C--N 1.272 -2.986 0 N-CA-C 108.054 -2.018 . . . . 51.14 108.054 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.8 100.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.49 0.662 . . . . 62.21 110.769 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 80.71 2.45 89.96 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 115.164 -0.926 . . . . 55.24 113.445 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -107.69 11.81 28.06 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.057 -1.09 . . . . 73.43 108.057 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.88 134.27 56.48 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 115.624 1.713 . . . . 73.42 115.624 -173.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -71.62 -34.97 70.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.005 -1.452 . . . . 64.24 109.515 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 41.8 mm -104.75 118.89 55.23 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.998 -0.546 . . . . 75.51 110.299 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -57.94 110.17 0.59 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.745 2.297 . . . . 73.34 111.489 176.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.33 -28.23 9.87 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.95 -0.643 . . . . 71.01 111.832 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -106.77 102.51 11.87 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.766 -0.827 . . . . 64.24 108.766 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -82.66 38.11 0.55 Allowed 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 123.721 0.809 . . . . 73.14 112.208 -170.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 75.2 m -103.2 178.44 4.56 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 113.268 0.84 . . . . 74.33 113.268 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.459 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 25.7 mm -93.96 131.32 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 CA-C-N 114.853 -1.067 . . . . 44.4 108.128 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 369' ' ' ASP . 28.9 m-85 -124.11 135.14 53.32 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 112.691 0.626 . . . . 73.03 112.691 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.69 116.57 5.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.072 -1.084 . . . . 62.34 108.072 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 28.3 m -107.57 -20.41 13.25 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 120.852 0.358 . . . . 74.12 111.537 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 331' ' ' PHE . 47.0 mmtm -149.34 159.06 44.61 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 107.524 -1.287 . . . . 75.51 107.524 177.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.441 HG22 ' HB2' ' A' ' 360' ' ' HIS . 75.9 mt -140.54 124.97 18.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 107.049 -1.463 . . . . 73.11 107.049 172.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 39.2 mm -85.62 116.49 28.89 Favored 'Isoleucine or valine' 0 C--O 1.253 1.28 0 N-CA-C 108.15 -1.055 . . . . 74.05 108.15 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.55 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 1.1 pp20? -66.23 147.53 53.18 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 107.257 -1.386 . . . . 73.1 107.257 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.485 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.69 -26.66 19.11 Favored Glycine 0 C--N 1.288 -2.123 0 N-CA-C 109.691 -1.364 . . . . 63.42 109.691 -175.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -69.98 156.83 53.49 Favored Glycine 0 C--O 1.272 2.489 0 N-CA-C 110.914 -0.874 . . . . 75.21 110.914 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -57.6 -41.17 80.71 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 109.792 -0.448 . . . . 53.42 109.792 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.655 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.99 -4.88 43.6 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 113.394 0.887 . . . . 73.25 113.394 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . 0.55 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 69.6 t60 -94.8 -38.18 10.88 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.641 -0.824 . . . . 54.04 109.136 172.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.485 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 72.7 mmtt -83.42 -57.2 3.35 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.976 -0.689 . . . . 73.23 111.362 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -85.54 -30.81 23.09 Favored 'General case' 0 CA--C 1.463 -2.383 0 CA-C-O 121.672 0.749 . . . . 70.34 109.588 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -43.31 -32.66 1.81 Allowed Glycine 0 CA--C 1.475 -2.413 0 CA-C-N 113.239 -1.801 . . . . 61.34 117.22 -168.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? 45.09 36.85 2.21 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 124.626 0.839 . . . . 74.41 110.408 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 29.9 tp -119.78 158.56 26.29 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 113.79 -1.55 . . . . 71.14 109.339 -168.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.75 145.23 49.63 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-N 115.82 -0.627 . . . . 71.54 109.936 -174.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 81.1 mt -66.77 119.23 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 108.991 -0.744 . . . . 71.24 108.991 175.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.76 3.33 20.25 Favored Glycine 0 C--N 1.314 -0.663 0 C-N-CA 120.984 -0.627 . . . . 71.33 111.996 -175.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 8.0 m-20 -73.25 133.02 43.83 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.818 0.673 . . . . 74.34 112.818 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 44.5 tttp -92.9 114.83 27.5 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.444 1.098 . . . . 70.42 108.473 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 83.9 mt -83.61 112.07 19.68 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 109.848 -0.427 . . . . 73.34 109.848 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.4 tt -83.7 -40.71 18.55 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.531 -1.213 . . . . 74.33 107.918 -176.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -162.6 145.82 11.24 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.689 -0.687 . . . . 71.2 109.72 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.56 130.19 49.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 109.377 -0.601 . . . . 74.12 109.377 175.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 44.93 67.27 0.73 Allowed 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 125.652 1.581 . . . . 71.02 110.343 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 66.43 -26.69 0.11 Allowed 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 114.771 1.397 . . . . 75.3 114.771 -176.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 42.5 t -78.84 125.7 38.41 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.343 0 O-C-N 121.651 -0.656 . . . . 73.44 110.487 -175.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -74.92 130.04 38.71 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 122.481 0.312 . . . . 74.0 110.521 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.6 0.09 22.34 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.474 0.546 . . . . 74.53 112.474 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -68.36 106.71 2.59 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.43 -0.582 . . . . 72.42 109.43 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 62.85 73.82 0.45 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 122.678 1.228 . . . . 60.23 113.077 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.56 169.71 16.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.515 -1.221 . . . . 71.24 107.834 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.518 ' OG1' ' HG2' ' A' ' 386' ' ' GLU . 3.0 p -76.63 147.85 37.3 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.639 -0.874 . . . . 65.12 108.639 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.603 ' O ' HG23 ' A' ' 388' ' ' VAL . 10.6 t-80 -57.52 -37.04 72.37 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.496 0.665 . . . . 74.54 109.446 -172.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -56.45 -44.05 80.12 Favored 'General case' 0 N--CA 1.403 -2.8 0 CA-C-N 113.88 -1.509 . . . . 72.42 112.826 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.518 ' HG2' ' OG1' ' A' ' 383' ' ' THR . 20.0 mm-40 -75.28 -29.33 60.1 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 109.189 -0.671 . . . . 63.24 109.189 -176.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.421 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -67.33 -58.12 5.38 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.489 -1.232 . . . . 50.14 109.086 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 384' ' ' HIS . 17.8 t -59.27 -41.42 83.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 N-CA-C 109.447 -0.575 . . . . 53.5 109.447 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 35.1 m -61.46 -35.63 78.16 Favored 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 115.977 -0.556 . . . . 71.13 111.477 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -69.07 -38.02 78.82 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 122.341 -0.224 . . . . 43.24 110.583 176.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 387' ' ' ALA . 6.1 mp -72.16 -28.92 63.55 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.419 -0.513 . . . . 71.23 110.596 176.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 61.5 mttm -73.91 -34.88 64.55 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 120.602 -0.439 . . . . 72.32 112.106 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -84.77 62.39 7.37 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.785 0.802 . . . . 61.43 110.877 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 22.5 p -125.6 152.44 45.13 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.311 -0.859 . . . . 73.43 109.282 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . 0.531 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 50.4 m -146.83 90.11 1.88 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 122.218 1.009 . . . . 70.13 111.072 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.497 ' H ' ' HB2' ' A' ' 324' ' ' LYS 0.265 22.1 m-20 62.2 14.35 6.6 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 111.951 -2.386 . . . . 73.31 115.208 170.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -157.77 107.6 2.15 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 108.034 -1.098 . . . . 70.54 108.034 173.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 43.7 t -114.73 123.73 70.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.787 -0.819 . . . . 34.04 108.787 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.74 95.7 6.83 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 105.108 -2.182 . . . . 65.13 105.108 174.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 8.0 tt -102.22 104.02 14.56 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-O 121.376 0.608 . . . . 72.53 109.582 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -93.61 112.03 23.83 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.138 -1.43 . . . . 52.15 107.138 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.426 HG21 ' HB3' ' A' ' 369' ' ' ASP . 4.7 p -119.16 146.17 24.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.209 -0.905 . . . . 62.22 110.557 -173.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.539 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -125.17 158.38 34.1 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.298 -1.001 . . . . 72.33 108.298 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -92.92 152.94 41.94 Favored Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 106.958 -1.497 . . . . 62.32 106.958 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -75.46 78.29 3.06 Favored 'Trans proline' 0 C--O 1.248 1.007 0 C-N-CA 121.46 1.44 . . . . 74.12 110.5 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 31.1 m -77.39 74.39 3.96 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 122.439 1.114 . . . . 74.32 112.304 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -168.08 18.79 0.08 OUTLIER Glycine 0 C--N 1.304 -1.209 0 CA-C-N 113.661 -1.608 . . . . 63.21 109.743 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 26.0 t -168.89 -168.31 0.85 Allowed 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 105.635 -1.987 . . . . 54.04 105.635 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -80.74 89.7 5.78 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.447 0.642 . . . . 71.31 109.494 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -86.91 143.78 27.25 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.127 -0.942 . . . . 75.04 110.895 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 78.7 m80 . . . . . 0 C--N 1.294 -1.838 0 N-CA-C 107.095 -1.446 . . . . 61.15 107.095 179.333 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.455 -2.71 0 N-CA-C 107.89 -1.152 . . . . 52.12 107.89 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . 0.523 ' HG2' ' H ' ' B' ' 143' ' ' THR . 36.4 ttt180 -162.03 177.09 10.07 Favored 'General case' 0 N--CA 1.395 -3.191 0 N-CA-C 106.36 -1.719 . . . . 73.31 106.36 -173.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.523 ' H ' ' HG2' ' B' ' 142' ' ' ARG . 33.4 p -67.24 178.81 1.37 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.783 1.233 . . . . 64.2 110.363 176.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . 0.404 ' HD2' ' OD1' ' B' ' 147' ' ' ASN . 34.8 mtt180 -152.12 151.3 30.89 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 109.146 -0.687 . . . . 73.02 109.146 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -85.28 175.1 9.12 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.018 -0.992 . . . . 64.22 108.962 170.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . 0.255 3.6 mpt_? 65.33 14.44 9.43 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.53 1.132 . . . . 54.4 113.617 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . 0.472 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.2 OUTLIER -155.29 163.87 39.55 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 107.988 -1.116 . . . . 73.54 107.988 173.494 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 334' ' ' ALA . 15.3 pt-20 -85.56 156.61 20.67 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.733 -0.839 . . . . 72.44 108.733 176.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 49.0 m -144.17 141.0 29.68 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.9 -0.5 . . . . 52.41 110.265 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . 0.486 ' HG2' ' OG ' ' A' ' 332' ' ' SER . 77.7 mt-30 -85.35 149.22 25.6 Favored 'General case' 0 CA--C 1.454 -2.742 0 CA-C-O 121.445 0.64 . . . . 63.33 111.631 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . 0.272 22.0 m . . . . . 1 N--CA 1.374 -4.253 0 CA-C-O 117.453 -1.261 . . . . 73.44 110.443 174.59 . . . . . . . . 2 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 CA--C 1.494 -1.193 0 N-CA-C 106.559 -1.645 . . . . 75.23 106.559 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.429 1.8 pm0 -114.61 134.4 55.09 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 116.319 1.97 . . . . 74.52 116.319 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 73.7 mt -124.43 112.88 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.037 0 CA-C-N 112.573 -2.103 . . . . 71.41 109.186 -173.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -79.66 124.97 29.05 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.416 -1.327 . . . . 70.34 107.416 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 45.2 mt -114.48 144.33 43.51 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.072 -1.084 . . . . 75.02 108.072 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 396' ' ' ASP . 54.3 mt -105.86 110.79 32.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 108.504 -0.925 . . . . 63.14 108.504 171.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.685 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 9.6 tmtt? -55.68 158.78 3.33 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 124.568 1.168 . . . . 64.12 111.601 177.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -144.37 -166.66 11.59 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 111.435 -0.666 . . . . 60.41 111.435 -176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.81 -15.08 46.22 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 123.324 2.683 . . . . 74.22 112.991 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 355' ' ' GLU . 37.0 ttpt -112.67 19.58 17.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.048 0.928 . . . . 74.33 109.248 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.92 -127.3 8.0 Favored Glycine 0 CA--C 1.497 -1.032 0 CA-C-N 114.994 -1.003 . . . . 54.42 111.31 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.537 ' HB2' HG23 ' B' ' 151' ' ' VAL . 4.0 mp -104.89 -22.72 13.11 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.224 -1.028 . . . . 73.52 108.224 178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 73.72 50.98 9.93 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 114.807 -1.088 . . . . 63.33 115.606 171.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -154.43 149.79 27.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.442 -0.577 . . . . 65.25 109.442 172.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 7.5 m -105.01 128.3 53.25 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 120.95 0.405 . . . . 74.53 109.919 -175.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.404 ' HB ' HG23 ' A' ' 348' ' ' ILE . 30.3 pt -122.82 151.58 27.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.596 -0.729 . . . . 73.11 111.03 -175.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -140.9 137.16 32.97 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 105.55 -2.018 . . . . 72.42 105.55 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 347' ' ' SER . . . 147.45 162.54 10.07 Favored Glycine 0 C--N 1.281 -2.49 0 N-CA-C 109.771 -1.332 . . . . 64.5 109.771 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.53 177.34 14.88 Favored Glycine 0 C--N 1.284 -2.345 0 N-CA-C 108.718 -1.753 . . . . 34.13 108.718 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 99.2 t -55.8 108.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 117.522 0.661 . . . . 73.2 109.971 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 86.45 -11.1 64.53 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.648 -0.706 . . . . 71.33 112.712 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' B' ' 145' ' ' GLN . 0.2 OUTLIER -106.39 9.74 31.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.051 -1.463 . . . . 63.21 107.051 179.162 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.95 121.66 4.97 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.939 1.296 . . . . 72.55 111.969 -175.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -82.28 -27.03 32.61 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.942 -1.026 . . . . 60.43 109.132 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.619 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 2.9 mp -116.52 131.48 23.84 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 106.779 -1.563 . . . . 75.2 106.779 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.53 107.01 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.571 2.18 . . . . 71.34 112.909 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 102.22 0.91 51.02 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.621 -0.718 . . . . 75.11 112.861 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.619 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 22.0 t70 -129.67 101.38 5.88 Favored 'General case' 0 C--O 1.245 0.825 0 CA-C-O 121.398 0.618 . . . . 72.45 109.617 -177.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.418 ' HB2' ' OE2' ' A' ' 381' ' ' GLU . 32.6 m-80 -87.1 38.01 0.79 Allowed 'General case' 0 CA--C 1.5 -0.96 0 O-C-N 121.556 -0.715 . . . . 74.1 110.684 -174.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.487 ' O ' ' HA3' ' A' ' 335' ' ' GLY . 14.3 m -86.3 157.43 19.91 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.703 0.763 . . . . 72.31 111.202 -176.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.404 HG23 ' HB ' ' A' ' 333' ' ' ILE . 38.4 mm -75.63 122.82 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.563 0 N-CA-C 106.606 -1.627 . . . . 74.14 106.606 173.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 342' ' ' ILE . 3.5 t80 -124.0 133.78 53.6 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 108.319 -0.993 . . . . 72.23 108.319 -173.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.412 HG21 HD21 ' A' ' 365' ' ' LEU . 43.9 t -74.82 109.78 8.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.851 -0.613 . . . . 71.4 109.581 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.564 ' O ' ' HD2' ' A' ' 352' ' ' LYS . 8.6 m -90.78 -36.73 14.1 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.975 -0.557 . . . . 74.44 109.976 -178.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.564 ' HD2' ' O ' ' A' ' 351' ' ' THR . 1.2 mptm? -144.6 156.46 44.14 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.099 -0.704 . . . . 55.35 109.099 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 71.6 mt -125.35 129.51 73.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 106.284 -1.747 . . . . 64.31 106.284 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 47.2 mm -85.64 141.83 13.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 123.525 0.516 . . . . 65.32 110.186 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 327' ' ' LYS . 0.9 OUTLIER -57.03 120.87 8.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.286 1.034 . . . . 72.14 112.584 -174.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 72.59 14.49 77.68 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 115.281 -0.872 . . . . 52.1 112.97 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -73.54 168.42 53.95 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.213 -1.155 . . . . 43.24 110.213 176.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -58.76 -39.11 80.03 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 117.312 0.556 . . . . 63.43 110.346 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.61 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -72.58 -15.16 61.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.225 0.536 . . . . 52.05 111.94 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -95.19 -23.56 17.22 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.959 -0.756 . . . . 74.45 108.959 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 4.0 tmmt? -95.76 -60.16 1.71 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.649 0.738 . . . . 73.32 111.062 -175.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -86.94 -31.14 20.82 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 122.336 1.065 . . . . 74.31 109.426 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.786 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -53.61 -50.41 53.66 Favored Glycine 0 CA--C 1.481 -2.072 0 N-CA-C 119.135 2.414 . . . . 43.41 119.135 -167.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.786 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 43.8 34.17 0.83 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.253 1.025 . . . . 64.23 109.676 -167.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 350' ' ' VAL . 21.7 tp -92.2 158.27 16.25 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 113.547 -1.66 . . . . 53.14 109.752 -169.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -117.07 144.3 44.8 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.726 0.774 . . . . 71.1 110.845 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 71.0 mt -65.85 119.99 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 106.108 -1.812 . . . . 63.02 106.108 167.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.416 ' HA2' ' CE2' ' A' ' 349' ' ' TYR . . . 115.46 3.45 20.72 Favored Glycine 0 C--N 1.295 -1.699 0 C-N-CA 119.669 -1.253 . . . . 50.24 112.16 -173.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 7.2 m-20 -75.8 137.19 40.36 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 113.139 0.792 . . . . 60.12 113.139 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -100.47 115.28 29.71 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.13 -1.063 . . . . 71.53 108.13 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 60.5 mt -84.67 115.51 22.7 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.236 0.541 . . . . 63.33 110.246 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.3 tt -81.77 -37.11 27.68 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.837 -1.529 . . . . 63.2 107.695 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 401' ' ' LYS . . . -163.34 157.25 19.85 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.79 -0.641 . . . . 71.22 111.216 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.473 HG12 HD11 ' A' ' 379' ' ' LEU . 14.5 p -133.88 122.93 43.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 107.569 -1.271 . . . . 45.22 107.569 172.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . 0.548 HD21 HG22 ' A' ' 394' ' ' THR . 89.3 m-20 62.2 29.32 17.44 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 124.036 1.874 . . . . 55.53 108.853 -174.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 67.21 10.42 7.7 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 109.515 -3.493 . . . . 73.13 113.479 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.9 t -79.94 124.49 38.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 106.576 -1.639 . . . . 74.13 106.576 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -64.35 127.51 31.79 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.009 0.744 . . . . 75.5 113.009 -175.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.473 HD11 HG12 ' A' ' 374' ' ' VAL . 6.9 mp -106.31 6.71 30.83 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 123.865 0.866 . . . . 74.22 110.973 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -76.91 122.97 25.6 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.16 -1.792 . . . . 52.13 106.16 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . 0.418 ' OE2' ' HB2' ' A' ' 346' ' ' ASN 0.32 1.5 mp0 48.52 83.09 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 116.062 1.875 . . . . 73.25 116.062 -172.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 15.8 m -149.85 157.82 6.12 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-N 113.428 -1.714 . . . . 53.55 107.735 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.8 m -81.16 140.73 34.81 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.424 -0.954 . . . . 73.41 108.424 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.561 ' O ' HG23 ' A' ' 388' ' ' VAL . 82.6 t60 -50.93 -46.18 60.77 Favored 'General case' 0 C--O 1.207 -1.168 0 N-CA-C 112.993 0.738 . . . . 74.13 112.993 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.43 ' HA ' ' OG1' ' B' ' 143' ' ' THR . 4.0 tp10 -59.24 -40.45 85.98 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.966 0.888 . . . . 63.42 109.677 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.0 tt0 -72.52 -39.76 67.33 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.074 -1.421 . . . . 72.2 108.856 -173.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.414 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -71.35 -46.17 61.17 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 114.449 -1.251 . . . . 44.13 110.997 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 384' ' ' HIS . 57.9 t -59.98 -41.64 86.85 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 N-CA-C 109.872 -0.418 . . . . 71.42 109.872 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 62.2 m -58.9 -35.63 73.35 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 123.443 0.464 . . . . 73.51 110.478 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.31 -34.54 78.57 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 122.075 -0.391 . . . . 71.13 110.82 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.9 mp -80.74 -30.3 36.21 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 120.426 -0.509 . . . . 72.03 110.943 176.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.453 ' HD2' ' OE ' ' B' ' 141' ' ' PCA . 51.7 mttm -73.91 -23.54 59.56 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.23 0.456 . . . . 74.2 112.23 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -77.69 49.41 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.371 0.605 . . . . 71.03 110.562 175.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.548 HG22 HD21 ' A' ' 375' ' ' ASN . 21.5 p -124.77 142.35 51.48 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 109.472 -0.566 . . . . 74.55 109.472 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 62.1 m -144.48 99.09 3.31 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 122.571 1.177 . . . . 72.01 112.076 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.685 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 7.7 m-20 65.58 12.36 8.16 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 111.023 -2.808 . . . . 73.03 112.819 168.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -160.76 129.37 4.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.332 -1.729 . . . . 74.45 106.332 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.7 t -139.53 141.74 34.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 107.668 -1.234 . . . . 52.2 107.668 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -118.5 95.93 5.07 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.756 -1.572 . . . . 73.1 106.756 174.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.58 130.72 35.85 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 122.785 0.434 . . . . 53.35 110.571 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 373' ' ' ALA . 22.7 ttmm -116.21 108.97 16.8 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.178 -1.045 . . . . 72.51 108.178 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 369' ' ' ASP . 7.9 p -113.38 155.39 14.6 Favored 'Isoleucine or valine' 0 C--O 1.269 2.113 0 CA-C-N 116.035 -0.53 . . . . 65.54 110.449 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -136.62 157.58 46.44 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.422 -1.325 . . . . 72.22 107.422 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 9.7 mmpt? -88.59 153.39 50.3 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 107.302 -1.37 . . . . 70.12 107.302 176.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . 0.456 ' HG3' ' OH ' ' A' ' 349' ' ' TYR . 29.2 Cg_endo -64.42 120.09 7.3 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 108.171 -1.511 . . . . 63.1 108.171 173.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 12.7 m -67.06 84.37 0.13 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.997 0.903 . . . . 73.34 112.668 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -168.14 165.09 38.52 Favored Glycine 0 N--CA 1.414 -2.788 0 N-CA-C 108.128 -1.989 . . . . 44.04 108.128 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 12.1 m -83.48 22.65 1.02 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 117.958 0.879 . . . . 41.31 110.682 -177.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -128.58 26.51 5.62 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.14 -1.059 . . . . 65.22 108.14 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -87.76 144.76 26.45 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.744 -0.662 . . . . 75.02 112.082 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 . . . . . 0 C--N 1.297 -1.677 0 N-CA-C 106.116 -1.809 . . . . 74.04 106.116 171.813 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . 0.47 ' N ' ' HG1' ' B' ' 143' ' ' THR . . . . . . . . 0 CA--C 1.48 -1.716 0 CA-C-O 121.299 0.571 . . . . 73.41 110.072 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 68.97 18.36 8.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 113.305 -1.771 . . . . 74.02 109.085 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.479 ' HB ' ' CD2' ' A' ' 384' ' ' HIS . 4.8 p -97.77 122.43 40.85 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 114.746 -1.115 . . . . 65.12 109.533 -176.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -153.8 171.67 18.55 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 107.99 -1.115 . . . . 73.31 107.99 -173.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . 0.506 ' HA ' ' OD1' ' A' ' 339' ' ' ASN . 20.9 mp0 -53.97 147.4 12.45 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.955 1.095 . . . . 74.33 113.955 -172.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 67.04 28.66 8.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 113.424 -1.716 . . . . 73.4 113.765 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . 0.513 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.1 OUTLIER -143.19 152.55 41.89 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 118.297 -1.361 . . . . 62.03 111.991 173.038 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -96.33 145.69 25.39 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.668 -1.234 . . . . 75.44 107.668 172.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 65.7 m -147.4 144.23 28.53 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.992 -0.443 . . . . 74.34 110.011 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -76.34 136.08 39.55 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.096 0.474 . . . . 73.31 110.593 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.537 HG23 ' HB2' ' A' ' 329' ' ' LEU . 4.3 m . . . . . 0 C--N 1.292 -1.912 0 CA-C-N 115.59 -0.732 . . . . 72.12 110.309 173.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 C--O 1.202 -1.442 0 N-CA-C 106.242 -1.762 . . . . 53.21 106.242 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.509 ' HB3' ' HG2' ' A' ' 401' ' ' LYS 0.343 1.8 pm0 -118.24 136.94 53.36 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 114.919 1.452 . . . . 64.42 114.919 -174.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 363' ' ' GLY . 75.3 mt -126.23 114.38 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 CA-C-N 113.214 -1.812 . . . . 73.25 110.048 -172.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.478 ' HG3' ' CZ ' ' A' ' 397' ' ' PHE . 0.9 OUTLIER -79.71 136.43 36.77 Favored 'General case' 0 C--N 1.279 -2.498 0 N-CA-C 107.718 -1.216 . . . . 63.2 107.718 172.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.59 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 97.0 mt -131.63 157.26 44.15 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.581 -0.525 . . . . 73.12 109.581 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 324' ' ' LYS . 2.4 mp -106.27 140.97 22.65 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 N-CA-C 106.006 -1.85 . . . . 74.2 106.006 171.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.521 ' HG2' ' H ' ' A' ' 325' ' ' GLY . 1.3 ttpm? -75.36 177.85 6.3 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.007 -1.108 . . . . 50.34 108.007 177.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.521 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -160.91 -172.26 27.97 Favored Glycine 0 C--N 1.284 -2.325 0 N-CA-C 110.848 -0.901 . . . . 73.53 110.848 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.12 -13.95 28.74 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.879 2.386 . . . . 73.52 112.064 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.433 ' HB3' ' NZ ' ' A' ' 327' ' ' LYS . 9.0 mtpm? -115.18 20.08 15.2 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 115.973 -0.558 . . . . 64.13 110.996 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.44 -127.12 7.96 Favored Glycine 0 C--N 1.299 -1.492 0 N-CA-C 110.643 -0.983 . . . . 61.1 110.643 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.441 ' HB2' HG23 ' B' ' 151' ' ' VAL . 4.9 mp -105.83 -27.19 11.4 Favored 'General case' 0 C--O 1.268 2.054 0 N-CA-C 108.235 -1.024 . . . . 61.0 108.235 178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 86.08 49.45 4.24 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 114.054 -1.43 . . . . 34.15 115.695 173.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -155.07 145.06 21.67 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 117.097 0.449 . . . . 73.32 111.144 172.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 14.5 m -96.34 126.38 41.5 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 124.005 0.922 . . . . 65.01 109.233 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 28.0 pt -117.11 144.37 25.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 116.28 -0.418 . . . . 72.12 111.377 -177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' B' ' 148' ' ' GLU . . . -130.99 136.16 48.27 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.414 -1.698 . . . . 64.33 106.414 174.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 145.12 161.45 9.06 Favored Glycine 0 C--N 1.268 -3.241 0 N-CA-C 109.685 -1.366 . . . . 54.03 109.685 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.82 173.49 13.22 Favored Glycine 0 N--CA 1.418 -2.512 0 N-CA-C 107.245 -2.342 . . . . 63.1 107.245 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 66.3 t -53.11 107.49 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 118.137 0.969 . . . . 72.24 110.554 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.45 -18.47 57.34 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.109 -0.951 . . . . 62.22 112.586 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.512 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 60.1 t30 -106.5 18.2 22.27 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.655 -0.498 . . . . 74.22 109.655 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.4 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -51.68 120.09 4.86 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.828 -0.624 . . . . 75.13 111.297 -178.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -76.96 -40.24 47.63 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.431 -0.804 . . . . 52.23 109.803 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.2 mm -104.29 120.72 49.85 Favored Pre-proline 0 C--N 1.303 -1.434 0 CA-C-N 115.736 -0.665 . . . . 71.03 109.715 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.6 106.61 0.16 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 123.28 2.653 . . . . 64.11 112.349 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 107.96 -3.42 33.72 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 115.475 -0.784 . . . . 63.4 111.881 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -132.38 98.0 4.26 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.569 -0.9 . . . . 64.24 108.569 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 64.4 t30 -83.37 38.05 0.59 Allowed 'General case' 0 CA--C 1.553 1.068 0 CA-C-O 121.953 0.882 . . . . 75.44 111.89 -170.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 73.7 m -102.12 178.46 4.6 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.682 -0.69 . . . . 72.31 112.765 -178.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 31.3 mm -88.94 129.37 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 114.969 -1.014 . . . . 51.22 108.644 -178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.555 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 35.6 m-85 -124.06 140.43 52.98 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.195 0.521 . . . . 74.2 111.691 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.415 HG21 HD21 ' A' ' 365' ' ' LEU . 42.7 t -78.94 111.0 15.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.132 -0.94 . . . . 60.31 109.243 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 25.7 m -88.28 -30.46 19.62 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.198 0.523 . . . . 74.03 110.882 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.428 ' HD3' ' N ' ' A' ' 353' ' ' ILE . 9.1 tmtt? -155.36 137.83 15.0 Favored 'General case' 0 C--O 1.203 -1.385 0 N-CA-C 108.284 -1.006 . . . . 71.23 108.284 -176.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.428 ' N ' ' HD3' ' A' ' 352' ' ' LYS . 74.1 mt -109.17 129.73 63.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.632 -1.247 . . . . 65.41 107.632 174.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 49.7 mm -77.47 126.33 37.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.358 0.599 . . . . 73.45 110.037 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.561 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.4 pm0 -62.31 127.04 29.45 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 114.39 -1.277 . . . . 75.31 110.739 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.442 ' H ' ' CD2' ' A' ' 360' ' ' HIS . . . 95.56 -19.56 53.72 Favored Glycine 0 N--CA 1.426 -1.994 0 CA-C-N 115.021 -0.99 . . . . 62.32 112.533 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -68.19 167.03 43.82 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 114.278 0.471 . . . . 64.05 114.278 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -61.26 -41.99 97.85 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.313 0.645 . . . . 52.24 111.132 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.425 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.11 -7.74 54.61 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 119.692 -0.803 . . . . 61.44 111.954 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . 0.442 ' CD2' ' H ' ' A' ' 356' ' ' GLY . 18.7 t60 -94.09 -30.53 14.62 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.928 -0.767 . . . . 73.4 108.928 176.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -89.65 -59.65 2.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.028 -0.533 . . . . 72.32 111.671 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -87.14 -38.96 15.96 Favored 'General case' 0 CA--C 1.475 -1.91 0 N-CA-C 108.608 -0.886 . . . . 54.21 108.608 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.56 ' HA2' HD21 ' A' ' 322' ' ' LEU . . . -44.68 -31.25 2.51 Favored Glycine 0 C--O 1.207 -1.57 0 N-CA-C 119.195 2.438 . . . . 42.54 119.195 -167.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.538 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 41.37 32.21 0.2 Allowed 'General case' 0 N--CA 1.515 2.808 0 CA-C-N 118.803 1.302 . . . . 75.31 111.377 -174.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . 0.415 HD21 HG21 ' A' ' 350' ' ' VAL . 43.7 tp -98.11 155.07 17.32 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.551 -1.204 . . . . 73.43 109.474 -170.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -125.08 150.98 46.27 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.344 0.592 . . . . 75.54 111.267 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 75.9 mt -65.95 122.98 17.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.297 -1.001 . . . . 64.24 108.297 173.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 113.25 -2.3 25.29 Favored Glycine 0 C--N 1.312 -0.788 0 C-N-CA 120.686 -0.769 . . . . 22.34 112.126 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 3.5 m-20 -72.13 136.68 46.59 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 112.83 0.678 . . . . 73.44 112.83 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.627 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 33.9 tttp -96.2 115.28 27.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.213 1.405 . . . . 74.12 109.648 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 68.3 mt -85.21 118.92 25.05 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.156 0.503 . . . . 63.12 109.693 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.3 tt -87.61 -39.38 15.11 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.074 -1.421 . . . . 62.01 108.093 -176.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -160.77 156.09 24.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.05 -0.523 . . . . 64.33 111.095 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.474 HG12 HD11 ' A' ' 379' ' ' LEU . 11.1 p -134.74 123.33 41.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 108.139 -1.06 . . . . 73.55 108.139 173.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . 0.573 HD21 HG22 ' A' ' 394' ' ' THR . 54.5 m-20 62.32 29.55 17.32 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 123.516 1.627 . . . . 74.4 108.282 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.5 t30 67.0 18.87 10.61 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 110.449 -3.068 . . . . 72.52 112.331 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 50.7 t -88.91 128.22 41.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 106.505 -1.665 . . . . 75.12 106.505 172.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.9 p -64.4 124.75 22.58 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 113.126 0.788 . . . . 74.51 113.126 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.474 HD11 HG12 ' A' ' 374' ' ' VAL . 7.5 mp -108.27 -2.48 19.24 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.561 0.745 . . . . 70.42 111.224 177.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -68.2 107.6 2.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.952 -0.567 . . . . 64.0 109.605 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 60.66 74.91 0.43 Allowed 'General case' 0 CA--C 1.545 0.775 0 O-C-N 124.619 1.199 . . . . 72.52 113.296 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 387' ' ' ALA . 24.1 m -135.05 167.09 26.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.183 -1.414 . . . . 72.33 107.183 176.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 51.6 p -79.73 141.22 36.56 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 118.918 0.781 . . . . 63.32 110.325 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.49 ' O ' HG23 ' A' ' 388' ' ' VAL . 82.7 t60 -45.56 -49.27 14.12 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.672 0.99 . . . . 71.21 113.672 -174.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.508 ' HA ' ' OG1' ' B' ' 143' ' ' THR . 10.0 tp10 -61.33 -38.78 88.13 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.212 0.53 . . . . 73.53 111.54 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.0 tt0 -70.46 -35.05 73.1 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.511 -0.922 . . . . 75.3 108.511 -177.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.435 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -70.54 -53.91 14.24 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 114.441 -1.254 . . . . 61.22 110.582 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.569 HG11 HG21 ' B' ' 143' ' ' THR . 44.5 t -59.54 -43.36 90.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 C-N-CA 121.147 -0.221 . . . . 61.15 110.57 -177.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 53.8 m -62.04 -30.32 70.89 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 111.953 0.353 . . . . 75.11 111.953 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.13 -35.08 78.98 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 122.124 -0.36 . . . . 53.53 110.331 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.7 mp -80.57 -28.61 37.15 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 120.394 -0.523 . . . . 71.14 110.783 176.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.427 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 54.3 mttm -74.31 -24.23 59.19 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.576 -0.45 . . . . 73.14 111.536 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -82.16 65.2 7.18 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.347 1.07 . . . . 71.52 110.19 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.573 HG22 HD21 ' A' ' 375' ' ' ASN . 13.3 p -130.65 145.63 51.96 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 113.987 -1.46 . . . . 71.31 107.679 177.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 43.8 m -141.77 91.28 2.35 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-O 122.568 1.175 . . . . 62.34 111.25 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.515 ' HA ' ' H ' ' A' ' 324' ' ' LYS 0.343 12.4 m-20 65.16 4.79 2.72 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 111.438 -2.619 . . . . 60.04 115.616 172.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . 0.478 ' CZ ' ' HG3' ' A' ' 321' ' ' LYS . 37.6 t80 -151.85 134.52 15.5 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 106.368 -1.716 . . . . 73.21 106.368 171.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.59 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.8 t -138.29 145.69 28.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.812 -1.181 . . . . 72.55 107.812 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -126.0 96.1 4.63 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.027 -1.101 . . . . 73.44 108.027 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.2 tt -92.63 132.84 36.54 Favored 'General case' 0 C--N 1.277 -2.546 0 C-N-CA 123.031 0.532 . . . . 75.04 110.739 -174.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.509 ' HG2' ' HB3' ' A' ' 319' ' ' GLU . 65.8 mttm -114.31 118.72 34.7 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.152 -0.684 . . . . 61.3 109.152 174.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 369' ' ' ASP . 3.6 p -118.58 149.04 21.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 CA-C-N 115.048 -0.978 . . . . 73.01 109.979 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.627 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.45 159.32 42.15 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 125.119 1.368 . . . . 63.0 107.337 178.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -84.93 154.43 60.96 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 109.267 -0.642 . . . . 52.12 109.267 175.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -46.55 119.33 3.11 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 124.204 3.269 . . . . 75.31 113.933 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 16.5 p -95.21 -12.03 27.02 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.415 -0.811 . . . . 73.23 111.963 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -102.47 22.52 37.23 Favored Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 120.713 -0.756 . . . . 32.11 111.735 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 13.9 t -167.96 -164.72 0.57 Allowed 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.521 -1.659 . . . . 63.42 106.521 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 63.1 t-80 -82.44 144.72 30.28 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.606 -1.257 . . . . 72.32 107.606 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -74.11 144.59 44.88 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 120.636 0.255 . . . . 70.14 110.644 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 . . . . . 0 C--N 1.297 -1.711 0 N-CA-C 106.76 -1.57 . . . . 71.32 106.76 175.358 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 120.959 0.409 . . . . 51.22 110.139 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -139.14 28.91 2.27 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.085 -1.08 . . . . 74.41 108.085 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.569 HG21 HG11 ' A' ' 388' ' ' VAL . 6.7 p -99.17 155.78 17.3 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 115.83 -0.623 . . . . 65.33 111.705 -175.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -153.8 134.95 14.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.051 -1.833 . . . . 64.24 106.051 -169.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 339' ' ' ASN . 13.3 pm0 -65.52 152.02 45.02 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.608 0.966 . . . . 54.22 113.608 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . 0.481 ' H ' ' CG ' ' A' ' 339' ' ' ASN 0.275 64.3 mtm180 67.67 59.53 0.48 Allowed 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 126.789 2.036 . . . . 63.4 112.984 -174.208 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 173.93 157.8 0.14 Allowed 'General case' 0 C--O 1.245 0.833 0 CA-C-N 110.966 -2.833 . . . . 74.14 107.494 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 334' ' ' ALA . 0.9 OUTLIER -95.96 157.18 16.01 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.232 0.539 . . . . 74.31 110.948 174.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 51.6 m -147.84 146.85 29.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.726 -0.842 . . . . 74.41 108.726 174.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 1.2 tt0 -79.79 137.84 37.09 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 120.996 0.427 . . . . 74.42 110.952 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 329' ' ' LEU . 15.7 m . . . . . 0 N--CA 1.426 -1.633 0 CA-C-N 115.711 -0.677 . . . . 74.21 110.767 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . 0.605 ' SD ' ' HE3' ' A' ' 404' ' ' LYS . 27.5 ttt . . . . . 0 CA--C 1.495 -1.168 0 N-CA-C 107.041 -1.466 . . . . 63.34 107.041 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.325 2.3 pm0 -115.87 137.56 51.99 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-O 122.202 1.001 . . . . 74.21 113.658 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 363' ' ' GLY . 70.2 mt -128.62 130.49 68.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 113.225 -1.807 . . . . 63.22 108.155 -169.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -108.07 107.66 18.42 Favored 'General case' 0 N--CA 1.411 -2.387 0 N-CA-C 108.348 -0.982 . . . . 73.13 108.348 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.55 HD21 ' HA2' ' A' ' 363' ' ' GLY . 93.3 mt -105.65 160.07 15.48 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.346 -0.843 . . . . 74.44 110.055 -176.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.2 113.41 42.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 N-CA-C 108.148 -1.056 . . . . 72.54 108.148 171.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.609 ' HB3' ' H ' ' A' ' 396' ' ' ASP . 0.0 OUTLIER -67.13 140.87 57.56 Favored 'General case' 0 C--O 1.207 -1.168 0 N-CA-C 106.953 -1.499 . . . . 70.23 106.953 174.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.497 ' N ' ' HD2' ' A' ' 324' ' ' LYS . . . -142.31 -161.2 8.67 Favored Glycine 0 C--N 1.27 -3.099 0 CA-C-O 119.946 -0.363 . . . . 73.23 112.498 -171.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.94 -12.92 37.43 Favored 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 123.829 3.02 . . . . 51.23 113.507 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -109.43 5.96 23.83 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.175 0.988 . . . . 71.41 108.932 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.99 -121.35 5.49 Favored Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 108.965 -1.654 . . . . 63.54 108.965 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.79 -26.2 11.38 Favored 'General case' 0 C--O 1.266 1.952 0 N-CA-C 107.844 -1.169 . . . . 75.22 107.844 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.41 43.49 6.54 Favored Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 113.707 -1.588 . . . . 63.11 114.675 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -155.22 151.1 27.72 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 117.056 0.428 . . . . 72.11 110.286 174.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 29.2 m -106.28 129.58 54.28 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 124.145 0.978 . . . . 74.44 109.578 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 14.8 pt -114.32 156.63 15.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.776 -0.647 . . . . 74.25 110.666 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -143.68 130.02 19.89 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.896 -1.89 . . . . 61.31 105.896 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 149.67 153.21 5.98 Favored Glycine 0 C--N 1.27 -3.094 0 N-CA-C 109.012 -1.635 . . . . 54.45 109.012 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.82 173.1 13.09 Favored Glycine 0 C--N 1.283 -2.39 0 N-CA-C 106.558 -2.617 . . . . 62.02 106.558 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.46 ' HA ' HD21 ' A' ' 346' ' ' ASN . 61.8 t -45.75 106.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 118.597 1.198 . . . . 74.34 111.705 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 93.01 -23.92 27.05 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.541 -0.754 . . . . 64.0 112.27 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.482 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 32.7 t-20 -97.78 19.41 13.75 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.353 -0.98 . . . . 70.31 108.353 -177.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.1 118.7 3.09 Favored 'General case' 0 C--O 1.257 1.493 0 CA-C-O 121.263 0.554 . . . . 62.31 110.301 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -77.75 -43.59 30.35 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.075 -0.966 . . . . 73.44 109.052 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 39.3 mm -103.65 131.25 22.21 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 108.119 -1.067 . . . . 74.12 108.119 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.1 110.46 0.48 Allowed 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 123.173 2.582 . . . . 60.11 113.551 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.86 -3.6 65.11 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.407 -0.815 . . . . 24.21 112.189 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 29.2 t0 -119.64 99.69 6.81 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.716 -0.846 . . . . 72.14 108.716 -176.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.46 HD21 ' HA ' ' A' ' 337' ' ' VAL . 51.7 t30 -84.0 26.04 0.77 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.532 0.682 . . . . 73.22 110.845 -171.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 20.0 m -88.5 172.29 9.46 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.369 0.604 . . . . 71.34 111.762 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 370' ' ' LYS . 18.3 mm -88.28 122.76 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 115.185 -0.916 . . . . 71.13 108.575 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 51.2 m-85 -123.62 131.93 53.74 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.031 0.443 . . . . 62.52 110.748 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.476 HG21 HD11 ' A' ' 365' ' ' LEU . 47.9 t -70.64 120.75 19.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.888 -0.597 . . . . 71.42 109.4 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 22.4 m -101.03 -23.16 14.56 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.102 0.477 . . . . 73.34 111.353 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -155.55 137.03 14.09 Favored 'General case' 0 C--O 1.201 -1.458 0 N-CA-C 107.618 -1.253 . . . . 70.03 107.618 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' A' ' 360' ' ' HIS . 73.4 mt -108.94 126.03 65.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 107.099 -1.445 . . . . 71.4 107.099 172.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 49.7 mm -74.48 134.9 28.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.293 0.568 . . . . 54.1 109.853 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.569 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.4 pm0 -62.39 120.84 11.81 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-O 122.45 1.119 . . . . 72.15 111.588 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 79.44 18.63 73.31 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-N 114.284 -1.325 . . . . 71.11 111.484 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.78 162.75 52.13 Favored Glycine 0 C--O 1.25 1.143 0 N-CA-C 111.783 -0.527 . . . . 71.02 111.783 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.61 98.97 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.892 -0.781 . . . . 75.33 108.892 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.528 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.64 -9.29 58.46 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.475 -0.89 . . . . 70.51 111.917 177.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . 0.445 ' HB2' HG22 ' A' ' 353' ' ' ILE . 23.7 t60 -88.85 -29.19 19.86 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.596 -0.89 . . . . 74.24 108.596 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.608 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 1.1 mmpm? -95.04 -57.65 2.37 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 113.13 0.789 . . . . 71.21 113.13 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -85.68 -43.05 13.75 Favored 'General case' 0 CA--C 1.457 -2.628 0 O-C-N 123.771 0.669 . . . . 72.11 110.647 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.576 ' O ' HD13 ' A' ' 320' ' ' ILE . . . -42.74 -25.5 0.33 Allowed Glycine 0 C--O 1.203 -1.79 0 N-CA-C 119.379 2.512 . . . . 73.31 119.379 -163.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.468 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.59 34.45 0.56 Allowed 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 119.133 1.467 . . . . 71.21 111.265 -178.588 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . 0.553 HD13 ' N ' ' A' ' 366' ' ' GLN . 2.6 tm? -109.36 148.6 30.81 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.163 -1.38 . . . . 65.41 107.786 -170.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . 0.553 ' N ' HD13 ' A' ' 365' ' ' LEU . 0.0 OUTLIER -117.06 142.06 47.46 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 109.796 -0.446 . . . . 75.44 109.796 -178.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.76 121.3 8.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.111 -1.07 . . . . 64.3 108.111 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.35 -4.45 21.76 Favored Glycine 0 N--CA 1.433 -1.54 0 N-CA-C 111.426 -0.67 . . . . 54.42 111.426 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.574 ' HB3' HG21 ' A' ' 402' ' ' VAL . 56.3 m-20 -75.63 136.28 40.45 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 113.193 0.812 . . . . 71.52 113.193 177.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 36.4 tttp -88.8 119.69 29.52 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 124.658 1.183 . . . . 74.13 111.135 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 79.1 mt -85.41 124.84 32.46 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.885 -0.783 . . . . 75.33 108.885 177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.482 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 5.3 tt -92.08 -40.16 11.22 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.336 -1.302 . . . . 74.22 107.965 -177.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -159.86 160.94 34.27 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 116.017 -0.538 . . . . 71.32 111.733 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.557 HG12 HD11 ' A' ' 379' ' ' LEU . 13.9 p -133.55 117.33 27.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.413 -0.958 . . . . 74.25 108.413 171.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 58.54 36.17 25.04 Favored 'General case' 0 CA--C 1.485 -1.526 0 CA-C-O 123.4 1.571 . . . . 73.54 109.347 -173.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 66.79 9.55 6.84 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 110.831 -2.895 . . . . 53.25 113.693 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.9 121.09 31.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.263 -1.754 . . . . 62.3 106.263 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.8 p -64.35 125.82 25.81 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 113.366 0.876 . . . . 74.41 113.366 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.557 HD11 HG12 ' A' ' 374' ' ' VAL . 7.1 mp -101.32 7.13 42.94 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.731 -1.122 . . . . 74.41 109.445 176.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.482 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 18.4 mm-40 -79.9 111.24 16.03 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.59 -1.186 . . . . 75.24 108.958 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 61.14 83.57 0.14 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.718 1.207 . . . . 72.33 112.232 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 19.7 m -153.58 165.21 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 125.563 1.545 . . . . 61.23 107.139 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.707 ' HB ' ' OE1' ' A' ' 386' ' ' GLU . 2.8 m -85.08 156.85 20.9 Favored 'General case' 0 C--O 1.258 1.539 0 N-CA-C 107.221 -1.4 . . . . 73.24 107.221 176.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.535 ' O ' HG23 ' A' ' 388' ' ' VAL . 85.7 t60 -57.13 -40.73 77.7 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-O 121.303 0.573 . . . . 72.34 109.988 -170.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -54.68 -46.64 74.1 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 114.187 -1.37 . . . . 71.31 113.871 177.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.707 ' OE1' ' HB ' ' A' ' 383' ' ' THR . 1.8 mp0 -71.72 -32.14 67.45 Favored 'General case' 0 CA--C 1.476 -1.872 0 CA-C-N 118.711 0.687 . . . . 73.32 109.423 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.6 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -64.46 -57.72 8.44 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 114.728 -1.124 . . . . 73.21 109.218 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 384' ' ' HIS . 21.7 t -61.35 -41.76 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 116.446 -0.343 . . . . 74.53 110.55 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 90.4 m -62.13 -34.35 76.2 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.071 -0.513 . . . . 62.44 111.433 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.08 80.05 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.522 -0.111 . . . . 71.5 110.859 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.1 mp -79.66 -32.47 41.55 Favored 'General case' 0 C--O 1.214 -0.77 0 C-N-CA 119.217 -0.993 . . . . 61.35 110.777 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -65.21 -35.41 80.97 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 112.663 0.616 . . . . 71.42 112.663 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -83.57 62.08 6.62 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.803 0.811 . . . . 74.4 110.926 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.437 ' HB ' HG22 ' A' ' 398' ' ' VAL . 41.9 p -132.28 149.52 52.35 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 107.526 -1.287 . . . . 65.25 107.526 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . 0.478 ' HA ' ' HE3' ' A' ' 324' ' ' LYS . 34.9 p -141.96 100.99 3.85 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 118.461 -1.296 . . . . 72.01 112.578 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.609 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 3.5 m-20 63.38 7.27 2.84 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 112.504 -2.135 . . . . 71.31 113.621 170.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -152.64 115.25 4.52 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 106.033 -1.84 . . . . 64.33 106.033 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 52.4 t -128.28 113.81 31.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 108.342 -0.984 . . . . 74.0 108.342 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -95.15 95.53 8.61 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.393 -1.336 . . . . 72.01 107.393 174.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.3 tt -89.97 139.02 31.01 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 116.147 -0.479 . . . . 72.32 109.748 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 40.6 tttp -126.84 111.7 14.48 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 108.403 -0.962 . . . . 73.25 108.403 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.574 HG21 ' HB3' ' A' ' 369' ' ' ASP . 2.1 p -115.05 145.94 20.13 Favored 'Isoleucine or valine' 0 C--O 1.266 1.96 0 C-N-CA 123.732 0.813 . . . . 61.13 110.597 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.74 147.77 46.89 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 106.266 -1.753 . . . . 75.51 106.266 174.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.605 ' HE3' ' SD ' ' A' ' 318' ' ' MET . 0.0 OUTLIER -95.82 156.0 37.78 Favored Pre-proline 0 C--N 1.293 -1.881 0 C-N-CA 119.774 -0.77 . . . . 61.35 109.102 178.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . 0.419 ' HG2' ' HB3' ' A' ' 410' ' ' HIS . 37.3 Cg_endo -71.31 63.78 2.76 Favored 'Trans proline' 0 CA--C 1.549 1.237 0 C-N-CA 122.096 1.864 . . . . 64.21 114.011 -176.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 26.7 m -85.32 88.19 7.47 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 107.755 -1.202 . . . . 25.32 107.755 177.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 134.96 -18.87 3.98 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 108.733 -1.747 . . . . 52.12 108.733 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 47.3 t -109.41 -169.61 1.51 Allowed 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 106.787 -1.56 . . . . 65.42 106.787 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -81.64 92.94 6.65 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.308 0.575 . . . . 52.13 111.11 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . 0.419 ' HB3' ' HG2' ' A' ' 405' ' ' PRO . 24.3 p-80 -95.08 142.04 28.0 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.628 -0.878 . . . . 71.42 108.628 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 . . . . . 0 C--N 1.296 -1.74 0 N-CA-C 103.598 -2.741 . . . . 75.31 103.598 -179.043 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.807 0 N-CA-C 108.101 -1.074 . . . . 73.32 108.101 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . 0.407 HH21 ' CD ' ' B' ' 148' ' ' GLU . 87.3 mtm-85 -92.76 20.61 6.32 Favored 'General case' 0 C--O 1.209 -1.045 0 O-C-N 123.398 0.436 . . . . 74.15 110.92 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 61.5 p -65.53 104.26 0.98 Allowed 'General case' 0 C--O 1.246 0.883 0 N-CA-C 109.331 -0.618 . . . . 63.23 109.331 -174.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . 0.537 ' HA ' ' HE ' ' B' ' 144' ' ' ARG . 0.3 OUTLIER -159.67 169.78 22.98 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 106.38 -1.711 . . . . 62.22 106.38 -174.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -85.05 154.27 22.19 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.625 -0.509 . . . . 70.33 109.625 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 66.02 13.29 9.0 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 125.748 1.619 . . . . 63.11 113.489 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . 0.469 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.2 OUTLIER -143.96 170.54 15.73 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.634 -0.427 . . . . 72.32 110.521 179.349 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.407 ' CD ' HH21 ' B' ' 142' ' ' ARG . 0.0 OUTLIER -95.51 166.62 11.77 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.185 0.517 . . . . 74.4 111.8 -177.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 40.7 m -146.06 123.97 12.01 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.736 -0.665 . . . . 75.05 109.608 166.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -68.25 130.14 42.02 Favored 'General case' 0 C--O 1.257 1.468 0 N-CA-C 108.563 -0.903 . . . . 60.25 108.563 172.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.434 HG11 ' CB ' ' A' ' 391' ' ' LEU . 5.3 t . . . . . 0 C--N 1.296 -1.726 0 CA-C-O 117.228 -1.368 . . . . 74.51 109.09 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 CA--C 1.485 -1.521 0 N-CA-C 106.309 -1.738 . . . . 75.3 106.309 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.477 2.0 pm0 -119.09 127.09 53.06 Favored 'General case' 0 N--CA 1.406 -2.641 0 N-CA-C 116.936 2.198 . . . . 63.1 116.936 -174.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.45 HG23 ' HD3' ' A' ' 364' ' ' LYS . 64.5 mt -102.54 106.17 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.623 0 CA-C-N 111.524 -2.58 . . . . 52.41 109.715 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.492 ' HD3' ' CZ ' ' A' ' 399' ' ' TYR . 28.9 ttpt -80.81 110.72 16.59 Favored 'General case' 0 N--CA 1.41 -2.427 0 N-CA-C 106.319 -1.734 . . . . 65.31 106.319 170.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.461 ' HA ' ' OD2' ' A' ' 362' ' ' ASP . 0.6 OUTLIER -110.33 145.7 37.01 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 113.944 -1.48 . . . . 73.35 109.734 -171.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 39.0 mm -105.2 116.8 49.71 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-O 121.306 0.574 . . . . 74.54 110.606 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.696 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 9.7 tmtt? -65.89 156.78 32.38 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.948 -1.024 . . . . 72.34 110.783 175.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -140.44 -165.97 10.5 Favored Glycine 0 C--N 1.303 -1.284 0 N-CA-C 110.748 -0.941 . . . . 73.21 110.748 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.91 -21.51 64.0 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 122.877 2.385 . . . . 71.41 112.59 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -91.61 -9.97 42.18 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.132 0.968 . . . . 64.44 110.449 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 97.42 -112.76 4.54 Favored Glycine 0 C--N 1.272 -3.014 0 N-CA-C 108.381 -1.887 . . . . 30.41 108.381 -171.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.5 mp -109.13 -35.64 6.26 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 117.89 0.845 . . . . 53.52 109.589 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 84.48 50.72 4.14 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.841 -1.171 . . . . 72.42 114.903 175.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 54.4 p90 -155.07 163.04 40.83 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 117.146 0.473 . . . . 73.31 110.239 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 66.2 m -108.78 132.72 53.7 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 109.757 -0.46 . . . . 73.01 109.757 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 19.3 pt -122.84 149.6 26.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 109.863 -0.421 . . . . 70.12 109.863 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.7 129.3 16.04 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.537 -0.912 . . . . 74.33 108.537 175.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 165.1 -178.24 40.23 Favored Glycine 0 C--N 1.283 -2.393 0 N-CA-C 108.63 -1.788 . . . . 74.43 108.63 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.03 173.22 13.22 Favored Glycine 0 C--N 1.279 -2.592 0 N-CA-C 108.466 -1.853 . . . . 52.12 108.466 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 90.6 t -56.15 100.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 117.682 0.741 . . . . 74.33 110.623 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 88.33 -2.08 84.79 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.373 -0.83 . . . . 34.43 112.616 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.525 ' CG ' ' H ' ' B' ' 146' ' ' ARG . 63.2 t30 -109.02 3.55 22.23 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.575 0.702 . . . . 74.31 109.644 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER -61.39 127.29 30.76 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 115.042 1.497 . . . . 73.3 115.042 -174.299 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -66.67 -32.25 73.45 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.876 -1.511 . . . . 73.45 110.809 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 43.3 mm -104.64 114.61 63.83 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 116.319 -0.4 . . . . 64.05 110.033 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.23 111.19 0.78 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.888 2.392 . . . . 53.41 111.789 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.07 -22.98 20.09 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.84 -0.695 . . . . 65.24 111.607 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -112.39 106.97 15.61 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.175 -0.676 . . . . 71.11 109.175 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -85.22 63.04 7.87 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.502 0.668 . . . . 73.12 111.095 -173.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.469 ' HB2' ' CE1' ' A' ' 349' ' ' TYR . 7.2 m -119.06 177.68 4.78 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 119.588 -0.845 . . . . 71.11 111.861 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 26.0 mm -98.15 131.67 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 N-CA-C 106.052 -1.833 . . . . 70.32 106.052 176.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 347' ' ' SER . 42.7 m-85 -123.72 132.55 53.85 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.574 0.583 . . . . 71.03 112.574 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.16 112.46 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.865 -1.062 . . . . 65.02 108.527 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.1 m -92.8 -28.69 16.41 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.458 0.647 . . . . 72.42 109.973 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 331' ' ' PHE . 54.3 tttm -155.89 153.57 29.87 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 108.249 -1.019 . . . . 72.32 108.249 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 86.9 mt -118.22 144.23 26.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 N-CA-C 104.873 -2.269 . . . . 52.34 104.873 169.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 39.6 mm -79.92 129.68 37.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.69 -0.485 . . . . 74.23 109.69 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.4 pm0 -63.78 105.02 0.75 Allowed 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.461 -1.245 . . . . 71.54 111.265 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.97 -2.35 63.9 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 114.521 -1.218 . . . . 44.42 112.387 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -69.99 172.04 41.15 Favored Glycine 0 C--O 1.244 0.76 0 O-C-N 123.697 0.293 . . . . 73.01 112.65 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -57.34 -44.12 84.02 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 122.976 0.511 . . . . 54.13 110.894 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.54 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.26 -9.87 58.94 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.726 0.639 . . . . 73.33 112.726 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -94.57 -24.3 17.29 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.19 -1.041 . . . . 62.44 108.19 177.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -89.93 -60.13 2.01 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-O 121.579 0.704 . . . . 63.34 110.054 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . 0.461 ' OD2' ' HA ' ' A' ' 322' ' ' LEU . 24.1 t70 -87.5 -44.66 11.13 Favored 'General case' 0 CA--C 1.46 -2.502 0 CA-C-N 114.588 -1.187 . . . . 72.41 111.485 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -42.82 -24.97 0.28 Allowed Glycine 0 CA--C 1.491 -1.46 0 N-CA-C 119.711 2.645 . . . . 75.2 119.711 -162.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.482 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 41.68 37.12 0.68 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 118.556 1.178 . . . . 74.4 111.34 -178.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 39.8 tp -108.22 158.16 17.69 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.33 -1.304 . . . . 74.21 110.355 -169.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -121.26 143.66 49.04 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.646 0.736 . . . . 70.31 110.756 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.48 126.35 25.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.235 -1.395 . . . . 73.34 107.235 169.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.91 -1.36 30.19 Favored Glycine 0 C--N 1.302 -1.307 0 C-N-CA 120.574 -0.822 . . . . 31.44 111.965 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 5.1 m-20 -66.46 132.07 47.45 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 113.239 0.829 . . . . 65.13 113.239 178.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 39.9 tttp -92.19 114.28 26.79 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.68 1.192 . . . . 73.31 108.752 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 91.7 mt -85.14 116.38 23.47 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.533 -0.467 . . . . 71.34 110.224 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.1 tt -88.02 -39.13 14.91 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.999 -1.482 . . . . 73.22 106.999 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -166.95 156.0 10.47 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.648 -0.705 . . . . 75.55 110.204 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.81 122.74 39.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.968 -0.753 . . . . 75.25 108.968 173.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . 0.556 HD21 HG22 ' A' ' 394' ' ' THR . 87.4 m-20 60.89 35.32 19.29 Favored 'General case' 0 CA--C 1.482 -1.655 0 CA-C-O 123.713 1.72 . . . . 72.52 108.895 -176.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 67.6 7.09 5.39 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 110.174 -3.194 . . . . 73.04 113.396 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 60.7 t -79.87 123.78 37.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 107.014 -1.476 . . . . 71.25 107.014 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.7 p -63.92 124.2 20.94 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.093 0.775 . . . . 71.51 113.093 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.74 -6.09 13.88 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.637 0.775 . . . . 70.11 110.216 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -72.58 105.07 4.08 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.337 -1.356 . . . . 53.45 107.337 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . 0.269 20.1 tt0 60.3 78.88 0.26 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.371 1.468 . . . . 73.21 113.829 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 30.5 m -147.04 175.15 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 107.592 -1.262 . . . . 72.41 107.592 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 75.0 p -81.06 155.22 26.43 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.442 -0.948 . . . . 64.3 108.442 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.575 ' O ' HG23 ' A' ' 388' ' ' VAL . 8.6 t-160 -58.93 -41.26 86.91 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.226 -0.657 . . . . 73.01 109.226 -172.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' B' ' 143' ' ' THR . 3.5 mp0 -51.03 -44.94 61.13 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.659 -1.155 . . . . 72.52 113.492 175.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -68.2 -33.37 74.3 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 121.547 0.689 . . . . 74.32 109.268 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -74.08 -58.8 3.06 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 114.488 -1.233 . . . . 70.04 110.417 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 384' ' ' HIS . 15.7 t -58.31 -40.18 76.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.679 0 O-C-N 123.292 0.37 . . . . 62.22 110.314 -176.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 95.6 m -63.26 -36.81 84.9 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 116.298 -0.41 . . . . 72.03 110.751 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.57 -34.75 77.68 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.396 -0.19 . . . . 74.23 110.739 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.49 -32.49 60.58 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 120.67 -0.412 . . . . 74.44 110.704 175.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 57.7 mttm -72.99 -26.44 61.34 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 120.57 -0.452 . . . . 62.24 112.145 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -80.83 48.88 1.13 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.988 -0.551 . . . . 72.4 110.619 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.556 HG22 HD21 ' A' ' 375' ' ' ASN . 41.7 p -124.43 147.93 47.96 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.438 -0.579 . . . . 73.44 109.438 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 65.9 m -147.4 99.08 3.09 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 122.512 1.149 . . . . 63.3 112.003 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.696 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 8.4 m-20 65.26 13.02 8.5 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 111.195 -2.73 . . . . 73.55 113.218 168.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -165.72 129.08 2.16 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 106.863 -1.532 . . . . 74.1 106.863 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.45 HG22 ' HB ' ' A' ' 394' ' ' THR . 38.9 t -142.39 142.75 26.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 122.735 0.414 . . . . 72.03 110.361 -177.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.492 ' CZ ' ' HD3' ' A' ' 321' ' ' LYS . 13.0 m-85 -118.68 95.6 4.91 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.811 -0.811 . . . . 73.15 108.811 168.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.4 tt -93.7 121.3 34.99 Favored 'General case' 0 C--N 1.284 -2.278 0 C-N-CA 123.383 0.673 . . . . 55.25 109.744 -177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -103.31 107.7 18.62 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.7 -0.852 . . . . 74.13 108.7 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.42 HG21 ' HB3' ' A' ' 369' ' ' ASP . 10.2 p -114.63 157.35 15.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 CA-C-N 114.815 -1.084 . . . . 72.21 110.194 -176.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -135.98 158.6 44.01 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.868 -1.53 . . . . 71.42 106.868 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.641 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 10.9 mmpt? -79.91 153.46 75.17 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 108.54 -0.911 . . . . 72.54 108.54 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -57.09 129.46 34.5 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.315 2.01 . . . . 72.43 113.157 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 6.6 m -70.67 88.36 0.7 Allowed 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.591 -1.186 . . . . 63.45 110.83 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . 167.74 -171.29 42.19 Favored Glycine 0 N--CA 1.41 -3.054 0 C-N-CA 120.392 -0.909 . . . . 62.23 110.982 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 28.6 t -81.12 -13.49 58.64 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.471 -0.566 . . . . 73.15 109.471 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -101.87 94.41 5.8 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.328 -1.36 . . . . 64.15 107.328 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -133.8 143.85 48.64 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 116.036 -0.529 . . . . 60.3 111.056 -178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 . . . . . 0 C--N 1.303 -1.44 0 N-CA-C 106.382 -1.71 . . . . 74.04 106.382 -178.905 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -0.989 0 N-CA-C 108.135 -1.061 . . . . 62.23 108.135 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 26.5 mtp-105 -100.19 -178.32 3.79 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.635 -1.246 . . . . 73.12 107.635 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.489 HG22 HG21 ' B' ' 149' ' ' THR . 72.7 p -53.59 152.06 5.41 Favored 'General case' 0 C--N 1.317 -0.815 0 O-C-N 124.715 1.259 . . . . 52.31 108.568 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -152.5 151.69 31.02 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 119.121 0.873 . . . . 72.41 113.333 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . 0.421 ' H ' ' HG2' ' B' ' 145' ' ' GLN . 10.2 pt20 -85.34 156.14 21.03 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.422 -1.717 . . . . 75.5 112.238 177.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . 0.525 ' H ' ' CG ' ' A' ' 339' ' ' ASN 0.256 38.6 mtm-85 67.15 34.09 5.2 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 125.625 1.57 . . . . 74.21 112.152 -174.666 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -168.12 171.41 9.54 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 111.382 -2.645 . . . . 72.14 106.067 173.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.03 161.55 15.08 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 107.44 -1.318 . . . . 73.21 107.44 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.489 HG21 HG22 ' B' ' 143' ' ' THR . 32.9 m -142.42 104.01 4.34 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 108.353 -0.98 . . . . 72.14 108.353 170.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -60.11 132.19 53.17 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.183 -1.372 . . . . 71.11 110.899 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 331' ' ' PHE . 17.8 m . . . . . 0 C--O 1.262 1.75 0 CA-C-N 116.082 -0.508 . . . . 71.12 111.163 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 51.8 tpp . . . . . 0 CA--C 1.512 -0.503 0 N-CA-C 108.327 -0.99 . . . . 54.31 108.327 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.474 2.0 pm0 -117.67 128.67 55.14 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 116.744 2.127 . . . . 62.52 116.744 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.445 HG23 ' HZ3' ' A' ' 364' ' ' LYS . 70.8 mt -117.33 106.75 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 CA-C-N 111.74 -2.482 . . . . 75.41 109.793 -174.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 398' ' ' VAL . 40.7 ttmt -85.74 132.6 34.1 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.458 -1.312 . . . . 63.23 107.458 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 74.1 mt -129.02 152.12 48.97 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.02 -1.104 . . . . 74.12 108.02 178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 35.7 mm -106.2 112.34 39.01 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.589 0 N-CA-C 107.781 -1.192 . . . . 64.4 107.781 171.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.594 ' HB3' ' H ' ' A' ' 396' ' ' ASP . 0.0 OUTLIER -59.86 135.88 57.83 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 108.608 -0.886 . . . . 75.11 108.608 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.431 ' N ' ' HD2' ' A' ' 324' ' ' LYS . . . -134.4 -161.12 9.43 Favored Glycine 0 C--N 1.287 -2.158 0 CA-C-N 116.281 -0.418 . . . . 43.22 113.008 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -62.08 -22.94 75.11 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 C-N-CA 123.894 3.062 . . . . 62.52 114.033 -177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -109.03 18.06 21.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.255 0.55 . . . . 43.44 109.93 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.86 -119.19 4.86 Favored Glycine 0 CA--C 1.492 -1.379 0 N-CA-C 109.967 -1.253 . . . . 64.43 109.967 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.27 -30.5 8.69 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.55 -1.278 . . . . 64.24 107.55 175.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.12 50.2 4.19 Favored Glycine 0 N--CA 1.432 -1.57 0 CA-C-N 114.532 -1.213 . . . . 75.33 115.403 171.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -154.88 159.87 40.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 117.061 0.43 . . . . 70.22 110.797 172.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.549 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 5.8 m -110.07 127.92 55.13 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 109.139 -0.689 . . . . 63.01 109.139 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 10.1 pt -117.72 154.15 19.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 122.495 0.318 . . . . 75.35 111.02 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.62 120.38 7.56 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.774 -1.565 . . . . 73.4 106.774 174.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 156.97 154.52 7.08 Favored Glycine 0 C--N 1.293 -1.831 0 N-CA-C 110.829 -0.908 . . . . 63.23 110.829 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.55 -177.27 19.36 Favored Glycine 0 C--N 1.293 -1.817 0 N-CA-C 108.484 -1.846 . . . . 54.34 108.484 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 86.1 t -53.52 108.53 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 117.972 0.886 . . . . 74.14 111.245 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 88.83 -16.99 53.26 Favored Glycine 0 C--O 1.219 -0.813 0 CA-C-N 115.271 -0.877 . . . . 74.43 112.419 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.463 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -107.27 9.61 30.01 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.913 -0.773 . . . . 74.01 108.913 -178.154 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.97 126.26 13.88 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 123.557 0.743 . . . . 70.25 112.26 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -82.34 -45.26 15.13 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.09 -0.959 . . . . 72.04 110.107 -173.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.7 122.11 45.87 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 108.246 -1.02 . . . . 75.31 108.246 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.81 105.16 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 123.156 2.571 . . . . 73.13 112.607 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.82 -6.25 29.37 Favored Glycine 0 N--CA 1.431 -1.64 0 CA-C-N 115.352 -0.84 . . . . 45.0 112.099 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -127.19 98.92 5.46 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.478 -0.934 . . . . 52.32 108.478 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -82.4 33.63 0.41 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.991 -1.004 . . . . 72.22 111.827 -170.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 66.7 m -100.35 173.25 6.68 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.807 -0.633 . . . . 74.03 112.033 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.3 mm -86.27 129.64 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 107.574 -1.269 . . . . 73.41 107.574 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 27.1 m-85 -123.78 139.48 53.94 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-N 118.384 0.538 . . . . 71.24 111.572 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 45.3 t -77.04 115.37 18.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 115.547 -0.751 . . . . 62.22 109.514 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 24.8 m -91.45 -28.91 17.33 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.973 -0.558 . . . . 70.42 110.263 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 85.0 mttt -152.52 160.39 43.23 Favored 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 109.268 -0.641 . . . . 72.12 109.268 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 80.0 mt -125.34 135.02 65.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 106.198 -1.779 . . . . 64.25 106.198 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 44.3 mm -85.27 137.54 20.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 C-N-CA 122.429 0.292 . . . . 71.34 111.159 -173.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.97 127.84 32.35 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.709 0.766 . . . . 61.34 112.795 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 70.18 9.86 64.57 Favored Glycine 0 C--N 1.315 -0.626 0 CA-C-N 115.558 -0.746 . . . . 72.52 112.706 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -74.74 160.63 53.02 Favored Glycine 0 N--CA 1.428 -1.894 0 N-CA-C 110.836 -0.906 . . . . 60.32 110.836 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -59.69 -42.02 92.04 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 109.733 -0.469 . . . . 72.33 109.733 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.562 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -72.3 -10.67 60.08 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 120.172 -0.611 . . . . 70.43 112.431 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -93.99 -29.58 15.17 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.635 -0.876 . . . . 61.43 108.635 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -94.17 -60.49 1.72 Allowed 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 122.955 1.359 . . . . 55.01 110.398 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -87.45 -25.66 23.64 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 112.47 -2.15 . . . . 73.35 110.467 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -44.11 -50.34 7.69 Favored Glycine 0 C--N 1.273 -2.967 0 N-CA-C 120.301 2.88 . . . . 65.11 120.301 -170.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 363' ' ' GLY 0.256 0.0 OUTLIER 47.99 31.29 2.34 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.383 1.592 . . . . 63.04 110.973 -164.521 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 9.8 tt -112.03 150.12 31.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.027 -0.988 . . . . 63.12 109.202 -170.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -122.21 152.43 40.0 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.294 0.569 . . . . 75.3 111.076 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 75.4 mt -65.96 129.26 30.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 107.0 -1.481 . . . . 74.25 107.0 170.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 107.72 3.34 34.63 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.471 -0.871 . . . . 62.03 112.172 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.573 ' HB3' HG21 ' A' ' 402' ' ' VAL . 1.4 m-20 -72.89 128.52 35.74 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.261 0.837 . . . . 73.31 113.261 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 42.1 tttp -92.78 114.52 27.1 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.788 1.235 . . . . 75.54 109.492 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 85.8 mt -80.53 111.92 17.4 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 120.961 0.41 . . . . 61.32 110.082 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.2 tt -86.75 -39.41 15.99 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.491 -1.231 . . . . 74.43 107.694 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -163.55 155.69 17.6 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.772 -0.649 . . . . 74.13 110.677 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 13.5 p -133.4 122.36 44.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 108.116 -1.068 . . . . 74.53 108.116 173.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . 0.569 HD21 HG22 ' A' ' 394' ' ' THR . 84.7 m-20 62.26 30.52 17.57 Favored 'General case' 0 CA--C 1.483 -1.62 0 CA-C-O 123.873 1.797 . . . . 43.32 108.445 -174.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.8 t30 66.32 16.89 10.58 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 109.831 -3.35 . . . . 52.44 112.556 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.95 125.28 40.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 106.557 -1.646 . . . . 74.13 106.557 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.1 p -61.62 123.3 17.53 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 113.557 0.947 . . . . 73.41 113.557 -175.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.28 -2.51 20.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.309 -0.86 . . . . 74.3 110.941 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -66.84 106.83 1.99 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.752 -0.658 . . . . 72.52 109.396 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 63.97 74.36 0.41 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 122.643 1.211 . . . . 74.52 113.591 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 21.4 m -137.29 169.5 19.37 Favored 'Isoleucine or valine' 0 C--O 1.249 1.03 0 N-CA-C 105.913 -1.884 . . . . 72.21 105.913 174.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.518 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 50.5 p -78.66 138.71 38.43 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.274 -0.97 . . . . 74.34 108.998 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.598 ' O ' HG23 ' A' ' 388' ' ' VAL . 85.8 t60 -47.49 -51.06 21.69 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.31 0.855 . . . . 72.41 113.31 -173.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.617 ' OE1' ' HA ' ' B' ' 144' ' ' ARG . 19.5 tt0 -65.04 -29.61 70.52 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.484 0.659 . . . . 53.21 110.663 -175.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 383' ' ' THR . 49.8 tt0 -72.87 -39.11 66.73 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.367 -0.975 . . . . 64.33 108.367 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.486 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -67.59 -46.52 72.36 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.759 -1.109 . . . . 70.03 109.96 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 384' ' ' HIS . 24.8 t -57.87 -43.55 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 109.681 -0.489 . . . . 25.3 109.681 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 85.0 m -57.95 -38.14 75.45 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 123.49 0.494 . . . . 74.52 110.681 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.05 -33.37 75.89 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.193 -0.317 . . . . 70.14 110.959 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.7 mp -81.73 -26.58 34.44 Favored 'General case' 0 C--O 1.211 -0.949 0 C-N-CA 120.494 -0.482 . . . . 53.03 111.28 176.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.441 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 62.2 mttm -75.82 -27.33 57.86 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.698 -0.401 . . . . 74.21 111.968 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -80.27 43.67 0.64 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.844 -0.616 . . . . 73.32 110.623 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.569 HG22 HD21 ' A' ' 375' ' ' ASN . 77.4 p -124.19 144.03 50.17 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.813 -0.81 . . . . 54.41 108.813 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . 0.516 ' HA ' ' HE3' ' A' ' 324' ' ' LYS . 65.4 m -146.02 116.92 7.73 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.568 0.699 . . . . 71.4 111.095 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.594 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 3.3 m-20 55.77 14.52 1.33 Allowed 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 127.882 2.473 . . . . 75.34 114.903 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -163.17 126.15 2.71 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.452 -1.314 . . . . 73.34 107.452 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 46.8 t -138.46 124.0 23.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.271 -1.011 . . . . 75.13 108.271 177.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -106.43 95.9 6.08 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 105.948 -1.871 . . . . 63.32 105.948 173.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.458 ' CD2' ' HB ' ' A' ' 402' ' ' VAL . 7.6 tt -95.14 114.58 26.39 Favored 'General case' 0 C--N 1.258 -3.374 0 N-CA-C 109.051 -0.722 . . . . 73.12 109.051 -176.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -99.58 108.66 21.11 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.795 -1.557 . . . . 72.15 106.795 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.573 HG21 ' HB3' ' A' ' 369' ' ' ASP . 10.3 p -115.73 162.2 13.93 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.753 0 N-CA-C 108.223 -1.028 . . . . 74.02 108.223 -175.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.9 148.83 47.26 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.58 -0.896 . . . . 73.45 108.58 173.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 404' ' ' LYS . 10.7 mmpt? -64.57 157.27 74.07 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 108.276 -1.009 . . . . 73.42 108.276 169.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -65.7 133.13 32.97 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 121.852 1.701 . . . . 61.25 112.814 -170.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 1.2 m -62.26 5.01 0.11 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 125.929 1.692 . . . . 70.1 113.775 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -95.19 12.76 67.88 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 110.178 -1.169 . . . . 51.54 110.178 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 22.7 t -163.66 -164.73 0.94 Allowed 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 105.823 -1.917 . . . . 74.43 105.823 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -72.36 103.08 3.32 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.985 0.422 . . . . 63.25 110.532 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -71.31 137.65 48.68 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.457 -0.792 . . . . 63.31 110.465 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 78.5 m80 . . . . . 0 C--N 1.3 -1.563 0 N-CA-C 106.593 -1.632 . . . . 74.55 106.593 -179.136 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.711 0 N-CA-C 106.791 -1.559 . . . . 74.3 106.791 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -87.97 -6.33 58.07 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 118.415 0.552 . . . . 73.12 111.778 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.517 ' HA ' ' CG2' ' B' ' 149' ' ' THR . 0.9 OUTLIER -119.52 118.44 31.06 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 123.502 0.501 . . . . 75.32 111.038 176.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . 0.617 ' HA ' ' OE1' ' A' ' 385' ' ' GLU . 1.2 mmp_? -157.12 157.76 35.09 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.794 1.238 . . . . 74.21 108.554 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -85.9 155.18 21.04 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 116.049 -0.523 . . . . 74.42 111.063 174.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 67.2 32.2 6.21 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.441 1.496 . . . . 74.44 112.753 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -160.49 178.47 9.51 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-N 113.558 -1.655 . . . . 71.04 107.558 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -89.28 144.85 25.78 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.29 -1.004 . . . . 63.11 108.29 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.517 ' CG2' ' HA ' ' B' ' 143' ' ' THR . 16.9 m -134.41 135.2 42.42 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 116.233 -0.44 . . . . 63.44 111.628 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -85.86 130.51 34.53 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-N 116.001 -0.545 . . . . 74.42 110.472 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.293 -1.861 0 CA-C-N 116.289 -0.414 . . . . 71.45 110.05 171.508 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 C--O 1.21 -1.016 0 N-CA-C 108.04 -1.096 . . . . 43.04 108.04 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.336 1.8 pm0 -103.45 131.86 50.2 Favored 'General case' 0 N--CA 1.411 -2.379 0 CA-C-O 123.012 1.387 . . . . 72.53 114.411 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.45 HG23 ' HD3' ' A' ' 364' ' ' LYS . 78.3 mt -113.93 106.49 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.97 0 CA-C-N 111.987 -2.37 . . . . 73.32 110.35 -172.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -85.55 105.9 16.48 Favored 'General case' 0 N--CA 1.402 -2.854 0 N-CA-C 104.324 -2.472 . . . . 75.21 104.324 170.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.421 HD21 ' HA ' ' A' ' 359' ' ' ALA . 0.4 OUTLIER -106.5 144.59 32.96 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 113.802 -1.545 . . . . 71.45 109.299 -171.349 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.1 mp -98.34 111.24 27.57 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 108.75 -0.833 . . . . 64.34 108.75 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -76.32 149.91 36.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.489 -0.778 . . . . 72.32 109.979 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -141.2 -160.07 8.16 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.466 -0.874 . . . . 62.04 112.23 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.35 -12.77 34.43 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.334 2.69 . . . . 72.55 113.362 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -102.35 8.72 40.18 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.302 -0.629 . . . . 74.13 109.302 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.74 -128.2 8.45 Favored Glycine 0 CA--C 1.477 -2.338 0 N-CA-C 108.764 -1.735 . . . . 35.43 108.764 -177.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.44 ' HB2' HG23 ' B' ' 151' ' ' VAL . 4.5 mp -98.52 -39.16 8.87 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.582 -2.007 . . . . 72.41 105.582 172.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.36 56.03 2.48 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 114.776 -1.102 . . . . 72.11 114.154 174.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . 0.414 ' HA ' ' H ' ' A' ' 354' ' ' ILE . 53.9 p90 -154.39 158.98 40.85 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.104 -0.702 . . . . 75.0 109.104 172.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' B' ' 149' ' ' THR . 10.9 m -107.32 128.82 54.79 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.165 -1.05 . . . . 74.3 108.165 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 25.2 pt -114.71 151.87 16.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 109.998 -0.371 . . . . 74.32 109.998 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -147.57 121.86 9.61 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.147 -1.427 . . . . 71.21 107.147 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 154.71 163.19 11.77 Favored Glycine 0 C--N 1.282 -2.437 0 N-CA-C 110.784 -0.926 . . . . 51.34 110.784 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.58 -174.16 21.14 Favored Glycine 0 CA--C 1.479 -2.195 0 N-CA-C 108.069 -2.012 . . . . 54.14 108.069 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.425 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 68.3 t -54.08 103.72 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 117.545 0.672 . . . . 54.24 110.921 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 82.33 -7.79 63.27 Favored Glycine 0 C--O 1.217 -0.934 0 CA-C-N 115.419 -0.81 . . . . 73.31 112.98 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.36 0.06 26.62 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.206 -1.035 . . . . 75.43 108.206 -178.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.449 ' HA ' ' HA2' ' A' ' 335' ' ' GLY . 0.0 OUTLIER -50.78 140.38 14.96 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 115.642 1.719 . . . . 61.25 115.642 -174.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -85.42 -33.64 21.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.439 -1.255 . . . . 73.43 109.078 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 46.4 mm -104.81 122.7 42.5 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.67 -0.695 . . . . 74.33 109.716 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.82 108.52 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.543 2.162 . . . . 62.22 111.412 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.29 -19.3 24.73 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.57 -0.824 . . . . 74.21 112.092 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 19.4 t70 -114.79 99.96 7.88 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.861 -1.163 . . . . 74.13 107.861 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.425 ' OD1' ' HA ' ' A' ' 337' ' ' VAL . 59.3 t30 -80.97 33.09 0.32 Allowed 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 124.018 0.927 . . . . 64.44 112.437 -169.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 68.1 m -100.01 176.97 5.24 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.772 0.656 . . . . 71.42 112.772 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.5 mm -92.2 132.66 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 107.513 -1.291 . . . . 72.44 107.513 -177.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 32.9 m-85 -124.1 137.49 54.56 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 112.62 0.6 . . . . 72.43 112.62 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 49.9 t -70.59 117.59 13.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 115.159 -0.928 . . . . 72.31 108.606 176.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.0 m -97.26 -29.87 13.3 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.515 0.674 . . . . 53.24 110.248 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -155.39 152.36 28.98 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 107.285 -1.376 . . . . 74.03 107.285 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 80.3 mt -121.42 109.56 25.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 106.357 -1.72 . . . . 70.21 106.357 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.414 ' H ' ' HA ' ' A' ' 331' ' ' PHE . 41.7 mm -52.21 133.73 14.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 O-C-N 124.711 1.257 . . . . 74.23 112.221 -171.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.536 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.1 pm0 -55.2 114.51 1.81 Allowed 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 125.361 1.464 . . . . 74.24 111.833 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 72.67 22.78 78.81 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 114.351 -1.295 . . . . 51.42 111.781 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.33 164.36 53.44 Favored Glycine 0 C--O 1.254 1.363 0 N-CA-C 111.466 -0.654 . . . . 74.54 111.466 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.13 96.46 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.983 -0.747 . . . . 61.32 108.983 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.541 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.69 -11.03 59.92 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.986 -0.552 . . . . 73.52 112.067 177.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -86.52 -30.52 21.88 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.711 -1.218 . . . . 74.51 107.711 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.588 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 1.2 mmpm? -95.52 -57.82 2.29 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.657 0.984 . . . . 75.23 113.657 176.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -85.41 -39.2 17.83 Favored 'General case' 0 CA--C 1.467 -2.25 0 C-N-CA 123.542 0.737 . . . . 55.02 111.164 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.541 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -42.68 -23.95 0.21 Allowed Glycine 0 C--N 1.3 -1.421 0 N-CA-C 119.316 2.486 . . . . 73.45 119.316 -166.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.476 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.4 38.3 1.17 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 118.576 1.188 . . . . 75.0 111.241 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 55.8 tp -112.86 157.59 21.23 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 114.25 -1.341 . . . . 74.34 110.099 -170.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -120.41 143.74 48.3 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 121.524 0.678 . . . . 73.52 111.174 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 76.9 mt -66.6 125.16 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 107.116 -1.439 . . . . 75.22 107.116 169.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 108.75 1.19 32.31 Favored Glycine 0 C--N 1.309 -0.935 0 C-N-CA 120.567 -0.825 . . . . 51.31 112.183 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 71.6 m-20 -75.49 138.27 41.47 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 112.698 0.629 . . . . 54.02 112.698 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 45.2 tttp -94.27 115.32 27.55 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.154 1.381 . . . . 74.44 108.994 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 95.7 mt -79.86 111.24 16.0 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.951 0.405 . . . . 62.35 109.999 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 403' ' ' ALA . 4.0 tt -83.09 -40.09 20.29 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.71 -1.589 . . . . 74.45 106.71 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.25 157.38 25.51 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.163 -0.926 . . . . 62.0 109.639 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.515 HG11 ' HG ' ' A' ' 391' ' ' LEU . 7.6 p -147.31 137.27 16.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.59 -0.893 . . . . 43.45 108.59 173.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 59.51 38.38 22.47 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 108.066 -1.087 . . . . 73.21 108.066 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.03 -8.06 0.45 Allowed 'General case' 0 CA--C 1.57 1.723 0 C-N-CA 125.846 1.658 . . . . 53.23 113.278 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.32 130.65 35.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.981 -0.748 . . . . 71.35 108.981 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.0 p -72.21 129.68 39.03 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 122.756 0.423 . . . . 73.23 111.35 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 8.2 mp -109.38 -3.7 16.91 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.766 0.654 . . . . 73.32 112.766 -179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -65.23 107.19 1.51 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.588 -0.523 . . . . 73.11 109.588 174.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 63.67 72.33 0.47 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 122.742 1.258 . . . . 54.25 113.359 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.59 164.35 31.15 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 N-CA-C 105.764 -1.939 . . . . 75.35 105.764 173.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.676 ' HB ' ' OE1' ' A' ' 386' ' ' GLU . 1.4 m -82.81 146.43 28.94 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.406 -1.331 . . . . 72.41 107.406 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.617 ' O ' HG23 ' A' ' 388' ' ' VAL . 67.9 t60 -51.05 -32.73 22.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.526 -0.761 . . . . 75.51 112.961 -173.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.426 ' OE1' ' HA ' ' B' ' 144' ' ' ARG . 7.3 tp10 -65.08 -42.66 93.89 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.519 -0.549 . . . . 75.25 109.519 -177.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.676 ' OE1' ' HB ' ' A' ' 383' ' ' THR . 1.8 mp0 -73.22 -32.46 64.77 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 108.864 -0.791 . . . . 63.1 108.864 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.514 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -62.32 -53.88 48.66 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.709 -1.132 . . . . 43.12 109.251 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 384' ' ' HIS . 33.2 t -57.34 -44.19 83.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 N-CA-C 109.746 -0.465 . . . . 52.2 109.746 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 80.6 m -57.51 -41.11 80.15 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 116.065 -0.516 . . . . 73.25 111.035 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -63.36 -38.04 89.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.729 0.3 . . . . 71.24 110.844 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.515 ' HG ' HG11 ' A' ' 374' ' ' VAL . 5.6 mp -76.47 -21.3 56.04 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 120.23 -0.588 . . . . 62.13 110.978 176.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.496 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 54.5 mttm -83.95 -27.27 28.62 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 113.474 0.916 . . . . 54.02 113.474 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -76.11 35.15 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.075 0.95 . . . . 71.32 112.681 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 8.1 p -124.76 161.05 27.25 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 122.899 0.48 . . . . 75.34 110.028 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 24.9 p -160.53 125.86 3.88 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.325 -0.62 . . . . 72.41 109.325 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 61.69 0.14 0.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 125.92 1.688 . . . . 75.45 113.757 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -168.12 137.49 2.49 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.589 -0.893 . . . . 75.11 108.589 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 62.1 t -136.66 125.71 36.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.614 -1.254 . . . . 72.33 107.614 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -101.21 95.59 6.63 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 105.144 -2.169 . . . . 74.14 105.144 173.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.3 tt -101.02 140.78 34.84 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 109.46 -0.57 . . . . 71.53 109.46 -176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -128.11 113.09 15.3 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.85 -0.426 . . . . 74.44 109.85 -175.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 54.1 t -105.19 145.26 13.7 Favored 'Isoleucine or valine' 0 C--O 1.269 2.12 0 C-N-CA 124.256 1.022 . . . . 71.35 111.03 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -117.17 156.39 27.75 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 104.618 -2.364 . . . . 35.01 104.618 169.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 410' ' ' HIS . 7.7 mmpt? -84.98 151.97 58.26 Favored Pre-proline 0 C--N 1.285 -2.228 0 C-N-CA 118.677 -1.209 . . . . 61.43 107.991 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.95 111.72 0.82 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.866 2.377 . . . . 54.35 112.111 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 6.9 m -87.98 -10.32 50.77 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.563 -0.744 . . . . 71.53 111.031 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -107.52 16.57 37.49 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 120.129 -1.034 . . . . 72.31 112.816 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 64.2 m -160.17 -179.42 7.73 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.982 -1.118 . . . . 63.13 107.982 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -76.67 124.84 28.25 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.82 -1.548 . . . . 74.02 106.82 176.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 404' ' ' LYS . 30.2 p80 -95.74 146.05 24.83 Favored 'General case' 0 C--N 1.286 -2.161 0 C-N-CA 120.971 -0.291 . . . . 65.32 111.63 -176.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 . . . . . 0 N--CA 1.419 -2.023 0 N-CA-C 104.389 -2.448 . . . . 73.31 104.389 166.955 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.453 -2.788 0 N-CA-C 108.47 -0.937 . . . . 65.5 108.47 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . . . . . . . . . 23.5 ttp85 -91.63 131.69 36.85 Favored 'General case' 0 N--CA 1.394 -3.233 0 O-C-N 125.148 1.53 . . . . 65.33 108.753 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.522 ' O ' ' HG2' ' B' ' 144' ' ' ARG . 40.2 p -116.53 156.01 27.66 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.821 -1.177 . . . . 75.4 107.821 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . 0.572 ' HA ' ' HE ' ' B' ' 144' ' ' ARG . 6.7 mmp_? 175.37 164.86 0.31 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 127.725 2.41 . . . . 72.35 108.051 172.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -86.26 171.77 10.99 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 123.565 0.541 . . . . 75.2 111.069 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 65.81 18.47 11.14 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.344 1.858 . . . . 63.41 113.669 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . 0.506 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.2 OUTLIER -152.32 178.27 9.69 Favored 'General case' 0 CA--C 1.489 -1.395 0 CA-C-N 116.026 -0.534 . . . . 71.03 109.62 -179.16 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -90.4 146.27 24.29 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.996 -0.742 . . . . 71.24 108.996 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 332' ' ' SER . 88.9 m -134.64 138.03 44.14 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.91 -0.587 . . . . 71.13 110.16 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -83.66 132.81 34.85 Favored 'General case' 0 C--O 1.254 1.319 0 N-CA-C 109.801 -0.444 . . . . 73.34 109.801 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.44 HG23 ' HB2' ' A' ' 329' ' ' LEU . 15.1 m . . . . . 0 C--N 1.296 -1.742 0 CA-C-O 116.767 -1.587 . . . . 74.11 112.63 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . 0.528 ' SD ' ' HE3' ' A' ' 404' ' ' LYS . 26.1 ttt . . . . . 0 CA--C 1.495 -1.156 0 N-CA-C 106.941 -1.503 . . . . 70.32 106.941 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 400' ' ' LEU 0.339 2.0 pm0 -115.58 132.17 56.71 Favored 'General case' 0 N--CA 1.408 -2.562 0 N-CA-C 115.013 1.486 . . . . 53.24 115.013 -175.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 363' ' ' GLY . 58.6 mt -116.63 111.75 36.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.351 0 CA-C-N 112.402 -2.181 . . . . 54.45 107.966 -173.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -82.71 110.5 17.81 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.207 -1.034 . . . . 64.22 108.207 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 92.6 mt -111.02 156.32 21.44 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.54 0.525 . . . . 61.11 110.327 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 1.6 mp -105.04 115.4 46.84 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 107.925 -1.139 . . . . 60.4 107.925 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 394' ' ' THR . 22.7 tptm -68.57 122.16 17.91 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.485 -0.78 . . . . 65.33 109.318 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -133.55 -154.42 7.39 Favored Glycine 0 C--N 1.306 -1.104 0 C-N-CA 120.61 -0.805 . . . . 71.43 113.274 -173.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.85 -40.3 39.56 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 124.79 3.66 . . . . 44.41 115.49 -175.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -109.09 16.48 22.51 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.248 0.547 . . . . 75.2 110.044 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.41 -118.22 4.6 Favored Glycine 0 N--CA 1.424 -2.124 0 CA-C-N 114.892 -1.049 . . . . 63.21 110.983 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.543 HD21 HG11 ' A' ' 398' ' ' VAL . 4.0 mp -96.02 -30.32 13.64 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.565 -1.272 . . . . 72.23 107.565 177.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.49 44.93 5.98 Favored Glycine 0 N--CA 1.435 -1.376 0 CA-C-N 114.853 -1.067 . . . . 45.4 114.487 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . 0.487 ' HA ' ' H ' ' A' ' 354' ' ' ILE . 50.7 p90 -152.43 156.7 40.0 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.823 -0.806 . . . . 71.14 108.823 172.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' B' ' 149' ' ' THR . 46.3 m -113.66 136.66 52.59 Favored 'General case' 0 C--N 1.282 -2.348 0 O-C-N 123.663 0.602 . . . . 51.02 110.829 -175.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 20.2 pt -120.26 149.6 23.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.409 -0.814 . . . . 64.3 112.435 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -145.15 114.59 7.15 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.285 -1.746 . . . . 40.32 106.285 174.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 164.19 164.18 18.83 Favored Glycine 0 C--N 1.285 -2.291 0 N-CA-C 109.015 -1.634 . . . . 60.34 109.015 -178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.01 178.93 15.94 Favored Glycine 0 CA--C 1.479 -2.214 0 N-CA-C 108.113 -1.995 . . . . 52.21 108.113 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 88.8 t -53.23 108.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 117.766 0.783 . . . . 73.23 110.738 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.65 -23.64 33.1 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.269 -0.878 . . . . 72.44 112.509 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.598 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 58.8 t30 -105.91 18.63 21.82 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.696 -0.483 . . . . 72.32 109.696 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -50.89 123.88 10.07 Favored 'General case' 0 C--O 1.257 1.476 0 C-N-CA 123.553 0.741 . . . . 54.3 110.518 -178.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -81.4 -40.1 23.96 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.146 -0.934 . . . . 74.1 109.977 -176.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 35.9 mm -103.65 126.11 32.9 Favored Pre-proline 0 C--N 1.309 -1.176 0 N-CA-C 109.2 -0.667 . . . . 72.35 109.2 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.14 102.73 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 123.108 2.539 . . . . 63.32 112.66 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.71 -7.2 29.75 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 115.828 -0.624 . . . . 75.2 112.033 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -123.92 96.84 5.1 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.049 -1.093 . . . . 74.13 108.049 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.414 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 65.3 t30 -83.03 36.92 0.52 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.587 -1.188 . . . . 72.11 112.08 -169.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 74.7 m -99.47 178.11 4.97 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.675 -0.693 . . . . 65.03 112.11 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 11.0 mm -88.72 131.6 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 107.899 -1.149 . . . . 73.34 107.899 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 26.8 m-85 -124.12 138.06 54.48 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 113.507 0.929 . . . . 64.34 113.507 -176.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 47.1 t -71.14 115.54 11.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 114.787 -1.097 . . . . 72.13 108.48 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 22.6 m -100.56 -25.98 13.99 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.4 0.619 . . . . 73.35 110.848 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.89 142.25 22.49 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.229 -1.397 . . . . 72.33 107.229 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 74.3 mt -109.64 107.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 106.023 -1.843 . . . . 72.33 106.023 172.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.487 ' H ' ' HA ' ' A' ' 331' ' ' PHE . 46.4 mm -57.9 127.22 16.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 O-C-N 124.478 1.111 . . . . 65.23 112.585 -170.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.616 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.1 pm0 -57.12 117.67 4.26 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 113.314 -1.766 . . . . 72.24 111.053 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 90.01 5.31 70.85 Favored Glycine 0 C--O 1.22 -0.747 0 CA-C-N 115.02 -0.991 . . . . 54.31 111.96 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.3 158.08 48.82 Favored Glycine 0 C--O 1.255 1.443 0 C-N-CA 121.548 -0.358 . . . . 22.13 112.808 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.88 -40.1 95.75 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.972 -0.751 . . . . 74.44 108.972 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.548 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.44 -9.82 58.91 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.9 -0.591 . . . . 52.42 111.504 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -87.22 -30.43 20.97 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.315 -0.995 . . . . 60.52 108.315 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.478 ' HA ' ' CE ' ' A' ' 361' ' ' LYS . 0.0 OUTLIER -95.83 -57.23 2.42 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 114.101 1.148 . . . . 70.2 114.101 176.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -85.2 -39.45 17.8 Favored 'General case' 0 CA--C 1.462 -2.414 0 O-C-N 123.58 0.55 . . . . 64.24 110.604 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.604 ' O ' HD13 ' A' ' 320' ' ' ILE . . . -42.72 -23.14 0.17 Allowed Glycine 0 C--O 1.199 -2.037 0 N-CA-C 119.199 2.44 . . . . 71.03 119.199 -164.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.469 ' HD2' ' C ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 43.68 32.22 0.54 Allowed 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 119.135 1.467 . . . . 62.33 111.872 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 43.9 tp -105.01 153.5 21.37 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 125.184 1.393 . . . . 61.32 109.246 -171.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -116.95 146.07 43.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.065 0.459 . . . . 73.34 111.224 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 74.9 mt -66.54 124.21 21.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 107.719 -1.215 . . . . 70.1 107.719 170.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.65 1.19 30.73 Favored Glycine 0 C--N 1.312 -0.774 0 N-CA-C 111.175 -0.77 . . . . 65.22 111.175 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.51 ' HB3' HG21 ' A' ' 402' ' ' VAL . 73.2 m-20 -75.71 138.75 41.5 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.981 1.104 . . . . 65.25 113.981 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.631 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 40.8 tttp -94.2 115.83 28.15 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.499 1.52 . . . . 73.11 110.043 -177.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.49 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 96.5 mt -80.28 112.61 17.77 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.954 -0.758 . . . . 72.03 108.954 176.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.4 tt -83.88 -37.57 22.24 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.952 -1.499 . . . . 62.42 106.952 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -162.68 158.0 22.55 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.568 -0.742 . . . . 74.12 111.186 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.408 HG12 HD11 ' A' ' 379' ' ' LEU . 13.8 p -133.82 125.45 49.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.629 -1.249 . . . . 75.42 107.629 171.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 59.55 36.62 22.86 Favored 'General case' 0 CA--C 1.47 -2.119 0 CA-C-O 124.287 1.994 . . . . 54.3 110.727 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.3 t30 61.99 13.2 5.44 Favored 'General case' 0 C--N 1.268 -2.935 0 CA-C-N 108.958 -3.746 . . . . 72.22 113.272 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.9 t -86.91 123.86 40.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 107.419 -1.326 . . . . 32.4 107.419 175.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.6 p -63.14 125.22 23.34 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.023 0.749 . . . . 72.33 113.023 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.408 HD11 HG12 ' A' ' 374' ' ' VAL . 7.2 mp -106.57 3.68 27.26 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 123.843 0.857 . . . . 73.14 111.247 178.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -66.58 112.64 4.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.756 -0.656 . . . . 73.45 110.238 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 60.1 49.82 7.1 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 122.722 1.249 . . . . 72.34 112.98 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.31 169.55 4.01 Favored 'Isoleucine or valine' 0 C--O 1.251 1.171 0 N-CA-C 107.937 -1.135 . . . . 51.31 107.937 173.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.481 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 76.5 p -81.64 141.13 33.95 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.845 -0.742 . . . . 75.0 109.755 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.57 ' O ' HG23 ' A' ' 388' ' ' VAL . 75.2 t60 -46.02 -45.33 15.85 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.267 0.84 . . . . 74.24 113.267 -176.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.469 ' HB2' ' HD2' ' B' ' 144' ' ' ARG . 59.9 tt0 -62.33 -39.15 92.12 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 120.937 0.399 . . . . 65.4 111.122 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 383' ' ' THR . 61.4 tt0 -69.53 -34.63 74.51 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 124.321 1.048 . . . . 72.43 108.559 -176.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.526 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -73.37 -53.9 9.63 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.823 -1.081 . . . . 75.11 110.633 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 384' ' ' HIS . 21.1 t -58.15 -41.38 80.61 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.597 0 N-CA-C 109.862 -0.421 . . . . 54.3 109.862 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 31.0 m -63.24 -31.67 72.87 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 116.224 -0.444 . . . . 74.14 110.938 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -69.35 -41.09 77.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.15 -0.315 . . . . 52.22 110.15 177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.3 mp -73.85 -23.99 59.7 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 119.937 -0.705 . . . . 72.23 110.406 177.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 54.9 mttm -79.12 -32.47 44.51 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 113.488 0.921 . . . . 74.22 113.488 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -84.01 64.5 8.2 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.949 0.88 . . . . 73.41 111.836 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.54 ' O ' ' HG2' ' A' ' 324' ' ' LYS . 12.4 p -148.62 149.46 31.56 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.422 -1.263 . . . . 74.23 108.38 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 26.8 p -148.62 128.02 13.08 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.271 -0.64 . . . . 74.41 109.271 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.435 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 31.8 t70 59.8 -1.22 0.17 Allowed 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 126.29 1.836 . . . . 71.41 114.406 177.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -159.73 120.8 3.16 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 120.607 -1.308 . . . . 73.12 110.718 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.543 HG11 HD21 ' A' ' 329' ' ' LEU . 80.4 t -136.15 145.13 31.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 124.281 1.032 . . . . 74.52 108.365 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.24 96.41 4.91 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.289 -1.374 . . . . 74.03 107.289 173.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 319' ' ' GLU . 4.8 tt -83.98 118.26 23.91 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.885 -1.154 . . . . 74.34 107.885 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -108.09 107.34 17.96 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.928 -1.138 . . . . 65.42 107.928 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 369' ' ' ASP . 3.0 p -111.3 148.69 14.41 Favored 'Isoleucine or valine' 0 C--O 1.267 1.998 0 CA-C-N 115.408 -0.814 . . . . 63.11 109.626 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.631 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.71 157.83 45.85 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 104.325 -2.472 . . . . 74.32 104.325 172.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.528 ' HE3' ' SD ' ' A' ' 318' ' ' MET . 0.0 OUTLIER -95.6 153.4 39.46 Favored Pre-proline 0 C--N 1.276 -2.599 0 C-N-CA 118.302 -1.359 . . . . 75.02 107.477 174.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' A' ' 410' ' ' HIS . 1.3 Cg_endo -35.56 100.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 125.145 3.897 . . . . 72.55 115.913 -173.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 13.2 p -96.21 -17.9 20.45 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.657 -1.156 . . . . 41.04 112.194 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -92.63 -4.13 65.95 Favored Glycine 0 N--CA 1.422 -2.291 0 C-N-CA 120.157 -1.021 . . . . 31.31 113.179 -176.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 22.2 t -167.53 -169.11 1.14 Allowed 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.871 -0.789 . . . . 75.55 108.871 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . 0.503 ' CE1' ' HB3' ' A' ' 411' ' ' HIS . 33.0 t-80 -81.26 157.05 25.29 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.895 -1.15 . . . . 71.32 107.895 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . 0.401 ' HB3' ' HG2' ' A' ' 405' ' ' PRO . 11.2 p-80 -89.27 46.52 1.39 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.789 0.804 . . . . 74.51 110.438 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.503 ' HB3' ' CE1' ' A' ' 409' ' ' HIS . 27.9 t-80 . . . . . 0 C--O 1.27 2.133 0 N-CA-C 105.198 -2.149 . . . . 61.14 105.198 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . 0.505 ' N ' ' HG1' ' B' ' 143' ' ' THR . . . . . . . . 0 C--O 1.218 -0.568 0 N-CA-C 109.977 -0.379 . . . . 74.32 109.977 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . 0.539 ' HA ' ' NE ' ' B' ' 142' ' ' ARG . 4.3 mmp_? 69.1 -19.08 0.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 126.034 1.733 . . . . 75.14 113.357 -178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.541 ' O ' ' HD2' ' B' ' 144' ' ' ARG 0.266 15.1 p -55.02 135.56 48.73 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 126.287 1.835 . . . . 53.13 107.242 168.043 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . 0.541 ' HD2' ' O ' ' B' ' 143' ' ' THR . 17.8 mmm180 -149.89 -164.53 2.04 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 119.806 1.185 . . . . 73.31 109.97 -173.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 339' ' ' ASN . 0.2 OUTLIER -69.3 144.34 53.58 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.392 0.615 . . . . 74.44 112.034 -173.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . 0.507 ' H ' ' CG ' ' A' ' 339' ' ' ASN 0.257 27.0 mmt180 65.66 39.55 4.84 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 126.061 1.744 . . . . 73.4 113.662 178.21 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . 0.514 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.1 OUTLIER -143.66 148.93 36.51 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 114.567 -1.197 . . . . 71.03 108.759 173.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.65 151.94 19.14 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.628 -1.619 . . . . 73.22 106.628 173.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 332' ' ' SER . 53.8 m -147.37 129.62 15.65 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 120.534 -0.466 . . . . 73.44 110.66 174.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . 0.42 ' HG3' HG13 ' A' ' 354' ' ' ILE . 16.5 tt0 -67.07 129.51 40.13 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.941 -0.762 . . . . 72.23 108.941 173.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 331' ' ' PHE . 15.4 m . . . . . 0 C--N 1.297 -1.71 0 N-CA-C 113.404 0.89 . . . . 63.22 113.404 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 56.8 tpp . . . . . 0 CA--C 1.487 -1.458 0 N-CA-C 106.032 -1.84 . . . . 74.23 106.032 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.426 1.8 pm0 -122.07 128.64 51.59 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 116.692 2.108 . . . . 45.55 116.692 -174.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.503 HG23 ' HD3' ' A' ' 364' ' ' LYS . 89.8 mt -105.23 106.57 20.76 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.623 0 CA-C-N 111.452 -2.613 . . . . 73.11 109.305 -176.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -77.68 113.89 15.98 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 103.883 -2.636 . . . . 70.31 103.883 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.06 147.68 31.99 Favored 'General case' 0 C--N 1.266 -3.023 0 O-C-N 124.478 1.111 . . . . 61.01 109.234 -171.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 68.3 mt -106.03 134.99 46.0 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.881 0 N-CA-C 108.114 -1.069 . . . . 72.03 108.114 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.493 ' H ' ' HA ' ' A' ' 396' ' ' ASP . 1.2 ttpm? -74.24 177.99 5.44 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.83 -0.804 . . . . 74.41 108.83 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.441 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -155.86 -172.52 23.44 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 120.374 -0.917 . . . . 73.45 110.943 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.38 -26.16 20.82 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 122.895 2.397 . . . . 65.25 112.277 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -88.92 -8.56 53.98 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 122.469 1.128 . . . . 73.03 108.886 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 95.93 -135.55 12.38 Favored Glycine 0 CA--C 1.482 -1.985 0 CA-C-N 113.618 -1.628 . . . . 74.33 109.355 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 4.8 mp -83.71 -45.5 13.32 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.429 -1.693 . . . . 75.32 106.429 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 83.32 53.74 3.35 Favored Glycine 0 N--CA 1.421 -2.316 0 CA-C-N 114.645 -1.161 . . . . 74.32 114.348 170.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -154.4 164.48 38.57 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 116.736 0.268 . . . . 73.21 110.334 172.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.529 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 10.2 m -112.54 129.35 56.39 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.632 -0.507 . . . . 61.53 109.632 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.9 pt -118.75 153.33 20.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 109.927 -0.397 . . . . 74.15 109.927 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -142.22 136.57 30.01 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.288 -1.745 . . . . 63.32 106.288 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 347' ' ' SER . . . 144.81 157.44 7.22 Favored Glycine 0 C--N 1.282 -2.428 0 N-CA-C 109.288 -1.525 . . . . 34.1 109.288 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 137.74 175.5 13.91 Favored Glycine 0 C--N 1.282 -2.453 0 N-CA-C 108.386 -1.886 . . . . 73.01 108.386 -175.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.51 HG22 ' OE2' ' A' ' 381' ' ' GLU . 68.7 t -50.7 110.89 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 117.719 0.76 . . . . 42.31 109.655 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 81.4 -17.04 14.95 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 121.267 -0.492 . . . . 54.42 113.298 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.28 3.65 38.37 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.592 -1.262 . . . . 62.43 107.592 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.424 HE22 ' HA ' ' A' ' 343' ' ' PRO . 0.0 OUTLIER -49.57 126.21 13.03 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.595 1.158 . . . . 74.14 111.288 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -76.83 -37.27 55.97 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.22 -0.9 . . . . 64.45 109.97 -175.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 345' ' ' ASP . 2.8 mp -104.82 126.76 30.35 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 109.344 -0.613 . . . . 64.51 109.344 177.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.424 ' HA ' HE22 ' A' ' 340' ' ' GLN . 18.7 Cg_endo -59.38 105.99 0.28 Allowed 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.842 2.362 . . . . 75.04 112.816 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 105.83 -1.22 38.82 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 115.553 -0.749 . . . . 43.43 111.931 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 342' ' ' ILE . 60.4 t0 -130.85 103.55 6.63 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 108.087 -1.079 . . . . 72.22 108.087 -178.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -76.91 65.05 2.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.501 1.143 . . . . 74.45 108.924 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.451 ' O ' ' HA3' ' A' ' 335' ' ' GLY . 5.2 p -97.09 134.6 40.22 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 113.289 -1.778 . . . . 74.21 112.38 -176.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 44.3 mm -80.94 119.14 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 N-CA-C 104.488 -2.412 . . . . 74.04 104.488 168.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -123.89 137.92 54.56 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 120.161 -0.616 . . . . 71.42 109.724 -169.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 49.5 t -78.58 111.41 15.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.266 -0.642 . . . . 44.5 109.266 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 12.5 m -96.42 -28.84 14.26 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.068 -0.515 . . . . 75.54 110.928 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 55.4 mttp -151.61 163.11 39.8 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 109.637 -0.505 . . . . 71.42 109.637 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.458 HG22 ' HB2' ' A' ' 360' ' ' HIS . 73.1 mt -131.54 127.48 59.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 106.644 -1.613 . . . . 72.44 106.644 174.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 50.6 mm -85.51 141.75 14.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 123.678 0.791 . . . . 70.12 111.466 -172.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.5 133.66 50.24 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.551 0.691 . . . . 74.44 112.339 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 70.88 7.46 62.05 Favored Glycine 0 C--N 1.312 -0.777 0 C-N-CA 120.598 -0.81 . . . . 75.05 112.454 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -67.39 148.89 50.41 Favored Glycine 0 N--CA 1.414 -2.807 0 N-CA-C 110.289 -1.124 . . . . 74.5 110.289 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.42 -34.27 77.38 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 109.432 -0.581 . . . . 43.31 109.432 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.574 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -76.1 -14.97 60.18 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 120.209 -0.597 . . . . 64.13 111.707 176.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . 0.458 ' HB2' HG22 ' A' ' 353' ' ' ILE . 39.6 t60 -84.14 -27.79 27.88 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.695 0.759 . . . . 72.41 109.18 177.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -96.69 -58.28 2.08 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 114.835 1.42 . . . . 53.51 114.835 173.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -85.81 -41.57 14.93 Favored 'General case' 0 CA--C 1.465 -2.309 0 C-N-CA 122.796 0.438 . . . . 74.41 111.155 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 359' ' ' ALA . . . -43.02 -25.0 0.31 Allowed Glycine 0 CA--C 1.491 -1.413 0 N-CA-C 118.79 2.276 . . . . 63.54 118.79 -165.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.503 ' HD3' HG23 ' A' ' 320' ' ' ILE . 0.0 OUTLIER 43.72 36.21 1.23 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.42 1.088 . . . . 63.04 111.167 -179.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 39.5 tp -115.69 152.89 32.33 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 114.168 -1.378 . . . . 70.51 108.368 -171.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -123.84 155.56 37.8 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.751 0.786 . . . . 72.33 111.605 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 80.3 mt -66.12 125.47 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 107.204 -1.406 . . . . 71.42 107.204 173.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.34 -6.83 21.0 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 120.04 -1.076 . . . . 50.55 111.949 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -75.8 142.37 42.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.487 0.551 . . . . 63.1 112.487 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 76.4 tttt -101.64 131.21 47.99 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.931 -0.766 . . . . 73.14 108.931 176.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 68.8 mt -95.81 120.77 36.68 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.964 0.411 . . . . 74.13 110.812 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 403' ' ' ALA . 40.0 mt -83.41 -39.73 20.25 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.433 -1.258 . . . . 74.2 109.736 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.23 157.93 26.47 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 120.015 -0.674 . . . . 55.12 112.088 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.493 HG12 HD11 ' A' ' 379' ' ' LEU . 14.7 p -134.28 121.69 38.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 107.984 -1.117 . . . . 54.44 107.984 172.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . 0.518 HD21 HG22 ' A' ' 394' ' ' THR . 79.1 m-20 64.4 27.79 13.62 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 123.909 1.814 . . . . 71.2 108.641 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.2 t30 66.17 16.4 10.43 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 109.791 -3.368 . . . . 72.32 111.835 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.8 t -83.84 125.44 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.171 -1.788 . . . . 72.31 106.171 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.7 p -62.96 125.49 24.16 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 124.012 0.82 . . . . 63.44 113.008 -175.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.493 HD11 HG12 ' A' ' 374' ' ' VAL . 6.2 mp -103.21 1.1 32.59 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.229 -0.896 . . . . 73.34 110.892 177.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -75.3 115.05 14.54 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.644 -0.873 . . . . 72.2 108.644 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . 0.51 ' OE2' HG22 ' A' ' 337' ' ' VAL . 19.7 tp10 62.22 83.42 0.15 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.557 1.17 . . . . 62.2 112.117 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 337' ' ' VAL . 23.9 m -153.21 165.8 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 113.24 -1.8 . . . . 75.52 107.606 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.469 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.0 OUTLIER -82.15 143.61 31.32 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.184 -1.043 . . . . 73.22 108.184 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.524 ' O ' HG23 ' A' ' 388' ' ' VAL . 86.1 t60 -50.6 -53.27 31.93 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 112.394 0.516 . . . . 72.42 112.394 -174.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.69 -27.35 68.28 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.129 -0.941 . . . . 70.44 111.217 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.9 tt0 -75.0 -34.47 61.97 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.796 -1.187 . . . . 72.42 107.796 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.46 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -73.08 -45.35 57.74 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.655 -1.157 . . . . 75.13 109.737 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 384' ' ' HIS . 15.4 t -56.95 -42.92 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.937 -0.764 . . . . 74.05 108.937 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 62.6 m -61.15 -36.3 79.41 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 116.016 -0.538 . . . . 63.42 110.936 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.64 -35.74 80.91 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.333 -0.23 . . . . 70.24 110.512 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.7 mp -78.03 -31.56 50.49 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 120.456 -0.498 . . . . 74.35 111.024 176.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -71.27 -25.75 62.59 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 120.569 -0.453 . . . . 73.3 112.167 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -82.68 65.39 7.78 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 122.227 1.013 . . . . 72.01 110.468 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.518 HG22 HD21 ' A' ' 375' ' ' ASN . 17.6 p -132.78 146.1 51.56 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.248 -1.342 . . . . 53.22 108.394 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 47.9 m -145.92 91.58 2.1 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 122.583 1.182 . . . . 63.03 111.426 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.493 ' HA ' ' H ' ' A' ' 324' ' ' LYS 0.346 14.4 m-20 65.08 4.44 2.55 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 111.427 -2.624 . . . . 70.35 116.075 170.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -156.39 130.32 8.48 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 106.987 -1.486 . . . . 73.44 106.987 170.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 394' ' ' THR . 27.6 t -138.09 149.3 24.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 124.187 0.995 . . . . 54.11 109.063 -172.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -116.34 95.9 5.28 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.248 -1.019 . . . . 71.42 108.248 170.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 7.5 tt -95.39 119.37 33.77 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-O 121.106 0.479 . . . . 53.44 109.999 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -102.4 110.41 22.35 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.793 -1.188 . . . . 60.24 107.793 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 3.0 p -110.87 144.51 18.69 Favored 'Isoleucine or valine' 0 C--O 1.274 2.356 0 C-N-CA 124.232 1.013 . . . . 53.51 111.526 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -137.64 159.93 40.62 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 125.907 1.683 . . . . 72.2 109.022 176.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.515 ' HG3' ' C ' ' A' ' 411' ' ' HIS . 0.4 OUTLIER -77.69 155.9 80.7 Favored Pre-proline 0 C--N 1.295 -1.788 0 N-CA-C 109.234 -0.654 . . . . 63.01 109.234 173.37 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -47.69 121.04 5.18 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 123.456 2.77 . . . . 73.45 111.675 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 7.0 m -84.2 -38.05 21.07 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.82 -1.082 . . . . 71.42 111.721 -172.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -101.57 38.68 3.05 Favored Glycine 0 C--N 1.292 -1.916 0 C-N-CA 120.096 -1.05 . . . . 72.41 113.08 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 33.2 t -165.7 -170.22 1.74 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.165 -1.421 . . . . 75.0 107.165 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -73.86 140.28 45.62 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 107.23 -1.396 . . . . 75.15 107.23 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -79.61 127.7 32.49 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 112.704 0.631 . . . . 75.21 112.704 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.515 ' C ' ' HG3' ' A' ' 404' ' ' LYS . 88.1 m-70 . . . . . 0 C--N 1.309 -1.171 0 N-CA-C 107.046 -1.465 . . . . 70.31 107.046 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 107.625 -1.25 . . . . 72.23 107.625 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . 0.406 ' HD3' ' H ' ' B' ' 143' ' ' THR . 0.1 OUTLIER -162.92 159.19 23.38 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 105.912 -1.885 . . . . 73.31 105.912 -175.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.406 ' H ' ' HD3' ' B' ' 142' ' ' ARG . 36.6 p -69.8 151.87 45.25 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.026 -1.472 . . . . 72.43 107.026 175.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . 0.509 ' NE ' ' HA ' ' B' ' 144' ' ' ARG . 3.3 mmp_? -152.24 137.75 17.72 Favored 'General case' 0 CA--C 1.487 -1.477 0 CA-C-N 119.085 0.857 . . . . 73.42 111.588 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -86.54 162.77 17.86 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 113.822 -1.536 . . . . 64.12 108.58 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 67.44 18.97 10.1 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.501 1.52 . . . . 74.22 112.519 -174.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -157.11 179.23 9.49 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.805 0.842 . . . . 71.14 108.913 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -91.78 144.96 24.96 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.155 -0.683 . . . . 71.31 109.155 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 86.6 m -134.63 142.69 46.96 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.722 -0.473 . . . . 62.42 109.722 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.87 145.4 36.27 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 122.942 0.497 . . . . 74.42 111.041 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 14.0 m . . . . . 0 C--O 1.261 1.676 0 CA-C-N 115.738 -0.665 . . . . 73.13 111.282 175.262 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 CA--C 1.495 -1.16 0 N-CA-C 107.192 -1.41 . . . . 64.2 107.192 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.323 2.0 pm0 -115.79 133.88 55.58 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-O 122.23 1.014 . . . . 70.24 113.364 -176.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 363' ' ' GLY . 77.3 mt -129.89 116.56 38.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 113.217 -1.81 . . . . 60.31 110.27 -168.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.453 ' HE3' ' HB3' ' A' ' 321' ' ' LYS . 1.3 ttpp -75.92 134.7 40.18 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.028 -0.73 . . . . 74.24 109.028 172.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.517 ' HA ' ' OD2' ' A' ' 362' ' ' ASP . 95.5 mt -131.78 152.15 51.16 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 123.556 0.535 . . . . 72.12 110.217 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.44 110.64 31.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.14 -1.059 . . . . 70.45 108.14 171.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.481 ' NZ ' ' HA ' ' A' ' 392' ' ' LYS . 79.1 tttt -76.94 130.23 37.24 Favored 'General case' 0 C--O 1.201 -1.457 0 C-N-CA 119.687 -0.805 . . . . 63.54 110.112 177.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -133.85 -163.77 10.47 Favored Glycine 0 C--N 1.298 -1.58 0 C-N-CA 119.766 -1.207 . . . . 25.3 111.905 -176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.64 -12.9 33.49 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 C-N-CA 123.775 2.983 . . . . 73.41 113.782 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -103.53 6.99 37.75 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 122.316 1.055 . . . . 63.33 108.805 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.21 -151.02 28.01 Favored Glycine 0 CA--C 1.493 -1.331 0 CA-C-N 114.303 -1.317 . . . . 51.13 110.213 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 5.6 mp -88.11 -16.51 33.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.747 -1.575 . . . . 71.14 106.747 166.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . 0.561 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 79.16 39.28 19.93 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 113.921 -1.491 . . . . 61.32 114.892 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 52.2 p90 -151.45 165.75 33.2 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 117.596 0.698 . . . . 55.45 110.487 175.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' B' ' 149' ' ' THR . 12.2 m -121.62 136.0 54.96 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 109.706 -0.479 . . . . 61.55 109.706 -178.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' B' ' 148' ' ' GLU . 17.9 pt -119.9 152.73 22.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 122.514 0.326 . . . . 51.43 111.761 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -149.2 114.65 5.56 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 104.997 -2.223 . . . . 74.02 104.997 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.66 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 162.3 156.21 8.35 Favored Glycine 0 C--N 1.286 -2.222 0 N-CA-C 109.709 -1.356 . . . . 73.32 109.709 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.68 -174.81 20.88 Favored Glycine 0 CA--C 1.484 -1.873 0 N-CA-C 108.908 -1.677 . . . . 42.35 108.908 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 96.1 t -51.68 108.47 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 117.498 0.649 . . . . 44.2 111.673 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 91.37 -21.57 34.44 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.114 -0.948 . . . . 61.14 112.773 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.66 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 57.6 t30 -107.08 26.88 9.59 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.24 -0.652 . . . . 72.31 109.24 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -55.29 119.6 5.8 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.888 -0.596 . . . . 55.34 110.674 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -78.9 -41.5 29.52 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.304 -0.862 . . . . 44.14 109.865 -175.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 43.5 mm -103.91 123.36 41.31 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 108.918 -0.771 . . . . 63.44 108.918 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.95 105.39 0.14 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.161 2.574 . . . . 74.21 112.419 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.97 -5.14 28.93 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.477 -0.783 . . . . 32.32 111.935 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -129.29 99.46 5.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.766 0.793 . . . . 72.42 108.973 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 66.1 t30 -82.8 35.33 0.46 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.384 1.074 . . . . 71.41 111.458 -171.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.449 ' CB ' ' HE3' ' A' ' 370' ' ' LYS . 68.2 m -104.79 177.89 4.72 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 113.035 0.754 . . . . 71.05 113.035 -176.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 10.7 mm -87.7 129.43 39.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.337 -0.847 . . . . 73.43 109.319 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 37.3 m-85 -124.26 136.73 54.36 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 113.47 0.915 . . . . 74.32 113.47 -177.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.424 HG21 HD21 ' A' ' 365' ' ' LEU . 60.4 t -71.65 117.2 14.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.688 -1.142 . . . . 74.41 108.51 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 10.4 m -106.28 -18.16 14.08 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 120.799 0.333 . . . . 52.21 111.581 -175.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.621 ' HG2' ' OE1' ' B' ' 148' ' ' GLU . 44.0 mmtm -149.89 154.95 39.17 Favored 'General case' 0 CA--C 1.49 -1.339 0 N-CA-C 108.609 -0.886 . . . . 72.14 108.609 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.427 ' CG2' ' HB2' ' A' ' 360' ' ' HIS . 57.0 mt -138.89 121.23 17.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 107.232 -1.395 . . . . 63.11 107.232 172.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 41.6 mm -86.0 133.15 30.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.385 -1.339 . . . . 71.24 107.385 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.43 144.83 56.64 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 106.627 -1.62 . . . . 73.24 106.627 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.47 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 92.08 -12.79 68.65 Favored Glycine 0 CA--C 1.475 -2.415 0 C-N-CA 119.36 -1.4 . . . . 55.15 110.672 178.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . 0.561 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -67.98 148.34 49.03 Favored Glycine 1 N--CA 1.396 -4.005 0 N-CA-C 108.716 -1.754 . . . . 71.41 108.716 172.722 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.48 77.08 Favored 'General case' 0 C--O 1.2 -1.532 0 N-CA-C 109.834 -0.432 . . . . 55.14 109.834 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.593 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -73.82 -11.74 60.47 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.671 -0.812 . . . . 74.22 112.486 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . 0.427 ' HB2' ' CG2' ' A' ' 353' ' ' ILE . 70.9 t60 -88.01 -43.95 11.35 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.423 -0.584 . . . . 70.54 109.423 177.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.47 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 73.4 mmtt -86.42 -57.83 2.85 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 122.143 0.973 . . . . 63.05 110.947 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . 0.517 ' OD2' ' HA ' ' A' ' 322' ' ' LEU . 35.2 t0 -81.75 -33.83 30.77 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 125.075 1.35 . . . . 74.43 109.38 -175.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.654 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -84.6 -16.91 65.03 Favored Glycine 0 C--N 1.289 -2.074 0 N-CA-C 117.37 1.708 . . . . 55.51 117.37 -169.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.654 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.31 34.23 0.49 Allowed 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 118.054 0.927 . . . . 65.21 112.619 -177.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . 0.424 HD21 HG21 ' A' ' 350' ' ' VAL . 33.0 tp -83.78 157.58 22.04 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.199 0.999 . . . . 60.05 111.453 -170.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -118.1 142.24 47.62 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.279 0.561 . . . . 62.21 111.414 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 84.3 mt -66.49 121.97 16.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 107.254 -1.387 . . . . 72.43 107.254 169.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 113.76 -1.72 24.56 Favored Glycine 0 C--N 1.309 -0.917 0 N-CA-C 110.936 -0.866 . . . . 63.33 110.936 -174.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.513 ' HB3' HG21 ' A' ' 402' ' ' VAL . 2.4 m-20 -73.14 138.32 45.69 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.265 0.469 . . . . 63.23 112.265 176.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 349' ' ' TYR . 64.1 tttt -99.95 115.99 30.95 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.164 -0.925 . . . . 61.42 110.369 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 82.1 mt -82.13 112.94 19.63 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.455 -0.572 . . . . 71.33 109.455 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.5 tt -82.31 -37.36 25.89 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.079 -1.418 . . . . 61.55 107.343 -177.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -162.85 157.45 21.34 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.057 -0.974 . . . . 72.12 109.122 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.491 HG11 ' HG ' ' A' ' 391' ' ' LEU . 10.0 p -142.86 121.85 8.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-O 121.138 0.494 . . . . 65.1 109.704 174.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 66.9 t30 44.56 78.86 0.05 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 126.246 1.818 . . . . 72.55 111.745 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 65.94 -29.42 0.13 Allowed 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 114.681 1.364 . . . . 74.4 114.681 -175.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 28.2 t -83.96 124.56 39.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 O-C-N 121.471 -0.768 . . . . 74.42 110.969 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 11.6 p -75.19 132.5 41.18 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.789 -0.449 . . . . 73.12 109.789 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.8 mp -108.51 -4.67 17.05 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.067 0.766 . . . . 73.24 113.067 -177.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -63.55 113.87 3.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.572 0.225 . . . . 62.4 111.376 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 59.57 39.91 20.93 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-O 122.807 1.289 . . . . 73.43 112.989 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 31.4 m -104.27 166.16 3.15 Favored 'Isoleucine or valine' 0 C--O 1.257 1.494 0 N-CA-C 106.644 -1.613 . . . . 72.13 106.644 171.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.54 ' HB ' ' OE1' ' A' ' 386' ' ' GLU . 0.4 OUTLIER -81.13 149.08 29.31 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 117.808 -1.557 . . . . 72.32 107.381 178.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.604 ' O ' HG23 ' A' ' 388' ' ' VAL . 79.8 t60 -53.77 -27.92 31.64 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 114.32 1.23 . . . . 74.13 114.32 -172.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.601 ' HB2' ' CG ' ' B' ' 144' ' ' ARG . 34.9 tt0 -65.87 -41.63 91.38 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 117.796 0.271 . . . . 74.12 110.293 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.54 ' OE1' ' HB ' ' A' ' 383' ' ' THR . 1.9 mp0 -68.38 -33.15 73.75 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 109.063 -0.718 . . . . 65.21 109.063 -177.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.575 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -64.96 -58.15 6.88 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.392 -1.276 . . . . 54.41 109.058 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 384' ' ' HIS . 40.6 t -54.58 -43.35 64.53 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 0 O-C-N 123.401 0.438 . . . . 74.14 110.146 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 93.1 m -59.17 -37.5 77.5 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.355 0.662 . . . . 55.21 111.911 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -68.51 -40.64 80.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.996 0.427 . . . . 72.43 110.077 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.575 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.1 mp -75.37 -19.95 59.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.201 0.524 . . . . 52.32 111.036 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.495 ' HE2' ' CG1' ' A' ' 388' ' ' VAL . 54.8 mttm -80.18 -41.53 25.1 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 113.429 0.9 . . . . 65.23 113.429 178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -84.99 65.68 9.36 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.918 0.866 . . . . 72.23 111.427 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 1.3 p -145.01 148.92 34.28 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 114.565 -1.198 . . . . 74.52 109.296 177.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 22.0 m -145.37 120.28 9.98 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.841 -0.8 . . . . 61.01 108.841 178.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 56.1 0.98 0.06 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 127.381 2.272 . . . . 74.51 116.49 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . 0.438 ' HE2' ' CE2' ' A' ' 399' ' ' TYR . 6.0 t80 -158.73 125.12 4.62 Favored 'General case' 0 N--CA 1.437 -1.077 0 O-C-N 121.297 -0.877 . . . . 72.44 109.805 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.2 t -141.37 145.86 24.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.17 -1.048 . . . . 64.13 108.17 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.438 ' CE2' ' HE2' ' A' ' 397' ' ' PHE . 21.1 m-85 -115.22 97.35 6.15 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.053 -0.721 . . . . 65.21 109.053 172.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 8.0 tt -87.01 134.42 33.49 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 110.271 -0.27 . . . . 71.55 110.271 -177.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -121.83 108.19 13.18 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.494 -0.928 . . . . 70.31 108.494 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.513 HG21 ' HB3' ' A' ' 369' ' ' ASP . 7.3 p -116.37 151.99 18.13 Favored 'Isoleucine or valine' 0 C--O 1.268 2.055 0 CA-C-O 121.561 0.696 . . . . 74.44 111.225 -175.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.86 158.66 43.95 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 125.153 1.381 . . . . 72.42 108.089 176.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.55 159.12 72.67 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 108.435 -0.95 . . . . 70.1 108.435 173.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . 0.496 ' HB2' ' OG ' ' A' ' 408' ' ' SER . 18.9 Cg_endo -52.67 105.52 0.12 Allowed 'Trans proline' 0 C--N 1.365 1.43 0 C-N-CA 123.634 2.889 . . . . 64.04 114.407 -172.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 5.8 m -73.61 -35.38 65.34 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.364 -0.834 . . . . 55.52 112.088 -171.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -80.91 31.91 2.49 Favored Glycine 0 C--N 1.292 -1.906 0 CA-C-N 116.027 -0.533 . . . . 71.32 113.483 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . 0.496 ' OG ' ' HB2' ' A' ' 405' ' ' PRO . 54.4 p -168.29 -172.68 1.79 Allowed 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 107.965 -1.124 . . . . 71.31 107.965 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -77.13 105.9 8.51 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.154 -0.684 . . . . 73.25 109.154 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . 0.467 ' HB3' ' O ' ' A' ' 405' ' ' PRO . 26.9 p-80 -107.48 142.45 37.32 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.22 -0.9 . . . . 73.43 111.032 -177.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 . . . . . 0 N--CA 1.423 -1.802 0 N-CA-C 104.005 -2.591 . . . . 65.54 104.005 177.389 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.878 0 N-CA-C 107.203 -1.406 . . . . 72.1 107.203 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . 0.437 ' HB3' ' OE1' ' A' ' 385' ' ' GLU . 19.8 mtp180 -120.2 130.43 54.54 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.141 -1.429 . . . . 74.12 107.141 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.433 HG21 HG21 ' B' ' 149' ' ' THR . 2.9 p -70.48 99.73 1.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 123.655 0.597 . . . . 75.3 111.497 -175.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . 0.601 ' CG ' ' HB2' ' A' ' 385' ' ' GLU . 52.2 mtt180 -154.5 -49.35 0.09 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 117.591 -1.644 . . . . 73.01 114.171 173.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . 0.656 26.2 mt-30 -96.52 119.58 35.27 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 121.088 3.736 . . . . 71.21 121.088 -173.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 47.28 44.45 15.95 Favored 'General case' 0 CA--C 1.488 -1.412 0 O-C-N 124.244 0.965 . . . . 71.43 111.461 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . 0.439 HD22 ' C ' ' B' ' 147' ' ' ASN . 0.2 OUTLIER -142.76 136.73 29.17 Favored 'General case' 0 N--CA 1.402 -2.857 0 CA-C-N 114.155 -1.384 . . . . 72.13 108.361 -176.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . 0.621 ' OE1' ' HG2' ' A' ' 352' ' ' LYS . 15.6 pt-20 -96.23 140.94 30.18 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 108.515 -0.92 . . . . 64.44 108.515 174.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 332' ' ' SER . 87.7 m -134.13 135.98 43.53 Favored 'General case' 0 C--N 1.282 -2.368 0 C-N-CA 120.745 -0.382 . . . . 62.4 111.625 -176.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -80.57 124.09 28.67 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.313 -0.995 . . . . 72.12 108.313 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 C--N 1.282 -2.337 0 N-CA-C 115.435 1.643 . . . . 73.04 115.435 -174.576 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 CA--C 1.492 -1.263 0 N-CA-C 106.721 -1.585 . . . . 61.13 106.721 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.405 2.0 pm0 -115.82 130.78 56.98 Favored 'General case' 0 C--N 1.266 -3.046 0 CA-C-O 122.784 1.278 . . . . 73.1 114.408 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 69.0 mt -122.54 112.98 36.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.456 0 CA-C-N 112.482 -2.144 . . . . 73.32 110.698 -169.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 321' ' ' LYS . 0.4 OUTLIER -73.57 127.71 33.5 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 106.982 -1.488 . . . . 73.31 106.982 171.356 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.572 ' HB2' ' HB ' ' A' ' 398' ' ' VAL . 98.3 mt -120.54 154.24 35.61 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.829 -1.175 . . . . 71.21 107.829 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 324' ' ' LYS . 47.0 mt -107.43 150.58 9.89 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.028 0 N-CA-C 106.448 -1.686 . . . . 71.33 106.448 171.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.516 ' O ' HG22 ' A' ' 323' ' ' ILE . 1.0 OUTLIER -76.26 178.67 6.28 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.07 -1.455 . . . . 73.22 107.07 173.103 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -164.93 -166.98 24.79 Favored Glycine 0 C--N 1.287 -2.193 0 C-N-CA 118.373 -1.87 . . . . 71.4 113.627 -175.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.56 -35.23 23.35 Favored 'Trans proline' 0 C--O 1.213 -0.753 0 C-N-CA 123.772 2.982 . . . . 62.21 112.41 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.414 ' NZ ' ' HA3' ' A' ' 356' ' ' GLY . 44.4 mttp -99.8 19.76 15.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.349 -0.611 . . . . 65.4 109.349 178.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.65 -123.97 6.5 Favored Glycine 0 CA--C 1.485 -1.84 0 N-CA-C 107.992 -2.043 . . . . 65.35 107.992 -176.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.442 HD11 ' OG1' ' A' ' 394' ' ' THR . 9.4 mp -93.13 -29.03 15.96 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.265 -1.383 . . . . 63.51 107.265 174.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . 0.544 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 77.49 39.82 24.83 Favored Glycine 0 N--CA 1.427 -1.92 0 CA-C-N 113.512 -1.676 . . . . 53.33 114.414 172.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -143.59 149.88 38.02 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 119.941 -0.703 . . . . 75.42 109.919 173.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.604 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 9.9 m -105.52 127.41 53.0 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-N 115.413 -0.812 . . . . 75.1 110.18 -176.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 22.6 pt -115.8 143.72 25.08 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-N 115.314 -0.857 . . . . 73.45 110.305 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -130.13 114.64 15.98 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 106.771 -1.566 . . . . 63.42 106.771 175.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 167.75 166.23 26.48 Favored Glycine 0 N--CA 1.408 -3.171 0 N-CA-C 110.609 -0.996 . . . . 61.2 110.609 177.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.12 177.12 14.72 Favored Glycine 0 N--CA 1.411 -2.995 0 N-CA-C 106.933 -2.467 . . . . 70.54 106.933 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.45 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 56.7 t -56.6 99.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 117.858 0.829 . . . . 64.31 110.035 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 95.22 -10.92 69.55 Favored Glycine 0 N--CA 1.432 -1.594 0 CA-C-O 119.148 -0.807 . . . . 44.43 114.237 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.594 ' HB2' ' HG3' ' B' ' 145' ' ' GLN . 63.5 t30 -106.88 10.28 30.64 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 118.767 1.284 . . . . 43.41 109.252 175.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.459 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -53.95 122.48 10.18 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 114.462 1.282 . . . . 71.23 114.462 -178.397 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -66.87 -35.15 79.37 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.021 -1.445 . . . . 75.13 109.412 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 38.5 mm -104.89 120.02 51.45 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 115.68 -0.691 . . . . 70.14 109.649 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.83 109.03 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.765 2.31 . . . . 74.23 111.574 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 111.12 -14.84 28.39 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.576 -0.821 . . . . 73.11 111.961 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -119.49 98.03 5.94 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 106.887 -1.523 . . . . 71.42 106.887 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.459 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 62.2 t30 -80.66 34.84 0.34 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 124.007 0.923 . . . . 72.13 112.531 -169.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 66.7 m -97.89 178.73 5.03 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.66 0.743 . . . . 75.43 112.751 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.514 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 18.2 mm -94.17 129.84 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.175 0 CA-C-N 114.777 -1.101 . . . . 54.51 108.062 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 30.1 m-85 -124.05 134.4 53.42 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 112.632 0.605 . . . . 63.23 112.632 -177.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.69 111.65 3.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.022 -1.473 . . . . 73.15 107.022 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 45.6 m -106.97 -24.08 12.12 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.367 0.603 . . . . 71.23 111.965 -173.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.604 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 57.7 mttp -149.34 149.74 31.37 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.818 -1.178 . . . . 72.23 107.818 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 65.7 mt -128.87 120.77 52.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.395 -0.965 . . . . 73.33 108.395 177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 31.2 mm -86.65 129.28 38.63 Favored 'Isoleucine or valine' 0 C--O 1.261 1.688 0 C-N-CA 123.34 0.656 . . . . 62.33 109.693 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.91 147.13 53.93 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 107.333 -1.358 . . . . 74.41 107.333 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . 0.579 ' H ' ' HE2' ' A' ' 361' ' ' LYS . . . 95.51 -15.25 63.57 Favored Glycine 0 C--N 1.278 -2.659 0 N-CA-C 109.657 -1.377 . . . . 71.14 109.657 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . 0.544 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -72.05 139.04 27.68 Favored Glycine 1 N--CA 1.392 -4.255 0 N-CA-C 107.922 -2.071 . . . . 72.24 107.922 170.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -65.24 -25.38 67.65 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 109.48 -0.563 . . . . 61.25 109.48 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.659 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.87 -10.41 59.41 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 120.392 -0.523 . . . . 72.33 111.767 176.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -94.66 -35.24 12.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.125 -1.065 . . . . 72.4 108.125 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.579 ' HE2' ' H ' ' A' ' 356' ' ' GLY . 75.5 mmtt -81.95 -58.56 2.92 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 120.125 -0.63 . . . . 73.42 111.173 -178.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -86.2 -35.12 20.26 Favored 'General case' 0 CA--C 1.472 -2.046 0 CA-C-O 122.028 0.918 . . . . 62.42 109.09 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.738 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -44.17 -29.22 1.54 Allowed Glycine 0 CA--C 1.487 -1.659 0 N-CA-C 119.924 2.729 . . . . 61.41 119.924 -165.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.738 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 39.98 34.75 0.2 Allowed 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 124.767 1.227 . . . . 65.12 111.92 -175.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 55.1 tp -107.03 153.55 22.43 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.597 -1.183 . . . . 74.11 109.362 -172.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -123.55 151.19 43.15 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.467 0.651 . . . . 73.23 112.18 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.14 125.76 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 108.1 -1.074 . . . . 74.21 108.1 172.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 114.99 -6.26 21.93 Favored Glycine 0 C--N 1.315 -0.623 0 C-N-CA 121.101 -0.571 . . . . 71.44 112.131 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.549 ' HB3' HG21 ' A' ' 402' ' ' VAL . 10.1 m-20 -75.02 137.09 41.27 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.208 0.818 . . . . 70.1 113.208 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.593 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 35.6 tttp -96.0 115.65 27.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.409 1.483 . . . . 75.32 109.477 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.408 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 68.1 mt -85.87 115.9 23.78 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.307 0.575 . . . . 62.55 110.224 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 5.1 tt -83.5 -37.77 22.66 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 113.692 -1.594 . . . . 74.21 107.273 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -161.81 155.86 21.94 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.157 -0.929 . . . . 75.1 109.467 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.525 HG11 ' HG ' ' A' ' 391' ' ' LEU . 7.6 p -134.76 117.63 23.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 N-CA-C 109.015 -0.735 . . . . 73.24 109.015 174.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 9.7 t30 44.91 74.79 0.12 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 125.836 1.655 . . . . 71.33 111.852 174.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 67.63 -23.57 0.12 Allowed 'General case' 0 CA--C 1.57 1.718 0 C-N-CA 125.386 1.474 . . . . 33.41 114.13 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 20.3 t -85.97 127.72 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 121.203 -0.936 . . . . 71.44 110.494 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.3 p -75.35 133.12 41.3 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 122.937 0.495 . . . . 75.54 110.833 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.435 HD21 HD11 ' A' ' 391' ' ' LEU . 7.9 mp -114.12 -4.7 13.11 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.899 1.074 . . . . 75.2 113.899 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -67.03 104.9 1.5 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.903 -0.406 . . . . 70.22 109.903 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 65.03 82.83 0.18 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.892 1.277 . . . . 73.52 113.812 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 20.6 m -143.42 163.88 15.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 106.156 -1.794 . . . . 34.23 106.156 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.9 m -79.81 149.07 31.15 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 119.17 0.895 . . . . 73.35 108.879 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.593 ' CD2' HD22 ' A' ' 339' ' ' ASN . 45.2 t-80 -46.45 -48.44 18.95 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.231 0.826 . . . . 74.44 113.231 -174.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.435 ' OE2' ' HD3' ' B' ' 142' ' ' ARG . 18.7 tp10 -60.84 -39.24 88.34 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.021 0.438 . . . . 63.15 110.447 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -69.29 -39.8 78.11 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.389 -0.967 . . . . 72.43 108.389 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -63.18 -58.3 7.68 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.354 -1.294 . . . . 62.41 110.257 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.522 ' HB ' HG21 ' B' ' 143' ' ' THR . 40.5 t -55.63 -40.36 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 123.464 0.477 . . . . 74.14 110.606 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 88.8 m -60.25 -38.05 82.31 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 116.389 -0.369 . . . . 52.14 111.813 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.28 86.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.67 0.272 . . . . 71.31 110.797 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.532 HD22 HG21 ' B' ' 151' ' ' VAL . 5.5 mp -77.83 -37.74 47.83 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.179 -0.608 . . . . 52.0 109.891 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 54.2 mttm -62.97 -31.79 72.98 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 113.642 0.978 . . . . 72.31 113.642 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -83.81 64.49 8.08 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.975 0.893 . . . . 74.14 111.67 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.446 ' HB ' HG22 ' A' ' 398' ' ' VAL . 13.3 p -132.36 153.91 50.29 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.77 -1.105 . . . . 72.1 109.288 178.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 41.8 m -143.77 96.73 2.95 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.429 1.109 . . . . 74.34 111.143 178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.509 ' HA ' ' H ' ' A' ' 324' ' ' LYS 0.4 9.0 m-20 57.57 6.06 0.38 Allowed 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 128.303 2.641 . . . . 71.35 118.063 172.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . 0.433 ' HE2' ' CZ ' ' A' ' 399' ' ' TYR . 31.2 t80 -156.31 127.75 7.14 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 107.004 -1.48 . . . . 64.22 107.004 171.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 24.1 t -138.69 142.82 33.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 123.269 0.627 . . . . 73.13 109.738 -174.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.433 ' CZ ' ' HE2' ' A' ' 397' ' ' PHE . 87.1 m-85 -111.6 96.41 6.07 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.837 -0.801 . . . . 73.32 108.837 172.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.505 HD13 HD11 ' A' ' 322' ' ' LEU . 6.6 tt -89.27 135.29 33.66 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.568 -0.707 . . . . 72.55 110.58 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -117.77 108.65 15.63 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.41 -0.959 . . . . 72.44 108.41 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 369' ' ' ASP . 3.6 p -113.77 151.86 15.54 Favored 'Isoleucine or valine' 0 C--O 1.266 1.935 0 CA-C-O 121.977 0.894 . . . . 64.44 110.842 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.593 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -135.28 157.91 45.7 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 104.362 -2.459 . . . . 71.41 104.362 174.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 410' ' ' HIS . 62.1 mttm -95.88 153.16 39.33 Favored Pre-proline 0 C--N 1.274 -2.69 0 C-N-CA 118.159 -1.417 . . . . 71.51 111.39 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -37.15 111.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 125.054 3.836 . . . . 74.14 115.74 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 1.5 p -95.48 -5.66 42.42 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.953 -1.021 . . . . 70.22 113.155 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -101.74 3.26 52.86 Favored Glycine 0 N--CA 1.438 -1.233 0 C-N-CA 120.01 -1.091 . . . . 71.12 112.492 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 68.4 m -161.33 -170.67 2.72 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.612 -1.255 . . . . 23.03 107.612 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -72.3 147.54 46.26 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.076 -0.713 . . . . 70.53 109.076 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 404' ' ' LYS . 3.1 p-80 -119.59 144.63 47.0 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 113.377 0.88 . . . . 73.41 113.377 -175.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 . . . . . 0 N--CA 1.433 -1.277 0 N-CA-C 106.137 -1.801 . . . . 73.31 106.137 179.751 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.459 -2.523 0 N-CA-C 108.092 -1.077 . . . . 71.22 108.092 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' B' ' 142' ' ' ARG . 46.8 ttt-85 -167.59 -53.22 0.02 OUTLIER 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 105.19 -2.152 . . . . 74.52 105.19 -169.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.522 HG21 ' HB ' ' A' ' 388' ' ' VAL . 34.8 p -97.51 178.83 5.06 Favored 'General case' 0 C--O 1.263 1.787 0 N-CA-C 102.386 -3.19 . . . . 64.44 102.386 164.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -151.78 97.4 2.35 Favored 'General case' 0 C--O 1.167 -3.248 0 CA-C-N 120.371 1.442 . . . . 73.3 107.799 -173.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . 0.594 ' HG3' ' HB2' ' A' ' 339' ' ' ASN . 28.9 tt0 -57.57 144.47 37.14 Favored 'General case' 0 C--N 1.258 -3.399 0 N-CA-C 113.493 0.923 . . . . 71.44 113.493 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . 0.41 ' HA ' ' OD1' ' A' ' 339' ' ' ASN . 0.2 OUTLIER 68.18 68.67 0.33 Allowed 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 125.215 1.406 . . . . 61.42 109.564 -162.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 177.44 164.99 0.59 Allowed 'General case' 0 CA--C 1.486 -1.511 0 CA-C-N 113.067 -1.878 . . . . 71.32 107.717 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.58 150.3 21.28 Favored 'General case' 0 N--CA 1.408 -2.537 0 C-N-CA 118.616 -1.234 . . . . 72.31 107.804 162.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 332' ' ' SER . 97.2 m -132.23 132.04 42.7 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.38 -0.6 . . . . 73.33 109.38 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -74.16 131.59 41.42 Favored 'General case' 0 C--O 1.252 1.19 0 CA-C-N 115.608 -0.723 . . . . 72.02 110.65 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.532 HG21 HD22 ' A' ' 391' ' ' LEU . 45.4 t . . . . . 0 C--N 1.286 -2.193 0 CA-C-N 115.099 -0.955 . . . . 64.22 108.686 173.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . 0.498 ' HB3' ' O ' ' A' ' 402' ' ' VAL . 24.0 ttt . . . . . 0 C--O 1.193 -1.872 0 N-CA-C 105.814 -1.921 . . . . 73.51 105.814 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.355 2.0 pm0 -117.23 135.99 53.39 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 115.605 1.705 . . . . 74.14 115.605 -174.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 363' ' ' GLY . 91.4 mt -116.48 110.2 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.298 0 CA-C-N 112.637 -2.074 . . . . 72.01 108.98 -176.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.401 ' HE2' ' CZ ' ' A' ' 399' ' ' TYR . 38.7 ttmt -74.3 125.67 28.97 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.101 -1.444 . . . . 75.34 107.101 171.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.406 HD21 ' CA ' ' A' ' 363' ' ' GLY . 6.0 mt -122.91 149.39 44.3 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.107 -0.952 . . . . 63.13 110.518 -175.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 37.8 mm -106.55 114.62 46.21 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.534 0 N-CA-C 109.064 -0.717 . . . . 74.03 109.064 173.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.759 ' HD2' ' H ' ' A' ' 396' ' ' ASP . 8.7 tmtt? -64.82 152.94 41.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.216 -0.661 . . . . 74.33 109.216 173.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -143.42 -159.5 8.0 Favored Glycine 0 C--N 1.296 -1.646 0 C-N-CA 120.615 -0.802 . . . . 63.35 111.678 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.56 -12.71 27.15 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.947 2.431 . . . . 62.41 112.493 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.434 ' HD2' ' HA2' ' A' ' 357' ' ' GLY . 40.6 ttmt -103.58 5.02 36.33 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.168 0.985 . . . . 73.33 108.818 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.02 -114.6 3.92 Favored Glycine 0 CA--C 1.488 -1.632 0 N-CA-C 108.283 -1.927 . . . . 74.31 108.283 -176.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.503 ' HB2' HG23 ' B' ' 151' ' ' VAL . 5.3 mp -112.22 -35.55 5.59 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.829 -1.174 . . . . 75.31 107.829 173.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 85.43 50.59 3.98 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.194 -0.912 . . . . 74.4 115.218 172.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . 0.513 ' O ' HG22 ' B' ' 151' ' ' VAL . 25.7 p90 -154.73 144.5 21.58 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.076 0.465 . . . . 73.13 110.199 172.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 17.3 m -92.76 125.99 37.64 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.41 -0.813 . . . . 71.34 109.454 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.479 HD12 HG21 ' A' ' 348' ' ' ILE . 49.9 pt -113.09 144.18 21.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 108.502 -0.925 . . . . 70.43 108.502 -178.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -138.83 131.66 29.29 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.753 -1.203 . . . . 74.32 107.753 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.567 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 144.77 164.12 10.41 Favored Glycine 0 C--N 1.28 -2.583 0 N-CA-C 109.606 -1.397 . . . . 61.15 109.606 -177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.09 177.16 14.76 Favored Glycine 0 CA--C 1.479 -2.206 0 N-CA-C 108.13 -1.988 . . . . 43.41 108.13 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 84.2 t -51.15 107.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 117.634 0.717 . . . . 62.44 110.954 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 91.34 -18.93 50.08 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.166 -0.925 . . . . 64.34 112.227 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.567 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 65.6 t30 -105.96 19.71 20.11 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.282 -0.636 . . . . 62.31 109.282 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.04 125.6 14.16 Favored 'General case' 0 C--O 1.251 1.167 0 CA-C-N 115.793 -0.64 . . . . 72.11 111.13 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -79.19 -49.11 13.07 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.127 -0.942 . . . . 75.41 109.768 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 55.7 mt -103.45 125.58 34.53 Favored Pre-proline 0 C--N 1.304 -1.407 0 CA-C-N 115.839 -0.619 . . . . 62.15 109.711 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -48.96 109.34 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 123.347 2.698 . . . . 73.13 112.638 177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 102.49 -2.24 49.81 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.387 -0.824 . . . . 43.55 112.265 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -128.93 96.89 4.47 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.747 -0.834 . . . . 63.4 108.747 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -83.07 33.03 0.44 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.927 0.87 . . . . 72.1 111.624 -171.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 56.7 m -98.96 178.08 5.05 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.798 -0.637 . . . . 61.5 111.933 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 9.1 mm -90.81 132.83 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 N-CA-C 107.995 -1.113 . . . . 61.33 107.995 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 39.6 m-85 -125.17 138.69 54.14 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 112.725 0.639 . . . . 65.11 112.725 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 50.9 t -68.05 118.03 11.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.296 -1.002 . . . . 75.41 108.296 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 17.4 m -105.27 -26.15 12.14 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.065 0.46 . . . . 73.34 111.285 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -156.7 138.08 13.88 Favored 'General case' 0 C--O 1.2 -1.544 0 N-CA-C 107.198 -1.408 . . . . 73.14 107.198 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 73.6 mt -110.37 128.35 66.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.342 -1.355 . . . . 70.15 107.342 172.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 50.1 mm -73.95 134.62 29.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.143 0.497 . . . . 74.53 109.848 -175.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.541 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 1.5 pm0 -62.68 125.55 24.33 Favored 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 124.482 1.113 . . . . 73.13 110.915 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 74.37 17.96 79.81 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.581 -1.191 . . . . 53.51 110.949 -175.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . 0.434 ' HA2' ' HD2' ' A' ' 327' ' ' LYS . . . -76.76 160.37 50.39 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 111.512 -0.635 . . . . 75.23 111.512 175.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.06 94.49 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.519 -0.919 . . . . 50.0 108.519 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.484 ' HA ' ' HA3' ' A' ' 363' ' ' GLY . . . -74.64 -5.93 45.82 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.251 -0.431 . . . . 71.24 111.75 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -93.77 -33.96 13.39 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.575 -0.898 . . . . 75.14 108.575 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -91.25 -59.75 2.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 123.215 1.483 . . . . 73.21 109.838 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -87.13 -34.13 19.2 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 112.422 -2.172 . . . . 70.03 111.004 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -58.05 -33.64 70.01 Favored Glycine 0 C--O 1.199 -2.035 0 N-CA-C 117.453 1.741 . . . . 62.51 117.453 -174.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.656 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.62 33.34 0.45 Allowed 'General case' 0 N--CA 1.508 2.426 0 CA-C-N 118.457 1.129 . . . . 75.34 111.109 -173.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 58.9 tp -99.34 155.65 17.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.415 -1.266 . . . . 75.4 109.696 -171.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -117.07 146.42 43.12 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.111 0.481 . . . . 54.42 110.296 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.2 mt -66.22 120.82 14.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 107.506 -1.294 . . . . 71.2 107.506 171.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.44 -6.62 20.85 Favored Glycine 0 C--N 1.313 -0.716 0 C-N-CA 120.818 -0.706 . . . . 53.21 112.535 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.447 ' HB3' HG21 ' A' ' 402' ' ' VAL . 4.7 m-20 -75.39 142.36 43.1 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 112.712 0.634 . . . . 74.24 112.712 177.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.532 ' HD2' ' HB3' ' A' ' 403' ' ' ALA . 9.2 ttmm -88.36 122.47 31.91 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 123.315 0.646 . . . . 73.22 110.02 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 3.5 mp -81.15 104.98 12.01 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.334 -1.728 . . . . 74.54 106.334 174.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 403' ' ' ALA . 5.7 tt -80.24 -37.74 32.38 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.053 -1.462 . . . . 63.13 107.053 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 401' ' ' LYS . . . -160.98 157.66 26.7 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.371 -0.831 . . . . 70.21 110.513 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.437 HG21 ' HG ' ' A' ' 391' ' ' LEU . 14.6 p -133.42 127.53 53.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.929 -1.137 . . . . 61.31 107.929 173.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 63.67 31.55 14.39 Favored 'General case' 0 C--O 1.206 -1.221 0 CA-C-O 124.011 1.862 . . . . 71.25 107.739 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 65.86 4.49 2.98 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 111.211 -2.722 . . . . 74.44 113.938 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 46.4 t -80.23 123.12 36.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.06 -1.089 . . . . 62.24 108.06 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.5 p -58.98 122.92 14.89 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.719 1.007 . . . . 75.14 113.719 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.42 -1.97 20.98 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 124.434 1.094 . . . . 64.51 111.356 177.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -64.77 108.53 1.76 Allowed 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.554 -0.536 . . . . 73.45 109.554 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 61.78 71.07 0.56 Allowed 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 122.527 1.156 . . . . 75.43 112.909 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.0 168.77 23.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 106.989 -1.486 . . . . 74.21 106.989 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.7 m -76.52 139.33 40.71 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.559 -0.904 . . . . 72.42 108.559 -177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.607 ' O ' HG23 ' A' ' 388' ' ' VAL . 84.8 t60 -48.42 -48.82 36.91 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.77 0.655 . . . . 73.4 112.77 -175.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -59.54 -42.58 92.65 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.936 -0.765 . . . . 75.02 108.936 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 383' ' ' THR . 49.3 tt0 -67.71 -32.44 73.08 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.213 -1.358 . . . . 71.01 109.115 -174.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.533 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -73.78 -50.51 20.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.828 -1.078 . . . . 32.25 110.289 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 384' ' ' HIS . 15.8 t -59.62 -46.99 92.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 109.819 -0.437 . . . . 71.44 109.819 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 42.7 m -62.78 -29.97 71.11 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.553 -0.748 . . . . 72.54 112.164 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -65.94 -34.53 78.33 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.124 -0.36 . . . . 71.35 110.248 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.5 mp -79.03 -33.61 44.62 Favored 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 120.253 -0.579 . . . . 73.12 110.738 176.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.443 ' HE2' HG12 ' A' ' 388' ' ' VAL . 62.0 mttm -67.23 -29.32 68.93 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.413 0.523 . . . . 72.54 112.413 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -80.21 48.14 0.97 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.44 0.638 . . . . 54.44 112.156 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.42 ' HB ' HG22 ' A' ' 398' ' ' VAL . 32.4 p -124.54 146.93 48.72 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.311 -0.996 . . . . 70.12 108.311 176.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 5.6 t -141.04 98.69 3.43 Favored 'General case' 0 N--CA 1.409 -2.509 0 C-N-CA 117.711 -1.596 . . . . 65.42 110.935 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.759 ' H ' ' HD2' ' A' ' 324' ' ' LYS . 6.2 m-20 65.63 16.13 10.36 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 110.89 -2.868 . . . . 63.11 112.951 166.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -161.65 115.54 1.92 Allowed 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.471 -1.307 . . . . 73.21 107.471 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 394' ' ' THR . 28.8 t -133.74 151.04 32.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 123.034 0.534 . . . . 65.21 110.518 -175.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.401 ' CZ ' ' HE2' ' A' ' 321' ' ' LYS . 29.4 m-85 -126.24 99.79 6.03 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.723 -1.214 . . . . 63.12 107.723 171.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.2 tt -91.75 119.5 31.64 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.525 -1.287 . . . . 62.35 107.525 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 373' ' ' ALA . 24.0 ttmm -103.64 107.89 18.93 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.693 -1.225 . . . . 74.25 107.693 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.498 ' O ' ' HB3' ' A' ' 318' ' ' MET . 1.9 p -107.58 149.99 10.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 CA-C-O 121.744 0.783 . . . . 71.12 110.498 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.585 ' HB2' HD12 ' A' ' 372' ' ' LEU . . . -136.52 159.6 41.31 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.82 -1.082 . . . . 70.05 108.14 176.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.421 ' HA ' ' HE3' ' A' ' 404' ' ' LYS . 0.0 OUTLIER -75.94 153.88 84.85 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 109.079 -0.712 . . . . 51.22 109.079 179.247 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . 0.499 ' HA ' ' OH ' ' A' ' 349' ' ' TYR . 10.7 Cg_endo -55.01 120.25 7.86 Favored 'Trans proline' 0 C--O 1.212 -0.79 0 C-N-CA 123.021 2.481 . . . . 72.44 112.524 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 4.8 m -96.61 9.67 40.85 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.625 0.726 . . . . 72.24 111.102 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -89.44 -156.93 32.45 Favored Glycine 0 N--CA 1.435 -1.377 0 C-N-CA 120.699 -0.762 . . . . 51.31 113.981 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 12.5 m -68.91 -27.23 65.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.994 0.902 . . . . 72.53 108.963 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -107.92 101.11 10.41 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 106.032 -1.84 . . . . 63.14 106.032 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -121.04 143.8 48.87 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 123.473 0.483 . . . . 74.53 112.067 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.469 ' H ' ' HG2' ' A' ' 405' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.056 0 C-N-CA 126.432 1.893 . . . . 75.05 107.392 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.473 -1.989 0 N-CA-C 107.779 -1.193 . . . . 74.22 107.779 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . 0.527 ' O ' ' HD3' ' B' ' 142' ' ' ARG . 2.4 tmt_? -133.45 -16.06 2.41 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 124.122 0.889 . . . . 71.45 108.62 -173.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.678 HG22 HG21 ' B' ' 149' ' ' THR . 17.9 p -84.24 114.03 21.53 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 107.798 -1.186 . . . . 71.25 107.798 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -154.88 143.93 20.98 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.629 -0.878 . . . . 74.33 108.629 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . 0.451 ' CD ' ' H ' ' B' ' 145' ' ' GLN . 5.0 pm0 -70.58 165.64 22.33 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.111 0.481 . . . . 74.43 111.601 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 66.57 28.44 9.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.803 1.641 . . . . 63.25 112.407 -174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -166.37 177.95 6.47 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-N 114.786 -1.097 . . . . 70.42 109.063 175.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.36 165.11 12.73 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.507 -0.923 . . . . 65.45 108.507 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.678 HG21 HG22 ' B' ' 143' ' ' THR . 27.6 m -147.14 129.06 15.39 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.409 -0.589 . . . . 74.22 109.409 170.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 41.6 tt0 -71.14 131.27 43.32 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-O 121.088 0.471 . . . . 70.42 110.771 175.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 331' ' ' PHE . 17.4 m . . . . . 0 C--N 1.301 -1.527 0 CA-C-O 116.786 -1.578 . . . . 70.03 111.627 176.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 64.4 ttp . . . . . 0 CA--C 1.5 -0.951 0 N-CA-C 107.451 -1.314 . . . . 71.21 107.451 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.297 1.6 pm0 -89.88 133.22 34.87 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 114.514 1.302 . . . . 72.42 114.514 -177.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 77.9 mt -120.16 114.95 45.75 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.677 0 CA-C-N 112.135 -2.302 . . . . 74.55 108.789 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -81.43 121.29 26.06 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.235 -1.024 . . . . 73.24 108.235 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.546 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 95.5 mt -118.4 150.06 40.17 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 124.363 1.039 . . . . 61.22 108.807 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 42.9 mm -106.37 116.75 50.78 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 N-CA-C 109.286 -0.635 . . . . 72.21 109.286 173.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 396' ' ' ASP . 12.1 tmtt? -71.13 153.63 42.37 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 107.707 -1.22 . . . . 74.43 107.707 171.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.415 ' O ' ' HE2' ' A' ' 324' ' ' LYS . . . -153.05 -154.94 6.91 Favored Glycine 0 C--N 1.302 -1.321 0 C-N-CA 119.625 -1.274 . . . . 41.5 113.291 -174.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.86 -22.59 36.2 Favored 'Trans proline' 0 C--O 1.217 -0.558 0 C-N-CA 123.165 2.577 . . . . 72.11 113.939 -175.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -106.07 20.57 18.74 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 122.224 1.011 . . . . 64.53 108.618 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.71 -133.61 11.96 Favored Glycine 0 CA--C 1.477 -2.298 0 CA-C-N 114.034 -1.439 . . . . 62.02 109.649 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 329' ' ' LEU . 14.6 tp -109.26 -34.96 6.41 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 106.903 -1.517 . . . . 62.34 106.903 175.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . 0.527 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 86.32 47.18 5.02 Favored Glycine 0 N--CA 1.429 -1.822 0 CA-C-N 113.746 -1.57 . . . . 53.04 116.72 171.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -152.48 150.19 29.35 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 117.928 0.864 . . . . 74.55 112.23 169.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 6.5 m -104.71 129.34 52.93 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.197 -0.91 . . . . 53.12 109.263 -177.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.427 HD11 ' HA ' ' A' ' 388' ' ' VAL . 47.9 pt -113.75 150.96 15.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 115.544 -0.753 . . . . 54.24 108.994 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.489 ' HA ' ' CE1' ' A' ' 384' ' ' HIS . . . -146.3 130.68 17.64 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.343 -1.354 . . . . 44.31 107.343 175.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 145.05 160.24 8.46 Favored Glycine 0 C--N 1.283 -2.372 0 N-CA-C 110.705 -0.958 . . . . 71.31 110.705 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.9 -175.26 20.69 Favored Glycine 0 N--CA 1.424 -2.122 0 N-CA-C 108.253 -1.939 . . . . 64.45 108.253 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 91.0 t -51.07 105.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 O-C-N 124.358 0.681 . . . . 73.05 111.392 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 87.38 -14.92 56.65 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.449 -0.796 . . . . 64.32 112.74 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.522 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -105.41 12.72 31.22 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.873 -1.158 . . . . 71.42 107.873 -177.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.502 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -53.31 126.65 21.89 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.614 0.766 . . . . 61.44 111.749 -176.476 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . 0.556 ' HB3' ' CD2' ' A' ' 349' ' ' TYR . 15.7 t60 -86.64 -38.0 17.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.63 -0.714 . . . . 75.32 110.003 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 37.9 mm -102.62 118.78 57.77 Favored Pre-proline 0 CA--C 1.499 -0.982 0 N-CA-C 109.929 -0.397 . . . . 74.32 109.929 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.07 110.62 0.46 Allowed 'Trans proline' 0 C--O 1.252 1.183 0 C-N-CA 123.093 2.529 . . . . 70.32 111.411 177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 108.29 -5.62 33.79 Favored Glycine 0 N--CA 1.429 -1.814 0 CA-C-N 115.143 -0.935 . . . . 64.55 112.159 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.414 ' HB3' ' OH ' ' A' ' 349' ' ' TYR . 40.4 t0 -131.67 104.33 6.87 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.183 -0.673 . . . . 61.43 109.183 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.502 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 66.3 t30 -83.92 37.91 0.62 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.282 1.039 . . . . 65.14 110.612 -173.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 50.1 m -103.95 177.65 4.78 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.96 -1.018 . . . . 74.42 112.235 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.418 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.5 mm -93.16 138.6 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.428 -0.953 . . . . 73.11 108.428 -177.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.556 ' CD2' ' HB3' ' A' ' 341' ' ' HIS . 95.8 m-85 -129.84 141.86 50.76 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 112.309 0.485 . . . . 35.52 112.309 -178.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 56.8 t -74.37 115.5 15.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 107.747 -1.205 . . . . 73.44 107.747 175.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 6.9 m -98.85 -24.2 15.08 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 121.388 0.613 . . . . 73.11 110.473 -175.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 332' ' ' SER . 33.3 ttmt -158.8 150.13 20.58 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 107.801 -1.185 . . . . 74.33 107.801 -173.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 60.1 mt -130.7 116.26 34.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 107.08 -1.452 . . . . 74.24 107.08 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 46.2 mm -84.99 124.68 40.13 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 C-N-CA 123.481 0.712 . . . . 73.13 110.491 -171.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.496 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 0.6 OUTLIER -60.53 147.26 42.05 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.873 -0.788 . . . . 72.53 108.873 -177.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 94.2 -24.63 26.12 Favored Glycine 0 CA--C 1.478 -2.265 0 N-CA-C 109.486 -1.446 . . . . 71.32 109.486 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . 0.527 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -68.53 142.86 39.52 Favored Glycine 1 N--CA 1.395 -4.053 0 N-CA-C 108.0 -2.04 . . . . 41.05 108.0 172.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 362' ' ' ASP . . . -63.87 -32.56 74.13 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.296 -0.631 . . . . 74.44 109.296 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.637 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.11 -4.62 39.71 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 120.7 -0.4 . . . . 73.32 111.744 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . 0.496 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 17.1 t60 -94.68 -49.2 5.73 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.694 -0.854 . . . . 73.01 108.694 173.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -79.27 -50.42 10.94 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.386 -0.825 . . . . 70.33 111.928 -174.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . 0.659 ' O ' ' HE2' ' A' ' 364' ' ' LYS . 11.4 t70 -85.76 -34.89 21.06 Favored 'General case' 0 CA--C 1.465 -2.303 0 C-N-CA 124.085 0.954 . . . . 75.33 109.888 177.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.637 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -42.39 -25.64 0.3 Allowed Glycine 0 CA--C 1.486 -1.763 0 N-CA-C 119.96 2.744 . . . . 64.53 119.96 -161.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.659 ' HE2' ' O ' ' A' ' 362' ' ' ASP . 0.0 OUTLIER 47.03 31.16 1.46 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.356 1.078 . . . . 70.11 111.069 178.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 48.6 tp -113.6 150.87 32.47 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 114.597 -1.183 . . . . 64.45 109.336 -170.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -122.88 148.44 45.43 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.388 0.614 . . . . 73.52 111.186 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.6 mt -65.97 126.05 24.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.272 -1.01 . . . . 65.43 108.272 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.64 -18.6 14.97 Favored Glycine 0 C--N 1.313 -0.748 0 N-CA-C 111.645 -0.582 . . . . 55.23 111.645 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -62.93 130.84 46.53 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-O 121.16 0.505 . . . . 72.01 111.827 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.546 ' HB2' ' CE1' ' A' ' 349' ' ' TYR . 50.9 tttt -88.84 127.01 35.62 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.562 -0.745 . . . . 65.24 110.581 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 3.3 mp -81.3 107.03 13.74 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.891 -1.522 . . . . 74.11 106.891 177.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' A' ' 403' ' ' ALA . 3.4 tt -80.31 -43.31 21.47 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 106.273 -1.751 . . . . 53.41 106.273 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -157.45 154.56 28.95 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.075 -0.966 . . . . 62.34 110.1 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.77 120.6 42.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 108.525 -0.917 . . . . 71.33 108.525 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . 0.496 HD21 HG22 ' A' ' 394' ' ' THR . 81.5 m-20 63.51 30.51 15.17 Favored 'General case' 0 CA--C 1.484 -1.574 0 CA-C-O 123.978 1.847 . . . . 71.11 108.321 -174.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.9 t30 66.57 16.15 10.32 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 109.793 -3.367 . . . . 74.44 112.605 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.88 124.36 39.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 106.271 -1.752 . . . . 71.52 106.271 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.9 p -65.08 125.36 24.69 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.893 0.701 . . . . 72.35 112.893 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.21 5.94 28.19 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 123.809 0.843 . . . . 64.33 111.108 178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.453 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 28.4 mm-40 -68.48 111.66 4.83 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.227 -0.657 . . . . 73.15 109.227 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 56.09 67.9 0.94 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.572 1.177 . . . . 72.53 113.22 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.72 167.63 23.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 107.112 -1.44 . . . . 53.34 107.112 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.477 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.6 m -74.89 142.41 44.06 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.29 -1.004 . . . . 74.12 108.29 -177.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.626 ' O ' HG23 ' A' ' 388' ' ' VAL . 86.3 t60 -52.93 -49.38 66.13 Favored 'General case' 0 C--O 1.213 -0.843 0 N-CA-C 112.252 0.464 . . . . 64.3 112.252 -176.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.419 ' HG3' ' OG1' ' B' ' 143' ' ' THR . 26.8 tt0 -61.64 -30.34 70.64 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.447 0.641 . . . . 73.11 111.435 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 383' ' ' THR . 50.5 tt0 -75.01 -35.74 61.96 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.044 -0.98 . . . . 75.03 108.426 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -75.09 -38.84 61.09 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.059 -0.973 . . . . 55.43 110.585 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 384' ' ' HIS . 11.7 t -65.08 -42.33 94.2 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 109.011 -0.737 . . . . 64.15 109.011 179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 60.9 m -60.32 -40.79 91.85 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 123.417 0.448 . . . . 72.45 110.08 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -62.26 -35.43 78.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.628 -0.26 . . . . 62.41 111.479 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.473 ' HG ' HG11 ' B' ' 151' ' ' VAL . 57.4 tp -82.34 -22.75 35.4 Favored 'General case' 0 N--CA 1.394 -3.272 0 C-N-CA 122.823 0.449 . . . . 74.13 109.904 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 388' ' ' VAL . 61.1 mttm -77.96 -21.63 50.7 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 120.869 0.366 . . . . 54.52 111.033 176.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -76.18 47.37 0.45 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.498 -0.774 . . . . 73.31 110.411 174.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.496 HG22 HD21 ' A' ' 375' ' ' ASN . 22.5 p -124.61 133.55 53.23 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.087 -1.079 . . . . 73.4 108.087 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . 0.528 ' HA ' ' HD2' ' A' ' 324' ' ' LYS . 50.8 m -139.15 97.73 3.36 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 118.814 -1.154 . . . . 63.33 111.798 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.62 ' HA ' ' O ' ' A' ' 324' ' ' LYS . 5.8 m-20 60.68 18.57 8.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 111.415 -2.63 . . . . 64.43 112.816 171.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -166.69 130.13 1.93 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.389 -1.278 . . . . 71.41 107.567 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.482 HG22 ' HB ' ' A' ' 394' ' ' THR . 22.0 t -145.24 143.43 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 122.832 0.453 . . . . 75.14 111.086 -176.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -117.04 96.78 5.61 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.378 -0.971 . . . . 63.24 108.378 167.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.89 113.95 25.74 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.97 -0.752 . . . . 72.1 108.97 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -93.06 109.7 21.18 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.546 -1.279 . . . . 74.33 107.546 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . . . . . . . . . 69.2 t -104.49 148.18 9.51 Favored 'Isoleucine or valine' 0 C--O 1.258 1.551 0 CA-C-O 121.368 0.604 . . . . 72.13 110.091 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.545 ' HB2' HD12 ' A' ' 372' ' ' LEU . . . -136.25 158.94 43.22 Favored 'General case' 0 N--CA 1.427 -1.616 0 C-N-CA 125.083 1.353 . . . . 43.32 107.543 176.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.42 ' HG3' ' C ' ' A' ' 411' ' ' HIS . 0.4 OUTLIER -81.55 153.31 70.79 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.826 -1.175 . . . . 71.11 107.826 173.237 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -49.34 123.26 9.93 Favored 'Trans proline' 0 N--CA 1.44 -1.647 0 C-N-CA 122.968 2.445 . . . . 64.14 112.199 177.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 2.6 m -95.74 20.65 9.49 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.022 -1.444 . . . . 75.15 109.663 -175.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -98.51 -140.92 11.72 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-N 115.242 -0.89 . . . . 43.41 111.988 -178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 16.4 m -92.08 10.55 28.72 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.263 0.554 . . . . 71.44 110.74 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -142.64 147.46 35.8 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 106.975 -1.491 . . . . 75.12 106.975 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -129.51 132.73 46.96 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 123.234 0.334 . . . . 72.53 110.159 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.42 ' C ' ' HG3' ' A' ' 404' ' ' LYS . 91.2 m-70 . . . . . 0 C--N 1.31 -1.132 0 N-CA-C 107.73 -1.211 . . . . 74.43 107.73 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.488 0 N-CA-C 110.609 -0.145 . . . . 73.52 110.609 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . 0.475 ' HE ' ' HB3' ' B' ' 142' ' ' ARG . 10.1 mtp180 69.32 178.27 0.26 Allowed 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.291 1.043 . . . . 74.44 113.149 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.419 ' OG1' ' HG3' ' A' ' 385' ' ' GLU . 17.5 p -96.97 152.74 18.42 Favored 'General case' 0 N--CA 1.405 -2.679 0 CA-C-N 113.211 -1.813 . . . . 72.11 106.796 175.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . 0.412 ' NE ' ' HA ' ' B' ' 144' ' ' ARG . 3.7 mmp_? -153.88 141.79 20.17 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 109.107 -0.701 . . . . 72.03 109.107 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -86.72 166.89 14.94 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 123.525 0.515 . . . . 75.11 111.035 176.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 67.72 21.33 9.28 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.063 1.745 . . . . 64.33 112.34 -174.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -155.54 178.86 9.75 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.897 -1.047 . . . . 62.3 108.52 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -92.21 149.97 21.16 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.393 -0.966 . . . . 73.32 108.393 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.414 HG21 HG22 ' B' ' 143' ' ' THR . 20.1 m -134.8 129.76 35.06 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.204 -0.665 . . . . 64.13 109.204 174.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 50.2 tt0 -85.29 139.98 31.18 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 112.631 0.604 . . . . 64.42 112.631 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.473 HG11 ' HG ' ' A' ' 391' ' ' LEU . 51.0 t . . . . . 0 C--N 1.312 -1.04 0 N-CA-C 106.641 -1.614 . . . . 74.45 106.641 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . 0.417 ' HB2' HG13 ' A' ' 402' ' ' VAL . 0.4 OUTLIER . . . . . 0 CA--C 1.487 -1.479 0 N-CA-C 108.93 -0.767 . . . . 75.15 108.93 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -132.84 121.19 22.56 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 108.171 -1.048 . . . . 71.24 108.171 171.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 64.5 mt -98.1 105.75 17.71 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.033 0 CA-C-N 114.275 -1.33 . . . . 72.23 108.531 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -89.24 102.43 15.09 Favored 'General case' 0 N--CA 1.38 -3.971 0 N-CA-C 105.105 -2.183 . . . . 74.22 105.105 169.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.457 ' HA ' ' OD2' ' A' ' 362' ' ' ASP . 0.5 OUTLIER -106.31 138.83 41.79 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 112.486 -2.143 . . . . 63.13 108.092 -170.15 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 25.8 mm -98.53 114.83 37.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 CA-C-O 121.344 0.593 . . . . 70.5 110.161 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -75.3 148.7 39.13 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.425 -0.807 . . . . 73.43 110.3 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -135.38 -161.09 9.2 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.857 -0.687 . . . . 75.14 111.86 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.64 -16.59 33.87 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.041 2.494 . . . . 75.41 113.333 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -101.66 10.23 40.33 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.318 1.056 . . . . 61.4 108.633 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.77 -128.67 8.7 Favored Glycine 0 CA--C 1.478 -2.234 0 CA-C-N 114.3 -1.318 . . . . 72.23 110.741 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.444 HD13 HG12 ' B' ' 151' ' ' VAL . 5.3 mp -101.35 -44.65 5.57 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 105.918 -1.882 . . . . 75.33 105.918 174.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 80.36 49.37 5.89 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 114.852 -1.067 . . . . 73.22 114.514 172.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -151.41 147.74 27.25 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.842 -0.429 . . . . 72.22 109.842 174.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 4.2 m -97.93 124.59 42.44 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 108.436 -0.95 . . . . 72.4 108.436 -176.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 46.4 pt -113.48 153.09 15.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 108.611 -0.885 . . . . 53.52 108.611 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -146.92 129.35 15.85 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.077 -0.712 . . . . 71.15 109.077 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 348' ' ' ILE . . . 152.35 165.55 13.33 Favored Glycine 0 C--N 1.282 -2.433 0 N-CA-C 110.208 -1.157 . . . . 61.31 110.208 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 136.69 -176.83 20.14 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 107.663 -2.175 . . . . 72.54 107.663 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.403 ' HA ' ' OD1' ' A' ' 346' ' ' ASN . 58.6 t -54.32 100.5 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.249 1.042 0 CA-C-O 122.096 0.951 . . . . 75.02 112.495 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 80.84 4.49 90.39 Favored Glycine 0 C--O 1.21 -1.404 0 CA-C-N 115.121 -0.945 . . . . 52.41 112.002 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.504 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 0.2 OUTLIER -106.46 11.66 30.5 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.782 -1.562 . . . . 74.41 106.782 178.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 0.0 OUTLIER -49.8 122.67 6.79 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.839 1.256 . . . . 72.13 112.701 -175.633 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -79.27 -38.52 35.24 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.307 -0.86 . . . . 73.13 109.572 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 46.5 mm -104.6 123.97 38.54 Favored Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 108.564 -0.902 . . . . 65.23 108.564 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.36 107.51 0.21 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.971 2.447 . . . . 63.1 112.293 178.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 110.89 -8.97 29.66 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-N 115.26 -0.882 . . . . 75.41 112.591 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . 0.448 ' HB2' ' OG ' ' A' ' 408' ' ' SER . 3.1 t70 -125.22 106.94 10.25 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.39 -0.924 . . . . 71.0 110.288 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 340' ' ' GLN . 61.9 t30 -80.37 28.19 0.32 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.734 1.214 . . . . 73.15 111.747 -171.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.635 ' OG ' ' HE2' ' A' ' 370' ' ' LYS . 24.9 m -99.28 175.63 5.81 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.841 -0.618 . . . . 61.44 112.134 -175.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.564 ' HA ' ' HA3' ' A' ' 335' ' ' GLY . 6.0 mm -89.72 132.2 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 108.016 -1.105 . . . . 73.44 108.016 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.596 ' CE2' ' HB2' ' A' ' 370' ' ' LYS . 68.0 m-85 -128.01 149.57 50.3 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.948 0.404 . . . . 72.24 111.868 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.1 t -75.69 123.72 32.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.482 -0.933 . . . . 74.42 108.482 175.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 33.2 m -108.11 -28.47 9.5 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.932 0.396 . . . . 54.35 111.474 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 50.9 mtmt -152.27 151.96 31.58 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.862 -0.792 . . . . 73.54 108.862 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.438 HG22 ' HB2' ' A' ' 360' ' ' HIS . 68.4 mt -129.41 121.98 54.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 106.623 -1.621 . . . . 74.24 106.623 174.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 50.0 mm -78.16 142.01 14.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 123.408 0.683 . . . . 75.45 112.173 -170.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.98 122.64 12.78 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.698 1.199 . . . . 75.24 112.28 -174.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 72.31 12.25 76.39 Favored Glycine 0 C--N 1.306 -1.087 0 CA-C-N 115.605 -0.725 . . . . 54.44 112.966 177.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -74.27 164.26 54.65 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 110.735 -0.946 . . . . 62.14 110.735 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.53 98.08 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.172 -0.677 . . . . 65.41 109.172 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.575 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.58 -4.6 40.91 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.134 -0.485 . . . . 63.13 112.015 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . 0.438 ' HB2' HG22 ' A' ' 353' ' ' ILE . 15.1 t60 -94.11 -32.69 13.66 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.849 -0.797 . . . . 75.34 108.849 176.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -95.8 -58.17 2.17 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.997 -0.681 . . . . 74.03 112.332 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . 0.457 ' OD2' ' HA ' ' A' ' 322' ' ' LEU . 27.7 t70 -86.18 -21.97 27.22 Favored 'General case' 0 CA--C 1.473 -2.019 0 CA-C-N 115.726 -0.67 . . . . 41.41 110.366 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 359' ' ' ALA . . . -43.0 -34.9 2.13 Favored Glycine 0 CA--C 1.479 -2.172 0 CA-C-O 117.751 -1.583 . . . . 33.41 116.144 -172.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? 42.8 40.37 2.07 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.937 0.875 . . . . 60.41 110.15 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 60.3 tp -133.45 154.39 50.83 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 113.588 -1.642 . . . . 73.23 108.977 -167.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -122.66 152.33 40.62 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.736 0.779 . . . . 73.35 111.141 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.7 mt -65.71 123.68 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 N-CA-C 108.024 -1.102 . . . . 60.42 108.024 174.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.17 -6.16 21.58 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.684 -0.769 . . . . 50.35 112.342 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.428 ' HB3' HG21 ' A' ' 402' ' ' VAL . 13.5 m-20 -74.23 141.62 45.39 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.026 0.75 . . . . 60.04 113.026 177.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.647 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 47.1 tttm -96.08 118.43 32.65 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 123.978 0.911 . . . . 63.44 110.31 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.475 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 3.0 mp -78.85 114.46 17.8 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.674 -1.232 . . . . 73.51 107.674 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.53 ' HA ' ' OE2' ' A' ' 380' ' ' GLU . 5.7 tt -86.84 -43.01 12.8 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.943 -1.132 . . . . 72.52 107.943 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -157.2 150.64 24.06 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.046 -0.524 . . . . 63.32 111.024 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 9.8 p -133.59 123.8 46.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 109.006 -0.739 . . . . 62.32 109.006 173.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . 0.583 HD21 HG22 ' A' ' 394' ' ' THR . 92.7 m-20 60.95 31.86 19.96 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-O 124.145 1.926 . . . . 75.41 109.536 -173.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 67.23 12.36 8.9 Favored 'General case' 0 C--N 1.281 -2.376 0 CA-C-N 109.08 -3.691 . . . . 73.25 112.903 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 54.9 t -82.29 125.3 39.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 106.697 -1.594 . . . . 73.42 106.697 173.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 9.8 p -66.74 126.55 29.36 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 123.61 0.569 . . . . 73.53 112.267 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.02 6.07 30.88 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.714 0.806 . . . . 53.33 110.725 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . 0.53 ' OE2' ' HA ' ' A' ' 372' ' ' LEU . 13.6 mm-40 -70.81 107.43 3.99 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.217 -0.901 . . . . 74.41 109.253 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 57.8 71.59 0.57 Allowed 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.371 1.081 . . . . 73.11 113.36 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.69 172.53 15.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.023 -1.473 . . . . 44.04 107.023 176.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 81.0 p -81.23 146.69 30.33 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.066 -1.054 . . . . 61.34 108.769 177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -52.33 -31.45 33.32 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 112.937 0.717 . . . . 62.32 112.937 -176.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.529 ' HA ' ' OG1' ' B' ' 143' ' ' THR . 14.0 tp10 -64.5 -40.85 96.42 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-O 120.625 0.25 . . . . 61.51 110.875 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.62 -40.22 80.44 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.637 -0.875 . . . . 71.14 108.637 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.425 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -62.42 -59.04 5.54 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.5 -1.227 . . . . 73.11 110.629 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.477 ' HB ' HG21 ' B' ' 143' ' ' THR . 90.4 t -57.3 -44.91 84.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 O-C-N 123.212 0.32 . . . . 73.1 111.546 -177.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 55.4 m -60.65 -34.12 73.82 Favored 'General case' 0 C--O 1.254 1.323 0 N-CA-C 111.927 0.343 . . . . 71.24 111.927 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.8 77.88 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 110.277 -0.268 . . . . 64.42 110.277 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.9 mp -79.28 -28.73 42.32 Favored 'General case' 0 C--O 1.218 -0.57 0 C-N-CA 120.339 -0.544 . . . . 64.44 110.792 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 388' ' ' VAL . 73.0 mmtt -61.94 -41.61 98.17 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 120.608 0.242 . . . . 73.33 111.014 176.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -77.46 70.7 3.88 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 122.561 1.172 . . . . 74.14 111.021 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.583 HG22 HD21 ' A' ' 375' ' ' ASN . 12.9 p -142.45 155.46 45.08 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 113.241 -1.8 . . . . 65.32 108.561 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 32.5 p -166.45 115.81 0.92 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.591 -0.522 . . . . 61.32 109.591 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . . . . . . . . . 29.8 t70 64.39 0.07 1.0 Allowed 'General case' 0 N--CA 1.502 2.172 0 C-N-CA 125.365 1.466 . . . . 74.44 112.043 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -163.48 137.87 6.04 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.532 -0.914 . . . . 72.53 108.532 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 48.0 t -139.51 120.62 15.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 106.437 -1.69 . . . . 71.53 106.437 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.22 95.13 5.76 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.134 -1.432 . . . . 61.21 107.134 177.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.4 tt -108.94 111.12 22.63 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-O 121.038 0.447 . . . . 73.32 110.439 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -88.24 121.25 30.43 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.013 -1.106 . . . . 54.11 108.013 176.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 369' ' ' ASP . 2.1 p -115.9 137.33 49.92 Favored 'Isoleucine or valine' 0 C--O 1.258 1.534 0 C-N-CA 123.578 0.751 . . . . 74.02 110.045 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.647 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.48 158.72 43.77 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.364 -0.976 . . . . 33.33 108.364 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . 0.447 ' HG3' ' C ' ' A' ' 411' ' ' HIS . 0.4 OUTLIER -78.43 153.77 79.04 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 108.723 -0.843 . . . . 53.11 108.723 175.255 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . 0.457 ' HG2' ' HA ' ' A' ' 410' ' ' HIS . 50.0 Cg_exo -35.41 125.21 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.914 3.743 . . . . 64.23 114.025 177.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 28.1 m -86.68 -38.12 17.32 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.577 -1.192 . . . . 70.4 111.291 -173.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -125.83 31.12 4.21 Favored Glycine 0 N--CA 1.432 -1.57 0 C-N-CA 119.349 -1.405 . . . . 62.34 112.92 -175.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . 0.448 ' OG ' ' HB2' ' A' ' 345' ' ' ASP . 33.9 p -154.55 -167.54 2.64 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.843 -0.428 . . . . 70.11 109.843 -178.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -71.03 109.56 5.2 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.93 -0.766 . . . . 74.44 108.93 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . 0.457 ' HA ' ' HG2' ' A' ' 405' ' ' PRO . 3.3 p-80 -71.14 132.84 45.63 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 115.163 1.542 . . . . 75.12 115.163 -176.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.447 ' C ' ' HG3' ' A' ' 404' ' ' LYS . 40.3 t-80 . . . . . 0 N--CA 1.435 -1.219 0 C-N-CA 126.293 1.837 . . . . 74.32 106.072 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . 0.413 ' OE ' ' HG3' ' A' ' 392' ' ' LYS . . . . . . . . 0 CA--C 1.488 -1.421 0 CA-C-O 121.229 0.538 . . . . 60.24 110.058 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . 0.459 ' O ' ' HD2' ' B' ' 142' ' ' ARG . 0.6 OUTLIER 68.91 45.88 0.92 Allowed 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 123.547 1.641 . . . . 70.33 108.691 173.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 385' ' ' GLU . 72.9 p -88.54 -176.4 5.28 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 112.409 -2.178 . . . . 73.32 106.684 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . 0.652 ' HB2' HD21 ' B' ' 147' ' ' ASN . 52.0 mtm180 -148.19 126.78 12.46 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.694 -1.595 . . . . 61.23 106.694 -172.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . 0.447 ' HA ' ' OD1' ' A' ' 339' ' ' ASN . 9.3 pt20 -86.64 164.92 16.53 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 113.452 0.908 . . . . 75.42 113.452 177.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . 0.464 ' H ' ' CG ' ' A' ' 339' ' ' ASN . 1.0 OUTLIER 66.92 29.01 8.44 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.491 1.916 . . . . 71.51 111.112 -175.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . 0.652 HD21 ' HB2' ' B' ' 144' ' ' ARG . 0.2 OUTLIER -164.74 -179.13 5.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.182 -1.372 . . . . 62.41 107.991 179.415 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.42 152.3 19.79 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 123.427 0.454 . . . . 63.24 112.208 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 41.9 m -142.51 141.82 32.15 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.886 -0.509 . . . . 75.01 109.862 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -77.16 152.99 34.62 Favored 'General case' 0 CA--C 1.462 -2.44 0 C-N-CA 123.918 0.887 . . . . 73.41 113.193 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.444 HG12 HD13 ' A' ' 329' ' ' LEU . 6.6 t . . . . . 0 N--CA 1.392 -3.354 0 C-N-CA 118.37 -1.332 . . . . 63.22 110.847 169.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 53.6 ttm . . . . . 0 C--O 1.205 -1.256 0 N-CA-C 106.107 -1.812 . . . . 64.23 106.107 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.428 1.9 pm0 -114.59 130.89 56.82 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 116.787 2.143 . . . . 60.13 116.787 -173.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.489 HG23 ' HD3' ' A' ' 364' ' ' LYS . 72.5 mt -111.88 112.66 41.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-N 111.573 -2.558 . . . . 70.01 108.83 -176.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . 0.639 ' HD3' ' CE1' ' A' ' 399' ' ' TYR . 30.6 ttpt -82.97 125.08 31.01 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.42 -0.955 . . . . 72.32 108.42 173.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.567 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 96.3 mt -119.29 154.06 34.08 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 124.904 1.377 . . . . 73.23 108.762 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 396' ' ' ASP . 49.5 mt -106.44 145.55 14.06 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.121 0 N-CA-C 106.467 -1.679 . . . . 64.42 106.467 169.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.537 ' H ' ' HA ' ' A' ' 396' ' ' ASP . 1.3 ttpm? -75.26 177.81 6.25 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.732 -1.211 . . . . 72.05 107.732 177.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . 0.465 ' H ' ' HG2' ' A' ' 324' ' ' LYS . . . -160.78 -167.91 21.93 Favored Glycine 0 C--N 1.289 -2.067 0 C-N-CA 119.949 -1.119 . . . . 63.11 111.665 -177.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.27 -29.23 32.58 Favored 'Trans proline' 0 C--O 1.214 -0.723 0 C-N-CA 123.166 2.578 . . . . 75.31 112.405 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -106.39 25.29 11.28 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.241 0.543 . . . . 71.4 110.041 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 83.99 -125.52 7.13 Favored Glycine 0 CA--C 1.485 -1.793 0 N-CA-C 109.442 -1.463 . . . . 62.13 109.442 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.423 ' HB2' HG23 ' B' ' 151' ' ' VAL . 5.7 mp -97.49 -30.84 12.66 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.288 -1.745 . . . . 62.21 106.288 173.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 357' ' ' GLY . . . 85.99 48.7 4.54 Favored Glycine 0 N--CA 1.429 -1.798 0 CA-C-N 114.057 -1.429 . . . . 75.55 115.041 173.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 352' ' ' LYS . 55.5 p90 -153.23 166.43 32.58 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.504 -0.554 . . . . 72.32 109.504 172.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 352' ' ' LYS . 9.5 m -117.9 136.78 53.24 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 120.597 -0.441 . . . . 74.03 110.18 -177.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.0 pt -119.06 152.46 21.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 122.496 0.319 . . . . 45.02 110.948 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -141.73 135.05 29.4 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.106 -1.813 . . . . 44.03 106.106 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 144.59 156.54 6.86 Favored Glycine 0 C--N 1.277 -2.696 0 N-CA-C 109.53 -1.428 . . . . 64.01 109.53 -176.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 133.23 178.5 15.61 Favored Glycine 0 C--N 1.281 -2.519 0 N-CA-C 107.321 -2.311 . . . . 54.24 107.321 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.458 ' HA ' HD21 ' A' ' 346' ' ' ASN . 83.6 t -45.48 106.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 117.839 0.82 . . . . 72.3 111.994 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 84.91 -13.56 53.17 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.216 -0.902 . . . . 54.53 112.499 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.48 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 63.2 t30 -105.23 21.15 17.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.012 -0.736 . . . . 64.35 109.012 -176.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.07 121.48 5.51 Favored 'General case' 0 C--O 1.256 1.436 0 CA-C-N 115.116 -0.947 . . . . 74.33 110.467 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -79.39 -43.4 23.49 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.11 -0.95 . . . . 73.13 108.734 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 37.4 mm -103.24 129.89 24.66 Favored Pre-proline 0 C--N 1.301 -1.503 0 CA-C-N 115.053 -0.976 . . . . 75.51 109.018 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.57 110.14 0.46 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 123.27 2.647 . . . . 71.22 113.292 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 97.83 -6.36 62.38 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.556 -0.747 . . . . 71.04 112.468 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -121.24 98.61 6.06 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.392 -0.966 . . . . 71.45 108.392 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.458 HD21 ' HA ' ' A' ' 337' ' ' VAL . 51.5 t30 -81.66 26.87 0.47 Allowed 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 124.362 1.065 . . . . 73.53 111.219 -170.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.515 ' CB ' ' HE3' ' A' ' 370' ' ' LYS . 55.1 m -93.94 173.57 7.6 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.16 0.8 . . . . 73.45 113.16 -174.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 34.5 mm -86.01 126.06 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 114.915 -1.039 . . . . 62.33 109.685 -177.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 370' ' ' LYS . 43.1 m-85 -124.01 132.69 53.72 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.199 0.523 . . . . 75.45 111.858 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.56 114.11 4.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 108.348 -0.982 . . . . 74.04 108.348 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 22.6 m -102.94 -20.95 14.05 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 120.865 0.364 . . . . 43.35 111.401 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 332' ' ' SER . 45.9 mmtm -150.71 159.46 44.51 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.342 -1.355 . . . . 75.31 107.342 177.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 61.3 mt -138.73 119.45 15.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 106.249 -1.76 . . . . 73.02 106.249 172.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 40.3 mm -86.07 118.01 31.79 Favored 'Isoleucine or valine' 0 C--O 1.255 1.387 0 N-CA-C 108.494 -0.928 . . . . 63.51 108.494 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.53 ' HA ' ' CG ' ' A' ' 360' ' ' HIS . 0.1 OUTLIER -65.62 147.42 53.43 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 107.181 -1.414 . . . . 71.33 107.181 -176.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 95.24 -16.62 60.92 Favored Glycine 0 C--N 1.289 -2.054 0 N-CA-C 109.275 -1.53 . . . . 71.31 109.275 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 330' ' ' GLY . . . -75.09 150.43 40.78 Favored Glycine 0 N--CA 1.4 -3.738 0 N-CA-C 106.726 -2.55 . . . . 54.43 106.726 170.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -60.84 -35.03 75.52 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.854 -0.424 . . . . 33.42 109.854 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.557 ' O ' ' HA3' ' A' ' 363' ' ' GLY . . . -75.35 -9.08 58.24 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 112.914 0.709 . . . . 64.41 112.914 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . 0.53 ' CG ' ' HA ' ' A' ' 355' ' ' GLU . 30.2 t-80 -94.95 -39.24 10.3 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.334 -0.947 . . . . 73.32 108.575 175.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -76.84 -57.19 3.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.861 -0.608 . . . . 62.01 110.949 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -85.84 -42.15 14.39 Favored 'General case' 0 CA--C 1.476 -1.882 0 C-N-CA 124.221 1.008 . . . . 74.43 111.32 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.569 ' O ' ' HD2' ' A' ' 364' ' ' LYS . . . -43.07 -20.56 0.09 OUTLIER Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 120.651 3.02 . . . . 52.44 120.651 -162.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.569 ' HD2' ' O ' ' A' ' 363' ' ' GLY . 0.0 OUTLIER 42.86 33.45 0.5 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 118.522 1.161 . . . . 72.43 111.921 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 41.6 tp -107.94 155.49 20.26 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.718 1.207 . . . . 41.55 109.706 -171.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -124.89 145.34 49.87 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.405 0.621 . . . . 64.33 111.641 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 83.9 mt -66.15 123.23 18.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 107.69 -1.226 . . . . 73.02 107.69 171.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.73 -7.92 19.69 Favored Glycine 0 C--N 1.311 -0.841 0 C-N-CA 121.173 -0.536 . . . . 71.44 111.835 -175.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.401 ' HB3' HG21 ' A' ' 402' ' ' VAL . 19.0 m-20 -68.68 137.14 53.9 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 112.563 0.579 . . . . 70.21 112.563 177.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.515 ' HE3' ' CB ' ' A' ' 347' ' ' SER . 72.4 tttt -98.71 116.83 31.8 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.288 -0.869 . . . . 71.02 109.957 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . . . . . . . . . 71.4 mt -83.96 114.5 21.74 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.226 0.536 . . . . 75.21 109.679 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 4.5 tt -81.0 -39.38 25.98 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.159 -1.382 . . . . 74.21 107.457 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.473 ' HB3' ' HD3' ' A' ' 401' ' ' LYS . . . -165.67 158.56 15.53 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.504 -0.771 . . . . 70.21 110.174 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.417 HG12 HD11 ' A' ' 379' ' ' LEU . 14.2 p -134.17 124.15 45.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.287 -1.005 . . . . 70.3 108.287 174.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . 0.537 HD21 HG22 ' A' ' 394' ' ' THR . 88.4 m-20 62.18 30.81 17.76 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 123.719 1.723 . . . . 64.2 109.268 -176.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 67.48 9.64 7.17 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 109.999 -3.273 . . . . 74.3 113.201 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.43 122.27 36.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 106.472 -1.677 . . . . 73.13 106.472 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.3 p -61.21 125.84 25.2 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.235 0.828 . . . . 74.11 113.235 -176.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.417 HD11 HG12 ' A' ' 374' ' ' VAL . 7.6 mp -106.6 -1.36 22.98 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.662 0.785 . . . . 71.32 110.71 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -73.45 113.88 11.05 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.405 -0.961 . . . . 70.45 108.405 172.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 63.75 83.87 0.16 Allowed 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 124.587 1.179 . . . . 71.32 111.919 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 23.5 m -153.15 164.62 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.234 -1.348 . . . . 65.24 108.705 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.6 m -83.0 139.61 33.19 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.258 -1.016 . . . . 73.43 108.258 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.558 ' O ' HG23 ' A' ' 388' ' ' VAL . 81.5 t60 -49.53 -47.47 48.96 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.031 0.752 . . . . 72.11 113.031 -175.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.422 ' HA ' ' HB ' ' B' ' 143' ' ' THR . 0.8 OUTLIER -59.09 -43.42 91.83 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.75 -0.833 . . . . 62.1 108.75 -178.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 383' ' ' THR . 47.8 tt0 -67.5 -31.39 71.48 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.031 -1.44 . . . . 73.32 108.974 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.504 ' O ' HD12 ' A' ' 391' ' ' LEU . . . -75.37 -49.92 17.55 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 114.7 -1.136 . . . . 74.21 110.456 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 384' ' ' HIS . 19.2 t -59.61 -46.47 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 N-CA-C 109.713 -0.477 . . . . 61.45 109.713 -178.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 52.0 m -62.12 -29.49 70.37 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.522 -0.763 . . . . 73.31 112.041 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -66.86 -31.92 72.85 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.689 -0.632 . . . . 52.11 110.4 175.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 387' ' ' ALA . 5.6 mp -82.2 -31.6 30.26 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 120.599 -0.44 . . . . 73.23 110.875 176.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -71.12 -27.82 63.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.074 0.398 . . . . 75.44 112.074 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -78.16 55.18 1.46 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.547 0.689 . . . . 64.21 110.641 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.537 HG22 HD21 ' A' ' 375' ' ' ASN . 22.1 p -127.46 152.54 47.42 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 109.122 -0.696 . . . . 64.03 109.122 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 324' ' ' LYS . 51.1 m -144.47 90.37 2.08 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.444 1.116 . . . . 73.05 111.628 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.537 ' HA ' ' H ' ' A' ' 324' ' ' LYS 0.267 9.1 m-20 61.96 17.2 8.76 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 111.636 -2.529 . . . . 62.31 115.329 170.074 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -161.61 122.15 2.67 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 107.075 -1.454 . . . . 73.44 107.075 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 21.7 t -140.1 143.45 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 122.509 0.323 . . . . 70.43 110.488 -175.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . 0.639 ' CE1' ' HD3' ' A' ' 321' ' ' LYS . 4.5 m-85 -117.64 96.45 5.39 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.265 0.555 . . . . 71.53 109.696 170.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.9 tt -88.67 123.21 32.9 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.675 -0.693 . . . . 61.34 109.683 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.473 ' HD3' ' HB3' ' A' ' 373' ' ' ALA . 26.7 mtpp -107.37 107.78 18.84 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.358 -0.979 . . . . 75.13 108.358 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' A' ' 369' ' ' ASP . 7.2 p -108.39 153.31 10.0 Favored 'Isoleucine or valine' 0 C--O 1.274 2.387 0 CA-C-N 115.403 -0.817 . . . . 73.11 110.231 -177.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -136.41 157.61 46.39 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 105.945 -1.872 . . . . 64.23 105.945 174.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -85.98 153.99 57.71 Favored Pre-proline 0 C--N 1.284 -2.25 0 C-N-CA 119.792 -0.763 . . . . 73.12 109.719 178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . 0.451 ' HA ' ' OH ' ' A' ' 349' ' ' TYR . 1.3 Cg_endo -42.38 120.39 1.64 Allowed 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 124.238 3.292 . . . . 73.12 114.089 -177.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 5.9 m -90.61 -7.68 52.1 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.065 -0.97 . . . . 61.45 111.017 -175.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -114.94 22.03 12.95 Favored Glycine 0 N--CA 1.433 -1.542 0 C-N-CA 120.368 -0.92 . . . . 44.33 111.809 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . . . . . . . . . 69.8 m -160.26 -172.56 3.63 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.753 -1.203 . . . . 55.22 107.753 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -78.68 151.58 32.13 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.37 -1.344 . . . . 73.53 107.37 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -77.77 130.7 37.05 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 123.216 0.323 . . . . 63.4 110.479 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 49.8 m80 . . . . . 0 C--N 1.302 -1.473 0 N-CA-C 106.5 -1.667 . . . . 61.31 106.5 179.393 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.232 0 N-CA-C 107.136 -1.431 . . . . 75.25 107.136 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . 0.442 ' HB3' HG23 ' B' ' 149' ' ' THR . 2.7 mmt180 -122.42 -61.65 1.45 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 123.68 0.613 . . . . 73.34 110.73 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.708 HG22 HG21 ' B' ' 149' ' ' THR . 76.1 p -66.36 101.01 0.69 Allowed 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 107.949 -1.13 . . . . 74.33 107.949 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -164.9 160.07 18.93 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.659 -1.237 . . . . 71.23 107.659 -173.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -83.08 163.28 21.01 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 120.892 0.377 . . . . 60.03 110.429 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 66.46 18.7 10.87 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.919 1.688 . . . . 61.55 112.894 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -152.99 172.12 17.32 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.242 0.544 . . . . 71.1 111.67 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -95.06 158.45 15.46 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.022 -0.99 . . . . 72.3 109.466 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.708 HG21 HG22 ' B' ' 143' ' ' THR . 23.0 m -144.93 138.58 26.98 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 116.567 -0.288 . . . . 71.32 110.329 175.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 13.9 tm0? -78.69 140.04 38.41 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.008 -0.542 . . . . 74.34 111.161 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 329' ' ' LEU . 18.1 m . . . . . 0 C--O 1.266 1.926 0 CA-C-N 115.476 -0.784 . . . . 64.51 112.275 178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 CA--C 1.485 -1.52 0 N-CA-C 106.207 -1.775 . . . . 72.33 106.207 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . 0.359 2.2 pm0 -121.46 131.0 53.91 Favored 'General case' 0 C--N 1.267 -2.981 0 N-CA-C 114.732 1.382 . . . . 73.22 114.732 -175.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 74.8 mt -116.96 113.7 43.66 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 CA-C-N 112.516 -2.129 . . . . 64.15 109.558 -172.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -92.81 112.4 24.34 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.323 -0.992 . . . . 35.13 108.323 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' LEU . . . . . 0.653 ' CD2' ' HA2' ' A' ' 363' ' ' GLY . 81.6 mt -107.27 152.85 23.57 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 124.363 1.039 . . . . 75.5 109.068 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 40.5 mt -106.16 126.46 61.72 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 107.917 -1.142 . . . . 74.24 107.917 169.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.47 ' HB3' ' H ' ' A' ' 396' ' ' ASP . 85.6 tttt -75.04 156.49 36.1 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.337 -0.392 . . . . 71.23 110.473 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . -148.57 -154.86 6.45 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.705 -0.759 . . . . 33.01 113.151 -174.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.27 -46.85 27.62 Favored 'Trans proline' 0 C--N 1.367 1.552 0 C-N-CA 124.039 3.159 . . . . 71.24 115.024 -173.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -98.47 25.82 6.03 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.265 0.555 . . . . 72.24 110.601 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' GLY . . . . . . . . . . . . . . . 84.81 -124.32 6.67 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 114.987 -1.006 . . . . 71.12 111.958 177.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.433 HD13 HG12 ' B' ' 151' ' ' VAL . 8.2 mp -90.89 -39.78 12.11 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.526 -1.287 . . . . 65.54 107.526 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 87.08 47.99 4.53 Favored Glycine 0 N--CA 1.402 -3.613 0 CA-C-N 113.937 -1.483 . . . . 72.23 113.261 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 329' ' ' LEU . 48.9 p90 -155.47 147.17 23.13 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.327 0.584 . . . . 74.33 111.526 170.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' B' ' 150' ' ' GLN . 51.1 m -96.17 132.16 41.88 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.175 -0.921 . . . . 63.23 109.151 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.411 ' HB ' HG22 ' A' ' 348' ' ' ILE . 46.9 pt -120.45 141.91 38.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 109.941 -0.392 . . . . 61.53 109.941 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . . . . . . . . . . . -139.58 125.59 19.81 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.768 -1.197 . . . . 64.21 107.768 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 339' ' ' ASN . . . 150.22 161.65 10.03 Favored Glycine 0 C--N 1.282 -2.438 0 N-CA-C 110.469 -1.052 . . . . 63.11 110.469 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . 134.05 -179.81 17.14 Favored Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 107.221 -2.352 . . . . 72.33 107.221 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 98.4 t -52.2 108.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 118.078 0.939 . . . . 65.52 110.778 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 94.78 -21.58 42.69 Favored Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.321 -0.854 . . . . 42.0 112.092 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' ASN . . . . . 0.61 ' O ' ' HA2' ' A' ' 335' ' ' GLY . 32.1 t-20 -105.75 13.43 29.68 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.06 -0.719 . . . . 40.04 109.06 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.91 120.57 4.46 Favored 'General case' 0 C--O 1.254 1.296 0 CA-C-O 121.513 0.673 . . . . 74.53 111.098 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -77.79 -45.07 25.6 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.029 -0.987 . . . . 63.15 109.451 -174.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 40.4 mm -103.35 124.14 39.21 Favored Pre-proline 0 C--N 1.3 -1.567 0 CA-C-N 115.309 -0.86 . . . . 74.35 109.16 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.66 108.01 0.25 Allowed 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 123.247 2.631 . . . . 70.15 112.512 178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 105.39 -4.12 40.4 Favored Glycine 0 N--CA 1.432 -1.599 0 CA-C-N 115.459 -0.791 . . . . 52.14 112.002 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -128.9 96.93 4.49 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.451 -0.944 . . . . 55.45 108.451 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -83.7 36.94 0.56 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.859 -1.064 . . . . 65.42 111.778 -170.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 72.0 m -98.66 177.34 5.34 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-N 115.613 -0.721 . . . . 70.5 111.249 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 371' ' ' LEU . 4.1 mm -91.54 138.85 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 N-CA-C 106.33 -1.73 . . . . 75.31 106.33 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 369' ' ' ASP . 22.4 m-85 -127.5 139.25 52.91 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 118.34 0.518 . . . . 75.14 111.639 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.24 123.46 22.87 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 N-CA-C 108.955 -0.757 . . . . 52.34 108.955 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 4.1 m -102.35 -28.5 12.21 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.383 0.611 . . . . 73.41 110.529 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.48 ' HZ2' HD13 ' A' ' 354' ' ' ILE . 60.8 tttm -155.62 147.72 23.5 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.245 -1.02 . . . . 73.03 108.245 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.454 HG22 ' HB2' ' A' ' 360' ' ' HIS . 76.5 mt -107.74 139.7 28.78 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 N-CA-C 105.412 -2.07 . . . . 64.24 105.412 169.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.48 HD13 ' HZ2' ' A' ' 352' ' ' LYS . 44.9 mm -85.17 129.74 37.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.147 0.499 . . . . 72.1 110.799 -174.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 355' ' ' GLU . 0.5 OUTLIER -57.62 115.75 2.97 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 125.586 1.554 . . . . 62.13 111.105 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 84.24 7.98 84.27 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.725 -0.75 . . . . 43.12 111.807 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -75.9 160.2 51.36 Favored Glycine 0 C--O 1.259 1.67 0 N-CA-C 111.769 -0.532 . . . . 71.42 111.769 177.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -63.29 -42.21 99.06 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.184 -0.672 . . . . 45.4 109.184 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.522 ' HA ' ' CA ' ' A' ' 363' ' ' GLY . . . -72.97 -6.74 47.4 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.852 -0.613 . . . . 74.42 111.427 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' HIS . . . . . 0.454 ' HB2' HG22 ' A' ' 353' ' ' ILE . 63.9 t60 -92.66 -33.92 14.18 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.592 0.71 . . . . 61.12 109.473 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.651 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 0.7 OUTLIER -92.9 -54.65 3.66 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.902 0.704 . . . . 62.52 112.902 177.6 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' ASP . . . . . 0.728 ' O ' ' HE2' ' A' ' 364' ' ' LYS . 23.3 t70 -85.33 -37.22 20.19 Favored 'General case' 0 CA--C 1.461 -2.458 0 O-C-N 124.16 0.912 . . . . 61.34 110.625 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' GLY . . . . . 0.653 ' HA2' ' CD2' ' A' ' 322' ' ' LEU . . . -41.2 -28.11 0.27 Allowed Glycine 0 CA--C 1.483 -1.966 0 N-CA-C 120.37 2.908 . . . . 62.23 120.37 -160.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.728 ' HE2' ' O ' ' A' ' 362' ' ' ASP . 0.0 OUTLIER 46.26 32.66 1.56 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 118.442 1.121 . . . . 72.04 110.877 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' LEU . . . . . . . . . . . . . 43.0 tp -115.4 155.55 27.2 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.776 1.231 . . . . 74.12 109.103 -170.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -120.62 149.04 43.09 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 121.388 0.613 . . . . 71.21 111.165 178.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 79.0 mt -66.17 122.65 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 107.454 -1.313 . . . . 73.02 107.454 172.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 115.57 -9.12 19.65 Favored Glycine 0 N--CA 1.426 -2.004 0 C-N-CA 120.476 -0.869 . . . . 41.34 113.013 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 349' ' ' TYR . 4.2 m-20 -61.47 142.32 57.09 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.233 0.827 . . . . 75.4 113.233 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 403' ' ' ALA . 43.3 tttp -93.27 115.01 27.61 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.491 1.117 . . . . 74.33 109.452 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 348' ' ' ILE . 4.2 mp -79.9 112.81 17.55 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.873 -0.788 . . . . 71.21 108.873 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 403' ' ' ALA . 5.8 tt -87.14 -40.16 14.87 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.057 -1.09 . . . . 74.22 108.057 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 401' ' ' LYS . . . -161.99 157.3 23.45 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.883 -0.599 . . . . 75.21 110.891 -177.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.7 p -134.28 123.11 42.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 108.624 -0.88 . . . . 63.42 108.624 173.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . 0.535 HD21 HG22 ' A' ' 394' ' ' THR . 91.8 m-20 60.49 31.59 20.33 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-O 124.089 1.899 . . . . 70.14 109.235 -174.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' ASN . . . . . . . . . . . . . 1.7 t30 66.26 15.84 10.23 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 109.48 -3.509 . . . . 70.3 112.509 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 55.2 t -84.08 125.98 40.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 106.522 -1.658 . . . . 73.32 106.522 173.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 7.8 p -61.66 123.69 18.62 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 123.605 0.762 . . . . 74.44 113.053 -176.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 391' ' ' LEU . 7.6 mp -110.81 -4.79 15.11 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.653 0.781 . . . . 71.35 111.387 177.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -65.65 106.29 1.44 Allowed 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.661 -0.496 . . . . 72.51 109.661 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 60.37 73.17 0.49 Allowed 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 124.616 1.198 . . . . 60.34 113.223 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.24 171.02 18.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 107.155 -1.424 . . . . 52.52 107.155 175.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 386' ' ' GLU . 1.8 m -76.96 142.52 39.98 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.613 -0.884 . . . . 74.25 108.613 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' HIS . . . . . 0.535 ' O ' HG23 ' A' ' 388' ' ' VAL . 82.4 t60 -51.17 -47.75 62.07 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 111.446 0.165 . . . . 52.13 111.446 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' GLU . . . . . 0.715 ' HA ' ' OG1' ' B' ' 143' ' ' THR . 7.4 tp10 -58.7 -37.39 75.98 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.835 0.826 . . . . 60.42 110.814 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 383' ' ' THR . 53.1 tt0 -73.85 -38.93 64.33 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.427 -1.26 . . . . 63.15 108.532 -174.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -70.19 -51.66 29.35 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.858 -1.065 . . . . 60.12 110.335 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' VAL . . . . . 0.546 HG11 HG21 ' B' ' 143' ' ' THR . 40.4 t -59.28 -40.69 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.717 -0.22 . . . . 72.03 110.936 -177.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' THR . . . . . . . . . . . . . 90.5 m -60.23 -35.5 75.61 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 116.689 -0.232 . . . . 74.51 110.99 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.37 -37.98 84.05 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.587 0.232 . . . . 52.25 110.649 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.421 HD11 HD21 ' A' ' 379' ' ' LEU . 6.2 mp -75.86 -32.01 59.54 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.248 -0.581 . . . . 72.13 110.841 176.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' LYS . . . . . 0.488 ' HG2' HG13 ' B' ' 151' ' ' VAL . 57.6 mttm -67.52 -36.09 80.36 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 112.619 0.6 . . . . 75.34 112.619 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -81.1 70.62 7.97 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.38 1.086 . . . . 72.51 110.786 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.535 HG22 HD21 ' A' ' 375' ' ' ASN . 7.9 p -139.56 157.78 45.23 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 113.745 -1.571 . . . . 73.44 109.433 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' SER . . . . . . . . . . . . . 20.1 p -162.61 122.26 2.31 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.117 -0.698 . . . . 63.34 109.117 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' ASP . . . . . 0.47 ' H ' ' HB3' ' A' ' 324' ' ' LYS . 3.6 m-20 59.81 1.42 0.31 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.516 1.526 . . . . 72.43 114.446 175.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -162.35 128.22 3.47 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 108.835 -0.802 . . . . 62.45 108.835 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 322' ' ' LEU . 47.6 t -140.32 111.94 4.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.766 -0.828 . . . . 61.45 108.766 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -94.07 96.44 9.66 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.481 -0.933 . . . . 74.21 108.481 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 4.3 tt -92.25 120.61 32.97 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 108.656 -0.868 . . . . 71.33 108.656 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 373' ' ' ALA . 25.1 ttmm -106.09 110.16 22.33 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.509 -1.293 . . . . 75.01 107.509 177.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 370' ' ' LYS . 2.7 p -113.0 149.2 15.52 Favored 'Isoleucine or valine' 0 C--O 1.274 2.374 0 CA-C-O 121.843 0.83 . . . . 74.04 111.394 -177.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 370' ' ' LYS . . . -128.12 158.37 38.19 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 114.595 -1.184 . . . . 70.31 108.446 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.76 164.64 45.94 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 109.145 -0.687 . . . . 74.13 109.145 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' PRO . . . . . 0.498 ' HD3' ' CE1' ' A' ' 410' ' ' HIS . 74.4 Cg_endo -76.86 125.24 7.95 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 121.388 1.392 . . . . 61.24 114.492 -168.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 2.5 m -61.45 -30.3 70.5 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.621 -1.172 . . . . 72.13 111.553 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' GLY . . . . . . . . . . . . . . . -138.27 47.24 0.94 Allowed Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.0 -1.095 . . . . 55.04 112.831 -177.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' SER . . . . . 0.418 ' HB3' ' HB2' ' A' ' 405' ' ' PRO . 23.1 t -166.26 -173.12 2.45 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.034 -1.469 . . . . 72.24 107.034 178.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -132.3 107.84 8.81 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 117.899 0.318 . . . . 73.22 111.24 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' HIS . . . . . 0.498 ' CE1' ' HD3' ' A' ' 405' ' ' PRO . 1.6 p-80 -150.79 144.85 25.35 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.969 -1.493 . . . . 75.32 106.969 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 58.1 m80 . . . . . 0 C--N 1.297 -1.69 0 N-CA-C 108.574 -0.899 . . . . 73.22 108.574 -178.235 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 141' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.812 0 N-CA-C 107.323 -1.362 . . . . 72.34 107.323 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 142' ' ' ARG . . . . . 0.488 ' HD2' ' OE2' ' A' ' 385' ' ' GLU . 15.5 mmt180 -117.0 170.49 8.6 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 123.588 0.555 . . . . 74.44 110.699 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.715 ' OG1' ' HA ' ' A' ' 385' ' ' GLU . 24.0 p -98.51 152.86 19.09 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.522 -1.288 . . . . 73.11 107.522 -172.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -152.27 176.64 11.39 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.717 -1.586 . . . . 70.31 106.717 -173.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 145' ' ' GLN . . . . . . . . . . . . . 18.6 pm0 -85.8 159.07 19.83 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-O 121.421 0.629 . . . . 73.43 112.51 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 66.31 19.14 11.01 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.397 1.879 . . . . 74.3 112.601 -177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 147' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -144.14 163.85 32.4 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.913 -0.585 . . . . 73.21 109.573 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.83 166.73 11.66 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.041 -0.527 . . . . 72.44 109.979 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.564 HG21 HG22 ' B' ' 143' ' ' THR . 86.5 m -144.44 126.04 15.04 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 109.544 -0.539 . . . . 60.13 109.544 168.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 332' ' ' SER . 20.9 tm0? -69.59 136.35 51.15 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.107 -0.952 . . . . 64.22 110.601 175.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.488 HG13 ' HG2' ' A' ' 392' ' ' LYS . 21.8 t . . . . . 0 C--N 1.305 -1.363 0 N-CA-C 107.724 -1.213 . . . . 71.51 107.724 175.601 . . . . . . . . 1 1 . 1 stop_ save_